1	Articles	NNPS	O	Articles	_	0	SENT_1	[p1l1908t169r2058b205],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_2	[p1l9t359r378b430],
2	P450	NN	O	p450	nn	4	SENT_2	[p1l400t364r551b413],
3	2C19	NN	O	2c19	nn	4	SENT_2	[p1l572t363r720b413],
4	polymorphism	NN	O	polymorphism	_	0	SENT_2	[p1l740t359r1188b430],
5	in	IN	O	in	_	0	SENT_2	[p1l1211t361r1263b413],
6	young	JJ	O	young	amod	7	SENT_2	[p1l1280t377r1472b431],
7	patients	NNS	O	patient	prep_in	4	SENT_2	[p1l1493t361r1747b430],
8	9	CD	NUMBER	9	nsubj	10	SENT_2	[p1l1876t366r2026b441],
9	@	IN	O	@	prep	8	SENT_2	[p1l1876t366r2026b441],
10	treated	VBN	O	treat	rcmod	4	SENT_2	[p1l6t450r232b505],
11	with	IN	O	with	_	0	SENT_2	[p1l248t450r388b504],
12	clopidogrel	NN	O	clopidogrel	prep_with	10	SENT_2	[p1l409t450r748b522],
13	after	IN	O	after	_	0	SENT_2	[p1l770t450r916b505],
14	myocardial	JJ	O	myocardial	amod	15	SENT_2	[p1l937t450r1270b521],
15	infarction	NN	O	infarction	prep_after	10	SENT_2	[p1l1293t450r1610b505],
16	:	:	O	:	_	0	SENT_2	[p1l1293t450r1610b505],
17	a	DT	O	a	det	18	SENT_2	[p1l8t559r39b595],
18	cohort	NN	O	cohort	dep	4	SENT_2	[p1l58t541r258b595],
19	study	NN	O	study	nn	20	SENT_2	[p1l277t541r449b612],
20	jean	NN	O	jean	dep	18	SENT_2	[p1l6t660r176b694],
21	.	.	O	.	_	0	SENT_2	[p1l6t660r176b694],

1	—	NN	O	—	_	0	SENT_3	[p1l6t660r176b694],
2	.	.	O	.	_	0	SENT_3	[p1l6t660r176b694],

1	Philippe	NNP	PERSON	Philippe	nn	2	SENT_4	[p1l6t660r176b694],
2	Collet	NNP	PERSON	Collet	_	0	SENT_4	[p1l184t660r259b691],
3	,	,	O	,	_	0	SENT_4	[p1l184t660r259b691],
4	jean	NN	O	jean	appos	2	SENT_4	[p1l264t660r454b692],
5	.	.	O	.	_	0	SENT_4	[p1l264t660r454b692],

1	—	NN	O	—	_	0	SENT_5	[p1l264t660r454b692],
2	.	.	O	.	_	0	SENT_5	[p1l264t660r454b692],

1	Sébastien	NNP	PERSON	Sébastien	nn	2	SENT_6	[p1l264t660r454b692],
2	Hulot	NNP	PERSON	Hulot	_	0	SENT_6	[p1l463t660r539b691],
3	,	,	O	,	_	0	SENT_6	[p1l463t660r539b691],
4	Anna	NNP	PERSON	Anna	nn	5	SENT_6	[p1l547t663r615b686],
5	Pena	NNP	PERSON	Pena	appos	2	SENT_6	[p1l624t663r691b691],
6	,	,	O	,	_	0	SENT_6	[p1l624t663r691b691],
7	Eric	NNP	PERSON	Eric	nn	8	SENT_6	[p1l700t662r744b686],
8	Villard	NNP	PERSON	Villard	appos	2	SENT_6	[p1l750t660r1016b694],
9	,	,	O	,	_	0	SENT_6	[p1l750t660r1016b694],
10	jean	NN	O	jean	appos	2	SENT_6	[p1l750t660r1016b694],
11	.	.	O	.	_	0	SENT_6	[p1l750t660r1016b694],

1	—	NN	O	—	_	0	SENT_7	[p1l750t660r1016b694],
2	.	.	O	.	_	0	SENT_7	[p1l750t660r1016b694],

1	Baptiste	NNP	PERSON	Baptiste	nn	2	SENT_8	[p1l750t660r1016b694],
2	Esteve	NNP	PERSON	Esteve	_	0	SENT_8	[p1l1023t663r1108b691],
3	,	,	O	,	_	0	SENT_8	[p1l1023t663r1108b691],
4	johanne	NN	PERSON	johanne	nn	5	SENT_8	[p1l1113t660r1220b692],
5	Silvain	NNP	PERSON	Silvain	appos	2	SENT_8	[p1l1227t660r1317b691],
6	,	,	O	,	_	0	SENT_8	[p1l1227t660r1317b691],
7	Laurent	NNP	PERSON	Laurent	nn	8	SENT_8	[p1l1326t662r1424b686],
8	Payot	NNP	PERSON	Payot	appos	2	SENT_8	[p1l1431t663r1509b694],
9	,	,	O	,	_	0	SENT_8	[p1l1431t663r1509b694],
10	Delphine	NNP	PERSON	Delphine	nn	11	SENT_8	[p1l1519t660r1629b694],
11	Brugier	NNP	PERSON	Brugier	appos	2	SENT_8	[p1l1636t662r1730b694],
12	,	,	O	,	_	0	SENT_8	[p1l1636t662r1730b694],
13	Guillaume	NNP	PERSON	Guillaume	nn	14	SENT_8	[p1l11t703r140b729],
14	Cayla	NNP	PERSON	Cayla	appos	2	SENT_8	[p1l148t703r222b737],
15	,	,	O	,	_	0	SENT_8	[p1l148t703r222b737],
16	Farzin	NNP	PERSON	Farzin	nn	17	SENT_8	[p1l232t705r307b729],
17	Beygui	NNP	PERSON	Beygui	appos	2	SENT_8	[p1l316t705r405b737],
18	,	,	O	,	_	0	SENT_8	[p1l316t705r405b737],
19	Gilbert	NNP	PERSON	Gilbert	nn	20	SENT_8	[p1l414t703r498b729],
20	Bensimon	NNP	PERSON	Bensimon	appos	2	SENT_8	[p1l505t705r636b733],
21	,	,	O	,	_	0	SENT_8	[p1l505t705r636b733],
22	Christian	NNP	PERSON	Christian	nn	23	SENT_8	[p1l645t703r757b729],
23	Funcl	NNP	PERSON	Funcl	appos	2	SENT_8	[p1l766t703r975b733],
24	<	JJR	O	<	amod	2	SENT_8	[p1l766t703r975b733],
25	.	.	O	.	_	0	SENT_8	[p1l766t703r975b733],

1	—	NN	O	—	_	0	SENT_9	[p1l766t703r975b733],
2	.	.	O	.	_	0	SENT_9	[p1l766t703r975b733],

1	Brentano	NNP	PERSON	Brentano	_	0	SENT_10	[p1l766t703r975b733],
2	,	,	O	,	_	0	SENT_10	[p1l766t703r975b733],
3	Gilles	NNP	PERSON	Gilles	nn	4	SENT_10	[p1l984t703r1049b729],
4	Montalescot	NNP	PERSON	Montalescot	appos	1	SENT_10	[p1l1057t703r1217b729],

1	Summar	NNP	O	Summar	nn	3	SENT_11	[p1l6t790r162b821],
2	Backgrounld	NNP	O	Backgrounld	nn	3	SENT_11	[p1l6t799r185b874],
3	Clopidogrel	NNP	O	Clopidogrel	nsubj	10	SENT_11	[p1l195t837r377b875],
4	and	CC	O	and	_	0	SENT_11	[p1l385t837r444b866],
5	low-dose	JJ	O	low-dose	amod	6	SENT_11	[p1l451t837r589b866],
6	aspirin	NN	O	aspirin	nsubj	10	SENT_11	[p1l597t838r706b875],
7	have	VBP	O	have	aux	10	SENT_11	[p1l714t837r786b866],
8	become	VBN	O	become	cop	10	SENT_11	[p1l794t837r916b866],
9	the	DT	O	the	det	10	SENT_11	[p1l924t837r973b866],
10	mainstay	NN	O	mainstay	_	0	SENT_11	[p1l982t838r1125b875],
11	oral	JJ	O	oral	amod	13	SENT_11	[p1l1133t837r1192b866],
12	antiplatelet	JJ	O	antiplatelet	amod	13	SENT_11	[p1l1200t837r1375b875],
13	regimen	NN	O	regimen	attr	10	SENT_11	[p1l1383t838r1515b875],
14	to	TO	O	to	aux	15	SENT_11	[p1l1523t843r1553b866],
15	prevent	VB	O	prevent	infmod	13	SENT_11	[p1l1561t843r1679b875],
16	recurrent	JJ	O	recurrent	acomp	15	SENT_11	[p1l1687t843r1834b866],
17	Lancet	NNP	O	Lancet	dep	15	SENT_11	[p1l1870t846r1939b864],
18	2oo9	CD	NUMBER	2oo9	num	17	SENT_11	[p1l1945t847r2007b867],
19	:	:	O	:	_	0	SENT_11	[p1l1945t847r2007b867],
20	373	CD	NUMBER	373	num	17	SENT_11	[p1l2014t847r2059b868],
21	;	:	O	;	_	0	SENT_11	[p1l2014t847r2059b868],
22	309-17	CD	NUMBER	309-17	num	17	SENT_11	[p1l2066t847r2145b867],
23	ischaemic	JJ	O	ischaemic	amod	24	SENT_11	[p1l6t883r163b912],
24	events	NNS	O	event	npadvmod	15	SENT_11	[p1l183t888r281b912],
25	after	IN	O	after	_	0	SENT_11	[p1l301t883r373b912],
26	acute	JJ	O	acute	amod	28	SENT_11	[p1l392t888r474b912],
27	coronary	JJ	O	coronary	amod	28	SENT_11	[p1l494t893r631b920],
28	syndromes	NNS	O	syndrome	prep_after	15	SENT_11	[p1l651t883r822b921],
29	or	CC	O	or	_	0	SENT_11	[p1l843t893r875b912],
30	stent	JJ	O	stent	amod	31	SENT_11	[p1l895t888r971b912],
31	placement	NN	O	placement	conj_or	28	SENT_11	[p1l990t883r1161b920],
32	.	.	O	.	_	0	SENT_11	[p1l990t883r1161b920],

1	The	DT	O	the	det	3	SENT_12	[p1l1182t883r1243b912],
2	frequent	JJ	O	frequent	amod	3	SENT_12	[p1l1262t883r1397b920],
3	genetic	JJ	O	genetic	nsubj	6	SENT_12	[p1l1416t884r1528b921],
4	functional	JJ	O	functional	amod	5	SENT_12	[p1l1548t883r1709b912],
5	variant	JJ	O	variant	amod	3	SENT_12	[p1l1727t884r1836b912],
6	Published	VBN	O	publish	dep	26	SENT_12	[p1l1873t893r1972b913],
7	Online	NN	O	online	nsubj	10	SENT_12	[p1l1979t893r2049b913],
8	681	CD	NUMBER	681	num	9	SENT_12	[p1l7t932r59b958],
9	G	NN	O	g	npadvmod	10	SENT_12	[p1l77t931r150b958],
10	>	JJR	O	>	xcomp	6	SENT_12	[p1l77t931r150b958],
11	A	DT	O	a	det	15	SENT_12	[p1l77t931r150b958],
12	(	CD	NUMBER	(	num	15	SENT_12	[p1l168t931r224b967],
13	*	NN	O	*	nn	15	SENT_12	[p1l168t931r224b967],
14	2	CD	NUMBER	2	num	15	SENT_12	[p1l168t931r224b967],
15	)	NN	O	)	dep	10	SENT_12	[p1l168t931r224b967],
16	of	IN	O	of	dep	10	SENT_12	[p1l243t929r279b958],
17	cytochrome	NN	O	cytochrome	nn	19	SENT_12	[p1l290t929r473b967],
18	P450	NN	O	p450	nn	19	SENT_12	[p1l491t930r567b958],
19	2C19	NN	O	2c19	pobj	16	SENT_12	[p1l586t931r662b958],
20	(	CD	NUMBER	(	num	22	SENT_12	[p1l682t931r848b967],
21	CYPZCI9	NN	O	cypzci9	nn	22	SENT_12	[p1l682t931r848b967],
22	)	NN	O	)	nsubj	26	SENT_12	[p1l682t931r848b967],
23	is	VBZ	O	be	cop	26	SENT_12	[p1l867t930r892b958],
24	an	DT	O	a	det	26	SENT_12	[p1l910t939r947b958],
25	important	JJ	O	important	amod	26	SENT_12	[p1l965t930r1122b966],
26	contributor	NN	O	contributor	_	0	SENT_12	[p1l1139t929r1317b958],
27	to	TO	O	to	_	0	SENT_12	[p1l1333t935r1363b958],
28	the	DT	O	the	det	30	SENT_12	[p1l1379t929r1429b958],
29	wide	JJ	O	wide	amod	30	SENT_12	[p1l1445t929r1519b958],
30	variability	NN	O	variability	prep_to	26	SENT_12	[p1l1535t929r1690b967],
31	between	IN	O	between	_	0	SENT_12	[p1l1706t929r1837b958],
32	individuals	NNS	O	individual	prep_between	30	SENT_12	[p1l7t975r179b1004],
33	of	IN	O	of	_	0	SENT_12	[p1l196t975r232b1004],
34	the	DT	O	the	det	36	SENT_12	[p1l242t975r291b1004],
35	antiplatelet	JJ	O	antiplatelet	amod	36	SENT_12	[p1l307t975r482b1012],
36	effect	NN	O	effect	prep_of	32	SENT_12	[p1l497t975r582b1004],
37	of	IN	O	of	_	0	SENT_12	[p1l597t975r633b1004],
38	clopidogrel	NN	O	clopidogrel	prep_of	36	SENT_12	[p1l643t975r825b1013],
39	.	.	O	.	_	0	SENT_12	[p1l643t975r825b1013],

1	We	PRP	O	we	nsubj	2	SENT_13	[p1l842t978r892b1004],
2	assessed	VBD	O	assess	_	0	SENT_13	[p1l908t975r1043b1004],
3	whether	IN	O	whether	complm	9	SENT_13	[p1l1057t975r1187b1004],
4	the	DT	O	the	det	8	SENT_13	[p1l1202t975r1251b1004],
5	CYP2C19	NN	O	cyp2c19	nn	8	SENT_13	[p1l1270t977r1453b1004],
6	*	NN	O	*	nn	8	SENT_13	[p1l1270t977r1453b1004],
7	2	CD	NUMBER	2	num	8	SENT_13	[p1l1270t977r1453b1004],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_13	[p1l1467t975r1699b1013],
9	affected	VBD	O	affect	ccomp	2	SENT_13	[p1l1715t975r1837b1004],
10	long-tenn	JJ	O	long-tenn	amod	11	SENT_13	[p1l6t1021r161b1059],
11	prognosis	NN	O	prognosis	dobj	9	SENT_13	[p1l172t1022r325b1059],
12	of	IN	O	of	_	0	SENT_13	[p1l336t1021r372b1050],
13	patients	NNS	O	patient	prep_of	11	SENT_13	[p1l377t1022r500b1058],
14	who	WP	O	who	nsubjpass	17	SENT_13	[p1l511t1021r577b1050],
15	were	VBD	O	be	auxpass	17	SENT_13	[p1l587t1031r662b1050],
16	chronically	RB	O	chronically	advmod	17	SENT_13	[p1l672t1021r845b1059],
17	treated	VBN	O	treat	rcmod	13	SENT_13	[p1l854t1021r962b1050],
18	with	IN	O	with	_	0	SENT_13	[p1l971t1021r1041b1050],
19	clopidogrel	NN	O	clopidogrel	prep_with	17	SENT_13	[p1l1051t1021r1233b1059],
20	.	.	O	.	_	0	SENT_13	[p1l1051t1021r1233b1059],

1	December	NNP	DATE	December	dep	10	SENT_14	[p1l6t1134r109b1154],
2	23	CD	DATE	23	num	1	SENT_14	[p1l116t1137r145b1157],
3	,	,	DATE	,	_	0	SENT_14	[p1l116t1137r145b1157],
4	2008	CD	DATE	2008	num	1	SENT_14	[p1l153t1134r206b1154],
5	DOl	NN	O	dol	dep	1	SENT_14	[p1l6t1170r219b1193, p1l6t1207r196b1232],
6	:10	CD	NUMBER	:10	num	5	SENT_14	[p1l6t1170r219b1193, p1l6t1207r196b1232],
7	r1016/S01406736	NN	O	r1016/s01406736	dep	10	SENT_14	[p1l6t1170r219b1193, p1l6t1207r196b1232],
8	(	CD	NUMBER	(	num	7	SENT_14	[p1l6t1170r219b1193, p1l6t1207r196b1232],
9	08	CD	NUMBER	08	num	10	SENT_14	[p1l6t1170r219b1193, p1l6t1207r196b1232],
10	)	NN	O	)	_	0	SENT_14	[p1l6t1170r219b1193, p1l6t1207r196b1232],
11	61845-0	CD	NUMBER	61845-0	num	12	SENT_14	[p1l6t1170r219b1193, p1l6t1207r196b1232],
12	lnstitut	NN	O	lnstitut	dep	10	SENT_14	[p1l6t1256r88b1275],
13	de	IN	O	de	_	0	SENT_14	[p1l94t1255r119b1275],
14	Cardiologie	NNP	O	Cardiologie	prep_de	12	SENT_14	[p1l125t1255r254b1281],
15	,	,	O	,	_	0	SENT_14	[p1l125t1255r254b1281],

1	INSERM	NN	ORGANIZATION	inserm	_	0	SENT_15	[p1l1896t1293r1981b1312],
2	856	CD	NUMBER	856	num	1	SENT_15	[p1l1988t1291r2036b1315],
3	,	,	O	,	_	0	SENT_15	[p1l1988t1291r2036b1315],
4	Université	NNP	O	Université	appos	1	SENT_15	[p1l2043t1292r2154b1312],

1	Methods	NNS	O	method	nsubjpass	52	SENT_16	[p1l6t1318r139b1346],
2	Between	IN	O	between	dep	3	SENT_16	[p1l149t1320r283b1346],
3	April	NNP	DATE	April	rcmod	1	SENT_16	[p1l291t1317r370b1355],
4	1	CD	DATE	1	num	3	SENT_16	[p1l380t1320r402b1350],
5	,	,	DATE	,	_	0	SENT_16	[p1l380t1320r402b1350],
6	1996	CD	DATE	1996	num	3	SENT_16	[p1l414t1319r492b1350],
7	,	,	O	,	_	0	SENT_16	[p1l414t1319r492b1350],
8	and	CC	O	and	_	0	SENT_16	[p1l503t1317r561b1346],
9	April	NNP	DATE	April	conj_and	1	SENT_16	[p1l569t1317r648b1355],
10	1	CD	DATE	1	num	9	SENT_16	[p1l658t1320r680b1350],
11	,	,	DATE	,	_	0	SENT_16	[p1l658t1320r680b1350],
12	2008	CD	DATE	2008	num	9	SENT_16	[p1l692t1319r773b1350],
13	,	,	O	,	_	0	SENT_16	[p1l692t1319r773b1350],
14	259	CD	NUMBER	259	num	9	SENT_16	[p1l785t1318r838b1346],
15	young	JJ	O	young	amod	16	SENT_16	[p1l848t1327r946b1355],
16	patients	NNS	O	patient	npadvmod	19	SENT_16	[p1l955t1318r1078b1355],
17	(	JJ	O	(	amod	18	SENT_16	[p1l1090t1317r1173b1355],
18	aged	JJ	O	aged	amod	16	SENT_16	[p1l1090t1317r1173b1355],
19	<	JJR	O	<	amod	9	SENT_16	[p1l1182t1318r1237b1346],
20	45	CD	DURATION	45	num	21	SENT_16	[p1l1182t1318r1237b1346],
21	years	NNS	NUMBER	year	tmod	19	SENT_16	[p1l1248t1320r1338b1355],
22	)	RB	O	)	advmod	9	SENT_16	[p1l1248t1320r1338b1355],
23	who	WP	O	who	nsubjpass	35	SENT_16	[p1l1349t1317r1415b1346],
24	survived	VBD	O	survive	rcmod	9	SENT_16	[p1l1425t1317r1556b1346],
25	a	DT	O	a	det	32	SENT_16	[p1l1565t1327r1581b1346],
26	ﬁrst	JJ	O	ﬁrst	amod	32	SENT_16	[p1l1591t1317r1653b1346],
27	myocardial	JJ	O	myocardial	amod	32	SENT_16	[p1l1662t1317r1835b1355],
28	Paris	NNP	LOCATION	Paris	nn	32	SENT_16	[p1l1872t1329r1922b1348],
29	5	CD	NUMBER	5	num	32	SENT_16	[p1l1929t1328r1949b1352],
30	,	,	O	,	_	0	SENT_16	[p1l1929t1328r1949b1352],
31	Hﬁpital	JJ	PERSON	hﬁpital	amod	32	SENT_16	[p1l1956t1328r2035b1354],
32	infarction	NN	O	infarction	dobj	24	SENT_16	[p1l7t1363r160b1391],
33	and	CC	O	and	_	0	SENT_16	[p1l170t1363r228b1391],
34	were	VBD	O	be	auxpass	35	SENT_16	[p1l237t1373r312b1391],
35	exposed	VBN	O	expose	rcmod	9	SENT_16	[p1l322t1363r447b1400],
36	to	TO	O	to	_	0	SENT_16	[p1l457t1368r486b1391],
37	clopidogrel	NN	O	clopidogrel	nn	38	SENT_16	[p1l496t1363r671b1400],
38	treatment	NN	O	treatment	prep_to	35	SENT_16	[p1l680t1368r834b1391],
39	for	IN	O	for	prep	35	SENT_16	[p1l844t1363r889b1391],
40	at	IN	DURATION	at	pcomp	39	SENT_16	[p1l898t1368r926b1391],
41	least	JJS	DURATION	least	pobj	40	SENT_16	[p1l935t1363r1007b1391],
42	a	DT	DURATION	a	det	43	SENT_16	[p1l1016t1373r1032b1391],
43	month	NN	DURATION	month	tmod	35	SENT_16	[p1l1042t1363r1156b1396],
44	,	,	O	,	_	0	SENT_16	[p1l1042t1363r1156b1396],
45	were	VBD	O	be	auxpass	46	SENT_16	[p1l1166t1373r1241b1391],
46	enrolled	VBN	O	enrol	_	0	SENT_16	[p1l1251t1363r1380b1391],
47	in	IN	O	in	_	0	SENT_16	[p1l1390t1364r1421b1391],
48	a	DT	O	a	det	50	SENT_16	[p1l1431t1373r1447b1391],
49	multicentre	JJ	O	multicentre	amod	50	SENT_16	[p1l1457t1363r1641b1391],
50	registry	NN	O	registry	prep_in	46	SENT_16	[p1l1651t1364r1769b1400],
51	and	CC	O	and	_	0	SENT_16	[p1l1778t1363r1836b1391],
52	underwent	VBD	O	undergo	conj_and	46	SENT_16	[p1l6t1408r177b1437],
53	CYP2C19	NN	O	cyp2c19	nn	56	SENT_16	[p1l192t1410r375b1437],
54	’	CD	NUMBER	’	num	56	SENT_16	[p1l192t1410r375b1437],
55	~	NN	O	~	nn	56	SENT_16	[p1l192t1410r375b1437],
56	‘	NN	O	‘	dobj	52	SENT_16	[p1l192t1410r375b1437],
57	2	CD	NUMBER	2	num	58	SENT_16	[p1l192t1410r375b1437],
58	determination	NN	O	determination	dep	56	SENT_16	[p1l386t1409r618b1437],
59	.	.	O	.	_	0	SENT_16	[p1l386t1409r618b1437],

1	The	DT	O	the	det	3	SENT_17	[p1l631t1409r692b1437],
2	primary	JJ	O	primary	amod	3	SENT_17	[p1l704t1410r830b1446],
3	endpoint	NN	O	endpoint	nsubj	6	SENT_17	[p1l842t1409r983b1446],
4	was	VBD	O	be	cop	6	SENT_17	[p1l994t1419r1052b1437],
5	a	DT	O	a	det	6	SENT_17	[p1l1065t1419r1082b1437],
6	composite	NN	O	composite	_	0	SENT_17	[p1l1094t1410r1255b1446],
7	of	IN	O	of	_	0	SENT_17	[p1l1268t1408r1303b1437],
8	death	NN	O	death	prep_of	6	SENT_17	[p1l1310t1409r1404b1442],
9	,	,	O	,	_	0	SENT_17	[p1l1310t1409r1404b1442],
10	myocardial	JJ	O	myocardial	amod	11	SENT_17	[p1l1418t1408r1591b1446],
11	infarction	NN	O	infarction	conj_and	6	SENT_17	[p1l1603t1408r1765b1442],
12	,	,	O	,	_	0	SENT_17	[p1l1603t1408r1765b1442],
13	and	CC	O	and	_	0	SENT_17	[p1l1778t1409r1837b1437],
14	urgent	JJ	O	urgent	amod	16	SENT_17	[p1l6t1460r111b1492],
15	coronary	JJ	O	coronary	amod	16	SENT_17	[p1l122t1465r259b1492],
16	revascularisation	NN	O	revascularisation	conj_and	6	SENT_17	[p1l270t1454r535b1483],
17	occurring	VBG	O	occur	partmod	16	SENT_17	[p1l546t1456r698b1492],
18	during	IN	O	during	_	0	SENT_17	[p1l709t1454r815b1492],
19	exposure	NN	O	exposure	prep_during	17	SENT_17	[p1l826t1464r966b1492],
20	to	TO	O	to	_	0	SENT_17	[p1l977t1460r1007b1483],
21	clopidogrel	NN	O	clopidogrel	prep_to	17	SENT_17	[p1l1018t1454r1200b1492],
22	.	.	O	.	_	0	SENT_17	[p1l1018t1454r1200b1492],

1	Follow-up	JJ	O	follow-up	nsubj	5	SENT_18	[p1l1214t1454r1368b1492],
2	was	VBD	O	be	cop	5	SENT_18	[p1l1379t1464r1437b1483],
3	every	DT	SET	every	quantmod	4	SENT_18	[p1l1450t1465r1531b1492],
4	6	CD	SET	6	num	5	SENT_18	[p1l1543t1457r1559b1483],
5	months	NNS	NUMBER	month	_	0	SENT_18	[p1l1571t1454r1700b1483],
6	.	.	O	.	_	0	SENT_18	[p1l1571t1454r1700b1483],

1	The	DT	O	the	det	2	SENT_19	[p1l1712t1454r1773b1483],
2	key	NN	O	key	_	0	SENT_19	[p1l1784t1454r1837b1492],

1	Pitié	NNP	O	Pitié	_	0	SENT_20	[p1l9t1567r183b1593],
2	.	.	O	.	_	0	SENT_20	[p1l9t1567r183b1593],

1	—	NN	O	—	_	0	SENT_21	[p1l9t1567r183b1593],
2	.	.	O	.	_	0	SENT_21	[p1l9t1567r183b1593],

1	Sa	FW	O	sa	nn	6	SENT_22	[p1l9t1567r183b1593],
2	|	FW	O	|	nn	6	SENT_22	[p1l9t1567r183b1593],
3	pétriére	FW	O	pétriére	nn	6	SENT_22	[p1l9t1567r183b1593],
4	(	FW	O	(	nn	6	SENT_22	[p1l190t1568r283b1592],
5	AP-HP	NN	O	ap-hp	nn	6	SENT_22	[p1l190t1568r283b1592],
6	)	NN	O	)	nsubj	34	SENT_22	[p1l190t1568r283b1592],
7	,	,	O	,	_	0	SENT_22	[p1l190t1568r283b1592],
8	Paris	NNP	LOCATION	Paris	appos	6	SENT_22	[p1l291t1568r347b1591],
9	,	,	O	,	_	0	SENT_22	[p1l291t1568r347b1591],
10	France	NNP	LOCATION	France	nn	14	SENT_22	[p1l9t1605r78b1623],
11	(	CD	NUMBER	(	num	14	SENT_22	[p1l85t1605r122b1629],
12	J-P	NNP	O	J-P	nn	14	SENT_22	[p1l85t1605r122b1629],
13	Collet	NNP	PERSON	Collet	nn	14	SENT_22	[p1l128t1603r187b1623],
14	MD	NNP	O	MD	appos	6	SENT_22	[p1l194t1605r233b1627],
15	,	,	O	,	_	0	SENT_22	[p1l194t1605r233b1627],
16	A	NNP	O	A	nn	20	SENT_22	[p1l8t1642r23b1660],
17	Pena	NNP	PERSON	Pena	nn	20	SENT_22	[p1l30t1642r79b1660],
18	PhD,J-B	NNP	PERSON	PhD,J-B	nn	20	SENT_22	[p1l86t1640r167b1664],
19	Esteve	NNP	PERSON	Esteve	nn	20	SENT_22	[p1l175t1642r239b1660],
20	MD	NNP	O	MD	appos	6	SENT_22	[p1l246t1642r286b1663],
21	,	,	O	,	_	0	SENT_22	[p1l246t1642r286b1663],
22	J	NNP	O	J	nn	24	SENT_22	[p1l6t1678r12b1701],
23	Silvain	NNP	O	Silvain	nn	24	SENT_22	[p1l20t1676r86b1696],
24	MD	NNP	O	MD	appos	6	SENT_22	[p1l94t1678r134b1700],
25	,	,	O	,	_	0	SENT_22	[p1l94t1678r134b1700],
26	G	NNP	O	G	nn	28	SENT_22	[p1l140t1678r154b1696],
27	Cayla	NNP	ORGANIZATION	Cayla	nn	28	SENT_22	[p1l161t1676r214b1702],
28	MD	NNP	ORGANIZATION	MD	appos	6	SENT_22	[p1l221t1678r261b1700],
29	,	,	O	,	_	0	SENT_22	[p1l221t1678r261b1700],
30	secondary	JJ	O	secondary	amod	31	SENT_22	[p1l6t1703r162b1741],
31	endpoint	NN	O	endpoint	appos	6	SENT_22	[p1l172t1703r313b1740],
32	was	VBD	O	be	cop	34	SENT_22	[p1l322t1713r381b1732],
33	stent	JJ	O	stent	amod	34	SENT_22	[p1l393t1708r469b1732],
34	thrombosis	NN	O	thrombosis	_	0	SENT_22	[p1l478t1703r656b1732],
35	proven	VBN	O	prove	partmod	34	SENT_22	[p1l667t1713r775b1740],
36	by	IN	O	by	_	0	SENT_22	[p1l785t1703r822b1741],
37	angiography	NN	O	angiography	agent	35	SENT_22	[p1l831t1703r1031b1741],
38	.	.	O	.	_	0	SENT_22	[p1l831t1703r1031b1741],

1	D	NN	O	d	nn	3	SENT_23	[p1l1872t1715r1886b1733],
2	Brugier	NN	O	brugier	nn	3	SENT_23	[p1l1894t1715r1967b1739],
3	PhD	NN	O	phd	_	0	SENT_23	[p1l1974t1713r2020b1737],
4	,	,	O	,	_	0	SENT_23	[p1l1974t1713r2020b1737],
5	F	NN	O	f	nn	7	SENT_23	[p1l2028t1715r2037b1733],
6	Beygui	NN	O	beyguus	nn	7	SENT_23	[p1l2045t1715r2112b1739],
7	MD	NN	O	md	appos	3	SENT_23	[p1l6t1761r45b1782],
8	,	,	O	,	_	0	SENT_23	[p1l6t1761r45b1782],

1	Prof	NNP	O	Prof	nn	5	SENT_24	[p1l1818t1791r1861b1811],
2	G	NNP	O	G	nn	5	SENT_24	[p1l1865t1792r1878b1811],
3	Montalescot	NNP	O	Montalescot	nn	5	SENT_24	[p1l1886t1791r2015b1811],
4	MD	NN	O	md	nn	5	SENT_24	[p1l2022t1792r2071b1816],
5	)	NN	O	)	_	0	SENT_24	[p1l2022t1792r2071b1816],
6	;	:	O	;	_	0	SENT_24	[p1l2022t1792r2071b1816],
7	Service	NNP	O	Service	dep	5	SENT_24	[p1l2078t1792r2154b1811],

1	Findings	NNS	O	finding	nsubj	9	SENT_25	[p1l8t1828r136b1864],
2	Median	JJ	MISC	median	amod	5	SENT_25	[p1l148t1828r259b1856],
3	clopidogrel	NN	O	clopidogrel	nn	5	SENT_25	[p1l274t1827r448b1865],
4	exposure	NN	O	exposure	nn	5	SENT_25	[p1l462t1837r603b1864],
5	time	NN	O	time	nsubj	8	SENT_25	[p1l616t1828r688b1856],
6	was	VBD	O	be	cop	8	SENT_25	[p1l701t1837r759b1856],
7	1-07	CD	NUMBER	1-07	num	8	SENT_25	[p1l775t1829r844b1856],
8	years	NNS	NUMBER	year	rcmod	1	SENT_25	[p1l858t1837r938b1865],
9	(	VBP	O	(	_	0	SENT_25	[p1l954t1829r1031b1865],
10	IQR	NN	O	iqr	nn	12	SENT_25	[p1l954t1829r1031b1865],
11	0	CD	NUMBER	0	num	12	SENT_25	[p1l1044t1829r1210b1865],
12	~	NN	O	~	dobj	9	SENT_25	[p1l1044t1829r1210b1865],
13	28	CD	NUMBER	28	number	14	SENT_25	[p1l1044t1829r1210b1865],
14	—	CD	NUMBER	—	dep	12	SENT_25	[p1l1044t1829r1210b1865],
15	3-0	CD	NUMBER	3-0	num	16	SENT_25	[p1l1044t1829r1210b1865],
16	)	NN	O	)	dep	14	SENT_25	[p1l1044t1829r1210b1865],
17	.	.	O	.	_	0	SENT_25	[p1l1044t1829r1210b1865],

1	Baseline	NN	O	baseline	nn	2	SENT_26	[p1l1227t1827r1359b1856],
2	characteristics	NNS	O	characteristic	nsubj	4	SENT_26	[p1l1373t1827r1596b1856],
3	were	VBD	O	be	cop	4	SENT_26	[p1l1610t1837r1685b1856],
4	balanced	JJ	O	balanced	dep	7	SENT_26	[p1l1698t1827r1837b1856],
5	between	IN	O	between	_	0	SENT_26	[p1l6t1873r137b1902],
6	carriers	NNS	O	carrier	prep_between	4	SENT_26	[p1l145t1874r262b1902],
7	(	VBP	O	(	_	0	SENT_26	[p1l273t1873r491b1911],
8	heterozygous	JJ	O	heterozygous	amod	9	SENT_26	[p1l273t1873r491b1911],
9	*	NN	O	*	dobj	7	SENT_26	[p1l500t1875r594b1910],
10	1	CD	NUMBER	1	dep	9	SENT_26	[p1l500t1875r594b1910],
11	/	:	O	/	punct	12	SENT_26	[p1l500t1875r594b1910],
12	*	CD	NUMBER	*	dep	10	SENT_26	[p1l500t1875r594b1910],
13	2	CD	NUMBER	2	dep	12	SENT_26	[p1l500t1875r594b1910],
14	,	,	O	,	_	0	SENT_26	[p1l500t1875r594b1910],
15	n	NN	O	n	appos	13	SENT_26	[p1l604t1876r691b1906],
16	=	JJ	O	=	amod	15	SENT_26	[p1l604t1876r691b1906],
17	64	CD	NUMBER	64	tmod	16	SENT_26	[p1l604t1876r691b1906],
18	;	:	O	;	_	0	SENT_26	[p1l604t1876r691b1906],
19	homozygous	JJ	O	homozygous	amod	23	SENT_26	[p1l700t1873r901b1911],
20	=	JJ	O	=	amod	23	SENT_26	[p1l910t1875r1007b1910],
21	'	''	O	'	_	0	SENT_26	[p1l910t1875r1007b1910],
22	~	NN	O	~	nn	23	SENT_26	[p1l910t1875r1007b1910],
23	‘	NN	O	‘	dep	15	SENT_26	[p1l910t1875r1007b1910],
24	2	CD	NUMBER	2	dep	23	SENT_26	[p1l910t1875r1007b1910],
25	/	:	O	/	punct	12	SENT_26	[p1l910t1875r1007b1910],
26	*	CD	NUMBER	*	number	27	SENT_26	[p1l910t1875r1007b1910],
27	2	CD	NUMBER	2	num	10	SENT_26	[p1l910t1875r1007b1910],
28	,	,	O	,	_	0	SENT_26	[p1l910t1875r1007b1910],
29	n	NN	O	n	dobj	7	SENT_26	[p1l1017t1876r1086b1911],
30	=	JJ	O	=	amod	32	SENT_26	[p1l1017t1876r1086b1911],
31	9	CD	NUMBER	9	tmod	30	SENT_26	[p1l1017t1876r1086b1911],
32	)	NN	O	)	dep	29	SENT_26	[p1l1017t1876r1086b1911],
33	and	CC	O	and	_	0	SENT_26	[p1l1097t1873r1155b1902],
34	non-carriers	JJ	O	non-carriers	amod	36	SENT_26	[p1l1163t1874r1353b1902],
35	(	NN	O	(	nn	36	SENT_26	[p1l1364t1876r1478b1911],
36	n	NN	O	n	dobj	7	SENT_26	[p1l1364t1876r1478b1911],
37	=	JJ	O	=	amod	39	SENT_26	[p1l1364t1876r1478b1911],
38	186	CD	NUMBER	186	tmod	37	SENT_26	[p1l1364t1876r1478b1911],
39	)	NN	O	)	dep	36	SENT_26	[p1l1364t1876r1478b1911],
40	of	IN	O	of	_	0	SENT_26	[p1l1489t1873r1524b1902],
41	C	NN	O	c	nn	43	SENT_26	[p1l1530t1875r1553b1902],
42	YP2C19	NN	O	yp2c19	nn	43	SENT_26	[p1l1555t1875r1713b1902],
43	*	NN	O	*	prep_of	39	SENT_26	[p1l1555t1875r1713b1902],
44	2	CD	NUMBER	2	num	45	SENT_26	[p1l1555t1875r1713b1902],
45	variant	NN	O	variant	nsubj	7	SENT_26	[p1l1719t1874r1835b1902],
46	.	.	O	.	_	0	SENT_26	[p1l1719t1874r1835b1902],

1	de	IN	O	de	_	0	SENT_27	[p1l6t1951r31b1971],
2	Pharmacologie	NNP	O	Pharmacologie	nn	6	SENT_27	[p1l38t1951r206b1977],
3	,	,	O	,	_	0	SENT_27	[p1l38t1951r206b1977],
4	Unité	NNP	O	Unité	appos	6	SENT_27	[p1l213t1951r272b1971],
5	de	IN	O	de	amod	6	SENT_27	[p1l278t1951r303b1971],
6	Pharmacogénétique	NNP	O	Pharmacogénétique	prep_de	16	SENT_27	[p1l7t1987r231b2014],
7	,	,	O	,	_	0	SENT_27	[p1l7t1987r231b2014],
8	INSERM	NNP	ORGANIZATION	INSERM	appos	6	SENT_27	[p1l7t2026r91b2044],
9	621	CD	NUMBER	621	num	8	SENT_27	[p1l99t2024r145b2048],
10	,	,	O	,	_	0	SENT_27	[p1l99t2024r145b2048],
11	H6pita	NN	O	h6pita	appos	8	SENT_27	[p1l153t2024r231b2050],
12	|	CD	NUMBER	|	num	11	SENT_27	[p1l153t2024r231b2050],
13	The	DT	O	the	det	15	SENT_27	[p1l6t2051r67b2080],
14	primary	JJ	O	primary	amod	15	SENT_27	[p1l85t2052r210b2089],
15	endpoint	NN	O	endpoint	dep	11	SENT_27	[p1l228t2051r369b2089],
16	occurred	VBD	O	occur	_	0	SENT_27	[p1l387t2051r524b2080],
17	more	RBR	O	more	advmod	18	SENT_27	[p1l542t2061r625b2080],
18	frequently	RB	O	frequently	advmod	16	SENT_27	[p1l643t2051r804b2089],
19	in	IN	O	in	_	0	SENT_27	[p1l822t2052r853b2080],
20	carriers	NNS	O	carrier	prep_in	18	SENT_27	[p1l872t2052r989b2080],
21	than	IN	O	than	dep	16	SENT_27	[p1l1008t2051r1078b2080],
22	in	IN	O	in	_	0	SENT_27	[p1l1097t2052r1128b2080],
23	non-carriers	JJ	O	non-carriers	amod	24	SENT_27	[p1l1146t2052r1337b2080],
24	(	NN	O	(	prep_in	16	SENT_27	[p1l1358t2052r1400b2089],
25	15	CD	NUMBER	15	num	24	SENT_27	[p1l1358t2052r1400b2089],
26	vs	CC	O	vs	_	0	SENT_27	[p1l1419t2061r1447b2080],
27	11	CD	NUMBER	11	num	28	SENT_27	[p1l1466t2054r1496b2080],
28	events	NNS	O	event	conj_vs	24	SENT_27	[p1l1514t2057r1621b2085],
29	;	:	O	;	_	0	SENT_27	[p1l1514t2057r1621b2085],
30	hazard	NN	O	hazard	nn	32	SENT_27	[p1l1640t2051r1747b2080],
31	ratio	NN	O	ratio	nn	32	SENT_27	[p1l1765t2052r1836b2080],
32	Pitié-Salpétriére	NNP	O	Pitié-Salpétriére	dep	24	SENT_27	[p1l1874t2060r2048b2087],
33	(	CD	NUMBER	(	num	35	SENT_27	[p1l6t2107r98b2131],
34	AP-HP	NN	O	ap-hp	nn	35	SENT_27	[p1l6t2107r98b2131],
35	)	NN	O	)	dep	32	SENT_27	[p1l6t2107r98b2131],
36	,	,	O	,	_	0	SENT_27	[p1l6t2107r98b2131],
37	Paris	NNP	LOCATION	Paris	appos	24	SENT_27	[p1l106t2107r162b2130],
38	,	,	O	,	_	0	SENT_27	[p1l106t2107r162b2130],
39	[	CD	NUMBER	[	num	46	SENT_27	[p1l7t2142r78b2176],
40	HR	NN	DURATION	hr	nn	46	SENT_27	[p1l7t2142r78b2176],
41	]	NN	O	]	nn	46	SENT_27	[p1l7t2142r78b2176],
42	3-69	CD	PERCENT	3-69	num	46	SENT_27	[p1l96t2141r168b2167],
43	[	CD	PERCENT	[	number	44	SENT_27	[p1l185t2140r261b2176],
44	95	CD	PERCENT	95	dep	45	SENT_27	[p1l185t2140r261b2176],
45	%	NN	PERCENT	%	dep	46	SENT_27	[p1l185t2140r261b2176],
46	CI	NN	O	ci	appos	24	SENT_27	[p1l278t2141r314b2167],
47	1-69-8-05	CD	NUMBER	1-69-8-05	num	48	SENT_27	[p1l332t2140r512b2176],
48	]	NN	O	]	nsubj	16	SENT_27	[p1l332t2140r512b2176],
49	,	,	O	,	_	0	SENT_27	[p1l332t2140r512b2176],
50	p	NN	O	p	appos	48	SENT_27	[p1l529t2140r700b2177],
51	=	JJ	O	=	amod	53	SENT_27	[p1l529t2140r700b2177],
52	0-0005	CD	NUMBER	0-0005	tmod	51	SENT_27	[p1l529t2140r700b2177],
53	)	NN	O	)	dep	50	SENT_27	[p1l529t2140r700b2177],
54	,	,	O	,	_	0	SENT_27	[p1l529t2140r700b2177],
55	as	IN	O	as	dep	56	SENT_27	[p1l717t2149r748b2167],
56	did	VBD	O	do	dep	48	SENT_27	[p1l764t2139r814b2167],
57	stent	JJ	O	stent	amod	59	SENT_27	[p1l830t2145r906b2167],
58	thrombosis	NN	O	thrombosis	nn	59	SENT_27	[p1l921t2139r1099b2167],
59	(	NN	O	(	dobj	56	SENT_27	[p1l1118t2139r1206b2177],
60	eight	CD	NUMBER	eight	dep	59	SENT_27	[p1l1118t2139r1206b2177],
61	vs	CC	O	vs	_	0	SENT_27	[p1l1221t2149r1250b2167],
62	four	CD	NUMBER	four	num	63	SENT_27	[p1l1264t2139r1331b2167],
63	events	NNS	O	event	dobj	56	SENT_27	[p1l1346t2145r1453b2172],
64	;	:	O	;	_	0	SENT_27	[p1l1346t2145r1453b2172],
65	HR	NN	DURATION	hr	dep	63	SENT_27	[p1l1471t2142r1526b2167],
66	6-02	CD	NUMBER	6-02	num	65	SENT_27	[p1l1541t2141r1613b2167],
67	[	CD	NUMBER	[	num	69	SENT_27	[p1l1630t2141r1835b2176],
68	1-81-20-04	CD	NUMBER	1-81-20-04	num	69	SENT_27	[p1l1630t2141r1835b2176],
69	]	NN	O	]	nsubj	56	SENT_27	[p1l1630t2141r1835b2176],
70	,	,	O	,	_	0	SENT_27	[p1l1630t2141r1835b2176],
71	p	NN	O	p	appos	69	SENT_27	[p1l6t2187r177b2222],
72	=	JJ	O	=	amod	74	SENT_27	[p1l6t2187r177b2222],
73	0-0009	CD	NUMBER	0-0009	tmod	72	SENT_27	[p1l6t2187r177b2222],
74	)	NN	O	)	dep	71	SENT_27	[p1l6t2187r177b2222],
75	.	.	O	.	_	0	SENT_27	[p1l6t2187r177b2222],

1	The	DT	O	the	det	3	SENT_28	[p1l195t2185r256b2213],
2	detrimental	JJ	O	detrimental	amod	3	SENT_28	[p1l274t2185r456b2213],
3	effect	NN	O	effect	nsubj	11	SENT_28	[p1l474t2185r558b2213],
4	of	IN	O	of	_	0	SENT_28	[p1l576t2185r611b2213],
5	the	DT	O	the	det	7	SENT_28	[p1l623t2185r672b2213],
6	CYP2C19	NN	O	cyp2c19	nn	7	SENT_28	[p1l692t2187r875b2213],
7	*	NN	O	*	prep_of	3	SENT_28	[p1l692t2187r875b2213],
8	2	CD	NUMBER	2	dep	7	SENT_28	[p1l692t2187r875b2213],
9	genetic	JJ	O	genetic	amod	7	SENT_28	[p1l891t2186r1004b2222],
10	variant	JJ	O	variant	amod	7	SENT_28	[p1l1021t2186r1129b2213],
11	persisted	VBD	O	persist	_	0	SENT_28	[p1l1146t2185r1288b2222],
12	from	IN	O	from	_	0	SENT_28	[p1l1305t2185r1383b2213],
13	6	CD	DURATION	6	num	14	SENT_28	[p1l1401t2187r1417b2213],
14	months	NNS	NUMBER	month	prep_from	11	SENT_28	[p1l1435t2185r1556b2213],
15	after	IN	O	after	_	0	SENT_28	[p1l1574t2185r1645b2213],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_28	[p1l1662t2185r1836b2222],
17	initiation	NN	O	initiation	prep_after	11	SENT_28	[p1l6t2232r149b2259],
18	up	IN	O	up	advmod	11	SENT_28	[p1l162t2241r203b2268],
19	to	TO	O	to	_	0	SENT_28	[p1l216t2236r245b2259],
20	the	DT	O	the	det	21	SENT_28	[p1l258t2231r308b2259],
21	end	NN	O	end	prep_to	18	SENT_28	[p1l321t2231r379b2259],
22	of	IN	O	of	_	0	SENT_28	[p1l392t2231r428b2259],
23	follow-up	NN	O	follow-up	nn	25	SENT_28	[p1l435t2231r583b2268],
24	(	CD	NUMBER	(	num	25	SENT_28	[p1l598t2233r664b2268],
25	HR	NN	DURATION	hr	prep_of	21	SENT_28	[p1l598t2233r664b2268],
26	3	CD	NUMBER	3	num	25	SENT_28	[p1l677t2233r692b2259],
27	-	:	O	-	_	0	SENT_28	[p1l700t2233r748b2259],
28	oo	NN	O	oo	dep	21	SENT_28	[p1l700t2233r748b2259],
29	[	CD	NUMBER	[	num	28	SENT_28	[p1l763t2232r949b2268],
30	1-27-7-10	CD	NUMBER	1-27-7-10	num	31	SENT_28	[p1l763t2232r949b2268],
31	]	NN	O	]	dep	28	SENT_28	[p1l763t2232r949b2268],
32	,	,	O	,	_	0	SENT_28	[p1l763t2232r949b2268],
33	p	NN	O	p	appos	21	SENT_28	[p1l964t2233r1116b2268],
34	=	JJ	O	=	amod	36	SENT_28	[p1l964t2233r1116b2268],
35	0-009	CD	NUMBER	0-009	tmod	34	SENT_28	[p1l964t2233r1116b2268],
36	)	NN	O	)	dep	33	SENT_28	[p1l964t2233r1116b2268],
37	.	.	O	.	_	0	SENT_28	[p1l964t2233r1116b2268],

1	After	IN	O	after	_	0	SENT_29	[p1l1130t2230r1210b2259],
2	multivariable	JJ	O	multivariable	amod	3	SENT_29	[p1l1222t2231r1430b2259],
3	analysis	NN	O	analysis	pobj	1	SENT_29	[p1l1443t2231r1575b2268],
4	,	,	O	,	_	0	SENT_29	[p1l1443t2231r1575b2268],
5	the	DT	O	the	det	7	SENT_29	[p1l1590t2230r1639b2259],
6	CYP2C19	NN	O	cyp2c19	nn	7	SENT_29	[p1l1655t2232r1838b2259],
7	*	NN	O	*	appos	3	SENT_29	[p1l1655t2232r1838b2259],
8	2	CD	NUMBER	2	dep	7	SENT_29	[p1l1655t2232r1838b2259],

1	France	NNP	LOCATION	France	nn	3	SENT_30	[p1l7t2345r76b2363],
2	(	CD	NUMBER	(	num	3	SENT_30	[p1l83t2344r102b2368],
3	E	NN	O	e	_	0	SENT_30	[p1l83t2344r102b2368],
4	Villard	NNP	O	Villard	nn	5	SENT_30	[p1l107t2343r172b2363],
5	PhD	NNP	O	PhD	dep	3	SENT_30	[p1l180t2343r225b2367],
6	,	,	O	,	_	0	SENT_30	[p1l180t2343r225b2367],
7	G	NNP	O	G	nn	9	SENT_30	[p1l6t2381r20b2400],
8	Bensimon	NNP	PERSON	Bensimon	nn	9	SENT_30	[p1l28t2381r130b2400],
9	MD	NNP	O	MD	appos	5	SENT_30	[p1l138t2381r210b2404],
10	,	,	O	,	_	0	SENT_30	[p1l138t2381r210b2404],
11	J	NNP	O	J	appos	5	SENT_30	[p1l138t2381r210b2404],
12	.	.	O	.	_	0	SENT_30	[p1l138t2381r210b2404],

1	—	NN	O	—	_	0	SENT_31	[p1l138t2381r210b2404],
2	.	.	O	.	_	0	SENT_31	[p1l138t2381r210b2404],

1	S	NN	O	s	dep	24	SENT_32	[p1l138t2381r210b2404],
2	Hulot	NN	PERSON	hulot	nn	3	SENT_32	[p1l218t2380r275b2400],
3	MD	NN	O	md	dep	1	SENT_32	[p1l282t2382r321b2403],
4	,	,	O	,	_	0	SENT_32	[p1l282t2382r321b2403],
5	ProfC	NNP	O	ProfC	nn	10	SENT_32	[p1l7t2416r66b2436],
6	Funck	NNP	PERSON	Funck	nn	10	SENT_32	[p1l74t2416r237b2436],
7	~	NNP	O	~	nn	10	SENT_32	[p1l74t2416r237b2436],
8	Brentano	NNP	PERSON	Brentano	nn	10	SENT_32	[p1l74t2416r237b2436],
9	MD	NN	O	md	nn	10	SENT_32	[p1l244t2417r294b2441],
10	)	NN	O	)	conj_and	3	SENT_32	[p1l244t2417r294b2441],
11	;	:	O	;	_	0	SENT_32	[p1l244t2417r294b2441],
12	and	CC	O	and	_	0	SENT_32	[p1l301t2416r341b2436],
13	Service	NNP	PERSON	Service	nn	15	SENT_32	[p1l6t2454r82b2473],
14	de	IN	PERSON	de	amod	15	SENT_32	[p1l88t2453r113b2473],
15	Cardiologie	NNP	PERSON	Cardiologie	dep	1	SENT_32	[p1l119t2453r248b2479],
16	,	,	O	,	_	0	SENT_32	[p1l119t2453r248b2479],
17	Hopital	NNP	O	Hopital	nn	19	SENT_32	[p1l256t2453r335b2479],
18	genetic	JJ	O	genetic	amod	19	SENT_32	[p1l6t2482r118b2519],
19	variant	NN	O	variant	nsubj	24	SENT_32	[p1l128t2482r237b2510],
20	was	VBD	O	be	cop	24	SENT_32	[p1l246t2491r304b2510],
21	the	DT	O	the	det	24	SENT_32	[p1l315t2481r364b2510],
22	only	JJ	O	only	amod	24	SENT_32	[p1l375t2481r442b2519],
23	independent	JJ	O	independent	amod	24	SENT_32	[p1l451t2481r650b2519],
24	predictor	NN	O	predictor	dep	28	SENT_32	[p1l660t2481r802b2519],
25	of	IN	O	of	_	0	SENT_32	[p1l812t2481r848b2510],
26	cardiovascular	JJ	O	cardiovascular	amod	27	SENT_32	[p1l853t2481r1077b2510],
27	events	NNS	O	event	prep_of	24	SENT_32	[p1l1087t2487r1185b2510],
28	(	VBP	O	(	_	0	SENT_32	[p1l1198t2484r1264b2519],
29	HR	NN	DURATION	hr	nn	31	SENT_32	[p1l1198t2484r1264b2519],
30	4-04	CD	NUMBER	4-04	num	31	SENT_32	[p1l1273t2484r1346b2510],
31	[	NN	O	[	dobj	28	SENT_32	[p1l1358t2484r1381b2519],
32	1	CD	NUMBER	1	num	34	SENT_32	[p1l1358t2484r1381b2519],
33	-	:	O	-	_	0	SENT_32	[p1l1388t2497r1393b2503],
34	81-9	CD	NUMBER	81-9	nsubj	28	SENT_32	[p1l1401t2483r1470b2510],
35	-	:	O	-	_	0	SENT_32	[p1l1478t2497r1483b2503],
36	02	CD	DATE	02	num	37	SENT_32	[p1l1490t2484r1544b2519],
37	]	NN	O	]	dep	34	SENT_32	[p1l1490t2484r1544b2519],
38	,	,	O	,	_	0	SENT_32	[p1l1490t2484r1544b2519],
39	p	NN	O	p	nn	41	SENT_32	[p1l1555t2484r1614b2519],
40	=	JJ	O	=	amod	41	SENT_32	[p1l1555t2484r1614b2519],
41	o	NN	O	o	appos	37	SENT_32	[p1l1555t2484r1614b2519],
42	-	:	O	-	_	0	SENT_32	[p1l1621t2497r1626b2503],
43	0006	CD	DATE	0006	number	44	SENT_32	[p1l1633t2484r1726b2519],
44	)	CD	NUMBER	)	dep	41	SENT_32	[p1l1633t2484r1726b2519],
45	.	.	O	.	_	0	SENT_32	[p1l1633t2484r1726b2519],

1	Intercommunal	NNP	O	Intercommunal	_	0	SENT_33	[p1l1874t2489r2041b2509],
2	de	NNP	O	de	nn	3	SENT_33	[p1l2048t2489r2073b2509],
3	Montreuil	NNP	O	Montreuil	dep	1	SENT_33	[p1l6t2535r120b2558],
4	,	,	O	,	_	0	SENT_33	[p1l6t2535r120b2558],

1	Montreuil	NNP	PERSON	Montreuil	nn	3	SENT_34	[p1l1824t2565r1938b2589],
2	,	,	O	,	_	0	SENT_34	[p1l1824t2565r1938b2589],
3	France	NNP	LOCATION	France	_	0	SENT_34	[p1l1946t2567r2015b2585],
4	(	CD	NUMBER	(	num	3	SENT_34	[p1l2022t2566r2041b2590],
5	L	NN	O	l	nn	7	SENT_34	[p1l2022t2566r2041b2590],
6	Payot	NN	O	payot	nn	7	SENT_34	[p1l2047t2567r2104b2591],
7	MD	NN	O	md	dep	3	SENT_34	[p1l2111t2566r2154b2590],
8	)	CD	NUMBER	)	dep	3	SENT_34	[p1l2111t2566r2154b2590],

1	lnte	NN	O	lnte	nn	2	SENT_35	[p1l8t2617r65b2642],
2	rpretation	NN	O	rpretation	_	0	SENT_35	[p1l69t2615r221b2650],
3	The	DT	O	the	det	8	SENT_35	[p1l230t2613r291b2642],
4	CYP2C19	NN	O	cyp2c19	nn	8	SENT_35	[p1l301t2615r484b2642],
5	*	NN	O	*	nn	8	SENT_35	[p1l301t2615r484b2642],
6	2	CD	NUMBER	2	num	8	SENT_35	[p1l301t2615r484b2642],
7	genetic	JJ	O	genetic	amod	8	SENT_35	[p1l491t2614r603b2651],
8	variant	NN	O	variant	nsubj	12	SENT_35	[p1l610t2614r719b2642],
9	is	VBZ	O	be	cop	12	SENT_35	[p1l727t2614r751b2642],
10	a	DT	O	a	det	12	SENT_35	[p1l760t2623r776b2642],
11	major	JJ	O	major	amod	12	SENT_35	[p1l784t2614r878b2651],
12	determinant	NN	O	determinant	rcmod	2	SENT_35	[p1l885t2613r1080b2642],
13	of	IN	O	of	_	0	SENT_35	[p1l1087t2613r1123b2642],
14	prognosis	NN	O	prognosis	prep_of	12	SENT_35	[p1l1125t2614r1279b2651],
15	in	IN	O	in	_	0	SENT_35	[p1l1288t2614r1319b2641],
16	young	JJ	O	young	amod	17	SENT_35	[p1l1326t2623r1424b2651],
17	patients	NNS	O	patient	prep_in	14	SENT_35	[p1l1432t2614r1555b2651],
18	who	WP	O	who	nsubj	20	SENT_35	[p1l1563t2613r1630b2642],
19	are	VBP	O	be	aux	20	SENT_35	[p1l1638t2623r1685b2642],
20	receiving	VBG	O	receive	rcmod	12	SENT_35	[p1l1693t2614r1836b2651],
21	Correspondence	NN	O	correspondence	dobj	20	SENT_35	[p1l1873t2614r2039b2640],
22	to	TO	O	to	prep	20	SENT_35	[p1l2044t2618r2071b2634],
23	:	:	O	:	_	0	SENT_35	[p1l2044t2618r2071b2634],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_35	[p1l6t2659r180b2697],
25	treatment	NN	O	treatment	dep	2	SENT_35	[p1l190t2665r344b2688],
26	after	IN	O	after	_	0	SENT_35	[p1l354t2659r425b2688],
27	myocardial	JJ	O	myocardial	amod	28	SENT_35	[p1l435t2659r608b2697],
28	infarction	NN	O	infarction	prep_after	25	SENT_35	[p1l618t2659r780b2688],
29	.	.	O	.	_	0	SENT_35	[p1l618t2659r780b2688],

1	P	NN	O	p	_	0	SENT_36	[p1l1873t2651r1974b2671],
2	'	''	O	'	_	0	SENT_36	[p1l1873t2651r1974b2671],
3	°	CD	NUMBER	°	prep	1	SENT_36	[p1l1873t2651r1974b2671],
4	fG	NN	O	fg	dep	3	SENT_36	[p1l1873t2651r1974b2671],
5	"	''	O	"	punct	4	SENT_36	[p1l1873t2651r1974b2671],
6	'	''	O	'	_	0	SENT_36	[p1l1873t2651r1974b2671],
7	e	SYM	O	e	dep	8	SENT_36	[p1l1873t2651r1974b2671],
8	‘	CD	NUMBER	‘	dep	9	SENT_36	[p1l1873t2651r1974b2671],
9	M	NN	O	m	dep	1	SENT_36	[p1l1981t2651r2114b2692],
10	°	CD	NUMBER	°	num	9	SENT_36	[p1l1981t2651r2114b2692],
11	"	``	O	"	punct	1	SENT_36	[p1l1981t2651r2114b2692],
12	t	NN	O	t	dep	1	SENT_36	[p1l1981t2651r2114b2692],
13	‘	NN	O	‘	amod	12	SENT_36	[p1l1981t2651r2114b2692],
14	f	FW	O	f	dep	13	SENT_36	[p1l1981t2651r2114b2692],
15	"	``	O	"	punct	18	SENT_36	[p1l1981t2651r2114b2692],
16	e	SYM	O	e	dep	18	SENT_36	[p1l1981t2651r2114b2692],
17	“	CD	NUMBER	“	number	18	SENT_36	[p1l1981t2651r2114b2692],
18	°	CD	NUMBER	°	dep	1	SENT_36	[p1l1981t2651r2114b2692],
19	t	NN	O	t	dep	18	SENT_36	[p1l1981t2651r2114b2692],
20	'	''	O	'	_	0	SENT_36	[p1l1981t2651r2114b2692],
21	Bureau	NNP	O	Bureau	dep	18	SENT_36	[p1l1873t2689r1943b2707],
22	236	CD	NUMBER	236	num	21	SENT_36	[p1l1951t2687r1995b2711],
23	,	,	O	,	_	0	SENT_36	[p1l1951t2687r1995b2711],
24	lnstitut	FW	O	lnstitut	dep	18	SENT_36	[p1l2004t2689r2078b2707],
25	de	FW	O	de	nn	26	SENT_36	[p1l2084t2687r2108b2707],
26	Cardiologie	FW	O	cardiologie	dep	18	SENT_36	[p1l1951t2724r2073b2750],
27	,	,	O	,	_	0	SENT_36	[p1l1951t2724r2073b2750],
28	Hépital	JJ	PERSON	hépital	appos	26	SENT_36	[p1l2081t2724r2154b2750],

1	Funding	NNP	O	Funding	nn	2	SENT_37	[p1l6t2752r127b2789],
2	Délégation	NNP	O	Délégation	_	0	SENT_37	[p1l139t2751r307b2789],
3	a	DT	O	a	det	6	SENT_37	[p1l317t2753r333b2780],
4	la	NNP	O	la	nn	6	SENT_37	[p1l343t2751r369b2780],
5	Recherche	NNP	O	Recherche	nn	6	SENT_37	[p1l380t2751r542b2780],
6	Clinique	NNP	O	Clinique	dep	2	SENT_37	[p1l553t2751r694b2789],
7	,	,	O	,	_	0	SENT_37	[p1l553t2751r694b2789],
8	Assistance	NNP	O	Assistance	nn	11	SENT_37	[p1l705t2752r870b2780],
9	Publique-Hépitaux	NNP	O	Publique-Hépitaux	nn	11	SENT_37	[p1l881t2751r1175b2789],
10	de	IN	O	de	amod	11	SENT_37	[p1l1185t2751r1221b2780],
11	Paris	NNP	LOCATION	Paris	appos	6	SENT_37	[p1l1232t2752r1316b2780],
12	.	.	O	.	_	0	SENT_37	[p1l1232t2752r1316b2780],

1	Pitié-Salpétriére	NNP	O	Pitié-Salpétriére	_	0	SENT_38	[p1l1872t2761r2040b2787],
2	,	,	O	,	_	0	SENT_38	[p1l1872t2761r2040b2787],
3	47	CD	NUMBER	47	num	4	SENT_38	[p1l2047t2763r2073b2784],
4	Boulevard	NNP	O	Boulevard	appos	1	SENT_38	[p1l6t2789r251b2837],

1	Introduction	NN	O	introduction	_	0	SENT_39	[p1l13t2956r570b3035],

1	Acute	JJ	O	acute	nsubj	11	SENT_40	[p1l6t3082r224b3145],
2	and	CC	O	and	_	0	SENT_40	[p1l249t3076r389b3145],
3	chronic	JJ	O	chronic	amod	5	SENT_40	[p1l412t3077r698b3145],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_40	[p1l722t3077r1147b3166],
5	treatment	NN	O	treatment	conj_and	1	SENT_40	[p1l1169t3090r1546b3145],
6	in	IN	O	in	_	0	SENT_40	[p1l1567t3081r1643b3143],
7	combination	NN	O	combination	prep_in	5	SENT_40	[p1l1667t3077r2151b3145],
8	with	IN	O	with	_	0	SENT_40	[p1l6t3186r174b3255],
9	aspirin	NN	O	aspirin	prep_with	7	SENT_40	[p1l227t3191r492b3275],
10	can	MD	O	can	aux	11	SENT_40	[p1l545t3211r675b3255],
11	prevent	VB	O	prevent	ccomp	35	SENT_40	[p1l727t3200r1015b3275],
12	recurrent	JJ	O	recurrent	amod	14	SENT_40	[p1l1065t3200r1424b3255],
13	ischaemic	JJ	O	ischaemic	amod	14	SENT_40	[p1l1475t3186r1858b3255],
14	events	NNS	O	event	dobj	11	SENT_40	[p1l1911t3200r2148b3255],
15	after	IN	O	after	_	0	SENT_40	[p1l9t3327r180b3395],
16	an	DT	O	a	det	19	SENT_40	[p1l227t3351r318b3395],
17	acute	JJ	O	acute	amod	19	SENT_40	[p1l367t3340r565b3395],
18	coronary	JJ	O	coronary	amod	19	SENT_40	[p1l614t3351r949b3416],
19	syndrome	NN	O	syndrome	prep_after	11	SENT_40	[p1l997t3327r1375b3416],
20	or	CC	O	or	_	0	SENT_40	[p1l1425t3351r1502b3395],
21	a	DT	O	a	det	24	SENT_40	[p1l1549t3351r1586b3395],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_40	[p1l1634t3340r2148b3416],
23	coronary	JJ	O	coronary	amod	24	SENT_40	[p1l8t3460r343b3525],
24	intervention	NN	O	intervention	prep_after	11	SENT_40	[p1l369t3440r882b3504],
25	}	CD	NUMBER	}	dep	24	SENT_40	[p1l369t3440r882b3504],
26	However	RB	O	however	advmod	11	SENT_40	[p1l912t3442r1262b3514],
27	,	,	O	,	_	0	SENT_40	[p1l912t3442r1262b3514],
28	many	JJ	O	many	amod	29	SENT_40	[p1l1293t3460r1507b3525],
29	patients	NNS	O	patient	nsubj	35	SENT_40	[p1l1533t3440r1834b3524],
30	on	IN	O	on	_	0	SENT_40	[p1l1865t3460r1960b3504],
31	dual	JJ	O	dual	amod	33	SENT_40	[p1l1988t3436r2151b3504],
32	antiplatelet	JJ	O	antiplatelet	amod	33	SENT_40	[p1l8t3544r435b3633],
33	therapy	NN	O	therapy	prep_on	29	SENT_40	[p1l519t3544r807b3634],
34	still	RB	O	still	advmod	35	SENT_40	[p1l894t3544r1029b3612],
35	have	VBP	O	have	_	0	SENT_40	[p1l1114t3544r1288b3612],
36	thrombotic	JJ	O	thrombotic	amod	37	SENT_40	[p1l1374t3544r1801b3612],
37	events	NNS	O	event	dobj	35	SENT_40	[p1l1887t3558r2147b3612],
38	.	.	O	.	_	0	SENT_40	[p1l1887t3558r2147b3612],

1	Attention	NN	O	attention	nsubj	4	SENT_41	[p2l6t21r364b85],
2	has	VBZ	O	have	aux	4	SENT_41	[p2l405t17r532b85],
3	recently	RB	DATE	recently	advmod	4	SENT_41	[p2l577t17r881b106],
4	focused	VBN	O	focus	_	0	SENT_41	[p2l921t17r1216b85],
5	on	IN	O	on	_	0	SENT_41	[p2l1258t41r1353b85],
6	the	DT	O	the	det	8	SENT_41	[p2l1394t17r1512b85],
7	wide	JJ	O	wide	amod	8	SENT_41	[p2l1553t17r1732b85],
8	variability	NN	O	variability	prep_on	4	SENT_41	[p2l1774t17r2153b106],
9	between	IN	O	between	_	0	SENT_41	[p2l6t125r324b194],
10	individuals	NNS	O	individual	prep_between	8	SENT_41	[p2l371t125r792b194],
11	of	IN	O	of	_	0	SENT_41	[p2l842t125r927b194],
12	response	NN	O	response	prep_of	10	SENT_41	[p2l960t150r1301b214],
13	to	TO	O	to	_	0	SENT_41	[p2l1348t139r1418b194],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_41	[p2l1467t125r1938b215],
15	}	NN	O	}	prep_to	4	SENT_41	[p2l1467t125r1938b215],
16	with	IN	O	with	_	0	SENT_41	[p2l1982t126r2151b194],
17	poor	JJ	O	poor	amod	18	SENT_41	[p2l7t260r182b324],
18	inhibition	NN	O	inhibition	prep_with	4	SENT_41	[p2l225t235r606b304],
19	of	IN	O	of	_	0	SENT_41	[p2l651t235r736b304],
20	the	DT	O	the	det	23	SENT_41	[p2l766t235r884b304],
21	platelet	NN	O	platelet	nn	23	SENT_41	[p2l929t235r1208b324],
22	P2Y12	NN	O	p2y12	nn	23	SENT_41	[p2l1255t242r1446b320],
23	receptor	NN	O	receptor	prep_of	18	SENT_41	[p2l1469t249r1785b324],
24	in	IN	O	in	_	0	SENT_41	[p2l1827t240r1903b302],
25	some	DT	O	some	det	26	SENT_41	[p2l1949t259r2150b304],
26	patients	NNS	O	patient	prep_in	23	SENT_41	[p2l7t349r356b434],
27	?	.	O	?	_	0	SENT_41	[p2l7t349r356b434],

1	Persistent	JJ	O	persistent	amod	4	SENT_42	[p2l452t349r829b413],
2	high	JJ	O	high	amod	4	SENT_42	[p2l917t345r1092b435],
3	platelet	NN	O	platelet	nn	4	SENT_42	[p2l1182t345r1460b434],
4	reactivity	NN	O	reactivity	nsubjpass	11	SENT_42	[p2l1550t349r1896b434],
5	with	IN	O	with	_	0	SENT_42	[p2l1982t345r2151b413],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_42	[p2l8t453r433b543],
7	treatment	NN	O	treatment	prep_with	4	SENT_42	[p2l487t467r864b522],
8	has	VBZ	O	have	aux	11	SENT_42	[p2l916t453r1044b522],
9	also	RB	O	also	advmod	11	SENT_42	[p2l1102t453r1248b522],
10	been	VBN	O	be	auxpass	11	SENT_42	[p2l1302t453r1486b522],
11	associated	VBN	O	associate	_	0	SENT_42	[p2l1542t453r1930b522],
12	with	IN	O	with	_	0	SENT_42	[p2l1982t453r2151b522],
13	more	JJR	O	more	dep	14	SENT_42	[p2l7t587r207b630],
14	frequent	JJ	O	frequent	amod	16	SENT_42	[p2l242t562r569b651],
15	adverse	JJ	O	adverse	amod	16	SENT_42	[p2l603t562r887b630],
16	events	NNS	O	event	prep_with	11	SENT_42	[p2l923t566r1241b640],
17	,	,	O	,	_	0	SENT_42	[p2l923t566r1241b640],
18	“	NN	O	“	appos	16	SENT_42	[p2l923t566r1241b640],
19	whereas	IN	O	whereas	mark	30	SENT_42	[p2l1273t562r1585b630],
20	a	DT	O	a	det	22	SENT_42	[p2l1623t587r1661b630],
21	higher	JJR	O	higher	amod	22	SENT_42	[p2l1693t562r1946b652],
22	dose	NN	O	dose	nsubj	30	SENT_42	[p2l1980t562r2150b630],
23	of	IN	O	of	_	0	SENT_42	[p2l8t672r93b739],
24	clopidogrel	NN	O	clopidogrel	prep_of	22	SENT_42	[p2l112t672r536b762],
25	or	CC	O	or	_	0	SENT_42	[p2l568t696r645b739],
26	more	JJR	O	more	amod	28	SENT_42	[p2l674t696r874b739],
27	potent	JJ	O	potent	amod	28	SENT_42	[p2l905t685r1149b761],
28	drugs	NNS	O	drug	prep_of	22	SENT_42	[p2l1179t672r1393b762],
29	can	MD	O	can	aux	30	SENT_42	[p2l1426t696r1556b739],
30	help	VB	O	help	advcl	11	SENT_42	[p2l1586t672r1750b761],
31	overcome	VB	O	overcome	dep	30	SENT_42	[p2l1783t696r2150b740],
32	such	JJ	O	such	amod	34	SENT_42	[p2l10t781r187b850],
33	poor	JJ	O	poor	amod	34	SENT_42	[p2l213t806r388b870],
34	response	NN	O	response	dobj	31	SENT_42	[p2l413t806r754b870],
35	and	CC	O	and	_	0	SENT_42	[p2l783t781r923b850],
36	improve	VB	O	improve	dep	30	SENT_42	[p2l949t786r1264b870],
37	clinical	JJ	O	clinical	amod	38	SENT_42	[p2l1294t781r1565b850],
38	outcome	NN	O	outcome	dobj	36	SENT_42	[p2l1593t786r2034b850],
39	.	.	O	.	_	0	SENT_42	[p2l1593t786r2034b850],

1	°	NN	O	°	nn	2	SENT_43	[p2l1593t786r2034b850],
2	‘	NN	O	‘	_	0	SENT_43	[p2l1593t786r2034b850],
3	1	CD	NUMBER	1	num	4	SENT_43	[p2l1593t786r2034b850],
4	°	NN	O	°	dep	2	SENT_43	[p2l1593t786r2034b850],

1	High	JJ	O	high	amod	3	SENT_44	[p2l83t890r275b980],
2	platelet	NN	O	platelet	nn	3	SENT_44	[p2l305t890r587b979],
3	reactivity	NN	O	reactivity	nsubj	8	SENT_44	[p2l616t895r965b980],
4	with	IN	O	with	_	0	SENT_44	[p2l992t890r1162b958],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_44	[p2l1194t890r1622b980],
6	could	MD	O	could	aux	8	SENT_44	[p2l1654t890r1863b958],
7	be	VB	O	be	cop	8	SENT_44	[p2l1891t890r1979b958],
8	due	JJ	O	due	_	0	SENT_44	[p2l2012t890r2150b958],
9	to	TO	O	to	_	0	SENT_44	[p2l6t1013r77b1067],
10	various	JJ	O	various	amod	11	SENT_44	[p2l102t1004r381b1068],
11	reasons	NNS	O	reason	prep_to	8	SENT_44	[p2l410t1024r702b1068],
12	including	VBG	O	include	_	0	SENT_44	[p2l730t1000r1100b1090],
13	polymorphism	NN	O	polymorphism	prep_including	11	SENT_44	[p2l1126t1000r1696b1089],
14	in	IN	O	in	_	0	SENT_44	[p2l1722t1004r1798b1066],
15	the	DT	O	the	det	16	SENT_44	[p2l1823t1000r1942b1067],
16	gene	NN	O	gene	prep_in	13	SENT_44	[p2l1970t1024r2150b1090],
17	encoding	VBG	O	encode	partmod	16	SENT_44	[p2l8t1108r362b1198],
18	the	DT	O	the	det	25	SENT_44	[p2l379t1108r498b1177],
19	cytochrome	NN	O	cytochrome	nn	25	SENT_44	[p2l518t1108r965b1198],
20	P450	NN	O	p450	nn	25	SENT_44	[p2l988t1113r1168b1177],
21	2C19	NN	O	2c19	nn	25	SENT_44	[p2l1190t1114r1372b1177],
22	enzyme	NN	O	enzyme	nn	25	SENT_44	[p2l1393t1132r1691b1198],
23	(	NN	O	(	nn	25	SENT_44	[p2l1716t1114r1801b1198],
24	C	NN	O	c	nn	25	SENT_44	[p2l1716t1114r1801b1198],
25	YP2C1	NN	O	yp2c1	dobj	17	SENT_44	[p2l1808t1114r2053b1177],
26	9	CD	NUMBER	9	num	27	SENT_44	[p2l2065t1115r2147b1198],
27	)	NN	O	)	dep	25	SENT_44	[p2l2065t1115r2147b1198],
28	,	,	O	,	_	0	SENT_44	[p2l2065t1115r2147b1198],
29	which	WDT	O	which	nsubj	30	SENT_44	[p2l6t1217r240b1285],
30	contributes	VBZ	O	contribute	rcmod	25	SENT_44	[p2l270t1217r703b1285],
31	to	TO	O	to	_	0	SENT_44	[p2l735t1231r805b1285],
32	the	DT	O	the	det	33	SENT_44	[p2l835t1217r954b1285],
33	variability	NN	O	variability	prep_to	30	SENT_44	[p2l983t1217r1366b1307],
34	of	IN	O	of	_	0	SENT_44	[p2l1395t1217r1480b1285],
35	platelet	NN	O	platelet	nn	36	SENT_44	[p2l1497t1217r1778b1306],
36	response	NN	O	response	prep_of	33	SENT_44	[p2l1806t1241r2150b1306],
37	to	TO	O	to	_	0	SENT_44	[p2l6t1340r77b1394],
38	clopidogrel	NN	O	clopidogrel	prep_to	30	SENT_44	[p2l115t1327r563b1417],
39	.	.	O	.	_	0	SENT_44	[p2l115t1327r563b1417],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	4	SENT_45	[p2l606t1327r1054b1417],
2	is	VBZ	O	be	cop	4	SENT_45	[p2l1090t1331r1149b1395],
3	a	DT	O	a	det	4	SENT_45	[p2l1189t1351r1226b1394],
4	prodrug	NN	O	prodrug	_	0	SENT_45	[p2l1261t1327r1573b1417],
5	that	WDT	O	that	nsubj	6	SENT_45	[p2l1608t1327r1757b1394],
6	has	VBZ	O	have	rcmod	4	SENT_45	[p2l1791t1327r1918b1395],
7	to	TO	O	to	aux	9	SENT_45	[p2l1956t1340r2027b1394],
8	be	VB	O	be	auxpass	9	SENT_45	[p2l2063t1327r2150b1395],
9	converted	VBN	O	convert	xcomp	6	SENT_45	[p2l8t1435r383b1504],
10	into	IN	O	into	_	0	SENT_45	[p2l414t1440r563b1504],
11	an	DT	O	a	det	13	SENT_45	[p2l598t1460r689b1504],
12	active	JJ	O	active	amod	13	SENT_45	[p2l722t1440r936b1504],
13	metabolite	NN	O	metabolite	prep_into	9	SENT_45	[p2l970t1435r1376b1504],
14	that	WDT	O	that	nsubj	18	SENT_45	[p2l1408t1435r1557b1504],
15	selectively	RB	O	selectively	advmod	18	SENT_45	[p2l1591t1435r1980b1525],
16	and	CC	O	and	_	0	SENT_45	[p2l2011t1435r2152b1504],
17	irreversibly	RB	O	irreversibly	advmod	18	SENT_45	[p2l7t1544r444b1633],
18	binds	VBZ	O	bind	rcmod	13	SENT_45	[p2l509t1544r720b1612],
19	to	TO	O	to	_	0	SENT_45	[p2l790t1557r861b1612],
20	the	DT	O	the	det	24	SENT_45	[p2l929t1544r1048b1612],
21	PZYH	NN	O	pzyh	nn	24	SENT_45	[p2l1121t1550r1313b1629],
22	platelet	NN	O	platelet	nn	24	SENT_45	[p2l1380t1544r1662b1633],
23	membrane	NN	O	membrane	nn	24	SENT_45	[p2l1728t1544r2150b1612],
24	receptor	NN	O	receptor	prep_to	18	SENT_45	[p2l7t1660r442b1744],
25	.	.	O	.	_	0	SENT_45	[p2l7t1660r442b1744],

1	“‘	NN	O	“‘	nsubj	7	SENT_46	[p2l7t1660r442b1744],
2	”	CD	NUMBER	”	num	3	SENT_46	[p2l7t1660r442b1744],
3	CYPZC19	NN	O	cypzc19	dep	1	SENT_46	[p2l474t1660r830b1723],
4	is	VBZ	O	be	cop	7	SENT_46	[p2l861t1659r920b1723],
5	a	DT	O	a	det	7	SENT_46	[p2l953t1679r990b1723],
6	key	JJ	O	key	amod	7	SENT_46	[p2l1018t1655r1147b1744],
7	enzyme	NN	O	enzyme	_	0	SENT_46	[p2l1176t1678r1474b1744],
8	in	IN	O	in	_	0	SENT_46	[p2l1504t1659r1580b1722],
9	this	DT	O	this	det	11	SENT_46	[p2l1608t1655r1748b1723],
10	activation	NN	O	activation	nn	11	SENT_46	[p2l1781t1659r2151b1723],
11	www	NN	O	www	prep_in	7	SENT_46	[p2l6t1925r542b1976],
12	.	.	O	.	_	0	SENT_46	[p2l6t1925r542b1976],

1	the	DT	O	the	det	2	SENT_47	[p2l6t1925r542b1976],
2	|	NN	O	|	_	0	SENT_47	[p2l6t1925r542b1976],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_47	[p2l6t1925r542b1976],
4	Vol	NNP	O	Vol	dep	2	SENT_47	[p2l585t1925r673b1976],
5	373	CD	NUMBER	373	num	6	SENT_47	[p2l692t1931r792b1983],
6	January	NNP	DATE	January	dep	2	SENT_47	[p2l834t1929r1052b1990],
7	24,2009	CD	DATE	24,2009	num	6	SENT_47	[p2l1069t1931r1320b1985],

1	de	IN	O	de	dep	54	SENT_48	[p2l1575t2116r1616b2149],
2	|	CD	NUMBER	|	num	3	SENT_48	[p2l1629t2116r1783b2159],
3	’	CD	NUMBER	’	pobj	1	SENT_48	[p2l1629t2116r1783b2159],
4	H6pita	NN	O	h6pita	nn	5	SENT_48	[p2l1629t2116r1783b2159],
5	|	NN	O	|	nsubjpass	54	SENT_48	[p2l1629t2116r1783b2159],
6	,	,	O	,	_	0	SENT_48	[p2l1629t2116r1783b2159],
7	75013	CD	NUMBER	75013	ccomp	54	SENT_48	[p2l1794t2120r1911b2155],
8	,	,	O	,	_	0	SENT_48	[p2l1794t2120r1911b2155],
9	Paris	NNP	LOCATION	Paris	appos	7	SENT_48	[p2l1925t2119r2012b2155],
10	,	,	O	,	_	0	SENT_48	[p2l1925t2119r2012b2155],
11	France	NNP	LOCATION	France	dep	45	SENT_48	[p2l2027t2119r2136b2149],
12	process	NN	O	process	dep	45	SENT_48	[p2l8t2197r301b2257],
13	,	,	O	,	_	0	SENT_48	[p2l8t2197r301b2257],
14	“	CD	NUMBER	“	dep	12	SENT_48	[p2l8t2197r301b2257],
15	"	``	O	"	punct	16	SENT_48	[p2l8t2197r301b2257],
16	16	CD	NUMBER	16	dep	14	SENT_48	[p2l8t2197r301b2257],
17	and	CC	O	and	prep	16	SENT_48	[p2l340t2194r439b2242],
18	the	DT	O	the	det	19	SENT_48	[p2l476t2194r560b2242],
19	presence	NN	O	presence	dep	17	SENT_48	[p2l599t2211r838b2257],
20	of	IN	O	of	_	0	SENT_48	[p2l878t2194r938b2242],
21	the	DT	O	the	prep_of	19	SENT_48	[p2l967t2194r1050b2242],
22	loss-of-function	NN	O	loss-of-function	prep	19	SENT_48	[p2l1089t2194r1513b2242],
23	9	CD	NUMBER	9	dep	22	SENT_48	[p2l1575t2178r2152b2222],
24	"	``	O	"	punct	19	SENT_48	[p2l1575t2178r2152b2222],
25	'	''	O	'	_	0	SENT_48	[p2l1575t2178r2152b2222],
26	°	CD	NUMBER	°	num	27	SENT_48	[p2l1575t2178r2152b2222],
27	s	NNS	O	s	dep	16	SENT_48	[p2l1575t2178r2152b2222],
28	"	``	O	"	punct	45	SENT_48	[p2l1575t2178r2152b2222],
29	"	``	O	"	punct	30	SENT_48	[p2l1575t2178r2152b2222],
30	°	CD	NUMBER	°	nsubj	45	SENT_48	[p2l1575t2178r2152b2222],
31	"	``	O	"	punct	30	SENT_48	[p2l1575t2178r2152b2222],
32	ta'°S°°t@'°5	NN	O	ta'°s°°t@'°5	nn	34	SENT_48	[p2l1575t2178r2152b2222],
33	"	''	O	"	punct	34	SENT_48	[p2l1575t2178r2152b2222],
34	aPhP	NN	O	aphp	dep	30	SENT_48	[p2l1575t2178r2152b2222],
35	'	''	O	'	_	0	SENT_48	[p2l1575t2178r2152b2222],
36	f	FW	O	f	dep	30	SENT_48	[p2l1575t2178r2152b2222],
37	'	''	O	'	_	0	SENT_48	[p2l1575t2178r2152b2222],
38	CYP2C19	NN	O	cyp2c19	prep	36	SENT_48	[p2l13t2275r263b2319],
39	681G	NN	O	681g	dep	38	SENT_48	[p2l300t2275r515b2319],
40	>	JJR	O	>	dep	36	SENT_48	[p2l300t2275r515b2319],
41	A	DT	O	a	det	43	SENT_48	[p2l300t2275r515b2319],
42	polymorphism	NN	O	polymorphism	nn	43	SENT_48	[p2l553t2271r953b2334],
43	(	NN	O	(	dep	40	SENT_48	[p2l996t2271r1116b2334],
44	also	RB	O	also	advmod	45	SENT_48	[p2l996t2271r1116b2334],
45	called	VBD	O	call	dep	9	SENT_48	[p2l1156t2271r1311b2319],
46	‘	CD	NUMBER	‘	dobj	45	SENT_48	[p2l1349t2274r1427b2334],
47	/	:	O	/	punct	45	SENT_48	[p2l1349t2274r1427b2334],
48	'	''	O	'	_	0	SENT_48	[p2l1349t2274r1427b2334],
49	\	SYM	O	\	dep	51	SENT_48	[p2l1349t2274r1427b2334],
50	‘	CD	NUMBER	‘	number	51	SENT_48	[p2l1349t2274r1427b2334],
51	2	CD	NUMBER	2	num	52	SENT_48	[p2l1349t2274r1427b2334],
52	)	NN	O	)	nsubjpass	54	SENT_48	[p2l1349t2274r1427b2334],
53	is	VBZ	O	be	auxpass	54	SENT_48	[p2l1470t2274r1511b2319],
54	associated	VBN	O	associate	dep	83	SENT_48	[p2l9t2347r284b2395],
55	with	IN	O	with	_	0	SENT_48	[p2l308t2347r427b2395],
56	reduced	VBN	O	reduce	amod	58	SENT_48	[p2l453t2347r669b2395],
57	clopidogrel	NN	O	clopidogrel	nn	58	SENT_48	[p2l695t2347r996b2410],
58	responsiveness	NN	O	responsiveness	prep_with	54	SENT_48	[p2l1022t2350r1432b2409],
59	in	IN	O	in	_	0	SENT_48	[p2l1460t2350r1513b2394],
60	healthy	JJ	O	healthy	amod	61	SENT_48	[p2l7t2424r206b2487],
61	people	NNS	O	people	prep_in	58	SENT_48	[p2l241t2424r418b2487],
62	and	CC	O	and	_	0	SENT_48	[p2l456t2424r555b2472],
63	in	IN	O	in	_	0	SENT_48	[p2l591t2427r644b2471],
64	patients	NNS	O	patient	conj_and	61	SENT_48	[p2l680t2427r893b2487],
65	with	IN	O	with	_	0	SENT_48	[p2l930t2424r1049b2472],
66	coronary	JJ	O	coronary	amod	68	SENT_48	[p2l1087t2441r1323b2487],
67	artery	NN	O	artery	nn	68	SENT_48	[p2l1359t2433r1515b2487],
68	disease	NN	O	disease	prep_with	64	SENT_48	[p2l9t2500r293b2548],
69	.17	CD	NUMBER	.17	number	70	SENT_48	[p2l9t2500r293b2548],
70	‘“	CD	NUMBER	‘“	dep	58	SENT_48	[p2l9t2500r293b2548],
71	However	RB	O	however	advmod	70	SENT_48	[p2l329t2505r577b2556],
72	,	,	O	,	_	0	SENT_48	[p2l329t2505r577b2556],
73	the	DT	O	the	det	75	SENT_48	[p2l612t2500r696b2549],
74	direct	JJ	O	direct	amod	75	SENT_48	[p2l731t2500r885b2549],
75	relation	NN	O	relation	nsubjpass	83	SENT_48	[p2l917t2500r1125b2549],
76	with	IN	O	with	_	0	SENT_48	[p2l1158t2500r1277b2549],
77	adverse	JJ	O	adverse	amod	79	SENT_48	[p2l1312t2500r1512b2549],
78	clinical	JJ	O	clinical	amod	79	SENT_48	[p2l9t2577r201b2625],
79	outcome	NN	O	outcome	prep_with	75	SENT_48	[p2l221t2587r454b2625],
80	has	VBZ	O	have	aux	83	SENT_48	[p2l473t2577r563b2625],
81	not	RB	O	not	neg	83	SENT_48	[p2l585t2587r673b2625],
82	been	VBN	O	be	auxpass	83	SENT_48	[p2l690t2577r820b2625],
83	shown	VBN	O	show	_	0	SENT_48	[p2l842t2577r1064b2625],
84	.	.	O	.	_	0	SENT_48	[p2l842t2577r1064b2625],

1	“	NN	O	“	_	0	SENT_49	[p2l842t2577r1064b2625],

1	Myocardial	JJ	O	myocardial	amod	2	SENT_50	[p2l60t2654r358b2716],
2	infarction	NN	O	infarction	nsubj	15	SENT_50	[p2l413t2654r679b2701],
3	in	IN	O	in	_	0	SENT_50	[p2l735t2657r789b2701],
4	patients	NNS	O	patient	dep	5	SENT_50	[p2l844t2657r1058b2716],
5	younger	JJR	O	younger	prep_in	2	SENT_50	[p2l1114t2671r1337b2717],
6	than	IN	O	than	_	0	SENT_50	[p2l1391t2654r1513b2701],
7	45	CD	DURATION	45	num	8	SENT_50	[p2l7t2732r64b2777],
8	years	NNS	NUMBER	year	prep_than	5	SENT_50	[p2l84t2746r221b2792],
9	is	VBZ	O	be	cop	15	SENT_50	[p2l241t2732r283b2777],
10	a	DT	O	a	det	15	SENT_50	[p2l303t2746r330b2777],
11	rare	JJ	O	rare	amod	15	SENT_50	[p2l348t2746r453b2777],
12	but	CC	O	but	_	0	SENT_50	[p2l471t2729r561b2777],
13	serious	JJ	O	serious	amod	15	SENT_50	[p2l580t2732r771b2777],
14	thrombotic	JJ	O	thrombotic	amod	15	SENT_50	[p2l791t2729r1093b2777],
15	event	NN	O	event	_	0	SENT_50	[p2l1112t2739r1268b2784],
16	,	,	O	,	_	0	SENT_50	[p2l1112t2739r1268b2784],
17	which	WDT	O	which	nsubjpass	20	SENT_50	[p2l1288t2729r1452b2777],
18	is	VBZ	O	be	auxpass	20	SENT_50	[p2l1470t2732r1512b2777],
19	often	RB	O	often	advmod	20	SENT_50	[p2l9t2805r146b2853],
20	treated	VBN	O	treat	rcmod	15	SENT_50	[p2l182t2805r369b2853],
21	by	IN	O	by	_	0	SENT_50	[p2l405t2805r468b2868],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_50	[p2l503t2815r867b2867],
23	coronary	JJ	O	coronary	amod	24	SENT_50	[p2l908t2822r1144b2868],
24	intervention	NN	O	intervention	agent	20	SENT_50	[p2l1181t2808r1513b2853],
25	and	CC	O	and	_	0	SENT_50	[p2l9t2882r108b2929],
26	stenting	NN	O	stenting	agent	20	SENT_50	[p2l165t2885r384b2945],
27	and	CC	O	and	_	0	SENT_50	[p2l440t2882r539b2929],
28	needs	VBZ	O	need	conj_and	20	SENT_50	[p2l595t2882r749b2929],
29	optimum	JJ	O	optimum	dobj	28	SENT_50	[p2l808t2885r1061b2944],
30	and	CC	O	and	_	0	SENT_50	[p2l1117t2882r1216b2929],
31	extended	JJ	O	extended	amod	33	SENT_50	[p2l1272t2882r1514b2929],
32	antiplatelet	JJ	O	antiplatelet	amod	33	SENT_50	[p2l9t2957r311b3019],
33	therapy	NN	O	therapy	dobj	28	SENT_50	[p2l354t2957r565b3020],
34	.	.	O	.	_	0	SENT_50	[p2l354t2957r565b3020],

1	We	PRP	O	we	nsubj	2	SENT_51	[p2l611t2962r695b3005],
2	assessed	VBD	O	assess	_	0	SENT_51	[p2l741t2957r972b3005],
3	the	DT	O	the	det	4	SENT_51	[p2l1015t2957r1099b3005],
4	effect	NN	O	effect	iobj	2	SENT_51	[p2l1145t2958r1291b3005],
5	of	IN	O	of	_	0	SENT_51	[p2l1335t2957r1394b3005],
6	the	DT	O	the	det	7	SENT_51	[p2l1429t2957r1513b3005],
7	CYP2C19	NN	O	cyp2c19	prep_of	4	SENT_51	[p2l13t3036r328b3081],
8	"	''	O	"	punct	7	SENT_51	[p2l13t3036r328b3081],
9	'	''	O	'	_	0	SENT_51	[p2l13t3036r328b3081],
10	\	JJ	O	\	amod	11	SENT_51	[p2l13t3036r328b3081],
11	‘	NN	O	‘	dep	4	SENT_51	[p2l13t3036r328b3081],
12	2	CD	NUMBER	2	num	14	SENT_51	[p2l13t3036r328b3081],
13	loss-of-function	JJ	O	loss-of-function	amod	14	SENT_51	[p2l347t3033r771b3081],
14	polymorphism	NN	O	polymorphism	npadvmod	21	SENT_51	[p2l794t3033r1194b3096],
15	in	IN	O	in	_	0	SENT_51	[p2l1216t3036r1270b3081],
16	a	DT	O	a	det	17	SENT_51	[p2l1293t3050r1319b3081],
17	cohort	NN	O	cohort	prep_in	14	SENT_51	[p2l1342t3033r1514b3081],
18	of	IN	O	of	_	0	SENT_51	[p2l9t3111r68b3158],
19	young	JJ	O	young	amod	20	SENT_51	[p2l99t3128r266b3174],
20	(	NN	O	(	prep_of	17	SENT_51	[p2l311t3114r419b3174],
21	<	JJR	O	<	amod	11	SENT_51	[p2l311t3114r419b3174],
22	45	CD	DURATION	45	num	23	SENT_51	[p2l311t3114r419b3174],
23	years	NNS	NUMBER	year	tmod	21	SENT_51	[p2l461t3116r617b3174],
24	)	CD	NUMBER	)	num	25	SENT_51	[p2l461t3116r617b3174],
25	patients	NNS	O	patient	dobj	2	SENT_51	[p2l662t3114r875b3173],
26	who	WP	O	who	nsubjpass	34	SENT_51	[p2l916t3111r1029b3158],
27	survived	VBD	O	survive	rcmod	25	SENT_51	[p2l1073t3111r1299b3158],
28	a	DT	O	a	det	31	SENT_51	[p2l1340t3128r1366b3158],
29	ﬁrst	JJ	O	ﬁrst	amod	31	SENT_51	[p2l1407t3111r1514b3158],
30	myocardial	JJ	O	myocardial	amod	31	SENT_51	[p2l8t3186r306b3249],
31	infarction	NN	O	infarction	dobj	27	SENT_51	[p2l325t3186r591b3234],
32	and	CC	O	and	_	0	SENT_51	[p2l611t3186r710b3234],
33	were	VBD	O	be	auxpass	34	SENT_51	[p2l727t3203r855b3234],
34	treated	VBN	O	treat	rcmod	25	SENT_51	[p2l874t3186r1061b3234],
35	chronically	RB	O	chronically	dep	34	SENT_51	[p2l1080t3186r1378b3249],
36	with	IN	O	with	_	0	SENT_51	[p2l1394t3186r1513b3234],
37	clopidogrel	NN	O	clopidogrel	prep_with	35	SENT_51	[p2l9t3262r323b3325],
38	.	.	O	.	_	0	SENT_51	[p2l9t3262r323b3325],

1	With	IN	O	with	_	0	SENT_52	[p2l57t3338r187b3386],
2	consideration	NN	O	consideration	prep_with	19	SENT_52	[p2l202t3338r568b3386],
3	of	IN	O	of	_	0	SENT_52	[p2l582t3338r641b3386],
4	the	DT	O	the	det	8	SENT_52	[p2l645t3338r728b3386],
5	early	JJ	O	early	amod	8	SENT_52	[p2l744t3338r871b3401],
6	and	CC	O	and	_	0	SENT_52	[p2l885t3338r983b3386],
7	extended	JJ	O	extended	amod	8	SENT_52	[p2l997t3338r1237b3386],
8	treatment	NN	O	treatment	prep_of	2	SENT_52	[p2l1249t3348r1514b3386],
9	with	IN	O	with	_	0	SENT_52	[p2l7t3414r125b3462],
10	clopidogrel	NN	O	clopidogrel	prep_with	8	SENT_52	[p2l170t3414r468b3477],
11	for	IN	O	for	_	0	SENT_52	[p2l512t3414r589b3462],
12	secondary	JJ	O	secondary	amod	13	SENT_52	[p2l634t3414r902b3477],
13	prevention	NN	O	prevention	prep_for	10	SENT_52	[p2l944t3417r1234b3476],
14	of	IN	O	of	_	0	SENT_52	[p2l1279t3414r1338b3462],
15	these	DT	O	these	det	16	SENT_52	[p2l1373t3414r1513b3462],
16	patients	NNS	O	patient	prep_of	13	SENT_52	[p2l8t3493r235b3553],
17	,	,	O	,	_	0	SENT_52	[p2l8t3493r235b3553],
18	we	PRP	O	we	nsubj	19	SENT_52	[p2l308t3507r381b3538],
19	decided	VBD	O	decide	_	0	SENT_52	[p2l455t3490r660b3538],
20	to	TO	O	to	aux	21	SENT_52	[p2l731t3500r780b3538],
21	assess	VB	O	assess	xcomp	19	SENT_52	[p2l854t3507r1016b3538],
22	the	DT	O	the	det	23	SENT_52	[p2l1090t3490r1173b3538],
23	effect	NN	O	effect	dobj	21	SENT_52	[p2l1247t3490r1391b3538],
24	of	IN	O	of	_	0	SENT_52	[p2l1463t3490r1522b3538],
25	C	NN	O	c	nn	26	SENT_52	[p2l13t3571r51b3615],
26	YP2C19	NN	O	yp2c19	prep_of	23	SENT_52	[p2l56t3570r326b3615],
27	"	''	O	"	punct	23	SENT_52	[p2l56t3570r326b3615],
28	"	``	O	"	punct	30	SENT_52	[p2l56t3570r326b3615],
29	2	CD	NUMBER	2	num	30	SENT_52	[p2l56t3570r326b3615],
30	polymorphism	NN	O	polymorphism	dep	23	SENT_52	[p2l337t3567r734b3630],
31	on	IN	O	on	_	0	SENT_52	[p2l749t3584r816b3615],
32	their	PRP$	O	they	poss	34	SENT_52	[p2l829t3567r957b3615],
33	long-term	JJ	O	long-term	amod	34	SENT_52	[p2l969t3567r1235b3630],
34	prognosis	NN	O	prognosis	prep_on	30	SENT_52	[p2l1249t3571r1511b3630],
35	during	IN	O	during	_	0	SENT_52	[p2l9t3643r189b3706],
36	clopidogrel	NN	O	clopidogrel	nn	37	SENT_52	[p2l221t3643r519b3706],
37	exposure	NN	O	exposure	prep_during	21	SENT_52	[p2l552t3660r805b3705],
38	.	.	O	.	_	0	SENT_52	[p2l552t3660r805b3705],

1	Only	RB	O	only	advmod	2	SENT_53	[p2l841t3643r969b3706],
2	patients	NNS	O	patient	nsubjpass	9	SENT_53	[p2l999t3646r1210b3705],
3	who	WP	O	who	nsubjpass	5	SENT_53	[p2l1242t3643r1354b3691],
4	were	VBD	O	be	auxpass	5	SENT_53	[p2l1385t3660r1512b3691],
5	exposed	VBN	O	expose	rcmod	2	SENT_53	[p2l9t3719r222b3781],
6	to	TO	O	to	_	0	SENT_53	[p2l242t3728r291b3767],
7	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_53	[p2l314t3719r613b3782],
8	were	VBD	O	be	auxpass	9	SENT_53	[p2l632t3736r760b3767],
9	assessed	VBN	O	assess	_	0	SENT_53	[p2l782t3719r1012b3767],
10	in	IN	O	in	_	0	SENT_53	[p2l1032t3722r1085b3766],
11	this	DT	O	this	det	12	SENT_53	[p2l1106t3719r1203b3767],
12	pharmacogenetic	JJ	O	pharmacogenetic	prep_in	9	SENT_53	[p2l1226t3719r1512b3781, p3l9t15r201b75],

1	investigation	NN	O	investigation	_	0	SENT_54	[p3l219t15r579b75],
2	.	.	O	.	_	0	SENT_54	[p3l219t15r579b75],

1	Articles	NNPS	O	Articles	_	0	SENT_55	[p3l101t476r251b512],

1	378	CD	NUMBER	378	num	2	SENT_56	[p3l942t831r1006b870],
2	patients	NNS	O	patient	npadvmod	3	SENT_56	[p3l1019t834r1160b875],
3	aged	JJ	O	aged	amod	4	SENT_56	[p3l1171t832r1254b875],
4	<	JJR	O	<	_	0	SENT_56	[p3l1266t836r1331b870],
5	45	CD	DURATION	45	num	6	SENT_56	[p3l1266t836r1331b870],
6	years	NNS	NUMBER	year	tmod	4	SENT_56	[p3l1340t843r1429b875],
7	enrolled	VBN	O	enrol	partmod	4	SENT_56	[p3l1440t832r1580b865],
8	between	IN	O	between	_	0	SENT_56	[p3l1023t887r1170b920],
9	April	NNP	DATE	April	prep_between	7	SENT_56	[p3l1181t887r1261b930],
10	1	CD	DATE	1	num	9	SENT_56	[p3l1274t891r1301b926],
11	,	,	DATE	,	_	0	SENT_56	[p3l1274t891r1301b926],
12	1996	CD	DATE	1996	num	9	SENT_56	[p3l1314t886r1415b926],
13	,	,	O	,	_	0	SENT_56	[p3l1314t886r1415b926],
14	and	CC	O	and	_	0	SENT_56	[p3l1427t887r1491b920],
15	April	NNP	DATE	April	prep_between	7	SENT_56	[p3l1501t887r1580b930],
16	1	CD	DATE	1	num	15	SENT_56	[p3l1594t891r1620b926],
17	,	,	DATE	,	_	0	SENT_56	[p3l1594t891r1620b926],
18	2008	CD	DATE	2008	num	15	SENT_56	[p3l1633t886r1723b920],

1	119	CD	NUMBER	119	num	2	SENT_57	[p3l1577t1012r1638b1046],
2	patients	NNS	O	patient	nsubj	4	SENT_57	[p3l1651t1010r1792b1051],
3	never	RB	O	never	neg	4	SENT_57	[p3l1805t1019r1900b1041],
4	exposed	VBN	O	expose	_	0	SENT_57	[p3l1910t1007r2052b1051],
5	to	TO	O	to	_	0	SENT_57	[p3l1651t1069r1688b1096],
6	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_57	[p3l1699t1062r1890b1106],

1	259	CD	NUMBER	259	num	2	SENT_58	[p3l943t1187r1007b1220],
2	patients	NNS	O	patient	_	0	SENT_58	[p3l1020t1185r1161b1225],
3	on	IN	O	on	_	0	SENT_58	[p3l1172t1193r1214b1215],
4	clopidogrel	NN	O	clopidogrel	prep_on	2	SENT_58	[p3l1227t1182r1418b1226],
5	during	IN	O	during	dep	2	SENT_58	[p3l1431t1182r1542b1226],
6	follow-up	JJ	O	follow-up	amod	8	SENT_58	[p3l1554t1182r1724b1225],
7	32	CD	NUMBER	32	num	8	SENT_58	[p3l968t1242r1008b1275],
8	MACE	NN	O	mace	pobj	5	SENT_58	[p3l1022t1240r1124b1270],
9	on	IN	O	on	dep	2	SENT_58	[p3l1135t1248r1178b1270],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_58	[p3l1190t1237r1382b1281],
11	therapy	NN	O	therapy	pobj	9	SENT_58	[p3l1392t1237r1526b1280],

1	216	CD	NUMBER	216	dep	2	SENT_59	[p3l733t1491r797b1525],
2	had	VBD	O	have	_	0	SENT_59	[p3l810t1492r872b1525],
3	clopidogrel	NN	O	clopidogrel	nsubj	10	SENT_59	[p3l884t1492r1075b1536],
4	as	IN	O	as	_	0	SENT_59	[p3l1088t1503r1122b1525],
5	ﬁrst	NN	O	ﬁrst	nn	8	SENT_59	[p3l1132t1491r1277b1525],
6	—	CD	NUMBER	—	num	8	SENT_59	[p3l1132t1491r1277b1525],
7	|	NN	O	|	nn	8	SENT_59	[p3l1132t1491r1277b1525],
8	ine	NN	O	ine	prep_as	3	SENT_59	[p3l1132t1491r1277b1525],
9	therapy	NN	O	therapy	nn	10	SENT_59	[p3l807t1547r941b1590],
10	ofthe	NN	O	ofthe	xcomp	2	SENT_59	[p3l951t1546r1051b1580],
11	qualifying	VBG	O	qualify	partmod	10	SENT_59	[p3l1061t1546r1232b1591],
12	event	NN	O	event	dobj	11	SENT_59	[p3l808t1608r905b1635],
13	(	CD	NUMBER	(	num	15	SENT_59	[p3l917t1604r1011b1644],
14	AC5	NN	O	ac5	nn	15	SENT_59	[p3l917t1604r1011b1644],
15	)	NN	O	)	nsubj	2	SENT_59	[p3l917t1604r1011b1644],

1	43	CD	NUMBER	43	num	2	SENT_60	[p3l1390t1496r1434b1530],
2	patients	NNS	O	patient	nsubj	3	SENT_60	[p3l1446t1495r1587b1535],
3	had	VBD	O	have	_	0	SENT_60	[p3l1600t1492r1662b1525],
4	clopidogrel	NN	O	clopidogrel	dobj	3	SENT_60	[p3l1673t1492r1865b1536],
5	initiated	VBN	O	initiate	partmod	4	SENT_60	[p3l1445t1547r1589b1580],
6	later	RB	O	later	advmod	5	SENT_60	[p3l1602t1547r1678b1580],
7	after	IN	O	after	_	0	SENT_60	[p3l1688t1546r1770b1580],
8	the	DT	O	the	det	10	SENT_60	[p3l1777t1547r1834b1580],
9	qualifying	VBG	O	qualify	amod	10	SENT_60	[p3l1444t1601r1615b1646],
10	event	NN	O	event	prep_after	5	SENT_60	[p3l1628t1608r1725b1635],

1	46	CD	NUMBER	46	num	2	SENT_61	[p3l1576t1764r1622b1802],
2	patients	NNS	O	patient	nsubj	3	SENT_61	[p3l1634t1767r1775b1808],
3	discontinued	VBN	O	discontinue	_	0	SENT_61	[p3l1786t1764r2012b1797],
4	clopidogrel	NN	O	clopidogrel	dobj	3	SENT_61	[p3l1634t1819r1826b1863],

1	213	CD	NUMBER	213	num	2	SENT_62	[p3l1101t1953r1162b1986],
2	patients	NNS	O	patient	npadvmod	3	SENT_62	[p3l1174t1951r1315b1992],
3	still	RB	O	still	advmod	9	SENT_62	[p3l1327t1948r1384b1981],
4	on	IN	O	on	_	0	SENT_62	[p3l1396t1960r1439b1981],
5	clopidogrel	NN	O	clopidogrel	prep_on	3	SENT_62	[p3l1180t2003r1371b2047],
6	at	IN	O	at	_	0	SENT_62	[p3l1384t2009r1418b2036],
7	the	DT	O	the	det	8	SENT_62	[p3l1426t2003r1483b2036],
8	last	JJ	O	last	prep_at	3	SENT_62	[p3l1496t2003r1554b2036],
9	follow	VB	O	follow	_	0	SENT_62	[p3l1179t2058r1349b2101],
10	—	CD	NUMBER	—	dobj	9	SENT_62	[p3l1179t2058r1349b2101],
11	up	IN	O	up	_	0	SENT_62	[p3l1179t2058r1349b2101],
12	visit	NN	O	visit	prep_up	9	SENT_62	[p3l1359t2061r1431b2091],

1	Figure	NNP	O	Figure	_	0	SENT_63	[p3l646t2231r760b2276],
2	1	CD	NUMBER	1	num	1	SENT_63	[p3l772t2229r895b2265],
3	:	:	O	:	_	0	SENT_63	[p3l772t2229r895b2265],
4	Tria	NNP	ORGANIZATION	Tria	dep	6	SENT_63	[p3l772t2229r895b2265],
5	|	CD	NUMBER	|	num	4	SENT_63	[p3l772t2229r895b2265],
6	proﬁle	JJ	O	proﬁle	amod	7	SENT_63	[p3l908t2229r1036b2276],
7	MACE	NN	O	mace	dep	1	SENT_63	[p3l647t2293r894b2337],
8	=	JJ	O	=	amod	12	SENT_63	[p3l647t2293r894b2337],
9	major	JJ	O	major	amod	12	SENT_63	[p3l647t2293r894b2337],
10	adverse	JJ	O	adverse	amod	12	SENT_63	[p3l905t2291r1046b2326],
11	cardiac	JJ	O	cardiac	amod	12	SENT_63	[p3l1058t2291r1187b2326],
12	event	NN	O	event	dep	7	SENT_63	[p3l1199t2297r1312b2326],
13	.	.	O	.	_	0	SENT_63	[p3l1199t2297r1312b2326],

1	ACS	NN	O	ac	_	0	SENT_64	[p3l1324t2293r1525b2326],
2	=	JJ	O	=	amod	5	SENT_64	[p3l1324t2293r1525b2326],
3	acute	JJ	O	acute	amod	5	SENT_64	[p3l1324t2293r1525b2326],
4	coronary	JJ	O	coronary	amod	5	SENT_64	[p3l1537t2303r1702b2337],
5	syndromes	NNS	O	syndrome	dep	1	SENT_64	[p3l1713t2291r1927b2337],
6	.	.	O	.	_	0	SENT_64	[p3l1713t2291r1927b2337],

1	Methods	NNS	O	method	nsubjpass	33	SENT_65	[p3l648t2413r922b2469],
2	Study	NNP	O	Study	nn	3	SENT_65	[p3l646t2497r804b2560],
3	design	NN	O	design	dep	1	SENT_65	[p3l817t2497r992b2560],
4	and	CC	O	and	_	0	SENT_65	[p3l1009t2497r1109b2545],
5	eligibility	NN	O	eligibility	dep	1	SENT_65	[p3l1124t2497r1378b2560],
6	Between	IN	O	between	_	0	SENT_65	[p3l648t2578r867b2622],
7	April	NNP	DATE	April	prep_between	33	SENT_65	[p3l888t2573r1017b2636],
8	1	CD	DATE	1	num	7	SENT_65	[p3l1041t2578r1075b2629],
9	,	,	DATE	,	_	0	SENT_65	[p3l1041t2578r1075b2629],
10	1996	CD	DATE	1996	num	7	SENT_65	[p3l1102t2577r1229b2629],
11	,	,	O	,	_	0	SENT_65	[p3l1102t2577r1229b2629],
12	and	CC	O	and	_	0	SENT_65	[p3l1254t2573r1350b2622],
13	April	NNP	DATE	April	conj_and	7	SENT_65	[p3l1371t2573r1499b2636],
14	1	CD	DATE	1	num	13	SENT_65	[p3l1523t2578r1557b2629],
15	,	,	DATE	,	_	0	SENT_65	[p3l1523t2578r1557b2629],
16	2008	CD	DATE	2008	num	13	SENT_65	[p3l1584t2578r1717b2629],
17	,	,	O	,	_	0	SENT_65	[p3l1584t2578r1717b2629],
18	378	CD	NUMBER	378	num	20	SENT_65	[p3l1745t2576r1828b2623],
19	consecutive	JJ	O	consecutive	amod	20	SENT_65	[p3l1852t2576r2150b2622],
20	patients	NNS	O	patient	prep_between	33	SENT_65	[p3l645t2653r847b2712],
21	aged	VBN	O	age	partmod	20	SENT_65	[p3l887t2650r1007b2713],
22	less	JJR	DURATION	less	mwe	23	SENT_65	[p3l1042t2650r1136b2698],
23	than	IN	DURATION	than	quantmod	24	SENT_65	[p3l1175t2650r1292b2698],
24	45	CD	DURATION	45	num	25	SENT_65	[p3l1327t2653r1383b2698],
25	years	NNS	NUMBER	year	tmod	21	SENT_65	[p3l1422t2667r1553b2713],
26	and	CC	O	and	_	0	SENT_65	[p3l1592t2650r1688b2698],
27	who	WP	O	who	nsubj	28	SENT_65	[p3l1723t2650r1833b2698],
28	survived	VBD	O	survive	prep_between	33	SENT_65	[p3l1872t2650r2087b2698],
29	a	DT	O	a	det	31	SENT_65	[p3l2125t2667r2151b2698],
30	myocardial	JJ	O	myocardial	amod	31	SENT_65	[p3l645t2727r930b2789],
31	infarction	NN	O	infarction	dobj	28	SENT_65	[p3l951t2727r1203b2774],
32	were	VBD	O	be	auxpass	33	SENT_65	[p3l1222t2744r1346b2774],
33	enrolled	VBN	O	enrol	_	0	SENT_65	[p3l1368t2727r1579b2774],
34	in	IN	O	in	_	0	SENT_65	[p3l1599t2730r1651b2774],
35	the	DT	O	the	det	37	SENT_65	[p3l1671t2727r1752b2774],
36	ongoing	JJ	O	ongoing	amod	37	SENT_65	[p3l1773t2730r1986b2790],
37	AFIII	NN	O	afiius	prep_in	33	SENT_65	[p3l2006t2730r2148b2788],
38	(	CD	NUMBER	(	num	39	SENT_65	[p3l649t2802r907b2865],
39	Appraisal	NN	O	appraisal	tmod	33	SENT_65	[p3l649t2802r907b2865],
40	of	IN	O	of	_	0	SENT_65	[p3l946t2802r1004b2850],
41	risk	NN	O	risk	nn	42	SENT_65	[p3l1032t2802r1129b2850],
42	Factors	NNS	O	factor	prep_of	39	SENT_65	[p3l1168t2805r1347b2850],
43	in	IN	O	in	_	0	SENT_65	[p3l1386t2805r1438b2849],
44	young	JJ	O	young	amod	46	SENT_65	[p3l1474t2819r1635b2865],
45	Ischemic	JJ	MISC	ischemic	amod	46	SENT_65	[p3l1675t2802r1909b2850],
46	patients	NNS	O	patient	prep_in	42	SENT_65	[p3l1946t2805r2149b2864],
47	Iustifying	VBG	O	iustify	xcomp	33	SENT_65	[p3l647t2878r892b2941],
48	aggressive	JJ	O	aggressive	amod	50	SENT_65	[p3l930t2881r1194b2941],
49	Intervention	NN	O	intervention	nn	50	SENT_65	[p3l1235t2881r1568b2941],
50	)	NN	O	)	dobj	47	SENT_65	[p3l1235t2881r1568b2941],
51	multicentre	JJ	O	multicentre	amod	52	SENT_65	[p3l1609t2878r1910b2926],
52	registry	NN	O	registry	tmod	47	SENT_65	[p3l1947t2881r2148b2941],
53	,	,	O	,	_	0	SENT_65	[p3l1947t2881r2148b2941],
54	which	WDT	O	which	nsubjpass	56	SENT_65	[p3l644t2955r802b3002],
55	was	VBD	O	be	auxpass	56	SENT_65	[p3l831t2972r927b3002],
56	dedicated	VBN	O	dedicate	rcmod	52	SENT_65	[p3l960t2955r1205b3002],
57	to	TO	O	to	_	0	SENT_65	[p3l1234t2964r1282b3002],
58	the	DT	O	the	det	59	SENT_65	[p3l1312t2955r1393b3002],
59	management	NN	O	management	prep_to	56	SENT_65	[p3l1424t2964r1769b3018],
60	of	IN	O	of	_	0	SENT_65	[p3l1799t2955r1857b3002],
61	premature	JJ	O	premature	amod	64	SENT_65	[p3l1878t2964r2150b3017],
62	coronary	JJ	O	coronary	amod	64	SENT_65	[p3l646t3047r872b3093],
63	artery	NN	O	artery	nn	64	SENT_65	[p3l891t3040r1039b3093],
64	disease	NN	O	disease	prep_of	59	SENT_65	[p3l1057t3030r1255b3085],
65	,	,	O	,	_	0	SENT_65	[p3l1057t3030r1255b3085],
66	including	VBG	O	include	_	0	SENT_65	[p3l1277t3030r1524b3093],
67	risk	NN	O	risk	nn	68	SENT_65	[p3l1544t3030r1641b3078],
68	factors	NNS	O	factor	prep_including	59	SENT_65	[p3l1660t3030r1829b3078],
69	and	CC	O	and	_	0	SENT_65	[p3l1851t3030r1947b3078],
70	genetic	JJ	O	genetic	amod	71	SENT_65	[p3l1967t3033r2151b3093],
71	proﬁling	NN	O	proﬁling	prep_including	59	SENT_65	[p3l645t3106r881b3169],
72	.	.	O	.	_	0	SENT_65	[p3l645t3106r881b3169],

1	This	DT	O	this	det	2	SENT_66	[p3l896t3106r1009b3154],
2	programme	NN	O	programme	nsubjpass	4	SENT_66	[p3l1024t3123r1331b3169],
3	was	VBD	O	be	auxpass	4	SENT_66	[p3l1344t3123r1440b3154],
4	designed	VBN	O	design	_	0	SENT_66	[p3l1455t3106r1687b3169],
5	in	IN	O	in	_	0	SENT_66	[p3l1700t3109r1752b3153],
6	1996	CD	DATE	1996	prep_in	4	SENT_66	[p3l1766t3110r1879b3154],
7	to	TO	O	to	aux	8	SENT_66	[p3l1893t3115r1941b3154],
8	identify	VB	O	identify	ccomp	4	SENT_66	[p3l1955t3106r2152b3169],
9	classic	JJ	O	classic	amod	13	SENT_66	[p3l646t3182r810b3230],
10	and	CC	O	and	_	0	SENT_66	[p3l832t3182r928b3230],
11	unusual	JJ	O	unusual	amod	13	SENT_66	[p3l947t3182r1158b3230],
12	risk	NN	O	risk	nn	13	SENT_66	[p3l1179t3182r1277b3230],
13	factors	NNS	O	factor	dobj	8	SENT_66	[p3l1296t3182r1480b3237],
14	,	,	O	,	_	0	SENT_66	[p3l1296t3182r1480b3237],
15	as	RB	O	as	_	0	SENT_66	[p3l1504t3199r1554b3230],
16	well	RB	O	well	_	0	SENT_66	[p3l1575t3182r1680b3230],
17	as	IN	O	as	_	0	SENT_66	[p3l1701t3199r1751b3230],
18	genetic	JJ	O	genetic	amod	19	SENT_66	[p3l1775t3185r1959b3245],
19	factors	NNS	O	factor	conj_and	13	SENT_66	[p3l1979t3182r2149b3230],
20	aifecting	VBG	O	aifect	partmod	19	SENT_66	[p3l646t3259r869b3321],
21	complex	JJ	O	complex	amod	22	SENT_66	[p3l885t3258r1102b3320],
22	phenotypes	NNS	O	phenotype	dobj	20	SENT_66	[p3l1115t3258r1409b3321],
23	of	IN	O	of	_	0	SENT_66	[p3l1427t3258r1484b3306],
24	coronary	JJ	O	coronary	amod	25	SENT_66	[p3l1491t3275r1717b3321],
25	thrombosis	NN	O	thrombosis	prep_of	22	SENT_66	[p3l1729t3258r2037b3313],
26	,	,	O	,	_	0	SENT_66	[p3l1729t3258r2037b3313],
27	and	CC	O	and	_	0	SENT_66	[p3l2055t3258r2151b3306],
28	to	TO	O	to	aux	29	SENT_66	[p3l645t3344r693b3383],
29	implement	VB	O	implement	conj_and	8	SENT_66	[p3l737t3335r1025b3397],
30	educational	JJ	O	educational	amod	31	SENT_66	[p3l1068t3335r1365b3383],
31	programmes	NNS	O	programme	dobj	29	SENT_66	[p3l1408t3352r1740b3398],
32	and	CC	O	and	_	0	SENT_66	[p3l1787t3335r1882b3383],
33	optimise	VB	O	optimise	conj_and	8	SENT_66	[p3l1926t3338r2150b3397],
34	medical	JJ	O	medical	amod	35	SENT_66	[p4l645t23r849b71],
35	treatment	NN	O	treatment	dobj	33	SENT_66	[p4l864t33r1119b71],
36	to	TO	O	to	aux	37	SENT_66	[p4l1133t33r1181b71],
37	prevent	VB	O	prevent	xcomp	33	SENT_66	[p4l1198t33r1393b86],
38	new	JJ	O	new	amod	40	SENT_66	[p4l1409t40r1517b71],
39	coronary	JJ	O	coronary	amod	40	SENT_66	[p4l1533t40r1759b86],
40	events	NNS	O	event	dobj	37	SENT_66	[p4l1775t33r1949b71],
41	.	.	O	.	_	0	SENT_66	[p4l1775t33r1949b71],

1	To	TO	O	to	aux	3	SENT_67	[p4l694t102r756b147],
2	be	VB	O	be	cop	3	SENT_67	[p4l773t99r833b147],
3	eligible	JJ	O	eligible	purpcl	15	SENT_67	[p4l851t99r1055b162],
4	,	,	O	,	_	0	SENT_67	[p4l851t99r1055b162],
5	patients	NNS	O	patient	nsubj	15	SENT_67	[p4l1074t102r1282b161],
6	(	CD	NUMBER	(	num	5	SENT_67	[p4l1305t99r1443b162],
7	aged	JJ	O	aged	amod	5	SENT_67	[p4l1305t99r1443b162],
8	>	JJR	O	>	dep	7	SENT_67	[p4l1460t103r1549b147],
9	18	CD	NUMBER	18	amod	5	SENT_67	[p4l1460t103r1549b147],
10	and	CC	O	and	_	0	SENT_67	[p4l1567t99r1664b147],
11	<	JJR	O	<	amod	5	SENT_67	[p4l1681t102r1770b147],
12	45	CD	DURATION	45	num	13	SENT_67	[p4l1681t102r1770b147],
13	years	NNS	NUMBER	year	tmod	14	SENT_67	[p4l1788t104r1940b162],
14	)	JJ	O	)	amod	5	SENT_67	[p4l1788t104r1940b162],
15	needed	VBN	O	need	_	0	SENT_67	[p4l1961t99r2151b147],
16	to	TO	O	to	aux	17	SENT_67	[p4l645t184r693b223],
17	have	VB	O	have	xcomp	15	SENT_67	[p4l723t175r843b223],
18	an	DT	O	a	det	21	SENT_67	[p4l874t192r937b223],
19	established	JJ	O	established	amod	21	SENT_67	[p4l967t175r1262b223],
20	coronary	JJ	O	coronary	amod	21	SENT_67	[p4l1292t192r1523b238],
21	disease	NN	O	disease	dobj	17	SENT_67	[p4l1552t175r1741b223],
22	deﬁned	VBN	O	deﬁned	partmod	21	SENT_67	[p4l1772t175r1970b223],
23	by	IN	O	by	_	0	SENT_67	[p4l1997t175r2059b238],
24	an	DT	O	a	det	25	SENT_67	[p4l2088t192r2151b223],
25	episode	NN	O	episode	agent	22	SENT_67	[p4l646t251r845b314],
26	of	IN	O	of	_	0	SENT_67	[p4l909t251r967b299],
27	myocardial	JJ	O	myocardial	amod	30	SENT_67	[p4l1020t251r1311b314],
28	infarction	NN	O	infarction	nn	30	SENT_67	[p4l1373t251r1632b299],
29	(	CD	NUMBER	(	num	30	SENT_67	[p4l1698t251r2035b314],
30	ST-elevation	NN	O	st-elevation	prep_of	25	SENT_67	[p4l1698t251r2035b314],
31	or	CC	O	or	_	0	SENT_67	[p4l2098t268r2151b299],
32	non-ST-elevation	JJ	O	non-st-elevation	amod	35	SENT_67	[p4l645t327r1090b375],
33	myocardial	JJ	O	myocardial	amod	35	SENT_67	[p4l1138t327r1429b390],
34	infarction	NN	O	infarction	nn	35	SENT_67	[p4l1476t327r1768b390],
35	)	NN	O	)	conj_or	25	SENT_67	[p4l1476t327r1768b390],
36	,	,	O	,	_	0	SENT_67	[p4l1476t327r1768b390],
37	exposure	NN	O	exposure	appos	35	SENT_67	[p4l1819t344r2054b389],
38	to	TO	O	to	_	0	SENT_67	[p4l2101t337r2150b375],
39	clopidogrel	NN	O	clopidogrel	nn	40	SENT_67	[p4l646t404r939b467],
40	therapy	NN	O	therapy	prep_to	37	SENT_67	[p4l959t404r1158b466],
41	(	CD	NUMBER	(	number	42	SENT_67	[p4l1181t407r1250b467],
42	75	CD	NUMBER	75	num	43	SENT_67	[p4l1181t407r1250b467],
43	mg	NN	O	mg	npadvmod	37	SENT_67	[p4l1274t421r1359b467],
44	per	IN	O	per	_	0	SENT_67	[p4l1379t421r1466b466],
45	day	NN	DURATION	day	prep_per	43	SENT_67	[p4l1486t404r1589b467],
46	)	CD	NUMBER	)	num	45	SENT_67	[p4l1486t404r1589b467],
47	for	IN	O	for	_	0	SENT_67	[p4l1614t404r1689b451],
48	at	IN	DURATION	at	quantmod	50	SENT_67	[p4l1709t413r1755b451],
49	least	JJS	DURATION	least	mwe	48	SENT_67	[p4l1773t404r1894b451],
50	1	CD	DURATION	1	num	51	SENT_67	[p4l1915t408r1937b451],
51	month	NN	NUMBER	month	prep_for	37	SENT_67	[p4l1957t404r2148b459],
52	,	,	O	,	_	0	SENT_67	[p4l1957t404r2148b459],
53	and	CC	O	and	_	0	SENT_67	[p4l646t479r743b527],
54	genotyping	VBG	O	genotype	conj_and	15	SENT_67	[p4l761t483r1056b542],
55	for	IN	O	for	_	0	SENT_67	[p4l1073t479r1148b527],
56	C	NN	O	c	nn	61	SENT_67	[p4l1169t483r1207b527],
57	YP2C19	NN	O	yp2c19	nn	61	SENT_67	[p4l1211t483r1478b527],
58	*	NN	O	*	nn	61	SENT_67	[p4l1211t483r1478b527],
59	2	CD	NUMBER	2	num	61	SENT_67	[p4l1211t483r1478b527],
60	(	NN	O	(	nn	61	SENT_67	[p4l1496t479r1667b542],
61	ﬁgure	NN	O	ﬁgure	prep_for	54	SENT_67	[p4l1496t479r1667b542],
62	1	CD	NUMBER	1	num	63	SENT_67	[p4l1686t484r1741b542],
63	)	NN	O	)	dep	61	SENT_67	[p4l1686t484r1741b542],
64	.	.	O	.	_	0	SENT_67	[p4l1686t484r1741b542],

1	This	DT	O	this	det	2	SENT_68	[p4l1760t479r1875b527],
2	study	NN	O	study	nsubjpass	4	SENT_68	[p4l1896t479r2037b542],
3	was	VBD	O	be	auxpass	4	SENT_68	[p4l2051t496r2149b527],
4	approved	VBN	O	approve	_	0	SENT_68	[p4l646t555r888b617],
5	by	IN	O	by	_	0	SENT_68	[p4l905t555r967b618],
6	the	DT	O	the	det	8	SENT_68	[p4l984t555r1066b603],
7	ethics	NNS	O	ethic	nn	8	SENT_68	[p4l1087t555r1238b603],
8	committee	NN	O	committee	agent	4	SENT_68	[p4l1260t558r1542b603],
9	at	IN	O	at	_	0	SENT_68	[p4l1563t565r1609b603],
10	the	DT	O	the	det	13	SENT_68	[p4l1626t555r1708b603],
11	Pitié-Salpétriere	NNP	ORGANIZATION	Pitié-Salpétriere	nn	13	SENT_68	[p4l1731t555r2150b617],
12	University	NNP	ORGANIZATION	University	nn	13	SENT_68	[p4l648t635r922b695],
13	Hospital	NNP	ORGANIZATION	Hospital	prep_at	4	SENT_68	[p4l948t632r1183b695],
14	,	,	O	,	_	0	SENT_68	[p4l948t632r1183b695],
15	Paris	NNP	LOCATION	Paris	nn	17	SENT_68	[p4l1214t635r1356b687],
16	,	,	O	,	_	0	SENT_68	[p4l1214t635r1356b687],
17	France	NNP	LOCATION	France	appos	13	SENT_68	[p4l1386t635r1573b680],
18	.	.	O	.	_	0	SENT_68	[p4l1386t635r1573b680],

1	We	PRP	O	we	nsubj	2	SENT_69	[p4l1600t637r1683b680],
2	obtained	VBD	O	obtain	_	0	SENT_69	[p4l1709t632r1938b680],
3	written	JJ	O	written	amod	5	SENT_69	[p4l1961t635r2151b680],
4	informed	VBN	O	inform	amod	5	SENT_69	[p4l645t708r894b756],
5	consent	NN	O	consent	dobj	2	SENT_69	[p4l912t718r1118b756],
6	from	IN	O	from	_	0	SENT_69	[p4l1135t708r1265b756],
7	every	DT	O	every	det	8	SENT_69	[p4l1284t725r1421b771],
8	patient	NN	O	patient	prep_from	5	SENT_69	[p4l1437t711r1633b770],
9	.	.	O	.	_	0	SENT_69	[p4l1437t711r1633b770],

1	Data	NNS	O	datum	nn	2	SENT_70	[p4l648t867r771b911],
2	collection	NN	O	collection	nsubj	6	SENT_70	[p4l786t862r1044b911],
3	and	CC	O	and	_	0	SENT_70	[p4l1062t862r1161b911],
4	follow-up	NN	O	follow-up	nn	5	SENT_70	[p4l1175t862r1439b925],
5	Patients	NNS	O	patient	conj_and	2	SENT_70	[p4l648t943r850b987],
6	entered	VBD	O	enter	_	0	SENT_70	[p4l886t940r1080b987],
7	the	DT	O	the	det	8	SENT_70	[p4l1112t940r1193b987],
8	registry	NN	O	registry	dobj	6	SENT_70	[p4l1227t943r1422b1003],
9	3	CD	DURATION	3	num	10	SENT_70	[p4l1457t944r1481b987],
10	months	NNS	NUMBER	month	tmod	6	SENT_70	[p4l1518t940r1716b987],
11	after	IN	O	after	_	0	SENT_70	[p4l1753t940r1868b987],
12	the	DT	O	the	det	15	SENT_70	[p4l1900t940r1981b987],
13	acute	JJ	O	acute	amod	15	SENT_70	[p4l2016t949r2150b987],
14	coronary	JJ	O	coronary	amod	15	SENT_70	[p4l646t1032r872b1078],
15	event	NN	O	event	prep_after	6	SENT_70	[p4l909t1025r1057b1063],
16	.	.	O	.	_	0	SENT_70	[p4l909t1025r1057b1063],

1	Medical	JJ	O	medical	amod	2	SENT_71	[p4l1100t1015r1301b1063],
2	history	NN	O	history	nsubjpass	7	SENT_71	[p4l1337t1015r1516b1078],
3	and	CC	O	and	_	0	SENT_71	[p4l1553t1015r1649b1063],
4	risk	NN	O	risk	nn	5	SENT_71	[p4l1685t1015r1783b1063],
5	factors	NNS	O	factor	conj_and	2	SENT_71	[p4l1819t1015r1989b1063],
6	were	VBD	O	be	auxpass	7	SENT_71	[p4l2027t1032r2150b1063],
7	assessed	VBN	O	assess	_	0	SENT_71	[p4l646t1091r878b1140],
8	.	.	O	.	_	0	SENT_71	[p4l646t1091r878b1140],

1	Blood	NN	O	blood	nn	2	SENT_72	[p4l917t1091r1063b1139],
2	pressure	NN	O	pressure	nsubjpass	12	SENT_72	[p4l1095t1108r1317b1154],
3	was	VBD	O	be	auxpass	4	SENT_72	[p4l1349t1108r1445b1140],
4	measured	VBN	O	measure	_	0	SENT_72	[p4l1480t1091r1737b1139],
5	to	TO	O	to	_	0	SENT_72	[p4l1768t1101r1816b1139],
6	the	DT	O	the	det	10	SENT_72	[p4l1849t1091r1930b1139],
7	nearest	JJS	O	nearest	amod	10	SENT_72	[p4l1963t1101r2152b1140],
8	2	CD	NUMBER	2	amod	10	SENT_72	[p4l647t1173r673b1216],
9	mm	NN	O	mm	nn	10	SENT_72	[p4l697t1186r807b1216],
10	Hg	NN	O	hg	prep_to	4	SENT_72	[p4l832t1174r912b1232],
11	and	CC	O	and	_	0	SENT_72	[p4l935t1169r1031b1216],
12	calculated	VBN	O	calculate	conj_and	4	SENT_72	[p4l1053t1169r1309b1216],
13	as	IN	O	as	_	0	SENT_72	[p4l1331t1186r1381b1216],
14	a	DT	O	a	det	15	SENT_72	[p4l1406t1186r1432b1216],
15	mean	NN	O	mean	prep_as	12	SENT_72	[p4l1455t1186r1601b1216],
16	of	IN	O	of	_	0	SENT_72	[p4l1625t1169r1683b1216],
17	three	CD	NUMBER	three	num	19	SENT_72	[p4l1695t1169r1828b1216],
18	consecutive	JJ	O	consecutive	amod	19	SENT_72	[p4l1852t1172r2150b1216],
19	readings	NNS	O	reading	prep_of	15	SENT_72	[p4l645t1244r879b1307],
20	.	.	O	.	_	0	SENT_72	[p4l645t1244r879b1307],

1	Hypertension	NN	O	hypertension	nsubjpass	3	SENT_73	[p4l902t1247r1255b1307],
2	was	VBD	O	be	auxpass	3	SENT_73	[p4l1270t1261r1367b1292],
3	identiﬁed	VBN	O	identiﬁed	_	0	SENT_73	[p4l1385t1244r1632b1292],
4	as	IN	O	as	_	0	SENT_73	[p4l1649t1261r1699b1292],
5	an	DT	O	a	det	8	SENT_73	[p4l1718t1261r1781b1292],
6	average	JJ	O	average	amod	8	SENT_73	[p4l1798t1261r1990b1307],
7	blood	NN	O	blood	nn	8	SENT_73	[p4l2007t1244r2151b1292],
8	pressure	NN	O	pressure	prep_as	3	SENT_73	[p4l645t1337r867b1382],
9	greater	JJR	O	greater	mwe	10	SENT_73	[p4l897t1329r1077b1383],
10	than	IN	O	than	quantmod	11	SENT_73	[p4l1103t1320r1220b1368],
11	140/90	CD	NUMBER	140/90	num	13	SENT_73	[p4l1251t1324r1417b1382],
12	mm	NN	O	mm	nn	13	SENT_73	[p4l1446t1337r1555b1367],
13	Hg	NN	O	hg	dep	3	SENT_73	[p4l1586t1325r1678b1383],
14	.	.	O	.	_	0	SENT_73	[p4l1586t1325r1678b1383],

1	Individuals	NNS	O	individual	nsubjpass	3	SENT_74	[p4l1712t1320r1998b1368],
2	were	VBD	O	be	auxpass	3	SENT_74	[p4l2026t1337r2150b1368],
3	qualiﬁed	VBN	O	qualiﬁed	_	0	SENT_74	[p4l646t1397r872b1459],
4	as	IN	O	as	_	0	SENT_74	[p4l920t1414r970b1444],
5	diabetic	JJ	O	diabetic	prep_as	3	SENT_74	[p4l1020t1397r1219b1444],
6	if	IN	O	if	mark	10	SENT_74	[p4l1267t1397r1312b1444],
7	they	PRP	O	they	nsubj	10	SENT_74	[p4l1350t1397r1460b1459],
8	were	VBD	O	be	aux	10	SENT_74	[p4l1505t1414r1629b1444],
9	previously	RB	DATE	previously	advmod	10	SENT_74	[p4l1677t1397r1943b1459],
10	taking	VBG	O	take	dep	3	SENT_74	[p4l1989t1397r2151b1460],
11	antidiabetic	JJ	O	antidiabetic	amod	12	SENT_74	[p4l646t1472r945b1520],
12	drugs	NNS	O	drug	dobj	10	SENT_74	[p4l964t1472r1108b1535],
13	or	CC	O	or	_	0	SENT_74	[p4l1129t1489r1182b1520],
14	if	IN	O	if	mark	18	SENT_74	[p4l1199t1472r1244b1519],
15	fasting	NN	O	fasting	nn	16	SENT_74	[p4l1253t1472r1428b1535],
16	glycaemia	NN	O	glycaemia	nsubj	18	SENT_74	[p4l1447t1472r1704b1535],
17	was	VBD	O	be	cop	18	SENT_74	[p4l1720t1489r1817b1520],
18	greater	JJR	O	greater	dep	3	SENT_74	[p4l1837t1482r2017b1535],
19	than	IN	O	than	_	0	SENT_74	[p4l2033t1472r2151b1520],
20	1-26	CD	NUMBER	1-26	num	21	SENT_74	[p4l647t1552r759b1596],
21	g/L	NN	O	g/l	prep_than	18	SENT_74	[p4l790t1553r879b1611],
22	on	IN	O	on	_	0	SENT_74	[p4l908t1565r973b1595],
23	two	CD	NUMBER	two	num	25	SENT_74	[p4l1002t1557r1093b1596],
24	blood	NN	O	blood	nn	25	SENT_74	[p4l1123t1548r1267b1596],
25	samplings	NNS	O	sampling	prep_on	21	SENT_74	[p4l1298t1548r1576b1611],
26	.	.	O	.	_	0	SENT_74	[p4l1298t1548r1576b1611],

1	Smoking	NN	O	smoking	nn	2	SENT_75	[p4l1613t1548r1845b1611],
2	status	NN	O	status	nsubjpass	4	SENT_75	[p4l1876t1557r2022b1596],
3	was	VBD	O	be	auxpass	4	SENT_75	[p4l2052t1565r2149b1596],
4	recorded	VBN	O	record	_	0	SENT_75	[p4l645t1624r872b1672],
5	as	IN	O	as	_	0	SENT_75	[p4l885t1641r935b1672],
6	active	JJ	O	active	prep_as	4	SENT_75	[p4l952t1628r1095b1672],
7	or	CC	O	or	_	0	SENT_75	[p4l1110t1641r1163b1672],
8	not	RB	O	not	prep_as	4	SENT_75	[p4l1176t1634r1272b1672],
9	.	.	O	.	_	0	SENT_75	[p4l1176t1634r1272b1672],

1	Familial	JJ	MISC	familial	amod	2	SENT_76	[p4l1292t1624r1497b1672],
2	history	NN	O	history	nsubjpass	8	SENT_76	[p4l1510t1624r1688b1687],
3	of	IN	O	of	_	0	SENT_76	[p4l1702t1624r1759b1672],
4	coronary	JJ	O	coronary	amod	6	SENT_76	[p4l1765t1641r1991b1687],
5	artery	NN	O	artery	nn	6	SENT_76	[p4l2004t1634r2152b1687],
6	disease	NN	O	disease	prep_of	2	SENT_76	[p4l9t2029r270b2098],
7	was	VBD	O	be	auxpass	8	SENT_76	[p4l293t2054r429b2098],
8	deﬁned	VBN	O	deﬁned	_	0	SENT_76	[p4l456t2029r730b2098],
9	as	IN	O	as	_	0	SENT_76	[p4l754t2054r824b2098],
10	any	DT	O	any	det	12	SENT_76	[p4l852t2054r980b2119],
11	coronary	JJ	O	coronary	amod	12	SENT_76	[p4l1002t2054r1322b2119],
12	event	NN	O	event	prep_as	8	SENT_76	[p4l1345t2043r1539b2098],
13	that	WDT	O	that	nsubj	14	SENT_76	[p4l1560t2029r1702b2098],
14	occurred	VBD	O	occur	rcmod	12	SENT_76	[p4l1724t2029r2044b2098],
15	in	IN	O	in	_	0	SENT_76	[p4l2067t2034r2140b2096],
16	ﬁrst-degree	JJ	O	ﬁrst-degree	amod	17	SENT_76	[p4l8t2138r420b2228],
17	relatives	NNS	O	relative	prep_in	14	SENT_76	[p4l443t2138r740b2206],
18	of	IN	O	of	_	0	SENT_76	[p4l765t2138r847b2206],
19	the	DT	O	the	det	20	SENT_76	[p4l854t2138r968b2206],
20	patient	NN	O	patient	prep_of	17	SENT_76	[p4l991t2143r1245b2227],
21	before	IN	O	before	_	0	SENT_76	[p4l1263t2138r1494b2206],
22	60	CD	DURATION	60	num	23	SENT_76	[p4l1517t2144r1600b2206],
23	years	NNS	NUMBER	year	prep_before	14	SENT_76	[p4l1621t2162r1807b2228],
24	of	IN	O	of	_	0	SENT_76	[p4l1832t2138r1914b2206],
25	age	NN	O	age	prep_of	23	SENT_76	[p4l1923t2162r2044b2228],
26	in	IN	O	in	_	0	SENT_76	[p4l2067t2143r2140b2205],
27	men	NNS	O	man	prep_in	25	SENT_76	[p4l8t2272r176b2316],
28	and	CC	O	and	_	0	SENT_76	[p4l205t2248r341b2316],
29	65	CD	DURATION	65	num	30	SENT_76	[p4l369t2252r450b2316],
30	years	NNS	NUMBER	year	prep_of	23	SENT_76	[p4l480t2272r665b2337],
31	in	IN	O	in	_	0	SENT_76	[p4l695t2252r769b2314],
32	women	NNS	O	woman	prep_in	30	SENT_76	[p4l795t2272r1088b2316],
33	.	.	O	.	_	0	SENT_76	[p4l795t2272r1088b2316],

1	A	DT	O	a	det	4	SENT_77	[p4l1119t2253r1179b2314],
2	fasting	JJ	O	fasting	amod	4	SENT_77	[p4l1206t2247r1454b2337],
3	blood	NN	O	blood	nn	4	SENT_77	[p4l1480t2247r1685b2316],
4	sample	NN	O	sample	nsubjpass	6	SENT_77	[p4l1715t2248r1974b2336],
5	was	VBD	O	be	auxpass	6	SENT_77	[p4l2001t2272r2137b2316],
6	taken	VBN	O	take	_	0	SENT_77	[p4l7t2357r208b2426],
7	for	IN	O	for	_	0	SENT_77	[p4l249t2357r353b2426],
8	plasma	NN	O	plasma	nn	9	SENT_77	[p4l392t2357r655b2446],
9	determination	NN	O	determination	prep_for	6	SENT_77	[p4l696t2357r1218b2426],
10	of	IN	O	of	_	0	SENT_77	[p4l1260t2357r1342b2426],
11	classic	JJ	O	classic	amod	15	SENT_77	[p4l1370t2357r1603b2426],
12	and	CC	O	and	_	0	SENT_77	[p4l1644t2357r1780b2426],
13	rare	JJ	O	rare	conj_and	11	SENT_77	[p4l1819t2382r1963b2426],
14	risk	NN	O	risk	nn	15	SENT_77	[p4l2004t2357r2142b2426],
15	factors	NNS	O	factor	prep_of	9	SENT_77	[p4l8t2466r249b2534],
16	of	IN	O	of	_	0	SENT_77	[p4l276t2466r358b2534],
17	coronary	JJ	O	coronary	amod	19	SENT_77	[p4l369t2490r689b2555],
18	artery	NN	O	artery	nn	19	SENT_77	[p4l712t2479r921b2556],
19	disease	NN	O	disease	prep_of	15	SENT_77	[p4l944t2466r1204b2534],
20	and	CC	O	and	_	0	SENT_77	[p4l1230t2466r1366b2534],
21	for	IN	O	for	_	0	SENT_77	[p4l1388t2466r1492b2534],
22	DNA	NN	MISC	dna	nn	23	SENT_77	[p4l1518t2471r1703b2534],
23	analysis	NN	O	analysis	prep_for	6	SENT_77	[p4l1726t2466r2031b2555],
24	.	.	O	.	_	0	SENT_77	[p4l1726t2466r2031b2555],

1	Follow-up	JJ	O	follow-up	nsubj	5	SENT_78	[p4l83t2575r449b2664],
2	was	VBD	O	be	cop	5	SENT_78	[p4l471t2600r610b2644],
3	every	DT	SET	every	quantmod	4	SENT_78	[p4l638t2600r831b2665],
4	6	CD	SET	6	num	5	SENT_78	[p4l855t2582r893b2644],
5	months	NNS	NUMBER	month	_	0	SENT_78	[p4l919t2576r1227b2654],
6	,	,	O	,	_	0	SENT_78	[p4l919t2576r1227b2654],
7	with	IN	O	with	_	0	SENT_78	[p4l1252t2576r1417b2644],
8	a	DT	O	a	det	10	SENT_78	[p4l1442t2600r1479b2644],
9	detailed	JJ	O	detailed	amod	10	SENT_78	[p4l1504t2575r1796b2644],
10	report	NN	O	report	prep_with	5	SENT_78	[p4l1819t2589r2047b2664],
11	of	IN	O	of	_	0	SENT_78	[p4l2070t2575r2153b2644],
12	drug	NN	O	drug	nn	13	SENT_78	[p4l9t2684r184b2774],
13	treatment	NN	O	treatment	prep_of	10	SENT_78	[p4l207t2698r593b2752],
14	.	.	O	.	_	0	SENT_78	[p4l207t2698r593b2752],

1	We	PRP	O	we	nsubj	2	SENT_79	[p4l620t2691r738b2753],
2	calculated	VBD	O	calculate	_	0	SENT_79	[p4l764t2684r1136b2752],
3	a	DT	O	a	det	5	SENT_79	[p4l1160t2709r1197b2752],
4	precise	JJ	O	precise	amod	5	SENT_79	[p4l1221t2689r1484b2773],
5	determination	NN	O	determination	dobj	2	SENT_79	[p4l1510t2684r2044b2752],
6	of	IN	O	of	_	0	SENT_79	[p4l2070t2684r2153b2752],
7	the	DT	O	the	det	8	SENT_79	[p4l7t2793r124b2861],
8	duration	NN	O	duration	prep_of	5	SENT_79	[p4l156t2793r476b2861],
9	of	IN	O	of	_	0	SENT_79	[p4l507t2793r591b2861],
10	exposure	NN	O	exposure	prep_of	8	SENT_79	[p4l610t2817r943b2882],
11	to	TO	O	to	_	0	SENT_79	[p4l974t2806r1042b2861],
12	clopidogrel	NN	O	clopidogrel	prep_to	2	SENT_79	[p4l1076t2793r1491b2883],
13	for	IN	O	for	_	0	SENT_79	[p4l1522t2793r1628b2861],
14	every	DT	O	every	det	18	SENT_79	[p4l1659t2817r1852b2882],
15	patient	NN	O	patient	nn	18	SENT_79	[p4l1881t2798r2141b2882],
16	(	CD	NUMBER	(	num	18	SENT_79	[p4l14t2902r185b2992],
17	ﬁrst	NN	O	ﬁrst	nn	18	SENT_79	[p4l14t2902r185b2992],
18	date	NN	O	date	prep_for	12	SENT_79	[p4l220t2902r371b2971],
19	of	IN	O	of	_	0	SENT_79	[p4l408t2902r491b2971],
20	prescription	NN	O	prescription	prep_of	18	SENT_79	[p4l513t2907r967b2991],
21	to	TO	O	to	aux	22	SENT_79	[p4l1000t2916r1069b2971],
22	end	VB	O	end	xcomp	2	SENT_79	[p4l1107t2902r1245b2971],
23	of	IN	O	of	_	0	SENT_79	[p4l1279t2902r1362b2971],
24	treatment	NN	O	treatment	prep_of	22	SENT_79	[p4l1383t2916r1752b2971],
25	or	CC	O	or	_	0	SENT_79	[p4l1786t2927r1862b2971],
26	end	NN	O	end	prep_of	22	SENT_79	[p4l1897t2902r2035b2971],
27	of	IN	O	of	_	0	SENT_79	[p4l2070t2902r2153b2971],
28	follow-up	NN	O	follow-up	prep_of	24	SENT_79	[p4l8t3011r359b3100],
29	when	WRB	O	when	advmod	33	SENT_79	[p4l399t3011r607b3079],
30	they	PRP	O	they	nsubj	33	SENT_79	[p4l646t3011r805b3101],
31	were	VBD	O	be	aux	33	SENT_79	[p4l842t3036r1020b3079],
32	still	RB	O	still	advmod	33	SENT_79	[p4l1064t3011r1197b3079],
33	receiving	VBG	O	receive	advcl	22	SENT_79	[p4l1237t3016r1577b3101],
34	clopidogrel	NN	O	clopidogrel	dobj	33	SENT_79	[p4l1619t3011r2035b3101],
35	at	IN	O	at	_	0	SENT_79	[p4l2076t3025r2141b3079],
36	the	DT	O	the	det	40	SENT_79	[p4l7t3121r124b3189],
37	study	NN	O	study	nn	40	SENT_79	[p4l170t3121r369b3210],
38	cut-off	JJ	O	cut-off	amod	40	SENT_79	[p4l410t3121r662b3189],
39	date	NN	O	date	nn	40	SENT_79	[p4l693t3121r892b3211],
40	)	NN	O	)	prep_at	33	SENT_79	[p4l693t3121r892b3211],
41	.	.	O	.	_	0	SENT_79	[p4l693t3121r892b3211],

1	We	PRP	O	we	nsubj	2	SENT_80	[p4l937t3127r1054b3189],
2	used	VBD	O	use	_	0	SENT_80	[p4l1096t3121r1273b3189],
3	time	NN	O	time	nn	4	SENT_80	[p4l1314t3125r1483b3188],
4	delays	NNS	O	delay	dobj	2	SENT_80	[p4l1527t3121r1752b3210],
5	from	IN	O	from	_	0	SENT_80	[p4l1797t3121r1982b3188],
6	the	DT	O	the	det	8	SENT_80	[p4l2023t3121r2139b3189],
7	qualifying	VBG	O	qualify	amod	8	SENT_80	[p4l9t3229r385b3319],
8	event	NN	O	event	conj_and	8	SENT_80	[p4l421t3243r620b3298],
9	to	TO	O	to	_	0	SENT_80	[p4l651t3243r720b3298],
10	initiation	NN	O	initiation	prep_to	8	SENT_80	[p4l756t3234r1099b3298],
11	of	IN	O	of	_	0	SENT_80	[p4l1134t3229r1217b3298],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_80	[p4l1239t3229r1655b3319],
13	therapy	NN	O	therapy	prep_of	10	SENT_80	[p4l1687t3229r1970b3319],
14	and	CC	O	and	_	0	SENT_80	[p4l2003t3230r2141b3298],
15	from	IN	O	from	_	0	SENT_80	[p4l8t3338r193b3406],
16	interruption	NN	O	interruption	prep_from	8	SENT_80	[p4l225t3343r684b3427],
17	of	IN	O	of	_	0	SENT_80	[p4l717t3338r800b3406],
18	clopidogrel	NN	O	clopidogrel	prep_of	16	SENT_80	[p4l820t3338r1235b3428],
19	to	TO	O	to	_	0	SENT_80	[p4l1265t3352r1334b3406],
20	the	DT	O	the	det	21	SENT_80	[p4l1366t3338r1483b3406],
21	end	NN	O	end	prep_to	2	SENT_80	[p4l1516t3338r1654b3406],
22	of	IN	O	of	_	0	SENT_80	[p4l1686t3338r1769b3406],
23	follow-up	NN	O	follow-up	prep_of	21	SENT_80	[p4l1788t3338r2139b3427],
24	as	IN	O	as	_	0	SENT_80	[p4l9t3473r81b3517],
25	adjustment	NN	O	adjustment	nn	26	SENT_80	[p4l168t3449r594b3538],
26	variables	NNS	O	variable	prep_as	2	SENT_80	[p4l673t3449r1021b3517],
27	.	.	O	.	_	0	SENT_80	[p4l673t3449r1021b3517],

1	All	DT	O	all	det	3	SENT_81	[p4l1107t3449r1214b3516],
2	clinical	JJ	O	clinical	amod	3	SENT_81	[p4l1297t3449r1562b3517],
3	events	NNS	O	event	nsubjpass	5	SENT_81	[p4l1645t3462r1878b3517],
4	were	VBD	O	be	auxpass	5	SENT_81	[p4l1961t3473r2139b3517],
5	adjudicated	VBN	O	adjudicate	_	0	SENT_81	[p4l9t3557r439b3647],
6	by	IN	O	by	_	0	SENT_81	[p4l472t3557r559b3647],
7	two	CD	NUMBER	two	num	9	SENT_81	[p4l590t3571r723b3626],
8	independent	JJ	O	independent	amod	9	SENT_81	[p4l758t3557r1233b3646],
9	cardiologists	NNS	O	cardiologist	agent	5	SENT_81	[p4l1267t3557r1735b3647],
10	who	WP	O	who	nsubjpass	12	SENT_81	[p4l1770t3557r1927b3626],
11	were	VBD	O	be	auxpass	12	SENT_81	[p4l1961t3582r2139b3626],
12	blinded	VBN	O	blind	rcmod	9	SENT_81	[p4l7t3666r292b3734],
13	to	TO	O	to	_	0	SENT_81	[p4l315t3680r384b3734],
14	the	DT	O	the	det	16	SENT_81	[p4l410t3666r527b3734],
15	genetic	JJ	O	genetic	amod	16	SENT_81	[p4l554t3671r821b3756],
16	analysis	NN	O	analysis	prep_to	12	SENT_81	[p4l847t3666r1160b3756],
17	.	.	O	.	_	0	SENT_81	[p4l847t3666r1160b3756],

1	Genotyping	NN	O	genotyping	nn	5	SENT_82	[p5l10t100r457b187],
2	and	CC	O	and	_	0	SENT_82	[p5l482t97r624b166],
3	biological	JJ	O	biological	conj_and	1	SENT_82	[p5l647t97r1010b187],
4	risk	NN	O	risk	nn	5	SENT_82	[p5l1039t97r1169b166],
5	factors	NNS	O	factor	nsubj	18	SENT_82	[p5l1187t96r1451b166],
6	Genomic	JJ	O	genomic	amod	7	SENT_82	[p5l11t212r348b276],
7	DNA	NN	O	dna	nsubjpass	9	SENT_82	[p5l416t212r602b276],
8	was	VBD	O	be	auxpass	9	SENT_82	[p5l664t232r801b276],
9	extracted	VBN	O	extract	rcmod	5	SENT_82	[p5l869t207r1197b276],
10	from	IN	O	from	_	0	SENT_82	[p5l1260t207r1442b276],
11	peripherial-blood	JJ	O	peripherial-blood	amod	12	SENT_82	[p5l1506t207r2141b296],
12	leucocytes	NNS	O	leucocyte	prep_from	9	SENT_82	[p5l7t316r381b406],
13	by	IN	O	by	_	0	SENT_82	[p5l408t316r495b406],
14	use	NN	O	use	agent	9	SENT_82	[p5l518t340r644b384],
15	of	IN	O	of	_	0	SENT_82	[p5l671t316r754b384],
16	standard	JJ	O	standard	amod	17	SENT_82	[p5l769t316r1088b384],
17	procedures	NNS	O	procedure	prep_of	14	SENT_82	[p5l1112t316r1520b405],
18	(	VBP	O	(	_	0	SENT_82	[p5l1554t323r1925b406],
19	Puregene	JJ	O	puregene	amod	22	SENT_82	[p5l1554t323r1925b406],
20	DNA	NN	O	dna	nn	22	SENT_82	[p5l1955t321r2141b384],
21	isolation	NN	O	isolation	nn	22	SENT_82	[p5l8t426r323b494],
22	kit	NN	O	kit	dobj	18	SENT_82	[p5l360t426r473b504],
23	,	,	O	,	_	0	SENT_82	[p5l360t426r473b504],
24	Merck	NNP	PERSON	Merck	nn	29	SENT_82	[p5l518t426r749b494],
25	Eurolab	NNP	PERSON	Eurolab	nn	29	SENT_82	[p5l791t426r1092b504],
26	,	,	O	,	_	0	SENT_82	[p5l791t426r1092b504],
27	Lyon	NNP	LOCATION	Lyon	appos	29	SENT_82	[p5l1139t432r1329b515],
28	,	,	O	,	_	0	SENT_82	[p5l1139t432r1329b515],
29	France	NNP	LOCATION	France	appos	22	SENT_82	[p5l1375t430r1662b516],
30	)	CD	NUMBER	)	num	29	SENT_82	[p5l1375t430r1662b516],
31	.	.	O	.	_	0	SENT_82	[p5l1375t430r1662b516],

1	C	NN	O	c	dep	13	SENT_83	[p5l1712t431r1766b494],
2	YP2C19	NN	O	yp2c19	dep	1	SENT_83	[p5l1772t430r2144b494],
3	"	''	O	"	punct	2	SENT_83	[p5l1772t430r2144b494],
4	2	CD	NUMBER	2	number	5	SENT_83	[p5l1772t430r2144b494],
5	(	CD	NUMBER	(	num	6	SENT_83	[p5l14t539r350b624],
6	681G	NN	O	681g	npadvmod	7	SENT_83	[p5l14t539r350b624],
7	>	JJR	O	>	dep	2	SENT_83	[p5l14t539r350b624],
8	A	DT	O	a	dep	7	SENT_83	[p5l14t539r350b624],
9	;	:	O	;	_	0	SENT_83	[p5l14t539r350b624],
10	rs4244285	NN	O	rs4244285	nn	11	SENT_83	[p5l384t539r767b624],
11	)	NN	O	)	nsubjpass	13	SENT_83	[p5l384t539r767b624],
12	was	VBD	O	be	auxpass	13	SENT_83	[p5l802t559r939b603],
13	genotyped	VBN	O	genotype	_	0	SENT_83	[p5l973t534r1352b624],
14	with	IN	O	with	_	0	SENT_83	[p5l1379t534r1543b603],
15	a	DT	O	a	det	17	SENT_83	[p5l1574t559r1611b603],
16	commercially	RB	O	commercially	advmod	17	SENT_83	[p5l1642t534r2142b624],
17	available	JJ	O	available	prep_with	13	SENT_83	[p5l9t643r323b711],
18	validated	VBN	O	validate	partmod	17	SENT_83	[p5l378t643r706b711],
19	drug	NN	O	drug	nn	28	SENT_83	[p5l761t643r933b733],
20	metabolism	NN	O	metabolism	nn	28	SENT_83	[p5l988t643r1426b711],
21	genotyping	NN	O	genotyping	nn	28	SENT_83	[p5l1482t648r1894b733],
22	assay	NN	O	assay	nn	28	SENT_83	[p5l1950t667r2142b733],
23	(	CD	NUMBER	(	num	28	SENT_83	[p5l14t756r334b842],
24	TaqMan	NNP	O	TaqMan	nn	28	SENT_83	[p5l14t756r334b842],
25	Validated	NNP	O	Validated	nn	28	SENT_83	[p5l372t752r714b820],
26	SNP	NN	O	snp	nn	28	SENT_83	[p5l758t757r916b819],
27	assays	NNS	O	assay	nn	28	SENT_83	[p5l960t776r1184b841],
28	C_25986767_70	NN	O	c_25986767_70	dobj	18	SENT_83	[p5l1230t756r1812b830],
29	,	,	O	,	_	0	SENT_83	[p5l1230t756r1812b830],
30	Applied	NNP	ORGANIZATION	Applied	nn	31	SENT_83	[p5l1855t752r2141b841],
31	Biosystems	NNP	ORGANIZATION	Biosystems	appos	28	SENT_83	[p5l13t866r443b951],
32	,	,	O	,	_	0	SENT_83	[p5l13t866r443b951],
33	Foster	NNP	LOCATION	Foster	nn	34	SENT_83	[p5l507t866r731b930],
34	City	NNP	LOCATION	City	appos	28	SENT_83	[p5l788t866r943b951],
35	,	,	O	,	_	0	SENT_83	[p5l788t866r943b951],
36	CA	NNP	LOCATION	CA	appos	28	SENT_83	[p5l1005t866r1137b940],
37	,	,	O	,	_	0	SENT_83	[p5l1005t866r1137b940],
38	USA	NNP	LOCATION	USA	appos	28	SENT_83	[p5l1201t866r1394b951],
39	)	CD	NUMBER	)	num	38	SENT_83	[p5l1201t866r1394b951],
40	with	IN	O	with	_	0	SENT_83	[p5l1454t861r1618b930],
41	the	DT	O	the	det	42	SENT_83	[p5l1673t861r1788b930],
42	790OHT	NN	O	790oht	prep_with	18	SENT_83	[p5l1844t866r2141b932],
43	sequence	NN	O	sequence	nn	49	SENT_83	[p5l11t994r350b1059],
44	detection	NN	O	detection	nn	49	SENT_83	[p5l413t970r748b1038],
45	system	NN	O	system	nn	49	SENT_83	[p5l811t983r1065b1059],
46	(	CD	NUMBER	(	num	49	SENT_83	[p5l1131t970r1438b1060],
47	Applied	NNP	O	Applied	nn	49	SENT_83	[p5l1131t970r1438b1060],
48	Biosystems	NNP	O	Biosystems	nn	49	SENT_83	[p5l1502t975r1958b1060],
49	)	NN	O	)	dep	42	SENT_83	[p5l1502t975r1958b1060],
50	.	.	O	.	_	0	SENT_83	[p5l1502t975r1958b1060],

1	We	PRP	O	we	nsubj	2	SENT_84	[p5l2022t977r2139b1039],
2	undertook	VBD	O	undertake	_	0	SENT_84	[p5l7t1080r391b1149],
3	a	DT	O	a	det	6	SENT_84	[p5l423t1105r461b1149],
4	real-time	JJ	O	real-time	amod	6	SENT_84	[p5l494t1080r822b1149],
5	PCR	NN	O	pcr	nn	6	SENT_84	[p5l860t1086r1025b1149],
6	ampliﬁcation	NN	O	ampliﬁcation	dobj	2	SENT_84	[p5l1058t1080r1546b1169],
7	with	IN	O	with	_	0	SENT_84	[p5l1577t1081r1740b1149],
8	sequencespeciﬁc	NN	O	sequencespeciﬁc	nn	9	SENT_84	[p5l1776t1105r2138b1169, p5l11t1189r284b1278],
9	primers	NNS	O	primer	prep_with	2	SENT_84	[p5l338t1194r628b1278],
10	for	IN	O	for	_	0	SENT_84	[p5l685t1189r791b1258],
11	amplifying	VBG	O	amplify	prepc_for	2	SENT_84	[p5l845t1189r1244b1279],
12	the	DT	O	the	det	13	SENT_84	[p5l1297t1189r1412b1258],
13	polymorphism	NN	O	polymorphism	dep	32	SENT_84	[p5l1468t1189r2014b1279],
14	of	IN	O	of	_	0	SENT_84	[p5l2070t1189r2153b1258],
15	interest	NN	O	interest	prep_of	13	SENT_84	[p5l8t1304r287b1367],
16	and	CC	O	and	_	0	SENT_84	[p5l401t1299r537b1367],
17	two	CD	NUMBER	two	num	22	SENT_84	[p5l649t1312r779b1367],
18	allele-speciﬁc	JJ	O	allele-speciﬁc	amod	22	SENT_84	[p5l896t1299r1385b1388],
19	TaqMan	NNP	O	TaqMan	nn	22	SENT_84	[p5l1497t1303r1797b1388],
20	minor	JJ	O	minor	amod	22	SENT_84	[p5l1910t1304r2141b1367],
21	groove-binding	JJ	O	groove-binding	amod	22	SENT_84	[p5l10t1408r567b1498],
22	probes	NNS	O	probe	conj_and	13	SENT_84	[p5l646t1408r891b1497],
23	for	IN	O	for	_	0	SENT_84	[p5l973t1408r1077b1477],
24	detection	NN	O	detection	prep_for	22	SENT_84	[p5l1156t1408r1492b1477],
25	of	IN	O	of	_	0	SENT_84	[p5l1572t1408r1654b1477],
26	the	DT	O	the	det	27	SENT_84	[p5l1719t1409r1834b1477],
27	alleles	NNS	O	allele	prep_of	24	SENT_84	[p5l1915t1409r2137b1477],
28	for	IN	O	for	_	0	SENT_84	[p5l8t1518r114b1587],
29	CYP2C19	NN	O	cyp2c19	prep_for	27	SENT_84	[p5l143t1523r589b1587],
30	"	''	O	"	punct	29	SENT_84	[p5l143t1523r589b1587],
31	"	``	O	"	punct	32	SENT_84	[p5l143t1523r589b1587],
32	2	LS	NUMBER	2	dep	11	SENT_84	[p5l143t1523r589b1587],
33	.	.	O	.	_	0	SENT_84	[p5l143t1523r589b1587],

1	Ampliﬁcation	NN	O	ampliﬁcation	nsubjpass	3	SENT_85	[p5l616t1518r1125b1607],
2	was	VBD	O	be	auxpass	3	SENT_85	[p5l1147t1542r1284b1587],
3	done	VBN	O	do	_	0	SENT_85	[p5l1313t1518r1492b1587],
4	in	IN	O	in	_	0	SENT_85	[p5l1517t1523r1591b1585],
5	a	DT	O	a	det	7	SENT_85	[p5l1616t1543r1653b1587],
6	ﬁnal	JJ	O	ﬁnal	amod	7	SENT_85	[p5l1678t1518r1842b1587],
7	volume	NN	O	volume	prep_in	3	SENT_85	[p5l1864t1518r2139b1587],
8	of	IN	O	of	_	0	SENT_85	[p5l9t1627r92b1695],
9	25	CD	NUMBER	25	num	10	SENT_85	[p5l115t1631r194b1694],
10	ul	NN	O	ul	prep_of	7	SENT_85	[p5l234t1627r303b1713],
11	in	IN	O	in	_	0	SENT_85	[p5l336t1632r409b1694],
12	accordance	NN	O	accordance	prep_in	10	SENT_85	[p5l443t1627r850b1695],
13	with	IN	O	with	_	0	SENT_85	[p5l882t1627r1045b1695],
14	manufacturer	NN	O	manufacturer	poss	16	SENT_85	[p5l1078t1627r1641b1695],
15	’s	POS	O	’s	_	0	SENT_85	[p5l1078t1627r1641b1695],
16	instructions	NNS	O	instruction	prep_with	3	SENT_85	[p5l1676t1632r2136b1695],
17	.	.	O	.	_	0	SENT_85	[p5l1676t1632r2136b1695],

1	After	IN	O	after	_	0	SENT_86	[p5l7t1736r194b1805],
2	PCR	NN	O	pcr	prep_after	12	SENT_86	[p5l233t1742r415b1815],
3	,	,	O	,	_	0	SENT_86	[p5l233t1742r415b1815],
4	ﬂuorescence	NN	O	ﬂuorescence	nn	5	SENT_86	[p5l456t1736r918b1805],
5	yield	NN	O	yield	nsubjpass	12	SENT_86	[p5l954t1737r1130b1826],
6	for	IN	O	for	_	0	SENT_86	[p5l1165t1736r1270b1805],
7	the	DT	O	the	det	10	SENT_86	[p5l1304t1736r1419b1805],
8	two	CD	NUMBER	two	num	10	SENT_86	[p5l1455t1750r1587b1805],
9	different	JJ	O	different	amod	10	SENT_86	[p5l1626t1736r1943b1805],
10	dyes	NNS	O	dye	prep_for	5	SENT_86	[p5l1979t1737r2137b1826],
11	was	VBD	O	be	auxpass	12	SENT_86	[p5l7t1869r144b1913],
12	measured	VBN	O	measure	dep	29	SENT_86	[p5l173t1845r539b1913],
13	and	CC	O	and	_	0	SENT_86	[p5l566t1845r702b1913],
14	presented	VBN	O	present	conj_and	12	SENT_86	[p5l727t1845r1091b1934],
15	in	IN	O	in	_	0	SENT_86	[p5l1116t1850r1190b1912],
16	a	DT	O	a	det	18	SENT_86	[p5l1218t1870r1254b1913],
17	two-dimensional	JJ	O	two-dimensional	amod	18	SENT_86	[p5l1280t1845r1900b1913],
18	graph	NN	O	graph	prep_in	12	SENT_86	[p5l1928t1845r2140b1935],
19	to	TO	O	to	aux	20	SENT_86	[p5l7t1969r76b2024],
20	obtain	VB	O	obtain	infmod	18	SENT_86	[p5l136t1956r366b2024],
21	the	DT	O	the	det	24	SENT_86	[p5l423t1956r539b2024],
22	allelic	JJ	O	allelic	amod	24	SENT_86	[p5l599t1956r809b2024],
23	discrimination	NN	O	discrimination	nn	24	SENT_86	[p5l868t1956r1411b2024],
24	plot	NN	O	plot	dobj	20	SENT_86	[p5l1468t1956r1609b2045],
25	and	CC	O	and	_	0	SENT_86	[p5l1667t1956r1804b2024],
26	identify	VB	O	identify	conj_and	20	SENT_86	[p5l1861t1956r2142b2045],
27	individual	JJ	O	individual	amod	28	SENT_86	[p5l8t2064r378b2133],
28	genotypes	NNS	O	genotype	dobj	26	SENT_86	[p5l476t2078r841b2154],
29	(	VBP	O	(	_	0	SENT_86	[p5l946t2070r1125b2154],
30	SDS	NN	O	sd	dobj	29	SENT_86	[p5l946t2070r1125b2154],
31	2.3	CD	NUMBER	2.3	num	32	SENT_86	[p5l1228t2071r1329b2133],
32	software	NN	O	software	nsubj	29	SENT_86	[p5l1432t2064r1757b2143],
33	,	,	O	,	_	0	SENT_86	[p5l1432t2064r1757b2143],
34	Applied	NNP	O	Applied	nn	35	SENT_86	[p5l1855t2064r2141b2153],
35	Biosystems	NNP	O	Biosystems	appos	32	SENT_86	[p5l13t2178r469b2263],
36	)	NN	O	)	dep	35	SENT_86	[p5l13t2178r469b2263],
37	.	.	O	.	_	0	SENT_86	[p5l13t2178r469b2263],

1	We	PRP	O	we	nsubj	3	SENT_87	[p5l507t2180r624b2242],
2	further	RB	O	further	advmod	3	SENT_87	[p5l659t2173r920b2241],
3	genotyped	VBD	O	genotype	_	0	SENT_87	[p5l954t2173r1333b2263],
4	all	DT	O	all	det	5	SENT_87	[p5l1367t2173r1451b2241],
5	patients	NNS	O	patient	dobj	3	SENT_87	[p5l1484t2178r1773b2262],
6	for	IN	O	for	_	0	SENT_87	[p5l1810t2173r1915b2241],
7	other	JJ	O	other	amod	46	SENT_87	[p5l1948t2173r2141b2241],
8	non-functional	JJ	O	non-functional	amod	9	SENT_87	[p5l8t2283r556b2350],
9	(	CD	NUMBER	(	dep	7	SENT_87	[p5l588t2287r714b2373],
10	"	``	O	"	punct	9	SENT_87	[p5l588t2287r714b2373],
11	"	``	O	"	punct	12	SENT_87	[p5l588t2287r714b2373],
12	3	CD	NUMBER	3	dep	9	SENT_87	[p5l588t2287r714b2373],
13	,	,	O	,	_	0	SENT_87	[p5l588t2287r714b2373],
14	*	CD	NUMBER	*	num	15	SENT_87	[p5l745t2287r844b2361],
15	4	CD	NUMBER	4	appos	9	SENT_87	[p5l745t2287r844b2361],
16	,	,	O	,	_	0	SENT_87	[p5l745t2287r844b2361],
17	*	CD	NUMBER	*	num	18	SENT_87	[p5l875t2287r978b2361],
18	5	CD	NUMBER	5	appos	15	SENT_87	[p5l875t2287r978b2361],
19	,	,	O	,	_	0	SENT_87	[p5l875t2287r978b2361],
20	*	CD	NUMBER	*	number	21	SENT_87	[p5l1009t2287r1115b2373],
21	6	CD	NUMBER	6	num	25	SENT_87	[p5l1009t2287r1115b2373],
22	)	NN	O	)	nn	25	SENT_87	[p5l1009t2287r1115b2373],
23	C	NN	O	c	nn	25	SENT_87	[p5l1155t2288r1209b2351],
24	YPZCJ9	NN	O	ypzcj9	nn	25	SENT_87	[p5l1215t2288r1498b2351],
25	variants	NNS	O	variant	appos	15	SENT_87	[p5l1519t2287r1808b2351],
26	with	IN	O	with	_	0	SENT_87	[p5l1836t2283r1999b2351],
27	the	DT	O	the	det	31	SENT_87	[p5l2024t2283r2139b2350],
28	same	JJ	O	same	amod	31	SENT_87	[p5l11t2416r202b2460],
29	method	NN	O	method	nn	31	SENT_87	[p5l281t2391r567b2460],
30	(	NN	O	(	nn	31	SENT_87	[p5l651t2396r970b2481],
31	TaqMan	NN	O	taqman	prep_with	25	SENT_87	[p5l651t2396r970b2481],
32	Validated	VBN	O	validate	partmod	31	SENT_87	[p5l1047t2391r1388b2460],
33	SNP	NN	O	snp	nn	34	SENT_87	[p5l1472t2397r1629b2460],
34	assays	NNS	O	assay	dobj	32	SENT_87	[p5l1711t2416r1957b2481],
35	:	:	O	:	_	0	SENT_87	[p5l1711t2416r1957b2481],
36	C	NN	O	c	dep	15	SENT_87	[p5l2042t2397r2142b2463],
37	_	CD	NUMBER	_	num	36	SENT_87	[p5l2042t2397r2142b2463],
38	27861809_10	CD	NUMBER	27861809_10	dep	36	SENT_87	[p5l11t2505r487b2578],
39	,	,	O	,	_	0	SENT_87	[p5l11t2505r487b2578],
40	C_30634136_10	NN	O	c_30634136_10	conj_and	38	SENT_87	[p5l555t2505r1136b2578],
41	,	,	O	,	_	0	SENT_87	[p5l555t2505r1136b2578],
42	C_27861810_10	NN	O	c_27861810_10	dep	36	SENT_87	[p5l1204t2505r1775b2578],
43	,	,	O	,	_	0	SENT_87	[p5l1204t2505r1775b2578],
44	and	CC	O	and	_	0	SENT_87	[p5l1842t2500r1978b2568],
45	C	NN	O	c	dep	36	SENT_87	[p5l2042t2505r2142b2572],
46	_	NN	O	_	prep_for	5	SENT_87	[p5l2042t2505r2142b2572],

1	27531918_10	CD	NUMBER	27531918_10	_	0	SENT_88	[p5l11t2614r478b2688],
2	,	,	O	,	_	0	SENT_88	[p5l11t2614r478b2688],
3	respectively	RB	O	respectively	advmod	4	SENT_88	[p5l516t2610r988b2700],
4	)	CD	NUMBER	)	rcmod	1	SENT_88	[p5l516t2610r988b2700],
5	.	.	O	.	_	0	SENT_88	[p5l516t2610r988b2700],

1	The	DT	O	the	det	2	SENT_89	[p5l1024t2610r1167b2678],
2	frequency	NN	O	frequency	_	0	SENT_89	[p5l1201t2610r1569b2699],
3	of	IN	O	of	_	0	SENT_89	[p5l1602t2610r1684b2677],
4	CYP2C19	NN	O	cyp2c19	nn	6	SENT_89	[p5l1712t2614r2144b2678],
5	*	CD	NUMBER	*	num	6	SENT_89	[p5l1712t2614r2144b2678],
6	‘	NN	O	‘	prep_of	2	SENT_89	[p5l1712t2614r2144b2678],
7	2	CD	NUMBER	2	num	9	SENT_89	[p5l1712t2614r2144b2678],
8	variant	JJ	O	variant	amod	9	SENT_89	[p5l7t2724r262b2788],
9	allele	NN	O	allele	nsubjpass	11	SENT_89	[p5l314t2719r502b2788],
10	is	VBZ	O	be	auxpass	11	SENT_89	[p5l555t2724r612b2788],
11	reported	VBN	O	report	rcmod	2	SENT_89	[p5l667t2719r979b2808],
12	to	TO	O	to	aux	16	SENT_89	[p5l1029t2733r1098b2788],
13	be	VB	O	be	cop	16	SENT_89	[p5l1150t2719r1235b2788],
14	around	RB	O	around	quantmod	15	SENT_89	[p5l1290t2719r1555b2788],
15	15	CD	PERCENT	15	num	16	SENT_89	[p5l1609t2724r1758b2790],
16	%	NN	PERCENT	%	xcomp	11	SENT_89	[p5l1609t2724r1758b2790],
17	in	IN	O	in	_	0	SENT_89	[p5l1812t2724r1885b2787],
18	white	JJ	O	white	amod	19	SENT_89	[p5l1936t2719r2139b2788],
19	populations	NNS	O	population	prep_in	16	SENT_89	[p5l8t2829r462b2918],
20	,	,	O	,	_	0	SENT_89	[p5l8t2829r462b2918],
21	whereas	IN	O	whereas	mark	27	SENT_89	[p5l539t2829r840b2897],
22	other	JJ	O	other	amod	25	SENT_89	[p5l919t2829r1112b2897],
23	C	NN	O	c	nn	25	SENT_89	[p5l1193t2834r1247b2897],
24	YP2C19	NN	O	yp2c19	nn	25	SENT_89	[p5l1253t2834r1536b2898],
25	variants	NNS	O	variant	nsubj	27	SENT_89	[p5l1606t2834r1894b2897],
26	have	VBP	O	have	aux	27	SENT_89	[p5l1971t2829r2139b2897],
27	expected	VBN	O	expect	advcl	16	SENT_89	[p5l9t2940r326b3029],
28	allelic	JJ	O	allelic	amod	29	SENT_89	[p5l350t2940r560b3008],
29	frequencies	NNS	O	frequency	dobj	27	SENT_89	[p5l584t2940r1010b3029],
30	of	IN	O	of	_	0	SENT_89	[p5l1038t2940r1120b3008],
31	less	JJR	O	less	mwe	32	SENT_89	[p5l1130t2940r1265b3008],
32	than	IN	O	than	quantmod	33	SENT_89	[p5l1290t2940r1457b3008],
33	1	CD	PERCENT	1	num	34	SENT_89	[p5l1484t2944r1709b3011],
34	%	NN	PERCENT	%	prep_of	29	SENT_89	[p5l1484t2944r1709b3011],
35	?	.	O	?	_	0	SENT_89	[p5l1484t2944r1709b3011],

1	”	NN	O	”	_	0	SENT_90	[p5l1484t2944r1709b3011],

1	In	IN	O	in	_	0	SENT_91	[p5l83t3055r162b3115],
2	addition	NN	O	addition	_	0	SENT_91	[p5l187t3049r494b3116],
3	to	TO	O	to	_	0	SENT_91	[p5l518t3062r587b3116],
4	the	DT	O	the	det	8	SENT_91	[p5l611t3049r728b3117],
5	classic	JJ	O	classic	amod	8	SENT_91	[p5l754t3049r993b3117],
6	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_91	[p5l1019t3049r1555b3117],
7	risk	NN	O	risk	nn	8	SENT_91	[p5l1578t3049r1720b3117],
8	factors	NNS	O	factor	prep_in_addition_to	12	SENT_91	[p5l1742t3049r2011b3127],
9	,	,	O	,	_	0	SENT_91	[p5l1742t3049r2011b3127],
10	we	PRP	O	we	nsubj	12	SENT_91	[p5l2037t3073r2139b3117],
11	systematically	RB	O	systematically	advmod	12	SENT_91	[p6l11t22r530b112],
12	measured	VBD	O	measure	_	0	SENT_91	[p6l616t22r987b91],
13	plasma	NN	O	plasma	nn	14	SENT_91	[p6l1072t22r1341b111],
14	concentrations	NNS	O	concentration	dobj	12	SENT_91	[p6l1429t27r1980b91],
15	of	IN	O	of	_	0	SENT_91	[p6l2070t22r2153b91],
16	biomarkers	NNS	O	biomarker	prep_of	14	SENT_91	[p6l7t131r455b209],
17	,	,	O	,	_	0	SENT_91	[p6l7t131r455b209],
18	which	WDT	O	which	nsubjpass	22	SENT_91	[p6l487t131r715b199],
19	have	VBP	O	have	aux	22	SENT_91	[p6l743t131r913b199],
20	previously	RB	DATE	previously	advmod	22	SENT_91	[p6l944t131r1330b221],
21	been	VBN	O	be	auxpass	22	SENT_91	[p6l1357t131r1537b199],
22	associated	VBN	O	associate	rcmod	16	SENT_91	[p6l1568t131r1947b199],
23	with	IN	O	with	_	0	SENT_91	[p6l1975t131r2140b199],
24	prognosis	NN	O	prognosis	prep_with	22	SENT_91	[p6l8t245r374b331],
25	of	IN	O	of	_	0	SENT_91	[p6l410t241r493b308],
26	coronary	JJ	O	coronary	amod	28	SENT_91	[p6l514t265r841b330],
27	artery	NN	O	artery	nn	28	SENT_91	[p6l873t254r1087b330],
28	disease	NN	O	disease	prep_of	24	SENT_91	[p6l1119t241r1405b309],
29	.	.	O	.	_	0	SENT_91	[p6l1119t241r1405b309],

1	Plasma	NN	O	plasma	nn	2	SENT_92	[p6l1446t241r1716b308],
2	ﬁbrinogen	NN	O	ﬁbrinogen	nsubjpass	4	SENT_92	[p6l1748t241r2140b331],
3	was	VBD	O	be	auxpass	4	SENT_92	[p6l7t374r145b418],
4	measured	VBN	O	measure	_	0	SENT_92	[p6l177t349r548b418],
5	by	IN	O	by	_	0	SENT_92	[p6l574t349r662b439],
6	the	DT	O	the	det	8	SENT_92	[p6l687t349r803b418],
7	Clauss	NNP	PERSON	Clauss	nn	8	SENT_92	[p6l835t349r1079b418],
8	method	NN	O	method	agent	4	SENT_92	[p6l1110t349r1417b418],
9	.	.	O	.	_	0	SENT_92	[p6l1110t349r1417b418],

1	We	PRP	O	we	nsubj	3	SENT_93	[p6l1448t356r1566b418],
2	also	RB	O	also	advmod	3	SENT_93	[p6l1597t349r1739b418],
3	measured	VBD	O	measure	_	0	SENT_93	[p6l1770t349r2141b418],
4	PAI-1	NN	O	pai-1	nn	8	SENT_93	[p6l13t463r214b525],
5	and	CC	O	and	_	0	SENT_93	[p6l302t458r440b526],
6	D-dimers	NNS	O	d-dimer	nn	8	SENT_93	[p6l530t458r877b526],
7	antigen	NN	O	antigen	nn	8	SENT_93	[p6l968t463r1248b548],
8	concentrations	NNS	O	concentration	nsubj	14	SENT_93	[p6l1336t463r1887b526],
9	with	IN	O	with	_	0	SENT_93	[p6l1975t458r2140b526],
10	commercially	RB	O	commercially	advmod	11	SENT_93	[p6l9t568r518b657],
11	available	JJ	O	available	amod	13	SENT_93	[p6l548t568r867b636],
12	ELISA	NN	O	elisa	nn	13	SENT_93	[p6l903t572r1141b635],
13	kits	NNS	O	kit	prep_with	8	SENT_93	[p6l1169t568r1300b635],
14	(	VBP	O	(	ccomp	3	SENT_93	[p6l1339t568r1878b658],
15	Asserachrom	NNP	O	Asserachrom	nn	22	SENT_93	[p6l1339t568r1878b658],
16	,	,	O	,	_	0	SENT_93	[p6l1339t568r1878b658],
17	Stago	NNP	PERSON	Stago	appos	22	SENT_93	[p6l1917t573r2136b658],
18	,	,	O	,	_	0	SENT_93	[p6l1917t573r2136b658],
19	Taverny	NNP	ORGANIZATION	Taverny	appos	22	SENT_93	[p6l7t681r317b766],
20	,	,	O	,	_	0	SENT_93	[p6l7t681r317b766],
21	France	NNP	LOCATION	France	appos	22	SENT_93	[p6l350t681r643b766],
22	)	NNP	O	)	dobj	14	SENT_93	[p6l350t681r643b766],
23	,	,	O	,	_	0	SENT_93	[p6l350t681r643b766],
24	as	IN	O	as	mark	26	SENT_93	[p6l673t701r745b745],
25	previously	RB	DATE	previously	advmod	26	SENT_93	[p6l773t676r1159b766],
26	described	VBN	O	describe	dep	22	SENT_93	[p6l1183t676r1608b745],
27	.	.	O	.	_	0	SENT_93	[p6l1183t676r1608b745],

1	“	NN	O	“	_	0	SENT_94	[p6l1183t676r1608b745],

1	Outcomes	NNS	O	outcome	_	0	SENT_95	[p6l10t900r395b963],

1	The	DT	O	the	det	3	SENT_96	[p6l7t1004r150b1073],
2	primary	JJ	O	primary	amod	3	SENT_96	[p6l180t1009r476b1094],
3	endpoint	NN	O	endpoint	nsubj	6	SENT_96	[p6l506t1004r838b1093],
4	was	VBD	O	be	cop	6	SENT_96	[p6l865t1029r1002b1073],
5	a	DT	O	a	det	6	SENT_96	[p6l1036t1029r1072b1073],
6	composite	NN	O	composite	_	0	SENT_96	[p6l1104t1009r1481b1093],
7	of	IN	O	of	_	0	SENT_96	[p6l1514t1004r1596b1073],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_96	[p6l1614t1005r2141b1073],
9	death	NN	O	death	prep_of	6	SENT_96	[p6l9t1113r229b1191],
10	,	,	O	,	_	0	SENT_96	[p6l9t1113r229b1191],
11	non-fatal	JJ	O	non-fatal	amod	13	SENT_96	[p6l315t1113r642b1181],
12	myocardial	JJ	O	myocardial	amod	13	SENT_96	[p6l724t1113r1131b1203],
13	infarction	NN	O	infarction	prep_of	6	SENT_96	[p6l1213t1113r1591b1191],
14	,	,	O	,	_	0	SENT_96	[p6l1213t1113r1591b1191],
15	and	CC	O	and	_	0	SENT_96	[p6l1678t1113r1814b1181],
16	urgent	JJ	O	urgent	amod	17	SENT_96	[p6l1894t1127r2141b1203],
17	revascularisation	NN	O	revascularisation	prep_of	6	SENT_96	[p6l8t1222r648b1290],
18	.	.	O	.	_	0	SENT_96	[p6l8t1222r648b1290],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_97	[p6l695t1222r1239b1290],
2	death	NN	O	death	nsubjpass	4	SENT_97	[p6l1279t1222r1481b1290],
3	was	VBD	O	be	auxpass	4	SENT_97	[p6l1520t1246r1656b1290],
4	regarded	VBN	O	regard	_	0	SENT_97	[p6l1700t1222r2025b1312],
5	as	IN	O	as	prep	4	SENT_97	[p6l2066t1246r2137b1290],

1	Articles	NNPS	O	Articles	_	0	SENT_98	[p6l6t1795r156b1831],
2	I	PRP	O	I	dep	1	SENT_98	[p6l205t1632r252b1831],

1	any	DT	O	any	det	2	SENT_99	[p6l9t2114r139b2179],
2	death	NN	O	death	_	0	SENT_99	[p6l179t2090r381b2158],
3	with	IN	O	with	_	0	SENT_99	[p6l420t2090r583b2158],
4	a	DT	O	a	det	7	SENT_99	[p6l626t2114r662b2158],
5	demonstrable	JJ	O	demonstrable	amod	7	SENT_99	[p6l705t2090r1209b2158],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_99	[p6l1253t2090r1780b2158],
7	cause	NN	O	cause	prep_with	2	SENT_99	[p6l1820t2114r2023b2158],
8	or	CC	O	or	_	0	SENT_99	[p6l2066t2114r2141b2158],
9	any	DT	O	any	det	10	SENT_99	[p6l9t2223r139b2287],
10	death	NN	O	death	prep_with	2	SENT_99	[p6l170t2198r371b2266],
11	not	RB	O	not	neg	13	SENT_99	[p6l402t2212r523b2266],
12	clearly	RB	O	clearly	advmod	13	SENT_99	[p6l554t2198r790b2288],
13	attributable	JJ	O	attributable	amod	2	SENT_99	[p6l821t2198r1240b2266],
14	to	TO	O	to	_	0	SENT_99	[p6l1272t2212r1340b2266],
15	a	DT	O	a	det	17	SENT_99	[p6l1374t2223r1411b2266],
16	non-cardiovascular	JJ	O	non-cardiovascular	amod	17	SENT_99	[p6l1442t2198r2141b2266],
17	cause	NN	O	cause	prep_to	13	SENT_99	[p6l9t2333r230b2377],
18	.	.	O	.	_	0	SENT_99	[p6l9t2333r230b2377],

1	Myocardial	JJ	O	myocardial	amod	2	SENT_100	[p6l292t2309r697b2398],
2	infarction	NN	O	infarction	nsubjpass	4	SENT_100	[p6l752t2309r1112b2377],
3	was	VBD	O	be	auxpass	4	SENT_100	[p6l1165t2333r1302b2377],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_100	[p6l1360t2309r1636b2377],
5	as	IN	O	as	_	0	SENT_100	[p6l1691t2333r1762b2377],
6	a	DT	O	a	det	9	SENT_100	[p6l1821t2333r1858b2377],
7	recent	JJ	O	recent	amod	9	SENT_100	[p6l1912t2322r2141b2377],
8	ischaemic	JJ	O	ischaemic	amod	9	SENT_100	[p6l8t2417r378b2486],
9	symptom	NN	O	symptom	prep_as	4	SENT_100	[p6l448t2431r794b2507],
10	with	IN	O	with	_	0	SENT_100	[p6l859t2417r1022b2486],
11	electrocardiographic	JJ	O	electrocardiographic	amod	12	SENT_100	[p6l1091t2417r1840b2507],
12	abnormalities	NNS	O	abnormality	prep_with	9	SENT_100	[p6l1908t2417r2139b2486, p6l8t2526r299b2594],
13	in	IN	O	in	_	0	SENT_100	[p6l331t2531r405b2593],
14	the	DT	O	the	det	18	SENT_100	[p6l433t2526r548b2594],
15	ST	JJ	O	st	amod	18	SENT_100	[p6l584t2530r680b2594],
16	segment	NN	O	segment	nn	18	SENT_100	[p6l711t2539r1027b2616],
17	(	NN	O	(	nn	18	SENT_100	[p6l1061t2526r1484b2616],
18	depression	NN	O	depression	prep_in	12	SENT_100	[p6l1061t2526r1484b2616],
19	or	CC	O	or	_	0	SENT_100	[p6l1514t2550r1590b2594],
20	elevation	NN	O	elevation	prep_with	9	SENT_100	[p6l1619t2526r1946b2594],
21	of	IN	O	of	_	0	SENT_100	[p6l1977t2526r2059b2594],
22	at	IN	O	at	quantmod	24	SENT_100	[p6l2077t2539r2141b2594],
23	least	JJS	O	least	mwe	22	SENT_100	[p6l7t2636r175b2703],
24	0-1	CD	NUMBER	0-1	num	26	SENT_100	[p6l215t2642r334b2703],
25	mV	NN	O	mv	nn	26	SENT_100	[p6l374t2642r530b2726],
26	)	NN	O	)	prep_of	20	SENT_100	[p6l374t2642r530b2726],
27	and	CC	O	and	_	0	SENT_100	[p6l578t2636r714b2703],
28	a	DT	O	a	det	31	SENT_100	[p6l755t2660r792b2703],
29	positive	JJ	O	positive	amod	31	SENT_100	[p6l832t2640r1113b2725],
30	troponin	NN	O	troponin	nn	31	SENT_100	[p6l1153t2640r1476b2725],
31	concentration	NN	O	concentration	conj_and	9	SENT_100	[p6l1517t2640r2024b2703],
32	as	IN	O	as	_	0	SENT_100	[p6l2066t2660r2138b2703],
33	deﬁned	JJ	O	deﬁned	prep_as	31	SENT_100	[p6l9t2744r286b2813],
34	locally	RB	O	locally	advmod	4	SENT_100	[p6l312t2744r553b2834],
35	.	.	O	.	_	0	SENT_100	[p6l312t2744r553b2834],

1	Urgent	JJ	O	urgent	amod	2	SENT_101	[p6l590t2751r850b2834],
2	revascularisation	NN	O	revascularisation	nsubjpass	4	SENT_101	[p6l877t2744r1499b2813],
3	was	VBD	O	be	auxpass	4	SENT_101	[p6l1526t2769r1662b2813],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_101	[p6l1695t2744r1971b2813],
5	as	IN	O	as	_	0	SENT_101	[p6l2000t2769r2071b2813],
6	a	DT	O	a	det	8	SENT_101	[p6l2103t2769r2140b2813],
7	coronary	JJ	O	coronary	amod	8	SENT_101	[p6l9t2877r332b2942],
8	(	CD	NUMBER	(	prep_as	4	SENT_101	[p6l433t2860r584b2943],
9	any	DT	O	any	det	12	SENT_101	[p6l433t2860r584b2943],
10	vessel	NN	O	vessel	nn	12	SENT_101	[p6l677t2853r916b2943],
11	)	NN	O	)	nn	12	SENT_101	[p6l677t2853r916b2943],
12	revascularisation	NN	O	revascularisation	tmod	4	SENT_101	[p6l1018t2853r1640b2921],
13	(	CD	NUMBER	(	num	18	SENT_101	[p6l1742t2860r1894b2943],
14	any	DT	O	any	det	15	SENT_101	[p6l1742t2860r1894b2943],
15	type	NN	O	type	npadvmod	16	SENT_101	[p6l1988t2866r2139b2942],
16	percutaneous	JJ	O	percutaneous	amod	18	SENT_101	[p6l8t2976r504b3051],
17	coronary	JJ	O	coronary	amod	18	SENT_101	[p6l558t2987r881b3052],
18	intervention	NN	O	intervention	nsubj	25	SENT_101	[p6l930t2967r1381b3031],
19	or	CC	O	or	_	0	SENT_101	[p6l1433t2987r1508b3031],
20	coronary	JJ	O	coronary	amod	24	SENT_101	[p6l1558t2987r1881b3052],
21	artery	NN	O	artery	nn	24	SENT_101	[p6l1931t2976r2142b3052],
22	bypass	NN	O	bypass	nn	24	SENT_101	[p6l7t3071r251b3161],
23	graft	NN	O	graft	nn	24	SENT_101	[p6l279t3071r468b3161],
24	)	NN	O	)	conj_or	18	SENT_101	[p6l279t3071r468b3161],
25	decided	VBD	O	decide	rcmod	12	SENT_101	[p6l499t3071r780b3140],
26	within	IN	O	within	_	0	SENT_101	[p6l802t3071r1041b3140],
27	24	CD	NUMBER	24	num	28	SENT_101	[p6l1067t3078r1150b3138],
28	h	NN	O	h	prep_within	25	SENT_101	[p6l1169t3071r1218b3138],
29	of	IN	O	of	_	0	SENT_101	[p6l1243t3071r1325b3140],
30	a	DT	O	a	det	32	SENT_101	[p6l1337t3096r1374b3140],
31	recurrent	JJ	O	recurrent	amod	32	SENT_101	[p6l1398t3085r1744b3140],
32	episode	NN	O	episode	prep_of	28	SENT_101	[p6l1767t3071r2044b3160],
33	of	IN	O	of	_	0	SENT_101	[p6l2070t3071r2153b3140],
34	myocardial	JJ	O	myocardial	amod	35	SENT_101	[p6l8t3181r415b3270],
35	ischaemia	NN	O	ischaemia	prep_of	32	SENT_101	[p6l439t3181r828b3249],
36	.	.	O	.	_	0	SENT_101	[p6l439t3181r828b3249],

1	Additionally	RB	O	additionally	advmod	4	SENT_102	[p6l78t3292r546b3381],
2	,	,	O	,	_	0	SENT_102	[p6l78t3292r546b3381],
3	we	PRP	O	we	nsubj	4	SENT_102	[p6l571t3316r674b3360],
4	assessed	VBD	O	assess	_	0	SENT_102	[p6l699t3292r1019b3360],
5	stent	JJ	O	stent	amod	6	SENT_102	[p6l1043t3305r1224b3360],
6	thrombosis	NN	O	thrombosis	dobj	4	SENT_102	[p6l1245t3292r1670b3360],
7	on	IN	O	on	_	0	SENT_102	[p6l1698t3316r1791b3360],
8	the	DT	O	the	det	9	SENT_102	[p6l1813t3292r1929b3360],
9	basis	NN	O	basis	prep_on	4	SENT_102	[p6l1953t3292r2138b3360],
10	of	IN	O	of	_	0	SENT_102	[p6l9t3400r92b3468],
11	deﬁnitions	NNS	O	deﬁnitions	prep_of	9	SENT_102	[p6l110t3400r510b3468],
12	from	IN	O	from	_	0	SENT_102	[p6l542t3400r727b3468],
13	the	DT	O	the	det	16	SENT_102	[p6l755t3400r871b3468],
14	Academic	NNP	ORGANIZATION	Academic	nn	16	SENT_102	[p6l900t3400r1269b3468],
15	Research	NNP	ORGANIZATION	Research	nn	16	SENT_102	[p6l1302t3400r1636b3468],
16	Consortium	NNP	ORGANIZATION	Consortium	prep_from	4	SENT_102	[p6l1668t3405r2136b3478],
17	,	,	O	,	_	0	SENT_102	[p6l1668t3405r2136b3478],
18	with	IN	O	with	_	0	SENT_102	[p6l7t3509r172b3577],
19	the	DT	O	the	det	21	SENT_102	[p6l209t3509r326b3577],
20	prespeciﬁed	JJ	O	prespeciﬁed	amod	21	SENT_102	[p6l365t3509r820b3598],
21	l	NN	O	l	prep_with	4	SENT_102	[p6l856t3509r983b3598],
22	<	JJR	O	<	amod	21	SENT_102	[p6l856t3509r983b3598],
23	ey	CD	NUMBER	ey	num	24	SENT_102	[p6l856t3509r983b3598],
24	endpoint	NN	O	endpoint	dep	22	SENT_102	[p6l1021t3509r1357b3598],
25	of	IN	O	of	_	0	SENT_102	[p6l1395t3509r1478b3577],
26	deﬁnite	JJ	O	deﬁnite	amod	27	SENT_102	[p6l1505t3509r1787b3577],
27	(	NN	O	(	prep_of	24	SENT_102	[p6l1833t3514r1937b3599],
28	ie	FW	O	ie	dep	24	SENT_102	[p6l1833t3514r1937b3599],
29	,	,	O	,	_	0	SENT_102	[p6l1833t3514r1937b3599],
30	total	JJ	O	total	amod	31	SENT_102	[p6l1978t3509r2140b3577],
31	occlusion	NN	O	occlusion	appos	24	SENT_102	[p6l9t3619r364b3687],
32	originating	VBG	O	originate	partmod	31	SENT_102	[p6l395t3623r809b3708],
33	in	IN	O	in	_	0	SENT_102	[p6l839t3623r913b3685],
34	or	CC	O	or	_	0	SENT_102	[p6l944t3643r1021b3687],
35	within	IN	O	within	_	0	SENT_102	[p6l1047t3619r1290b3687],
36	5	CD	NUMBER	5	num	37	SENT_102	[p6l1324t3623r1358b3687],
37	mm	NN	O	mm	prep_in	32	SENT_102	[p6l1392t3643r1548b3685],
38	of	IN	O	of	_	0	SENT_102	[p6l1578t3618r1661b3687],
39	the	DT	O	the	det	41	SENT_102	[p6l1678t3619r1794b3687],
40	stent	JJ	O	stent	amod	41	SENT_102	[p6l1827t3625r2028b3708],
41	)	NN	O	)	prep_of	37	SENT_102	[p6l1827t3625r2028b3708],
42	or	CC	O	or	_	0	SENT_102	[p6l2065t3643r2141b3687],
43	visible	JJ	O	visible	amod	44	SENT_102	[p6l7t3727r245b3795],
44	thrombus	NN	O	thrombus	conj_or	41	SENT_102	[p6l274t3727r641b3795],
45	within	IN	O	within	_	0	SENT_102	[p6l670t3727r913b3795],
46	the	DT	O	the	det	47	SENT_102	[p6l940t3727r1057b3795],
47	stent	NN	O	stent	prep_within	32	SENT_102	[p6l1089t3741r1270b3795],
48	or	CC	O	or	_	0	SENT_102	[p6l1297t3752r1374b3795],
49	within	IN	O	within	_	0	SENT_102	[p6l1399t3727r1642b3795],
50	5	CD	NUMBER	5	num	51	SENT_102	[p6l1674t3732r1708b3795],
51	mm	NN	O	mm	prep_within	32	SENT_102	[p6l1740t3752r1896b3794],
52	of	IN	O	of	_	0	SENT_102	[p6l1925t3727r2008b3795],
53	the	DT	O	the	det	54	SENT_102	[p6l2023t3727r2139b3795],
54	wvvw	NN	O	wvvw	prep_of	51	SENT_102	[p6l803t1492r1336b1543],
55	.	.	O	.	_	0	SENT_102	[p6l803t1492r1336b1543],

1	the	DT	O	the	det	2	SENT_103	[p6l803t1492r1336b1543],
2	|	NN	O	|	_	0	SENT_103	[p6l803t1492r1336b1543],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_103	[p6l803t1492r1336b1543],
4	Vol	NNP	O	Vol	dep	2	SENT_103	[p6l1379t1492r1466b1543],
5	373	CD	NUMBER	373	num	4	SENT_103	[p6l1486t1498r1585b1550],
6	January	NNP	DATE	January	tmod	4	SENT_103	[p6l1626t1496r1843b1557],
7	24	CD	DATE	24	num	6	SENT_103	[p6l1861t1498r1946b1552],
8	,	,	DATE	,	_	0	SENT_103	[p6l1861t1498r1946b1552],
9	2009	CD	DATE	2009	num	6	SENT_103	[p6l1965t1498r2110b1550],

1	stent	NN	O	stent	_	0	SENT_104	[p7l11t43r192b98],
2	in	IN	O	in	_	0	SENT_104	[p7l244t34r318b97],
3	the	DT	O	the	det	4	SENT_104	[p7l371t30r487b98],
4	presence	NN	O	presence	prep_in	1	SENT_104	[p7l542t54r873b119],
5	of	IN	O	of	_	0	SENT_104	[p7l928t30r1011b98],
6	an	DT	O	a	det	10	SENT_104	[p7l1053t54r1142b98],
7	acute	JJ	O	acute	amod	8	SENT_104	[p7l1197t43r1391b98],
8	ischaemic	JJ	O	ischaemic	amod	10	SENT_104	[p7l1445t30r1821b98],
9	clinical	JJ	O	clinical	amod	10	SENT_104	[p7l1875t30r2140b98],
10	syndrome	NN	O	syndrome	prep_of	4	SENT_104	[p7l11t140r382b229],
11	within	IN	O	within	_	0	SENT_104	[p7l407t140r649b208],
12	48	CD	NUMBER	48	num	13	SENT_104	[p7l673t146r755b208],
13	h.	NN	O	h.	prep_within	10	SENT_104	[p7l781t140r896b207],
14	25	CD	NUMBER	25	dep	1	SENT_104	[p7l781t140r896b207],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_105	[p7l10t358r385b427],
2	analyses	NNS	O	analysis	nsubj	4	SENT_105	[p7l410t358r728b448],
3	We	PRP	O	we	nsubj	4	SENT_105	[p7l7t476r125b539],
4	compared	VBD	O	compare	_	0	SENT_105	[p7l185t470r558b559],
5	baseline	NN	O	baseline	nn	6	SENT_105	[p7l613t470r920b538],
6	characteristics	NNS	O	characteristic	dobj	4	SENT_105	[p7l981t470r1512b538],
7	of	IN	O	of	_	0	SENT_105	[p7l1574t470r1656b538],
8	patients	NNS	O	patient	prep_of	6	SENT_105	[p7l1702t474r1995b559],
9	by	IN	O	by	_	0	SENT_105	[p7l2055t470r2142b559],
10	genotypes	NNS	O	genotype	prep_by	4	SENT_105	[p7l10t592r381b668],
11	with	IN	O	with	_	0	SENT_105	[p7l420t578r585b647],
12	the	DT	O	the	det	14	SENT_105	[p7l621t578r737b647],
13	X2	NN	O	x2	nn	14	SENT_105	[p7l777t585r852b665],
14	test	NN	O	test	prep_with	10	SENT_105	[p7l890t592r1022b647],
15	for	IN	O	for	_	0	SENT_105	[p7l1059t578r1165b647],
16	categorical	JJ	O	categorical	amod	17	SENT_105	[p7l1202t578r1599b668],
17	variables	NNS	O	variable	prep_for	14	SENT_105	[p7l1635t578r1962b647],
18	and	CC	O	and	_	0	SENT_105	[p7l2003t578r2141b647],
19	Student	NN	O	student	poss	22	SENT_105	[p7l14t687r357b755],
20	’s	POS	O	’s	_	0	SENT_105	[p7l14t687r357b755],
21	t	NN	O	t	nn	22	SENT_105	[p7l421t700r444b754],
22	test	NN	O	test	conj_and	14	SENT_105	[p7l500t701r632b755],
23	or	CC	O	or	_	0	SENT_105	[p7l691t712r767b755],
24	one-way	JJ	O	one-way	amod	25	SENT_105	[p7l826t712r1132b777],
25	ANOVA	NNP	O	ANOVA	conj_and	14	SENT_105	[p7l1188t692r1495b756],
26	for	IN	O	for	_	0	SENT_105	[p7l1553t687r1660b755],
27	continuous	JJ	O	continuous	amod	28	SENT_105	[p7l1718t692r2138b755],
28	variables	NNS	O	variable	prep_for	25	SENT_105	[p7l7t797r334b865],
29	as	IN	O	as	_	0	SENT_105	[p7l363t821r436b865],
30	appropriate	JJ	O	appropriate	prep_as	4	SENT_105	[p7l464t801r912b886],
31	.	.	O	.	_	0	SENT_105	[p7l464t801r912b886],

1	Follow-up	JJ	O	follow-up	nsubjpass	5	SENT_106	[p7l83t906r449b995],
2	of	IN	O	of	_	0	SENT_106	[p7l487t906r570b975],
3	patients	NNS	O	patient	prep_of	1	SENT_106	[p7l593t911r888b995],
4	was	VBD	O	be	auxpass	5	SENT_106	[p7l925t931r1063b975],
5	censored	VBN	O	censor	_	0	SENT_106	[p7l1102t906r1438b975],
6	at	IN	O	at	_	0	SENT_106	[p7l1474t920r1539b975],
7	the	DT	O	the	det	8	SENT_106	[p7l1573t906r1689b975],
8	date	NN	O	date	prep_at	5	SENT_106	[p7l1727t906r1879b975],
9	of	IN	O	of	_	0	SENT_106	[p7l1917t906r2001b975],
10	the	DT	O	the	det	13	SENT_106	[p7l2022t906r2139b975],
11	ﬁrst	NN	O	ﬁrst	nn	13	SENT_106	[p7l8t1017r158b1085],
12	recurrent	JJ	O	recurrent	amod	13	SENT_106	[p7l225t1030r576b1085],
13	event	NN	O	event	prep_of	8	SENT_106	[p7l643t1030r842b1085],
14	corresponding	VBG	O	correspond	ccomp	5	SENT_106	[p7l909t1017r1453b1107],
15	to	TO	O	to	_	0	SENT_106	[p7l1520t1030r1588b1085],
16	the	DT	O	the	det	18	SENT_106	[p7l1656t1017r1773b1085],
17	primary	JJ	O	primary	amod	18	SENT_106	[p7l1842t1022r2142b1107],
18	endpoint	NN	O	endpoint	prep_to	14	SENT_106	[p7l9t1159r346b1248],
19	and	CC	O	and	_	0	SENT_106	[p7l383t1159r521b1226],
20	occurring	VBG	O	occur	ccomp	5	SENT_106	[p7l558t1163r918b1249],
21	during	IN	O	during	_	0	SENT_106	[p7l956t1159r1208b1249],
22	exposure	NN	O	exposure	prep_during	20	SENT_106	[p7l1246t1183r1580b1248],
23	to	TO	O	to	_	0	SENT_106	[p7l1617t1172r1685b1226],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_106	[p7l1725t1159r2140b1249],
25	treatment	NN	O	treatment	prep_to	20	SENT_106	[p7l7t1282r394b1337],
26	.	.	O	.	_	0	SENT_106	[p7l7t1282r394b1337],

1	In	IN	O	in	_	0	SENT_107	[p7l441t1275r519b1336],
2	patients	NNS	O	patient	prep_in	9	SENT_107	[p7l558t1273r852b1357],
3	without	IN	O	without	_	0	SENT_107	[p7l892t1268r1183b1337],
4	an	DT	O	a	det	5	SENT_107	[p7l1222t1293r1311b1337],
5	event	NN	O	event	prep_without	2	SENT_107	[p7l1351t1282r1567b1347],
6	,	,	O	,	_	0	SENT_107	[p7l1351t1282r1567b1347],
7	follow-up	NN	O	follow-up	nsubjpass	9	SENT_107	[p7l1610t1268r1961b1357],
8	was	VBD	O	be	auxpass	9	SENT_107	[p7l1999t1293r2138b1337],
9	censored	VBN	O	censor	_	0	SENT_107	[p7l9t1377r345b1445],
10	either	CC	O	either	preconj	9	SENT_107	[p7l365t1377r582b1445],
11	at	IN	O	at	_	0	SENT_107	[p7l602t1390r667b1445],
12	the	DT	O	the	det	13	SENT_107	[p7l684t1377r801b1445],
13	date	NN	O	date	prep_at	9	SENT_107	[p7l823t1377r975b1445],
14	of	IN	O	of	_	0	SENT_107	[p7l997t1377r1080b1445],
15	end	NN	O	end	prep_of	13	SENT_107	[p7l1089t1377r1227b1445],
16	of	IN	O	of	_	0	SENT_107	[p7l1247t1377r1330b1445],
17	clopidogrel	NN	O	clopidogrel	nn	18	SENT_107	[p7l1338t1377r1753b1467],
18	treatment	NN	O	treatment	prep_of	15	SENT_107	[p7l1772t1390r2141b1445],
19	or	CC	O	or	_	0	SENT_107	[p7l9t1512r86b1556],
20	at	IN	O	at	_	0	SENT_107	[p7l134t1501r199b1556],
21	the	DT	O	the	det	24	SENT_107	[p7l244t1488r360b1556],
22	last	JJ	O	last	amod	24	SENT_107	[p7l408t1488r537b1556],
23	follow-up	JJ	O	follow-up	amod	24	SENT_107	[p7l584t1487r935b1576],
24	visit	NN	O	visit	prep_at	9	SENT_107	[p7l981t1492r1137b1556],
25	when	WRB	O	when	advmod	29	SENT_107	[p7l1181t1488r1388b1556],
26	patients	NNS	O	patient	nsubj	29	SENT_107	[p7l1436t1492r1730b1576],
27	were	VBD	O	be	aux	29	SENT_107	[p7l1778t1512r1957b1556],
28	still	RB	O	still	advmod	29	SENT_107	[p7l2008t1488r2140b1556],
29	taking	VBG	O	take	advcl	9	SENT_107	[p7l7t1596r242b1686],
30	the	DT	O	the	det	31	SENT_107	[p7l281t1596r397b1665],
31	drug	NN	O	drug	dobj	29	SENT_107	[p7l439t1596r632b1686],
32	.	.	O	.	_	0	SENT_107	[p7l439t1596r632b1686],

1	The	DT	O	the	det	2	SENT_108	[p7l675t1596r818b1665],
2	time	NN	O	time	nsubjpass	9	SENT_108	[p7l858t1601r1028b1665],
3	to	TO	O	to	aux	4	SENT_108	[p7l1067t1610r1137b1665],
4	ﬁrst	VB	O	ﬁrst	infmod	2	SENT_108	[p7l1178t1596r1327b1665],
5	cardiovascular	JJ	O	cardiovascular	amod	6	SENT_108	[p7l1367t1596r1903b1665],
6	event	NN	O	event	dobj	4	SENT_108	[p7l1943t1610r2141b1665],
7	was	VBD	O	be	auxpass	9	SENT_108	[p7l7t1730r145b1774],
8	then	RB	O	then	advmod	9	SENT_108	[p7l212t1706r382b1774],
9	compared	VBN	O	compare	_	0	SENT_108	[p7l447t1706r820b1795],
10	between	IN	O	between	_	0	SENT_108	[p7l883t1706r1195b1774],
11	genotypes	NNS	O	genotype	prep_between	9	SENT_108	[p7l1261t1719r1633b1796],
12	(	CD	NUMBER	(	num	13	SENT_108	[p7l1706t1711r2008b1796],
13	carriers	NNS	O	carrier	dobj	9	SENT_108	[p7l1706t1711r2008b1796],
14	vs	CC	O	vs	_	0	SENT_108	[p7l2076t1730r2141b1773],
15	non-carriers	NNS	O	non-carrier	dobj	9	SENT_108	[p7l8t1820r463b1884],
16	of	IN	O	of	_	0	SENT_108	[p7l513t1815r596b1884],
17	CYP2C19	NN	O	cyp2c19	prep_of	15	SENT_108	[p7l637t1820r1075b1884],
18	"	''	O	"	punct	15	SENT_108	[p7l637t1820r1075b1884],
19	"	``	O	"	punct	15	SENT_108	[p7l637t1820r1075b1884],
20	2	CD	NUMBER	2	num	22	SENT_108	[p7l637t1820r1075b1884],
21	allele	NN	O	allele	nn	22	SENT_108	[p7l1118t1816r1332b1905],
22	)	NN	O	)	dep	15	SENT_108	[p7l1118t1816r1332b1905],
23	with	IN	O	with	_	0	SENT_108	[p7l1382t1816r1548b1884],
24	log-rank	JJ	O	log-rank	amod	25	SENT_108	[p7l1593t1816r1905b1905],
25	tests	NNS	O	test	prep_with	22	SENT_108	[p7l1949t1829r2136b1884],
26	.	.	O	.	_	0	SENT_108	[p7l1949t1829r2136b1884],

1	Cumulative	JJ	O	cumulative	amod	3	SENT_109	[p7l11t1925r444b1994],
2	incidence	NN	O	incidence	nn	3	SENT_109	[p7l463t1925r821b1994],
3	rates	NNS	O	rate	nsubjpass	5	SENT_109	[p7l840t1939r1015b1994],
4	were	VBD	O	be	auxpass	5	SENT_109	[p7l1034t1950r1211b1994],
5	calculated	VBN	O	calculate	_	0	SENT_109	[p7l1231t1925r1602b1994],
6	and	CC	O	and	_	0	SENT_109	[p7l1620t1925r1758b1994],
7	expressed	VBN	O	express	conj_and	5	SENT_109	[p7l1776t1925r2141b2014],
8	as	IN	O	as	_	0	SENT_109	[p7l9t2059r81b2103],
9	number	NN	O	number	prep_as	5	SENT_109	[p7l120t2035r424b2103],
10	of	IN	O	of	_	0	SENT_109	[p7l458t2035r542b2103],
11	new	JJ	O	new	amod	13	SENT_109	[p7l565t2059r720b2103],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_109	[p7l755t2035r1291b2103],
13	events	NNS	O	event	prep_of	9	SENT_109	[p7l1326t2048r1558b2103],
14	divided	VBN	O	divide	partmod	13	SENT_109	[p7l1598t2035r1870b2103],
15	by	IN	O	by	_	0	SENT_109	[p7l1903t2035r1990b2124],
16	the	DT	O	the	det	17	SENT_109	[p7l2023t2035r2139b2103],
17	number	NN	O	number	agent	14	SENT_109	[p7l8t2145r312b2213],
18	of	IN	O	of	_	0	SENT_109	[p7l377t2144r460b2213],
19	patient-years	NNS	O	patient-year	prep_of	17	SENT_109	[p7l511t2149r986b2234],
20	of	IN	O	of	_	0	SENT_109	[p7l1055t2144r1138b2213],
21	exposure	NN	O	exposure	prep_of	19	SENT_109	[p7l1191t2169r1524b2233],
22	to	TO	O	to	_	0	SENT_109	[p7l1589t2158r1658b2213],
23	clopidogrel	NN	O	clopidogrel	nn	25	SENT_109	[p7l1725t2144r2140b2234],
24	(	NN	O	(	nn	25	SENT_109	[p7l14t2253r340b2343],
25	number	NN	O	number	prep_to	14	SENT_109	[p7l14t2253r340b2343],
26	of	IN	O	of	_	0	SENT_109	[p7l371t2253r454b2321],
27	events	NNS	O	event	prep_of	25	SENT_109	[p7l474t2267r706b2321],
28	per	IN	O	per	_	0	SENT_109	[p7l739t2278r862b2342],
29	100	CD	NUMBER	100	num	30	SENT_109	[p7l895t2259r1014b2321],
30	patient-years	NNS	O	patient-year	prep_per	27	SENT_109	[p7l1046t2258r1569b2343],
31	)	CD	NUMBER	)	dep	30	SENT_109	[p7l1046t2258r1569b2343],
32	.	.	O	.	_	0	SENT_109	[p7l1046t2258r1569b2343],

1	We	PRP	O	we	nsubj	2	SENT_110	[p7l1604t2260r1721b2322],
2	undertook	VBD	O	undertake	_	0	SENT_110	[p7l1753t2253r2142b2321],
3	Cox	NN	PERSON	cox	nn	5	SENT_110	[p7l11t2368r150b2430],
4	regression	NN	O	regression	nn	5	SENT_110	[p7l184t2367r575b2453],
5	analyses	NNS	O	analysis	dobj	2	SENT_110	[p7l612t2363r920b2452],
6	to	TO	O	to	aux	7	SENT_110	[p7l958t2376r1027b2430],
7	calculate	VB	O	calculate	xcomp	2	SENT_110	[p7l1065t2363r1387b2430],
8	the	DT	O	the	det	10	SENT_110	[p7l1423t2363r1539b2430],
9	hazard	NN	O	hazard	nn	10	SENT_110	[p7l1575t2363r1831b2430],
10	ratio	NN	O	ratio	dobj	7	SENT_110	[p7l1866t2367r2034b2430],
11	to	TO	O	to	aux	12	SENT_110	[p7l2070t2376r2139b2430],
12	achieve	VB	O	achieve	xcomp	7	SENT_110	[p7l9t2472r283b2540],
13	a	DT	O	a	det	16	SENT_110	[p7l305t2496r342b2540],
14	ﬁrst	JJ	O	ﬁrst	amod	16	SENT_110	[p7l362t2471r511b2540],
15	cardiovascular	JJ	O	cardiovascular	amod	16	SENT_110	[p7l531t2472r1068b2540],
16	event	NN	O	event	dobj	12	SENT_110	[p7l1088t2485r1287b2540],
17	according	VBG	O	accord	_	0	SENT_110	[p7l1307t2472r1671b2561],
18	to	TO	O	to	prepc_according_to	12	SENT_110	[p7l1690t2485r1758b2540],
19	genotype	NN	O	genotype	pobj	12	SENT_110	[p7l1782t2485r2135b2561],
20	.	.	O	.	_	0	SENT_110	[p7l1782t2485r2135b2561],

1	The	DT	O	the	advmod	6	SENT_111	[p7l7t2580r151b2648],
2	three	CD	NUMBER	three	num	4	SENT_111	[p7l191t2580r383b2648],
3	genotype	NN	O	genotype	nn	4	SENT_111	[p7l426t2594r761b2670],
4	categories	NNS	O	category	nsubjpass	6	SENT_111	[p7l804t2585r1174b2670],
5	were	VBD	O	be	auxpass	6	SENT_111	[p7l1216t2605r1393b2649],
6	collapsed	VBN	O	collapse	_	0	SENT_111	[p7l1436t2580r1781b2669],
7	into	IN	O	into	_	0	SENT_111	[p7l1820t2585r1966b2648],
8	two	CD	NUMBER	two	prep_into	6	SENT_111	[p7l2007t2594r2139b2648],
9	categories	NNS	O	category	xcomp	6	SENT_111	[p7l9t2694r401b2780],
10	,	,	O	,	_	0	SENT_111	[p7l9t2694r401b2780],
11	resulting	VBG	O	result	dep	9	SENT_111	[p7l429t2690r764b2780],
12	in	IN	O	in	_	0	SENT_111	[p7l787t2694r862b2756],
13	a	DT	O	a	det	15	SENT_111	[p7l887t2714r924b2757],
14	dominant	JJ	O	dominant	amod	15	SENT_111	[p7l949t2690r1316b2757],
15	model	NN	O	model	prep_in	11	SENT_111	[p7l1338t2690r1573b2757],
16	of	IN	O	of	_	0	SENT_111	[p7l1598t2690r1681b2757],
17	inheritance	NN	O	inheritance	prep_of	15	SENT_111	[p7l1692t2690r2136b2757],
18	:	:	O	:	_	0	SENT_111	[p7l1692t2690r2136b2757],
19	"	``	O	"	punct	9	SENT_111	[p7l9t2803r205b2887],
20	'	''	O	'	_	0	SENT_111	[p7l9t2803r205b2887],
21	~	FW	O	~	nn	22	SENT_111	[p7l9t2803r205b2887],
22	‘	FW	O	‘	dep	6	SENT_111	[p7l9t2803r205b2887],
23	1	CD	NUMBER	1	xcomp	22	SENT_111	[p7l9t2803r205b2887],
24	/	:	O	/	punct	35	SENT_111	[p7l9t2803r205b2887],
25	*	CD	NUMBER	*	num	28	SENT_111	[p7l9t2803r205b2887],
26	1	CD	NUMBER	1	num	28	SENT_111	[p7l9t2803r205b2887],
27	(	CD	NUMBER	(	num	28	SENT_111	[p7l237t2803r737b2888],
28	non-carriers	NNS	O	non-carrier	nsubj	35	SENT_111	[p7l237t2803r737b2888],
29	)	CD	NUMBER	)	dep	28	SENT_111	[p7l237t2803r737b2888],
30	versus	CC	O	versus	cc	29	SENT_111	[p7l768t2823r1006b2867],
31	"	``	O	"	punct	35	SENT_111	[p7l1036t2803r1238b2887],
32	'	''	O	'	_	0	SENT_111	[p7l1036t2803r1238b2887],
33	~	FW	O	~	nn	34	SENT_111	[p7l1036t2803r1238b2887],
34	‘	FW	O	‘	advmod	35	SENT_111	[p7l1036t2803r1238b2887],
35	1	CD	NUMBER	1	dep	23	SENT_111	[p7l1036t2803r1238b2887],
36	/	:	O	/	punct	37	SENT_111	[p7l1036t2803r1238b2887],
37	*	CD	NUMBER	*	dep	35	SENT_111	[p7l1036t2803r1238b2887],
38	2	CD	NUMBER	2	dep	37	SENT_111	[p7l1036t2803r1238b2887],
39	and	CC	O	and	cc	38	SENT_111	[p7l1267t2798r1405b2867],
40	"	``	O	"	punct	23	SENT_111	[p7l1431t2803r1641b2887],
41	'	''	O	'	_	0	SENT_111	[p7l1431t2803r1641b2887],
42	~	FW	O	~	nn	43	SENT_111	[p7l1431t2803r1641b2887],
43	‘	FW	O	‘	dep	44	SENT_111	[p7l1431t2803r1641b2887],
44	2	CD	NUMBER	2	dep	47	SENT_111	[p7l1431t2803r1641b2887],
45	/	:	O	/	punct	47	SENT_111	[p7l1431t2803r1641b2887],
46	*	CD	NUMBER	*	num	47	SENT_111	[p7l1431t2803r1641b2887],
47	2	CD	NUMBER	2	dep	50	SENT_111	[p7l1431t2803r1641b2887],
48	(	CD	NUMBER	(	num	49	SENT_111	[p7l1676t2803r2002b2888],
49	carriers	NNS	O	carrier	nsubj	50	SENT_111	[p7l1676t2803r2002b2888],
50	)	VBP	O	)	ccomp	6	SENT_111	[p7l1676t2803r2002b2888],
51	for	IN	O	for	_	0	SENT_111	[p7l2035t2798r2141b2867],
52	CYP2C19	NN	O	cyp2c19	prep_for	50	SENT_111	[p7l15t2912r453b2976],
53	"	''	O	"	punct	52	SENT_111	[p7l15t2912r453b2976],
54	"	``	O	"	punct	52	SENT_111	[p7l15t2912r453b2976],
55	‘	NN	O	‘	nn	57	SENT_111	[p7l15t2912r453b2976],
56	2	CD	NUMBER	2	num	57	SENT_111	[p7l15t2912r453b2976],
57	allele	NN	O	allele	dep	52	SENT_111	[p7l494t2907r704b2975],
58	.	.	O	.	_	0	SENT_111	[p7l494t2907r704b2975],

1	To	TO	O	to	aux	2	SENT_112	[p7l751t2912r839b2975],
2	adjust	VB	O	adjust	purpcl	9	SENT_112	[p7l885t2907r1112b2997],
3	for	IN	O	for	_	0	SENT_112	[p7l1155t2907r1261b2975],
4	comparisons	NNS	O	comparison	prep_for	2	SENT_112	[p7l1304t2912r1782b2996],
5	between	IN	O	between	_	0	SENT_112	[p7l1828t2907r2140b2975],
6	groups	NNS	O	group	prep_between	4	SENT_112	[p7l10t3041r286b3107],
7	,	,	O	,	_	0	SENT_112	[p7l10t3041r286b3107],
8	we	PRP	O	we	nsubj	9	SENT_112	[p7l305t3041r408b3084],
9	selected	VBD	O	select	_	0	SENT_112	[p7l429t3017r724b3084],
10	factors	NNS	O	factor	dobj	9	SENT_112	[p7l740t3017r986b3084],
11	that	WDT	O	that	nsubjpass	13	SENT_112	[p7l1006t3017r1151b3084],
12	are	VBP	O	be	auxpass	13	SENT_112	[p7l1168t3041r1279b3084],
13	known	VBN	O	know	rcmod	10	SENT_112	[p7l1296t3017r1554b3085],
14	to	TO	O	to	aux	16	SENT_112	[p7l1570t3030r1639b3084],
15	be	VB	O	be	auxpass	16	SENT_112	[p7l1656t3017r1742b3084],
16	associated	VBN	O	associate	xcomp	13	SENT_112	[p7l1761t3017r2141b3084],
17	with	IN	O	with	_	0	SENT_112	[p7l7t3125r172b3194],
18	recurrent	JJ	O	recurrent	amod	21	SENT_112	[p7l232t3139r584b3194],
19	acute	JJ	O	acute	amod	21	SENT_112	[p7l644t3139r838b3194],
20	coronary	JJ	O	coronary	amod	21	SENT_112	[p7l900t3150r1227b3215],
21	thrombosis	NN	O	thrombosis	prep_with	16	SENT_112	[p7l1284t3125r1709b3194],
22	and	CC	O	and	_	0	SENT_112	[p7l1773t3125r1911b3194],
23	poor	JJ	O	poor	amod	24	SENT_112	[p7l1970t3150r2141b3214],
24	response	NN	O	response	conj_and	21	SENT_112	[p7l8t3258r342b3323],
25	to	TO	O	to	_	0	SENT_112	[p7l404t3247r473b3302],
26	clopidogrel	NN	O	clopidogrel	prep_to	16	SENT_112	[p7l536t3234r971b3324],
27	,	,	O	,	_	0	SENT_112	[p7l536t3234r971b3324],
28	including	VBG	O	include	_	0	SENT_112	[p7l1035t3234r1394b3324],
29	body-mass	JJ	O	body-mass	amod	30	SENT_112	[p7l1454t3234r1851b3323],
30	index	NN	O	index	prep_including	16	SENT_112	[p7l1915t3234r2136b3312],
31	,	,	O	,	_	0	SENT_112	[p7l1915t3234r2136b3312],
32	smoking	NN	O	smoking	nn	33	SENT_112	[p7l11t3344r336b3434],
33	status	NN	O	status	prep_including	16	SENT_112	[p7l404t3357r639b3422],
34	,	,	O	,	_	0	SENT_112	[p7l404t3357r639b3422],
35	diabetes	NN	O	diabetes	nn	36	SENT_112	[p7l709t3344r1011b3411],
36	status	NN	O	status	prep_including	16	SENT_112	[p7l1082t3357r1317b3422],
37	,	,	O	,	_	0	SENT_112	[p7l1082t3357r1317b3422],
38	stent	NN	O	stent	nn	39	SENT_112	[p7l1388t3357r1569b3411],
39	implantation	NN	O	implantation	conj_and	30	SENT_112	[p7l1633t3344r2136b3433],
40	,	,	O	,	_	0	SENT_112	[p7l1633t3344r2136b3433],
41	initial	JJ	O	initial	amod	45	SENT_112	[p7l8t3452r225b3521],
42	ST-segment	NN	O	st-segment	nn	45	SENT_112	[p7l270t3457r710b3542],
43	elevation	NN	O	elevation	nn	45	SENT_112	[p7l749t3452r1082b3521],
44	myocardial	JJ	O	myocardial	amod	45	SENT_112	[p7l1121t3452r1534b3542],
45	infarction	NN	O	infarction	conj_and	30	SENT_112	[p7l1574t3452r1959b3530],
46	,	,	O	,	_	0	SENT_112	[p7l1574t3452r1959b3530],
47	and	CC	O	and	_	0	SENT_112	[p7l2003t3452r2141b3521],
48	use	NN	O	use	conj_and	30	SENT_112	[p7l7t3585r135b3629],
49	of	IN	O	of	_	0	SENT_112	[p7l160t3561r243b3629],
50	proton-pump	NN	O	proton-pump	nn	51	SENT_112	[p7l252t3574r752b3650],
51	inhibitors	NNS	O	inhibitor	prep_of	48	SENT_112	[p7l775t3561r1161b3629],
52	.	.	O	.	_	0	SENT_112	[p7l775t3561r1161b3629],

1	To	TO	O	to	aux	2	SENT_113	[p7l1187t3565r1273b3629],
2	describe	VB	O	describe	purpcl	16	SENT_113	[p7l1298t3561r1606b3629],
3	the	DT	O	the	det	4	SENT_113	[p7l1629t3561r1745b3629],
4	frequency	NN	O	frequency	dobj	2	SENT_113	[p7l1769t3561r2142b3651],
5	of	IN	O	of	_	0	SENT_113	[p7l9t3670r92b3739],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_113	[p7l163t3671r699b3739],
7	events	NNS	O	event	prep_of	4	SENT_113	[p7l781t3684r1013b3739],
8	according	VBG	O	accord	_	0	SENT_113	[p7l1099t3671r1463b3760],
9	to	TO	O	to	prepc_according_to	2	SENT_113	[p7l1544t3684r1613b3739],
10	time	NN	O	time	pobj	2	SENT_113	[p7l1695t3675r1865b3739],
11	since	IN	O	since	_	0	SENT_113	[p7l1951t3675r2139b3739],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_113	[p8l9t16r425b106],
13	initiation	NN	O	initiation	prep_since	10	SENT_113	[p8l501t21r862b94],
14	,	,	O	,	_	0	SENT_113	[p8l501t21r862b94],
15	we	PRP	O	we	nsubj	16	SENT_113	[p8l940t41r1042b85],
16	constructed	VBD	O	construct	_	0	SENT_113	[p8l1120t16r1558b85],
17	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	18	SENT_113	[p8l1637t16r2141b105],
18	curves	NNS	O	curve	dobj	16	SENT_113	[p8l9t150r245b194],
19	for	IN	O	for	_	0	SENT_113	[p8l298t126r404b194],
20	cumulative	JJ	O	cumulative	amod	22	SENT_113	[p8l453t126r867b194],
21	event-free	RB	O	event-free	advmod	20	SENT_113	[p8l919t126r1285b194],
22	survival	NN	O	survival	prep_for	16	SENT_113	[p8l1338t126r1625b194],
23	for	IN	O	for	_	0	SENT_113	[p8l1674t126r1781b194],
24	the	DT	O	the	det	27	SENT_113	[p8l1828t126r1945b194],
25	prespeciﬁed	JJ	O	prespeciﬁed	amod	27	SENT_113	[p8l1995t150r2138b215, p8l11t235r340b324],
26	primary	JJ	O	primary	amod	27	SENT_113	[p8l355t240r655b325],
27	endpoint	NN	O	endpoint	prep_for	16	SENT_113	[p8l671t236r1025b324],
28	.	.	O	.	_	0	SENT_113	[p8l671t236r1025b324],

1	Data	NNS	O	datum	nsubjpass	3	SENT_114	[p8l1049t242r1218b304],
2	were	VBD	O	be	auxpass	3	SENT_114	[p8l1232t260r1410b304],
3	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_114	[p8l1431t235r1759b304],
4	according	VBG	O	accord	_	0	SENT_114	[p8l1776t236r2140b325],
5	to	TO	O	to	prepc_according_to	3	SENT_114	[p8l7t358r77b412],
6	CYP2C19	NN	O	cyp2c19	pobj	3	SENT_114	[p8l141t349r578b413],
7	"	''	O	"	punct	6	SENT_114	[p8l141t349r578b413],
8	2	CD	NUMBER	2	num	9	SENT_114	[p8l141t349r578b413],
9	genotype	NN	O	genotype	dep	6	SENT_114	[p8l633t358r968b434],
10	and	CC	O	and	_	0	SENT_114	[p8l1027t344r1165b412],
11	were	VBD	O	be	auxpass	12	SENT_114	[p8l1218t369r1397b412],
12	compared	VBN	O	compare	conj_and	3	SENT_114	[p8l1455t344r1828b433],
13	by	IN	O	by	_	0	SENT_114	[p8l1882t344r1969b434],
14	the	DT	O	the	det	16	SENT_114	[p8l2023t344r2139b412],
15	log-rank	JJ	O	log-rank	amod	16	SENT_114	[p8l7t454r320b544],
16	test	NN	O	test	agent	12	SENT_114	[p8l356t467r505b522],
17	.	.	O	.	_	0	SENT_114	[p8l356t467r505b522],

1	Comparisons	NNS	O	comparison	nsubjpass	3	SENT_115	[p8l553t459r1048b543],
2	are	VBP	O	be	auxpass	3	SENT_115	[p8l1091t478r1203b522],
3	expressed	VBN	O	express	_	0	SENT_115	[p8l1245t454r1611b543],
4	as	IN	O	as	_	0	SENT_115	[p8l1651t478r1722b522],
5	univariate	JJ	O	univariate	amod	7	SENT_115	[p8l1764t459r2139b522],
6	hazard	NN	O	hazard	nn	7	SENT_115	[p8l7t564r263b632],
7	ratios	NNS	O	ratio	prep_as	3	SENT_115	[p8l288t568r492b632],
8	and	CC	O	and	_	0	SENT_115	[p8l522t564r660b632],
9	95	CD	PERCENT	95	number	10	SENT_115	[p8l687t568r846b635],
10	%	NN	PERCENT	%	amod	11	SENT_115	[p8l687t568r846b635],
11	CIs	NNS	O	ci	prep_as	3	SENT_115	[p8l876t569r1020b642],
12	,	,	O	,	_	0	SENT_115	[p8l876t569r1020b642],
13	including	VBG	O	include	_	0	SENT_115	[p8l1049t564r1409b653],
14	the	DT	O	the	det	16	SENT_115	[p8l1433t564r1550b632],
15	entire	JJ	O	entire	amod	16	SENT_115	[p8l1577t568r1793b632],
16	duration	NN	O	duration	prep_including	3	SENT_115	[p8l1821t564r2140b632],
17	of	IN	O	of	_	0	SENT_115	[p8l9t673r92b742],
18	follow-up	NN	O	follow-up	prep_of	16	SENT_115	[p8l133t673r503b762],
19	.	.	O	.	_	0	SENT_115	[p8l133t673r503b762],

1	We	PRP	O	we	nsubj	2	SENT_116	[p8l559t680r677b742],
2	used	VBD	O	use	_	0	SENT_116	[p8l730t673r907b742],
3	a	DT	O	a	det	5	SENT_116	[p8l960t698r997b742],
4	similar	JJ	O	similar	amod	5	SENT_116	[p8l1053t673r1315b742],
5	method	NN	O	method	dobj	2	SENT_116	[p8l1366t673r1655b742],
6	to	TO	O	to	aux	7	SENT_116	[p8l1706t687r1775b742],
7	describe	VB	O	describe	xcomp	2	SENT_116	[p8l1831t673r2139b742],
8	www	NN	O	www	dobj	7	SENT_116	[p8l7t942r540b993],
9	.	.	O	.	_	0	SENT_116	[p8l7t942r540b993],

1	the	DT	O	the	det	2	SENT_117	[p8l7t942r540b993],
2	|	NN	O	|	_	0	SENT_117	[p8l7t942r540b993],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_117	[p8l7t942r540b993],
4	Vol	NNP	O	Vol	dep	2	SENT_117	[p8l583t942r670b993],
5	373	CD	NUMBER	373	num	4	SENT_117	[p8l690t948r789b1000],
6	January	NNP	DATE	January	tmod	4	SENT_117	[p8l830t947r1047b1007],
7	24	CD	DATE	24	num	6	SENT_117	[p8l1065t948r1150b1001],
8	,	,	DATE	,	_	0	SENT_117	[p8l1065t948r1150b1001],
9	2009	CD	DATE	2009	num	6	SENT_117	[p8l1169t948r1314b1000],

1	Overall	JJ	O	overall	amod	3	SENT_118	[p9l810t120r946b156],
2	(	NN	O	(	nn	3	SENT_118	[p9l959t122r1121b165],
3	N	NN	O	n	_	0	SENT_118	[p9l959t122r1121b165],
4	=	JJ	O	=	dep	3	SENT_118	[p9l959t122r1121b165],
5	259	CD	NUMBER	259	number	6	SENT_118	[p9l959t122r1121b165],
6	)	CD	NUMBER	)	num	10	SENT_118	[p9l959t122r1121b165],
7	CYP2C19	NN	O	cyp2c19	nn	10	SENT_118	[p9l1164t121r1382b161],
8	*	NN	O	*	nn	10	SENT_118	[p9l1164t121r1382b161],
9	2	CD	NUMBER	2	num	10	SENT_118	[p9l1164t121r1382b161],
10	allele	NN	O	allele	dep	4	SENT_118	[p9l1395t120r1495b156],

1	Non	JJ	O	non	amod	3	SENT_119	[p9l1167t219r1396b252],
2	—	NN	O	—	nn	3	SENT_119	[p9l1167t219r1396b252],
3	carriers	NNS	O	carrier	nsubj	4	SENT_119	[p9l1167t219r1396b252],
4	(	VBP	O	(	_	0	SENT_119	[p9l1409t215r1567b261],
5	N	NN	O	n	dobj	4	SENT_119	[p9l1409t215r1567b261],
6	=	JJ	O	=	advmod	4	SENT_119	[p9l1409t215r1567b261],
7	186	CD	NUMBER	186	num	8	SENT_119	[p9l1409t215r1567b261],
8	)	NN	O	)	dep	6	SENT_119	[p9l1409t215r1567b261],

1	Carriers	NNS	O	carrier	dep	2	SENT_120	[p9l1623t218r1762b252],
2	(	VBP	O	(	_	0	SENT_120	[p9l1775t218r1903b261],
3	N	NN	O	n	dep	4	SENT_120	[p9l1775t218r1903b261],
4	=	JJ	O	=	acomp	2	SENT_120	[p9l1775t218r1903b261],
5	73	CD	NUMBER	73	num	8	SENT_120	[p9l1775t218r1903b261],
6	)	NN	O	)	nn	8	SENT_120	[p9l1775t218r1903b261],
7	p	NN	O	p	nn	8	SENT_120	[p9l1951t228r1973b263],
8	value	NN	O	value	nsubj	2	SENT_120	[p9l1984t216r2082b252],

1	Age	NNP	O	Age	_	0	SENT_121	[p9l70t314r142b358],
2	(	CD	NUMBER	(	num	3	SENT_121	[p9l155t313r277b358],
3	years	NNS	NUMBER	year	dep	1	SENT_121	[p9l155t313r277b358],
4	)	RB	O	)	advmod	7	SENT_121	[p9l155t313r277b358],
5	Male	JJ	O	male	amod	7	SENT_121	[p9l71t398r159b434],
6	sex	NN	O	sex	nn	7	SENT_121	[p9l171t411r230b434],
7	BMI	NN	O	bmus	rcmod	3	SENT_121	[p9l72t481r141b513],
8	(	CD	NUMBER	(	num	9	SENT_121	[p9l156t477r295b525],
9	kg/m2	NN	O	kg/m2	dep	7	SENT_121	[p9l156t477r295b525],
10	)	CD	NUMBER	)	num	11	SENT_121	[p9l156t477r295b525],
11	Race	NN	O	race	dep	1	SENT_121	[p9l72t561r154b593],
12	or	CC	O	or	_	0	SENT_121	[p9l165t569r204b593],
13	ethnic	JJ	O	ethnic	amod	14	SENT_121	[p9l215t557r331b593],
14	background	NN	O	background	dep	1	SENT_121	[p9l343t557r564b605],
15	White	NNP	MISC	White	nn	18	SENT_121	[p9l109t637r221b673],
16	European	NNP	MISC	European	nn	18	SENT_121	[p9l235t640r409b684],
17	North	NNP	MISC	North	nn	18	SENT_121	[p9l112t716r219b752],
18	African	NNP	MISC	African	dep	1	SENT_121	[p9l231t716r362b752],
19	Black	JJ	MISC	black	amod	22	SENT_121	[p9l112t796r206b832],
20	Asian	JJ	MISC	asian	amod	22	SENT_121	[p9l110t878r210b911],
21	Risk	NN	MISC	risk	nn	22	SENT_121	[p9l72t955r144b991],
22	factors	NNS	O	factor	dep	18	SENT_121	[p9l154t954r281b991],
23	Familial	JJ	MISC	familial	amod	24	SENT_121	[p9l112t1034r251b1070],
24	history	NN	O	history	dep	1	SENT_121	[p9l267t1034r395b1081],
25	of	IN	O	of	_	0	SENT_121	[p9l405t1034r445b1070],
26	CAD	NNP	O	CAD	prep_of	24	SENT_121	[p9l454t1037r533b1070],
27	Active	JJ	O	active	amod	29	SENT_121	[p9l110t1117r226b1149],
28	cigarette	NN	O	cigarette	nn	29	SENT_121	[p9l238t1117r402b1161],
29	smoking	NN	O	smoking	dep	1	SENT_121	[p9l414t1113r573b1161],
30	Dyslipidaemia	NNP	O	Dyslipidaemia	nn	32	SENT_121	[p9l112t1193r372b1240],
31	Arterial	JJ	O	arterial	amod	32	SENT_121	[p9l110t1272r245b1308],
32	hypertension	NN	O	hypertension	dep	29	SENT_121	[p9l261t1272r505b1319],
33	Diabetes	NNP	O	Diabetes	nn	36	SENT_121	[p9l112t1352r271b1388],
34	mellitus	NN	O	mellitus	nn	36	SENT_121	[p9l285t1352r432b1388],
35	Clinical	JJ	O	clinical	amod	36	SENT_121	[p9l71t1432r200b1468],
36	presentation	NN	O	presentation	dep	1	SENT_121	[p9l213t1435r451b1479],
37	STEMI	NNP	O	STEMI	nn	38	SENT_121	[p9l110t1514r225b1547],
38	Non	NNP	O	Non	dep	36	SENT_121	[p9l112t1594r322b1627],
39	.	.	O	.	_	0	SENT_121	[p9l112t1594r322b1627],

1	—	NN	O	—	_	0	SENT_122	[p9l112t1594r322b1627],
2	.	.	O	.	_	0	SENT_122	[p9l112t1594r322b1627],

1	STEM	NN	O	stem	nn	3	SENT_123	[p9l112t1594r322b1627],
2	|	CD	NUMBER	|	num	3	SENT_123	[p9l112t1594r322b1627],
3	Number	NN	O	number	nsubj	41	SENT_123	[p9l72t1670r224b1706],
4	of	IN	O	of	_	0	SENT_123	[p9l235t1670r275b1706],
5	vessels	NNS	O	vessel	prep_of	3	SENT_123	[p9l282t1670r410b1706],
6	Single	JJ	O	single	amod	11	SENT_123	[p9l110t1750r223b1797],
7	Double	JJ	O	double	amod	11	SENT_123	[p9l112t1829r242b1865],
8	Triple	JJ	O	triple	amod	11	SENT_123	[p9l108t1909r212b1956],
9	Revascularisation	NN	O	revascularisation	nn	11	SENT_123	[p9l72t1988r392b2024],
10	PCI	NN	O	pcus	nn	11	SENT_123	[p9l112t2070r166b2104],
11	Bypass	NN	O	bypass	dep	5	SENT_123	[p9l112t2150r236b2194],
12	Bare	JJ	O	bare	amod	18	SENT_123	[p9l112t2227r315b2263],
13	—	NN	O	—	nn	18	SENT_123	[p9l112t2227r315b2263],
14	meta	NN	O	meta	nn	18	SENT_123	[p9l112t2227r315b2263],
15	|	NN	O	|	nn	18	SENT_123	[p9l112t2227r315b2263],
16	stent	NN	O	stent	nn	18	SENT_123	[p9l329t2233r424b2263],
17	Drug	NN	O	drug	nn	18	SENT_123	[p9l112t2306r349b2353],
18	—	NN	O	—	dep	11	SENT_123	[p9l112t2306r349b2353],
19	eluting	VBG	O	elute	partmod	3	SENT_123	[p9l112t2306r349b2353],
20	stent	NN	O	stent	nsubj	29	SENT_123	[p9l362t2313r458b2342],
21	No	DT	O	no	det	29	SENT_123	[p9l112t2389r164b2421],
22	stent	NN	O	stent	nn	29	SENT_123	[p9l176t2392r272b2421],
23	Polyvascular	JJ	O	polyvascular	amod	29	SENT_123	[p9l72t2465r300b2512],
24	disease	NN	O	disease	nn	29	SENT_123	[p9l310t2465r443b2501],
25	H	NN	O	h	nn	29	SENT_123	[p9l72t2548r95b2579],
26	IV	CD	NUMBER	iv	num	29	SENT_123	[p9l102t2548r137b2580],
27	disease	NN	O	disease	nn	29	SENT_123	[p9l147t2544r280b2580],
28	Drug	NN	O	drug	nn	29	SENT_123	[p9l72t2627r159b2671],
29	therapy	NN	O	therapy	xcomp	19	SENT_123	[p9l170t2624r314b2670],
30	during	IN	O	during	_	0	SENT_123	[p9l324t2624r445b2671],
31	follow	VB	O	follow	prepc_during	19	SENT_123	[p9l457t2623r640b2670],
32	—	CD	NUMBER	—	dobj	31	SENT_123	[p9l457t2623r640b2670],
33	up	IN	O	up	_	0	SENT_123	[p9l457t2623r640b2670],
34	Clopidogrel	NNP	O	Clopidogrel	nn	35	SENT_123	[p9l111t2703r322b2750],
35	initiation	NN	O	initiation	prep_up	31	SENT_123	[p9l338t2706r507b2739],
36	at	IN	O	at	_	0	SENT_123	[p9l520t2710r556b2739],
37	ﬁrst	JJ	O	ﬁrst	amod	40	SENT_123	[p9l566t2703r640b2739],
38	event	NN	O	event	nn	40	SENT_123	[p9l651t2710r756b2739],
39	Aspirin	NN	O	aspirin	nn	40	SENT_123	[p9l110t2786r239b2829],
40	Statins	NNS	O	statin	prep_at	35	SENT_123	[p9l110t2865r239b2898],
41	[	VBP	O	[	_	0	SENT_123	[p9l112t2941r132b2988],
42	3	CD	NUMBER	3	num	45	SENT_123	[p9l112t2941r132b2988],
43	blockers	NNS	O	blocker	nn	45	SENT_123	[p9l146t2941r297b2977],
44	ACE	NN	O	ace	nn	45	SENT_123	[p9l110t3021r382b3057],
45	—	NN	O	—	dobj	41	SENT_123	[p9l110t3021r382b3057],
46	inhibitors	NNS	O	inhibitor	nn	50	SENT_123	[p9l110t3021r382b3057],
47	Calcium	NN	O	calcium	nn	50	SENT_123	[p9l111t3100r256b3136],
48	blockers	NNS	O	blocker	nn	50	SENT_123	[p9l271t3100r421b3136],
49	Vitamin	NN	O	vitamin	nn	50	SENT_123	[p9l109t3183r257b3216],
50	K	NN	O	k	dep	45	SENT_123	[p9l273t3183r294b3215],
51	antagonist	NN	O	antagonist	nn	53	SENT_123	[p9l305t3183r507b3227],
52	Proton-pump	NN	MISC	proton-pump	nn	53	SENT_123	[p9l112t3262r367b3306],
53	inhibitors	NNS	O	inhibitor	dep	50	SENT_123	[p9l380t3259r558b3295],

1	Data	NNS	O	datum	nsubj	6	SENT_124	[p9l52t3380r130b3410],
2	are	VBP	O	be	cop	6	SENT_124	[p9l141t3388r192b3410],
3	mean	JJ	O	mean	amod	6	SENT_124	[p9l205t3388r299b3410],
4	(	JJ	O	(	amod	6	SENT_124	[p9l313t3379r384b3419],
5	SD	NN	O	sd	nn	6	SENT_124	[p9l313t3379r384b3419],
6	)	NN	O	)	_	0	SENT_124	[p9l313t3379r384b3419],
7	or	CC	O	or	_	0	SENT_124	[p9l396t3388r431b3410],
8	number	NN	O	number	conj_or	6	SENT_124	[p9l443t3377r579b3410],
9	(	CD	PERCENT	(	num	10	SENT_124	[p9l590t3379r655b3419],
10	%	NN	PERCENT	%	dep	8	SENT_124	[p9l590t3379r655b3419],
11	)	CD	NUMBER	)	dep	8	SENT_124	[p9l590t3379r655b3419],
12	.	.	O	.	_	0	SENT_124	[p9l590t3379r655b3419],

1	BM	NN	O	bm	nn	2	SENT_125	[p9l670t3377r950b3420],
2	|	NN	O	|	_	0	SENT_125	[p9l670t3377r950b3420],
3	=	JJ	O	=	amod	4	SENT_125	[p9l670t3377r950b3420],
4	body	NN	O	body	dep	2	SENT_125	[p9l670t3377r950b3420],
5	—	CD	NUMBER	—	num	7	SENT_125	[p9l670t3377r950b3420],
6	mass	NN	O	mass	nn	7	SENT_125	[p9l670t3377r950b3420],
7	index	NN	O	index	dep	4	SENT_125	[p9l963t3377r1064b3410],
8	.	.	O	.	_	0	SENT_125	[p9l963t3377r1064b3410],

1	CAD	NN	O	cad	_	0	SENT_126	[p9l1076t3379r1328b3420],
2	=	JJ	O	=	amod	5	SENT_126	[p9l1076t3379r1328b3420],
3	coronary	JJ	O	coronary	amod	5	SENT_126	[p9l1076t3379r1328b3420],
4	artery	NN	O	artery	nn	5	SENT_126	[p9l1338t3383r1440b3420],
5	disease	NN	O	disease	dep	1	SENT_126	[p9l1449t3377r1581b3410],
6	.	.	O	.	_	0	SENT_126	[p9l1449t3377r1581b3410],

1	STEM	NN	O	stem	nn	2	SENT_127	[p9l1594t3377r1943b3410],
2	|	NN	O	|	nsubj	10	SENT_127	[p9l1594t3377r1943b3410],
3	=	JJ	O	=	dep	2	SENT_127	[p9l1594t3377r1943b3410],
4	ST	JJ	O	st	dobj	3	SENT_127	[p9l1594t3377r1943b3410],
5	—	NN	O	—	dep	4	SENT_127	[p9l1594t3377r1943b3410],
6	e	SYM	O	e	dep	4	SENT_127	[p9l1594t3377r1943b3410],
7	|	SYM	O	|	dep	10	SENT_127	[p9l1594t3377r1943b3410],
8	evation	NN	O	evation	nn	10	SENT_127	[p9l1594t3377r1943b3410],
9	myocardial	JJ	O	myocardial	amod	10	SENT_127	[p9l52t3436r239b3480],
10	infarction	NN	O	infarction	_	0	SENT_127	[p9l253t3436r429b3470],
11	.	.	O	.	_	0	SENT_127	[p9l253t3436r429b3470],

1	PC	NN	O	pc	nn	2	SENT_128	[p9l443t3439r756b3480],
2	|	NN	O	|	_	0	SENT_128	[p9l443t3439r756b3480],
3	=	JJ	O	=	amod	6	SENT_128	[p9l443t3439r756b3480],
4	percutaneous	JJ	O	percutaneous	amod	6	SENT_128	[p9l443t3439r756b3480],
5	coronary	JJ	O	coronary	amod	6	SENT_128	[p9l767t3448r920b3480],
6	intervention	NN	O	intervention	dep	2	SENT_128	[p9l932t3439r1156b3470],
7	.	.	O	.	_	0	SENT_128	[p9l932t3439r1156b3470],

1	ACE	NN	O	ace	nn	3	SENT_129	[p9l1167t3439r1465b3481],
2	=	JJ	O	=	amod	3	SENT_129	[p9l1167t3439r1465b3481],
3	angiotensin	NN	O	angiotensin	_	0	SENT_129	[p9l1167t3439r1465b3481],
4	converting	VBG	O	convert	partmod	3	SENT_129	[p9l1478t3439r1664b3481],
5	enzyme	NN	O	enzyme	dobj	4	SENT_129	[p9l1676t3448r1819b3480],
6	.	.	O	.	_	0	SENT_129	[p9l1676t3448r1819b3480],

1	Table	NNP	O	Table	_	0	SENT_130	[p9l50t3547r149b3583],
2	1	CD	NUMBER	1	num	1	SENT_130	[p9l160t3552r192b3583],
3	:	:	O	:	_	0	SENT_130	[p9l160t3552r192b3583],
4	Baseline	NN	O	baseline	nn	5	SENT_130	[p9l206t3547r366b3583],
5	characteristics	NNS	O	characteristic	dep	1	SENT_130	[p9l377t3547r660b3583],
6	of	IN	O	of	_	0	SENT_130	[p9l671t3547r713b3583],
7	patients	NNS	O	patient	prep_of	5	SENT_130	[p9l722t3549r886b3594],
8	according	VBG	O	accord	_	0	SENT_130	[p9l897t3547r1089b3595],
9	to	TO	O	to	prepc_according_to	7	SENT_130	[p9l1099t3553r1142b3583],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_130	[p9l1154t3549r1372b3589],
11	*	NN	O	*	pobj	7	SENT_130	[p9l1154t3549r1372b3589],
12	2	CD	NUMBER	2	num	15	SENT_130	[p9l1154t3549r1372b3589],
13	genotype	NN	O	genotype	nn	15	SENT_130	[p9l1384t3553r1573b3595],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_130	[p9l9t3708r387b3756],
15	events	NNS	O	event	dep	5	SENT_130	[p9l408t3718r572b3756],
16	that	WDT	O	that	nsubj	17	SENT_130	[p9l594t3708r696b3756],
17	occurred	VBD	O	occur	rcmod	15	SENT_130	[p9l717t3708r948b3756],
18	from	IN	O	from	_	0	SENT_130	[p9l968t3708r1098b3756],
19	6	CD	DURATION	6	num	20	SENT_130	[p9l1120t3712r1147b3756],
20	months	NNS	NUMBER	month	prep_from	17	SENT_130	[p9l1169t3708r1372b3756],
21	after	IN	O	after	_	0	SENT_130	[p9l1395t3708r1514b3756],
22	clopidogrel	NN	O	clopidogrel	nn	23	SENT_130	[p10l9t21r302b84],
23	initiation	NN	O	initiation	prep_after	17	SENT_130	[p10l336t24r578b68],
24	up	IN	O	up	advmod	17	SENT_130	[p10l612t38r680b83],
25	to	TO	O	to	_	0	SENT_130	[p10l714t30r763b68],
26	the	DT	O	the	det	27	SENT_130	[p10l797t21r879b68],
27	end	NN	O	end	prep_to	24	SENT_130	[p10l915t21r1013b68],
28	of	IN	O	of	_	0	SENT_130	[p10l1047t21r1106b68],
29	follow-up	NN	O	follow-up	prep_of	27	SENT_130	[p10l1131t21r1392b83],
30	.	.	O	.	_	0	SENT_130	[p10l1131t21r1392b83],

1	We	PRP	O	we	nsubj	2	SENT_131	[p10l1429t26r1512b69],
2	assessed	VBD	O	assess	_	0	SENT_131	[p10l9t96r234b144],
3	the	DT	O	the	det	4	SENT_131	[p10l253t96r335b144],
4	risk	NN	O	risk	dobj	2	SENT_131	[p10l356t96r456b144],
5	of	IN	O	of	_	0	SENT_131	[p10l475t96r534b144],
6	stent	JJ	O	stent	amod	7	SENT_131	[p10l547t106r675b144],
7	thrombosis	NN	O	thrombosis	prep_of	4	SENT_131	[p10l693t96r993b144],
8	in	IN	O	in	_	0	SENT_131	[p10l1015t100r1068b143],
9	the	DT	O	the	det	10	SENT_131	[p10l1087t96r1169b144],
10	subgroup	NN	O	subgroup	prep_in	2	SENT_131	[p10l1192t96r1441b159],
11	of	IN	O	of	_	0	SENT_131	[p10l1463t96r1522b144],
12	223	CD	NUMBER	223	num	13	SENT_131	[p10l10t177r98b220],
13	patients	NNS	O	patient	prep_of	10	SENT_131	[p10l119t175r327b235],
14	with	IN	O	with	_	0	SENT_131	[p10l345t172r462b221],
15	stent	NN	O	stent	nn	16	SENT_131	[p10l482t182r609b220],
16	implantation	NN	O	implantation	prep_with	2	SENT_131	[p10l626t172r981b235],
17	.	.	O	.	_	0	SENT_131	[p10l626t172r981b235],

1	A	DT	O	a	det	5	SENT_132	[p10l57t253r99b297],
2	multivariable	JJ	O	multivariable	amod	5	SENT_132	[p10l149t250r500b297],
3	Cox	NN	O	cox	nn	5	SENT_132	[p10l553t253r651b297],
4	regression	NN	O	regression	nn	5	SENT_132	[p10l700t253r977b313],
5	model	NN	O	model	nsubjpass	8	SENT_132	[p10l1028t250r1193b297],
6	was	VBD	O	be	auxpass	8	SENT_132	[p10l1243t267r1341b297],
7	then	RB	O	then	advmod	8	SENT_132	[p10l1393t250r1513b297],
8	constructed	VBN	O	construct	_	0	SENT_132	[p10l9t325r317b374],
9	with	IN	O	with	_	0	SENT_132	[p10l357t325r473b374],
10	use	NN	O	use	prep_with	8	SENT_132	[p10l514t342r604b374],
11	of	IN	O	of	_	0	SENT_132	[p10l646t325r705b374],
12	a	DT	O	a	det	15	SENT_132	[p10l738t343r764b374],
13	limited	JJ	O	limited	amod	15	SENT_132	[p10l804t325r995b374],
14	stepwise-selection	NN	O	stepwise-selection	nn	15	SENT_132	[p10l1037t325r1513b388],
15	procedure	NN	O	procedure	prep_of	10	SENT_132	[p10l8t402r275b465],
16	for	IN	O	for	_	0	SENT_132	[p10l317t402r392b450],
17	event-free	RB	O	event-free	advmod	8	SENT_132	[p10l434t402r693b451],
18	survival	NN	O	survival	prep_for	8	SENT_132	[p10l737t402r952b451],
19	.	.	O	.	_	0	SENT_132	[p10l737t402r952b451],

1	We	PRP	O	we	nsubj	2	SENT_133	[p10l996t407r1079b451],
2	considered	VBD	O	consider	_	0	SENT_133	[p10l1123t402r1411b451],
3	all	DT	O	all	det	5	SENT_133	[p10l1453t402r1513b450],
4	baseline	NN	O	baseline	nn	5	SENT_133	[p10l7t480r224b528],
5	characteristics	NNS	O	characteristic	dobj	2	SENT_133	[p10l274t480r649b528],
6	in	IN	O	in	_	0	SENT_133	[p10l699t483r752b527],
7	the	DT	O	the	det	8	SENT_133	[p10l799t480r882b528],
8	model	NN	O	model	prep_in	2	SENT_133	[p10l930t480r1096b528],
9	if	IN	O	if	mark	12	SENT_133	[p10l1145t480r1190b527],
10	they	PRP	O	they	nsubj	12	SENT_133	[p10l1228t480r1341b543],
11	were	VBD	O	be	cop	12	SENT_133	[p10l1386t497r1512b528],
12	signiﬁcant	NN	O	signiﬁcant	advcl	2	SENT_133	[p10l10t556r287b619],
13	at	IN	O	at	_	0	SENT_133	[p10l307t566r353b604],
14	Ol	NN	O	ol	nn	16	SENT_133	[p10l374t561r472b604],
15	=	JJ	O	=	amod	16	SENT_133	[p10l374t561r472b604],
16	o	NN	O	o	prep_at	12	SENT_133	[p10l374t561r472b604],
17	-	:	O	-	_	0	SENT_133	[p10l485t584r492b592],
18	20	CD	DATE	20	dep	16	SENT_133	[p10l506t561r565b604],
19	in	IN	O	in	_	0	SENT_133	[p10l586t559r639b603],
20	the	DT	O	the	det	22	SENT_133	[p10l658t556r741b604],
21	univariate	JJ	O	univariate	amod	22	SENT_133	[p10l761t559r1026b604],
22	model	NN	O	model	prep_in	18	SENT_133	[p10l1047t556r1225b604],
23	.	.	O	.	_	0	SENT_133	[p10l1047t556r1225b604],

1	The	DT	O	the	det	2	SENT_134	[p10l1248t556r1349b604],
2	effect	NN	O	effect	nsubjpass	10	SENT_134	[p10l1371t557r1514b604],
3	of	IN	O	of	_	0	SENT_134	[p10l9t632r67b679],
4	a	DT	O	a	det	6	SENT_134	[p10l76t649r103b679],
5	delayed	VBN	O	delay	amod	6	SENT_134	[p10l121t632r318b695],
6	start	NN	O	start	prep_of	2	SENT_134	[p10l336t641r451b680],
7	of	IN	O	of	_	0	SENT_134	[p10l468t632r527b679],
8	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_134	[p10l536t632r829b695],
9	was	VBD	O	be	auxpass	10	SENT_134	[p10l845t649r942b680],
10	entered	VBN	O	enter	_	0	SENT_134	[p10l962t632r1161b680],
11	in	IN	O	in	_	0	SENT_134	[p10l1178t635r1231b679],
12	the	DT	O	the	det	13	SENT_134	[p10l1247t632r1329b679],
13	model	NN	O	model	prep_in	10	SENT_134	[p10l1347t632r1513b680],

1	Articles	NNPS	O	Articles	_	0	SENT_135	[p10l101t1096r251b1132],

1	Median	JJ	MISC	median	amod	2	SENT_136	[p10l880t1439r1004b1471],
2	time	NN	O	time	_	0	SENT_136	[p10l1015t1441r1093b1471],
3	to	TO	O	to	_	0	SENT_136	[p10l1103t1445r1140b1471],
4	event	NN	O	event	prep_to	2	SENT_136	[p10l1151t1445r1254b1471],
5	:	:	O	:	_	0	SENT_136	[p10l1151t1445r1254b1471],

1	2-07	CD	NUMBER	2-07	num	2	SENT_137	[p10l879t1508r952b1541],
2	years	NNS	DURATION	year	nsubj	3	SENT_137	[p10l961t1515r1048b1547],
3	(	VBP	O	(	_	0	SENT_137	[p10l1059t1506r1131b1545],
4	IQR	NN	O	iqr	nn	5	SENT_137	[p10l1059t1506r1131b1545],
5	O-72-3-31	NN	O	o-72-3-31	dobj	3	SENT_137	[p10l1142t1506r1318b1545],
6	)	CD	NUMBER	)	num	5	SENT_137	[p10l1142t1506r1318b1545],

1	Number	NN	O	number	_	0	SENT_138	[p10l691t2106r724b2244],
2	of	IN	O	of	_	0	SENT_138	[p10l691t2060r724b2096],
3	patients	NNS	O	patient	prep_of	1	SENT_138	[p10l694t1914r733b2052],
4	with	IN	O	with	_	0	SENT_138	[p10l691t1821r723b1896],
5	events	NNS	O	event	prep_with	1	SENT_138	[p10l697t1698r724b1808],

1	Years	NNS	DURATION	year	_	0	SENT_139	[p10l1188t2609r1276b2639],
2	from	IN	O	from	_	0	SENT_139	[p10l1286t2606r1368b2639],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_139	[p10l1381t2606r1568b2649],
4	initiation	NN	O	initiation	prep_from	1	SENT_139	[p10l1582t2609r1736b2639],

1	Figure	NN	O	figure	_	0	SENT_140	[p10l643t2769r756b2815],
2	2	CD	NUMBER	2	num	1	SENT_140	[p10l764t2773r797b2803],
3	:	:	O	:	_	0	SENT_140	[p10l764t2773r797b2803],
4	Cumulative	JJ	O	cumulative	amod	5	SENT_140	[p10l808t2768r1031b2804],
5	occurrence	NN	O	occurrence	dep	1	SENT_140	[p10l1041t2779r1248b2804],
6	of	IN	O	of	_	0	SENT_140	[p10l1259t2767r1301b2804],
7	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_140	[p10l1309t2768r1586b2804],
8	death	NN	O	death	prep_of	5	SENT_140	[p10l1595t2768r1718b2810],
9	,	,	O	,	_	0	SENT_140	[p10l1595t2768r1718b2810],
10	non-fatal	JJ	O	non-fatal	amod	12	SENT_140	[p10l1731t2767r1910b2804],
11	myocardial	JJ	O	myocardial	amod	12	SENT_140	[p10l1924t2768r2135b2814],
12	infarction	NN	O	infarction	prep_of	5	SENT_140	[p10l644t2829r845b2871],
13	,	,	O	,	_	0	SENT_140	[p10l644t2829r845b2871],
14	or	CC	O	or	_	0	SENT_140	[p10l856t2841r896b2865],
15	urgent	JJ	O	urgent	amod	16	SENT_140	[p10l906t2835r1036b2876],
16	revascularisation	NN	O	revascularisation	prep_of	5	SENT_140	[p10l1048t2829r1374b2865],
17	during	IN	O	during	_	0	SENT_140	[p10l1385t2829r1512b2876],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_140	[p10l1524t2829r1740b2876],
19	exposure	NN	O	exposure	prep_during	16	SENT_140	[p10l1752t2841r1928b2875],
20	as	IN	O	as	_	0	SENT_140	[p10l644t2976r694b3007],
21	a	DT	O	a	det	24	SENT_140	[p10l718t2976r744b3007],
22	categorical	JJ	O	categorical	amod	24	SENT_140	[p10l766t2959r1046b3022],
23	variable	JJ	O	variable	amod	24	SENT_140	[p10l1066t2959r1271b3007],
24	(	NN	O	(	prep_as	19	SENT_140	[p10l1297t2959r1511b3022],
25	delayed	VBN	O	delay	partmod	5	SENT_140	[p10l1297t2959r1511b3022],
26	vs	CC	O	vs	_	0	SENT_140	[p10l1531t2976r1577b3007],
27	immediate	JJ	O	immediate	amod	28	SENT_140	[p10l1597t2959r1882b3007],
28	initiation	NN	O	initiation	conj_vs	5	SENT_140	[p10l1903t2962r2145b3007],
29	at	IN	O	at	_	0	SENT_140	[p10l644t3045r690b3083],
30	the	DT	O	the	det	31	SENT_140	[p10l712t3035r794b3083],
31	time	NN	O	time	prep_at	28	SENT_140	[p10l818t3038r938b3083],
32	of	IN	O	of	_	0	SENT_140	[p10l964t3035r1022b3083],
33	qualifying	VBG	O	qualify	prepc_of	31	SENT_140	[p10l1038t3035r1303b3098],
34	event	NN	O	event	nn	35	SENT_140	[p10l1328t3040r1499b3098],
35	)	NN	O	)	dobj	33	SENT_140	[p10l1328t3040r1499b3098],
36	.	.	O	.	_	0	SENT_140	[p10l1328t3040r1499b3098],

1	Variables	NNS	O	variable	nsubj	8	SENT_141	[p10l1526t3035r1765b3083],
2	remaining	VBG	O	remain	partmod	1	SENT_141	[p10l1791t3038r2068b3098],
3	in	IN	O	in	_	0	SENT_141	[p10l2092t3038r2145b3082],
4	the	DT	O	the	det	6	SENT_141	[p10l642t3112r724b3159],
5	ﬁnal	JJ	O	ﬁnal	amod	6	SENT_141	[p10l748t3112r865b3159],
6	model	NN	O	model	prep_in	2	SENT_141	[p10l888t3112r1054b3159],
7	Were	VBD	O	be	cop	8	SENT_141	[p10l1075t3129r1201b3159],
8	signiﬁcant	NN	O	signiﬁcant	_	0	SENT_141	[p10l1227t3112r1503b3175],
9	at	IN	O	at	_	0	SENT_141	[p10l1526t3121r1572b3159],
10	Ol	NN	O	ol	prep_at	8	SENT_141	[p10l1597t3115r1800b3159],
11	=	JJ	O	=	amod	10	SENT_141	[p10l1597t3115r1800b3159],
12	0-05	CD	NUMBER	0-05	tmod	11	SENT_141	[p10l1597t3115r1800b3159],
13	.	.	O	.	_	0	SENT_141	[p10l1597t3115r1800b3159],

1	We	PRP	O	we	nsubj	2	SENT_142	[p10l1826t3116r1909b3160],
2	checked	VBD	O	check	_	0	SENT_142	[p10l1933t3112r2146b3159],
3	the	DT	O	the	det	5	SENT_142	[p10l642t3187r724b3235],
4	proportional-hazards	JJ	O	proportional-hazards	amod	5	SENT_142	[p10l767t3187r1319b3249],
5	assumption	NN	O	assumption	dobj	2	SENT_142	[p10l1365t3190r1675b3249],
6	individually	RB	O	individually	advmod	2	SENT_142	[p10l1718t3187r2029b3250],
7	for	IN	O	for	_	0	SENT_142	[p10l2071t3187r2146b3235],
8	each	DT	O	each	det	9	SENT_142	[p10l644t3263r762b3311],
9	variable	JJ	O	variable	prep_for	2	SENT_142	[p10l806t3263r1011b3311],
10	entered	VBN	O	enter	partmod	9	SENT_142	[p10l1058t3263r1256b3311],
11	in	IN	O	in	_	0	SENT_142	[p10l1301t3266r1353b3310],
12	the	DT	O	the	det	14	SENT_142	[p10l1397t3263r1480b3311],
13	multivariable	JJ	O	multivariable	amod	14	SENT_142	[p10l1525t3263r1875b3311],
14	analysis	NN	O	analysis	prep_in	10	SENT_142	[p10l1921t3263r2142b3326],
15	.	.	O	.	_	0	SENT_142	[p10l1921t3263r2142b3326],

1	Estimates	NNS	O	estimate	nsubjpass	11	SENT_143	[p10l646t3343r898b3387],
2	for	IN	O	for	_	0	SENT_143	[p10l927t3340r1002b3387],
3	hazard	NN	O	hazard	nn	4	SENT_143	[p10l1027t3340r1207b3387],
4	ratios	NNS	O	ratio	prep_for	1	SENT_143	[p10l1233t3343r1377b3387],
5	and	CC	O	and	_	0	SENT_143	[p10l1407t3340r1504b3387],
6	corresponding	JJ	O	corresponding	amod	9	SENT_143	[p10l1530t3340r1913b3403],
7	95	CD	PERCENT	95	number	8	SENT_143	[p10l1941t3343r2054b3390],
8	%	NN	PERCENT	%	amod	9	SENT_143	[p10l1941t3343r2054b3390],
9	CI	NN	O	ci	conj_and	1	SENT_143	[p10l2083t3343r2142b3387],
10	Were	VBD	O	be	auxpass	11	SENT_143	[p10l642t3432r767b3463],
11	obtained	VBN	O	obtain	_	0	SENT_143	[p10l786t3415r1015b3463],
12	for	IN	O	for	_	0	SENT_143	[p10l1032t3415r1107b3463],
13	every	DT	O	every	det	16	SENT_143	[p10l1125t3432r1261b3478],
14	signiﬁcant	NN	O	signiﬁcant	nn	16	SENT_143	[p10l1280t3415r1556b3478],
15	outcome	NN	O	outcome	nn	16	SENT_143	[p10l1574t3425r1802b3463],
16	factor	NN	O	factor	prep_for	11	SENT_143	[p10l1820t3415r1977b3463],
17	.	.	O	.	_	0	SENT_143	[p10l1820t3415r1977b3463],

1	Data	NNS	O	datum	nsubjpass	3	SENT_144	[p10l696t3496r814b3539],
2	are	VBP	O	be	auxpass	3	SENT_144	[p10l836t3508r914b3539],
3	presented	VBN	O	present	_	0	SENT_144	[p10l935t3491r1195b3553],
4	as	IN	O	as	mark	6	SENT_144	[p10l1216t3508r1267b3539],
5	means	NNS	O	means	nsubj	6	SENT_144	[p10l1290t3508r1463b3539],
6	(	VBP	O	(	advcl	3	SENT_144	[p10l1489t3494r1601b3554],
7	SD	NN	O	sd	dobj	6	SENT_144	[p10l1489t3494r1601b3554],
8	)	CD	NUMBER	)	num	7	SENT_144	[p10l1489t3494r1601b3554],
9	or	CC	O	or	_	0	SENT_144	[p10l1626t3508r1680b3539],
10	median	JJ	O	median	amod	12	SENT_144	[p10l1700t3491r1900b3539],
11	(	NN	O	(	nn	12	SENT_144	[p10l1925t3495r2067b3554],
12	IQR	NN	O	iqr	dobj	6	SENT_144	[p10l1925t3495r2067b3554],
13	)	CD	NUMBER	)	npadvmod	6	SENT_144	[p10l1925t3495r2067b3554],
14	as	IN	O	as	_	0	SENT_144	[p10l2092t3508r2143b3539],
15	appropriate	JJ	O	appropriate	prep_as	6	SENT_144	[p10l644t3570r959b3630],
16	.	.	O	.	_	0	SENT_144	[p10l644t3570r959b3630],

1	All	DT	O	all	det	2	SENT_145	[p10l982t3567r1057b3614],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_145	[p10l1078t3567r1296b3630],
3	were	VBD	O	be	auxpass	4	SENT_145	[p10l1317t3584r1442b3615],
4	done	VBN	O	do	_	0	SENT_145	[p10l1464t3567r1592b3615],
5	with	IN	O	with	_	0	SENT_145	[p10l1612t3567r1729b3615],
6	the	DT	O	the	det	7	SENT_145	[p10l1749t3567r1831b3615],
7	use	NN	O	use	prep_with	4	SENT_145	[p10l1851t3584r1941b3615],
8	of	IN	O	of	_	0	SENT_145	[p10l1963t3567r2022b3615],
9	SAS	NNP	ORGANIZATION	SAS	nn	12	SENT_145	[p10l2037t3571r2142b3615],
10	software	NN	O	software	nn	12	SENT_145	[p10l645t3643r864b3691],
11	(	NN	O	(	nn	12	SENT_145	[p10l886t3646r1094b3706],
12	version	NN	O	version	prep_of	7	SENT_145	[p10l886t3646r1094b3706],
13	9.1	CD	NUMBER	9.1	num	14	SENT_145	[p10l1113t3648r1215b3706],
14	)	NN	O	)	dep	12	SENT_145	[p10l1113t3648r1215b3706],
15	.	.	O	.	_	0	SENT_145	[p10l1113t3648r1215b3706],

1	All	DT	O	all	det	3	SENT_146	[p10l1235t3643r1310b3690],
2	p	NN	O	p	nn	3	SENT_146	[p10l1328t3660r1359b3705],
3	values	NNS	O	value	nsubj	5	SENT_146	[p10l1377t3643r1539b3691],
4	are	VBP	O	be	cop	5	SENT_146	[p10l1560t3660r1639b3691],
5	two-sided	JJ	O	two-sided	_	0	SENT_146	[p10l1656t3643r1922b3691],
6	.	.	O	.	_	0	SENT_146	[p10l1656t3643r1922b3691],

1	Role	NN	O	role	nsubj	11	SENT_147	[p11l646t53r756b101],
2	of	IN	O	of	_	0	SENT_147	[p11l771t52r828b101],
3	the	DT	O	the	det	5	SENT_147	[p11l837t53r926b101],
4	funding	NN	O	funding	nn	5	SENT_147	[p11l940t52r1153b116],
5	source	NN	O	source	prep_of	1	SENT_147	[p11l1171t69r1342b101],
6	The	DT	O	the	det	7	SENT_147	[p11l642t129r743b177],
7	sponsors	NNS	O	sponsor	dep	5	SENT_147	[p11l770t146r1003b192],
8	of	IN	O	of	_	0	SENT_147	[p11l1030t129r1088b177],
9	the	DT	O	the	det	10	SENT_147	[p11l1103t129r1185b177],
10	study	NN	O	study	prep_of	7	SENT_147	[p11l1212t129r1353b192],
11	had	VBD	O	have	_	0	SENT_147	[p11l1375t129r1473b177],
12	no	DT	O	no	det	13	SENT_147	[p11l1497t146r1563b177],
13	role	NN	O	role	dobj	11	SENT_147	[p11l1588t129r1687b177],
14	in	IN	O	in	_	0	SENT_147	[p11l1713t133r1765b176],
15	study	NN	O	study	nn	16	SENT_147	[p11l1791t129r1932b192],
16	design	NN	O	design	prep_in	13	SENT_147	[p11l1956t129r2142b192],
17	,	,	O	,	_	0	SENT_147	[p11l1956t129r2142b192],
18	data	NNS	O	datum	nn	19	SENT_147	[p11l644t205r751b253],
19	collection	NN	O	collection	conj_or	13	SENT_147	[p11l781t205r1046b260],
20	,	,	O	,	_	0	SENT_147	[p11l781t205r1046b260],
21	data	NN	O	datum	nn	22	SENT_147	[p11l1078t205r1185b253],
22	analysis	NN	O	analysis	appos	19	SENT_147	[p11l1214t205r1436b268],
23	,	,	O	,	_	0	SENT_147	[p11l1214t205r1436b268],
24	interpretation	NN	O	interpretation	dobj	11	SENT_147	[p11l1467t208r1831b267],
25	of	IN	O	of	_	0	SENT_147	[p11l1860t205r1919b253],
26	data	NNS	O	datum	prep_of	24	SENT_147	[p11l1939t205r2060b260],
27	,	,	O	,	_	0	SENT_147	[p11l1939t205r2060b260],
28	or	CC	O	or	_	0	SENT_147	[p11l2092t222r2146b253],
29	writing	NN	O	writing	dobj	11	SENT_147	[p11l642t285r833b345],
30	of	IN	O	of	_	0	SENT_147	[p11l851t282r909b329],
31	the	DT	O	the	det	32	SENT_147	[p11l917t282r999b329],
32	report	NN	O	report	prep_of	29	SENT_147	[p11l1017t291r1190b344],
33	.	.	O	.	_	0	SENT_147	[p11l1017t291r1190b344],

1	All	DT	O	all	det	2	SENT_148	[p11l1209t282r1284b329],
2	authors	NNS	O	author	nsubj	3	SENT_148	[p11l1302t282r1500b329],
3	had	VBD	O	have	_	0	SENT_148	[p11l1518t282r1616b329],
4	full	JJ	O	full	amod	5	SENT_148	[p11l1633t282r1721b329],
5	access	NN	O	access	dobj	3	SENT_148	[p11l1739t299r1900b329],
6	to	TO	O	to	_	0	SENT_148	[p11l1918t291r1967b329],
7	all	PDT	O	all	predet	9	SENT_148	[p11l1986t282r2046b329],
8	the	DT	O	the	det	9	SENT_148	[p11l2062t282r2144b329],
9	data	NNS	O	datum	prep_to	3	SENT_148	[p11l644t357r751b405],
10	in	IN	O	in	_	0	SENT_148	[p11l781t360r833b404],
11	the	DT	O	the	det	12	SENT_148	[p11l862t357r944b405],
12	study	NN	O	study	prep_in	9	SENT_148	[p11l976t357r1123b420],
13	.	.	O	.	_	0	SENT_148	[p11l976t357r1123b420],

1	The	DT	O	the	det	3	SENT_149	[p11l1154t357r1256b405],
2	corresponding	JJ	O	corresponding	amod	3	SENT_149	[p11l1287t357r1669b420],
3	author	NN	O	author	nsubj	4	SENT_149	[p11l1700t357r1873b405],
4	had	VBD	O	have	_	0	SENT_149	[p11l1901t357r1999b405],
5	ﬁnal	JJ	O	ﬁnal	amod	6	SENT_149	[p11l2027t357r2145b405],
6	responsibility	NN	O	responsibility	dobj	4	SENT_149	[p11l643t433r1002b496],
7	for	IN	O	for	_	0	SENT_149	[p11l1018t433r1093b481],
8	the	DT	O	the	det	9	SENT_149	[p11l1110t433r1192b481],
9	decision	NN	O	decision	prep_for	6	SENT_149	[p11l1211t433r1429b481],
10	to	TO	O	to	aux	11	SENT_149	[p11l1446t442r1495b481],
11	submit	VB	O	submit	infmod	9	SENT_149	[p11l1515t433r1701b481],
12	for	IN	O	for	_	0	SENT_149	[p11l1718t433r1793b481],
13	publication	NN	O	publication	prep_for	11	SENT_149	[p11l1810t433r2120b495],
14	.	.	O	.	_	0	SENT_149	[p11l1810t433r2120b495],

1	Results	NNS	O	result	npadvmod	16	SENT_150	[p11l647t579r863b635],
2	Of	IN	O	of	_	0	SENT_150	[p11l645t665r717b713],
3	the	DT	O	the	det	5	SENT_150	[p11l722t665r804b713],
4	378	CD	NUMBER	378	num	5	SENT_150	[p11l823t668r907b715],
5	patients	NNS	O	patient	prep_of	16	SENT_150	[p11l923t668r1130b727],
6	who	WP	O	who	nsubj	7	SENT_150	[p11l1145t665r1256b713],
7	entered	VBD	O	enter	rcmod	5	SENT_150	[p11l1273t665r1471b713],
8	the	DT	O	the	det	11	SENT_150	[p11l1484t665r1566b713],
9	secondary	JJ	O	secondary	amod	11	SENT_150	[p11l1584t665r1847b728],
10	prevention	NN	O	prevention	nn	11	SENT_150	[p11l1860t668r2145b727],
11	programme	NN	O	programme	dobj	7	SENT_150	[p11l643t759r970b805],
12	,	,	O	,	_	0	SENT_150	[p11l643t759r970b805],
13	119	CD	NUMBER	119	nsubjpass	16	SENT_150	[p11l994t746r1072b790],
14	were	VBD	O	be	auxpass	16	SENT_150	[p11l1092t759r1217b789],
15	not	RB	O	not	neg	16	SENT_150	[p11l1238t751r1324b789],
16	treated	VBN	O	treat	dep	29	SENT_150	[p11l1343t742r1525b789],
17	by	IN	O	by	_	0	SENT_150	[p11l1543t742r1605b804],
18	clopidogrel	NN	O	clopidogrel	agent	16	SENT_150	[p11l1624t742r1917b805],
19	because	IN	O	because	mark	25	SENT_150	[p11l1936t742r2144b789],
20	premature	JJ	O	premature	amod	23	SENT_150	[p11l643t827r920b879],
21	coronary	JJ	O	coronary	amod	23	SENT_150	[p11l948t834r1179b880],
22	artery	NN	O	artery	nn	23	SENT_150	[p11l1205t827r1356b880],
23	disease	NN	O	disease	nsubj	25	SENT_150	[p11l1383t817r1571b865],
24	had	VBD	O	have	aux	25	SENT_150	[p11l1598t817r1696b865],
25	occurred	VBN	O	occur	advcl	16	SENT_150	[p11l1723t817r1953b865],
26	before	IN	O	before	_	0	SENT_150	[p11l1978t817r2144b865],
27	clopidogrel	NN	O	clopidogrel	prep_before	25	SENT_150	[p11l644t893r936b956],
28	was	VBD	O	be	auxpass	29	SENT_150	[p11l960t910r1057b941],
29	made	VBN	O	make	_	0	SENT_150	[p11l1084t893r1229b941],
30	available	JJ	O	available	acomp	29	SENT_150	[p11l1255t893r1480b941],
31	in	IN	O	in	_	0	SENT_150	[p11l1506t896r1559b940],
32	1999	CD	DATE	1999	prep_in	29	SENT_150	[p11l1585t897r1700b941],
33	(	CD	NUMBER	(	num	36	SENT_150	[p11l1731t893r1901b956],
34	ﬁgure	NN	O	ﬁgure	nn	36	SENT_150	[p11l1731t893r1901b956],
35	1	CD	NUMBER	1	num	36	SENT_150	[p11l1929t897r1983b956],
36	)	NN	O	)	nsubjpass	29	SENT_150	[p11l1929t897r1983b956],
37	.	.	O	.	_	0	SENT_150	[p11l1929t897r1983b956],

1	Thus	RB	O	thus	advmod	3	SENT_151	[p11l2010t893r2143b941],
2	we	PRP	O	we	nsubj	3	SENT_151	[p11l642t987r714b1017],
3	analysed	VBD	O	analyse	_	0	SENT_151	[p11l761t970r988b1032],
4	259	CD	NUMBER	259	num	5	SENT_151	[p11l1035t973r1125b1018],
5	patients	NNS	O	patient	dobj	3	SENT_151	[p11l1171t973r1379b1032],
6	who	WP	O	who	nsubjpass	9	SENT_151	[p11l1425t970r1536b1017],
7	were	VBD	O	be	auxpass	9	SENT_151	[p11l1581t987r1707b1017],
8	all	DT	O	all	advmod	9	SENT_151	[p11l1754t970r1814b1017],
9	treated	VBN	O	treat	rcmod	5	SENT_151	[p11l1859t970r2041b1017],
10	by	IN	O	by	_	0	SENT_151	[p11l2085t970r2146b1032],
11	clopidogrel	NN	O	clopidogrel	agent	9	SENT_151	[p11l644t1045r949b1108],
12	.	.	O	.	_	0	SENT_151	[p11l644t1045r949b1108],

1	Most	JJS	O	most	amod	2	SENT_152	[p11l695t1126r825b1169],
2	patients	NNS	O	patient	nsubj	5	SENT_152	[p11l846t1124r1053b1183],
3	were	VBD	O	be	cop	5	SENT_152	[p11l1077t1138r1202b1169],
4	white	JJ	O	white	amod	5	SENT_152	[p11l1224t1121r1369b1169],
5	men	NNS	O	man	_	0	SENT_152	[p11l1392t1138r1512b1169],
6	with	IN	O	with	_	0	SENT_152	[p11l1533t1121r1650b1169],
7	a	DT	O	a	det	9	SENT_152	[p11l1673t1138r1699b1168],
8	high	JJ	O	high	amod	9	SENT_152	[p11l1721t1121r1841b1184],
9	prevalence	NN	O	prevalence	prep_with	5	SENT_152	[p11l1864t1121r2144b1183],
10	of	IN	O	of	_	0	SENT_152	[p11l644t1198r702b1245],
11	familial	JJ	O	familial	amod	12	SENT_152	[p11l724t1198r925b1245],
12	history	NN	O	history	prep_of	9	SENT_152	[p11l955t1198r1138b1260],
13	of	IN	O	of	_	0	SENT_152	[p11l1168t1198r1227b1245],
14	coronary	JJ	O	coronary	amod	20	SENT_152	[p11l1249t1215r1480b1260],
15	artery	NN	O	artery	nn	20	SENT_152	[p11l1510t1207r1661b1260],
16	disease	NN	O	disease	nn	20	SENT_152	[p11l1691t1198r1880b1245],
17	(	NN	O	(	nn	20	SENT_152	[p11l1915t1198r2055b1261],
18	table	NN	O	table	nn	20	SENT_152	[p11l1915t1198r2055b1261],
19	1	CD	NUMBER	1	num	20	SENT_152	[p11l2088t1202r2142b1261],
20	)	NN	O	)	prep_of	12	SENT_152	[p11l2088t1202r2142b1261],
21	.	.	O	.	_	0	SENT_152	[p11l2088t1202r2142b1261],

1	Around	IN	O	around	_	0	SENT_153	[p11l642t1273r846b1321],
2	half	NN	O	half	prep_around	8	SENT_153	[p11l887t1273r997b1321],
3	of	IN	O	of	_	0	SENT_153	[p11l1031t1273r1090b1321],
4	patients	NNS	O	patient	prep_of	2	SENT_153	[p11l1123t1276r1330b1335],
5	were	VBD	O	be	cop	8	SENT_153	[p11l1373t1290r1498b1321],
6	still	RB	O	still	advmod	8	SENT_153	[p11l1543t1273r1636b1321],
7	actively	RB	O	actively	advmod	8	SENT_153	[p11l1680t1273r1873b1336],
8	smoking	NN	O	smoking	_	0	SENT_153	[p11l1916t1273r2145b1336],
9	3	CD	DURATION	3	num	10	SENT_153	[p11l646t1353r670b1397],
10	months	NNS	NUMBER	month	tmod	8	SENT_153	[p11l711t1349r913b1397],
11	after	IN	O	after	_	0	SENT_153	[p11l954t1349r1072b1397],
12	the	DT	O	the	det	15	SENT_153	[p11l1109t1349r1191b1397],
13	qualifying	VBG	O	qualify	amod	15	SENT_153	[p11l1230t1349r1496b1412],
14	event	NN	O	event	nn	15	SENT_153	[p11l1535t1358r1675b1397],
15	(	NN	O	(	prep_after	8	SENT_153	[p11l1716t1349r1856b1412],
16	table	NN	O	table	dep	8	SENT_153	[p11l1716t1349r1856b1412],
17	1	CD	NUMBER	1	num	18	SENT_153	[p11l1897t1353r1951b1412],
18	)	NN	O	)	dep	16	SENT_153	[p11l1897t1353r1951b1412],
19	.	.	O	.	_	0	SENT_153	[p11l1897t1353r1951b1412],

1	Other	JJ	O	other	amod	4	SENT_154	[p11l1994t1349r2146b1397],
2	conventional	JJ	O	conventional	amod	4	SENT_154	[p11l644t1425r982b1473],
3	risk	NN	O	risk	nn	4	SENT_154	[p11l1020t1425r1120b1473],
4	factors	NNS	O	factor	nsubj	16	SENT_154	[p11l1156t1425r1330b1473],
5	for	IN	O	for	_	0	SENT_154	[p11l1370t1425r1445b1473],
6	coronary	JJ	O	coronary	amod	8	SENT_154	[p11l1483t1442r1714b1488],
7	artery	NN	O	artery	nn	8	SENT_154	[p11l1751t1435r1903b1488],
8	disease	NN	O	disease	prep_for	4	SENT_154	[p11l1940t1425r2142b1480],
9	,	,	O	,	_	0	SENT_154	[p11l1940t1425r2142b1480],
10	including	VBG	O	include	_	0	SENT_154	[p11l643t1501r896b1564],
11	diabetes	NN	O	diabetes	prep_including	4	SENT_154	[p11l927t1501r1140b1549],
12	and	CC	O	and	_	0	SENT_154	[p11l1174t1501r1271b1549],
13	hypertension	NN	O	hypertension	prep_including	4	SENT_154	[p11l1300t1501r1661b1564],
14	,	,	O	,	_	0	SENT_154	[p11l1300t1501r1661b1564],
15	were	VBD	O	be	cop	16	SENT_154	[p11l1693t1518r1818b1549],
16	infrequent	JJ	O	infrequent	_	0	SENT_154	[p11l1849t1501r2142b1563],
17	.	.	O	.	_	0	SENT_154	[p11l1849t1501r2142b1563],

1	The	DT	O	the	det	3	SENT_155	[p11l642t1577r743b1624],
2	initial	JJ	O	initial	amod	3	SENT_155	[p11l765t1577r918b1624],
3	presentation	NN	O	presentation	nsubj	8	SENT_155	[p11l939t1580r1271b1639],
4	was	VBD	O	be	cop	8	SENT_155	[p11l1291t1594r1388b1624],
5	predominantly	RB	O	predominantly	advmod	6	SENT_155	[p11l1412t1577r1803b1639],
6	ST-elevation	JJ	MISC	st-elevation	amod	8	SENT_155	[p11l1828t1577r2145b1624],
7	myocardial	JJ	O	myocardial	amod	8	SENT_155	[p11l643t1653r934b1716],
8	infarction	NN	O	infarction	_	0	SENT_155	[p11l977t1653r1248b1708],
9	,	,	O	,	_	0	SENT_155	[p11l977t1653r1248b1708],
10	underlying	VBG	O	underlie	partmod	8	SENT_155	[p11l1293t1653r1582b1716],
11	the	DT	O	the	det	12	SENT_155	[p11l1624t1653r1706b1701],
12	importance	NN	O	importance	dobj	10	SENT_155	[p11l1750t1656r2051b1716],
13	of	IN	O	of	_	0	SENT_155	[p11l2096t1653r2154b1701],
14	acute	JJ	O	acute	amod	16	SENT_155	[p11l644t1739r780b1777],
15	coronary	JJ	O	coronary	amod	16	SENT_155	[p11l805t1746r1036b1792],
16	thrombosis	NN	O	thrombosis	prep_of	12	SENT_155	[p11l1057t1729r1356b1777],
17	in	IN	O	in	_	0	SENT_155	[p11l1381t1732r1434b1776],
18	this	DT	O	this	det	19	SENT_155	[p11l1456t1729r1552b1777],
19	population	NN	O	population	prep_in	16	SENT_155	[p11l1577t1729r1875b1791],
20	.	.	O	.	_	0	SENT_155	[p11l1577t1729r1875b1791],

1	Coronary	JJ	O	coronary	amod	3	SENT_156	[p11l1903t1733r2146b1792],
2	artery	NN	O	artery	nn	3	SENT_156	[p11l644t1814r795b1867],
3	disease	NN	O	disease	nsubj	6	SENT_156	[p11l824t1805r1012b1853],
4	was	VBD	O	be	cop	6	SENT_156	[p11l1041t1822r1138b1853],
5	single	JJ	O	single	amod	6	SENT_156	[p11l1171t1805r1326b1868],
6	vessel	NN	O	vessel	_	0	SENT_156	[p11l1355t1805r1510b1853],
7	in	IN	O	in	dep	6	SENT_156	[p11l1540t1808r1592b1852],
8	about	IN	O	about	_	0	SENT_156	[p11l1622t1805r1770b1853],
9	two-thirds	NNS	O	two-third	prep_about	6	SENT_156	[p11l1797t1805r2063b1853],
10	of	IN	O	of	_	0	SENT_156	[p11l2096t1805r2154b1853],
11	patients	NNS	O	patient	prep_of	9	SENT_156	[p11l643t1884r865b1944],
12	.	.	O	.	_	0	SENT_156	[p11l643t1884r865b1944],

1	Percutaneous	JJ	O	percutaneous	amod	3	SENT_157	[p11l895t1886r1249b1929],
2	coronary	JJ	O	coronary	amod	3	SENT_157	[p11l1275t1898r1506b1944],
3	intervention	NN	O	intervention	nsubjpass	8	SENT_157	[p11l1529t1884r1853b1929],
4	with	IN	O	with	_	0	SENT_157	[p11l1876t1881r1993b1929],
5	stent	NN	O	stent	nn	6	SENT_157	[p11l2019t1891r2146b1929],
6	placement	NN	O	placement	prep_with	3	SENT_157	[p11l8t2286r400b2375],
7	was	VBD	O	be	auxpass	8	SENT_157	[p11l436t2310r575b2355],
8	done	VBN	O	do	_	0	SENT_157	[p11l618t2286r800b2355],
9	in	IN	O	in	_	0	SENT_157	[p11l840t2291r915b2353],
10	most	JJS	O	most	amod	11	SENT_157	[p11l955t2300r1142b2355],
11	patients	NNS	O	patient	prep_in	8	SENT_157	[p11l1180t2291r1496b2375],
12	,	,	O	,	_	0	SENT_157	[p11l1180t2291r1496b2375],
13	with	IN	O	with	_	0	SENT_157	[p11l1538t2286r1703b2355],
14	bare-metal	JJ	O	bare-metal	amod	15	SENT_157	[p11l1741t2286r2140b2355],
15	stents	NNS	O	stent	prep_with	8	SENT_157	[p11l11t2408r226b2463],
16	used	VBN	O	use	partmod	15	SENT_157	[p11l277t2395r455b2463],
17	more	RBR	O	more	advmod	18	SENT_157	[p11l505t2419r700b2463],
18	frequently	RB	O	frequently	advmod	16	SENT_157	[p11l751t2395r1137b2484],
19	than	IN	O	than	_	0	SENT_157	[p11l1184t2395r1353b2463],
20	drug-eluting	JJ	O	drug-eluting	amod	21	SENT_157	[p11l1405t2395r1870b2485],
21	stents	NNS	O	stent	prep_than	18	SENT_157	[p11l1923t2408r2137b2463],
22	(	RB	O	(	advmod	18	SENT_157	[p11l14t2504r213b2594],
23	table	NN	O	table	nn	25	SENT_157	[p11l14t2504r213b2594],
24	1	CD	NUMBER	1	num	25	SENT_157	[p11l272t2511r349b2594],
25	)	NN	O	)	dobj	16	SENT_157	[p11l272t2511r349b2594],
26	.	.	O	.	_	0	SENT_157	[p11l272t2511r349b2594],

1	Baseline	NN	O	baseline	nn	2	SENT_158	[p11l413t2505r725b2573],
2	characteristics	NNS	O	characteristic	nsubj	5	SENT_158	[p11l782t2504r1313b2573],
3	were	VBD	O	be	cop	5	SENT_158	[p11l1370t2529r1548b2573],
4	well	RB	O	well	advmod	5	SENT_158	[p11l1602t2505r1754b2573],
5	balanced	JJ	O	balanced	_	0	SENT_158	[p11l1808t2505r2141b2573],
6	between	IN	O	between	_	0	SENT_158	[p11l7t2613r319b2681],
7	the	DT	O	the	det	9	SENT_158	[p11l342t2613r459b2681],
8	two	CD	NUMBER	two	num	9	SENT_158	[p11l483t2627r615b2681],
9	groups	NNS	O	group	prep_between	5	SENT_158	[p11l642t2637r898b2703],
10	deﬁned	VBN	O	deﬁned	partmod	9	SENT_158	[p11l926t2613r1205b2681],
11	by	IN	O	by	_	0	SENT_158	[p11l1228t2613r1314b2703],
12	C	NN	O	c	nn	13	SENT_158	[p11l1344t2618r1398b2681],
13	YP2C19	NN	O	yp2c19	agent	10	SENT_158	[p11l1405t2618r1782b2682],
14	’	CD	NUMBER	’	num	16	SENT_158	[p11l1405t2618r1782b2682],
15	~	NN	O	~	nn	16	SENT_158	[p11l1405t2618r1782b2682],
16	‘	NN	O	‘	dep	13	SENT_158	[p11l1405t2618r1782b2682],
17	2	CD	NUMBER	2	num	20	SENT_158	[p11l1405t2618r1782b2682],
18	genotype	NN	O	genotype	nn	20	SENT_158	[p11l1804t2627r2139b2703],
19	(	NN	O	(	nn	20	SENT_158	[p11l14t2723r213b2813],
20	table	NN	O	table	dep	16	SENT_158	[p11l14t2723r213b2813],
21	1	CD	NUMBER	1	num	22	SENT_158	[p11l242t2729r318b2813],
22	)	NN	O	)	dep	16	SENT_158	[p11l242t2729r318b2813],
23	.	.	O	.	_	0	SENT_158	[p11l242t2729r318b2813],

1	Aspirin	NN	O	aspirin	nsubj	12	SENT_159	[p11l78t2836r378b2920],
2	,	,	O	,	_	0	SENT_159	[p11l78t2836r378b2920],
3	statins	NNS	O	statin	conj_and	1	SENT_159	[p11l459t2836r720b2910],
4	,	,	O	,	_	0	SENT_159	[p11l459t2836r720b2910],
5	and	CC	O	and	_	0	SENT_159	[p11l799t2832r937b2900],
6	[	NN	O	[	conj_and	1	SENT_159	[p11l1017t2831r1057b2919],
7	3	CD	NUMBER	3	num	8	SENT_159	[p11l1017t2831r1057b2919],
8	blockers	NNS	O	blocker	dep	6	SENT_159	[p11l1131t2831r1441b2900],
9	were	VBD	O	be	cop	12	SENT_159	[p11l1516t2856r1694b2900],
10	long-term	JJ	O	long-term	amod	12	SENT_159	[p11l1769t2831r2140b2921],
11	treatment	NN	O	treatment	nn	12	SENT_159	[p11l7t2954r376b3008],
12	options	NNS	O	option	_	0	SENT_159	[p11l410t2945r684b3029],
13	in	IN	O	in	_	0	SENT_159	[p11l720t2945r795b3007],
14	almost	RB	O	almost	quantmod	15	SENT_159	[p11l829t2940r1081b3008],
15	all	DT	O	all	num	16	SENT_159	[p11l1114t2940r1199b3008],
16	patients	NNS	O	patient	prep_in	12	SENT_159	[p11l1232t2945r1526b3029],
17	(	RB	O	(	advmod	12	SENT_159	[p11l1569t2940r1767b3030],
18	table	NN	O	table	nn	20	SENT_159	[p11l1569t2940r1767b3030],
19	1	CD	NUMBER	1	num	20	SENT_159	[p11l1804t2946r1880b3030],
20	)	NN	O	)	dep	12	SENT_159	[p11l1804t2946r1880b3030],
21	.	.	O	.	_	0	SENT_159	[p11l1804t2946r1880b3030],

1	A	DT	O	a	det	3	SENT_160	[p11l1917t2945r1977b3007],
2	few	JJ	O	few	amod	3	SENT_160	[p11l2009t2940r2142b3008],
3	patients	NNS	O	patient	nsubj	9	SENT_160	[p11l8t3054r302b3139],
4	(	IN	O	(	_	0	SENT_160	[p11l336t3056r523b3140],
5	n	NN	O	n	prep_(	9	SENT_160	[p11l336t3056r523b3140],
6	=	JJ	O	=	amod	8	SENT_160	[p11l336t3056r523b3140],
7	8	CD	NUMBER	8	num	8	SENT_160	[p11l336t3056r523b3140],
8	)	NN	O	)	nsubj	9	SENT_160	[p11l336t3056r523b3140],
9	received	VBD	O	receive	_	0	SENT_160	[p11l554t3050r862b3118],
10	vitamin	NN	O	vitamin	nn	12	SENT_160	[p11l884t3054r1172b3118],
11	K	NN	O	k	nn	12	SENT_160	[p11l1201t3056r1255b3116],
12	antagonists	NNS	O	antagonist	dobj	9	SENT_160	[p11l1279t3054r1704b3140],
13	in	IN	O	in	_	0	SENT_160	[p11l1732t3054r1806b3116],
14	addition	NN	O	addition	_	0	SENT_160	[p11l1833t3050r2140b3118],
15	to	TO	O	to	_	0	SENT_160	[p11l7t3172r76b3227],
16	antiplatelet	JJ	O	antiplatelet	amod	17	SENT_160	[p11l123t3158r540b3247],
17	agents	NNS	O	agent	prep_in_addition_to	9	SENT_160	[p11l584t3172r822b3248],
18	either	CC	O	either	dep	9	SENT_160	[p11l870t3158r1088b3227],
19	because	IN	O	because	conj	9	SENT_160	[p11l1129t3158r1425b3227],
20	of	IN	O	of	pcomp	19	SENT_160	[p11l1472t3158r1555b3227],
21	an	DT	O	a	det	24	SENT_160	[p11l1588t3183r1677b3227],
22	established	JJ	O	established	amod	24	SENT_160	[p11l1723t3158r2141b3227],
23	antiphospholipid	NN	O	antiphospholipid	nn	24	SENT_160	[p11l9t3267r649b3356],
24	syndrome	NN	O	syndrome	pobj	20	SENT_160	[p11l703t3267r1074b3357],
25	after	IN	O	after	_	0	SENT_160	[p11l1127t3267r1295b3335],
26	the	DT	O	the	det	30	SENT_160	[p11l1344t3267r1460b3335],
27	qualifying	VBG	O	qualify	amod	30	SENT_160	[p11l1514t3267r1890b3357],
28	event	NN	O	event	nn	30	SENT_160	[p11l1942t3281r2141b3335],
29	(	NN	O	(	nn	30	SENT_160	[p11l14t3381r201b3467],
30	n	NN	O	n	prep_after	9	SENT_160	[p11l14t3381r201b3467],
31	=	JJ	O	=	amod	30	SENT_160	[p11l14t3381r201b3467],
32	5	CD	NUMBER	5	number	33	SENT_160	[p11l14t3381r201b3467],
33	)	CD	NUMBER	)	dep	31	SENT_160	[p11l14t3381r201b3467],
34	or	CC	O	or	_	0	SENT_160	[p11l239t3401r316b3444],
35	a	DT	O	a	det	37	SENT_160	[p11l347t3401r384b3444],
36	previous	JJ	O	previous	amod	37	SENT_160	[p11l415t3381r732b3466],
37	history	NN	O	history	conj_or	31	SENT_160	[p11l765t3377r1024b3466],
38	of	IN	O	of	_	0	SENT_160	[p11l1055t3377r1138b3445],
39	cardioembolic	JJ	O	cardioembolic	amod	40	SENT_160	[p11l1157t3377r1686b3445],
40	stroke	NN	O	stroke	prep_of	37	SENT_160	[p11l1720t3377r1945b3445],
41	with	IN	O	with	_	0	SENT_160	[p11l1975t3377r2140b3445],
42	severe	JJ	O	severe	amod	47	SENT_160	[p11l11t3510r240b3554],
43	left	JJ	O	left	amod	47	SENT_160	[p11l281t3485r401b3554],
44	ventricular	JJ	O	ventricular	amod	47	SENT_160	[p11l439t3485r847b3554],
45	dysfunction	NN	O	dysfunction	nn	47	SENT_160	[p11l888t3485r1330b3575],
46	(	NN	O	(	nn	47	SENT_160	[p11l1377t3492r1588b3575],
47	n	NN	O	n	prep_with	40	SENT_160	[p11l1377t3492r1588b3575],
48	=	JJ	O	=	amod	50	SENT_160	[p11l1377t3492r1588b3575],
49	3	CD	NUMBER	3	tmod	48	SENT_160	[p11l1377t3492r1588b3575],
50	)	NN	O	)	dep	31	SENT_160	[p11l1377t3492r1588b3575],
51	.	.	O	.	_	0	SENT_160	[p11l1377t3492r1588b3575],

1	Proton-pump	JJ	O	proton-pump	amod	2	SENT_161	[p11l1638t3492r2139b3574],
2	inhibitors	NNS	O	inhibitor	nsubjpass	4	SENT_161	[p11l8t3595r373b3663],
3	were	VBD	O	be	auxpass	4	SENT_161	[p11l407t3619r584b3663],
4	used	VBN	O	use	_	0	SENT_161	[p11l617t3595r795b3663],
5	in	IN	O	in	dep	4	SENT_161	[p11l827t3600r901b3662],
6	around	IN	O	around	_	0	SENT_161	[p11l934t3595r1203b3663],
7	a	DT	O	a	det	8	SENT_161	[p11l1236t3619r1273b3663],
8	third	JJ	ORDINAL	third	prep_around	4	SENT_161	[p11l1304t3595r1489b3663],
9	of	IN	O	of	_	0	SENT_161	[p11l1521t3595r1604b3663],
10	patients	NNS	O	patient	prep_of	8	SENT_161	[p11l1624t3600r1940b3684],
11	,	,	O	,	_	0	SENT_161	[p11l1624t3600r1940b3684],
12	with	IN	O	with	_	0	SENT_161	[p11l1975t3595r2140b3663],
13	no	DT	O	no	det	15	SENT_161	[p12l8t41r102b84],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_161	[p12l177t17r569b107],
15	differences	NNS	O	difference	prep_with	8	SENT_161	[p12l640t17r1050b85],
16	according	VBG	O	accord	_	0	SENT_161	[p12l1124t17r1489b107],
17	to	TO	O	to	prepc_according_to	4	SENT_161	[p12l1558t30r1627b84],
18	CYP2C19	NN	O	cyp2c19	pobj	4	SENT_161	[p12l1706t21r2144b85],
19	"	''	O	"	punct	18	SENT_161	[p12l1706t21r2144b85],
20	"	``	O	"	punct	18	SENT_161	[p12l1706t21r2144b85],
21	2	CD	NUMBER	2	num	24	SENT_161	[p12l1706t21r2144b85],
22	genotype	NN	O	genotype	nn	24	SENT_161	[p12l9t139r345b215],
23	(	NN	O	(	nn	24	SENT_161	[p12l377t125r576b215],
24	table	NN	O	table	dep	18	SENT_161	[p12l377t125r576b215],
25	1	CD	NUMBER	1	num	26	SENT_161	[p12l605t131r682b215],
26	)	NN	O	)	dep	24	SENT_161	[p12l605t131r682b215],
27	.	.	O	.	_	0	SENT_161	[p12l605t131r682b215],

1	The	DT	O	the	det	4	SENT_162	[p12l78t234r221b302],
2	ﬁrst	JJ	O	ﬁrst	amod	4	SENT_162	[p12l246t234r396b302],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_162	[p12l420t234r835b324],
4	treatment	NN	O	treatment	nsubj	13	SENT_162	[p12l858t247r1227b302],
5	given	VBN	O	give	prep	4	SENT_162	[p12l1251t239r1451b324],
6	to	TO	O	to	pcomp	5	SENT_162	[p12l1474t247r1543b302],
7	a	DT	O	a	det	8	SENT_162	[p12l1570t258r1606b302],
8	patient	NN	O	patient	pobj	6	SENT_162	[p12l1630t239r1891b323],
9	in	IN	O	in	_	0	SENT_162	[p12l1914t239r1988b301],
10	our	PRP$	O	we	poss	12	SENT_162	[p12l2014t258r2141b302],
11	study	NN	O	study	nn	12	SENT_162	[p12l11t344r211b433],
12	population	NN	O	population	prep_in	8	SENT_162	[p12l227t343r633b432],
13	was	VBD	O	be	_	0	SENT_162	[p12l649t368r788b412],
14	on	IN	O	on	_	0	SENT_162	[p12l811t368r904b412],
15	Feb	NNP	DATE	Feb	prep_on	13	SENT_162	[p12l927t344r1055b412],
16	10	CD	DATE	10	num	15	SENT_162	[p12l1078t350r1172b422],
17	,	,	DATE	,	_	0	SENT_162	[p12l1078t350r1172b422],
18	1999	CD	DATE	1999	num	15	SENT_162	[p12l1198t350r1381b412],
19	.	.	O	.	_	0	SENT_162	[p12l1198t350r1381b412],

1	Clopidogrel	NN	O	clopidogrel	nn	2	SENT_163	[p12l1407t343r1842b433],
2	therapy	NN	O	therapy	nsubjpass	4	SENT_163	[p12l1860t344r2142b433],
3	was	VBD	O	be	auxpass	4	SENT_163	[p12l7t477r145b521],
4	started	VBN	O	start	_	0	SENT_163	[p12l195t452r446b521],
5	as	IN	O	as	_	0	SENT_163	[p12l491t477r563b521],
6	the	DT	O	the	det	8	SENT_163	[p12l609t452r726b521],
7	ﬁrst-line	NN	O	ﬁrst-line	nn	8	SENT_163	[p12l772t452r1086b521],
8	therapy	NN	O	therapy	prep_as	4	SENT_163	[p12l1131t452r1413b542],
9	of	IN	O	of	_	0	SENT_163	[p12l1457t452r1540b521],
10	acute	JJ	O	acute	amod	12	SENT_163	[p12l1573t466r1768b521],
11	coronary	JJ	O	coronary	amod	12	SENT_163	[p12l1814t477r2142b542],
12	syndromes	NNS	O	syndrome	prep_of	8	SENT_163	[p12l11t561r418b650],
13	in	IN	O	in	_	0	SENT_163	[p12l477t566r552b628],
14	216	CD	PERCENT	216	number	15	SENT_163	[p12l611t567r730b629],
15	(	CD	PERCENT	(	prep_in	4	SENT_163	[p12l794t565r996b651],
16	84	CD	PERCENT	84	num	17	SENT_163	[p12l794t565r996b651],
17	%	NN	PERCENT	%	dep	15	SENT_163	[p12l794t565r996b651],
18	)	CD	NUMBER	)	num	19	SENT_163	[p12l794t565r996b651],
19	patients	NNS	O	patient	dep	17	SENT_163	[p12l1059t566r1374b650],
20	.	.	O	.	_	0	SENT_163	[p12l1059t566r1374b650],

1	In	IN	O	in	_	0	SENT_164	[p12l1439t568r1518b628],
2	the	DT	O	the	det	5	SENT_164	[p12l1573t561r1689b629],
3	remaining	VBG	O	remain	amod	5	SENT_164	[p12l1747t566r2140b651],
4	43	CD	NUMBER	43	num	5	SENT_164	[p12l7t677r86b739],
5	patients	NNS	O	patient	prep_in	9	SENT_164	[p12l128t675r443b759],
6	,	,	O	,	_	0	SENT_164	[p12l128t675r443b759],
7	clopidogrel	NN	O	clopidogrel	nsubjpass	9	SENT_164	[p12l486t670r900b760],
8	was	VBD	O	be	auxpass	9	SENT_164	[p12l936t695r1075b739],
9	started	VBN	O	start	_	0	SENT_164	[p12l1117t671r1368b739],
10	after	IN	O	after	_	0	SENT_164	[p12l1405t670r1574b739],
11	the	DT	O	the	det	13	SENT_164	[p12l1608t671r1725b739],
12	qualifying	VBG	O	qualify	amod	13	SENT_164	[p12l1764t670r2140b760],
13	event	NN	O	event	prep_after	9	SENT_164	[p12l9t793r226b857],
14	,	,	O	,	_	0	SENT_164	[p12l9t793r226b857],
15	with	IN	O	with	mark	23	SENT_164	[p12l282t779r448b847],
16	a	DT	O	a	det	19	SENT_164	[p12l504t804r541b847],
17	median	JJ	O	median	amod	19	SENT_164	[p12l595t779r879b847],
18	time	NN	O	time	nn	19	SENT_164	[p12l932t784r1102b847],
19	delay	NN	O	delay	nsubj	23	SENT_164	[p12l1159t779r1351b869],
20	of	IN	O	of	_	0	SENT_164	[p12l1405t779r1488b847],
21	8-4	CD	NUMBER	8-4	num	22	SENT_164	[p12l1531t785r1659b847],
22	years	NNS	NUMBER	year	prep_of	19	SENT_164	[p12l1708t803r1897b869],
23	(	VBP	O	(	dep	13	SENT_164	[p12l1961t785r2141b869],
24	IQR	NN	O	iqr	nn	26	SENT_164	[p12l1961t785r2141b869],
25	3-6-9-O	JJ	O	3-6-9-o	amod	26	SENT_164	[p12l13t894r361b978],
26	)	NN	O	)	dobj	23	SENT_164	[p12l13t894r361b978],
27	,	,	O	,	_	0	SENT_164	[p12l13t894r361b978],
28	because	IN	O	because	_	0	SENT_164	[p12l408t888r705b956],
29	of	IN	O	of	_	0	SENT_164	[p12l751t888r834b956],
30	a	DT	O	a	det	35	SENT_164	[p12l867t912r904b956],
31	newly	RB	O	newly	advmod	32	SENT_164	[p12l949t888r1168b978],
32	scheduled	VBN	O	schedule	amod	35	SENT_164	[p12l1214t888r1590b956],
33	percutaneous	JJ	O	percutaneous	amod	35	SENT_164	[p12l1634t901r2137b977],
34	coronary	JJ	O	coronary	amod	35	SENT_164	[p12l9t1022r337b1087],
35	intervention	NN	O	intervention	prep_because_of	26	SENT_164	[p12l357t1002r817b1066],
36	or	CC	O	or	_	0	SENT_164	[p12l840t1022r917b1066],
37	based	VBN	O	base	dobj	23	SENT_164	[p12l936t997r1150b1066],
38	on	IN	O	on	_	0	SENT_164	[p12l1173t1022r1266b1066],
39	a	DT	O	a	det	41	SENT_164	[p12l1289t1022r1326b1066],
40	medical	JJ	O	medical	amod	41	SENT_164	[p12l1348t998r1642b1066],
41	decision	NN	O	decision	prep_on	37	SENT_164	[p12l1666t998r1975b1066],
42	that	WDT	O	that	nsubjpass	45	SENT_164	[p12l1996t997r2141b1066],
43	was	VBD	O	be	auxpass	45	SENT_164	[p12l7t1130r145b1174],
44	not	RB	O	not	neg	45	SENT_164	[p12l173t1120r296b1174],
45	driven	VBN	O	drive	rcmod	41	SENT_164	[p12l321t1106r557b1174],
46	by	IN	O	by	_	0	SENT_164	[p12l581t1106r668b1196],
47	an	DT	O	a	det	49	SENT_164	[p12l693t1131r782b1174],
48	acute	JJ	O	acute	amod	49	SENT_164	[p12l809t1120r1003b1174],
49	event	NN	O	event	agent	45	SENT_164	[p12l1030t1120r1246b1174],
50	.	.	O	.	_	0	SENT_164	[p12l1030t1120r1246b1174],

1	At	IN	O	at	_	0	SENT_165	[p12l77t1222r159b1285],
2	the	DT	O	the	det	5	SENT_165	[p12l217t1217r333b1285],
3	last	JJ	O	last	amod	5	SENT_165	[p12l393t1217r522b1285],
4	follow-up	JJ	O	follow-up	amod	5	SENT_165	[p12l581t1217r932b1306],
5	visit	NN	O	visit	prep_at	11	SENT_165	[p12l992t1221r1164b1295],
6	,	,	O	,	_	0	SENT_165	[p12l992t1221r1164b1295],
7	213	CD	NUMBER	213	num	8	SENT_165	[p12l1230t1223r1347b1285],
8	patients	NNS	O	patient	nsubj	11	SENT_165	[p12l1411t1221r1705b1306],
9	were	VBD	O	be	aux	11	SENT_165	[p12l1766t1241r1944b1285],
10	still	RB	O	still	advmod	11	SENT_165	[p12l2008t1217r2140b1285],
11	receiving	VBG	O	receive	_	0	SENT_165	[p12l8t1330r348b1415],
12	a	DT	O	a	det	14	SENT_165	[p12l406t1350r443b1394],
13	maintenance	NN	O	maintenance	nn	14	SENT_165	[p12l499t1330r986b1394],
14	dose	NN	O	dose	dobj	11	SENT_165	[p12l1045t1326r1211b1394],
15	of	IN	O	of	_	0	SENT_165	[p12l1270t1325r1353b1394],
16	75	CD	NUMBER	75	num	17	SENT_165	[p12l1395t1330r1472b1396],
17	mg	NN	O	mg	prep_of	14	SENT_165	[p12l1533t1350r1654b1415],
18	per	IN	O	per	_	0	SENT_165	[p12l1710t1350r1832b1414],
19	day	NN	DURATION	day	prep_per	17	SENT_165	[p12l1888t1325r2014b1415],
20	of	IN	O	of	_	0	SENT_165	[p12l2070t1325r2153b1394],
21	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_165	[p12l9t1434r444b1524],
22	,	,	O	,	_	0	SENT_165	[p12l9t1434r444b1524],
23	of	IN	O	of	_	0	SENT_165	[p12l485t1434r568b1502],
24	whom	WP	O	whom	rel	31	SENT_165	[p12l590t1434r828b1502],
25	208	CD	PERCENT	208	number	26	SENT_165	[p12l867t1440r995b1502],
26	(	CD	PERCENT	(	amod	29	SENT_165	[p12l1039t1439r1246b1524],
27	98	CD	PERCENT	98	num	28	SENT_165	[p12l1039t1439r1246b1524],
28	%	NN	PERCENT	%	dep	26	SENT_165	[p12l1039t1439r1246b1524],
29	)	NN	O	)	nsubj	31	SENT_165	[p12l1039t1439r1246b1524],
30	also	RB	O	also	advmod	31	SENT_165	[p12l1290t1434r1432b1502],
31	received	VBD	O	receive	rcmod	21	SENT_165	[p12l1470t1434r1777b1502],
32	low-dose	JJ	O	low-dose	amod	33	SENT_165	[p12l1812t1434r2139b1502],
33	aspirin	NN	O	aspirin	dobj	31	SENT_165	[p12l9t1548r269b1633],
34	in	IN	O	in	_	0	SENT_165	[p12l305t1548r379b1610],
35	combination	NN	O	combination	prep_in	31	SENT_165	[p12l415t1544r908b1612],
36	.	.	O	.	_	0	SENT_165	[p12l415t1544r908b1612],

1	The	DT	O	the	det	4	SENT_166	[p12l946t1544r1089b1611],
2	46	CD	NUMBER	46	num	4	SENT_166	[p12l1124t1550r1206b1611],
3	remaining	VBG	O	remain	amod	4	SENT_166	[p12l1243t1548r1636b1634],
4	patients	NNS	O	patient	nsubj	15	SENT_166	[p12l1671t1548r1965b1633],
5	had	VBD	O	have	aux	6	SENT_166	[p12l2002t1544r2141b1612],
6	stopped	VBN	O	stop	rcmod	4	SENT_166	[p12l11t1652r302b1741],
7	clopidogrel	NN	O	clopidogrel	dobj	6	SENT_166	[p12l326t1652r742b1742],
8	after	IN	O	after	_	0	SENT_166	[p12l767t1652r936b1721],
9	a	DT	O	a	det	11	SENT_166	[p12l960t1677r997b1721],
10	median	JJ	O	median	amod	11	SENT_166	[p12l1021t1652r1305b1721],
11	time	NN	O	time	prep_after	6	SENT_166	[p12l1328t1657r1498b1721],
12	of	IN	O	of	_	0	SENT_166	[p12l1525t1652r1608b1721],
13	321	CD	DURATION	321	num	14	SENT_166	[p12l1624t1658r1743b1721],
14	days	NNS	NUMBER	day	prep_of	11	SENT_166	[p12l1768t1652r1928b1742],
15	(	VBP	O	(	_	0	SENT_166	[p12l1961t1658r2141b1742],
16	IQR	NN	O	iqr	nn	18	SENT_166	[p12l1961t1658r2141b1742],
17	69-366	CD	NUMBER	69-366	num	18	SENT_166	[p12l10t1767r297b1851],
18	)	NN	O	)	dobj	15	SENT_166	[p12l10t1767r297b1851],
19	and	CC	O	and	_	0	SENT_166	[p12l362t1761r500b1829],
20	were	VBD	O	be	auxpass	22	SENT_166	[p12l556t1786r734b1829],
21	then	RB	O	then	advmod	22	SENT_166	[p12l793t1761r962b1829],
22	left	VBN	O	leave	conj_and	15	SENT_166	[p12l1020t1761r1139b1829],
23	receiving	VBG	O	receive	xcomp	22	SENT_166	[p12l1197t1766r1538b1851],
24	only	RB	O	only	advmod	26	SENT_166	[p12l1597t1761r1756b1851],
25	low-dose	JJ	O	low-dose	amod	26	SENT_166	[p12l1812t1761r2139b1829],
26	aspirin	NN	O	aspirin	dobj	23	SENT_166	[p12l9t1876r287b1961],
27	.	.	O	.	_	0	SENT_166	[p12l9t1876r287b1961],

1	Interruption	NN	O	interruption	nsubj	7	SENT_167	[p12l318t1876r782b1961],
2	of	IN	O	of	_	0	SENT_167	[p12l806t1872r889b1940],
3	treatment	NN	O	treatment	prep_of	1	SENT_167	[p12l898t1885r1267b1940],
4	was	VBD	O	be	cop	7	SENT_167	[p12l1287t1896r1425b1940],
5	a	DT	O	a	det	7	SENT_167	[p12l1452t1896r1489b1940],
6	medical	JJ	O	medical	amod	7	SENT_167	[p12l1512t1872r1806b1940],
7	decision	NN	O	decision	_	0	SENT_167	[p12l1830t1872r2140b1940],
8	in	IN	O	in	_	0	SENT_167	[p12l8t1985r83b2047],
9	all	DT	O	all	det	10	SENT_167	[p12l117t1980r202b2049],
10	cases	NNS	O	case	prep_in	7	SENT_167	[p12l237t2005r448b2049],
11	.	.	O	.	_	0	SENT_167	[p12l237t2005r448b2049],

1	The	DT	O	the	det	5	SENT_168	[p12l484t1980r627b2049],
2	median	JJ	O	median	amod	5	SENT_168	[p12l662t1980r946b2049],
3	clopidogrel	NN	O	clopidogrel	nn	5	SENT_168	[p12l980t1980r1395b2070],
4	exposure	NN	O	exposure	nn	5	SENT_168	[p12l1430t2005r1763b2069],
5	time	NN	O	time	nsubj	8	SENT_168	[p12l1796t1985r1966b2049],
6	was	VBD	O	be	cop	8	SENT_168	[p12l1999t2005r2137b2049],
7	1-07	CD	NUMBER	1-07	num	8	SENT_168	[p12l11t2093r169b2160],
8	years	NNS	NUMBER	year	_	0	SENT_168	[p12l235t2113r426b2179],
9	(	VBP	O	(	rcmod	8	SENT_168	[p12l504t2095r684b2179],
10	IQR	NN	O	iqr	nn	12	SENT_168	[p12l504t2095r684b2179],
11	0-28-3-O	NN	O	0-28-3-o	nn	12	SENT_168	[p12l754t2095r1157b2179],
12	)	NN	O	)	dobj	9	SENT_168	[p12l754t2095r1157b2179],
13	.	.	O	.	_	0	SENT_168	[p12l754t2095r1157b2179],

1	The	DT	O	the	det	3	SENT_169	[p12l1234t2090r1378b2157],
2	longest	JJS	O	longest	amod	3	SENT_169	[p12l1447t2090r1720b2180],
3	follow-up	JJ	O	follow-up	nsubj	12	SENT_169	[p12l1788t2090r2139b2179],
4	measured	VBN	O	measure	partmod	3	SENT_169	[p12l8t2199r380b2268],
5	in	IN	O	in	_	0	SENT_169	[p12l404t2204r479b2266],
6	a	DT	O	a	det	7	SENT_169	[p12l506t2224r542b2268],
7	patient	NN	O	patient	prep_in	4	SENT_169	[p12l568t2204r828b2288],
8	receiving	VBG	O	receive	partmod	7	SENT_169	[p12l852t2204r1192b2289],
9	clopidogrel	NN	O	clopidogrel	dobj	8	SENT_169	[p12l1219t2199r1634b2289],
10	was	VBD	O	be	cop	12	SENT_169	[p12l1657t2224r1796b2268],
11	8	CD	DURATION	8	num	12	SENT_169	[p12l1825t2205r1865b2267],
12	years	NNS	NUMBER	year	_	0	SENT_169	[p12l1890t2224r2101b2289],
13	.	.	O	.	_	0	SENT_169	[p12l1890t2224r2101b2289],

1	Of	IN	O	of	_	0	SENT_170	[p12l82t2308r186b2376],
2	the	DT	O	the	det	4	SENT_170	[p12l246t2308r364b2376],
3	259	CD	NUMBER	259	num	4	SENT_170	[p12l442t2313r571b2377],
4	patients	NNS	O	patient	prep_of	11	SENT_170	[p12l647t2313r971b2397],
5	,	,	O	,	_	0	SENT_170	[p12l647t2313r971b2397],
6	186	CD	PERCENT	186	number	7	SENT_170	[p12l1052t2314r1173b2376],
7	(	CD	PERCENT	(	nsubj	11	SENT_170	[p12l1254t2313r1459b2398],
8	72	CD	PERCENT	72	num	9	SENT_170	[p12l1254t2313r1459b2398],
9	%	NN	PERCENT	%	dep	7	SENT_170	[p12l1254t2313r1459b2398],
10	)	CD	NUMBER	)	dep	7	SENT_170	[p12l1254t2313r1459b2398],
11	were	VBD	O	be	_	0	SENT_170	[p12l1537t2333r1718b2377],
12	wild-type	JJ	O	wild-type	amod	13	SENT_170	[p12l1791t2308r2139b2398],
13	homozygotes	NNS	O	homozygote	nsubj	14	SENT_170	[p12l7t2418r513b2508],
14	(	VBP	O	(	ccomp	11	SENT_170	[p12l587t2422r859b2508],
15	"	``	O	"	punct	14	SENT_170	[p12l587t2422r859b2508],
16	1	CD	NUMBER	1	dobj	14	SENT_170	[p12l587t2422r859b2508],
17	/	:	O	/	punct	18	SENT_170	[p12l587t2422r859b2508],
18	*	CD	NUMBER	*	dep	16	SENT_170	[p12l587t2422r859b2508],
19	‘	CD	NUMBER	‘	nsubj	21	SENT_170	[p12l587t2422r859b2508],
20	1	CD	NUMBER	1	num	21	SENT_170	[p12l587t2422r859b2508],
21	)	NN	O	)	rcmod	16	SENT_170	[p12l587t2422r859b2508],
22	,	,	O	,	_	0	SENT_170	[p12l587t2422r859b2508],
23	64	CD	PERCENT	64	dep	21	SENT_170	[p12l931t2424r1016b2485],
24	(	CD	PERCENT	(	num	26	SENT_170	[p12l1083t2422r1294b2508],
25	25	CD	PERCENT	25	num	26	SENT_170	[p12l1083t2422r1294b2508],
26	%	NN	PERCENT	%	nsubj	29	SENT_170	[p12l1083t2422r1294b2508],
27	)	CD	NUMBER	)	dep	26	SENT_170	[p12l1083t2422r1294b2508],
28	were	VBD	O	be	cop	29	SENT_170	[p12l1364t2442r1545b2486],
29	heterozygotes	NNS	O	heterozygote	rcmod	23	SENT_170	[p12l1611t2418r2137b2508],
30	(	CD	NUMBER	(	dep	29	SENT_170	[p12l14t2531r295b2616],
31	"	``	O	"	punct	21	SENT_170	[p12l14t2531r295b2616],
32	'	''	O	'	_	0	SENT_170	[p12l14t2531r295b2616],
33	\	SYM	O	\	dep	35	SENT_170	[p12l14t2531r295b2616],
34	‘	CD	NUMBER	‘	nsubj	35	SENT_170	[p12l14t2531r295b2616],
35	1	CD	NUMBER	1	dep	14	SENT_170	[p12l14t2531r295b2616],
36	/	:	O	/	punct	50	SENT_170	[p12l14t2531r295b2616],
37	*	CD	NUMBER	*	number	38	SENT_170	[p12l14t2531r295b2616],
38	2	CD	NUMBER	2	num	39	SENT_170	[p12l14t2531r295b2616],
39	)	NN	O	)	nsubj	50	SENT_170	[p12l14t2531r295b2616],
40	,	,	O	,	_	0	SENT_170	[p12l14t2531r295b2616],
41	and	CC	O	and	_	0	SENT_170	[p12l334t2526r474b2595],
42	nine	CD	NUMBER	nine	num	43	SENT_170	[p12l508t2531r678b2595],
43	(	NN	O	(	conj_and	39	SENT_170	[p12l719t2531r884b2616],
44	3	CD	PERCENT	3	number	45	SENT_170	[p12l719t2531r884b2616],
45	%	NN	PERCENT	%	amod	43	SENT_170	[p12l719t2531r884b2616],
46	)	CD	NUMBER	)	dep	39	SENT_170	[p12l719t2531r884b2616],
47	were	VBD	O	be	cop	50	SENT_170	[p12l923t2551r1104b2595],
48	homozygous	JJ	O	homozygous	amod	50	SENT_170	[p12l1139t2526r1626b2616],
49	(	NN	O	(	nn	50	SENT_170	[p12l1669t2531r1933b2616],
50	*	NN	O	*	dep	35	SENT_170	[p12l1669t2531r1933b2616],
51	2	CD	NUMBER	2	dep	50	SENT_170	[p12l1669t2531r1933b2616],
52	/	:	O	/	punct	50	SENT_170	[p12l1669t2531r1933b2616],
53	"	``	O	"	punct	35	SENT_170	[p12l1669t2531r1933b2616],
54	'	''	O	'	_	0	SENT_170	[p12l1669t2531r1933b2616],
55	~	FW	O	~	nn	56	SENT_170	[p12l1669t2531r1933b2616],
56	‘	FW	O	‘	dep	59	SENT_170	[p12l1669t2531r1933b2616],
57	2	CD	NUMBER	2	number	58	SENT_170	[p12l1669t2531r1933b2616],
58	)	CD	NUMBER	)	npadvmod	59	SENT_170	[p12l1669t2531r1933b2616],
59	with	IN	O	with	dep	11	SENT_170	[p12l1971t2526r2140b2595],
60	respect	NN	O	respect	pobj	59	SENT_170	[p12l8t2648r281b2724],
61	to	TO	O	to	_	0	SENT_170	[p12l307t2648r377b2703],
62	the	DT	O	the	prep_to	59	SENT_170	[p12l406t2635r524b2703],
63	"	``	O	"	punct	62	SENT_170	[p12l555t2640r639b2702],
64	"	``	O	"	punct	65	SENT_170	[p12l555t2640r639b2702],
65	2	CD	NUMBER	2	dep	62	SENT_170	[p12l555t2640r639b2702],
66	allelic	JJ	O	allelic	amod	67	SENT_170	[p12l671t2635r892b2703],
67	variant	NN	O	variant	dep	65	SENT_170	[p12l919t2640r1203b2703],
68	.	.	O	.	_	0	SENT_170	[p12l919t2640r1203b2703],

1	The	DT	O	the	det	3	SENT_171	[p12l1235t2635r1380b2703],
2	allelic	JJ	O	allelic	amod	3	SENT_171	[p12l1411t2635r1631b2703],
3	frequency	NN	O	frequency	nsubj	17	SENT_171	[p12l1660t2635r2041b2724],
4	of	IN	O	of	_	0	SENT_171	[p12l2069t2635r2153b2703],
5	CYP2C19	NN	O	cyp2c19	prep_of	3	SENT_171	[p12l15t2749r461b2813],
6	"	''	O	"	punct	5	SENT_171	[p12l15t2749r461b2813],
7	'	''	O	'	_	0	SENT_171	[p12l15t2749r461b2813],
8	~	FW	O	~	nn	10	SENT_171	[p12l15t2749r461b2813],
9	‘	FW	O	‘	dep	10	SENT_171	[p12l15t2749r461b2813],
10	2	CD	NUMBER	2	advmod	13	SENT_171	[p12l15t2749r461b2813],
11	was	VBD	O	be	cop	13	SENT_171	[p12l497t2769r638b2813],
12	15-8	CD	PERCENT	15-8	num	13	SENT_171	[p12l684t2749r926b2816],
13	%	NN	PERCENT	%	_	0	SENT_171	[p12l684t2749r926b2816],
14	and	CC	O	and	_	0	SENT_171	[p12l969t2745r1109b2812],
15	did	VBD	O	do	aux	17	SENT_171	[p12l1150t2745r1270b2813],
16	not	RB	O	not	neg	17	SENT_171	[p12l1310t2758r1435b2812],
17	vary	VB	O	vary	conj_and	13	SENT_171	[p12l1473t2769r1631b2834],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_171	[p12l1673t2745r2142b2835],
19	between	IN	O	between	_	0	SENT_171	[p12l7t2853r326b2922],
20	race	NN	O	race	prep_between	17	SENT_171	[p12l350t2878r504b2922],
21	or	CC	O	or	_	0	SENT_171	[p12l530t2878r608b2922],
22	ethnic	JJ	O	ethnic	amod	23	SENT_171	[p12l632t2853r868b2922],
23	groups	NNS	O	group	prep_between	17	SENT_171	[p12l894t2878r1154b2943],
24	(	RB	O	(	advmod	25	SENT_171	[p12l1187t2853r1390b2943],
25	table	NN	O	table	rcmod	23	SENT_171	[p12l1187t2853r1390b2943],
26	1	CD	NUMBER	1	num	27	SENT_171	[p12l1418t2860r1497b2943],
27	)	NN	O	)	dep	25	SENT_171	[p12l1418t2860r1497b2943],
28	.	.	O	.	_	0	SENT_171	[p12l1418t2860r1497b2943],

1	C	NN	O	c	nsubjpass	7	SENT_172	[p12l1532t2859r1586b2922],
2	YP2C19	NN	O	yp2c19	dep	1	SENT_172	[p12l1594t2858r1974b2922],
3	"	''	O	"	punct	2	SENT_172	[p12l1594t2858r1974b2922],
4	"	``	O	"	punct	2	SENT_172	[p12l1594t2858r1974b2922],
5	3	CD	NUMBER	3	dep	2	SENT_172	[p12l1594t2858r1974b2922],
6	was	VBD	O	be	auxpass	7	SENT_172	[p12l1997t2878r2137b2922],
7	detected	VBN	O	detect	_	0	SENT_172	[p12l9t2962r326b3030],
8	in	IN	O	in	_	0	SENT_172	[p12l360t2967r435b3029],
9	two	CD	PERCENT	two	prep_in	7	SENT_172	[p12l469t2975r603b3030],
10	(	CD	PERCENT	(	number	11	SENT_172	[p12l645t2966r801b3052],
11	1	CD	PERCENT	1	num	12	SENT_172	[p12l645t2966r801b3052],
12	%	NN	PERCENT	%	npadvmod	7	SENT_172	[p12l645t2966r801b3052],
13	)	CD	NUMBER	)	num	14	SENT_172	[p12l645t2966r801b3052],
14	patients	NNS	O	patient	dep	12	SENT_172	[p12l841t2967r1143b3051],
15	and	CC	O	and	_	0	SENT_172	[p12l1182t2962r1321b3030],
16	CYP2C19	NN	O	cyp2c19	conj_and	12	SENT_172	[p12l1362t2967r1805b3030],
17	"	''	O	"	punct	16	SENT_172	[p12l1362t2967r1805b3030],
18	"	``	O	"	punct	16	SENT_172	[p12l1362t2967r1805b3030],
19	4	CD	NUMBER	4	dep	16	SENT_172	[p12l1362t2967r1805b3030],
20	in	IN	O	in	_	0	SENT_172	[p12l1834t2967r1910b3029],
21	three	CD	PERCENT	three	number	22	SENT_172	[p12l1943t2962r2139b3030],
22	(	CD	PERCENT	(	prep_in	7	SENT_172	[p12l14t3076r196b3161],
23	1	CD	PERCENT	1	number	24	SENT_172	[p12l14t3076r196b3161],
24	%	NN	PERCENT	%	amod	22	SENT_172	[p12l14t3076r196b3161],
25	)	CD	NUMBER	)	prep_in	7	SENT_172	[p12l14t3076r196b3161],
26	.	.	O	.	_	0	SENT_172	[p12l14t3076r196b3161],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_173	[p12l246t3076r691b3140],
2	"	''	O	"	punct	1	SENT_173	[p12l246t3076r691b3140],
3	"	``	O	"	punct	4	SENT_173	[p12l246t3076r691b3140],
4	5	CD	NUMBER	5	nsubjpass	11	SENT_173	[p12l246t3076r691b3140],
5	and	CC	O	and	cc	4	SENT_173	[p12l727t3071r867b3140],
6	"	``	O	"	punct	4	SENT_173	[p12l905t3076r991b3140],
7	"	``	O	"	punct	8	SENT_173	[p12l905t3076r991b3140],
8	6	CD	NUMBER	6	dep	4	SENT_173	[p12l905t3076r991b3140],
9	were	VBD	O	be	auxpass	11	SENT_173	[p12l1029t3096r1210b3140],
10	not	RB	O	not	neg	11	SENT_173	[p12l1249t3085r1374b3140],
11	recorded	VBN	O	record	rcmod	1	SENT_173	[p12l1411t3072r1746b3140],
12	in	IN	O	in	_	0	SENT_173	[p12l1783t3076r1859b3138],
13	any	DT	O	any	prep_in	11	SENT_173	[p12l1898t3096r2031b3161],
14	of	IN	O	of	_	0	SENT_173	[p12l2069t3071r2153b3140],
15	the	DT	O	the	det	16	SENT_173	[p12l7t3181r126b3250],
16	patients	NNS	O	patient	prep_of	13	SENT_173	[p12l160t3186r484b3270],
17	.	.	O	.	_	0	SENT_173	[p12l160t3186r484b3270],

1	We	PRP	O	we	nsubj	2	SENT_174	[p12l521t3188r640b3250],
2	noted	VBD	O	note	_	0	SENT_174	[p12l675t3181r890b3250],
3	no	DT	O	no	det	4	SENT_174	[p12l923t3206r1017b3250],
4	deviation	NN	O	deviation	dobj	2	SENT_174	[p12l1054t3181r1403b3250],
5	from	IN	O	from	_	0	SENT_174	[p12l1437t3181r1624b3250],
6	the	DT	O	the	det	8	SENT_174	[p12l1657t3181r1776b3250],
7	expected	VBN	O	expect	amod	8	SENT_174	[p12l1812t3181r2141b3270],
8	proportions	NNS	O	proportion	prep_from	4	SENT_174	[p12l8t3295r456b3379],
9	of	IN	O	of	_	0	SENT_174	[p12l485t3290r569b3358],
10	genotypes	NNS	O	genotype	prep_of	8	SENT_174	[p12l582t3303r962b3380],
11	in	IN	O	in	_	0	SENT_174	[p12l990t3295r1065b3357],
12	the	DT	O	the	det	13	SENT_174	[p12l1089t3290r1208b3358],
13	population	NN	O	population	prep_in	10	SENT_174	[p12l1234t3290r1648b3379],
14	predicted	VBN	O	predict	partmod	13	SENT_174	[p12l1673t3290r2031b3379],
15	by	IN	O	by	_	0	SENT_174	[p12l2053t3290r2142b3380],
16	the	DT	O	the	det	18	SENT_174	[p12l7t3399r126b3468],
17	I-Iardy-Weinberg	NN	O	i-iardy-weinberg	nn	18	SENT_174	[p12l182t3400r815b3489],
18	equilibrium	NN	O	equilibrium	agent	14	SENT_174	[p12l867t3400r1325b3488],
19	for	IN	O	for	_	0	SENT_174	[p12l1376t3399r1485b3468],
20	polymorphisms	NNS	O	polymorphism	prep_for	18	SENT_174	[p12l1534t3399r2137b3489],
21	(	CD	NUMBER	(	num	22	SENT_174	[p12l14t3514r358b3598],
22	p	NN	O	p	npadvmod	23	SENT_174	[p12l14t3514r358b3598],
23	>	JJR	O	>	amod	20	SENT_174	[p12l14t3514r358b3598],
24	O-40	CD	NUMBER	o-40	num	25	SENT_174	[p12l14t3514r358b3598],
25	)	NN	O	)	dep	4	SENT_174	[p12l14t3514r358b3598],
26	.	.	O	.	_	0	SENT_174	[p12l14t3514r358b3598],

1	Baseline	NN	O	baseline	nn	2	SENT_175	[p12l393t3508r712b3576],
2	demographics	NNS	O	demographic	nsubj	11	SENT_175	[p12l742t3508r1304b3598],
3	,	,	O	,	_	0	SENT_175	[p12l742t3508r1304b3598],
4	clinical	JJ	O	clinical	amod	5	SENT_175	[p12l1336t3508r1609b3576],
5	presentation	NN	O	presentation	conj_and	2	SENT_175	[p12l1635t3513r2136b3597],
6	,	,	O	,	_	0	SENT_175	[p12l1635t3513r2136b3597],
7	and	CC	O	and	_	0	SENT_175	[p12l9t3617r150b3685],
8	therapy	NN	O	therapy	conj_and	2	SENT_175	[p12l226t3617r514b3707],
9	did	VBD	O	do	aux	11	SENT_175	[p12l592t3617r712b3685],
10	not	RB	O	not	neg	11	SENT_175	[p12l789t3630r913b3685],
11	differ	VB	O	differ	_	0	SENT_175	[p12l992t3617r1198b3685],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_175	[p12l1278t3617r1746b3707],
13	between	IN	O	between	_	0	SENT_175	[p12l1821t3617r2140b3685],
14	wild-type	JJ	O	wild-type	amod	16	SENT_175	[p12l7t3727r354b3816],
15	homozygous	JJ	O	homozygous	amod	16	SENT_175	[p12l390t3727r877b3816],
16	patients	NNS	O	patient	prep_between	11	SENT_175	[p12l916t3731r1217b3815],
17	and	CC	O	and	_	0	SENT_175	[p12l1257t3726r1397b3795],
18	those	DT	O	those	prep_between	11	SENT_175	[p12l1431t3726r1635b3795],
19	carrying	VBG	O	carry	xcomp	11	SENT_175	[p12l1673t3731r1986b3816],
20	the	DT	O	the	dobj	19	SENT_175	[p12l2020t3726r2139b3795],

1	C	NN	O	c	_	0	SENT_176	[p13l15t22r69b85],
2	YP2C19	NN	O	yp2c19	dobj	1	SENT_176	[p13l77t22r461b86],
3	"	''	O	"	punct	2	SENT_176	[p13l77t22r461b86],
4	'	''	O	'	_	0	SENT_176	[p13l77t22r461b86],
5	~	FW	O	~	nn	6	SENT_176	[p13l77t22r461b86],
6	‘	FW	O	‘	rcmod	2	SENT_176	[p13l77t22r461b86],
7	2	CD	NUMBER	2	dep	6	SENT_176	[p13l77t22r461b86],
8	allelic	JJ	O	allelic	amod	11	SENT_176	[p13l487t17r708b85],
9	variant	JJ	O	variant	amod	11	SENT_176	[p13l735t22r1001b85],
10	(	NN	O	(	nn	11	SENT_176	[p13l1034t17r1238b107],
11	table	NN	O	table	dep	7	SENT_176	[p13l1034t17r1238b107],
12	1	CD	NUMBER	1	num	13	SENT_176	[p13l1270t23r1349b107],
13	)	NN	O	)	dep	7	SENT_176	[p13l1270t23r1349b107],
14	.	.	O	.	_	0	SENT_176	[p13l1270t23r1349b107],

1	Furthermore	RB	O	furthermore	advmod	11	SENT_177	[p13l1386t17r1894b95],
2	,	,	O	,	_	0	SENT_177	[p13l1386t17r1894b95],
3	mean	VB	O	mean	csubj	11	SENT_177	[p13l1926t42r2140b85],
4	follow-up	NN	O	follow-up	nsubj	7	SENT_177	[p13l8t127r368b216],
5	did	VBD	O	do	aux	7	SENT_177	[p13l396t127r516b195],
6	not	RB	O	not	neg	7	SENT_177	[p13l539t140r664b195],
7	differ	VB	O	differ	ccomp	3	SENT_177	[p13l689t127r895b195],
8	according	VBG	O	accord	_	0	SENT_177	[p13l920t127r1293b217],
9	to	TO	O	to	prepc_according_to	7	SENT_177	[p13l1317t140r1387b195],
10	genotypes	NNS	O	genotype	pobj	7	SENT_177	[p13l1415t140r1795b217],
11	(	VBP	O	(	_	0	SENT_177	[p13l1829t131r1978b217],
12	2-7	CD	NUMBER	2-7	num	14	SENT_177	[p13l1829t131r1978b217],
13	[	CD	NUMBER	[	num	14	SENT_177	[p13l2006t132r2138b216],
14	SD	NN	O	sd	dobj	11	SENT_177	[p13l2006t132r2138b216],
15	2-4	CD	NUMBER	2-4	num	17	SENT_177	[p13l11t242r154b324],
16	]	CD	NUMBER	]	num	17	SENT_177	[p13l11t242r154b324],
17	years	NNS	NUMBER	year	npadvmod	11	SENT_177	[p13l208t260r402b325],
18	for	IN	O	for	_	0	SENT_177	[p13l457t235r565b304],
19	carriers	NNS	O	carrier	prep_for	11	SENT_177	[p13l616t240r902b304],
20	and	CC	O	and	_	0	SENT_177	[p13l957t235r1098b304],
21	2-9	CD	NUMBER	2-9	num	22	SENT_177	[p13l1150t242r1277b304],
22	[	CD	NUMBER	[	conj_and	19	SENT_177	[p13l1335t240r1505b324],
23	2-5	CD	NUMBER	2-5	number	24	SENT_177	[p13l1335t240r1505b324],
24	]	CD	NUMBER	]	num	25	SENT_177	[p13l1335t240r1505b324],
25	years	NNS	NUMBER	year	npadvmod	22	SENT_177	[p13l1558t260r1753b325],
26	for	IN	O	for	_	0	SENT_177	[p13l1807t235r1916b304],
27	noncarriers	NNS	O	noncarrier	prep_for	22	SENT_177	[p13l1965t260r2138b304, p13l9t349r318b422],
28	;	:	O	;	_	0	SENT_177	[p13l1965t260r2138b304, p13l9t349r318b422],
29	p	NN	O	p	nn	31	SENT_177	[p13l349t350r491b433],
30	=	JJ	O	=	amod	31	SENT_177	[p13l349t350r491b433],
31	o	NN	O	o	conj_and	19	SENT_177	[p13l349t350r491b433],
32	-	:	O	-	_	0	SENT_177	[p13l510t384r521b395],
33	51	CD	NUMBER	51	num	34	SENT_177	[p13l543t349r667b434],
34	)	NN	O	)	prep_for	11	SENT_177	[p13l543t349r667b434],
35	.	.	O	.	_	0	SENT_177	[p13l543t349r667b434],

1	In	IN	O	in	_	0	SENT_178	[p13l83t461r162b522],
2	the	DT	O	the	det	4	SENT_178	[p13l232t455r348b523],
3	259	CD	NUMBER	259	num	4	SENT_178	[p13l423t459r551b523],
4	patients	NNS	O	patient	prep_in	13	SENT_178	[p13l624t459r918b544],
5	on	IN	O	on	_	0	SENT_178	[p13l993t479r1087b523],
6	a	DT	O	a	det	8	SENT_178	[p13l1159t479r1197b523],
7	maintenance	NN	O	maintenance	nn	8	SENT_178	[p13l1268t459r1756b523],
8	dose	NN	O	dose	prep_on	4	SENT_178	[p13l1829t455r1996b523],
9	of	IN	O	of	_	0	SENT_178	[p13l2070t455r2153b523],
10	clopidogrel	NN	O	clopidogrel	prep_of	8	SENT_178	[p13l9t563r444b653],
11	,	,	O	,	_	0	SENT_178	[p13l9t563r444b653],
12	we	PRP	O	we	nsubj	13	SENT_178	[p13l470t588r573b632],
13	recorded	VBD	O	record	_	0	SENT_178	[p13l599t563r928b632],
14	32	CD	NUMBER	32	num	18	SENT_178	[p13l956t570r1036b632],
15	major	JJ	O	major	amod	18	SENT_178	[p13l1064t568r1287b653],
16	adverse	JJ	O	adverse	amod	18	SENT_178	[p13l1311t563r1589b632],
17	cardiac	JJ	O	cardiac	amod	18	SENT_178	[p13l1617t563r1879b632],
18	events	NNS	O	event	dobj	13	SENT_178	[p13l1905t577r2137b632],
19	in	IN	O	in	_	0	SENT_178	[p13l8t677r83b739],
20	26	CD	NUMBER	26	num	21	SENT_178	[p13l137t678r219b740],
21	patients	NNS	O	patient	prep_in	13	SENT_178	[p13l273t677r567b761],
22	during	IN	O	during	_	0	SENT_178	[p13l623t672r874b762],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_178	[p13l927t672r1342b762],
24	exposure	NN	O	exposure	prep_during	13	SENT_178	[p13l1395t696r1748b761],
25	.	.	O	.	_	0	SENT_178	[p13l1395t696r1748b761],

1	Figure	NN	O	figure	nsubj	3	SENT_179	[p13l1808t677r2045b762],
2	2	CD	NUMBER	2	num	1	SENT_179	[p13l2100t679r2137b739],
3	shows	VBZ	O	show	_	0	SENT_179	[p13l11t782r238b850],
4	the	DT	O	the	det	6	SENT_179	[p13l312t782r429b849],
5	cumulative	JJ	O	cumulative	amod	6	SENT_179	[p13l503t782r917b850],
6	frequency	NN	O	frequency	dobj	3	SENT_179	[p13l991t782r1363b871],
7	of	IN	O	of	_	0	SENT_179	[p13l1435t782r1519b849],
8	events	NNS	O	event	prep_of	6	SENT_179	[p13l1580t795r1812b850],
9	during	IN	O	during	_	0	SENT_179	[p13l1888t782r2140b872],
10	treatment	NN	O	treatment	prep_during	3	SENT_179	[p13l7t904r376b959],
11	with	IN	O	with	_	0	SENT_179	[p13l409t890r575b958],
12	clopidogrel	NN	O	clopidogrel	prep_with	10	SENT_179	[p13l612t890r1046b980],
13	.	.	O	.	_	0	SENT_179	[p13l612t890r1046b980],

1	Six	CD	NUMBER	six	num	2	SENT_180	[p13l1092t895r1198b959],
2	patients	NNS	O	patient	nsubj	3	SENT_180	[p13l1232t895r1527b979],
3	had	VBD	O	have	_	0	SENT_180	[p13l1564t890r1703b959],
4	more	RBR	O	more	advmod	5	SENT_180	[p13l1739t915r1934b959],
5	than	IN	O	than	advmod	3	SENT_180	[p13l1971t890r2140b959],

1	Articles	NNPS	O	Articles	_	0	SENT_181	[p13l6t1463r156b1499],
2	I	PRP	O	I	dep	1	SENT_181	[p13l205t1300r252b1499],

1	one	CD	NUMBER	one	num	4	SENT_182	[p13l9t1783r144b1827],
2	new	JJ	O	new	amod	4	SENT_182	[p13l205t1783r361b1827],
3	cardiovascular	JJ	O	cardiovascular	amod	4	SENT_182	[p13l421t1759r957b1827],
4	event	NN	O	event	_	0	SENT_182	[p13l1018t1772r1216b1827],
5	during	IN	O	during	_	0	SENT_182	[p13l1277t1759r1528b1848],
6	this	DT	O	this	det	8	SENT_182	[p13l1588t1758r1725b1827],
7	follow-up	JJ	O	follow-up	amod	8	SENT_182	[p13l1788t1758r2139b1847],
8	period	NN	O	period	prep_during	4	SENT_182	[p13l8t1868r266b1957],
9	.	.	O	.	_	0	SENT_182	[p13l8t1868r266b1957],

1	Results	NNS	O	result	nsubjpass	4	SENT_183	[p13l310t1868r576b1937],
2	are	VBP	O	be	auxpass	4	SENT_183	[p13l616t1893r727b1937],
3	also	RB	O	also	advmod	4	SENT_183	[p13l765t1868r907b1937],
4	expressed	VBN	O	express	_	0	SENT_183	[p13l946t1868r1312b1957],
5	as	IN	O	as	_	0	SENT_183	[p13l1348t1892r1420b1937],
6	number	NN	O	number	prep_as	4	SENT_183	[p13l1459t1868r1762b1937],
7	of	IN	O	of	_	0	SENT_183	[p13l1798t1868r1880b1937],
8	events	NNS	O	event	prep_of	6	SENT_183	[p13l1905t1882r2137b1937],
9	per	IN	O	per	_	0	SENT_183	[p13l8t2002r130b2067],
10	patient-year	NN	O	patient-year	prep_per	8	SENT_183	[p13l154t1982r595b2067],
11	of	IN	O	of	_	0	SENT_183	[p13l621t1978r704b2045],
12	exposure	NN	O	exposure	prep_of	10	SENT_183	[p13l717t2002r1051b2067],
13	to	TO	O	to	_	0	SENT_183	[p13l1076t1991r1145b2045],
14	clopidogrel	NN	O	clopidogrel	nn	16	SENT_183	[p13l1173t1978r1588b2068],
15	(	NN	O	(	nn	16	SENT_183	[p13l1619t1978r1818b2068],
16	table	NN	O	table	prep_to	4	SENT_183	[p13l1619t1978r1818b2068],
17	2	CD	NUMBER	2	num	18	SENT_183	[p13l1846t1984r1932b2068],
18	)	NN	O	)	dep	16	SENT_183	[p13l1846t1984r1932b2068],
19	.	.	O	.	_	0	SENT_183	[p13l1846t1984r1932b2068],

1	12	CD	NUMBER	12	num	2	SENT_184	[p13l82t2094r154b2155],
2	patients	NNS	O	patient	nsubj	3	SENT_184	[p13l186t2092r480b2176],
3	presented	VBN	O	present	_	0	SENT_184	[p13l512t2087r880b2176],
4	with	IN	O	with	_	0	SENT_184	[p13l906t2087r1071b2156],
5	a	DT	O	a	det	8	SENT_184	[p13l1102t2112r1138b2156],
6	deﬁnite	JJ	O	deﬁnite	amod	8	SENT_184	[p13l1168t2087r1450b2156],
7	stent	NN	O	stent	nn	8	SENT_184	[p13l1483t2101r1664b2156],
8	thrombosis	NN	O	thrombosis	prep_with	3	SENT_184	[p13l1690t2087r2135b2156],
9	.	.	O	.	_	0	SENT_184	[p13l1690t2087r2135b2156],

1	Clinical	JJ	O	clinical	amod	2	SENT_185	[p13l11t2196r296b2264],
2	presentation	NN	O	presentation	nsubj	7	SENT_185	[p13l351t2201r821b2285],
3	was	VBD	O	be	cop	7	SENT_185	[p13l874t2220r1013b2264],
4	an	DT	O	a	det	7	SENT_185	[p13l1072t2220r1161b2264],
5	ST-elevation	NN	O	st-elevation	nn	7	SENT_185	[p13l1222t2196r1672b2264],
6	myocardial	JJ	O	myocardial	amod	7	SENT_185	[p13l1727t2196r2140b2286],
7	infarction	NN	O	infarction	_	0	SENT_185	[p13l9t2306r375b2373],
8	in	IN	O	in	_	0	SENT_185	[p13l404t2310r479b2372],
9	all	DT	O	all	det	10	SENT_185	[p13l509t2306r594b2373],
10	cases	NNS	O	case	prep_in	7	SENT_185	[p13l624t2330r835b2373],
11	.	.	O	.	_	0	SENT_185	[p13l624t2330r835b2373],

1	Stent	JJ	O	stent	amod	2	SENT_186	[p13l875t2311r1065b2373],
2	thrombosis	NN	O	thrombosis	nsubj	3	SENT_186	[p13l1092t2306r1517b2373],
3	occurred	VBD	O	occur	_	0	SENT_186	[p13l1551t2306r1878b2373],
4	in	IN	O	in	_	0	SENT_186	[p13l1906t2310r1981b2372],
5	ﬁve	NN	O	ﬁve	nn	6	SENT_186	[p13l2010t2306r2139b2373],
6	patients	NNS	O	patient	prep_in	3	SENT_186	[p13l8t2420r303b2504],
7	with	IN	O	with	_	0	SENT_186	[p13l351t2415r517b2484],
8	a	DT	O	a	det	10	SENT_186	[p13l566t2440r602b2484],
9	bare-metal	JJ	O	bare-metal	amod	10	SENT_186	[p13l649t2415r1048b2484],
10	stent	NN	O	stent	prep_with	6	SENT_186	[p13l1098t2429r1279b2484],
11	and	CC	O	and	_	0	SENT_186	[p13l1327t2415r1465b2484],
12	in	IN	O	in	_	0	SENT_186	[p13l1511t2420r1586b2483],
13	seven	CD	NUMBER	seven	prep_in	3	SENT_186	[p13l1636t2440r1843b2484],
14	with	IN	O	with	_	0	SENT_186	[p13l1889t2415r2054b2484],
15	a	DT	O	a	det	17	SENT_186	[p13l2103t2440r2140b2484],
16	drug-eluting	JJ	O	drug-eluting	amod	17	SENT_186	[p13l9t2524r475b2614],
17	stent	NN	O	stent	prep_with	3	SENT_186	[p13l508t2537r706b2592],
18	.	.	O	.	_	0	SENT_186	[p13l508t2537r706b2592],

1	Four	CD	NUMBER	four	nsubj	8	SENT_187	[p13l745t2528r918b2592],
2	of	IN	O	of	_	0	SENT_187	[p13l949t2524r1032b2592],
3	these	DT	O	these	det	5	SENT_187	[p13l1049t2524r1244b2592],
4	stent	JJ	O	stent	amod	5	SENT_187	[p13l1279t2537r1460b2592],
5	thromboses	NNS	O	thrombose	prep_of	1	SENT_187	[p13l1488t2524r1929b2592],
6	were	VBD	O	be	cop	8	SENT_187	[p13l1961t2548r2139b2592],
7	subacute	JJ	O	subacute	amod	8	SENT_187	[p13l11t2635r340b2703],
8	(	NN	O	(	_	0	SENT_187	[p13l371t2641r529b2724],
9	<	JJR	O	<	amod	8	SENT_187	[p13l371t2641r529b2724],
10	30	CD	DURATION	30	num	11	SENT_187	[p13l371t2641r529b2724],
11	days	NNS	NUMBER	day	tmod	9	SENT_187	[p13l555t2635r764b2724],
12	)	RB	O	)	advmod	8	SENT_187	[p13l555t2635r764b2724],
13	,	,	O	,	_	0	SENT_187	[p13l555t2635r764b2724],
14	three	CD	NUMBER	three	nsubj	17	SENT_187	[p13l791t2635r983b2703],
15	were	VBD	O	be	cop	17	SENT_187	[p13l1007t2659r1185b2703],
16	late	JJ	O	late	amod	17	SENT_187	[p13l1210t2635r1340b2703],
17	(	NN	O	(	dep	8	SENT_187	[p13l1371t2641r1479b2724],
18	30	CD	DURATION	30	num	19	SENT_187	[p13l1371t2641r1479b2724],
19	days	NNS	NUMBER	day	nsubj	20	SENT_187	[p13l1506t2635r1750b2724],
20	—	VBP	O	—	rcmod	17	SENT_187	[p13l1506t2635r1750b2724],
21	1	CD	DURATION	1	num	22	SENT_187	[p13l1506t2635r1750b2724],
22	year	NN	NUMBER	year	tmod	20	SENT_187	[p13l1772t2641r1974b2724],
23	)	RB	O	)	advmod	20	SENT_187	[p13l1772t2641r1974b2724],
24	,	,	O	,	_	0	SENT_187	[p13l1772t2641r1974b2724],
25	and	CC	O	and	_	0	SENT_187	[p13l2003t2635r2141b2703],
26	ﬁve	NN	O	ﬁve	nsubj	34	SENT_187	[p13l8t2743r138b2812],
27	were	VBD	O	be	cop	34	SENT_187	[p13l164t2768r342b2812],
28	very	RB	O	very	advmod	34	SENT_187	[p13l368t2768r523b2833],
29	late	JJ	O	late	amod	30	SENT_187	[p13l548t2743r678b2812],
30	(	NN	O	(	pobj	28	SENT_187	[p13l712t2750r816b2833],
31	>	JJR	O	>	amod	34	SENT_187	[p13l712t2750r816b2833],
32	1	CD	DURATION	1	num	33	SENT_187	[p13l712t2750r816b2833],
33	year	NN	NUMBER	year	tmod	31	SENT_187	[p13l841t2750r1043b2833],
34	)	NN	O	)	conj_and	8	SENT_187	[p13l841t2750r1043b2833],
35	.	.	O	.	_	0	SENT_187	[p13l841t2750r1043b2833],

1	Of	IN	O	of	_	0	SENT_188	[p13l1077t2743r1179b2812],
2	note	NN	O	note	prep_of	12	SENT_188	[p13l1194t2757r1375b2822],
3	,	,	O	,	_	0	SENT_188	[p13l1194t2757r1375b2822],
4	four	CD	NUMBER	four	nsubj	12	SENT_188	[p13l1406t2743r1563b2812],
5	of	IN	O	of	_	0	SENT_188	[p13l1590t2743r1673b2812],
6	the	DT	O	the	det	7	SENT_188	[p13l1686t2743r1803b2812],
7	ﬁve	NN	O	ﬁve	prep_of	4	SENT_188	[p13l1831t2743r1960b2812],
8	very	RB	O	very	advmod	7	SENT_188	[p13l1986t2768r2142b2833],
9	late	RB	O	late	advmod	7	SENT_188	[p13l7t2853r138b2921],
10	stent	JJ	O	stent	amod	11	SENT_188	[p13l227t2866r408b2921],
11	thromboses	NNS	O	thrombose	dep	7	SENT_188	[p13l491t2853r932b2921],
12	occurred	VBD	O	occur	_	0	SENT_188	[p13l1022t2853r1349b2921],
13	in	IN	O	in	_	0	SENT_188	[p13l1434t2858r1508b2920],
14	patients	NNS	O	patient	prep_in	12	SENT_188	[p13l1594t2858r1888b2942],
15	with	IN	O	with	_	0	SENT_188	[p13l1974t2853r2140b2921],
16	drug-eluting	JJ	O	drug-eluting	amod	17	SENT_188	[p13l9t2964r475b3053],
17	stents	NNS	O	stent	prep_with	12	SENT_188	[p13l503t2977r738b3032],
18	.	.	O	.	_	0	SENT_188	[p13l503t2977r738b3032],

1	The	DT	O	the	det	2	SENT_189	[p13l78t3072r221b3140],
2	CYP2C19	NN	O	cyp2c19	nsubjpass	8	SENT_189	[p13l312t3077r750b3140],
3	"	''	O	"	punct	2	SENT_189	[p13l312t3077r750b3140],
4	"	``	O	"	punct	6	SENT_189	[p13l312t3077r750b3140],
5	2	CD	NUMBER	2	num	6	SENT_189	[p13l312t3077r750b3140],
6	variant	NN	O	variant	dep	2	SENT_189	[p13l828t3077r1088b3140],
7	was	VBD	O	be	auxpass	8	SENT_189	[p13l1168t3096r1306b3140],
8	associated	VBN	O	associate	_	0	SENT_189	[p13l1393t3072r1773b3140],
9	with	IN	O	with	_	0	SENT_189	[p13l1853t3072r2019b3140],
10	a	DT	O	a	det	11	SENT_189	[p13l2103t3097r2140b3140],
11	wvvw	NN	O	wvvw	prep_with	8	SENT_189	[p13l803t1160r1336b1211],
12	.	.	O	.	_	0	SENT_189	[p13l803t1160r1336b1211],

1	the	DT	O	the	det	2	SENT_190	[p13l803t1160r1336b1211],
2	|	NN	O	|	_	0	SENT_190	[p13l803t1160r1336b1211],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_190	[p13l803t1160r1336b1211],
4	Vol	NNP	O	Vol	dep	2	SENT_190	[p13l1379t1160r1466b1211],
5	373	CD	NUMBER	373	num	4	SENT_190	[p13l1486t1166r1585b1218],
6	January	NNP	DATE	January	tmod	4	SENT_190	[p13l1626t1164r1843b1225],
7	24	CD	DATE	24	num	6	SENT_190	[p13l1861t1166r1946b1220],
8	,	,	DATE	,	_	0	SENT_190	[p13l1861t1166r1946b1220],
9	2009	CD	DATE	2009	num	6	SENT_190	[p13l1965t1166r2110b1218],

1	signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_191	[p14l11t27r403b117],
2	increase	NN	O	increase	_	0	SENT_191	[p14l439t32r746b95],
3	in	IN	O	in	_	0	SENT_191	[p14l784t32r858b94],
4	the	DT	O	the	det	5	SENT_191	[p14l894t27r1010b95],
5	rate	NN	O	rate	prep_in	2	SENT_191	[p14l1047t40r1186b95],
6	of	IN	O	of	_	0	SENT_191	[p14l1225t27r1308b95],
7	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_191	[p14l1332t27r1868b95],
8	events	NNS	O	event	prep_of	5	SENT_191	[p14l1905t40r2137b95],
9	(	RB	O	(	advmod	5	SENT_191	[p14l14t136r213b226],
10	table	NN	O	table	nn	12	SENT_191	[p14l14t136r213b226],
11	2	CD	NUMBER	2	num	12	SENT_191	[p14l245t143r329b226],
12	)	NN	O	)	dep	5	SENT_191	[p14l245t143r329b226],
13	.	.	O	.	_	0	SENT_191	[p14l245t143r329b226],

1	The	DT	O	the	det	3	SENT_192	[p14l361t137r505b205],
2	primary	JJ	O	primary	amod	3	SENT_192	[p14l533t141r834b226],
3	endpoint	NN	O	endpoint	nsubjpass	5	SENT_192	[p14l862t137r1198b225],
4	was	VBD	O	be	auxpass	5	SENT_192	[p14l1223t161r1362b205],
5	reached	VBN	O	reach	_	0	SENT_192	[p14l1393t137r1686b205],
6	by	IN	O	by	_	0	SENT_192	[p14l1712t137r1799b226],
7	11	CD	NUMBER	11	agent	5	SENT_192	[p14l1828t143r1896b203],
8	of	IN	O	of	_	0	SENT_192	[p14l1925t136r2008b205],
9	the	DT	O	the	det	13	SENT_192	[p14l2023t137r2139b205],
10	186	CD	NUMBER	186	num	13	SENT_192	[p14l11t251r129b313],
11	wild-type	JJ	O	wild-type	amod	13	SENT_192	[p14l234t245r573b335],
12	homozygote	NN	O	homozygote	nn	13	SENT_192	[p14l677t245r1137b335],
13	patients	NNS	O	patient	prep_of	7	SENT_192	[p14l1242t250r1557b334],
14	,	,	O	,	_	0	SENT_192	[p14l1242t250r1557b334],
15	13	CD	NUMBER	13	agent	5	SENT_192	[p14l1668t251r1740b313],
16	of	IN	O	of	_	0	SENT_192	[p14l1849t245r1932b313],
17	the	DT	O	the	det	20	SENT_192	[p14l2023t245r2139b313],
18	64	CD	NUMBER	64	num	20	SENT_192	[p14l10t361r95b422],
19	heterozygote	NN	O	heterozygote	nn	20	SENT_192	[p14l107t355r585b445],
20	patients	NNS	O	patient	prep_of	15	SENT_192	[p14l604t359r920b444],
21	,	,	O	,	_	0	SENT_192	[p14l604t359r920b444],
22	and	CC	O	and	_	0	SENT_192	[p14l944t355r1081b422],
23	two	CD	NUMBER	two	conj_and	7	SENT_192	[p14l1097t368r1230b422],
24	of	IN	O	of	_	0	SENT_192	[p14l1251t355r1333b422],
25	the	DT	O	the	det	28	SENT_192	[p14l1338t355r1454b422],
26	nine	CD	NUMBER	nine	num	28	SENT_192	[p14l1474t359r1641b422],
27	homozygous	JJ	O	homozygous	amod	28	SENT_192	[p14l1660t355r2137b445],
28	patients	NNS	O	patient	prep_of	23	SENT_192	[p14l8t469r323b553],
29	.	.	O	.	_	0	SENT_192	[p14l8t469r323b553],

1	Table	NNP	O	Table	nsubj	3	SENT_193	[p14l349t465r545b533],
2	2	CD	NUMBER	2	num	1	SENT_193	[p14l572t471r609b532],
3	shows	VBZ	O	show	_	0	SENT_193	[p14l638t465r864b533],
4	the	DT	O	the	det	6	SENT_193	[p14l889t464r1005b533],
5	hazard	NN	O	hazard	nn	6	SENT_193	[p14l1029t465r1284b533],
6	ratios	NNS	O	ratio	dobj	3	SENT_193	[p14l1307t469r1512b533],
7	for	IN	O	for	_	0	SENT_193	[p14l1538t464r1644b533],
8	the	DT	O	the	det	9	SENT_193	[p14l1665t465r1781b533],
9	effects	NNS	O	effect	prep_for	6	SENT_193	[p14l1807t465r2043b533],
10	of	IN	O	of	_	0	SENT_193	[p14l2070t464r2153b533],
11	the	DT	O	the	det	13	SENT_193	[p14l7t573r123b641],
12	C	NN	O	c	nn	13	SENT_193	[p14l164t578r218b641],
13	YP2C19	NN	O	yp2c19	prep_of	9	SENT_193	[p14l225t578r601b642],
14	"	''	O	"	punct	9	SENT_193	[p14l225t578r601b642],
15	'	''	O	'	_	0	SENT_193	[p14l225t578r601b642],
16	~	FW	O	~	nn	19	SENT_193	[p14l225t578r601b642],
17	‘	FW	O	‘	dep	19	SENT_193	[p14l225t578r601b642],
18	2	CD	NUMBER	2	num	19	SENT_193	[p14l225t578r601b642],
19	variant	NN	O	variant	advmod	3	SENT_193	[p14l628t578r888b641],
20	on	IN	O	on	_	0	SENT_193	[p14l920t598r1014b641],
21	clinical	JJ	O	clinical	amod	22	SENT_193	[p14l1047t573r1312b641],
22	outcomes	NNS	O	outcome	prep_on	3	SENT_193	[p14l1346t587r1726b641],
23	.	.	O	.	_	0	SENT_193	[p14l1346t587r1726b641],

1	Figure	NNP	O	Figure	nn	2	SENT_194	[p14l1766t578r2005b663],
2	3A	NN	O	3a	nsubj	3	SENT_194	[p14l2042t578r2141b641],
3	shows	VBZ	O	show	_	0	SENT_194	[p14l11t684r238b752],
4	the	DT	O	the	det	8	SENT_194	[p14l280t684r396b752],
5	Kaplan-Meier	NNP	MISC	Kaplan-Meier	nn	8	SENT_194	[p14l442t684r947b773],
6	cumulative	JJ	O	cumulative	amod	8	SENT_194	[p14l987t684r1400b752],
7	event-free	RB	O	event-free	advmod	6	SENT_194	[p14l1443t684r1809b752],
8	survival	NN	O	survival	dobj	3	SENT_194	[p14l1853t684r2140b752],
9	in	IN	O	in	_	0	SENT_194	[p14l8t797r83b859],
10	carriers	NNS	O	carrier	prep_in	8	SENT_194	[p14l123t797r402b860],
11	and	CC	O	and	_	0	SENT_194	[p14l445t792r582b860],
12	non-carriers	NNS	O	non-carrier	conj_and	10	SENT_194	[p14l620t797r1074b860],
13	of	IN	O	of	_	0	SENT_194	[p14l1117t792r1200b860],
14	the	DT	O	the	det	15	SENT_194	[p14l1225t792r1341b860],
15	CYP2C19	NN	O	cyp2c19	prep_of	10	SENT_194	[p14l1388t797r1825b860],
16	"	''	O	"	punct	10	SENT_194	[p14l1388t797r1825b860],
17	"	``	O	"	punct	10	SENT_194	[p14l1388t797r1825b860],
18	2	CD	NUMBER	2	num	19	SENT_194	[p14l1388t797r1825b860],
19	variant	NN	O	variant	dep	10	SENT_194	[p14l1858t797r2136b860],
20	.	.	O	.	_	0	SENT_194	[p14l1858t797r2136b860],

1	The	DT	O	the	det	2	SENT_195	[p14l7t901r151b969],
2	effect	NN	O	effect	nsubjpass	18	SENT_195	[p14l192t902r395b969],
3	of	IN	O	of	_	0	SENT_195	[p14l434t901r517b969],
4	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_195	[p14l551t906r989b970],
5	"	''	O	"	punct	4	SENT_195	[p14l551t906r989b970],
6	"	``	O	"	punct	4	SENT_195	[p14l551t906r989b970],
7	2	CD	NUMBER	2	dep	4	SENT_195	[p14l551t906r989b970],
8	was	VBD	O	be	auxpass	9	SENT_195	[p14l1023t925r1162b969],
9	seen	VBN	O	see	_	0	SENT_195	[p14l1207t925r1374b969],
10	in	IN	O	in	_	0	SENT_195	[p14l1414t906r1488b968],
11	the	DT	O	the	det	13	SENT_195	[p14l1527t901r1643b969],
12	early	JJ	O	early	amod	13	SENT_195	[p14l1685t901r1863b991],
13	period	NN	O	period	prep_in	9	SENT_195	[p14l1901t901r2141b990],
14	after	IN	O	after	_	0	SENT_195	[p14l9t1011r177b1078],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_195	[p14l207t1011r621b1101],
16	initiation	NN	O	initiation	prep_after	9	SENT_195	[p14l651t1015r993b1078],
17	but	CC	O	but	_	0	SENT_195	[p14l1021t1011r1146b1078],
18	persisted	VBD	O	persist	conj_but	9	SENT_195	[p14l1174t1011r1513b1100],
19	also	RB	O	also	advmod	18	SENT_195	[p14l1542t1011r1684b1078],
20	throughout	IN	O	throughout	_	0	SENT_195	[p14l1714t1011r2141b1101],
21	the	DT	O	the	det	23	SENT_195	[p14l7t1120r124b1189],
22	follow-up	JJ	O	follow-up	amod	23	SENT_195	[p14l144t1120r496b1209],
23	period	NN	O	period	prep_throughout	18	SENT_195	[p14l517t1120r756b1209],
24	of	IN	O	of	_	0	SENT_195	[p14l776t1120r859b1189],
25	exposure	NN	O	exposure	prep_of	23	SENT_195	[p14l868t1145r1221b1209],
26	.	.	O	.	_	0	SENT_195	[p14l868t1145r1221b1209],

1	Indeed	RB	O	indeed	advmod	22	SENT_196	[p14l1249t1120r1524b1199],
2	,	,	O	,	_	0	SENT_196	[p14l1249t1120r1524b1199],
3	in	IN	O	in	_	0	SENT_196	[p14l1548t1125r1622b1188],
4	the	DT	O	the	det	6	SENT_196	[p14l1641t1120r1757b1189],
5	landmark	NN	O	landmark	nn	6	SENT_196	[p14l1777t1120r2142b1189],
6	analysis	NN	O	analysis	nsubj	7	SENT_196	[p14l9t1229r302b1318],
7	starting	VBG	O	start	prepc_in	22	SENT_196	[p14l338t1234r622b1319],
8	6	CD	DURATION	6	num	9	SENT_196	[p14l656t1235r694b1297],
9	months	NNS	NUMBER	month	tmod	7	SENT_196	[p14l728t1229r1014b1297],
10	after	IN	O	after	_	0	SENT_196	[p14l1050t1229r1218b1297],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_196	[p14l1249t1229r1665b1319],
12	initiation	NN	O	initiation	prep_after	7	SENT_196	[p14l1697t1234r2039b1297],
13	to	TO	O	to	_	0	SENT_196	[p14l2070t1242r2139b1297],
14	the	DT	O	the	det	15	SENT_196	[p14l7t1340r124b1408],
15	end	NN	O	end	prep_to	7	SENT_196	[p14l160t1340r299b1408],
16	of	IN	O	of	_	0	SENT_196	[p14l334t1340r417b1408],
17	follow-up	NN	O	follow-up	prep_of	15	SENT_196	[p14l439t1340r809b1429],
18	,	,	O	,	_	0	SENT_196	[p14l439t1340r809b1429],
19	the	DT	O	the	det	21	SENT_196	[p14l847t1340r963b1408],
20	primary	JJ	O	primary	amod	21	SENT_196	[p14l999t1344r1299b1429],
21	endpoint	NN	O	endpoint	nsubj	22	SENT_196	[p14l1333t1340r1670b1429],
22	occurred	VBD	O	occur	_	0	SENT_196	[p14l1704t1340r2032b1408],
23	in	IN	O	in	_	0	SENT_196	[p14l2065t1344r2140b1407],
24	ten	CD	PERCENT	ten	prep_in	22	SENT_196	[p14l7t1462r126b1517],
25	(	CD	PERCENT	(	number	26	SENT_196	[p14l167t1453r329b1538],
26	8	CD	PERCENT	8	num	27	SENT_196	[p14l167t1453r329b1538],
27	%	NN	PERCENT	%	dobj	22	SENT_196	[p14l167t1453r329b1538],
28	)	CD	NUMBER	)	tmod	45	SENT_196	[p14l167t1453r329b1538],
29	of	IN	O	of	_	0	SENT_196	[p14l372t1448r455b1517],
30	non-carriers	NNS	O	non-carrier	prep_of	28	SENT_196	[p14l477t1453r931b1517],
31	and	CC	O	and	_	0	SENT_196	[p14l971t1448r1108b1517],
32	nine	CD	PERCENT	nine	number	33	SENT_196	[p14l1144t1453r1310b1517],
33	(	CD	PERCENT	(	conj_and	30	SENT_196	[p14l1353t1453r1551b1538],
34	15	CD	PERCENT	15	num	35	SENT_196	[p14l1353t1453r1551b1538],
35	%	NN	PERCENT	%	dep	33	SENT_196	[p14l1353t1453r1551b1538],
36	)	CD	NUMBER	)	nsubj	45	SENT_196	[p14l1353t1453r1551b1538],
37	of	IN	O	of	_	0	SENT_196	[p14l1594t1448r1677b1517],
38	CYP2C19	NN	O	cyp2c19	prep_of	36	SENT_196	[p14l1706t1453r2144b1517],
39	"	''	O	"	punct	36	SENT_196	[p14l1706t1453r2144b1517],
40	'	''	O	'	_	0	SENT_196	[p14l1706t1453r2144b1517],
41	~	FW	O	~	nn	44	SENT_196	[p14l1706t1453r2144b1517],
42	‘	FW	O	‘	dep	44	SENT_196	[p14l1706t1453r2144b1517],
43	2	CD	NUMBER	2	num	44	SENT_196	[p14l1706t1453r2144b1517],
44	carriers	NNS	O	carrier	advmod	45	SENT_196	[p14l9t1562r288b1625],
45	(	VBP	O	(	rcmod	27	SENT_196	[p14l323t1557r565b1647],
46	ﬁgure	NN	O	ﬁgure	nn	48	SENT_196	[p14l323t1557r565b1647],
47	3B	NN	O	3b	nn	48	SENT_196	[p14l595t1563r736b1647],
48	)	NN	O	)	dobj	45	SENT_196	[p14l595t1563r736b1647],
49	.	.	O	.	_	0	SENT_196	[p14l595t1563r736b1647],

1	We	PRP	O	we	nsubj	2	SENT_197	[p14l78t1673r195b1734],
2	recorded	VBD	O	record	_	0	SENT_197	[p14l264t1667r592b1734],
3	the	DT	O	the	det	5	SENT_197	[p14l658t1667r774b1734],
4	same	JJ	O	same	amod	5	SENT_197	[p14l846t1691r1038b1734],
5	effect	NN	O	effect	dobj	2	SENT_197	[p14l1108t1667r1311b1734],
6	of	IN	O	of	_	0	SENT_197	[p14l1377t1666r1460b1734],
7	the	DT	O	the	det	9	SENT_197	[p14l1514t1667r1630b1734],
8	C	NN	O	c	nn	9	SENT_197	[p14l1706t1672r1760b1734],
9	YP2C19	NN	O	yp2c19	prep_of	5	SENT_197	[p14l1767t1671r2144b1734],
10	"	''	O	"	punct	9	SENT_197	[p14l1767t1671r2144b1734],
11	"	``	O	"	punct	9	SENT_197	[p14l1767t1671r2144b1734],
12	2	CD	NUMBER	2	dep	9	SENT_197	[p14l1767t1671r2144b1734],

1	loss-oﬁfunction	JJ	O	loss-oﬁfunction	amod	2	SENT_198	[p14l7t1775r592b1844],
2	polymorphism	NN	O	polymorphism	_	0	SENT_198	[p14l685t1775r1240b1865],
3	irrespective	RB	O	irrespective	_	0	SENT_198	[p14l1334t1780r1764b1864],
4	of	IN	O	of	_	0	SENT_198	[p14l1860t1775r1943b1844],
5	the	DT	O	the	det	6	SENT_198	[p14l2022t1775r2139b1844],
6	condition	NN	O	condition	prep_irrespective_of	2	SENT_198	[p14l9t1884r364b1952],
7	of	IN	O	of	_	0	SENT_198	[p14l407t1884r490b1952],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_198	[p14l520t1884r936b1974],
9	initiation	NN	O	initiation	prep_of	6	SENT_198	[p14l978t1889r1338b1952],
10	.	.	O	.	_	0	SENT_198	[p14l978t1889r1338b1952],

1	We	PRP	O	we	nsubj	2	SENT_199	[p14l1383t1891r1501b1953],
2	noted	VBD	O	note	_	0	SENT_199	[p14l1544t1884r1756b1952],
3	a	DT	O	a	det	6	SENT_199	[p14l1797t1908r1835b1952],
4	similar	JJ	O	similar	amod	5	SENT_199	[p14l1879t1884r2141b1952],
5	detrimental	JJ	O	detrimental	amod	6	SENT_199	[p14l9t1994r445b2062],
6	effect	NN	O	effect	nsubjpass	78	SENT_199	[p14l488t1994r690b2062],
7	of	IN	O	of	_	0	SENT_199	[p14l732t1993r815b2062],
8	the	DT	O	the	det	10	SENT_199	[p14l843t1994r959b2062],
9	genetic	JJ	O	genetic	amod	10	SENT_199	[p14l1004t1998r1271b2083],
10	variant	NN	O	variant	prep_of	6	SENT_199	[p14l1310t1998r1570b2062],
11	in	IN	O	in	_	0	SENT_199	[p14l1611t1998r1685b2060],
12	patients	NNS	O	patient	prep_in	10	SENT_199	[p14l1727t1998r2021b2082],
13	in	IN	O	in	_	0	SENT_199	[p14l2065t1998r2140b2060],
14	whom	WP	O	whom	rel	18	SENT_199	[p14l7t2102r244b2170],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_199	[p14l268t2102r683b2192],
16	therapy	NN	O	therapy	nsubjpass	18	SENT_199	[p14l704t2102r986b2192],
17	was	VBD	O	be	auxpass	18	SENT_199	[p14l1005t2126r1143b2170],
18	started	VBN	O	start	rcmod	12	SENT_199	[p14l1171t2102r1422b2170],
19	as	IN	O	as	_	0	SENT_199	[p14l1444t2126r1516b2170],
20	the	DT	O	the	det	21	SENT_199	[p14l1540t2102r1656b2170],
21	treatment	NN	O	treatment	prep_as	18	SENT_199	[p14l1679t2116r2048b2170],
22	of	IN	O	of	_	0	SENT_199	[p14l2070t2102r2153b2170],
23	the	DT	O	the	det	74	SENT_199	[p14l7t2211r124b2279],
24	qualifying	VBG	O	qualify	dep	74	SENT_199	[p14l147t2211r523b2301],
25	acute	JJ	O	acute	amod	28	SENT_199	[p14l545t2224r739b2279],
26	coronary	JJ	O	coronary	amod	28	SENT_199	[p14l762t2235r1090b2300],
27	event	NN	O	event	nn	28	SENT_199	[p14l1110t2224r1309b2279],
28	(	NN	O	(	dobj	24	SENT_199	[p14l1335t2217r1478b2301],
29	216	CD	NUMBER	216	num	30	SENT_199	[p14l1335t2217r1478b2301],
30	patients	NNS	O	patient	dep	28	SENT_199	[p14l1501t2216r1817b2300],
31	,	,	O	,	_	0	SENT_199	[p14l1501t2216r1817b2300],
32	primary	JJ	O	primary	amod	33	SENT_199	[p14l1842t2216r2142b2301],
33	endpoint	NN	O	endpoint	appos	30	SENT_199	[p14l9t2321r346b2409],
34	in	IN	O	in	_	0	SENT_199	[p14l363t2325r438b2387],
35	nine	CD	NUMBER	nine	prep_in	33	SENT_199	[p14l457t2325r624b2389],
36	of	IN	O	of	_	0	SENT_199	[p14l645t2320r728b2389],
37	156	CD	NUMBER	156	num	38	SENT_199	[p14l736t2325r855b2389],
38	non-carriers	NNS	O	non-carrier	prep_of	33	SENT_199	[p14l876t2325r1330b2389],
39	vs	CC	O	vs	_	0	SENT_199	[p14l1351t2345r1417b2388],
40	eight	CD	NUMBER	eight	conj_vs	28	SENT_199	[p14l1435t2321r1622b2410],
41	of	IN	O	of	_	0	SENT_199	[p14l1641t2320r1724b2389],
42	60	CD	NUMBER	60	num	43	SENT_199	[p14l1731t2327r1816b2389],
43	carriers	NNS	O	carrier	prep_of	40	SENT_199	[p14l1836t2325r2136b2399],
44	;	:	O	;	_	0	SENT_199	[p14l1836t2325r2136b2399],
45	unadjusted	JJ	O	unadjusted	amod	47	SENT_199	[p14l7t2429r428b2519],
46	hazard	NN	O	hazard	nn	47	SENT_199	[p14l444t2429r700b2497],
47	ratio	NN	O	ratio	dep	40	SENT_199	[p14l718t2434r886b2497],
48	3-05	CD	PERCENT	3-05	num	52	SENT_199	[p14l909t2434r1076b2497],
49	[	CD	PERCENT	[	number	50	SENT_199	[p14l1102t2434r1283b2518],
50	95	CD	PERCENT	95	dep	51	SENT_199	[p14l1102t2434r1283b2518],
51	%	NN	PERCENT	%	dep	52	SENT_199	[p14l1102t2434r1283b2518],
52	CI	NN	O	ci	dep	47	SENT_199	[p14l1305t2434r1388b2497],
53	1	CD	NUMBER	1	dep	47	SENT_199	[p14l1414t2435r1472b2496],
54	-	:	O	-	_	0	SENT_199	[p14l1414t2435r1472b2496],
55	14	CD	NUMBER	14	dep	40	SENT_199	[p14l1492t2435r1652b2497],
56	—	CD	NUMBER	—	number	57	SENT_199	[p14l1492t2435r1652b2497],
57	8	CD	NUMBER	8	dep	55	SENT_199	[p14l1492t2435r1652b2497],
58	-	:	O	-	_	0	SENT_199	[p14l1670t2468r1682b2480],
59	19	CD	DATE	19	dep	40	SENT_199	[p14l1702t2435r1818b2518],
60	]	NN	O	]	dep	59	SENT_199	[p14l1702t2435r1818b2518],
61	;	:	O	;	_	0	SENT_199	[p14l1702t2435r1818b2518],
62	p	NN	O	p	nn	64	SENT_199	[p14l1840t2435r1979b2518],
63	=	JJ	O	=	amod	64	SENT_199	[p14l1840t2435r1979b2518],
64	O	NN	O	o	dep	40	SENT_199	[p14l1840t2435r1979b2518],
65	-	:	O	-	_	0	SENT_199	[p14l1997t2468r2008b2480],
66	02	CD	DATE	02	num	67	SENT_199	[p14l2026t2435r2134b2519],
67	)	NN	O	)	dep	64	SENT_199	[p14l2026t2435r2134b2519],
68	and	CC	O	and	_	0	SENT_199	[p14l9t2539r147b2606],
69	in	IN	O	in	dep	74	SENT_199	[p14l176t2543r250b2605],
70	those	DT	O	those	nsubj	73	SENT_199	[p14l277t2539r477b2606],
71	in	IN	O	in	_	0	SENT_199	[p14l507t2543r582b2605],
72	whom	WP	O	whom	prep_in	70	SENT_199	[p14l609t2539r846b2606],
73	clopidogrel	VBP	O	clopidogrel	pcomp	69	SENT_199	[p14l876t2539r1291b2629],
74	initiation	NN	O	initiation	prep_of	21	SENT_199	[p14l1320t2543r1663b2606],
75	was	VBD	O	be	auxpass	76	SENT_199	[p14l1690t2563r1828b2606],
76	delayed	VBN	O	delay	ccomp	2	SENT_199	[p14l1861t2539r2141b2628],
77	and	CC	O	and	_	0	SENT_199	[p14l9t2648r147b2715],
78	started	VBN	O	start	conj_and	76	SENT_199	[p14l226t2648r477b2715],
79	at	IN	O	at	_	0	SENT_199	[p14l555t2661r620b2715],
80	a	DT	O	a	det	83	SENT_199	[p14l696t2672r734b2715],
81	later	JJ	O	later	amod	83	SENT_199	[p14l810t2648r976b2715],
82	scheduled	VBN	O	schedule	amod	83	SENT_199	[p14l1054t2648r1430b2715],
83	revascularisation	NN	O	revascularisation	prep_at	76	SENT_199	[p14l1507t2648r2140b2715],

1	(	NN	O	(	_	0	SENT_200	[p14l14t2763r114b2846],
2	43	CD	NUMBER	43	num	3	SENT_200	[p14l14t2763r114b2846],
3	patients	NNS	O	patient	dep	1	SENT_200	[p14l149t2761r464b2845],
4	;	:	O	;	_	0	SENT_200	[p14l149t2761r464b2845],
5	primary	JJ	O	primary	amod	6	SENT_200	[p14l499t2761r799b2846],
6	endpoint	NN	O	endpoint	dep	1	SENT_200	[p14l829t2756r1166b2845],
7	in	IN	O	in	_	0	SENT_200	[p14l1195t2761r1270b2823],
8	two	CD	NUMBER	two	prep_in	6	SENT_200	[p14l1299t2770r1431b2825],
9	of	IN	O	of	_	0	SENT_200	[p14l1465t2756r1548b2824],
10	30	CD	NUMBER	30	num	11	SENT_200	[p14l1570t2762r1652b2824],
11	non-carriers	NNS	O	non-carrier	prep_of	6	SENT_200	[p14l1683t2761r2137b2824],
12	vs	CC	O	vs	_	0	SENT_200	[p14l8t2891r74b2935],
13	seven	CD	TIME	seven	dep	1	SENT_200	[p14l124t2891r330b2935],
14	of	IN	TIME	of	_	0	SENT_200	[p14l380t2867r463b2935],
15	13	CD	TIME	13	num	16	SENT_200	[p14l501t2873r573b2935],
16	carriers	NNS	O	carrier	prep_of	13	SENT_200	[p14l627t2871r926b2945],
17	;	:	O	;	_	0	SENT_200	[p14l627t2871r926b2945],
18	unadjusted	JJ	O	unadjusted	amod	20	SENT_200	[p14l977t2867r1398b2956],
19	hazard	NN	O	hazard	nn	20	SENT_200	[p14l1445t2867r1701b2935],
20	ratio	NN	O	ratio	dep	1	SENT_200	[p14l1748t2871r1916b2935],
21	6-82	CD	NUMBER	6-82	num	22	SENT_200	[p14l1967t2873r2137b2935],
22	[	NN	O	[	dep	20	SENT_200	[p14l13t2982r65b3064],
23	1	CD	NUMBER	1	dep	22	SENT_200	[p14l13t2982r65b3064],
24	-	:	O	-	_	0	SENT_200	[p14l81t3015r92b3026],
25	41-32	CD	DATE	41-32	dep	1	SENT_200	[p14l108t2982r316b3044],
26	-	:	O	-	_	0	SENT_200	[p14l335t3015r346b3026],
27	99	CD	NUMBER	99	num	28	SENT_200	[p14l366t2982r469b3064],
28	]	NN	O	]	dep	25	SENT_200	[p14l366t2982r469b3064],
29	;	:	O	;	_	0	SENT_200	[p14l479t3000r492b3054],
30	p	NN	O	p	nn	32	SENT_200	[p14l520t2981r659b3064],
31	=	JJ	O	=	amod	32	SENT_200	[p14l520t2981r659b3064],
32	O	NN	O	o	dep	1	SENT_200	[p14l520t2981r659b3064],
33	-	:	O	-	_	0	SENT_200	[p14l677t3015r688b3026],
34	006	CD	NUMBER	006	num	35	SENT_200	[p14l707t2981r883b3065],
35	)	NN	O	)	dep	32	SENT_200	[p14l707t2981r883b3065],
36	.	.	O	.	_	0	SENT_200	[p14l707t2981r883b3065],

1	The	DT	O	the	det	2	SENT_201	[p14l78t3084r221b3152],
2	hazard	NN	O	hazard	nsubjpass	15	SENT_201	[p14l247t3084r503b3152],
3	associated	VBN	O	associate	partmod	2	SENT_201	[p14l529t3084r908b3152],
4	with	IN	O	with	_	0	SENT_201	[p14l931t3084r1097b3152],
5	CYP2C19	NN	O	cyp2c19	prep_with	3	SENT_201	[p14l1129t3089r1567b3153],
6	"	''	O	"	punct	5	SENT_201	[p14l1129t3089r1567b3153],
7	'	''	O	'	_	0	SENT_201	[p14l1129t3089r1567b3153],
8	~	FW	O	~	nn	12	SENT_201	[p14l1129t3089r1567b3153],
9	‘	FW	O	‘	dep	12	SENT_201	[p14l1129t3089r1567b3153],
10	2	CD	NUMBER	2	num	12	SENT_201	[p14l1129t3089r1567b3153],
11	genetic	JJ	O	genetic	amod	12	SENT_201	[p14l1590t3089r1858b3174],
12	variant	NN	O	variant	advmod	3	SENT_201	[p14l1881t3089r2141b3152],
13	was	VBD	O	be	auxpass	15	SENT_201	[p14l7t3218r145b3262],
14	mainly	RB	O	mainly	advmod	15	SENT_201	[p14l174t3194r435b3283],
15	driven	VBN	O	drive	_	0	SENT_201	[p14l462t3194r698b3261],
16	by	IN	O	by	_	0	SENT_201	[p14l723t3194r810b3283],
17	a	DT	O	a	det	19	SENT_201	[p14l836t3218r874b3261],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_201	[p14l903t3194r1296b3284],
19	increase	NN	O	increase	agent	15	SENT_201	[p14l1321t3198r1629b3261],
20	in	IN	O	in	_	0	SENT_201	[p14l1657t3198r1732b3260],
21	the	DT	O	the	det	22	SENT_201	[p14l1757t3194r1873b3261],
22	rate	NN	O	rate	prep_in	19	SENT_201	[p14l1901t3207r2041b3261],
23	of	IN	O	of	_	0	SENT_201	[p14l2070t3194r2153b3261],
24	myocardial	JJ	O	myocardial	amod	29	SENT_201	[p14l8t3302r421b3392],
25	infarction	NN	O	infarction	nn	29	SENT_201	[p14l452t3302r818b3371],
26	(	NN	O	(	nn	29	SENT_201	[p14l854t3302r1053b3392],
27	table	NN	O	table	nn	29	SENT_201	[p14l854t3302r1053b3392],
28	2	CD	NUMBER	2	num	29	SENT_201	[p14l1087t3309r1172b3392],
29	)	NN	O	)	prep_of	22	SENT_201	[p14l1087t3309r1172b3392],
30	.	.	O	.	_	0	SENT_201	[p14l1087t3309r1172b3392],

1	In	IN	O	in	_	0	SENT_202	[p14l1211t3309r1289b3369],
2	patients	NNS	O	patient	prep_in	10	SENT_202	[p14l1319t3307r1613b3391],
3	who	WP	O	who	nsubj	4	SENT_202	[p14l1644t3302r1802b3371],
4	received	VBD	O	receive	rcmod	2	SENT_202	[p14l1834t3302r2141b3371],
5	a	DT	O	a	det	6	SENT_202	[p14l9t3435r47b3479],
6	stent	NN	O	stent	dobj	4	SENT_202	[p14l69t3424r267b3489],
7	,	,	O	,	_	0	SENT_202	[p14l69t3424r267b3489],
8	we	PRP	O	we	nsubj	10	SENT_202	[p14l288t3435r391b3479],
9	also	RB	O	also	advmod	10	SENT_202	[p14l413t3411r555b3479],
10	noted	VBD	O	note	_	0	SENT_202	[p14l576t3411r788b3479],
11	a	DT	O	a	det	14	SENT_202	[p14l807t3435r844b3479],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_202	[p14l866t3411r1323b3501],
13	higher	JJR	O	higher	amod	14	SENT_202	[p14l1339t3411r1587b3501],
14	rate	NN	O	rate	dobj	10	SENT_202	[p14l1606t3424r1745b3479],
15	of	IN	O	of	_	0	SENT_202	[p14l1766t3411r1849b3479],
16	deﬁnite	JJ	O	deﬁnite	amod	18	SENT_202	[p14l1857t3411r2139b3479],
17	stent	NN	O	stent	nn	18	SENT_202	[p14l11t3534r192b3588],
18	thrombosis	NN	O	thrombosis	prep_of	14	SENT_202	[p14l228t3521r653b3588],
19	in	IN	O	in	_	0	SENT_202	[p14l694t3525r768b3587],
20	carriers	NNS	O	carrier	prep_in	10	SENT_202	[p14l808t3525r1087b3588],
21	of	IN	O	of	_	0	SENT_202	[p14l1129t3521r1212b3588],
22	the	DT	O	the	det	24	SENT_202	[p14l1237t3521r1353b3588],
23	CYP2C19	NN	O	cyp2c19	nn	24	SENT_202	[p14l1400t3525r1837b3589],
24	*	NN	O	*	prep_of	20	SENT_202	[p14l1400t3525r1837b3589],
25	2	CD	NUMBER	2	num	27	SENT_202	[p14l1400t3525r1837b3589],
26	genetic	JJ	O	genetic	amod	27	SENT_202	[p14l1873t3525r2140b3611],
27	variant	NN	O	variant	npadvmod	28	SENT_202	[p14l7t3634r267b3698],
28	than	IN	O	than	advmod	10	SENT_202	[p14l292t3629r461b3698],
29	in	IN	O	in	_	0	SENT_202	[p14l488t3634r563b3696],
30	non-carriers	JJ	O	non-carriers	amod	34	SENT_202	[p14l591t3634r1045b3698],
31	(	NN	O	(	nn	34	SENT_202	[p14l1081t3629r1279b3719],
32	table	NN	O	table	nn	34	SENT_202	[p14l1081t3629r1279b3719],
33	2	CD	NUMBER	2	num	34	SENT_202	[p14l1310t3636r1396b3719],
34	)	NN	O	)	prep_in	10	SENT_202	[p14l1310t3636r1396b3719],
35	.	.	O	.	_	0	SENT_202	[p14l1310t3636r1396b3719],

1	I-Iowever	NNP	O	I-Iowever	nsubj	31	SENT_203	[p14l1432t3636r1774b3708],
2	,	,	O	,	_	0	SENT_203	[p14l1432t3636r1774b3708],
3	when	WRB	O	when	advmod	5	SENT_203	[p14l1804t3629r2011b3698],
4	we	PRP	O	we	nsubj	5	SENT_203	[p14l2037t3654r2139b3698],
5	excluded	VBD	O	exclude	advcl	31	SENT_203	[p14l9t3738r338b3806],
6	deﬁnite	JJ	O	deﬁnite	amod	8	SENT_203	[p14l368t3738r650b3806],
7	stent	NN	O	stent	nn	8	SENT_203	[p14l683t3751r864b3806],
8	thrombosis	NN	O	thrombosis	dobj	5	SENT_203	[p14l892t3738r1338b3816],
9	,	,	O	,	_	0	SENT_203	[p14l892t3738r1338b3816],
10	the	DT	O	the	det	11	SENT_203	[p14l1371t3738r1488b3806],
11	effect	NN	O	effect	nsubj	31	SENT_203	[p14l1520t3738r1722b3806],
12	of	IN	O	of	_	0	SENT_203	[p14l1752t3738r1835b3806],
13	the	DT	O	the	det	14	SENT_203	[p14l1851t3738r1967b3806],
14	loss	NN	O	loss	prep_of	11	SENT_203	[p14l1997t3738r2137b3806],
15	of	IN	O	of	_	0	SENT_203	[p15l9t29r92b97],
16	function	NN	O	function	prep_of	14	SENT_203	[p15l104t29r421b97],
17	of	IN	O	of	_	0	SENT_203	[p15l446t29r529b97],
18	C	NN	O	c	nn	19	SENT_203	[p15l547t35r601b97],
19	YP2C19	NN	O	yp2c19	prep_of	16	SENT_203	[p15l608t34r984b97],
20	"	''	O	"	punct	31	SENT_203	[p15l608t34r984b97],
21	'	''	O	'	_	0	SENT_203	[p15l608t34r984b97],
22	~	FW	O	~	nn	23	SENT_203	[p15l608t34r984b97],
23	‘	FW	O	‘	amod	24	SENT_203	[p15l608t34r984b97],
24	2	CD	NUMBER	2	nsubj	31	SENT_203	[p15l608t34r984b97],
25	on	IN	O	on	_	0	SENT_203	[p15l1005t54r1099b97],
26	other	JJ	O	other	amod	28	SENT_203	[p15l1124t30r1319b97],
27	ischaemic	JJ	O	ischaemic	amod	28	SENT_203	[p15l1342t30r1717b97],
28	events	NNS	O	event	prep_on	24	SENT_203	[p15l1742t43r1974b97],
29	was	VBD	O	be	cop	31	SENT_203	[p15l1999t54r2138b97],
30	not	RB	O	not	neg	31	SENT_203	[p15l8t152r131b207],
31	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_203	[p15l180t138r573b228],
32	in	IN	O	in	_	0	SENT_203	[p15l619t143r693b205],
33	these	DT	O	these	det	34	SENT_203	[p15l740t138r936b207],
34	patients	NNS	O	patient	prep_in	31	SENT_203	[p15l984t143r1278b227],
35	with	IN	O	with	_	0	SENT_203	[p15l1327t138r1492b207],
36	stents	NNS	O	stent	prep_with	31	SENT_203	[p15l1542t152r1757b207],
37	(	CD	NUMBER	(	num	38	SENT_203	[p15l1813t144r2136b228],
38	p	NN	O	p	dep	36	SENT_203	[p15l1813t144r2136b228],
39	=	JJ	O	=	amod	41	SENT_203	[p15l1813t144r2136b228],
40	0-11	CD	NUMBER	0-11	tmod	39	SENT_203	[p15l1813t144r2136b228],
41	)	NN	O	)	dep	38	SENT_203	[p15l1813t144r2136b228],
42	,	,	O	,	_	0	SENT_203	[p15l1813t144r2136b228],
43	although	IN	O	although	mark	46	SENT_203	[p15l9t247r341b337],
44	it	PRP	O	it	nsubj	46	SENT_203	[p15l379t252r430b314],
45	became	VBD	O	become	cop	46	SENT_203	[p15l465t247r752b315],
46	signiﬁcant	NN	O	signiﬁcant	advcl	31	SENT_203	[p15l793t247r1186b337],
47	in	IN	O	in	_	0	SENT_203	[p15l1223t252r1298b314],
48	the	DT	O	the	det	54	SENT_203	[p15l1335t247r1452b315],
49	adjusted	JJ	O	adjusted	amod	54	SENT_203	[p15l1492t247r1807b336],
50	analysis	NN	O	analysis	nn	54	SENT_203	[p15l1845t247r2138b336],
51	(	NN	O	(	nn	54	SENT_203	[p15l14t358r213b447],
52	table	NN	O	table	nn	54	SENT_203	[p15l14t358r213b447],
53	2	CD	NUMBER	2	num	54	SENT_203	[p15l244t364r329b447],
54	)	NN	O	)	prep_in	46	SENT_203	[p15l244t364r329b447],
55	.	.	O	.	_	0	SENT_203	[p15l244t364r329b447],

1	When	WRB	O	when	advmod	3	SENT_204	[p15l359t358r587b426],
2	we	PRP	O	we	nsubj	3	SENT_204	[p15l612t382r715b426],
3	took	VBD	O	take	advcl	42	SENT_204	[p15l742t358r905b426],
4	into	IN	O	into	_	0	SENT_204	[p15l931t362r1076b426],
5	account	NN	O	account	prep_into	3	SENT_204	[p15l1106t371r1397b426],
6	the	DT	O	the	det	9	SENT_204	[p15l1422t358r1538b426],
7	other	JJ	O	other	amod	9	SENT_204	[p15l1568t358r1763b426],
8	C	NN	O	c	nn	9	SENT_204	[p15l1796t363r1850b426],
9	YPZC	NN	O	ypzc	dep	12	SENT_204	[p15l1857t363r2063b426],
10	19	CD	NUMBER	19	num	11	SENT_204	[p15l2069t364r2144b426],
11	variants	NNS	O	variant	dep	9	SENT_204	[p15l7t471r300b534],
12	(	VBP	O	(	parataxis	42	SENT_204	[p15l351t471r456b556],
13	‘	CD	NUMBER	‘	number	14	SENT_204	[p15l351t471r456b556],
14	*	CD	NUMBER	*	num	15	SENT_204	[p15l351t471r456b556],
15	3	CD	NUMBER	3	dobj	12	SENT_204	[p15l351t471r456b556],
16	to	TO	O	to	_	0	SENT_204	[p15l500t480r570b534],
17	"	``	O	"	punct	19	SENT_204	[p15l614t471r721b556],
18	"	``	O	"	punct	19	SENT_204	[p15l614t471r721b556],
19	‘	NN	O	‘	prep_to	12	SENT_204	[p15l614t471r721b556],
20	6	CD	NUMBER	6	num	19	SENT_204	[p15l614t471r721b556],
21	)	NN	O	)	dep	19	SENT_204	[p15l614t471r721b556],
22	that	WDT	O	that	nsubj	24	SENT_204	[p15l768t466r913b534],
23	were	VBD	O	be	cop	24	SENT_204	[p15l952t491r1130b534],
24	present	JJ	DATE	present	rcmod	19	SENT_204	[p15l1173t480r1453b555],
25	in	IN	O	in	_	0	SENT_204	[p15l1493t471r1568b533],
26	three	CD	NUMBER	three	num	27	SENT_204	[p15l1609t466r1800b534],
27	patients	NNS	O	patient	prep_in	19	SENT_204	[p15l1843t471r2137b555],
28	without	IN	O	without	_	0	SENT_204	[p15l7t575r297b643],
29	the	DT	O	the	det	31	SENT_204	[p15l334t575r450b643],
30	C	NN	O	c	nn	31	SENT_204	[p15l498t580r552b643],
31	YP2C19	NN	O	yp2c19	prep_without	19	SENT_204	[p15l559t580r936b643],
32	*	CD	NUMBER	*	num	35	SENT_204	[p15l559t580r936b643],
33	‘	NN	O	‘	nn	35	SENT_204	[p15l559t580r936b643],
34	2	CD	NUMBER	2	num	35	SENT_204	[p15l559t580r936b643],
35	variant	NN	O	variant	nsubj	12	SENT_204	[p15l969t580r1247b653],
36	,	,	O	,	_	0	SENT_204	[p15l969t580r1247b653],
37	the	DT	O	the	det	39	SENT_204	[p15l1290t575r1406b643],
38	overall	JJ	O	overall	amod	39	SENT_204	[p15l1448t575r1693b643],
39	results	NNS	O	result	nsubj	42	SENT_204	[p15l1733t575r1980b643],
40	did	VBD	O	do	aux	42	SENT_204	[p15l2023t575r2141b643],
41	not	RB	O	not	neg	42	SENT_204	[p15l8t698r131b753],
42	change	VB	O	change	_	0	SENT_204	[p15l156t685r440b774],
43	.	.	O	.	_	0	SENT_204	[p15l156t685r440b774],

1	We	PRP	O	we	nsubj	2	SENT_205	[p15l78t800r195b861],
2	measured	VBD	O	measure	_	0	SENT_205	[p15l236t793r605b861],
3	all	DT	O	all	det	5	SENT_205	[p15l645t793r729b861],
4	risk	NN	O	risk	nn	5	SENT_205	[p15l768t793r908b861],
5	biomarkers	NNS	O	biomarker	dobj	2	SENT_205	[p15l945t793r1368b861],
6	3	CD	DURATION	3	num	7	SENT_205	[p15l1415t800r1448b861],
7	months	NNS	NUMBER	month	tmod	2	SENT_205	[p15l1492t793r1777b861],
8	after	IN	O	after	_	0	SENT_205	[p15l1820t793r1987b861],
9	the	DT	O	the	det	11	SENT_205	[p15l2024t793r2140b861],
10	index	NN	O	index	nn	11	SENT_205	[p15l8t903r212b970],
11	event	NN	O	event	prep_after	2	SENT_205	[p15l237t916r450b970],
12	.	.	O	.	_	0	SENT_205	[p15l237t916r450b970],

1	We	PRP	O	we	nsubj	2	SENT_206	[p15l480t909r597b971],
2	noted	VBD	O	note	_	0	SENT_206	[p15l624t903r834b970],
3	no	DT	O	no	det	5	SENT_206	[p15l859t927r952b970],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_206	[p15l981t903r1371b993],
5	differences	NNS	O	difference	dobj	2	SENT_206	[p15l1396t903r1803b970],
6	between	IN	O	between	_	0	SENT_206	[p15l1830t903r2140b971],
7	www	NN	O	www	prep_between	5	SENT_206	[p15l7t1173r540b1224],
8	.	.	O	.	_	0	SENT_206	[p15l7t1173r540b1224],

1	the	DT	O	the	det	2	SENT_207	[p15l7t1173r540b1224],
2	|	NN	O	|	_	0	SENT_207	[p15l7t1173r540b1224],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_207	[p15l7t1173r540b1224],
4	Vol	NNP	O	Vol	dep	2	SENT_207	[p15l583t1173r670b1224],
5	373	CD	NUMBER	373	num	4	SENT_207	[p15l689t1179r789b1231],
6	January	NNP	DATE	January	tmod	4	SENT_207	[p15l830t1178r1047b1238],
7	24	CD	DATE	24	num	6	SENT_207	[p15l1065t1179r1150b1232],
8	,	,	DATE	,	_	0	SENT_207	[p15l1065t1179r1150b1232],
9	2009	CD	DATE	2009	num	6	SENT_207	[p15l1169t1179r1314b1231],

1	CYP2C19	NN	O	cyp2c19	dep	319	SENT_208	[p16l979t121r1196b161],
2	*	NN	O	*	dep	319	SENT_208	[p16l979t121r1196b161],
3	2	CD	NUMBER	2	dep	319	SENT_208	[p16l979t121r1196b161],
4	allele	NN	O	allele	dep	319	SENT_208	[p16l1209t120r1309b156],
5	p	NN	O	p	dep	319	SENT_208	[p16l1835t132r1859b167],
6	value	NN	O	value	dep	319	SENT_208	[p16l1870t120r1975b156],
7	Non	NNP	O	Non	dep	319	SENT_208	[p16l981t219r1210b252],
8	—	CD	NUMBER	—	dep	319	SENT_208	[p16l981t219r1210b252],
9	carriers	NNS	O	carrier	dep	319	SENT_208	[p16l981t219r1210b252],
10	(	VBP	O	(	dep	319	SENT_208	[p16l1223t215r1381b261],
11	N	NN	O	n	dep	319	SENT_208	[p16l1223t215r1381b261],
12	=	JJ	O	=	dep	319	SENT_208	[p16l1223t215r1381b261],
13	186	CD	NUMBER	186	dep	319	SENT_208	[p16l1223t215r1381b261],
14	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1223t215r1381b261],
15	Carriers	NNS	O	carrier	dep	319	SENT_208	[p16l1429t218r1567b252],
16	(	VBP	O	(	dep	319	SENT_208	[p16l1581t218r1709b261],
17	N	NN	O	n	dep	319	SENT_208	[p16l1581t218r1709b261],
18	=	JJ	O	=	dep	319	SENT_208	[p16l1581t218r1709b261],
19	73	CD	NUMBER	73	dep	319	SENT_208	[p16l1581t218r1709b261],
20	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1581t218r1709b261],
21	Primary	JJ	O	primary	dep	319	SENT_208	[p16l72t312r225b358],
22	endpoint	NN	O	endpoint	dep	319	SENT_208	[p16l236t311r419b358],
23	(	NN	O	(	dep	319	SENT_208	[p16l431t311r571b356],
24	death	NN	O	death	dep	319	SENT_208	[p16l431t311r571b356],
25	,	,	O	,	_	0	SENT_208	[p16l431t311r571b356],
26	non-fatal	JJ	O	non-fatal	dep	319	SENT_208	[p16l585t311r767b347],
27	myocardial	JJ	O	myocardial	dep	319	SENT_208	[p16l781t311r997b358],
28	infarction	NN	O	infarction	dep	319	SENT_208	[p16l1011t311r1216b353],
29	,	,	O	,	_	0	SENT_208	[p16l1011t311r1216b353],
30	urgent	JJ	O	urgent	dep	319	SENT_208	[p16l1229t317r1361b358],
31	revascularisation	NN	O	revascularisation	dep	319	SENT_208	[p16l1374t311r1722b356],
32	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1374t311r1722b356],
33	Absolute	JJ	O	absolute	dep	319	SENT_208	[p16l70t390r236b426],
34	number	NN	O	number	dep	319	SENT_208	[p16l250t390r396b426],
35	of	IN	O	of	dep	319	SENT_208	[p16l406t390r446b426],
36	events	NNS	O	event	dep	319	SENT_208	[p16l455t397r577b426],
37	(	CD	NUMBER	(	dep	319	SENT_208	[p16l590t392r641b436],
38	n	NN	O	n	dep	319	SENT_208	[p16l590t392r641b436],
39	)	CD	NUMBER	)	dep	319	SENT_208	[p16l590t392r641b436],
40	11	CD	NUMBER	11	dep	319	SENT_208	[p16l985t395r1026b426],
41	15	CD	NUMBER	15	dep	319	SENT_208	[p16l1433t395r1475b432],
42	Event	NN	O	event	dep	319	SENT_208	[p16l72t473r175b506],
43	rate	NN	O	rate	dep	319	SENT_208	[p16l189t477r259b506],
44	per	IN	O	per	dep	319	SENT_208	[p16l271t482r330b517],
45	100	CD	NUMBER	100	dep	319	SENT_208	[p16l342t475r411b506],
46	patient	NN	O	patient	dep	319	SENT_208	[p16l424t473r670b517],
47	—	CD	NUMBER	—	dep	319	SENT_208	[p16l424t473r670b517],
48	years	NNS	NUMBER	year	dep	319	SENT_208	[p16l424t473r670b517],
49	2-89	CD	NUMBER	2-89	dep	319	SENT_208	[p16l1006t469r1089b511],
50	10-90	CD	NUMBER	10-90	dep	319	SENT_208	[p16l1431t475r1538b511],
51	Unadjusted	JJ	O	unadjusted	dep	319	SENT_208	[p16l72t549r284b596],
52	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l298t553r349b585],
53	(	NN	O	(	dep	319	SENT_208	[p16l362t551r457b595],
54	95	CD	PERCENT	95	dep	319	SENT_208	[p16l362t551r457b595],
55	%	NN	PERCENT	%	dep	319	SENT_208	[p16l362t551r457b595],
56	CI	NN	O	ci	dep	319	SENT_208	[p16l469t551r516b595],
57	)	CD	NUMBER	)	dep	319	SENT_208	[p16l469t551r516b595],
58	10	CD	NUMBER	10	dep	319	SENT_208	[p16l1007t554r1062b585],
59	3-69	CD	NUMBER	3-69	dep	319	SENT_208	[p16l1455t549r1539b591],
60	(	NN	O	(	dep	319	SENT_208	[p16l1553t549r1770b595],
61	169-805	CD	NUMBER	169-805	dep	319	SENT_208	[p16l1553t549r1770b595],
62	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1553t549r1770b595],
63	00005	CD	NUMBER	00005	dep	319	SENT_208	[p16l1868t554r2000b591],
64	Adjusted	VBN	O	adjust	dep	319	SENT_208	[p16l69t629r237b676],
65	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l251t632r301b665],
66	(	NN	O	(	dep	319	SENT_208	[p16l314t631r409b674],
67	95	CD	PERCENT	95	dep	319	SENT_208	[p16l314t631r409b674],
68	%	NN	PERCENT	%	dep	319	SENT_208	[p16l314t631r409b674],
69	CI	NN	O	ci	dep	319	SENT_208	[p16l422t630r489b674],
70	)	CD	NUMBER	)	dep	319	SENT_208	[p16l422t630r489b674],
71	*	CD	NUMBER	*	dep	319	SENT_208	[p16l422t630r489b674],
72	10	CD	NUMBER	10	dep	319	SENT_208	[p16l1007t634r1062b665],
73	538	CD	NUMBER	538	dep	319	SENT_208	[p16l1455t628r1536b670],
74	(	NN	O	(	dep	319	SENT_208	[p16l1550t631r1782b674],
75	232-1247	CD	NUMBER	232-1247	dep	319	SENT_208	[p16l1550t631r1782b674],
76	)	NN	O	)	dep	319	SENT_208	[p16l1550t631r1782b674],
77	<	JJR	O	<	dep	319	SENT_208	[p16l1844t633r2000b665],
78	0-0001	CD	NUMBER	0-0001	dep	319	SENT_208	[p16l1844t633r2000b665],
79	Cardiovascular	NNP	O	Cardiovascular	dep	319	SENT_208	[p16l70t708r359b744],
80	death	NN	O	death	dep	319	SENT_208	[p16l369t708r481b744],
81	Absolute	JJ	O	absolute	dep	319	SENT_208	[p16l70t788r236b824],
82	number	NN	O	number	dep	319	SENT_208	[p16l250t788r396b824],
83	of	IN	O	of	dep	319	SENT_208	[p16l406t787r446b824],
84	events	NNS	O	event	dep	319	SENT_208	[p16l455t794r577b824],
85	(	CD	NUMBER	(	dep	319	SENT_208	[p16l590t790r641b833],
86	n	NN	O	n	dep	319	SENT_208	[p16l590t790r641b833],
87	)	CD	NUMBER	)	dep	319	SENT_208	[p16l590t790r641b833],
88	1	CD	NUMBER	1	dep	319	SENT_208	[p16l1007t793r1026b823],
89	2	CD	NUMBER	2	dep	319	SENT_208	[p16l1455t792r1474b823],
90	Event	NN	O	event	dep	319	SENT_208	[p16l72t870r176b903],
91	rate	NN	O	rate	dep	319	SENT_208	[p16l189t874r259b903],
92	per	IN	O	per	dep	319	SENT_208	[p16l270t879r330b914],
93	100	CD	NUMBER	100	dep	319	SENT_208	[p16l341t872r411b903],
94	person	NN	O	person	dep	319	SENT_208	[p16l423t879r662b914],
95	—	CD	NUMBER	—	dep	319	SENT_208	[p16l423t879r662b914],
96	years	NNS	NUMBER	year	dep	319	SENT_208	[p16l423t879r662b914],
97	0-26	CD	NUMBER	0-26	dep	319	SENT_208	[p16l1004t867r1087b903],
98	1-45	CD	NUMBER	1-45	dep	319	SENT_208	[p16l1456t872r1535b908],
99	Unadjusted	JJ	O	unadjusted	dep	319	SENT_208	[p16l72t947r284b994],
100	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l298t950r349b982],
101	(	NN	O	(	dep	319	SENT_208	[p16l362t948r457b992],
102	95	CD	PERCENT	95	dep	319	SENT_208	[p16l362t948r457b992],
103	%	NN	PERCENT	%	dep	319	SENT_208	[p16l362t948r457b992],
104	CI	NN	O	ci	dep	319	SENT_208	[p16l469t948r516b992],
105	)	CD	NUMBER	)	dep	319	SENT_208	[p16l469t948r516b992],
106	1-0	CD	NUMBER	1-0	dep	319	SENT_208	[p16l1007t951r1062b983],
107	5-74	CD	NUMBER	5-74	dep	319	SENT_208	[p16l1455t951r1534b988],
108	(	NN	O	(	dep	319	SENT_208	[p16l1546t946r1788b992],
109	0-52-63-48	CD	NUMBER	0-52-63-48	dep	319	SENT_208	[p16l1546t946r1788b992],
110	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1546t946r1788b992],
111	0-10	CD	NUMBER	0-10	dep	319	SENT_208	[p16l1868t951r1948b983],
112	Adjusted	VBN	O	adjust	dep	319	SENT_208	[p16l69t1026r237b1073],
113	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l251t1029r301b1062],
114	(	NN	O	(	dep	319	SENT_208	[p16l314t1028r409b1071],
115	95	CD	PERCENT	95	dep	319	SENT_208	[p16l314t1028r409b1071],
116	%	NN	PERCENT	%	dep	319	SENT_208	[p16l314t1028r409b1071],
117	Cl	NN	O	cl	dep	319	SENT_208	[p16l422t1028r489b1071],
118	)	CD	NUMBER	)	dep	319	SENT_208	[p16l422t1028r489b1071],
119	*	CD	NUMBER	*	dep	319	SENT_208	[p16l422t1028r489b1071],
120	T	NN	O	t	dep	319	SENT_208	[p16l1008t1029r1025b1064],
121	T	NN	O	t	dep	319	SENT_208	[p16l1458t1029r1475b1064],
122	Myocardial	JJ	O	myocardial	dep	319	SENT_208	[p16l71t1105r287b1152],
123	infarction	NN	O	infarction	dep	319	SENT_208	[p16l301t1105r493b1141],
124	Absolute	JJ	O	absolute	dep	319	SENT_208	[p16l70t1185r236b1221],
125	number	NN	O	number	dep	319	SENT_208	[p16l250t1185r396b1221],
126	of	IN	O	of	dep	319	SENT_208	[p16l406t1184r446b1221],
127	events	NNS	O	event	dep	319	SENT_208	[p16l455t1191r577b1221],
128	(	CD	NUMBER	(	dep	319	SENT_208	[p16l590t1187r641b1230],
129	n	NN	O	n	dep	319	SENT_208	[p16l590t1187r641b1230],
130	)	CD	NUMBER	)	dep	319	SENT_208	[p16l590t1187r641b1230],
131	6	CD	NUMBER	6	dep	319	SENT_208	[p16l1004t1184r1025b1221],
132	10	CD	NUMBER	10	dep	319	SENT_208	[p16l1431t1190r1475b1221],
133	Event	NN	O	event	dep	319	SENT_208	[p16l72t1268r175b1300],
134	rate	NN	O	rate	dep	319	SENT_208	[p16l189t1271r259b1300],
135	per	IN	O	per	dep	319	SENT_208	[p16l271t1276r330b1311],
136	100	CD	NUMBER	100	dep	319	SENT_208	[p16l342t1269r411b1300],
137	patient	NN	O	patient	dep	319	SENT_208	[p16l423t1267r670b1311],
138	—	CD	NUMBER	—	dep	319	SENT_208	[p16l423t1267r670b1311],
139	years	NNS	NUMBER	year	dep	319	SENT_208	[p16l423t1267r670b1311],
140	1-58	CD	NUMBER	1-58	dep	319	SENT_208	[p16l1007t1264r1086b1305],
141	7-27	CD	NUMBER	7-27	dep	319	SENT_208	[p16l1455t1269r1534b1304],
142	Unadjusted	JJ	O	unadjusted	dep	319	SENT_208	[p16l72t1344r284b1391],
143	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l298t1347r349b1379],
144	(	NN	O	(	dep	319	SENT_208	[p16l362t1345r457b1389],
145	95	CD	PERCENT	95	dep	319	SENT_208	[p16l362t1345r457b1389],
146	%	NN	PERCENT	%	dep	319	SENT_208	[p16l362t1345r457b1389],
147	Cl	NN	O	cl	dep	319	SENT_208	[p16l469t1345r516b1389],
148	)	CD	NUMBER	)	dep	319	SENT_208	[p16l469t1345r516b1389],
149	1-0	CD	NUMBER	1-0	dep	319	SENT_208	[p16l1007t1348r1062b1379],
150	4-54	CD	NUMBER	4-54	dep	319	SENT_208	[p16l1452t1348r1537b1385],
151	(	NN	O	(	dep	319	SENT_208	[p16l1550t1343r1785b1389],
152	1-64-12-53	CD	NUMBER	1-64-12-53	dep	319	SENT_208	[p16l1550t1343r1785b1389],
153	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1550t1343r1785b1389],
154	0-001	CD	NUMBER	0-001	dep	319	SENT_208	[p16l1868t1348r1974b1379],
155	Adjusted	VBN	O	adjust	dep	319	SENT_208	[p16l70t1423r237b1470],
156	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l251t1426r301b1459],
157	(	NN	O	(	dep	319	SENT_208	[p16l314t1425r409b1468],
158	95	CD	PERCENT	95	dep	319	SENT_208	[p16l314t1425r409b1468],
159	%	NN	PERCENT	%	dep	319	SENT_208	[p16l314t1425r409b1468],
160	CI	NN	O	ci	dep	319	SENT_208	[p16l422t1425r489b1468],
161	)	CD	NUMBER	)	dep	319	SENT_208	[p16l422t1425r489b1468],
162	*	CD	NUMBER	*	dep	319	SENT_208	[p16l422t1425r489b1468],
163	10	CD	NUMBER	10	dep	319	SENT_208	[p16l1007t1428r1062b1459],
164	557	CD	NUMBER	557	dep	319	SENT_208	[p16l1455t1428r1534b1464],
165	(	NN	O	(	dep	319	SENT_208	[p16l1546t1423r1784b1468],
166	194-1601	CD	NUMBER	194-1601	dep	319	SENT_208	[p16l1546t1423r1784b1468],
167	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1546t1423r1784b1468],
168	0001	CD	DATE	0001	dep	319	SENT_208	[p16l1868t1428r1974b1459],
169	Urgent	NNP	O	Urgent	dep	319	SENT_208	[p16l71t1506r209b1550],
170	revascularisation	NN	O	revascularisation	dep	319	SENT_208	[p16l221t1502r554b1538],
171	Absolute	JJ	O	absolute	dep	319	SENT_208	[p16l70t1582r236b1618],
172	number	NN	O	number	dep	319	SENT_208	[p16l250t1582r396b1618],
173	of	IN	O	of	dep	319	SENT_208	[p16l406t1582r446b1618],
174	events	NNS	O	event	dep	319	SENT_208	[p16l455t1589r577b1618],
175	(	CD	NUMBER	(	dep	319	SENT_208	[p16l590t1584r641b1627],
176	n	NN	O	n	dep	319	SENT_208	[p16l590t1584r641b1627],
177	)	CD	NUMBER	)	dep	319	SENT_208	[p16l590t1584r641b1627],
178	4	CD	NUMBER	4	dep	319	SENT_208	[p16l1002t1587r1027b1623],
179	3	CD	NUMBER	3	dep	319	SENT_208	[p16l1455t1587r1475b1623],
180	Event	NN	O	event	dep	319	SENT_208	[p16l72t1665r175b1697],
181	rate	NN	O	rate	dep	319	SENT_208	[p16l189t1668r259b1697],
182	per	IN	O	per	dep	319	SENT_208	[p16l271t1673r330b1708],
183	100	CD	NUMBER	100	dep	319	SENT_208	[p16l342t1666r411b1697],
184	patient	NN	O	patient	dep	319	SENT_208	[p16l423t1664r670b1708],
185	—	CD	NUMBER	—	dep	319	SENT_208	[p16l423t1664r670b1708],
186	years	NNS	NUMBER	year	dep	319	SENT_208	[p16l423t1664r670b1708],
187	1-05	CD	NUMBER	1-05	dep	319	SENT_208	[p16l1007t1666r1085b1702],
188	2-18	CD	NUMBER	2-18	dep	319	SENT_208	[p16l1455t1661r1534b1697],
189	Unadjusted	JJ	O	unadjusted	dep	319	SENT_208	[p16l72t1741r284b1788],
190	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l298t1744r349b1776],
191	(	NN	O	(	dep	319	SENT_208	[p16l362t1743r457b1786],
192	95	CD	PERCENT	95	dep	319	SENT_208	[p16l362t1743r457b1786],
193	%	NN	PERCENT	%	dep	319	SENT_208	[p16l362t1743r457b1786],
194	Cl	NN	O	cl	dep	319	SENT_208	[p16l469t1742r516b1786],
195	)	CD	NUMBER	)	dep	319	SENT_208	[p16l469t1742r516b1786],
196	1-0	CD	NUMBER	1-0	dep	319	SENT_208	[p16l1007t1746r1062b1777],
197	1-94	CD	NUMBER	1-94	dep	319	SENT_208	[p16l1456t1746r1540b1782],
198	(	NN	O	(	dep	319	SENT_208	[p16l1553t1740r1767b1786],
199	0-43-8-73	CD	NUMBER	0-43-8-73	dep	319	SENT_208	[p16l1553t1740r1767b1786],
200	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1553t1740r1767b1786],
201	0-38	CD	NUMBER	0-38	dep	319	SENT_208	[p16l1868t1740r1950b1782],
202	Adjusted	VBN	O	adjust	dep	319	SENT_208	[p16l70t1820r237b1867],
203	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l251t1823r301b1856],
204	(	NN	O	(	dep	319	SENT_208	[p16l314t1822r409b1865],
205	95	CD	PERCENT	95	dep	319	SENT_208	[p16l314t1822r409b1865],
206	%	NN	PERCENT	%	dep	319	SENT_208	[p16l314t1822r409b1865],
207	Cl	NN	O	cl	dep	319	SENT_208	[p16l422t1822r489b1865],
208	)	CD	NUMBER	)	dep	319	SENT_208	[p16l422t1822r489b1865],
209	*	CD	NUMBER	*	dep	319	SENT_208	[p16l422t1822r489b1865],
210	1-0	CD	NUMBER	1-0	dep	319	SENT_208	[p16l1007t1825r1062b1856],
211	3-24	CD	NUMBER	3-24	dep	319	SENT_208	[p16l1455t1825r1537b1861],
212	(	NN	O	(	dep	319	SENT_208	[p16l1549t1820r1792b1865],
213	0-69-15-09	CD	NUMBER	0-69-15-09	dep	319	SENT_208	[p16l1549t1820r1792b1865],
214	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1549t1820r1792b1865],
215	0-13	CD	NUMBER	0-13	dep	319	SENT_208	[p16l1868t1825r1946b1861],
216	Deﬁnite	NNP	O	Deﬁnite	dep	319	SENT_208	[p16l72t1899r227b1936],
217	stent	NN	O	stent	dep	319	SENT_208	[p16l239t1905r342b1936],
218	thrombosisi	NN	O	thrombosisus	dep	319	SENT_208	[p16l350t1899r600b1938],
219	Absolute	JJ	O	absolute	dep	319	SENT_208	[p16l70t1979r236b2015],
220	number	NN	O	number	dep	319	SENT_208	[p16l250t1979r396b2015],
221	of	IN	O	of	dep	319	SENT_208	[p16l406t1979r446b2015],
222	events	NNS	O	event	dep	319	SENT_208	[p16l455t1986r577b2015],
223	(	CD	NUMBER	(	dep	319	SENT_208	[p16l591t1981r641b2024],
224	n	NN	O	n	dep	319	SENT_208	[p16l591t1981r641b2024],
225	)	CD	NUMBER	)	dep	319	SENT_208	[p16l591t1981r641b2024],
226	4	CD	NUMBER	4	dep	319	SENT_208	[p16l1003t1984r1027b2020],
227	8	CD	NUMBER	8	dep	319	SENT_208	[p16l1453t1979r1475b2015],
228	Event	NN	O	event	dep	319	SENT_208	[p16l72t2062r176b2094],
229	rate	NN	O	rate	dep	319	SENT_208	[p16l189t2065r259b2094],
230	per	IN	O	per	dep	319	SENT_208	[p16l270t2071r330b2105],
231	1000	CD	DATE	1000	dep	319	SENT_208	[p16l341t2063r436b2094],
232	person	NN	O	person	dep	319	SENT_208	[p16l449t2071r688b2105],
233	—	CD	NUMBER	—	dep	319	SENT_208	[p16l449t2071r688b2105],
234	years	NNS	NUMBER	year	dep	319	SENT_208	[p16l449t2071r688b2105],
235	1-14	CD	NUMBER	1-14	dep	319	SENT_208	[p16l1007t2063r1086b2099],
236	6-79	CD	NUMBER	6-79	dep	319	SENT_208	[p16l1453t2058r1534b2100],
237	Unadjusted	JJ	O	unadjusted	dep	319	SENT_208	[p16l72t2138r284b2185],
238	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l298t2141r349b2174],
239	(	NN	O	(	dep	319	SENT_208	[p16l362t2140r457b2183],
240	95	CD	PERCENT	95	dep	319	SENT_208	[p16l362t2140r457b2183],
241	%	NN	PERCENT	%	dep	319	SENT_208	[p16l362t2140r457b2183],
242	Cl	NN	O	cl	dep	319	SENT_208	[p16l469t2140r516b2183],
243	)	CD	NUMBER	)	dep	319	SENT_208	[p16l469t2140r516b2183],
244	1-0	CD	NUMBER	1-0	dep	319	SENT_208	[p16l1007t2143r1062b2174],
245	6-02	CD	NUMBER	6-02	dep	319	SENT_208	[p16l1453t2138r1534b2174],
246	(	NN	O	(	dep	319	SENT_208	[p16l1549t2138r1787b2183],
247	1-81-20-04	CD	NUMBER	1-81-20-04	dep	319	SENT_208	[p16l1549t2138r1787b2183],
248	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1549t2138r1787b2183],
249	O-0009	NN	O	o-0009	dep	319	SENT_208	[p16l1868t2143r2003b2179],
250	Adjusted	VBN	O	adjust	dep	319	SENT_208	[p16l70t2217r237b2264],
251	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l251t2220r301b2253],
252	(	NN	O	(	dep	319	SENT_208	[p16l314t2219r409b2263],
253	95	CD	PERCENT	95	dep	319	SENT_208	[p16l314t2219r409b2263],
254	%	NN	PERCENT	%	dep	319	SENT_208	[p16l314t2219r409b2263],
255	Cl	NN	O	cl	dep	319	SENT_208	[p16l422t2219r489b2262],
256	)	CD	NUMBER	)	dep	319	SENT_208	[p16l422t2219r489b2262],
257	*	CD	NUMBER	*	dep	319	SENT_208	[p16l422t2219r489b2262],
258	1-0	CD	NUMBER	1-0	dep	319	SENT_208	[p16l1007t2222r1062b2253],
259	6-04	CD	NUMBER	6-04	dep	319	SENT_208	[p16l1453t2217r1539b2258],
260	(	NN	O	(	dep	319	SENT_208	[p16l1551t2217r1787b2262],
261	175-2080	CD	NUMBER	175-2080	dep	319	SENT_208	[p16l1551t2217r1787b2262],
262	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1551t2217r1787b2262],
263	0004	CD	DATE	0004	dep	319	SENT_208	[p16l1868t2222r1979b2258],
264	lschaemic	JJ	O	lschaemic	dep	319	SENT_208	[p16l72t2296r262b2333],
265	endpoint	NN	O	endpoint	dep	319	SENT_208	[p16l274t2296r457b2343],
266	not	RB	O	not	dep	319	SENT_208	[p16l469t2302r536b2333],
267	related	JJ	O	related	dep	319	SENT_208	[p16l549t2296r685b2333],
268	to	TO	O	to	dep	319	SENT_208	[p16l694t2302r737b2333],
269	stent	JJ	O	stent	dep	319	SENT_208	[p16l748t2302r851b2333],
270	thrombosis	NN	O	thrombosis	dep	319	SENT_208	[p16l860t2296r1131b2339],
271	:	:	O	:	_	0	SENT_208	[p16l860t2296r1131b2339],
272	l	NN	O	l	dep	319	SENT_208	[p16l860t2296r1131b2339],
273	=	JJ	O	=	dep	319	SENT_208	[p16l860t2296r1131b2339],
274	§	CD	NUMBER	§	dep	319	SENT_208	[p16l860t2296r1131b2339],
275	Absolute	JJ	O	absolute	dep	319	SENT_208	[p16l70t2376r236b2412],
276	number	NN	O	number	dep	319	SENT_208	[p16l250t2376r396b2412],
277	of	IN	O	of	dep	319	SENT_208	[p16l406t2376r446b2412],
278	events	NNS	O	event	dep	319	SENT_208	[p16l455t2383r577b2412],
279	(	CD	NUMBER	(	dep	319	SENT_208	[p16l590t2378r641b2422],
280	n	NN	O	n	dep	319	SENT_208	[p16l590t2378r641b2422],
281	)	NN	O	)	dep	319	SENT_208	[p16l590t2378r641b2422],
282	7	CD	NUMBER	7	dep	319	SENT_208	[p16l1005t2382r1027b2417],
283	6	CD	NUMBER	6	dep	319	SENT_208	[p16l1453t2376r1475b2412],
284	Event	NN	O	event	dep	319	SENT_208	[p16l72t2459r175b2492],
285	rate	NN	O	rate	dep	319	SENT_208	[p16l189t2462r259b2492],
286	per	IN	O	per	dep	319	SENT_208	[p16l271t2468r330b2502],
287	100	CD	NUMBER	100	dep	319	SENT_208	[p16l342t2460r411b2491],
288	patient	NN	O	patient	dep	319	SENT_208	[p16l423t2459r670b2502],
289	—	CD	NUMBER	—	dep	319	SENT_208	[p16l423t2459r670b2502],
290	years	NNS	NUMBER	year	dep	319	SENT_208	[p16l423t2459r670b2502],
291	1-99	CD	NUMBER	1-99	dep	319	SENT_208	[p16l1007t2460r1089b2497],
292	5-09	CD	NUMBER	5-09	dep	319	SENT_208	[p16l1455t2460r1537b2497],
293	Unadjusted	JJ	O	unadjusted	dep	319	SENT_208	[p16l72t2535r284b2582],
294	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l298t2538r349b2571],
295	(	NN	O	(	dep	319	SENT_208	[p16l362t2537r457b2580],
296	95	CD	PERCENT	95	dep	319	SENT_208	[p16l362t2537r457b2580],
297	%	NN	PERCENT	%	dep	319	SENT_208	[p16l362t2537r457b2580],
298	CI	NN	O	ci	dep	319	SENT_208	[p16l469t2537r516b2581],
299	)	CD	NUMBER	)	dep	319	SENT_208	[p16l469t2537r516b2581],
300	10	CD	NUMBER	10	dep	319	SENT_208	[p16l1007t2540r1062b2571],
301	2-38	CD	NUMBER	2-38	dep	319	SENT_208	[p16l1455t2535r1536b2576],
302	(	NN	O	(	dep	319	SENT_208	[p16l1550t2537r1759b2580],
303	079-713	CD	NUMBER	079-713	dep	319	SENT_208	[p16l1550t2537r1759b2580],
304	)	NN	O	)	dep	319	SENT_208	[p16l1550t2537r1759b2580],
305	011	CD	NUMBER	011	dep	319	SENT_208	[p16l1868t2540r1945b2571],
306	Adjusted	VBN	O	adjust	dep	319	SENT_208	[p16l70t2614r237b2662],
307	HR	NN	DURATION	hr	dep	319	SENT_208	[p16l251t2618r301b2650],
308	(	NN	O	(	dep	319	SENT_208	[p16l314t2616r409b2660],
309	95	CD	PERCENT	95	dep	319	SENT_208	[p16l314t2616r409b2660],
310	%	NN	PERCENT	%	dep	319	SENT_208	[p16l314t2616r409b2660],
311	Cl	NN	O	cl	dep	319	SENT_208	[p16l422t2616r489b2660],
312	)	CD	NUMBER	)	dep	319	SENT_208	[p16l422t2616r489b2660],
313	*	CD	NUMBER	*	dep	319	SENT_208	[p16l422t2616r489b2660],
314	1-0	CD	NUMBER	1-0	dep	319	SENT_208	[p16l1007t2619r1062b2650],
315	3-31	CD	NUMBER	3-31	dep	319	SENT_208	[p16l1455t2619r1532b2656],
316	(	NN	O	(	dep	319	SENT_208	[p16l1546t2616r1780b2660],
317	1-05-10-47	CD	DATE	1-05-10-47	dep	319	SENT_208	[p16l1546t2616r1780b2660],
318	)	CD	NUMBER	)	dep	319	SENT_208	[p16l1546t2616r1780b2660],
319	0-04	CD	NUMBER	0-04	_	0	SENT_208	[p16l1868t2619r1954b2655],

1	HR	NN	DURATION	hr	_	0	SENT_209	[p16l52t2732r239b2766],
2	=	JJ	O	=	amod	4	SENT_209	[p16l52t2732r239b2766],
3	hazard	NN	O	hazard	nn	4	SENT_209	[p16l52t2732r239b2766],
4	ratio	NN	O	ratio	dep	1	SENT_209	[p16l252t2735r339b2766],
5	.	.	O	.	_	0	SENT_209	[p16l252t2735r339b2766],

1	*	NN	O	*	_	0	SENT_210	[p16l352t2732r526b2776],
2	Adjusted	VBN	O	adjust	rcmod	1	SENT_210	[p16l352t2732r526b2776],
3	for	IN	O	for	_	0	SENT_210	[p16l535t2732r586b2766],
4	baseline	NN	O	baseline	nn	5	SENT_210	[p16l597t2732r736b2766],
5	body	NN	O	body	prep_for	2	SENT_210	[p16l748t2732r937b2776],
6	—	CD	NUMBER	—	num	8	SENT_210	[p16l748t2732r937b2776],
7	mass	NN	O	mass	nn	8	SENT_210	[p16l748t2732r937b2776],
8	index	NN	O	index	dobj	2	SENT_210	[p16l949t2732r1051b2772],
9	,	,	O	,	_	0	SENT_210	[p16l949t2732r1051b2772],
10	smoking	NN	O	smoking	nn	11	SENT_210	[p16l1063t2732r1211b2776],
11	status	NN	O	status	appos	8	SENT_210	[p16l1224t2738r1337b2772],
12	,	,	O	,	_	0	SENT_210	[p16l1224t2738r1337b2772],
13	diabetes	NN	O	diabetes	nn	14	SENT_210	[p16l1348t2732r1493b2766],
14	status	NN	O	status	appos	8	SENT_210	[p16l1504t2738r1617b2772],
15	,	,	O	,	_	0	SENT_210	[p16l1504t2738r1617b2772],
16	stent	NN	O	stent	nn	17	SENT_210	[p16l1629t2738r1718b2766],
17	implantation	NN	O	implantation	appos	8	SENT_210	[p16l1730t2732r1965b2776],
18	,	,	O	,	_	0	SENT_210	[p16l1730t2732r1965b2776],
19	initial	JJ	O	initial	amod	21	SENT_210	[p16l1979t2732r2073b2766],
20	ST	JJ	O	st	amod	21	SENT_210	[p16l50t2792r266b2826],
21	—	NN	O	—	appos	8	SENT_210	[p16l50t2792r266b2826],
22	e	SYM	O	e	dep	8	SENT_210	[p16l50t2792r266b2826],
23	|	SYM	O	|	dep	24	SENT_210	[p16l50t2792r266b2826],
24	evation	NN	O	evation	dep	1	SENT_210	[p16l50t2792r266b2826],
25	myocardial	JJ	O	myocardial	amod	26	SENT_210	[p16l280t2792r467b2836],
26	infarction	NN	O	infarction	dep	24	SENT_210	[p16l481t2792r657b2831],
27	,	,	O	,	_	0	SENT_210	[p16l481t2792r657b2831],
28	and	CC	O	and	dep	26	SENT_210	[p16l669t2792r734b2826],
29	use	NN	O	use	dep	26	SENT_210	[p16l745t2803r800b2826],
30	of	IN	O	of	dep	29	SENT_210	[p16l811t2792r848b2826],
31	proton	NN	O	proton	nn	34	SENT_210	[p16l856t2798r1095b2836],
32	—	CD	NUMBER	—	num	34	SENT_210	[p16l856t2798r1095b2836],
33	pump	NN	O	pump	nn	34	SENT_210	[p16l856t2798r1095b2836],
34	inhibitors	NNS	O	inhibitor	pobj	30	SENT_210	[p16l1108t2792r1282b2826],
35	.	.	O	.	_	0	SENT_210	[p16l1108t2792r1282b2826],

1	All	PDT	O	all	predet	3	SENT_211	[p16l1293t2792r1335b2825],
2	these	DT	O	these	det	3	SENT_211	[p16l1345t2792r1439b2826],
3	variables	NNS	O	variable	nsubjpass	5	SENT_211	[p16l1449t2792r1601b2826],
4	were	VBD	O	be	auxpass	5	SENT_211	[p16l1610t2803r1694b2826],
5	chosen	VBN	O	choose	_	0	SENT_211	[p16l1705t2792r1825b2826],
6	because	IN	O	because	_	0	SENT_211	[p16l1838t2792r1974b2826],
7	of	IN	O	of	_	0	SENT_211	[p16l1985t2792r2022b2826],
8	their	PRP$	O	they	poss	10	SENT_211	[p16l2028t2792r2110b2826],
9	established	JJ	O	established	amod	10	SENT_211	[p16l50t2852r245b2885],
10	association	NN	O	association	prep_because_of	5	SENT_211	[p16l255t2855r448b2885],
11	with	IN	O	with	_	0	SENT_211	[p16l458t2852r535b2885],
12	recurrent	JJ	O	recurrent	amod	15	SENT_211	[p16l550t2858r707b2885],
13	acute	JJ	O	acute	amod	15	SENT_211	[p16l717t2858r811b2885],
14	coronary	JJ	O	coronary	amod	15	SENT_211	[p16l821t2863r975b2895],
15	events	NNS	O	event	prep_with	10	SENT_211	[p16l985t2858r1098b2885],
16	or	CC	O	or	_	0	SENT_211	[p16l1108t2863r1144b2885],
17	poor	JJ	O	poor	amod	18	SENT_211	[p16l1153t2863r1235b2895],
18	response	NN	O	response	prep_with	10	SENT_211	[p16l1247t2863r1399b2895],
19	to	TO	O	to	_	0	SENT_211	[p16l1408t2858r1445b2885],
20	clopidog	NN	O	clopidog	nn	21	SENT_211	[p16l1456t2852r1604b2896],
21	rel	NN	O	rel	prep_to	5	SENT_211	[p16l1610t2852r1658b2885],
22	.	.	O	.	_	0	SENT_211	[p16l1610t2852r1658b2885],

1	tNon	NN	O	tnon	nsubj	2	SENT_212	[p16l1671t2852r1945b2888],
2	—	CD	NUMBER	—	_	0	SENT_212	[p16l1671t2852r1945b2888],
3	eva	NN	O	eva	nn	4	SENT_212	[p16l1671t2852r1945b2888],
4	|	NN	O	|	dobj	2	SENT_212	[p16l1671t2852r1945b2888],
5	uab	NN	O	uab	nn	6	SENT_212	[p16l1671t2852r1945b2888],
6	|	NN	O	|	dep	4	SENT_212	[p16l1671t2852r1945b2888],
7	e	SYM	O	e	dep	4	SENT_212	[p16l1671t2852r1945b2888],
8	because	IN	O	because	_	0	SENT_212	[p16l1957t2852r2092b2885],
9	ofthe	JJ	O	ofthe	amod	11	SENT_212	[p16l50t2911r150b2945],
10	small	JJ	O	small	amod	11	SENT_212	[p16l161t2911r250b2945],
11	number	NN	O	number	prep_because	2	SENT_212	[p16l264t2912r400b2945],
12	of	IN	O	of	_	0	SENT_212	[p16l409t2911r446b2945],
13	deaths	NNS	O	death	prep_of	11	SENT_212	[p16l454t2912r578b2945],
14	.	.	O	.	_	0	SENT_212	[p16l454t2912r578b2945],

1	iAna	NNP	O	iAna	nsubj	18	SENT_213	[p16l591t2912r751b2955],
2	|	CD	NUMBER	|	num	3	SENT_213	[p16l591t2912r751b2955],
3	ysis	NN	O	ysis	nsubjpass	5	SENT_213	[p16l591t2912r751b2955],
4	was	VBD	O	be	auxpass	5	SENT_213	[p16l760t2923r827b2945],
5	undertaken	VBN	O	undertake	rcmod	1	SENT_213	[p16l838t2911r1034b2945],
6	in	IN	O	in	_	0	SENT_213	[p16l1048t2915r1077b2945],
7	the	DT	O	the	det	9	SENT_213	[p16l1087t2912r1144b2945],
8	223	CD	NUMBER	223	num	9	SENT_213	[p16l1156t2916r1218b2950],
9	patients	NNS	O	patient	prep_in	5	SENT_213	[p16l1230t2915r1372b2955],
10	(	IN	O	(	_	0	SENT_213	[p16l1384t2911r1461b2954],
11	162	CD	NUMBER	162	num	14	SENT_213	[p16l1384t2911r1461b2954],
12	non	JJ	O	non	amod	14	SENT_213	[p16l1475t2914r1691b2951],
13	—	NN	O	—	nn	14	SENT_213	[p16l1475t2914r1691b2951],
14	carriers	NNS	O	carrier	prep_(	5	SENT_213	[p16l1475t2914r1691b2951],
15	,	,	O	,	_	0	SENT_213	[p16l1475t2914r1691b2951],
16	61	CD	NUMBER	61	num	17	SENT_213	[p16l1704t2911r1746b2945],
17	carriers	NNS	O	carrier	appos	14	SENT_213	[p16l1757t2913r1894b2954],
18	)	VBP	O	)	_	0	SENT_213	[p16l1757t2913r1894b2954],
19	with	IN	O	with	_	0	SENT_213	[p16l1904t2911r1982b2945],
20	stent	NN	O	stent	nn	21	SENT_213	[p16l1994t2918r2083b2945],
21	implantation	NN	O	implantation	prep_with	18	SENT_213	[p16l51t2971r286b3015],
22	.	.	O	.	_	0	SENT_213	[p16l51t2971r286b3015],

1	§	RB	O	§	advmod	2	SENT_214	[p16l300t2971r423b3011],
2	Refers	VBZ	O	refer	_	0	SENT_214	[p16l300t2971r423b3011],
3	to	TO	O	to	_	0	SENT_214	[p16l431t2978r468b3005],
4	acute	JJ	O	acute	prep_to	2	SENT_214	[p16l479t2978r572b3005],
5	coronary	JJ	O	coronary	amod	6	SENT_214	[p16l584t2983r737b3015],
6	events	NNS	O	event	nsubj	2	SENT_214	[p16l747t2978r860b3005],
7	occurring	VBG	O	occur	partmod	6	SENT_214	[p16l870t2974r1031b3016],
8	either	CC	O	either	dep	7	SENT_214	[p16l1044t2971r1145b3005],
9	in	IN	O	in	_	0	SENT_214	[p16l1157t2974r1185b3005],
10	patients	NNS	O	patient	prep_in	7	SENT_214	[p16l1197t2974r1339b3015],
11	who	WP	O	who	nsubj	13	SENT_214	[p16l1348t2971r1424b3005],
12	never	RB	O	never	neg	13	SENT_214	[p16l1437t2983r1532b3005],
13	received	VBD	O	receive	rcmod	10	SENT_214	[p16l1544t2971r1684b3005],
14	a	DT	O	a	det	15	SENT_214	[p16l1695t2983r1713b3005],
15	stent	NN	O	stent	dobj	13	SENT_214	[p16l1724t2978r1812b3005],
16	before	IN	O	before	_	0	SENT_214	[p16l1824t2971r1934b3005],
17	or	CC	O	or	_	0	SENT_214	[p16l1944t2983r1980b3005],
18	in	IN	O	in	_	0	SENT_214	[p16l1991t2974r2020b3005],
19	those	DT	O	those	prep_in	13	SENT_214	[p16l48t3031r146b3065],
20	with	IN	O	with	_	0	SENT_214	[p16l155t3031r232b3065],
21	stents	NNS	O	stent	prep_with	13	SENT_214	[p16l244t3037r349b3065],
22	in	IN	O	in	_	0	SENT_214	[p16l362t3034r390b3065],
23	whom	WP	O	whom	rel	27	SENT_214	[p16l401t3031r512b3065],
24	the	DT	O	the	det	26	SENT_214	[p16l522t3031r579b3065],
25	recurrent	JJ	O	recurrent	amod	26	SENT_214	[p16l592t3037r749b3065],
26	event	NN	O	event	nsubj	27	SENT_214	[p16l760t3037r857b3065],
27	occurred	VBD	O	occur	rcmod	6	SENT_214	[p16l867t3031r1016b3065],
28	in	IN	O	in	mark	32	SENT_214	[p16l1028t3034r1056b3065],
29	a	DT	O	a	det	31	SENT_214	[p16l1069t3043r1087b3065],
30	non	JJ	O	non	amod	31	SENT_214	[p16l1100t3031r1314b3065],
31	—	NN	O	—	nsubj	32	SENT_214	[p16l1100t3031r1314b3065],
32	stented	VBD	O	stent	advcl	27	SENT_214	[p16l1100t3031r1314b3065],
33	artery	NN	O	artery	dobj	32	SENT_214	[p16l1325t3037r1432b3075],
34	.	.	O	.	_	0	SENT_214	[p16l1325t3037r1432b3075],

1	Table	NNP	O	Table	dep	105	SENT_215	[p16l50t3142r149b3178],
2	2	CD	NUMBER	2	dep	105	SENT_215	[p16l158t3147r192b3178],
3	:	:	O	:	_	0	SENT_215	[p16l158t3147r192b3178],
4	Main	NNP	O	Main	dep	105	SENT_215	[p16l205t3144r303b3178],
5	effects	NNS	O	effect	dep	105	SENT_215	[p16l315t3142r445b3178],
6	of	IN	O	of	dep	105	SENT_215	[p16l456t3142r498b3178],
7	CYP2C19	NN	O	cyp2c19	dep	105	SENT_215	[p16l508t3144r725b3183],
8	*	NN	O	*	dep	105	SENT_215	[p16l508t3144r725b3183],
9	2	CD	NUMBER	2	dep	105	SENT_215	[p16l508t3144r725b3183],
10	gene	NN	O	gene	dep	105	SENT_215	[p16l738t3154r833b3190],
11	variant	NN	O	variant	dep	105	SENT_215	[p16l843t3144r986b3178],
12	on	IN	O	on	dep	105	SENT_215	[p16l996t3154r1045b3178],
13	cardiovascular	JJ	O	cardiovascular	dep	105	SENT_215	[p16l1058t3142r1341b3178],
14	outcomes	NNS	O	outcome	dep	105	SENT_215	[p16l1351t3148r1546b3178],
15	carriers	NNS	O	carrier	dep	105	SENT_215	[p16l9t3323r204b3367],
16	and	CC	O	and	dep	105	SENT_215	[p16l241t3319r338b3367],
17	non-carriers	NNS	O	non-carrier	dep	105	SENT_215	[p16l372t3323r689b3367],
18	of	IN	O	of	dep	105	SENT_215	[p16l727t3319r785b3367],
19	the	DT	O	the	dep	105	SENT_215	[p16l809t3319r891b3367],
20	CYP2C19	NN	O	cyp2c19	dep	105	SENT_215	[p16l931t3323r1238b3367],
21	"	''	O	"	dep	105	SENT_215	[p16l931t3323r1238b3367],
22	'	''	O	'	_	0	SENT_215	[p16l931t3323r1238b3367],
23	~	FW	O	~	dep	105	SENT_215	[p16l931t3323r1238b3367],
24	’	FW	O	’	dep	105	SENT_215	[p16l931t3323r1238b3367],
25	2	CD	NUMBER	2	dep	105	SENT_215	[p16l931t3323r1238b3367],
26	allele	NN	O	allele	dep	105	SENT_215	[p16l1271t3319r1404b3367],
27	for	IN	O	for	dep	105	SENT_215	[p16l1439t3319r1514b3367],
28	plasma	NN	O	plasma	dep	105	SENT_215	[p17l8t21r196b83],
29	concentrations	NNS	O	concentration	dep	105	SENT_215	[p17l218t24r603b69],
30	of	IN	O	of	dep	105	SENT_215	[p17l627t21r685b69],
31	ﬁbrinogen	NN	O	ﬁbrinogen	dep	105	SENT_215	[p17l697t21r972b84],
32	(	CD	NUMBER	(	dep	105	SENT_215	[p17l997t26r1102b84],
33	3-4	CD	NUMBER	3-4	dep	105	SENT_215	[p17l997t26r1102b84],
34	g	NN	O	g	dep	105	SENT_215	[p17l1121t26r1174b84],
35	/	:	O	/	dep	105	SENT_215	[p17l1121t26r1174b84],
36	L	NN	O	l	dep	105	SENT_215	[p17l1181t26r1210b68],
37	vs	CC	O	vs	dep	105	SENT_215	[p17l1230t38r1277b68],
38	3	LS	NUMBER	3	dep	105	SENT_215	[p17l1299t26r1345b69],
39	-	:	O	-	_	0	SENT_215	[p17l1299t26r1345b69],
40	3	CD	DATE	3	dep	105	SENT_215	[p17l1361t26r1384b69],
41	g	NN	O	g	dep	105	SENT_215	[p17l1409t26r1462b84],
42	/	:	O	/	dep	105	SENT_215	[p17l1409t26r1462b84],
43	L	NN	O	l	dep	105	SENT_215	[p17l1468t26r1510b76],
44	;	:	O	;	_	0	SENT_215	[p17l1468t26r1510b76],
45	p	NN	O	p	dep	105	SENT_215	[p17l8t102r228b162],
46	=	JJ	O	=	dep	105	SENT_215	[p17l8t102r228b162],
47	0-49	CD	NUMBER	0-49	dep	105	SENT_215	[p17l8t102r228b162],
48	)	NN	O	)	dep	105	SENT_215	[p17l8t102r228b162],
49	,	,	O	,	_	0	SENT_215	[p17l8t102r228b162],
50	PAI-1	NN	O	pai-1	dep	105	SENT_215	[p17l274t102r415b145],
51	(	CD	NUMBER	(	dep	105	SENT_215	[p17l461t101r595b162],
52	39-5	CD	NUMBER	39-5	dep	105	SENT_215	[p17l461t101r595b162],
53	ng/mL	NN	O	ng/ml	dep	105	SENT_215	[p17l639t103r821b162],
54	vs	CC	O	vs	dep	105	SENT_215	[p17l862t115r908b146],
55	38-6	CD	NUMBER	38-6	dep	105	SENT_215	[p17l951t102r1068b146],
56	ng/L	NN	O	ng/l	dep	105	SENT_215	[p17l1111t103r1249b162],
57	,	,	O	,	_	0	SENT_215	[p17l1111t103r1249b162],
58	p	NN	O	p	dep	105	SENT_215	[p17l1293t101r1510b162],
59	=	JJ	O	=	dep	105	SENT_215	[p17l1293t101r1510b162],
60	O-51	NN	O	o-51	dep	105	SENT_215	[p17l1293t101r1510b162],
61	)	NN	O	)	dep	105	SENT_215	[p17l1293t101r1510b162],
62	,	,	O	,	_	0	SENT_215	[p17l1293t101r1510b162],
63	D-dimers	JJ	O	d-dimers	dep	105	SENT_215	[p17l11t175r254b223],
64	(	NN	O	(	dep	105	SENT_215	[p17l302t178r406b238],
65	307	CD	NUMBER	307	dep	105	SENT_215	[p17l302t178r406b238],
66	ng/mL	NN	O	ng/ml	dep	105	SENT_215	[p17l447t179r630b238],
67	vs	CC	O	vs	dep	105	SENT_215	[p17l671t192r717b223],
68	303	CD	NUMBER	303	dep	105	SENT_215	[p17l761t179r848b223],
69	ng/mL	NN	O	ng/ml	dep	105	SENT_215	[p17l893t179r1088b238],
70	,	,	O	,	_	0	SENT_215	[p17l893t179r1088b238],
71	p	NN	O	p	dep	105	SENT_215	[p17l1132t179r1355b238],
72	=	JJ	O	=	dep	105	SENT_215	[p17l1132t179r1355b238],
73	O-82	NN	O	o-82	dep	105	SENT_215	[p17l1132t179r1355b238],
74	)	NN	O	)	dep	105	SENT_215	[p17l1132t179r1355b238],
75	,	,	O	,	_	0	SENT_215	[p17l1132t179r1355b238],
76	total	JJ	O	total	dep	105	SENT_215	[p17l1399t175r1513b223],
77	cholesterol	NN	O	cholesterol	dep	105	SENT_215	[p17l9t251r292b299],
78	(	CD	NUMBER	(	dep	105	SENT_215	[p17l357t254r483b314],
79	1-78	CD	NUMBER	1-78	dep	105	SENT_215	[p17l357t254r483b314],
80	g/L	NN	O	g/l	dep	105	SENT_215	[p17l546t256r634b314],
81	vs	CC	O	vs	dep	105	SENT_215	[p17l694t268r740b298],
82	1-77	CD	NUMBER	1-77	dep	105	SENT_215	[p17l802t254r908b301],
83	g/L	NN	O	g/l	dep	105	SENT_215	[p17l968t256r1070b314],
84	,	,	O	,	_	0	SENT_215	[p17l968t256r1070b314],
85	p	NN	O	p	dep	105	SENT_215	[p17l1133t255r1353b314],
86	=	JJ	O	=	dep	105	SENT_215	[p17l1133t255r1353b314],
87	0-49	CD	NUMBER	0-49	dep	105	SENT_215	[p17l1133t255r1353b314],
88	)	NN	O	)	dep	105	SENT_215	[p17l1133t255r1353b314],
89	,	,	O	,	_	0	SENT_215	[p17l1133t255r1353b314],
90	and	CC	O	and	dep	105	SENT_215	[p17l1417t251r1514b299],
91	LDL-cholesterol	NN	O	ldl-cholesterol	dep	105	SENT_215	[p17l11t328r423b375],
92	(	CD	NUMBER	(	dep	105	SENT_215	[p17l448t332r641b391],
93	0-99g	JJ	O	0-99g	dep	105	SENT_215	[p17l448t332r641b391],
94	/	:	O	/	dep	105	SENT_215	[p17l448t332r641b391],
95	L	NN	O	l	dep	105	SENT_215	[p17l647t333r677b375],
96	vs	CC	O	vs	dep	105	SENT_215	[p17l697t345r743b375],
97	1-02	CD	NUMBER	1-02	dep	105	SENT_215	[p17l764t332r877b375],
98	g	NN	O	g	dep	105	SENT_215	[p17l900t333r953b391],
99	/	:	O	/	dep	105	SENT_215	[p17l900t333r953b391],
100	L	NN	O	l	dep	105	SENT_215	[p17l960t333r1001b383],
101	,	,	O	,	_	0	SENT_215	[p17l960t333r1001b383],
102	p	NN	O	p	dep	105	SENT_215	[p17l1024t331r1242b391],
103	=	JJ	O	=	dep	105	SENT_215	[p17l1024t331r1242b391],
104	O-97	NN	O	o-97	dep	105	SENT_215	[p17l1024t331r1242b391],
105	)	NN	O	)	_	0	SENT_215	[p17l1024t331r1242b391],
106	.	.	O	.	_	0	SENT_215	[p17l1024t331r1242b391],

1	Similarly	RB	O	similarly	advmod	13	SENT_216	[p17l1270t328r1511b390],
2	,	,	O	,	_	0	SENT_216	[p17l1270t328r1511b390],
3	differences	NNS	O	difference	nsubj	13	SENT_216	[p17l9t403r295b452],
4	between	IN	O	between	_	0	SENT_216	[p17l328t403r546b452],
5	patients	NNS	O	patient	conj_or	5	SENT_216	[p17l577t406r783b466],
6	with	IN	O	with	_	0	SENT_216	[p17l815t403r931b452],
7	or	CC	O	or	_	0	SENT_216	[p17l963t421r1017b452],
8	without	IN	O	without	_	0	SENT_216	[p17l1046t403r1249b452],
9	an	DT	O	a	det	10	SENT_216	[p17l1280t421r1343b452],
10	event	NN	O	event	prep_with	5	SENT_216	[p17l1375t413r1514b452],
11	were	VBD	O	be	cop	13	SENT_216	[p17l7t497r131b528],
12	not	RB	O	not	neg	13	SENT_216	[p17l186t490r272b528],
13	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_216	[p17l326t480r600b543],
14	for	IN	O	for	_	0	SENT_216	[p17l653t480r728b528],
15	plasma	NN	O	plasma	nn	16	SENT_216	[p17l780t480r968b542],
16	concentrations	NNS	O	concentration	prep_for	13	SENT_216	[p17l1022t483r1407b528],
17	of	IN	O	of	_	0	SENT_216	[p17l1463t480r1522b528],
18	ﬁbrinogen	NN	O	ﬁbrinogen	amod	83	SENT_216	[p17l8t557r283b620],
19	(	CD	NUMBER	(	num	18	SENT_216	[p17l299t561r402b620],
20	3-3	CD	NUMBER	3-3	num	21	SENT_216	[p17l299t561r402b620],
21	g/Lvs	NNS	O	g/lvs	dep	18	SENT_216	[p17l418t562r565b620],
22	3-3	CD	NUMBER	3-3	num	23	SENT_216	[p17l579t561r663b604],
23	g/L	NN	O	g/l	dep	21	SENT_216	[p17l679t560r1013b620],
24	,	,	O	,	_	0	SENT_216	[p17l679t560r1013b620],
25	p	NN	O	p	appos	21	SENT_216	[p17l679t560r1013b620],
26	=	JJ	O	=	amod	25	SENT_216	[p17l679t560r1013b620],
27	0-72	CD	NUMBER	0-72	num	28	SENT_216	[p17l679t560r1013b620],
28	)	NN	O	)	tmod	26	SENT_216	[p17l679t560r1013b620],
29	,	,	O	,	_	0	SENT_216	[p17l679t560r1013b620],
30	PAI-1	NN	O	pai-1	npadvmod	32	SENT_216	[p17l1031t560r1514b620],
31	(	CD	NUMBER	(	num	30	SENT_216	[p17l1031t560r1514b620],
32	44-8ng	JJ	O	44-8ng	amod	28	SENT_216	[p17l1031t560r1514b620],
33	/	:	O	/	punct	45	SENT_216	[p17l1031t560r1514b620],
34	mL	NN	O	ml	nsubj	45	SENT_216	[p17l1031t560r1514b620],
35	vs	CC	O	vs	_	0	SENT_216	[p17l8t649r54b680],
36	38-9	CD	NUMBER	38-9	num	37	SENT_216	[p17l80t637r198b680],
37	ng/L	NN	O	ng/l	nsubj	45	SENT_216	[p17l223t637r361b695],
38	,	,	O	,	_	0	SENT_216	[p17l223t637r361b695],
39	p	NN	O	p	appos	37	SENT_216	[p17l388t637r610b695],
40	=	JJ	O	=	amod	42	SENT_216	[p17l388t637r610b695],
41	O-38	NN	O	o-38	nn	42	SENT_216	[p17l388t637r610b695],
42	)	NN	O	)	dep	39	SENT_216	[p17l388t637r610b695],
43	,	,	O	,	_	0	SENT_216	[p17l388t637r610b695],
44	D-dimers	NNS	O	d-dimer	conj_vs	34	SENT_216	[p17l640t632r883b680],
45	(	VBP	O	(	dep	25	SENT_216	[p17l912t635r1072b695],
46	251-7	CD	NUMBER	251-7	num	47	SENT_216	[p17l912t635r1072b695],
47	ng/mL	NN	O	ng/ml	dobj	45	SENT_216	[p17l1095t637r1276b695],
48	vs	CC	O	vs	_	0	SENT_216	[p17l1299t649r1346b680],
49	313-4	CD	NUMBER	313-4	num	50	SENT_216	[p17l1371t637r1516b680],
50	ng/mL	NN	O	ng/ml	dobj	45	SENT_216	[p17l8t713r202b771],
51	,	,	O	,	_	0	SENT_216	[p17l8t713r202b771],
52	p	NN	O	p	dep	45	SENT_216	[p17l231t711r446b771],
53	=	JJ	O	=	amod	55	SENT_216	[p17l231t711r446b771],
54	0-47	CD	NUMBER	0-47	tmod	53	SENT_216	[p17l231t711r446b771],
55	)	NN	O	)	dep	52	SENT_216	[p17l231t711r446b771],
56	,	,	O	,	_	0	SENT_216	[p17l231t711r446b771],
57	total	JJ	O	total	amod	58	SENT_216	[p17l474t708r587b756],
58	cholesterol	NN	O	cholesterol	conj_and	52	SENT_216	[p17l614t708r897b756],
59	(	CD	NUMBER	(	num	61	SENT_216	[p17l927t712r1058b771],
60	1-98	CD	NUMBER	1-98	num	61	SENT_216	[p17l927t712r1058b771],
61	g/L	NN	O	g/l	dep	58	SENT_216	[p17l1086t713r1175b771],
62	vs	CC	O	vs	_	0	SENT_216	[p17l1200t725r1246b755],
63	1-75	CD	NUMBER	1-75	num	64	SENT_216	[p17l1272t711r1379b758],
64	g/L	NN	O	g/l	conj_vs	58	SENT_216	[p17l1409t713r1510b771],
65	,	,	O	,	_	0	SENT_216	[p17l1409t713r1510b771],
66	p	NN	O	p	appos	64	SENT_216	[p17l8t789r231b848],
67	=	JJ	O	=	amod	69	SENT_216	[p17l8t789r231b848],
68	0-22	CD	NUMBER	0-22	tmod	67	SENT_216	[p17l8t789r231b848],
69	)	NN	O	)	dep	66	SENT_216	[p17l8t789r231b848],
70	,	,	O	,	_	0	SENT_216	[p17l8t789r231b848],
71	and	CC	O	and	_	0	SENT_216	[p17l274t785r371b832],
72	LDL-cholesterol	NN	O	ldl-cholesterol	conj_and	52	SENT_216	[p17l412t785r824b832],
73	(	CD	NUMBER	(	num	72	SENT_216	[p17l868t789r998b848],
74	1-20	CD	NUMBER	1-20	num	75	SENT_216	[p17l868t789r998b848],
75	g/L	NN	O	g/l	dep	72	SENT_216	[p17l1039t790r1128b848],
76	vs	CC	O	vs	_	0	SENT_216	[p17l1167t802r1213b832],
77	0-97	CD	NUMBER	0-97	num	78	SENT_216	[p17l1252t788r1370b834],
78	g/L	NN	O	g/l	appos	21	SENT_216	[p17l1409t790r1510b848],
79	,	,	O	,	_	0	SENT_216	[p17l1409t790r1510b848],
80	p	NN	O	p	appos	78	SENT_216	[p17l8t865r225b924],
81	=	JJ	O	=	amod	80	SENT_216	[p17l8t865r225b924],
82	0-10	CD	NUMBER	0-10	tmod	81	SENT_216	[p17l8t865r225b924],
83	)	NN	O	)	prep_of	16	SENT_216	[p17l8t865r225b924],
84	.	.	O	.	_	0	SENT_216	[p17l8t865r225b924],

1	After	IN	O	after	dep	10	SENT_217	[p17l57t936r191b985],
2	multivariable	JJ	O	multivariable	amod	6	SENT_217	[p17l220t937r570b985],
3	stepwise	JJ	O	stepwise	amod	6	SENT_217	[p17l602t940r824b999],
4	Cox	NN	O	cox	nn	6	SENT_217	[p17l857t940r954b985],
5	regression	NN	O	regression	nn	6	SENT_217	[p17l982t940r1258b1000],
6	analysis	NN	O	analysis	pobj	1	SENT_217	[p17l1289t937r1510b1000],
7	,	,	O	,	_	0	SENT_217	[p17l1289t937r1510b1000],
8	the	DT	O	the	det	10	SENT_217	[p17l7t1014r89b1061],
9	C	NN	O	c	nn	10	SENT_217	[p17l127t1017r165b1061],
10	YP2C19	NN	O	yp2c19	_	0	SENT_217	[p17l170t1017r436b1062],
11	"	''	O	"	punct	10	SENT_217	[p17l170t1017r436b1062],
12	"	``	O	"	punct	19	SENT_217	[p17l170t1017r436b1062],
13	2	CD	NUMBER	2	num	15	SENT_217	[p17l170t1017r436b1062],
14	Variant	JJ	O	variant	amod	15	SENT_217	[p17l464t1017r648b1061],
15	allele	NN	O	allele	nsubj	19	SENT_217	[p17l679t1014r814b1061],
16	was	VBD	O	be	cop	19	SENT_217	[p17l845t1031r943b1061],
17	the	DT	O	the	det	19	SENT_217	[p17l976t1014r1058b1061],
18	only	JJ	O	only	amod	19	SENT_217	[p17l1092t1014r1204b1076],
19	signiﬁcant	NN	O	signiﬁcant	rcmod	10	SENT_217	[p17l1236t1014r1514b1077],

1	I	PRP	O	I	_	0	SENT_218	[p17l6t1315r54b1514],
2	Articles	NNPS	O	Articles	dep	1	SENT_218	[p17l101t1478r251b1514],

1	23	CD	NUMBER	23	num	2	SENT_219	[p18l263t317r302b358],
2	0	CD	NUMBER	0	_	0	SENT_219	[p18l325t316r378b349],
3	'	''	O	'	_	0	SENT_219	[p18l325t316r378b349],
4	9	CD	NUMBER	9	dep	2	SENT_219	[p18l325t316r378b349],
5	______________	CD	NUMBER	______________	num	8	SENT_219	[p18l745t352r999b364],
6	__	NN	O	__	nn	8	SENT_219	[p18l1009t360r1038b364],
7	E	NN	O	e	nn	8	SENT_219	[p18l261t385r293b440],
8	o-8	NN	O	o-8	nsubj	11	SENT_219	[p18l325t408r378b441],
9	_____________	CD	NUMBER	_____________	num	10	SENT_219	[p18l1034t393r1311b442],
10	__	CD	NUMBER	__	dep	8	SENT_219	[p18l1320t438r1350b442],
11	E	NN	O	e	rcmod	2	SENT_219	[p18l272t443r293b474],
12	3	CD	NUMBER	3	dobj	11	SENT_219	[p18l272t479r293b515],
13	"	``	O	"	punct	12	SENT_219	[p18l1356t480r1658b484],
14	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
15	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
16	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
17	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
18	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
19	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
20	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
21	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
22	"	``	O	"	punct	24	SENT_219	[p18l1356t480r1658b484],
23	"	``	O	"	punct	24	SENT_219	[p18l1667t481r1694b487],
24	E	NN	O	e	dep	12	SENT_219	[p18l272t526r293b575],
25	0-7	CD	NUMBER	0-7	dep	24	SENT_219	[p18l328t510r380b543],
26	_________________	CD	NUMBER	_________________	tmod	24	SENT_219	[p18l1693t553r2014b557],
27	__	NN	O	__	prep	24	SENT_219	[p18l2023t553r2045b557],
28	‘	CD	NUMBER	‘	num	29	SENT_219	[p18l260t577r293b592, p18l267t594r293b651],
29	4g	NN	O	4g	dep	27	SENT_219	[p18l260t577r293b592, p18l267t594r293b651],
30	06	CD	DURATION	06	tmod	24	SENT_219	[p18l325t602r378b636],
31	HR	NN	DURATION	hr	prep	24	SENT_219	[p18l1526t602r1674b641],
32	=	JJ	O	=	amod	33	SENT_219	[p18l1526t602r1674b641],
33	3-69	CD	PERCENT	3-69	dep	31	SENT_219	[p18l1526t602r1674b641],
34	(	CD	PERCENT	(	tmod	24	SENT_219	[p18l1687t604r1774b645],
35	95	CD	PERCENT	95	num	36	SENT_219	[p18l1687t604r1774b645],
36	%	NN	PERCENT	%	dep	37	SENT_219	[p18l1687t604r1774b645],
37	CI	NN	O	ci	prep	24	SENT_219	[p18l1787t605r1815b636],
38	1-69-8-05	CD	NUMBER	1-69-8-05	number	39	SENT_219	[p18l1828t602r2014b645],
39	)	CD	NUMBER	)	num	40	SENT_219	[p18l1828t602r2014b645],
40	OJ	NN	ORGANIZATION	oj	npadvmod	41	SENT_219	[p18l272t656r293b673],
41	>	JJR	O	>	dep	37	SENT_219	[p18l272t674r293b694],
42	=	JJ	O	=	tmod	24	SENT_219	[p18l1871t674r1993b703],
43	o-ooo	NN	O	o-ooo	prep	24	SENT_219	[p18l1871t674r1993b703],
44	$	$	MONEY	$	dep	43	SENT_219	[p18l272t696r293b741],
45	0-5	CD	MONEY	0-5	num	44	SENT_219	[p18l327t704r378b738],
46	P	NN	O	p	dep	24	SENT_219	[p18l1848t681r1868b713],
47	5	CD	NUMBER	5	tmod	24	SENT_219	[p18l1996t674r2014b707],
48	.2	NN	NUMBER	.2	prep	24	SENT_219	[p18l263t743r293b771],
49	4	CD	NUMBER	4	dep	48	SENT_219	[p18l267t774r293b789],
50	-	:	O	-	_	0	SENT_219	[p18l267t774r293b789],
51	‘	CD	NUMBER	‘	num	53	SENT_219	[p18l267t774r293b789],
52	Lg	NN	O	lg	nn	53	SENT_219	[p18l261t790r293b874],
53	CYP219	NN	O	cyp219	dep	24	SENT_219	[p18l456t810r623b846],
54	*	NN	O	*	num	59	SENT_219	[p18l456t810r623b846],
55	2	CD	NUMBER	2	number	54	SENT_219	[p18l456t810r623b846],
56	3	CD	NUMBER	3	number	54	SENT_219	[p18l263t879r293b921],
57	0_1	CD	NUMBER	0_1	number	54	SENT_219	[p18l329t894r379b922],
58	-----	CD	NUMBER	-----	num	59	SENT_219	[p18l459t892r542b896],
59	Carriers	NNS	O	carrier	dep	53	SENT_219	[p18l574t878r701b908],

1	1	LS	NUMBER	1	dep	2	SENT_220	[p18l459t959r541b962],
2	Non	NN	O	non	_	0	SENT_220	[p18l575t944r785b975],
3	—	CD	NUMBER	—	num	4	SENT_220	[p18l575t944r785b975],
4	carriers	NNS	O	carrier	dep	2	SENT_220	[p18l575t944r785b975],

1	O	NN	O	o	_	0	SENT_221	[p18l359t990r379b1019],

1	F	NN	O	f	nn	3	SENT_222	[p18l988t1111r1004b1141],
2	ll	NN	O	ll	nn	3	SENT_222	[p18l1030t1108r1044b1141],
3	—	NN	O	—	_	0	SENT_222	[p18l1102t1128r1113b1131],
4	d	NN	O	d	dep	3	SENT_222	[p18l1170t1108r1190b1141],
5	'	''	O	'	_	0	SENT_222	[p18l1265t1110r1270b1115],

1	Numberat	NN	O	numberat	nn	4	SENT_223	[p18l69t1138r253b1171],
2	risk	NN	O	risk	nn	4	SENT_223	[p18l262t1138r321b1171],
3	o	NN	O	o	nn	4	SENT_223	[p18l1006t1119r1026b1141],
4	ow	NN	O	ow	_	0	SENT_223	[p18l1048t1119r1100b1141],
5	up	IN	O	up	dep	4	SENT_223	[p18l1118t1119r1159b1151],
6	uratron	NN	O	uratron	pobj	5	SENT_223	[p18l1194t1114r1316b1141],
7	(	CD	NUMBER	(	num	8	SENT_223	[p18l1329t1109r1441b1151],
8	years	NNS	NUMBER	year	tmod	6	SENT_223	[p18l1329t1109r1441b1151],
9	)	IN	O	)	dep	4	SENT_223	[p18l1329t1109r1441b1151],

1	Non	JJ	O	non	amod	3	SENT_224	[p18l124t1200r322b1231],
2	—	NN	O	—	nn	3	SENT_224	[p18l124t1200r322b1231],
3	carriers	NNS	O	carrier	dep	12	SENT_224	[p18l124t1200r322b1231],
4	186	CD	NUMBER	186	number	5	SENT_224	[p18l366t1197r429b1231],
5	100	CD	NUMBER	100	num	7	SENT_224	[p18l688t1202r749b1231],
6	68	CD	NUMBER	68	number	7	SENT_224	[p18l1023t1197r1065b1231],
7	50	CD	NUMBER	50	dep	3	SENT_224	[p18l1345t1202r1386b1236],
8	35	CD	NUMBER	35	dep	7	SENT_224	[p18l1665t1202r1704b1236],
9	23	CD	NUMBER	23	num	10	SENT_224	[p18l1986t1202r2025b1236],
10	*	NN	O	*	dep	12	SENT_224	[p18l162t1258r197b1290],
11	2	CD	NUMBER	2	num	12	SENT_224	[p18l162t1258r197b1290],
12	carriers	NNS	O	carrier	dep	18	SENT_224	[p18l208t1260r322b1290],
13	73	CD	NUMBER	73	number	14	SENT_224	[p18l390t1262r429b1295],
14	35	CD	NUMBER	35	dep	12	SENT_224	[p18l709t1262r748b1295],
15	23	CD	NUMBER	23	num	16	SENT_224	[p18l1027t1262r1066b1295],
16	15	CD	NUMBER	15	dep	14	SENT_224	[p18l1348t1262r1385b1295],
17	8	CD	NUMBER	8	num	18	SENT_224	[p18l1685t1257r1704b1290],
18	5	CD	NUMBER	5	_	0	SENT_224	[p18l2007t1262r2025b1295],

1	B	NN	O	b	_	0	SENT_225	[p18l351t1347r377b1386],

1	1	CD	NUMBER	1	_	0	SENT_226	[p18l327t1415r377b1444],
2	'	''	O	'	_	0	SENT_226	[p18l327t1415r377b1444],
3	0	CD	NUMBER	0	nsubj	16	SENT_226	[p18l327t1415r377b1444],
4	--	:	O	--	_	0	SENT_226	[p18l427t1427r1157b1488],
5	:	:	O	:	_	0	SENT_226	[p18l427t1427r1157b1488],
6	a	DT	O	a	dep	7	SENT_226	[p18l427t1427r1157b1488],
7	jg	NN	O	jg	dep	3	SENT_226	[p18l262t1513r302b1568],
8	09	CD	NUMBER	09	dep	7	SENT_226	[p18l323t1512r377b1545],
9	"	``	O	"	punct	16	SENT_226	[p18l582t1495r843b1501],
10	"	``	O	"	punct	16	SENT_226	[p18l582t1495r843b1501],
11	"	``	O	"	punct	16	SENT_226	[p18l582t1495r843b1501],
12	"	``	O	"	punct	16	SENT_226	[p18l582t1495r843b1501],
13	"	``	O	"	punct	16	SENT_226	[p18l582t1495r843b1501],
14	"	``	O	"	punct	16	SENT_226	[p18l582t1495r843b1501],
15	"	``	O	"	punct	16	SENT_226	[p18l582t1495r843b1501],
16	"	``	O	"	rcmod	1	SENT_226	[p18l582t1495r843b1501],
17	'	''	O	'	_	0	SENT_226	[p18l852t1497r885b1537],
18	1	CD	NUMBER	1	number	19	SENT_226	[p18l852t1497r885b1537],
19	_________	CD	NUMBER	_________	num	20	SENT_226	[p18l894t1533r1060b1538],
20	__	NNS	O	__	dep	16	SENT_226	[p18l1069t1534r1098b1537],
21	"	``	O	"	punct	20	SENT_226	[p18l1159t1500r1303b1522],
22	j	NN	O	j	dep	20	SENT_226	[p18l1159t1500r1303b1522],
23	E	NN	O	e	dep	22	SENT_226	[p18l261t1582r293b1636],
24	0.8	CD	NUMBER	0.8	tmod	16	SENT_226	[p18l323t1604r377b1638],
25	.....	NN	O	.....	prep	16	SENT_226	[p18l1100t1581r1492b1631],
26	.....	CD	NUMBER	.....	dep	25	SENT_226	[p18l1100t1581r1492b1631],
27	.....	CD	NUMBER	.....	tmod	16	SENT_226	[p18l1100t1581r1492b1631],
28	....	NN	O	....	prep	16	SENT_226	[p18l1100t1581r1492b1631],
29	2	CD	NUMBER	2	dep	28	SENT_226	[p18l1501t1627r1531b1631, p18l272t1640r293b1670],
30	I	PRP	O	I	dep	16	SENT_226	[p18l1533t1635r1536b1665],
31	3	CD	NUMBER	3	dep	30	SENT_226	[p18l272t1676r293b1711],
32	I	PRP	O	I	nsubj	33	SENT_226	[p18l1533t1674r1536b1704],
33	.....	VBP	O	.....	rcmod	16	SENT_226	[p18l1544t1702r1846b1706],
34	.....	CD	NUMBER	.....	number	35	SENT_226	[p18l1544t1702r1846b1706],
35	.....	CD	NUMBER	.....	dobj	33	SENT_226	[p18l1544t1702r1846b1706],
36	.	.	O	.	_	0	SENT_226	[p18l1544t1702r1846b1706],

1	-	:	O	-	_	0	SENT_227	[p18l1855t1702r1880b1706],
2	.	.	O	.	_	0	SENT_227	[p18l1855t1702r1880b1706],

1	$	$	MONEY	$	dep	15	SENT_228	[p18l272t1722r293b1760],
2	0-7	CD	MONEY	0-7	num	1	SENT_228	[p18l327t1706r378b1739],
3	H	NN	O	h	dep	1	SENT_228	[p18l260t1761r293b1801],
4	;	:	O	;	_	0	SENT_228	[p18l260t1761r293b1801],
5	HR	NN	DURATION	hr	nn	8	SENT_228	[p18l1539t1754r1686b1789],
6	=	JJ	O	=	amod	8	SENT_228	[p18l1539t1754r1686b1789],
7	3-O0	JJ	O	3-o0	amod	8	SENT_228	[p18l1539t1754r1686b1789],
8	(	NN	O	(	dep	3	SENT_228	[p18l1699t1752r1785b1792],
9	95	CD	PERCENT	95	number	10	SENT_228	[p18l1699t1752r1785b1792],
10	%	NN	PERCENT	%	amod	8	SENT_228	[p18l1699t1752r1785b1792],
11	CI	NN	O	ci	dep	15	SENT_228	[p18l1798t1753r1826b1784],
12	127-710	CD	NUMBER	127-710	num	11	SENT_228	[p18l1840t1752r2014b1792],
13	)	CD	NUMBER	)	num	15	SENT_228	[p18l1840t1752r2014b1792],
14	‘	CD	NUMBER	‘	num	15	SENT_228	[p18l267t1813r293b1869],
15	g	NN	O	g	dep	29	SENT_228	[p18l267t1813r293b1869],
16	06	CD	NUMBER	06	num	17	SENT_228	[p18l323t1799r377b1832],
17	p	NN	O	p	dep	15	SENT_228	[p18l1868t1822r2014b1860],
18	=	JJ	O	=	amod	27	SENT_228	[p18l1868t1822r2014b1860],
19	O-O09	NN	O	o-o09	nn	27	SENT_228	[p18l1868t1822r2014b1860],
20	5	CD	NUMBER	5	num	27	SENT_228	[p18l272t1871r293b1909],
21	O	NN	O	o	nn	27	SENT_228	[p18l326t1901r346b1930],
22	2	CD	NUMBER	2	num	27	SENT_228	[p18l263t1921r293b1967],
23	‘	CD	NUMBER	‘	num	27	SENT_228	[p18l350t1901r377b1934],
24	5	CD	NUMBER	5	num	27	SENT_228	[p18l350t1901r377b1934],
25	E	NN	O	e	nn	27	SENT_228	[p18l261t1971r293b2012],
26	D	NN	O	d	nn	27	SENT_228	[p18l272t2017r293b2035],
27	E	NN	O	e	rcmod	17	SENT_228	[p18l272t2040r293b2070],
28	3	CD	NUMBER	3	num	29	SENT_228	[p18l263t2076r293b2118],
29	0.1	CD	NUMBER	0.1	_	0	SENT_228	[p18l327t2090r378b2119],

1	O	NN	O	o	nn	2	SENT_229	[p18l359t2187r379b2215],
2	O	NN	O	o	_	0	SENT_229	[p18l407t2248r427b2277],
3	1	CD	NUMBER	1	number	4	SENT_229	[p18l728t2248r745b2276],
4	2	CD	NUMBER	2	dep	2	SENT_229	[p18l1047t2248r1064b2276],
5	3	CD	NUMBER	3	num	6	SENT_229	[p18l1369t2248r1387b2281],
6	4	CD	NUMBER	4	dep	4	SENT_229	[p18l1685t2248r1708b2281],

1	Number	NN	O	number	dep	8	SENT_230	[p18l69t2334r211b2368],
2	at	IN	O	at	_	0	SENT_230	[p18l218t2340r253b2368],
3	risk	NN	O	risk	nn	5	SENT_230	[p18l262t2334r321b2368],
4	Follow-up	JJ	MISC	follow-up	amod	5	SENT_230	[p18l622t2304r793b2348],
5	duration	NN	O	duration	prep_at	1	SENT_230	[p18l804t2304r950b2337],
6	(	CD	NUMBER	(	num	7	SENT_230	[p18l964t2306r1075b2347],
7	years	NNS	NUMBER	year	tmod	5	SENT_230	[p18l964t2306r1075b2347],
8	)	RB	O	)	_	0	SENT_230	[p18l964t2306r1075b2347],
9	from	IN	O	from	_	0	SENT_230	[p18l1086t2304r1169b2337],
10	6	CD	DURATION	6	num	11	SENT_230	[p18l1183t2304r1203b2337],
11	months	NNS	NUMBER	month	prep_from	8	SENT_230	[p18l1217t2304r1348b2337],
12	after	IN	O	after	dep	8	SENT_230	[p18l1359t2304r1440b2337],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_230	[p18l1450t2304r1638b2348],
14	initiation	NN	O	initiation	pobj	12	SENT_230	[p18l1652t2307r1807b2337],

1	Non	JJ	O	non	amod	3	SENT_231	[p18l124t2397r322b2427],
2	—	NN	O	—	nn	3	SENT_231	[p18l124t2397r322b2427],
3	carriers	NNS	O	carrier	dep	11	SENT_231	[p18l124t2397r322b2427],
4	122	CD	NUMBER	122	number	5	SENT_231	[p18l367t2398r424b2427],
5	80	CD	NUMBER	80	dep	3	SENT_231	[p18l704t2394r747b2427],
6	60	CD	NUMBER	60	num	7	SENT_231	[p18l1023t2394r1066b2427],
7	40	CD	NUMBER	40	dep	5	SENT_231	[p18l1344t2398r1388b2432],
8	27	CD	NUMBER	27	num	9	SENT_231	[p18l1671t2398r1710b2432],
9	*	NN	O	*	dep	11	SENT_231	[p18l163t2455r197b2486],
10	2	CD	NUMBER	2	num	11	SENT_231	[p18l163t2455r197b2486],
11	carriers	NNS	O	carrier	dep	16	SENT_231	[p18l208t2457r322b2487],
12	61	CD	NUMBER	61	number	13	SENT_231	[p18l386t2453r425b2487],
13	27	CD	DATE	27	dep	11	SENT_231	[p18l709t2458r748b2491],
14	21	CD	DATE	21	dep	13	SENT_231	[p18l1028t2458r1067b2486],
15	15	CD	DATE	15	num	16	SENT_231	[p18l1350t2458r1387b2492],
16	8	CD	DATE	8	_	0	SENT_231	[p18l1689t2453r1709b2487],

1	Figure	NNP	O	Figure	_	0	SENT_232	[p18l9t2622r122b2668],
2	3	CD	NUMBER	3	num	1	SENT_232	[p18l131t2626r166b2662],
3	:	:	O	:	_	0	SENT_232	[p18l131t2626r166b2662],
4	Cumulative	JJ	O	cumulative	amod	6	SENT_232	[p18l177t2621r403b2656],
5	Kaplan-Meier	NN	O	kaplan-meier	nn	6	SENT_232	[p18l416t2621r678b2667],
6	estimates	NNS	O	estimate	conj_or	1	SENT_232	[p18l688t2622r881b2656],
7	of	IN	O	of	_	0	SENT_232	[p18l891t2620r933b2656],
8	the	DT	O	the	det	9	SENT_232	[p18l939t2621r1005b2656],
9	rates	NNS	O	rate	prep_of	6	SENT_232	[p18l1018t2627r1113b2656],
10	of	IN	O	of	_	0	SENT_232	[p18l1124t2620r1166b2656],
11	ﬁrst	JJ	O	ﬁrst	amod	15	SENT_232	[p18l1173t2620r1254b2656],
12	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_232	[p18l1265t2621r1547b2656],
13	event	NN	O	event	nn	15	SENT_232	[p18l1557t2627r1669b2656],
14	(	NN	O	(	nn	15	SENT_232	[p18l1681t2621r1820b2666],
15	death	NN	O	death	prep_of	9	SENT_232	[p18l1681t2621r1820b2666],
16	,	,	O	,	_	0	SENT_232	[p18l1681t2621r1820b2666],
17	non-fatal	JJ	O	non-fatal	amod	19	SENT_232	[p18l1834t2620r2015b2656],
18	myocardial	JJ	O	myocardial	amod	19	SENT_232	[p18l10t2682r225b2728],
19	infarction	NN	O	infarction	conj_or	1	SENT_232	[p18l239t2681r443b2724],
20	,	,	O	,	_	0	SENT_232	[p18l239t2681r443b2724],
21	or	CC	O	or	_	0	SENT_232	[p18l455t2693r496b2717],
22	urgent	JJ	O	urgent	amod	24	SENT_232	[p18l506t2688r638b2729],
23	revascularisation	NN	O	revascularisation	nn	24	SENT_232	[p18l651t2682r998b2727],
24	)	NN	O	)	conj_or	1	SENT_232	[p18l651t2682r998b2727],
25	during	IN	O	during	_	0	SENT_232	[p18l1010t2682r1139b2729],
26	the	DT	O	the	det	28	SENT_232	[p18l1149t2682r1215b2717],
27	follow-up	JJ	O	follow-up	amod	28	SENT_232	[p18l1225t2681r1419b2728],
28	period	NN	O	period	prep_during	24	SENT_232	[p18l1430t2682r1557b2728],
29	(	CD	NUMBER	(	num	28	SENT_232	[p18l1569t2684r1626b2727],
30	A	DT	O	a	det	31	SENT_232	[p18l1569t2684r1626b2727],
31	)	NN	O	)	dep	28	SENT_232	[p18l1569t2684r1626b2727],
32	and	CC	O	and	_	0	SENT_232	[p18l1638t2682r1712b2717],
33	from	IN	O	from	_	0	SENT_232	[p18l1720t2681r1817b2717],
34	6	CD	DURATION	6	num	35	SENT_232	[p18l1830t2681r1853b2717],
35	months	NNS	NUMBER	month	prep_from	24	SENT_232	[p18l1868t2682r2019b2717],
36	after	IN	O	after	_	0	SENT_232	[p18l2031t2681r2125b2717],
37	clopidogrel	NN	O	clopidogrel	nn	40	SENT_232	[p18l8t2744r227b2790],
38	initiation	NN	O	initiation	nn	40	SENT_232	[p18l241t2745r424b2779],
39	(	NN	O	(	nn	40	SENT_232	[p18l438t2746r492b2789],
40	B	NN	O	b	prep_after	35	SENT_232	[p18l438t2746r492b2789],
41	)	CD	NUMBER	)	num	42	SENT_232	[p18l438t2746r492b2789],
42	HR	NN	DURATION	hr	dep	1	SENT_232	[p18l11t2805r211b2840],
43	=	JJ	O	=	amod	45	SENT_232	[p18l11t2805r211b2840],
44	hazard	NN	O	hazard	nn	45	SENT_232	[p18l11t2805r211b2840],
45	ratio	NN	O	ratio	dep	42	SENT_232	[p18l225t2808r319b2840],
46	.	.	O	.	_	0	SENT_232	[p18l225t2808r319b2840],

1	factor	NN	O	factor	_	0	SENT_233	[p18l644t2920r794b2968],
2	that	WDT	O	that	nsubjpass	5	SENT_233	[p18l844t2920r946b2968],
3	was	VBD	O	be	auxpass	5	SENT_233	[p18l996t2937r1093b2968],
4	independently	RB	O	independently	advmod	5	SENT_233	[p18l1146t2920r1525b2983],
5	associated	VBN	O	associate	rcmod	1	SENT_233	[p18l1577t2920r1844b2968],
6	with	IN	O	with	_	0	SENT_233	[p18l1893t2920r2010b2968],
7	the	DT	O	the	det	8	SENT_233	[p18l2061t2920r2142b2968],
8	occurrence	NN	O	occurrence	prep_with	5	SENT_233	[p18l645t3014r933b3044],
9	of	IN	O	of	_	0	SENT_233	[p18l990t2997r1048b3044],
10	a	DT	O	a	det	13	SENT_233	[p18l1095t3014r1121b3044],
11	new	JJ	O	new	amod	13	SENT_233	[p18l1176t3014r1285b3044],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_233	[p18l1340t2997r1717b3044],
13	event	NN	O	event	prep_of	8	SENT_233	[p18l1771t3006r1911b3044],
14	during	IN	O	during	_	0	SENT_233	[p18l1966t2997r2143b3060],
15	follow-up	JJ	O	follow-up	amod	18	SENT_233	[p18l644t3072r891b3134],
16	(	NN	O	(	nn	18	SENT_233	[p18l950t3072r1145b3135],
17	hazard	NN	O	hazard	nn	18	SENT_233	[p18l950t3072r1145b3135],
18	ratio	NN	O	ratio	prep_during	5	SENT_233	[p18l1198t3075r1317b3120],
19	4-04	CD	PERCENT	4-04	num	23	SENT_233	[p18l1371t3077r1491b3120],
20	[	CD	PERCENT	[	number	21	SENT_233	[p18l1545t3075r1672b3134],
21	95	CD	PERCENT	95	dep	22	SENT_233	[p18l1545t3075r1672b3134],
22	%	NN	PERCENT	%	dep	23	SENT_233	[p18l1545t3075r1672b3134],
23	CI	NN	O	ci	dep	1	SENT_233	[p18l1729t3076r1788b3120],
24	1-81-9-O2	NN	O	1-81-9-o2	nn	25	SENT_233	[p18l1846t3077r2140b3134],
25	]	NN	O	]	dep	23	SENT_233	[p18l1846t3077r2140b3134],
26	;	:	O	;	_	0	SENT_233	[p18l1846t3077r2140b3134],
27	p	NN	O	p	dep	1	SENT_233	[p18l644t3152r931b3211],
28	=	JJ	O	=	amod	30	SENT_233	[p18l644t3152r931b3211],
29	O-0006	NN	O	o-0006	nn	30	SENT_233	[p18l644t3152r931b3211],
30	)	NN	O	)	dep	27	SENT_233	[p18l644t3152r931b3211],
31	.	.	O	.	_	0	SENT_233	[p18l644t3152r931b3211],

1	Results	NNS	O	result	nsubj	3	SENT_234	[p18l969t3148r1156b3196],
2	were	VBD	O	be	cop	3	SENT_234	[p18l1188t3165r1313b3196],
3	similar	JJ	O	similar	_	0	SENT_234	[p18l1348t3148r1533b3196],
4	with	IN	O	with	_	0	SENT_234	[p18l1563t3148r1679b3196],
5	adjustments	NNS	O	adjustment	prep_with	3	SENT_234	[p18l1712t3148r2035b3211],
6	for	IN	O	for	_	0	SENT_234	[p18l2069t3148r2144b3196],
7	delayed	VBN	O	delay	amod	9	SENT_234	[p18l645t3225r842b3287],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_234	[p18l858t3225r1151b3288],
9	initiation	NN	O	initiation	prep_for	5	SENT_234	[p18l1167t3228r1408b3272],
10	and	CC	O	and	_	0	SENT_234	[p18l1426t3225r1523b3272],
11	other	JJ	O	other	amod	12	SENT_234	[p18l1539t3225r1677b3272],
12	covariates	NNS	O	covariate	prep_for	5	SENT_234	[p18l1694t3228r1964b3272],
13	.	.	O	.	_	0	SENT_234	[p18l1694t3228r1964b3272],

1	When	WRB	O	when	advmod	3	SENT_235	[p18l1983t3225r2143b3273],
2	we	PRP	O	we	nsubj	3	SENT_235	[p18l643t3317r715b3348],
3	included	VBD	O	include	dep	39	SENT_235	[p18l749t3300r978b3348],
4	only	RB	O	only	advmod	15	SENT_235	[p18l1012t3300r1124b3363],
5	the	DT	O	the	quantmod	6	SENT_235	[p18l1155t3300r1237b3348],
6	223	CD	NUMBER	223	num	7	SENT_235	[p18l1273t3305r1361b3348],
7	patients	NNS	O	patient	pobj	4	SENT_235	[p18l1397t3303r1604b3362],
8	with	IN	O	with	_	0	SENT_235	[p18l1638t3300r1754b3348],
9	stents	NNS	O	stent	prep_with	4	SENT_235	[p18l1789t3310r1940b3348],
10	in	IN	O	in	_	0	SENT_235	[p18l1976t3303r2028b3347],
11	the	DT	O	the	det	12	SENT_235	[p18l2060t3300r2142b3348],
12	model	NN	O	model	prep_in	9	SENT_235	[p18l644t3376r823b3431],
13	,	,	O	,	_	0	SENT_235	[p18l644t3376r823b3431],
14	we	PRP	O	we	nsubj	15	SENT_235	[p18l869t3393r941b3424],
15	noted	VBD	O	note	ccomp	3	SENT_235	[p18l987t3376r1136b3424],
16	the	DT	O	the	det	18	SENT_235	[p18l1180t3376r1262b3424],
17	same	JJ	O	same	amod	18	SENT_235	[p18l1309t3393r1445b3424],
18	effect	NN	O	effect	dobj	15	SENT_235	[p18l1491t3376r1634b3424],
19	(	RB	O	(	rcmod	18	SENT_235	[p18l1682t3376r1920b3439],
20	adjusted	VBN	O	adjust	dep	19	SENT_235	[p18l1682t3376r1920b3439],
21	hazard	NN	O	hazard	nn	22	SENT_235	[p18l1964t3376r2144b3424],
22	ratio	NN	O	ratio	dep	20	SENT_235	[p18l644t3456r763b3500],
23	4-09	CD	NUMBER	4-09	npadvmod	22	SENT_235	[p18l788t3457r907b3501],
24	[	CD	NUMBER	[	number	25	SENT_235	[p18l936t3456r1229b3515],
25	1-81-9-25	CD	NUMBER	1-81-9-25	num	26	SENT_235	[p18l936t3456r1229b3515],
26	]	NN	O	]	dep	23	SENT_235	[p18l936t3456r1229b3515],
27	for	IN	O	for	_	0	SENT_235	[p18l1257t3453r1332b3500],
28	the	DT	O	the	det	29	SENT_235	[p18l1356t3453r1438b3500],
29	presence	NN	O	presence	prep_for	22	SENT_235	[p18l1463t3470r1696b3515],
30	of	IN	O	of	_	0	SENT_235	[p18l1723t3453r1782b3500],
31	the	DT	O	the	prep_of	22	SENT_235	[p18l1797t3453r1879b3500],
32	"	``	O	"	punct	22	SENT_235	[p18l1906t3456r1964b3499],
33	'	''	O	'	_	0	SENT_235	[p18l1906t3456r1964b3499],
34	~	FW	O	~	nn	37	SENT_235	[p18l1906t3456r1964b3499],
35	‘	FW	O	‘	dep	37	SENT_235	[p18l1906t3456r1964b3499],
36	2	CD	NUMBER	2	num	37	SENT_235	[p18l1906t3456r1964b3499],
37	allele	NN	O	allele	advmod	3	SENT_235	[p18l1993t3453r2140b3507],
38	;	:	O	;	_	0	SENT_235	[p18l1993t3453r2140b3507],
39	p	NN	O	p	_	0	SENT_235	[p18l644t3532r931b3591],
40	=	JJ	O	=	amod	42	SENT_235	[p18l644t3532r931b3591],
41	0-0008	CD	NUMBER	0-0008	tmod	40	SENT_235	[p18l644t3532r931b3591],
42	)	NN	O	)	dep	39	SENT_235	[p18l644t3532r931b3591],
43	.	.	O	.	_	0	SENT_235	[p18l644t3532r931b3591],

1	We	PRP	O	we	nsubj	2	SENT_236	[p18l971t3533r1054b3576],
2	noted	VBD	O	note	_	0	SENT_236	[p18l1092t3528r1241b3576],
3	no	DT	O	no	det	5	SENT_236	[p18l1278t3545r1344b3576],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_236	[p18l1384t3528r1661b3591],
5	eifect	NN	O	eifect	dobj	2	SENT_236	[p18l1698t3529r1840b3576],
6	of	IN	O	of	_	0	SENT_236	[p18l1878t3528r1936b3576],
7	use	NN	O	use	prep_of	5	SENT_236	[p18l1965t3545r2054b3576],
8	of	IN	O	of	_	0	SENT_236	[p18l2094t3528r2152b3576],
9	proton-pump	NN	O	proton-pump	nn	10	SENT_236	[p18l644t3613r995b3666],
10	inhibitors	NNS	O	inhibitor	prep_of	7	SENT_236	[p18l1030t3604r1301b3651],
11	.	.	O	.	_	0	SENT_236	[p18l1030t3604r1301b3651],

1	Plasma	NN	O	plasma	nn	2	SENT_237	[p18l1341t3604r1531b3651],
2	biomarkers	NNS	O	biomarker	nsubjpass	5	SENT_237	[p18l1564t3604r1863b3651],
3	were	VBD	O	be	auxpass	5	SENT_237	[p18l1898t3621r2023b3652],
4	not	RB	O	not	neg	5	SENT_237	[p18l2058t3613r2144b3651],
5	taken	VBN	O	take	_	0	SENT_237	[p18l644t3680r788b3728],
6	into	IN	O	into	_	0	SENT_237	[p18l837t3683r939b3728],
7	account	NN	O	account	prep_into	5	SENT_237	[p18l991t3690r1195b3728],
8	in	IN	O	in	_	0	SENT_237	[p18l1244t3684r1296b3727],
9	View	NNP	O	View	prep_in	7	SENT_237	[p18l1344t3683r1464b3728],
10	of	IN	O	of	_	0	SENT_237	[p18l1513t3680r1572b3728],
11	the	DT	O	the	det	13	SENT_237	[p18l1611t3680r1693b3728],
12	non-signiﬁcant	JJ	O	non-signiﬁcant	amod	13	SENT_237	[p18l1744t3680r2144b3743],
13	correlation	NN	O	correlation	prep_of	9	SENT_237	[p18l645t3756r929b3804],
14	between	IN	O	between	_	0	SENT_237	[p18l949t3756r1168b3804],
15	baseline	NN	O	baseline	nn	17	SENT_237	[p18l1188t3756r1404b3804],
16	plasma	NN	O	plasma	nn	17	SENT_237	[p18l1426t3756r1614b3818],
17	concentrations	NNS	O	concentration	prep_between	13	SENT_237	[p18l1636t3759r2023b3804],
18	and	CC	O	and	_	0	SENT_237	[p18l2047t3756r2144b3804],
19	clinical	JJ	O	clinical	amod	20	SENT_237	[p19l645t14r831b62],
20	outcome	NN	O	outcome	prep_between	13	SENT_237	[p19l850t23r1077b62],
21	after	IN	O	after	_	0	SENT_237	[p19l1096t14r1214b62],
22	univariable	JJ	O	univariable	amod	23	SENT_237	[p19l1230t14r1525b62],
23	analysis	NN	O	analysis	prep_after	5	SENT_237	[p19l1545t14r1765b76],
24	.	.	O	.	_	0	SENT_237	[p19l1545t14r1765b76],

1	Discussion	NN	O	discussion	nn	2	SENT_238	[p19l648t162r967b215],
2	Results	NNS	O	result	nsubj	7	SENT_238	[p19l647t243r834b291],
3	from	IN	O	from	_	0	SENT_238	[p19l871t243r1000b291],
4	our	PRP$	O	we	poss	5	SENT_238	[p19l1036t260r1126b291],
5	study	NN	O	study	prep_from	2	SENT_238	[p19l1161t243r1302b306],
6	have	VBP	O	have	aux	7	SENT_238	[p19l1334t243r1454b291],
7	shown	VBN	O	show	_	0	SENT_238	[p19l1492t243r1663b291],
8	that	IN	O	that	complm	15	SENT_238	[p19l1697t243r1799b291],
9	CYP2C19	NN	O	cyp2c19	nn	11	SENT_238	[p19l1838t246r2146b291],
10	*	CD	NUMBER	*	num	11	SENT_238	[p19l1838t246r2146b291],
11	‘	NN	O	‘	nsubj	15	SENT_238	[p19l1838t246r2146b291],
12	2	CD	NUMBER	2	num	13	SENT_238	[p19l1838t246r2146b291],
13	polymorphism	NN	O	polymorphism	dep	11	SENT_238	[p19l644t320r1034b382],
14	greatly	RB	O	greatly	advmod	15	SENT_238	[p19l1080t320r1256b383],
15	affects	VBZ	O	affect	ccomp	7	SENT_238	[p19l1300t320r1466b367],
16	clinical	JJ	O	clinical	amod	17	SENT_238	[p19l1514t320r1700b367],
17	outcome	NN	O	outcome	dobj	15	SENT_238	[p19l1746t329r1973b367],
18	in	IN	O	in	_	0	SENT_238	[p19l2019t323r2071b367],
19	a	DT	O	a	det	20	SENT_238	[p19l2117t337r2143b367],
20	population	NN	O	population	prep_in	17	SENT_238	[p19l644t395r929b457],
21	of	IN	O	of	_	0	SENT_238	[p19l951t395r1010b443],
22	young	JJ	O	young	amod	23	SENT_238	[p19l1021t412r1185b458],
23	patients	NNS	O	patient	prep_of	20	SENT_238	[p19l1206t398r1413b457],
24	with	IN	O	with	_	0	SENT_238	[p19l1435t395r1552b443],
25	myocardial	JJ	O	myocardial	amod	26	SENT_238	[p19l1573t395r1864b458],
26	infarction	NN	O	infarction	prep_with	15	SENT_238	[p19l1885t395r2143b443],
27	on	IN	O	on	_	0	SENT_238	[p19l645t488r711b519],
28	extended	JJ	O	extended	amod	30	SENT_238	[p19l730t471r965b519],
29	clopidogrel	NN	O	clopidogrel	nn	30	SENT_238	[p19l983t471r1275b534],
30	treatment	NN	O	treatment	prep_on	26	SENT_238	[p19l1292t481r1552b519],
31	with	IN	O	with	_	0	SENT_238	[p19l1567t471r1684b519],
32	a	DT	O	a	det	34	SENT_238	[p19l1702t488r1728b519],
33	long	JJ	O	long	amod	34	SENT_238	[p19l1745t471r1862b534],
34	follow-up	NN	O	follow-up	prep_with	30	SENT_238	[p19l1880t471r2140b533],
35	.	.	O	.	_	0	SENT_238	[p19l1880t471r2140b533],

1	This	DT	O	this	det	3	SENT_239	[p19l643t548r758b595],
2	novel	JJ	O	novel	amod	3	SENT_239	[p19l799t548r940b595],
3	ﬁnding	NN	O	ﬁnding	_	0	SENT_239	[p19l978t548r1169b611],
4	of	IN	O	of	_	0	SENT_239	[p19l1209t548r1268b595],
5	a	DT	O	a	det	6	SENT_239	[p19l1298t565r1324b595],
6	strong	JJ	O	strong	prep_of	3	SENT_239	[p19l1365t557r1531b611],
7	independent	JJ	O	independent	prep	6	SENT_239	[p19l1569t548r1903b610],
8	relation	NN	O	relation	dep	7	SENT_239	[p19l1941t548r2143b595],
9	between	IN	O	between	_	0	SENT_239	[p19l7t952r319b1021],
10	CYP2C19	CD	NUMBER	cyp2c19	prep_between	6	SENT_239	[p19l371t957r809b1021],
11	"	``	O	"	punct	6	SENT_239	[p19l371t957r809b1021],
12	'	''	O	'	_	0	SENT_239	[p19l371t957r809b1021],
13	~	FW	O	~	nn	14	SENT_239	[p19l371t957r809b1021],
14	‘	FW	O	‘	amod	3	SENT_239	[p19l371t957r809b1021],
15	2	CD	NUMBER	2	nsubj	21	SENT_239	[p19l371t957r809b1021],
16	and	CC	O	and	_	0	SENT_239	[p19l851t952r988b1021],
17	recurrent	JJ	O	recurrent	amod	19	SENT_239	[p19l1032t966r1384b1021],
18	coronary	JJ	O	coronary	amod	19	SENT_239	[p19l1428t977r1756b1042],
19	events	NNS	O	event	nsubj	21	SENT_239	[p19l1800t966r2032b1021],
20	is	VBZ	O	be	cop	21	SENT_239	[p19l2080t957r2137b1021],
21	consistent	JJ	O	consistent	dep	3	SENT_239	[p19l9t1066r391b1129],
22	in	IN	O	in	_	0	SENT_239	[p19l441t1066r516b1128],
23	a	DT	O	a	det	25	SENT_239	[p19l569t1086r606b1129],
24	subset	NN	O	subset	nn	25	SENT_239	[p19l660t1061r899b1129],
25	analysis	NN	O	analysis	prep_in	21	SENT_239	[p19l950t1061r1264b1151],
26	,	,	O	,	_	0	SENT_239	[p19l950t1061r1264b1151],
27	with	IN	O	with	_	0	SENT_239	[p19l1317t1061r1483b1129],
28	both	DT	O	both	preconj	29	SENT_239	[p19l1533t1061r1702b1129],
29	acute	JJ	O	acute	amod	32	SENT_239	[p19l1755t1075r1949b1129],
30	and	CC	O	and	_	0	SENT_239	[p19l2003t1061r2141b1129],
31	long-term	JJ	O	long-term	conj_and	29	SENT_239	[p19l7t1171r378b1261],
32	effects	NNS	O	effect	prep_with	3	SENT_239	[p19l408t1171r666b1249],
33	,	,	O	,	_	0	SENT_239	[p19l408t1171r666b1249],
34	of	IN	O	of	_	0	SENT_239	[p19l699t1171r782b1238],
35	stent-related	JJ	O	stent-related	amod	39	SENT_239	[p19l801t1171r1262b1239],
36	and	CC	O	and	_	0	SENT_239	[p19l1291t1171r1429b1238],
37	stent-independent	JJ	O	stent-independent	conj_and	35	SENT_239	[p19l1460t1171r2141b1260],
38	coronary	JJ	O	coronary	amod	39	SENT_239	[p19l9t1304r337b1369],
39	events	NNS	O	event	prep_of	3	SENT_239	[p19l362t1294r615b1348],
40	.	.	O	.	_	0	SENT_239	[p19l362t1294r615b1348],

1	The	DT	O	the	det	3	SENT_240	[p19l78t1388r221b1456],
2	active	JJ	O	active	amod	3	SENT_240	[p19l251t1393r457b1456],
3	metabolite	NN	O	metabolite	nsubj	15	SENT_240	[p19l487t1388r878b1456],
4	of	IN	O	of	_	0	SENT_240	[p19l909t1388r991b1456],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_240	[p19l1008t1388r1438b1478],
6	,	,	O	,	_	0	SENT_240	[p19l1008t1388r1438b1478],
7	which	WDT	O	which	nsubj	9	SENT_240	[p19l1469t1388r1696b1456],
8	irreversibly	RB	O	irreversibly	advmod	9	SENT_240	[p19l1724t1388r2142b1477],
9	blocks	VBZ	O	block	rcmod	3	SENT_240	[p19l7t1499r239b1567],
10	platelet	NN	O	platelet	nn	13	SENT_240	[p19l269t1499r539b1588],
11	ADP	NN	O	adp	nn	13	SENT_240	[p19l564t1504r740b1566],
12	PZYH	NN	O	pzyh	nn	13	SENT_240	[p19l774t1505r960b1584],
13	receptors	NNS	O	receptor	dobj	9	SENT_240	[p19l987t1512r1348b1588],
14	,	,	O	,	_	0	SENT_240	[p19l987t1512r1348b1588],
15	arises	VBZ	O	arise	_	0	SENT_240	[p19l1380t1503r1588b1567],
16	from	IN	O	from	_	0	SENT_240	[p19l1619t1499r1802b1567],
17	complex	JJ	O	complex	amod	19	SENT_240	[p19l1831t1499r2142b1588],
18	biochemical	JJ	O	biochemical	amod	19	SENT_240	[p19l7t1607r459b1676],
19	reactions	NNS	O	reaction	prep_from	15	SENT_240	[p19l566t1612r900b1676],
20	involving	VBG	O	involve	_	0	SENT_240	[p19l1010t1607r1352b1697],
21	several	JJ	O	several	amod	23	SENT_240	[p19l1462t1607r1714b1676],
22	different	JJ	O	different	amod	23	SENT_240	[p19l1821t1607r2141b1676],
23	cytochromes	NNS	O	cytochrome	prep_involving	19	SENT_240	[p19l9t1716r498b1806],
24	,	,	O	,	_	0	SENT_240	[p19l9t1716r498b1806],
25	of	IN	O	of	_	0	SENT_240	[p19l527t1716r610b1784],
26	which	WDT	O	which	rel	28	SENT_240	[p19l620t1716r846b1785],
27	CYPZC19	NN	O	cypzc19	nsubj	28	SENT_240	[p19l873t1721r1218b1785],
28	has	VBZ	O	have	rcmod	23	SENT_240	[p19l1243t1716r1368b1784],
29	a	DT	O	a	det	31	SENT_240	[p19l1395t1741r1433b1784],
30	key	JJ	O	key	amod	31	SENT_240	[p19l1455t1716r1582b1806],
31	role	NN	O	role	dobj	28	SENT_240	[p19l1604t1716r1763b1784],
32	.	.	O	.	_	0	SENT_240	[p19l1604t1716r1763b1784],

1	CYPZC19	NN	O	cypzc19	nn	3	SENT_241	[p19l1794t1721r2139b1785],
2	catalytic	JJ	O	catalytic	amod	3	SENT_241	[p19l9t1827r305b1916],
3	eﬂiciency	NN	O	eﬂiciency	nsubjpass	6	SENT_241	[p19l340t1827r693b1916],
4	is	VBZ	O	be	auxpass	6	SENT_241	[p19l725t1831r783b1895],
5	mainly	RB	O	mainly	advmod	6	SENT_241	[p19l820t1827r1078b1916],
6	affected	VBN	O	affect	_	0	SENT_241	[p19l1112t1827r1400b1895],
7	by	IN	O	by	_	0	SENT_241	[p19l1432t1827r1520b1916],
8	the	DT	O	the	det	10	SENT_241	[p19l1551t1827r1667b1895],
9	C	NN	O	c	nn	10	SENT_241	[p19l1709t1832r1763b1895],
10	YP2C19	NN	O	yp2c19	agent	6	SENT_241	[p19l1770t1831r2144b1895],
11	"	''	O	"	punct	10	SENT_241	[p19l1770t1831r2144b1895],
12	'	''	O	'	_	0	SENT_241	[p19l1770t1831r2144b1895],
13	~	FW	O	~	nn	14	SENT_241	[p19l1770t1831r2144b1895],
14	‘	FW	O	‘	dep	16	SENT_241	[p19l1770t1831r2144b1895],
15	2	CD	NUMBER	2	num	16	SENT_241	[p19l1770t1831r2144b1895],
16	polymorphism	NN	O	polymorphism	dep	10	SENT_241	[p19l8t1935r559b2025],
17	in	IN	O	in	_	0	SENT_241	[p19l580t1940r655b2002],
18	exon	NN	O	exon	prep_in	16	SENT_241	[p19l677t1960r850b2004],
19	5	CD	NUMBER	5	num	18	SENT_241	[p19l876t1940r932b2013],
20	,	,	O	,	_	0	SENT_241	[p19l876t1940r932b2013],
21	which	WDT	O	which	nsubj	22	SENT_241	[p19l956t1935r1182b2004],
22	results	VBZ	O	result	rcmod	18	SENT_241	[p19l1204t1935r1448b2004],
23	in	IN	O	in	_	0	SENT_241	[p19l1473t1940r1547b2002],
24	a	DT	O	a	det	28	SENT_241	[p19l1570t1960r1606b2004],
25	truncated	VBN	O	truncate	dep	28	SENT_241	[p19l1627t1935r1983b2004],
26	and	CC	O	and	_	0	SENT_241	[p19l2004t1935r2141b2004],
27	non-functional	JJ	O	non-functional	conj_and	25	SENT_241	[p19l8t2044r561b2112],
28	enzyme	NN	O	enzyme	prep_in	22	SENT_241	[p19l611t2068r900b2133],
29	by	IN	O	by	_	0	SENT_241	[p19l949t2044r1035b2133],
30	creating	VBG	O	create	agent	6	SENT_241	[p19l1083t2049r1382b2134],
31	an	DT	O	a	det	34	SENT_241	[p19l1431t2068r1520b2112],
32	aberrant	JJ	O	aberrant	amod	34	SENT_241	[p19l1570t2044r1883b2112],
33	splice	NN	O	splice	nn	34	SENT_241	[p19l1933t2044r2140b2133],
34	site	NN	O	site	dobj	30	SENT_241	[p19l11t2158r198b2222],
35	.	.	O	.	_	0	SENT_241	[p19l11t2158r198b2222],

1	“	NN	O	“	nsubj	8	SENT_242	[p19l11t2158r198b2222],
2	The	DT	O	the	det	4	SENT_242	[p19l223t2154r366b2221],
3	resulting	VBG	O	result	amod	4	SENT_242	[p19l394t2154r726b2244],
4	decrease	NN	O	decrease	dep	1	SENT_242	[p19l754t2154r1069b2222],
5	in	IN	O	in	_	0	SENT_242	[p19l1096t2158r1171b2220],
6	CYPZC19	NN	O	cypzc19	nn	7	SENT_242	[p19l1200t2159r1545b2222],
7	activity	NN	O	activity	prep_in	1	SENT_242	[p19l1575t2158r1833b2243],
8	leads	VBZ	O	lead	_	0	SENT_242	[p19l1856t2154r2043b2222],
9	to	TO	O	to	_	0	SENT_242	[p19l2070t2167r2139b2221],
10	decreased	VBN	O	decrease	amod	11	SENT_242	[p19l9t2262r375b2331],
11	exposure	NN	O	exposure	prep_to	8	SENT_242	[p19l396t2287r726b2351],
12	to	TO	O	to	_	0	SENT_242	[p19l747t2276r816b2331],
13	clopidogrel	NN	O	clopidogrel	nn	16	SENT_242	[p19l839t2262r1251b2352],
14	active	JJ	O	active	amod	16	SENT_242	[p19l1273t2267r1478b2331],
15	metabolite	NN	O	metabolite	nn	16	SENT_242	[p19l1500t2262r1981b2331],
16	“	NN	O	“	prep_to	11	SENT_242	[p19l1500t2262r1981b2331],
17	and	CC	O	and	_	0	SENT_242	[p19l2004t2263r2141b2331],
18	to	TO	O	to	_	0	SENT_242	[p19l7t2385r76b2439],
19	a	DT	O	a	det	22	SENT_242	[p19l115t2396r152b2439],
20	reduced	VBN	O	reduce	amod	22	SENT_242	[p19l189t2371r486b2439],
21	pharmacodynamic	JJ	O	pharmacodynamic	amod	22	SENT_242	[p19l522t2371r1217b2461],
22	response	NN	O	response	prep_to	8	SENT_242	[p19l1253t2395r1585b2460],
23	to	TO	O	to	_	0	SENT_242	[p19l1621t2385r1690b2439],
24	clopidogrel	NN	O	clopidogrel	prep_to	22	SENT_242	[p19l1729t2371r2140b2461],
25	with	IN	O	with	_	0	SENT_242	[p19l7t2481r171b2549],
26	a	DT	O	a	det	30	SENT_242	[p19l252t2505r290b2549],
27	subsequent	JJ	O	subsequent	amod	30	SENT_242	[p19l373t2481r799b2570],
28	high	JJ	O	high	amod	30	SENT_242	[p19l877t2481r1047b2571],
29	platelet	NN	O	platelet	nn	30	SENT_242	[p19l1127t2481r1397b2570],
30	reactivity	NN	O	reactivity	prep_with	24	SENT_242	[p19l1477t2485r1811b2570],
31	during	IN	O	during	_	0	SENT_242	[p19l1891t2481r2140b2571],
32	treatment	NN	O	treatment	prep_during	30	SENT_242	[p19l7t2603r390b2658],
33	.	.	O	.	_	0	SENT_242	[p19l7t2603r390b2658],

1	Furata	NNP	PERSON	Furata	dep	8	SENT_243	[p19l459t2594r691b2658],
2	and	CC	O	and	_	0	SENT_243	[p19l752t2589r889b2658],
3	colleagues	NNS	O	colleague	dep	8	SENT_243	[p19l950t2589r1377b2679],
4	”	CD	NUMBER	”	num	5	SENT_243	[p19l950t2589r1377b2679],
5	report	NN	O	report	dep	8	SENT_243	[p19l1437t2603r1664b2678],
6	a	DT	O	a	det	8	SENT_243	[p19l1724t2614r1761b2658],
7	so-called	JJ	O	so-called	amod	8	SENT_243	[p19l1824t2589r2141b2658],
8	gene-dose	NN	O	gene-dose	dep	19	SENT_243	[p19l10t2698r379b2788],
9	effect	NN	O	effect	dep	8	SENT_243	[p19l457t2698r658b2766],
10	of	IN	O	of	_	0	SENT_243	[p19l735t2698r817b2766],
11	the	DT	O	the	det	13	SENT_243	[p19l879t2698r996b2766],
12	C	NN	O	c	nn	13	SENT_243	[p19l1079t2703r1133b2766],
13	YP2C19	NN	O	yp2c19	prep_of	9	SENT_243	[p19l1140t2703r1514b2767],
14	"	''	O	"	punct	13	SENT_243	[p19l1140t2703r1514b2767],
15	'	''	O	'	_	0	SENT_243	[p19l1140t2703r1514b2767],
16	~	FW	O	~	nn	17	SENT_243	[p19l1140t2703r1514b2767],
17	‘	FW	O	‘	amod	9	SENT_243	[p19l1140t2703r1514b2767],
18	2	CD	NUMBER	2	num	19	SENT_243	[p19l1140t2703r1514b2767],
19	allele	NN	O	allele	dep	33	SENT_243	[p19l1588t2698r1777b2766],
20	on	IN	O	on	dep	19	SENT_243	[p19l1855t2723r1949b2766],
21	the	DT	O	the	det	22	SENT_243	[p19l2024t2698r2140b2766],
22	pharmacokinetics	NNS	O	pharmacokinetic	pobj	20	SENT_243	[p19l8t2808r669b2897],
23	and	CC	O	and	_	0	SENT_243	[p19l737t2808r874b2876],
24	pharmacodynamics	NNS	O	pharmacodynamic	pobj	20	SENT_243	[p19l937t2808r1666b2897],
25	of	IN	O	of	_	0	SENT_243	[p19l1735t2808r1817b2876],
26	protonpump	NN	O	protonpump	nn	27	SENT_243	[p19l1868t2821r2138b2897, p19l8t2942r230b3006],
27	inhibitors	NNS	O	inhibitor	prep_of	22	SENT_243	[p19l256t2917r638b2996],
28	,	,	O	,	_	0	SENT_243	[p19l256t2917r638b2996],
29	which	WDT	O	which	nsubj	33	SENT_243	[p19l663t2917r890b2986],
30	are	VBP	O	be	cop	33	SENT_243	[p19l915t2942r1026b2986],
31	also	RB	O	also	advmod	33	SENT_243	[p19l1052t2917r1193b2986],
32	CYP2C19	NN	O	cyp2c19	nn	33	SENT_243	[p19l1221t2923r1566b2986],
33	substrates	NNS	O	substrate	_	0	SENT_243	[p19l1595t2917r2034b2986],
34	?	.	O	?	_	0	SENT_243	[p19l1595t2917r2034b2986],
35	"	''	O	"	punct	33	SENT_243	[p19l1595t2917r2034b2986],

1	In	IN	O	in	_	0	SENT_244	[p19l2062t2924r2140b2985],
2	a	DT	O	a	det	5	SENT_244	[p19l9t3052r47b3096],
3	double-blind	JJ	O	double-blind	amod	5	SENT_244	[p19l66t3027r536b3096],
4	placebo-controlled	JJ	O	placebo-controlled	amod	5	SENT_244	[p19l553t3027r1235b3116],
5	trial	NN	O	trial	prep_in	17	SENT_244	[p19l1251t3027r1464b3106],
6	,	,	O	,	_	0	SENT_244	[p19l1251t3027r1464b3106],
7	”	CD	NUMBER	”	num	8	SENT_244	[p19l1251t3027r1464b3106],
8	co-administration	NN	O	co-administration	nsubjpass	17	SENT_244	[p19l1481t3027r2141b3096],
9	of	IN	O	of	_	0	SENT_244	[p20l9t18r92b85],
10	the	DT	O	the	det	13	SENT_244	[p20l97t18r213b85],
11	proton-pump	NN	O	proton-pump	nn	13	SENT_244	[p20l232t31r728b107],
12	inhibitor	NN	O	inhibitor	nn	13	SENT_244	[p20l748t18r1076b86],
13	omeprazole	NN	O	omeprazole	prep_of	8	SENT_244	[p20l1094t18r1528b107],
14	with	IN	O	with	_	0	SENT_244	[p20l1545t18r1710b86],
15	clopidogrel	NN	O	clopidogrel	prep_with	13	SENT_244	[p20l1729t18r2141b108],
16	was	VBD	O	be	auxpass	17	SENT_244	[p20l7t151r144b195],
17	associated	VBN	O	associate	_	0	SENT_244	[p20l198t126r574b195],
18	with	IN	O	with	_	0	SENT_244	[p20l621t126r786b195],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_244	[p20l838t126r1291b216],
20	higher	JJR	O	higher	amod	23	SENT_244	[p20l1338t126r1584b216],
21	platelet	NN	O	platelet	nn	23	SENT_244	[p20l1632t126r1902b215],
22	PZYH	NN	O	pzyh	nn	23	SENT_244	[p20l1954t133r2140b211],
23	reactivity	NN	O	reactivity	prep_with	17	SENT_244	[p20l8t240r352b325],
24	,	,	O	,	_	0	SENT_244	[p20l8t240r352b325],
25	and	CC	O	and	_	0	SENT_244	[p20l392t235r529b303],
26	patients	NNS	O	patient	nsubj	32	SENT_244	[p20l563t240r855b324],
27	receiving	VBG	O	receive	partmod	26	SENT_244	[p20l892t240r1230b325],
28	chronic	JJ	O	chronic	amod	29	SENT_244	[p20l1266t235r1545b303],
29	treatment	NN	O	treatment	dobj	27	SENT_244	[p20l1578t249r1945b303],
30	with	IN	O	with	_	0	SENT_244	[p20l1976t235r2141b303],
31	omeprazole	NN	O	omeprazole	prep_with	27	SENT_244	[p20l9t345r443b434],
32	had	VBD	O	have	conj_and	17	SENT_244	[p20l496t345r634b412],
33	a	DT	O	a	det	34	SENT_244	[p20l687t369r724b412],
34	4-3-times	NNS	O	4-3-time	nsubj	36	SENT_244	[p20l775t349r1131b413],
35	greater	JJR	O	greater	amod	36	SENT_244	[p20l1188t358r1447b435],
36	chance	NN	O	chance	xcomp	32	SENT_244	[p20l1499t345r1756b413],
37	of	IN	O	of	_	0	SENT_244	[p20l1811t345r1893b413],
38	being	VBG	O	be	cop	40	SENT_244	[p20l1932t345r2140b435],
39	suboptimum	JJ	O	suboptimum	amod	40	SENT_244	[p20l11t454r494b543],
40	responders	NNS	O	responder	prepc_of	36	SENT_244	[p20l550t454r961b543],
41	than	IN	O	than	mark	42	SENT_244	[p20l1018t454r1186b523],
42	did	VBD	O	do	advcl	32	SENT_244	[p20l1243t454r1360b523],
43	those	DT	O	those	dobj	42	SENT_244	[p20l1413t454r1611b523],
44	treated	VBN	O	treat	partmod	43	SENT_244	[p20l1667t454r1923b523],
45	with	IN	O	with	_	0	SENT_244	[p20l1976t454r2141b523],
46	clopidogrel	NN	O	clopidogrel	prep_with	44	SENT_244	[p20l9t563r421b653],
47	alone	RB	O	alone	advmod	44	SENT_244	[p20l481t563r697b631],
48	.	.	O	.	_	0	SENT_244	[p20l481t563r697b631],

1	However	RB	O	however	advmod	20	SENT_245	[p20l763t570r1103b641],
2	,	,	O	,	_	0	SENT_245	[p20l763t570r1103b641],
3	neither	DT	O	neither	det	8	SENT_245	[p20l1165t563r1434b631],
4	C	NN	O	c	nn	8	SENT_245	[p20l1497t568r1551b631],
5	YPZC	NN	O	ypzc	nn	8	SENT_245	[p20l1557t568r1763b631],
6	19	CD	NUMBER	19	num	8	SENT_245	[p20l1769t569r1843b632],
7	poly	NN	O	poly	nn	8	SENT_245	[p20l1897t563r2142b653],
8	—	NN	O	—	nsubjpass	20	SENT_245	[p20l1897t563r2142b653],
9	morphism	NN	O	morphism	nn	10	SENT_245	[p20l8t673r403b762],
10	status	NN	O	status	dep	8	SENT_245	[p20l438t686r650b741],
11	nor	CC	O	nor	_	0	SENT_245	[p20l685t697r814b740],
12	clopidogrel	NN	O	clopidogrel	nn	14	SENT_245	[p20l846t673r1258b763],
13	suboptimum	NN	O	suboptimum	nn	14	SENT_245	[p20l1293t673r1776b762],
14	response	NN	O	response	nsubjpass	20	SENT_245	[p20l1808t697r2140b762],
15	before	IN	O	before	_	0	SENT_245	[p20l7t782r241b851],
16	exposure	NN	O	exposure	prep_before	14	SENT_245	[p20l279t807r610b871],
17	to	TO	O	to	_	0	SENT_245	[p20l646t796r714b851],
18	omeprazole	NN	O	omeprazole	prep_to	8	SENT_245	[p20l753t782r1186b871],
19	was	VBD	O	be	auxpass	20	SENT_245	[p20l1222t807r1359b851],
20	reported	VBN	O	report	_	0	SENT_245	[p20l1398t782r1712b871],
21	in	IN	O	in	_	0	SENT_245	[p20l1747t787r1821b850],
22	the	DT	O	the	det	24	SENT_245	[p20l1856t782r1972b851],
23	two	CD	NUMBER	two	num	24	SENT_245	[p20l2007t796r2139b851],
24	groups	NNS	O	group	prep_in	20	SENT_245	[p20l10t915r284b981],
25	.	.	O	.	_	0	SENT_245	[p20l10t915r284b981],

1	In	IN	O	in	_	0	SENT_246	[p20l319t898r397b958],
2	our	PRP$	O	we	poss	3	SENT_246	[p20l426t915r553b959],
3	study	NN	O	study	prep_in	6	SENT_246	[p20l582t891r789b981],
4	,	,	O	,	_	0	SENT_246	[p20l582t891r789b981],
5	we	PRP	O	we	nsubj	6	SENT_246	[p20l818t915r921b959],
6	recorded	VBD	O	record	_	0	SENT_246	[p20l949t891r1275b959],
7	no	DT	O	no	det	9	SENT_246	[p20l1301t915r1394b959],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_246	[p20l1425t891r1815b981],
9	effect	NN	O	effect	dobj	6	SENT_246	[p20l1842t891r2043b959],
10	of	IN	O	of	_	0	SENT_246	[p20l2070t891r2153b959],
11	use	NN	O	use	prep_of	9	SENT_246	[p20l7t1025r134b1069],
12	of	IN	O	of	_	0	SENT_246	[p20l218t1001r301b1068],
13	proton-pump	NN	O	proton-pump	nn	14	SENT_246	[p20l370t1014r866b1090],
14	inhibitors	NNS	O	inhibitor	prep_of	11	SENT_246	[p20l949t1001r1331b1068],
15	.	.	O	.	_	0	SENT_246	[p20l949t1001r1331b1068],

1	Although	IN	O	although	mark	5	SENT_247	[p20l1416t1001r1767b1091],
2	medical	JJ	O	medical	amod	3	SENT_247	[p20l1849t1001r2141b1069],
3	treatment	NN	O	treatment	nsubjpass	5	SENT_247	[p20l7t1123r374b1178],
4	was	VBD	O	be	auxpass	5	SENT_247	[p20l397t1134r535b1178],
5	updated	VBN	O	update	advcl	16	SENT_247	[p20l563t1109r864b1198],
6	every	DT	SET	every	det	8	SENT_247	[p20l891t1134r1084b1199],
7	6	CD	SET	6	num	8	SENT_247	[p20l1110t1115r1149b1178],
8	months	NNS	NUMBER	month	tmod	5	SENT_247	[p20l1177t1109r1462b1178],
9	during	IN	O	during	_	0	SENT_247	[p20l1493t1109r1743b1199],
10	follow-up	NN	O	follow-up	prep_during	5	SENT_247	[p20l1770t1109r2137b1198],
11	,	,	O	,	_	0	SENT_247	[p20l1770t1109r2137b1198],
12	we	PRP	O	we	nsubj	16	SENT_247	[p20l7t1243r109b1287],
13	can	MD	O	can	aux	16	SENT_247	[p20l150t1232r402b1287],
14	not	RB	O	not	neg	16	SENT_247	[p20l150t1232r402b1287],
15	be	VB	O	be	cop	16	SENT_247	[p20l439t1219r524b1287],
16	certain	JJ	O	certain	_	0	SENT_247	[p20l566t1224r819b1287],
17	of	IN	O	of	_	0	SENT_247	[p20l859t1219r942b1287],
18	the	DT	O	the	det	19	SENT_247	[p20l967t1219r1082b1287],
19	status	NN	O	status	prep_of	16	SENT_247	[p20l1126t1232r1337b1287],
20	of	IN	O	of	_	0	SENT_247	[p20l1380t1219r1462b1287],
21	the	DT	O	the	det	23	SENT_247	[p20l1488t1219r1604b1287],
22	proton-pump	NN	O	proton-pump	nn	23	SENT_247	[p20l1644t1232r2140b1308],
23	inhibitor	NN	O	inhibitor	prep_of	19	SENT_247	[p20l8t1328r336b1396],
24	at	IN	O	at	_	0	SENT_247	[p20l381t1342r446b1396],
25	the	DT	O	the	det	26	SENT_247	[p20l488t1329r603b1396],
26	time	NN	O	time	prep_at	16	SENT_247	[p20l648t1333r817b1396],
27	of	IN	O	of	_	0	SENT_247	[p20l864t1328r947b1396],
28	the	DT	O	the	det	29	SENT_247	[p20l978t1329r1094b1396],
29	event	NN	O	event	prep_of	26	SENT_247	[p20l1140t1342r1355b1407],
30	,	,	O	,	_	0	SENT_247	[p20l1140t1342r1355b1407],
31	which	WDT	O	which	nsubj	32	SENT_247	[p20l1401t1328r1628b1396],
32	restricts	VBZ	O	restrict	rcmod	29	SENT_247	[p20l1673t1333r1967b1396],
33	our	PRP$	O	we	poss	34	SENT_247	[p20l2015t1353r2142b1396],
34	assessment	NN	O	assessment	dobj	32	SENT_247	[p20l9t1451r437b1505],
35	of	IN	O	of	_	0	SENT_247	[p20l462t1437r544b1505],
36	their	PRP$	O	they	poss	37	SENT_247	[p20l555t1437r731b1505],
37	effect	NN	O	effect	prep_of	34	SENT_247	[p20l755t1438r956b1505],
38	on	IN	O	on	_	0	SENT_247	[p20l981t1462r1074b1505],
39	clinical	JJ	O	clinical	amod	40	SENT_247	[p20l1100t1437r1362b1505],
40	outcome	NN	O	outcome	prep_on	37	SENT_247	[p20l1388t1451r1727b1505],
41	.	.	O	.	_	0	SENT_247	[p20l1388t1451r1727b1505],

1	Improvement	NN	O	improvement	nsubj	19	SENT_248	[p20l83t1554r598b1636],
2	in	IN	O	in	_	0	SENT_248	[p20l646t1552r721b1614],
3	the	DT	O	the	det	5	SENT_248	[p20l769t1547r886b1615],
4	pharmacodynamic	JJ	O	pharmacodynamic	amod	5	SENT_248	[p20l936t1547r1635b1636],
5	response	NN	O	response	prep_in	1	SENT_248	[p20l1685t1571r2018b1636],
6	of	IN	O	of	_	0	SENT_248	[p20l2070t1547r2153b1615],
7	poor	JJ	O	poor	amod	8	SENT_248	[p20l8t1682r180b1746],
8	responders	NNS	O	responder	prep_of	5	SENT_248	[p20l222t1658r637b1746],
9	to	TO	O	to	_	0	SENT_248	[p20l682t1671r751b1726],
10	treatment	NN	O	treatment	prep_to	8	SENT_248	[p20l796t1671r1165b1726],
11	after	IN	O	after	_	0	SENT_248	[p20l1209t1657r1377b1726],
12	ex-vivo	NN	O	ex-vivo	nn	13	SENT_248	[p20l1420t1662r1671b1726],
13	addition	NN	O	addition	prep_after	10	SENT_248	[p20l1717t1657r2025b1726],
14	of	IN	O	of	_	0	SENT_248	[p20l2070t1657r2153b1726],
15	clopidogrel	NN	O	clopidogrel	poss	18	SENT_248	[p20l9t1766r478b1856],
16	’s	POS	O	’s	_	0	SENT_248	[p20l9t1766r478b1856],
17	active	JJ	O	active	amod	18	SENT_248	[p20l513t1771r721b1834],
18	metabolite	NN	O	metabolite	prep_of	13	SENT_248	[p20l754t1766r1149b1834],
19	suggests	VBZ	O	suggest	_	0	SENT_248	[p20l1184t1780r1500b1856],
20	that	IN	O	that	complm	33	SENT_248	[p20l1533t1766r1678b1834],
21	all	DT	O	all	det	22	SENT_248	[p20l1710t1766r1794b1834],
22	patients	NNS	O	patient	nsubj	33	SENT_248	[p20l1826t1771r2136b1855],
23	’	IN	O	’	_	0	SENT_248	[p20l1826t1771r2136b1855],
24	P2Y	NN	O	p2y	prep_’	29	SENT_248	[p20l13t1881r200b1960],
25	,	,	O	,	_	0	SENT_248	[p20l13t1881r200b1960],
26	,	,	O	,	_	0	SENT_248	[p20l13t1881r200b1960],
27	receptors	NNS	O	receptor	nsubj	29	SENT_248	[p20l227t1889r569b1964],
28	will	MD	O	will	aux	29	SENT_248	[p20l597t1875r732b1943],
29	respond	VB	O	respond	rcmod	22	SENT_248	[p20l760t1875r1064b1964],
30	to	TO	O	to	_	0	SENT_248	[p20l1089t1889r1158b1943],
31	thienopyridine	NN	O	thienopyridine	nn	32	SENT_248	[p20l1186t1875r1739b1965],
32	inhibition	NN	O	inhibition	prep_to	29	SENT_248	[p20l1767t1875r2140b1943],
33	provided	VBD	O	provide	ccomp	19	SENT_248	[p20l8t1986r336b2075],
34	that	IN	O	that	complm	38	SENT_248	[p20l367t1986r512b2054],
35	the	DT	O	the	det	37	SENT_248	[p20l543t1986r660b2054],
36	active	JJ	O	active	amod	37	SENT_248	[p20l695t1990r903b2054],
37	metabolite	NN	O	metabolite	nsubj	38	SENT_248	[p20l938t1986r1332b2054],
38	reaches	VBZ	O	reach	ccomp	33	SENT_248	[p20l1366t1986r1646b2054],
39	an	DT	O	a	det	41	SENT_248	[p20l1683t2010r1773b2054],
40	adequate	JJ	O	adequate	amod	41	SENT_248	[p20l1807t1986r2139b2075],
41	concentration	NN	O	concentration	dobj	38	SENT_248	[p20l9t2099r592b2163],
42	.	.	O	.	_	0	SENT_248	[p20l9t2099r592b2163],

1	”	NN	O	”	nn	2	SENT_249	[p20l9t2099r592b2163],
2	Evidence	NN	O	evidence	nsubj	3	SENT_249	[p20l653t2095r982b2163],
3	suggests	VBZ	O	suggest	_	0	SENT_249	[p20l1042t2108r1357b2184],
4	that	IN	O	that	complm	6	SENT_249	[p20l1416t2095r1561b2163],
5	patients	NNS	O	patient	nsubj	6	SENT_249	[p20l1617t2099r1910b2183],
6	have	VBP	O	have	ccomp	3	SENT_249	[p20l1969t2095r2139b2163],
7	variable	JJ	O	variable	amod	8	SENT_249	[p20l7t2203r298b2271],
8	responses	NNS	O	response	dobj	6	SENT_249	[p20l363t2227r734b2292],
9	to	TO	O	to	_	0	SENT_249	[p20l799t2217r869b2271],
10	clopidogrel	NN	O	clopidogrel	prep_to	6	SENT_249	[p20l935t2203r1350b2293],
11	and	CC	O	and	_	0	SENT_249	[p20l1416t2203r1554b2271],
12	that	IN	O	that	complm	23	SENT_249	[p20l1616t2203r1762b2271],
13	a	DT	O	a	det	15	SENT_249	[p20l1826t2228r1862b2271],
14	lesser	JJR	O	lesser	amod	15	SENT_249	[p20l1925t2203r2141b2271],
15	response	NN	O	response	nsubj	23	SENT_249	[p20l8t2337r342b2402],
16	to	TO	O	to	_	0	SENT_249	[p20l370t2326r439b2381],
17	the	DT	O	the	det	18	SENT_249	[p20l467t2313r583b2380],
18	drug	NN	O	drug	prep_to	15	SENT_249	[p20l613t2313r787b2403],
19	could	MD	O	could	aux	23	SENT_249	[p20l816t2313r1020b2381],
20	be	VB	O	be	cop	23	SENT_249	[p20l1045t2313r1131b2381],
21	a	DT	O	a	det	23	SENT_249	[p20l1161t2337r1198b2380],
22	risk	NN	O	risk	nn	23	SENT_249	[p20l1225t2313r1367b2380],
23	factor	NN	O	factor	ccomp	3	SENT_249	[p20l1393t2313r1605b2380],
24	for	IN	O	for	_	0	SENT_249	[p20l1632t2313r1739b2380],
25	ischaemic	JJ	O	ischaemic	amod	26	SENT_249	[p20l1765t2313r2140b2381],
26	complications	NNS	O	complication	prep_for	23	SENT_249	[p20l9t2421r722b2510],
27	.	.	O	.	_	0	SENT_249	[p20l9t2421r722b2510],

1	“’	NN	O	“’	nsubjpass	24	SENT_250	[p20l9t2421r722b2510],
2	5	CD	NUMBER	5	num	1	SENT_250	[p20l9t2421r722b2510],
3	*	CD	NUMBER	*	number	4	SENT_250	[p20l9t2421r722b2510],
4	29	CD	NUMBER	29	num	5	SENT_250	[p20l9t2421r722b2510],
5	’	NN	O	’	dep	1	SENT_250	[p20l9t2421r722b2510],
6	3	CD	NUMBER	3	num	7	SENT_250	[p20l9t2421r722b2510],
7	°	NN	O	°	dep	1	SENT_250	[p20l9t2421r722b2510],
8	This	DT	O	this	det	9	SENT_250	[p20l749t2421r912b2490],
9	occurrence	NN	O	occurrence	dep	7	SENT_250	[p20l944t2446r1374b2500],
10	,	,	O	,	_	0	SENT_250	[p20l944t2446r1374b2500],
11	which	WDT	O	which	nsubj	13	SENT_250	[p20l1404t2422r1632b2490],
12	might	MD	O	might	aux	13	SENT_250	[p20l1661t2421r1887b2511],
13	derive	VB	O	derive	rcmod	1	SENT_250	[p20l1915t2422r2139b2490],
14	from	IN	O	from	_	0	SENT_250	[p20l8t2530r193b2598],
15	the	DT	O	the	det	16	SENT_250	[p20l213t2530r329b2598],
16	presence	NN	O	presence	prep_from	13	SENT_250	[p20l350t2554r682b2619],
17	of	IN	O	of	_	0	SENT_250	[p20l705t2530r788b2598],
18	the	DT	O	the	det	20	SENT_250	[p20l794t2530r911b2598],
19	genetic	JJ	O	genetic	amod	20	SENT_250	[p20l934t2535r1201b2620],
20	variant	NN	O	variant	prep_of	16	SENT_250	[p20l1220t2535r1497b2608],
21	,	,	O	,	_	0	SENT_250	[p20l1220t2535r1497b2608],
22	can	MD	O	can	aux	24	SENT_250	[p20l1523t2555r1651b2598],
23	be	VB	O	be	auxpass	24	SENT_250	[p20l1670t2530r1757b2598],
24	overcome	VBN	O	overcome	_	0	SENT_250	[p20l1779t2555r2139b2598],
25	acutely	RB	O	acutely	advmod	24	SENT_250	[p20l9t2640r270b2729],
26	by	IN	O	by	_	0	SENT_250	[p20l301t2640r389b2729],
27	increasing	VBG	O	increase	agent	24	SENT_250	[p20l422t2644r812b2730],
28	the	DT	O	the	det	30	SENT_250	[p20l845t2640r962b2707],
29	loading	VBG	O	load	amod	30	SENT_250	[p20l996t2640r1275b2730],
30	dose	NN	O	dose	dobj	27	SENT_250	[p20l1311t2640r1478b2707],
31	of	IN	O	of	_	0	SENT_250	[p20l1515t2640r1598b2707],
32	clopidogrel	NN	O	clopidogrel	prep_of	30	SENT_250	[p20l1621t2640r2036b2730],
33	to	TO	O	to	aux	34	SENT_250	[p20l2070t2653r2139b2707],
34	improve	VB	O	improve	infmod	30	SENT_250	[p20l8t2754r317b2838],
35	platelet	NN	O	platelet	nn	36	SENT_250	[p20l349t2749r622b2838],
36	inhibition	NN	O	inhibition	dobj	34	SENT_250	[p20l652t2749r1025b2818],
37	with	IN	O	with	_	0	SENT_250	[p20l1054t2749r1219b2818],
38	a	DT	O	a	det	40	SENT_250	[p20l1251t2774r1288b2818],
39	faster	RBR	O	faster	advmod	40	SENT_250	[p20l1320t2749r1527b2818],
40	onset	NN	O	onset	prep_with	34	SENT_250	[p20l1558t2763r1759b2818],
41	of	IN	O	of	_	0	SENT_250	[p20l1790t2749r1873b2818],
42	action	NN	O	action	nn	54	SENT_250	[p20l1892t2754r2136b2828],
43	,	,	O	,	_	0	SENT_250	[p20l1892t2754r2136b2828],
44	fewer	JJR	O	fewer	amod	46	SENT_250	[p20l8t2858r216b2926],
45	poor	JJ	O	poor	amod	46	SENT_250	[p20l258t2883r430b2947],
46	responders	NNS	O	responder	nn	54	SENT_250	[p20l473t2858r1042b2947],
47	,	,	O	,	_	0	SENT_250	[p20l473t2858r1042b2947],
48	“	NN	O	“	nn	54	SENT_250	[p20l473t2858r1042b2947],
49	132	CD	NUMBER	132	num	48	SENT_250	[p20l473t2858r1042b2947],
50	and	CC	O	and	_	0	SENT_250	[p20l1088t2858r1225b2926],
51	possibly	RB	O	possibly	advmod	52	SENT_250	[p20l1268t2858r1573b2948],
52	better	JJR	O	better	nn	54	SENT_250	[p20l1614t2858r1831b2926],
53	clinical	JJ	O	clinical	amod	54	SENT_250	[p20l1875t2858r2140b2926],
54	outcomes	NNS	O	outcome	prep_of	40	SENT_250	[p20l9t2971r457b3036],
55	.	.	O	.	_	0	SENT_250	[p20l9t2971r457b3036],

1	”	NN	O	”	nn	3	SENT_251	[p20l9t2971r457b3036],
2	Similar	JJ	O	similar	amod	3	SENT_251	[p20l509t2968r778b3036],
3	ﬁndings	NNS	O	ﬁndings	nsubjpass	6	SENT_251	[p20l822t2968r1130b3058],
4	have	VBP	O	have	aux	6	SENT_251	[p20l1176t2968r1347b3036],
5	been	VBN	O	be	auxpass	6	SENT_251	[p20l1392t2968r1573b3036],
6	noted	VBN	O	note	_	0	SENT_251	[p20l1618t2968r1829b3035],
7	for	IN	O	for	_	0	SENT_251	[p20l1873t2968r1980b3035],
8	the	DT	O	the	det	10	SENT_251	[p20l2022t2968r2139b3036],
9	chronic	JJ	O	chronic	amod	10	SENT_251	[p20l9t3076r291b3145],
10	phase	NN	O	phase	prep_for	6	SENT_251	[p20l317t3076r533b3165],
11	with	IN	O	with	_	0	SENT_251	[p20l558t3076r724b3145],
12	the	DT	O	the	det	14	SENT_251	[p20l749t3076r865b3145],
13	maintenance	NN	O	maintenance	nn	14	SENT_251	[p20l893t3081r1380b3145],
14	dose	NN	O	dose	prep_with	6	SENT_251	[p20l1409t3076r1576b3145],
15	of	IN	O	of	_	0	SENT_251	[p20l1605t3076r1688b3145],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_251	[p20l1703t3076r2136b3166],
17	,	,	O	,	_	0	SENT_251	[p20l1703t3076r2136b3166],
18	which	WDT	O	which	nsubj	19	SENT_251	[p20l7t3185r235b3253],
19	has	VBZ	O	have	rcmod	16	SENT_251	[p20l259t3185r384b3253],
20	possible	JJ	O	possible	amod	22	SENT_251	[p20l412t3185r716b3274],
21	prognostic	JJ	O	prognostic	amod	22	SENT_251	[p20l742t3190r1138b3275],
22	implications	NNS	O	implication	dobj	19	SENT_251	[p20l1163t3185r1764b3274],
23	.33	CD	NUMBER	.33	number	24	SENT_251	[p20l1163t3185r1764b3274],
24	‘	CD	NUMBER	‘	dep	22	SENT_251	[p20l1163t3185r1764b3274],
25	36	CD	NUMBER	36	dep	24	SENT_251	[p20l1163t3185r1764b3274],

1	The	DT	O	the	det	5	SENT_252	[p21l78t17r221b85],
2	recent	JJ	O	recent	amod	5	SENT_252	[p21l245t30r477b85],
3	EXCELSIOR	NN	O	excelsior	nn	5	SENT_252	[p21l502t21r977b85],
4	study	NN	O	study	nn	5	SENT_252	[p21l1001t17r1240b106],
5	“	NN	O	“	nsubj	6	SENT_252	[p21l1001t17r1240b106],
6	showed	VBD	O	show	_	0	SENT_252	[p21l1264t17r1546b85],
7	the	DT	O	the	det	8	SENT_252	[p21l1566t17r1683b85],
8	effect	NN	O	effect	dobj	6	SENT_252	[p21l1707t17r1909b85],
9	of	IN	O	of	_	0	SENT_252	[p21l1931t17r2014b85],
10	the	DT	O	the	det	16	SENT_252	[p21l2023t17r2139b85],
11	single	JJ	O	single	amod	16	SENT_252	[p21l11t125r231b215],
12	nucleotide	NN	O	nucleotide	nn	16	SENT_252	[p21l257t125r647b194],
13	polymorphism	NN	O	polymorphism	nn	16	SENT_252	[p21l674t125r1228b215],
14	C	NN	O	c	nn	16	SENT_252	[p21l1261t131r1315b194],
15	YP2C19	NN	O	yp2c19	nn	16	SENT_252	[p21l1322t130r1698b194],
16	*	NN	O	*	prep_of	8	SENT_252	[p21l1322t130r1698b194],
17	2	CD	NUMBER	2	dep	16	SENT_252	[p21l1322t130r1698b194],
18	on	IN	O	on	_	0	SENT_252	[p21l1722t150r1815b194],
19	residual	JJ	O	residual	amod	21	SENT_252	[p21l1841t125r2140b194],
20	platelet	NN	O	platelet	nn	21	SENT_252	[p21l8t234r280b323],
21	activity	NN	O	activity	prep_on	6	SENT_252	[p21l342t239r603b324],
22	in	IN	O	in	_	0	SENT_252	[p21l663t239r738b301],
23	patients	NNS	O	patient	prep_in	21	SENT_252	[p21l799t239r1094b323],
24	treated	VBN	O	treat	partmod	23	SENT_252	[p21l1157t234r1415b302],
25	with	IN	O	with	_	0	SENT_252	[p21l1474t234r1640b302],
26	clopidogrel	NN	O	clopidogrel	prep_with	24	SENT_252	[p21l1703t234r2136b324],
27	,	,	O	,	_	0	SENT_252	[p21l1703t234r2136b324],
28	providing	VBG	O	provide	xcomp	24	SENT_252	[p21l8t344r369b434],
29	additional	JJ	O	additional	amod	30	SENT_252	[p21l396t344r768b411],
30	evidence	NN	O	evidence	dobj	28	SENT_252	[p21l795t344r1118b412],
31	of	IN	O	of	_	0	SENT_252	[p21l1145t344r1228b411],
32	the	DT	O	the	det	33	SENT_252	[p21l1240t344r1356b411],
33	eifect	NN	O	eifect	prep_of	30	SENT_252	[p21l1384t344r1587b412],
34	of	IN	O	of	_	0	SENT_252	[p21l1612t344r1695b411],
35	this	DT	O	this	det	37	SENT_252	[p21l1707t344r1843b412],
36	genetic	JJ	O	genetic	amod	37	SENT_252	[p21l1873t348r2140b434],
37	variant	NN	O	variant	prep_of	33	SENT_252	[p21l7t457r267b521],
38	on	IN	O	on	_	0	SENT_252	[p21l295t477r389b521],
39	platelet	NN	O	platelet	nn	40	SENT_252	[p21l416t452r689b541],
40	response	NN	O	response	prep_on	37	SENT_252	[p21l717t477r1051b541],
41	to	TO	O	to	_	0	SENT_252	[p21l1078t466r1148b521],
42	clopidogrel	NN	O	clopidogrel	prep_to	28	SENT_252	[p21l1179t452r1612b542],
43	.	.	O	.	_	0	SENT_252	[p21l1179t452r1612b542],

1	However	RB	O	however	advmod	7	SENT_253	[p21l1649t459r1992b531],
2	,	,	O	,	_	0	SENT_253	[p21l1649t459r1992b531],
3	the	DT	O	the	det	4	SENT_253	[p21l2022t452r2139b521],
4	investigators	NNS	O	investigator	nsubj	7	SENT_253	[p21l8t566r481b651],
5	could	MD	O	could	aux	7	SENT_253	[p21l526t561r730b629],
6	not	RB	O	not	neg	7	SENT_253	[p21l770t574r893b629],
7	assess	VB	O	assess	_	0	SENT_253	[p21l933t585r1161b629],
8	the	DT	O	the	det	10	SENT_253	[p21l1203t561r1319b629],
9	clinical	JJ	O	clinical	amod	10	SENT_253	[p21l1363t561r1628b629],
10	effect	NN	O	effect	dobj	7	SENT_253	[p21l1670t561r1872b629],
11	of	IN	O	of	_	0	SENT_253	[p21l1912t561r1995b629],
12	the	DT	O	the	prep_of	10	SENT_253	[p21l2023t561r2139b629],
13	"	``	O	"	punct	12	SENT_253	[p21l9t676r92b739],
14	"	``	O	"	punct	17	SENT_253	[p21l9t676r92b739],
15	2	CD	NUMBER	2	num	17	SENT_253	[p21l9t676r92b739],
16	allelic	JJ	O	allelic	amod	17	SENT_253	[p21l130t672r345b740],
17	variant	NN	O	variant	dep	12	SENT_253	[p21l376t676r653b750],
18	,	,	O	,	_	0	SENT_253	[p21l376t676r653b750],
19	probably	RB	O	probably	advmod	7	SENT_253	[p21l690t672r1016b761],
20	because	IN	O	because	_	0	SENT_253	[p21l1046t672r1342b740],
21	of	IN	O	of	_	0	SENT_253	[p21l1378t672r1461b740],
22	the	DT	O	the	det	24	SENT_253	[p21l1480t672r1597b740],
23	few	JJ	O	few	amod	24	SENT_253	[p21l1631t672r1764b740],
24	events	NNS	O	event	prep_because_of	7	SENT_253	[p21l1797t685r2030b740],
25	in	IN	O	in	prep	7	SENT_253	[p21l2065t676r2140b739],

1	Articles	NNPS	O	Articles	_	0	SENT_254	[p21l6t1244r156b1280],
2	I	PRP	O	I	dep	1	SENT_254	[p21l204t1081r252b1279],

1	this	DT	O	this	det	3	SENT_255	[p21l7t1539r144b1608],
2	low-risk	JJ	O	low-risk	amod	3	SENT_255	[p21l171t1540r471b1608],
3	population	NN	O	population	_	0	SENT_255	[p21l494t1539r899b1628],
4	with	IN	O	with	_	0	SENT_255	[p21l923t1539r1089b1608],
5	little	JJ	O	little	amod	6	SENT_255	[p21l1113t1539r1278b1608],
6	follow-up	NN	O	follow-up	prep_with	3	SENT_255	[p21l1305t1539r1676b1628],
7	,	,	O	,	_	0	SENT_255	[p21l1305t1539r1676b1628],
8	resulting	VBG	O	result	partmod	3	SENT_255	[p21l1705t1540r2040b1629],
9	in	IN	O	in	_	0	SENT_255	[p21l2066t1544r2140b1606],
10	insuiﬁcient	JJ	O	insuiﬁcient	amod	11	SENT_255	[p21l8t1649r437b1718],
11	power	NN	O	power	prep_in	8	SENT_255	[p21l463t1674r693b1738],
12	to	TO	O	to	aux	13	SENT_255	[p21l718t1663r786b1718],
13	detect	VB	O	detect	xcomp	8	SENT_255	[p21l815t1649r1035b1718],
14	a	DT	O	a	det	16	SENT_255	[p21l1062t1674r1099b1718],
15	modest	JJ	O	modest	amod	16	SENT_255	[p21l1125t1649r1402b1718],
16	difference	NN	O	difference	dobj	13	SENT_255	[p21l1429t1649r1802b1718],
17	between	IN	O	between	_	0	SENT_255	[p21l1828t1649r2140b1718],
18	the	DT	O	the	det	20	SENT_255	[p21l7t1759r124b1827],
19	two	CD	NUMBER	two	num	20	SENT_255	[p21l170t1772r302b1827],
20	groups	NNS	O	group	prep_between	16	SENT_255	[p21l351t1783r627b1849],
21	.	.	O	.	_	0	SENT_255	[p21l351t1783r627b1849],

1	By	IN	O	by	_	0	SENT_256	[p21l682t1765r769b1848],
2	contrast	NN	O	contrast	prep_by	6	SENT_256	[p21l815t1772r1132b1837],
3	,	,	O	,	_	0	SENT_256	[p21l815t1772r1132b1837],
4	our	PRP$	O	we	poss	5	SENT_256	[p21l1182t1783r1310b1826],
5	study	NN	O	study	nsubj	6	SENT_256	[p21l1358t1759r1557b1848],
6	shows	VBZ	O	show	_	0	SENT_256	[p21l1604t1759r1831b1827],
7	a	DT	O	a	det	9	SENT_256	[p21l1881t1783r1918b1826],
8	clear	JJ	O	clear	amod	9	SENT_256	[p21l1965t1759r2141b1826],
9	relation	NN	O	relation	dobj	6	SENT_256	[p21l8t1868r296b1937],
10	between	IN	O	between	_	0	SENT_256	[p21l328t1868r639b1937],
11	the	DT	O	the	det	12	SENT_256	[p21l671t1868r788b1937],
12	presence	NN	O	presence	prep_between	9	SENT_256	[p21l822t1893r1154b1957],
13	of	IN	O	of	_	0	SENT_256	[p21l1188t1868r1272b1937],
14	this	DT	O	this	det	16	SENT_256	[p21l1291t1868r1427b1937],
15	allelic	JJ	O	allelic	amod	16	SENT_256	[p21l1465t1868r1679b1937],
16	variant	NN	O	variant	prep_of	12	SENT_256	[p21l1710t1873r1970b1937],
17	and	CC	O	and	_	0	SENT_256	[p21l2003t1868r2141b1937],
18	the	DT	O	the	det	19	SENT_256	[p21l7t1977r124b2045],
19	risk	NN	O	risk	prep_between	9	SENT_256	[p21l151t1977r292b2045],
20	of	IN	O	of	_	0	SENT_256	[p21l317t1977r400b2045],
21	new	JJ	O	new	amod	24	SENT_256	[p21l414t2001r570b2045],
22	thrombotic	JJ	O	thrombotic	amod	24	SENT_256	[p21l592t1977r1011b2045],
23	vascular	JJ	O	vascular	amod	24	SENT_256	[p21l1034t1977r1342b2045],
24	events	NNS	O	event	prep_of	19	SENT_256	[p21l1368t1990r1621b2045],
25	.	.	O	.	_	0	SENT_256	[p21l1368t1990r1621b2045],

1	Patients	NNS	O	patient	nsubj	15	SENT_257	[p21l1655t1981r1948b2045],
2	with	IN	O	with	_	0	SENT_257	[p21l1975t1977r2140b2045],
3	one	CD	NUMBER	one	num	4	SENT_257	[p21l9t2111r144b2155],
4	*	NN	O	*	prep_with	1	SENT_257	[p21l214t2091r297b2153],
5	2	CD	NUMBER	2	num	6	SENT_257	[p21l214t2091r297b2153],
6	allele	NN	O	allele	nsubj	7	SENT_257	[p21l370t2087r560b2155],
7	had	VBD	O	have	rcmod	4	SENT_257	[p21l629t2087r767b2155],
8	a	DT	O	a	det	10	SENT_257	[p21l836t2111r874b2155],
9	higher	JJR	O	higher	amod	10	SENT_257	[p21l941t2087r1189b2177],
10	risk	NN	O	risk	dobj	7	SENT_257	[p21l1256t2087r1397b2155],
11	of	IN	O	of	_	0	SENT_257	[p21l1465t2087r1548b2155],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_257	[p21l1605t2087r2141b2155],
13	recurrence	NN	O	recurrence	prep_of	10	SENT_257	[p21l8t2220r411b2263],
14	than	IN	O	than	prep	7	SENT_257	[p21l472t2195r642b2263],
15	did	VBD	O	do	_	0	SENT_257	[p21l705t2195r822b2263],
16	those	DT	O	those	dobj	15	SENT_257	[p21l882t2195r1081b2263],
17	without	IN	O	without	_	0	SENT_257	[p21l1142t2195r1432b2263],
18	"	``	O	"	punct	19	SENT_257	[p21l1493t2200r1576b2262],
19	2	CD	NUMBER	2	prep_without	15	SENT_257	[p21l1493t2200r1576b2262],
20	allele	NN	O	allele	dep	19	SENT_257	[p21l1642t2195r1852b2263],
21	.	.	O	.	_	0	SENT_257	[p21l1642t2195r1852b2263],

1	These	DT	O	these	det	3	SENT_258	[p21l1917t2195r2139b2263],
2	heterozygous	JJ	O	heterozygous	amod	3	SENT_258	[p21l7t2304r504b2394],
3	carriers	NNS	O	carrier	nsubj	5	SENT_258	[p21l539t2309r817b2372],
4	could	MD	O	could	aux	5	SENT_258	[p21l852t2304r1056b2372],
5	represent	VB	O	represent	_	0	SENT_258	[p21l1086t2317r1441b2393],
6	up	RP	DURATION	up	prt	5	SENT_258	[p21l1469t2328r1565b2393],
7	to	TO	DURATION	to	_	0	SENT_258	[p21l1596t2317r1665b2372],
8	a	DT	DURATION	a	det	9	SENT_258	[p21l1698t2328r1735b2372],
9	quarter	NN	DURATION	quarter	prep_to	5	SENT_258	[p21l1767t2317r2040b2393],
10	of	IN	O	of	_	0	SENT_258	[p21l2070t2304r2153b2372],
11	patients	NNS	O	patient	prep_of	9	SENT_258	[p21l8t2418r303b2502],
12	according	VBG	O	accord	_	0	SENT_258	[p21l335t2414r700b2503],
13	to	TO	O	to	prepc_according_to	5	SENT_258	[p21l727t2427r797b2482],
14	ethnic	JJ	O	ethnic	amod	15	SENT_258	[p21l828t2414r1060b2482],
15	origin	NN	O	origin	pobj	5	SENT_258	[p21l1090t2418r1332b2503],
16	,	,	O	,	_	0	SENT_258	[p21l1090t2418r1332b2503],
17	further	JJ	O	further	appos	15	SENT_258	[p21l1365t2413r1630b2482],
18	emphasising	VBG	O	emphasise	partmod	17	SENT_258	[p21l1660t2414r2140b2503],
19	the	DT	O	the	det	21	SENT_258	[p21l7t2522r124b2591],
20	clinical	JJ	O	clinical	amod	21	SENT_258	[p21l151t2522r416b2591],
21	relevance	NN	O	relevance	dobj	18	SENT_258	[p21l441t2522r791b2591],
22	of	IN	O	of	_	0	SENT_258	[p21l818t2522r901b2591],
23	our	PRP$	O	we	poss	24	SENT_258	[p21l915t2547r1043b2591],
24	ﬁnding	NN	O	ﬁnding	prep_of	21	SENT_258	[p21l1067t2522r1357b2612],
25	.	.	O	.	_	0	SENT_258	[p21l1067t2522r1357b2612],

1	The	DT	O	the	det	2	SENT_259	[p21l78t2631r221b2699],
2	magnitude	NN	O	magnitude	nsubj	48	SENT_259	[p21l293t2631r700b2721],
3	of	IN	O	of	_	0	SENT_259	[p21l773t2631r856b2699],
4	the	DT	O	the	det	6	SENT_259	[p21l913t2631r1029b2699],
5	detrimental	JJ	O	detrimental	amod	6	SENT_259	[p21l1102t2631r1538b2699],
6	effect	NN	O	effect	prep_of	2	SENT_259	[p21l1610t2631r1812b2699],
7	of	IN	O	of	_	0	SENT_259	[p21l1883t2631r1965b2699],
8	the	DT	O	the	det	9	SENT_259	[p21l2023t2631r2139b2699],
9	CYP2C19	NN	O	cyp2c19	prep_of	6	SENT_259	[p21l15t2745r453b2809],
10	"	''	O	"	punct	9	SENT_259	[p21l15t2745r453b2809],
11	"	``	O	"	punct	6	SENT_259	[p21l15t2745r453b2809],
12	2	CD	NUMBER	2	num	14	SENT_259	[p21l15t2745r453b2809],
13	genetic	JJ	O	genetic	amod	14	SENT_259	[p21l492t2745r759b2830],
14	variant	NN	O	variant	nsubj	16	SENT_259	[p21l798t2745r1058b2809],
15	was	VBD	O	be	cop	16	SENT_259	[p21l1096t2765r1235b2809],
16	unexpected	JJ	O	unexpected	dep	6	SENT_259	[p21l1277t2741r1705b2829],
17	in	IN	O	in	_	0	SENT_259	[p21l1745t2745r1819b2807],
18	view	NN	O	view	prep_in	16	SENT_259	[p21l1859t2745r2029b2809],
19	of	IN	O	of	_	0	SENT_259	[p21l2070t2740r2153b2809],
20	the	DT	O	the	det	22	SENT_259	[p21l7t2849r124b2917],
21	clinical	JJ	O	clinical	amod	22	SENT_259	[p21l158t2849r423b2917],
22	beneﬁts	NNS	O	beneﬁts	prep_of	18	SENT_259	[p21l454t2849r749b2917],
23	that	WDT	O	that	nsubjpass	25	SENT_259	[p21l783t2849r928b2917],
24	were	VBD	O	be	auxpass	25	SENT_259	[p21l957t2874r1135b2917],
25	recorded	VBN	O	record	rcmod	22	SENT_259	[p21l1169t2849r1496b2917],
26	with	IN	O	with	_	0	SENT_259	[p21l1526t2849r1691b2917],
27	clopidogrel	NN	O	clopidogrel	prep_with	25	SENT_259	[p21l1725t2849r2140b2939],
28	in	IN	O	in	_	0	SENT_259	[p21l8t2964r83b3026],
29	previous	JJ	O	previous	amod	30	SENT_259	[p21l101t2964r419b3048],
30	studies	NNS	O	study	prep_in	25	SENT_259	[p21l443t2959r703b3027],
31	that	WDT	O	that	nsubj	32	SENT_259	[p21l723t2959r868b3027],
32	used	VBD	O	use	rcmod	30	SENT_259	[p21l884t2959r1061b3027],
33	similar	JJ	O	similar	amod	35	SENT_259	[p21l1082t2959r1344b3027],
34	clinical	JJ	O	clinical	amod	35	SENT_259	[p21l1362t2959r1628b3027],
35	endpoints	NNS	O	endpoint	dobj	32	SENT_259	[p21l1647t2959r2140b3048],
36	.37	CD	NUMBER	.37	num	39	SENT_259	[p21l1647t2959r2140b3048],
37	’38	CD	NUMBER	’38	num	39	SENT_259	[p21l1647t2959r2140b3048],
38	Most	JJS	O	most	amod	39	SENT_259	[p21l12t3076r195b3138],
39	patients	NNS	O	patient	nsubj	43	SENT_259	[p21l231t3074r525b3159],
40	in	IN	O	in	_	0	SENT_259	[p21l565t3074r639b3137],
41	our	PRP$	O	we	poss	42	SENT_259	[p21l678t3094r806b3138],
42	study	NN	O	study	prep_in	39	SENT_259	[p21l844t3070r1044b3159],
43	presented	VBD	O	present	rcmod	35	SENT_259	[p21l1078t3070r1447b3159],
44	with	IN	O	with	_	0	SENT_259	[p21l1481t3070r1647b3138],
45	ST-elevation	NN	O	st-elevation	nn	47	SENT_259	[p21l1690t3070r2140b3138],
46	myocardial	JJ	O	myocardial	amod	47	SENT_259	[p21l8t3178r421b3268],
47	infarction	NN	O	infarction	prep_with	43	SENT_259	[p21l462t3178r959b3247],
48	—	VBD	O	—	_	0	SENT_259	[p21l462t3178r959b3247],
49	a	DT	O	a	det	51	SENT_259	[p21l462t3178r959b3247],
50	clinical	JJ	O	clinical	amod	51	SENT_259	[p21l999t3178r1264b3247],
51	presentation	NN	O	presentation	dobj	48	SENT_259	[p21l1304t3183r1774b3267],
52	which	WDT	O	which	nsubjpass	54	SENT_259	[p21l1812t3178r2040b3247],
53	is	VBZ	O	be	auxpass	54	SENT_259	[p21l2080t3183r2137b3247],
54	associated	VBN	O	associate	rcmod	51	SENT_259	[p21l9t3287r389b3355],
55	with	IN	O	with	_	0	SENT_259	[p21l411t3287r577b3356],
56	a	DT	O	a	det	58	SENT_259	[p21l603t3312r640b3355],
57	high	JJ	O	high	amod	58	SENT_259	[p21l664t3287r835b3377],
58	rate	NN	O	rate	prep_with	54	SENT_259	[p21l860t3301r999b3355],
59	of	IN	O	of	_	0	SENT_259	[p21l1027t3287r1110b3355],
60	recurrent	JJ	O	recurrent	amod	61	SENT_259	[p21l1122t3301r1474b3355],
61	events	NNS	O	event	prep_of	58	SENT_259	[p21l1499t3301r1752b3365],
62	,	,	O	,	_	0	SENT_259	[p21l1499t3301r1752b3365],
63	especially	RB	O	especially	advmod	54	SENT_259	[p21l1783t3287r2142b3377],
64	in	IN	O	in	_	0	SENT_259	[p21l8t3402r83b3465],
65	the	DT	O	the	det	66	SENT_259	[p21l122t3398r238b3466],
66	case	NN	O	case	prep_in	54	SENT_259	[p21l281t3422r435b3466],
67	of	IN	O	of	_	0	SENT_259	[p21l477t3398r560b3466],
68	premature	JJ	O	premature	amod	70	SENT_259	[p21l587t3411r981b3487],
69	coronary	JJ	O	coronary	amod	70	SENT_259	[p21l1023t3422r1351b3487],
70	disease	NN	O	disease	prep_of	66	SENT_259	[p21l1390t3398r1658b3466],
71	when	WRB	O	when	advmod	79	SENT_259	[p21l1698t3398r1904b3466],
72	other	JJ	O	other	amod	73	SENT_259	[p21l1946t3398r2141b3466],
73	genetic	JJ	O	genetic	nsubj	79	SENT_259	[p21l10t3511r277b3596],
74	and	CC	O	and	_	0	SENT_259	[p21l333t3506r470b3575],
75	environmental	JJ	O	environmental	amod	76	SENT_259	[p21l526t3506r1076b3575],
76	factors	NNS	O	factor	conj_and	73	SENT_259	[p21l1131t3506r1378b3575],
77	might	MD	O	might	aux	79	SENT_259	[p21l1436t3506r1662b3596],
78	particularly	RB	O	particularly	advmod	79	SENT_259	[p21l1715t3506r2142b3596],
79	expose	VB	O	expose	advcl	54	SENT_259	[p21l9t3640r258b3705],
80	these	DT	O	these	det	81	SENT_259	[p21l287t3616r482b3684],
81	patients	NNS	O	patient	dobj	79	SENT_259	[p21l512t3621r807b3705],
82	to	TO	O	to	_	0	SENT_259	[p21l837t3629r906b3684],
83	new	JJ	O	new	amod	85	SENT_259	[p21l937t3640r1092b3684],
84	vascular	JJ	O	vascular	amod	85	SENT_259	[p21l1118t3616r1425b3684],
85	events	NNS	O	event	prep_to	79	SENT_259	[p21l1454t3629r1707b3684],
86	.	.	O	.	_	0	SENT_259	[p21l1454t3629r1707b3684],

1	Premature	JJ	O	premature	amod	2	SENT_260	[p21l1745t3623r2139b3684],
2	wvvw	NN	O	wvvw	_	0	SENT_260	[p21l803t941r1336b992],
3	.	.	O	.	_	0	SENT_260	[p21l803t941r1336b992],

1	the	DT	O	the	det	2	SENT_261	[p21l803t941r1336b992],
2	|	NN	O	|	_	0	SENT_261	[p21l803t941r1336b992],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_261	[p21l803t941r1336b992],
4	Vol	NNP	O	Vol	dep	2	SENT_261	[p21l1379t941r1466b992],
5	373	CD	NUMBER	373	num	4	SENT_261	[p21l1486t947r1585b999],
6	January	NNP	DATE	January	tmod	4	SENT_261	[p21l1626t945r1843b1006],
7	24	CD	DATE	24	num	6	SENT_261	[p21l1861t947r1946b1001],
8	,	,	DATE	,	_	0	SENT_261	[p21l1861t947r1946b1001],
9	2009	CD	DATE	2009	num	6	SENT_261	[p21l1965t947r2110b999],

1	coronary	JJ	O	coronary	amod	3	SENT_262	[p22l9t42r337b107],
2	artery	NN	O	artery	nn	3	SENT_262	[p22l362t31r577b107],
3	disease	NN	O	disease	nsubjpass	6	SENT_262	[p22l602t18r869b86],
4	is	VBZ	O	be	auxpass	6	SENT_262	[p22l896t22r954b86],
5	also	RB	O	also	advmod	6	SENT_262	[p22l983t18r1126b86],
6	characterised	VBN	O	characterise	_	0	SENT_262	[p22l1154t18r1649b86],
7	by	IN	O	by	_	0	SENT_262	[p22l1673t18r1760b107],
8	increased	VBN	O	increase	amod	10	SENT_262	[p22l1784t18r2141b86],
9	plasma	NN	O	plasma	nn	10	SENT_262	[p22l8t127r277b216],
10	concentrations	NNS	O	concentration	agent	6	SENT_262	[p22l359t132r910b196],
11	of	IN	O	of	_	0	SENT_262	[p22l995t127r1078b196],
12	prothrombotic	JJ	O	prothrombotic	amod	15	SENT_262	[p22l1146t127r1691b216],
13	and	CC	O	and	_	0	SENT_262	[p22l1773t127r1910b196],
14	proinﬂammatory	JJ	O	proinﬂammatory	conj_and	12	SENT_262	[p22l1991t152r2138b216, p22l8t236r523b325],
15	biomarkers	NNS	O	biomarker	prep_of	10	SENT_262	[p22l537t236r985b314],
16	,	,	O	,	_	0	SENT_262	[p22l537t236r985b314],
17	with	IN	O	with	_	0	SENT_262	[p22l1004t236r1169b304],
18	resulting	VBG	O	result	amod	19	SENT_262	[p22l1186t236r1521b326],
19	hypoﬁbrinolysis	NN	O	hypoﬁbrinolysis	prep_with	6	SENT_262	[p22l1536t236r2137b325],
20	associated	VBN	O	associate	partmod	19	SENT_262	[p22l9t346r389b414],
21	with	IN	O	with	_	0	SENT_262	[p22l423t345r588b414],
22	recurrent	JJ	O	recurrent	amod	23	SENT_262	[p22l625t359r976b414],
23	acute	JJ	O	acute	amod	25	SENT_262	[p22l1012t359r1206b414],
24	coronary	JJ	O	coronary	amod	25	SENT_262	[p22l1245t370r1573b435],
25	syndromes	NNS	O	syndrome	prep_with	20	SENT_262	[p22l1609t346r2141b435],
26	.39	CD	NUMBER	.39	dobj	20	SENT_262	[p22l1609t346r2141b435],
27	'	''	O	'	_	0	SENT_262	[p22l1609t346r2141b435],
28	4	CD	NUMBER	4	number	29	SENT_262	[p22l1609t346r2141b435],
29	°	CD	NUMBER	°	nsubj	46	SENT_262	[p22l1609t346r2141b435],
30	However	RB	O	however	advmod	29	SENT_262	[p22l13t461r355b533],
31	,	,	O	,	_	0	SENT_262	[p22l13t461r355b533],
32	the	DT	O	the	det	33	SENT_262	[p22l389t454r505b523],
33	absence	NN	O	absence	appos	29	SENT_262	[p22l538t454r833b523],
34	of	IN	O	of	_	0	SENT_262	[p22l866t454r950b523],
35	signiﬁcant	NN	O	signiﬁcant	nn	36	SENT_262	[p22l971t454r1363b544],
36	correlation	NN	O	correlation	prep_of	33	SENT_262	[p22l1394t454r1798b523],
37	between	IN	O	between	_	0	SENT_262	[p22l1828t454r2140b523],
38	basal	JJ	O	basal	amod	41	SENT_262	[p22l7t563r196b631],
39	biological	JJ	O	biological	amod	41	SENT_262	[p22l215t563r575b653],
40	risk	NN	O	risk	nn	41	SENT_262	[p22l596t563r737b631],
41	factors	NNS	O	factor	prep_between	36	SENT_262	[p22l755t563r1002b631],
42	and	CC	O	and	_	0	SENT_262	[p22l1026t563r1164b631],
43	further	JJ	O	further	amod	45	SENT_262	[p22l1183t563r1448b631],
44	thrombotic	JJ	O	thrombotic	amod	45	SENT_262	[p22l1466t563r1884b631],
45	events	NNS	O	event	prep_between	36	SENT_262	[p22l1905t577r2137b632],
46	lends	VBZ	O	lend	rcmod	26	SENT_262	[p22l7t673r206b741],
47	support	NN	O	support	dobj	46	SENT_262	[p22l235t686r522b762],
48	to	TO	O	to	_	0	SENT_262	[p22l543t686r613b740],
49	the	DT	O	the	det	51	SENT_262	[p22l636t673r753b740],
50	dominating	VBG	O	dominate	amod	51	SENT_262	[p22l779t673r1215b763],
51	effect	NN	O	effect	prep_to	46	SENT_262	[p22l1240t673r1442b741],
52	of	IN	O	of	_	0	SENT_262	[p22l1466t673r1549b741],
53	the	DT	O	the	det	55	SENT_262	[p22l1558t673r1675b740],
54	C	NN	O	c	nn	55	SENT_262	[p22l1706t678r1761b740],
55	YP2C19	NN	O	yp2c19	prep_of	51	SENT_262	[p22l1767t677r2144b741],
56	"	''	O	"	punct	55	SENT_262	[p22l1767t677r2144b741],
57	"	``	O	"	punct	55	SENT_262	[p22l1767t677r2144b741],
58	2	CD	NUMBER	2	num	61	SENT_262	[p22l1767t677r2144b741],
59	single	JJ	O	single	amod	61	SENT_262	[p22l11t781r231b871],
60	nucleotide	NN	O	nucleotide	nn	61	SENT_262	[p22l336t781r726b850],
61	polymorphism	NN	O	polymorphism	dep	55	SENT_262	[p22l831t781r1404b871],
62	.	.	O	.	_	0	SENT_262	[p22l831t781r1404b871],

1	The	DT	O	the	det	2	SENT_263	[p22l1511t781r1655b850],
2	fact	NN	O	fact	nsubj	29	SENT_263	[p22l1760t781r1895b850],
3	that	IN	O	that	nsubj	4	SENT_263	[p22l1996t781r2141b850],
4	C	NN	O	c	rcmod	2	SENT_263	[p22l15t895r69b958],
5	YP2C19	NN	O	yp2c19	dobj	4	SENT_263	[p22l76t895r453b958],
6	"	''	O	"	punct	5	SENT_263	[p22l76t895r453b958],
7	"	``	O	"	punct	5	SENT_263	[p22l76t895r453b958],
8	2	CD	NUMBER	2	num	9	SENT_263	[p22l76t895r453b958],
9	allele	NN	O	allele	nsubjpass	12	SENT_263	[p22l485t890r676b958],
10	has	VBZ	O	have	aux	12	SENT_263	[p22l711t890r836b958],
11	been	VBN	O	be	auxpass	12	SENT_263	[p22l872t890r1053b958],
12	associated	VBN	O	associate	rcmod	5	SENT_263	[p22l1089t890r1469b958],
13	with	IN	O	with	_	0	SENT_263	[p22l1502t890r1667b958],
14	higher	JJR	O	higher	amod	15	SENT_263	[p22l1701t890r1949b980],
15	concentrations	NNS	O	concentration	prep_with	12	SENT_263	[p22l1983t914r2138b958, p22l9t1005r424b1069],
16	of	IN	O	of	_	0	SENT_263	[p22l493t1001r576b1069],
17	inﬂammatory	JJ	O	inﬂammatory	amod	18	SENT_263	[p22l629t1001r1144b1090],
18	markers	NNS	O	marker	prep_of	15	SENT_263	[p22l1207t1001r1536b1079],
19	,	,	O	,	_	0	SENT_263	[p22l1207t1001r1536b1079],
20	notably	RB	O	notably	advmod	2	SENT_263	[p22l1605t1001r1880b1090],
21	interleukin	NN	O	interleukin	dep	2	SENT_263	[p22l1943t1005r2138b1069, p22l7t1109r245b1178],
22	6	CD	NUMBER	6	num	21	SENT_263	[p22l303t1115r341b1178],
23	and	CC	O	and	_	0	SENT_263	[p22l400t1109r537b1178],
24	high-sensitivity	JJ	O	high-sensitivity	amod	26	SENT_263	[p22l591t1109r1167b1199],
25	C-reactive	JJ	MISC	c-reactive	amod	26	SENT_263	[p22l1224t1114r1590b1178],
26	protein	NN	O	protein	conj_and	21	SENT_263	[p22l1646t1114r1935b1198],
27	,	,	O	,	_	0	SENT_263	[p22l1646t1114r1935b1198],
28	also	RB	O	also	advmod	29	SENT_263	[p22l1996t1109r2139b1178],
29	raises	VBZ	O	raise	_	0	SENT_263	[p22l8t1223r220b1286],
30	the	DT	O	the	det	31	SENT_263	[p22l277t1218r394b1286],
31	possibility	NN	O	possibility	dobj	29	SENT_263	[p22l451t1218r833b1307],
32	that	IN	O	that	complm	37	SENT_263	[p22l885t1218r1031b1286],
33	CYP2C19	NN	O	cyp2c19	nn	34	SENT_263	[p22l1092t1223r1530b1286],
34	*	NN	O	*	nsubj	37	SENT_263	[p22l1092t1223r1530b1286],
35	2	CD	NUMBER	2	dep	34	SENT_263	[p22l1092t1223r1530b1286],
36	can	MD	O	can	aux	37	SENT_263	[p22l1583t1242r1710b1286],
37	affect	VB	O	affect	ccomp	29	SENT_263	[p22l1768t1218r1969b1286],
38	the	DT	O	the	det	41	SENT_263	[p22l2022t1218r2139b1286],
39	underlying	VBG	O	underlie	amod	41	SENT_263	[p22l7t1328r419b1417],
40	cardiovascular	JJ	O	cardiovascular	amod	41	SENT_263	[p22l504t1327r1040b1396],
41	risk	NN	O	risk	dobj	37	SENT_263	[p22l1124t1328r1265b1396],
42	in	IN	O	in	_	0	SENT_263	[p22l1347t1332r1422b1394],
43	addition	NN	O	addition	prep_in	41	SENT_263	[p22l1508t1328r1815b1396],
44	to	TO	O	to	_	0	SENT_263	[p22l1898t1341r1968b1396],
45	its	PRP$	O	its	poss	47	SENT_263	[p22l2053t1332r2137b1396],
46	pharmacogenetic	JJ	O	pharmacogenetic	amod	47	SENT_263	[p22l8t1436r655b1526],
47	effect	NN	O	effect	prep_to	37	SENT_263	[p22l682t1437r884b1505],
48	on	IN	O	on	_	0	SENT_263	[p22l909t1461r1002b1505],
49	clopidogrel	NN	O	clopidogrel	prep_on	37	SENT_263	[p22l1029t1436r1506b1526],
50	.	.	O	.	_	0	SENT_263	[p22l1029t1436r1506b1526],

1	“	NN	O	“	_	0	SENT_264	[p22l1029t1436r1506b1526],

1	The	DT	O	the	det	3	SENT_265	[p22l78t1545r223b1613],
2	consistent	JJ	O	consistent	amod	3	SENT_265	[p22l250t1550r638b1613],
3	increase	NN	O	increase	nsubj	21	SENT_265	[p22l661t1550r973b1613],
4	in	IN	O	in	_	0	SENT_265	[p22l999t1550r1075b1612],
5	clinical	JJ	O	clinical	amod	7	SENT_265	[p22l1100t1545r1370b1613],
6	ischaemic	JJ	O	ischaemic	amod	7	SENT_265	[p22l1395t1545r1776b1613],
7	events	NNS	O	event	prep_in	3	SENT_265	[p22l1802t1559r2037b1613],
8	in	IN	O	in	_	0	SENT_265	[p22l2065t1550r2140b1612],
9	carriers	NNS	O	carrier	prep_in	7	SENT_265	[p22l9t1659r293b1723],
10	of	IN	O	of	_	0	SENT_265	[p22l372t1655r456b1722],
11	the	DT	O	the	det	14	SENT_265	[p22l517t1655r634b1722],
12	genetic	JJ	O	genetic	amod	14	SENT_265	[p22l711t1659r983b1745],
13	variant	JJ	O	variant	amod	14	SENT_265	[p22l1055t1659r1320b1723],
14	CYP2C19	NN	O	cyp2c19	prep_of	9	SENT_265	[p22l1400t1659r1843b1723],
15	"	''	O	"	punct	14	SENT_265	[p22l1400t1659r1843b1723],
16	"	``	O	"	punct	14	SENT_265	[p22l1400t1659r1843b1723],
17	2	CD	NUMBER	2	dep	14	SENT_265	[p22l1400t1659r1843b1723],
18	is	VBZ	O	be	cop	21	SENT_265	[p22l1914t1659r1972b1723],
19	an	DT	O	a	det	21	SENT_265	[p22l2050t1679r2140b1723],
20	important	JJ	O	important	amod	21	SENT_265	[p22l8t1768r391b1852],
21	ﬁnding	NN	O	ﬁnding	_	0	SENT_265	[p22l429t1763r724b1853],
22	.	.	O	.	_	0	SENT_265	[p22l429t1763r724b1853],

1	We	PRP	O	we	nsubj	4	SENT_266	[p22l767t1770r885b1832],
2	could	MD	O	could	aux	4	SENT_266	[p22l926t1763r1133b1832],
3	have	VB	O	have	aux	4	SENT_266	[p22l1170t1763r1343b1832],
4	underestimated	VBN	O	underestimate	_	0	SENT_266	[p22l1382t1763r1984b1832],
5	the	DT	O	the	det	6	SENT_266	[p22l2021t1763r2139b1832],
6	effect	NN	O	effect	nsubj	13	SENT_266	[p22l9t1872r214b1940],
7	of	IN	O	of	_	0	SENT_266	[p22l250t1872r334b1940],
8	the	DT	O	the	det	11	SENT_266	[p22l356t1872r474b1940],
9	CYP2C19	NN	O	cyp2c19	nn	11	SENT_266	[p22l518t1877r961b1940],
10	*	CD	NUMBER	*	num	11	SENT_266	[p22l518t1877r961b1940],
11	‘	NN	O	‘	prep_of	6	SENT_266	[p22l518t1877r961b1940],
12	2	CD	NUMBER	2	num	13	SENT_266	[p22l518t1877r961b1940],
13	genotype	NN	O	genotype	xcomp	4	SENT_266	[p22l995t1885r1336b1962],
14	on	IN	O	on	_	0	SENT_266	[p22l1374t1896r1468b1940],
15	clinical	JJ	O	clinical	amod	16	SENT_266	[p22l1505t1872r1775b1940],
16	outcome	NN	O	outcome	prep_on	13	SENT_266	[p22l1812t1885r2139b1940],
17	in	IN	O	in	_	0	SENT_266	[p22l8t1986r84b2048],
18	view	NN	O	view	prep_in	16	SENT_266	[p22l151t1986r323b2050],
19	of	IN	O	of	_	0	SENT_266	[p22l392t1982r475b2049],
20	delayed	VBN	O	delay	amod	22	SENT_266	[p22l532t1982r817b2071],
21	biological	JJ	O	biological	amod	22	SENT_266	[p22l883t1982r1250b2072],
22	sampling	NN	O	sampling	prep_of	18	SENT_266	[p22l1321t1982r1674b2072],
23	to	TO	O	to	aux	24	SENT_266	[p22l1742t1995r1812b2049],
24	ensure	VB	O	ensure	xcomp	4	SENT_266	[p22l1883t2006r2139b2050],
25	appropriate	JJ	O	appropriate	amod	26	SENT_266	[p22l9t2095r445b2179],
26	measures	NNS	O	measure	dobj	24	SENT_266	[p22l502t2115r865b2159],
27	of	IN	O	of	_	0	SENT_266	[p22l925t2090r1009b2159],
28	the	DT	O	the	det	30	SENT_266	[p22l1051t2090r1168b2159],
29	biological	JJ	O	biological	amod	30	SENT_266	[p22l1224t2090r1590b2180],
30	factors	NNS	O	factor	prep_of	26	SENT_266	[p22l1646t2090r1897b2159],
31	away	RB	O	away	_	0	SENT_266	[p22l1957t2115r2142b2180],
32	from	IN	O	from	_	0	SENT_266	[p22l8t2200r195b2268],
33	the	DT	O	the	det	35	SENT_266	[p22l226t2200r344b2268],
34	initial	JJ	O	initial	amod	35	SENT_266	[p22l376t2200r597b2268],
35	modiﬁcations	NNS	O	modiﬁcations	prep_away_from	24	SENT_266	[p22l629t2200r1148b2268],
36	that	WDT	O	that	nsubjpass	38	SENT_266	[p22l1181t2200r1328b2268],
37	were	VBD	O	be	auxpass	38	SENT_266	[p22l1357t2224r1537b2268],
38	induced	VBN	O	induce	rcmod	35	SENT_266	[p22l1569t2200r1876b2268],
39	by	IN	O	by	_	0	SENT_266	[p22l1905t2200r1993b2289],
40	the	DT	O	the	det	43	SENT_266	[p22l2021t2200r2139b2268],
41	acute	JJ	O	acute	amod	43	SENT_266	[p22l9t2323r207b2378],
42	myocardial	JJ	O	myocardial	amod	43	SENT_266	[p22l252t2310r671b2399],
43	infarction	NN	O	infarction	agent	38	SENT_266	[p22l715t2309r1107b2378],
44	.	.	O	.	_	0	SENT_266	[p22l715t2309r1107b2378],

1	The	DT	O	the	det	2	SENT_267	[p22l1155t2310r1300b2378],
2	heterogeneity	NN	O	heterogeneity	nsubj	18	SENT_267	[p22l1343t2309r1864b2399],
3	of	IN	O	of	_	0	SENT_267	[p22l1907t2309r1991b2378],
4	the	DT	O	the	det	5	SENT_267	[p22l2021t2309r2139b2378],
5	time	NN	O	time	prep_of	2	SENT_267	[p22l7t2423r180b2487],
6	of	IN	O	of	_	0	SENT_267	[p22l261t2418r345b2487],
7	treatment	NN	O	treatment	prep_of	5	SENT_267	[p22l409t2432r784b2487],
8	and	CC	O	and	_	0	SENT_267	[p22l863t2418r1002b2487],
9	the	DT	O	the	det	11	SENT_267	[p22l1079t2418r1197b2487],
10	delayed	VBN	O	delay	amod	11	SENT_267	[p22l1278t2418r1562b2508],
11	initiation	NN	O	initiation	conj_and	5	SENT_267	[p22l1640t2423r1989b2487],
12	of	IN	O	of	_	0	SENT_267	[p22l2069t2418r2153b2487],
13	clopidogrel	NN	O	clopidogrel	prep_of	11	SENT_267	[p22l9t2527r432b2617],
14	in	IN	O	in	_	0	SENT_267	[p22l464t2532r539b2594],
15	some	DT	O	some	det	16	SENT_267	[p22l573t2551r773b2595],
16	patients	NNS	O	patient	prep_in	11	SENT_267	[p22l805t2532r1105b2616],
17	are	VBP	O	be	cop	18	SENT_267	[p22l1140t2551r1253b2595],
18	indicative	JJ	O	indicative	_	0	SENT_267	[p22l1285t2527r1651b2595],
19	of	IN	O	of	_	0	SENT_267	[p22l1685t2527r1769b2595],
20	the	DT	O	the	det	22	SENT_267	[p22l1787t2527r1904b2595],
21	study	NN	O	study	nn	22	SENT_267	[p22l1940t2527r2142b2617],
22	design	NN	O	design	prep_of	18	SENT_267	[p22l9t2637r279b2726],
23	,	,	O	,	_	0	SENT_267	[p22l9t2637r279b2726],
24	but	CC	O	but	_	0	SENT_267	[p22l305t2637r431b2705],
25	were	VBD	O	be	auxpass	26	SENT_267	[p22l452t2661r632b2705],
26	accounted	VBN	O	account	conj_but	18	SENT_267	[p22l658t2636r1043b2705],
27	for	IN	O	for	prep	26	SENT_267	[p22l1066t2636r1174b2705],
28	in	IN	O	in	pcomp	27	SENT_267	[p22l1196t2641r1272b2703],
29	the	DT	O	the	det	31	SENT_267	[p22l1295t2637r1412b2705],
30	statistical	JJ	O	statistical	amod	31	SENT_267	[p22l1439t2637r1793b2705],
31	analysis	NN	O	analysis	pobj	28	SENT_267	[p22l1818t2636r2136b2726],
32	.	.	O	.	_	0	SENT_267	[p22l1818t2636r2136b2726],

1	However	RB	O	however	advmod	10	SENT_268	[p22l13t2752r360b2823],
2	,	,	O	,	_	0	SENT_268	[p22l13t2752r360b2823],
3	the	DT	O	the	det	5	SENT_268	[p22l409t2745r527b2813],
4	long	JJ	O	long	amod	5	SENT_268	[p22l572t2745r739b2835],
5	follow-up	NN	O	follow-up	nsubj	10	SENT_268	[p22l785t2745r1141b2834],
6	of	IN	O	of	_	0	SENT_268	[p22l1189t2745r1273b2813],
7	our	PRP$	O	we	poss	9	SENT_268	[p22l1307t2770r1436b2813],
8	study	NN	O	study	nn	9	SENT_268	[p22l1483t2745r1685b2835],
9	population	NN	O	population	prep_of	5	SENT_268	[p22l1729t2745r2140b2834],
10	shows	VBZ	O	show	_	0	SENT_268	[p22l11t2854r241b2922],
11	the	DT	O	the	det	12	SENT_268	[p22l289t2854r407b2922],
12	effect	NN	O	effect	dobj	10	SENT_268	[p22l456t2854r661b2922],
13	over	IN	O	over	_	0	SENT_268	[p22l708t2878r868b2922],
14	time	NN	O	time	prep_over	12	SENT_268	[p22l912t2859r1084b2922],
15	of	IN	O	of	_	0	SENT_268	[p22l1133t2854r1217b2922],
16	this	DT	O	this	det	18	SENT_268	[p22l1249t2854r1388b2922],
17	genetic	JJ	O	genetic	amod	18	SENT_268	[p22l1439t2859r1710b2944],
18	variant	NN	O	variant	prep_of	14	SENT_268	[p22l1755t2859r2019b2922],
19	in	IN	O	in	_	0	SENT_268	[p22l2065t2859r2140b2921],
20	patients	NNS	O	patient	prep_in	10	SENT_268	[p22l8t2968r308b3052],
21	treated	VBN	O	treat	partmod	20	SENT_268	[p22l374t2963r637b3032],
22	with	IN	O	with	_	0	SENT_268	[p22l700t2963r867b3032],
23	clopidogrel	NN	O	clopidogrel	prep_with	21	SENT_268	[p22l933t2963r1375b3053],
24	,	,	O	,	_	0	SENT_268	[p22l933t2963r1375b3053],
25	as	IN	O	as	mark	26	SENT_268	[p22l1445t2988r1518b3032],
26	opposed	VBN	O	oppose	advcl	10	SENT_268	[p22l1587t2963r1903b3052],
27	to	TO	O	to	_	0	SENT_268	[p22l1966t2977r2036b3032],
28	a	DT	O	a	det	29	SENT_268	[p22l2103t2988r2140b3032],
29	population	NN	O	population	prep_to	26	SENT_268	[p22l8t3073r420b3162],
30	with	IN	O	with	_	0	SENT_268	[p22l478t3073r646b3141],
31	percutaneous	JJ	O	percutaneous	amod	33	SENT_268	[p22l706t3087r1217b3162],
32	coronary	JJ	O	coronary	amod	33	SENT_268	[p22l1282t3098r1614b3163],
33	intervention	NN	O	intervention	prep_with	26	SENT_268	[p22l1673t3078r2140b3141],
34	that	WDT	O	that	nsubj	44	SENT_268	[p22l7t3183r155b3251],
35	has	VBZ	O	have	aux	37	SENT_268	[p22l195t3183r322b3251],
36	follow-up	JJ	O	follow-up	advmod	37	SENT_268	[p22l368t3183r724b3272],
37	limited	VBN	O	limit	rcmod	33	SENT_268	[p22l767t3183r1041b3251],
38	to	TO	O	to	_	0	SENT_268	[p22l1082t3196r1151b3251],
39	6	CD	DURATION	6	num	40	SENT_268	[p22l1198t3189r1236b3251],
40	months	NNS	NUMBER	month	prep_to	37	SENT_268	[p22l1280t3183r1571b3251],
41	after	IN	O	after	_	0	SENT_268	[p22l1618t3183r1788b3251],
42	stenting	VBG	O	stent	prepc_after	37	SENT_268	[p22l1833t3187r2140b3273],
43	and	CC	O	and	_	0	SENT_268	[p22l9t3291r149b3360],
44	misses	VBZ	O	miss	conj_and	37	SENT_268	[p22l184t3296r442b3360],
45	the	DT	O	the	det	46	SENT_268	[p22l480t3292r597b3360],
46	effect	NN	O	effect	dobj	44	SENT_268	[p22l636t3292r841b3360],
47	of	IN	O	of	_	0	SENT_268	[p22l878t3291r961b3360],
48	genetic	JJ	O	genetic	amod	49	SENT_268	[p22l987t3296r1258b3381],
49	determinants	NNS	O	determinant	prep_of	46	SENT_268	[p22l1295t3291r1802b3360],
50	on	IN	O	on	_	0	SENT_268	[p22l1843t3316r1937b3360],
51	later	JJ	O	later	amod	52	SENT_268	[p22l1972t3292r2141b3360],
52	events	NNS	O	event	prep_on	44	SENT_268	[p22l9t3414r267b3468],
53	.	.	O	.	_	0	SENT_268	[p22l9t3414r267b3468],

1	The	DT	O	the	det	3	SENT_269	[p22l308t3400r454b3468],
2	median	JJ	O	median	amod	3	SENT_269	[p22l493t3400r780b3468],
3	time	NN	O	time	nsubj	17	SENT_269	[p22l817t3405r990b3468],
4	from	IN	O	from	_	0	SENT_269	[p22l1029t3400r1215b3468],
5	the	DT	O	the	det	7	SENT_269	[p22l1252t3400r1370b3468],
6	qualifying	VBG	O	qualify	amod	7	SENT_269	[p22l1410t3400r1793b3490],
7	event	NN	O	event	prep_from	3	SENT_269	[p22l1832t3414r2034b3469],
8	to	TO	O	to	_	0	SENT_269	[p22l2069t3414r2139b3468],
9	recurrent	JJ	O	recurrent	amod	12	SENT_269	[p23l8t30r366b85],
10	acute	JJ	O	acute	amod	12	SENT_269	[p23l391t30r588b85],
11	thrombotic	JJ	O	thrombotic	amod	12	SENT_269	[p23l614t17r1038b85],
12	event	NN	O	event	prep_to	7	SENT_269	[p23l1065t30r1267b85],
13	was	VBD	O	be	cop	17	SENT_269	[p23l1290t41r1429b85],
14	more	JJR	DURATION	more	mwe	15	SENT_269	[p23l1458t41r1656b85],
15	than	IN	DURATION	than	quantmod	16	SENT_269	[p23l1681t17r1853b85],
16	2	CD	DURATION	2	num	17	SENT_269	[p23l1881t23r1918b84],
17	years	NNS	NUMBER	year	_	0	SENT_269	[p23l1945t41r2138b106],
18	in	IN	O	in	_	0	SENT_269	[p23l8t130r84b192],
19	our	PRP$	O	we	poss	20	SENT_269	[p23l115t150r244b194],
20	study	NN	O	study	prep_in	17	SENT_269	[p23l275t125r487b215],
21	.	.	O	.	_	0	SENT_269	[p23l275t125r487b215],

1	The	DT	O	the	det	3	SENT_270	[p23l520t125r665b194],
2	extended	JJ	O	extended	amod	3	SENT_270	[p23l697t125r1037b194],
3	duration	NN	O	duration	nsubjpass	18	SENT_270	[p23l1067t125r1392b194],
4	of	IN	O	of	_	0	SENT_270	[p23l1423t125r1506b194],
5	dual	JJ	O	dual	amod	7	SENT_270	[p23l1524t125r1686b194],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_270	[p23l1717t125r2141b214],
7	therapy	NN	O	therapy	prep_of	3	SENT_270	[p23l7t234r294b324],
8	to	TO	O	to	_	0	SENT_270	[p23l324t248r394b302],
9	more	JJR	DURATION	more	mwe	10	SENT_270	[p23l429t259r627b302],
10	than	IN	DURATION	than	quantmod	11	SENT_270	[p23l661t234r832b302],
11	a	DT	DURATION	a	num	12	SENT_270	[p23l867t259r904b302],
12	year	NN	DURATION	year	prep_to	7	SENT_270	[p23l936t259r1094b324],
13	in	IN	O	in	_	0	SENT_270	[p23l1126t239r1202b301],
14	our	PRP$	O	we	poss	16	SENT_270	[p23l1236t259r1366b302],
15	study	NN	O	study	nn	16	SENT_270	[p23l1400t234r1603b324],
16	population	NN	O	population	prep_in	3	SENT_270	[p23l1634t234r2046b323],
17	is	VBZ	O	be	auxpass	18	SENT_270	[p23l2080t239r2138b302],
18	justiﬁed	VBN	O	justiﬁed	_	0	SENT_270	[p23l8t344r319b433],
19	by	IN	O	by	_	0	SENT_270	[p23l385t344r473b433],
20	the	DT	O	the	det	21	SENT_270	[p23l538t344r656b412],
21	search	NN	O	search	agent	18	SENT_270	[p23l729t344r971b412],
22	of	IN	O	of	_	0	SENT_270	[p23l1040t344r1124b411],
23	an	DT	O	a	det	26	SENT_270	[p23l1181t368r1271b411],
24	optimum	JJ	O	optimum	amod	26	SENT_270	[p23l1340t348r1696b433],
25	long-term	JJ	O	long-term	amod	26	SENT_270	[p23l1763t344r2140b434],
26	prevention	NN	O	prevention	prep_of	21	SENT_270	[p23l8t458r419b542],
27	in	IN	O	in	_	0	SENT_270	[p23l444t458r519b520],
28	patients	NNS	O	patient	prep_in	26	SENT_270	[p23l543t458r843b542],
29	with	IN	O	with	_	0	SENT_270	[p23l869t453r1036b522],
30	premature	JJ	O	premature	amod	32	SENT_270	[p23l1061t467r1460b542],
31	coronary	JJ	O	coronary	amod	32	SENT_270	[p23l1487t478r1820b543],
32	disease	NN	O	disease	prep_with	28	SENT_270	[p23l1844t453r2136b531],
33	,	,	O	,	_	0	SENT_270	[p23l1844t453r2136b531],

1	vWvw	NN	O	vwvw	_	0	SENT_271	[p23l7t723r540b774],
2	.	.	O	.	_	0	SENT_271	[p23l7t723r540b774],

1	the	DT	O	the	det	2	SENT_272	[p23l7t723r540b774],
2	|	NN	O	|	_	0	SENT_272	[p23l7t723r540b774],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_272	[p23l7t723r540b774],
4	Vol	NNP	O	Vol	dep	2	SENT_272	[p23l583t723r670b774],
5	373	CD	NUMBER	373	num	6	SENT_272	[p23l689t729r789b781],
6	January	NNP	DATE	January	dep	2	SENT_272	[p23l830t727r1047b788],
7	24,2009	CD	DATE	24,2009	num	6	SENT_272	[p23l1064t729r1314b783],

1	persistent	JJ	O	persistent	amod	3	SENT_273	[p23l9t919r278b979],
2	risk	NN	O	risk	nn	3	SENT_273	[p23l295t916r397b965],
3	factors	NNS	O	factor	_	0	SENT_273	[p23l415t916r594b965],
4	such	JJ	O	such	_	0	SENT_273	[p23l616t916r741b965],
5	as	IN	O	as	_	0	SENT_273	[p23l760t933r812b965],
6	serious	JJ	O	serious	amod	8	SENT_273	[p23l834t919r1026b965],
7	familial	JJ	O	familial	amod	8	SENT_273	[p23l1047t916r1254b965],
8	history	NN	O	history	prep_such_as	3	SENT_273	[p23l1271t916r1460b980],
9	of	IN	O	of	_	0	SENT_273	[p23l1478t916r1538b965],
10	premature	JJ	O	premature	amod	12	SENT_273	[p23l9t1004r293b1058],
11	myocardial	JJ	O	myocardial	amod	12	SENT_273	[p23l316t995r615b1058],
12	infarction	NN	O	infarction	prep_of	8	SENT_273	[p23l637t995r903b1043],
13	or	CC	O	or	_	0	SENT_273	[p23l926t1012r981b1043],
14	persistent	JJ	O	persistent	amod	15	SENT_273	[p23l1002t998r1270b1058],
15	smoking	NN	O	smoking	prep_such_as	3	SENT_273	[p23l1294t995r1529b1059],
16	after	IN	O	after	_	0	SENT_273	[p23l10t1072r132b1121],
17	the	DT	O	the	det	20	SENT_273	[p23l182t1072r266b1121],
18	index	NN	O	index	nn	20	SENT_273	[p23l319t1072r467b1121],
19	myocardial	JJ	O	myocardial	amod	20	SENT_273	[p23l518t1072r817b1136],
20	infarction	NN	O	infarction	prep_after	15	SENT_273	[p23l869t1072r1149b1128],
21	,	,	O	,	_	0	SENT_273	[p23l869t1072r1149b1128],
22	and	CC	O	and	_	0	SENT_273	[p23l1205t1072r1304b1121],
23	a	DT	O	a	det	27	SENT_273	[p23l1357t1090r1383b1121],
24	low	JJ	O	low	amod	27	SENT_273	[p23l1434t1072r1530b1121],
25	spontaneous	JJ	O	spontaneous	amod	27	SENT_273	[p23l11t1159r352b1213],
26	bleeding	NN	O	bleeding	nn	27	SENT_273	[p23l391t1150r625b1214],
27	risk	NN	O	risk	conj_and	8	SENT_273	[p23l662t1150r765b1198],
28	in	IN	O	in	_	0	SENT_273	[p23l802t1153r855b1198],
29	this	DT	O	this	det	31	SENT_273	[p23l892t1150r991b1198],
30	young	JJ	O	young	amod	31	SENT_273	[p23l1029t1167r1198b1214],
31	population	NN	O	population	prep_in	27	SENT_273	[p23l1235t1150r1529b1213],
32	with	IN	O	with	_	0	SENT_273	[p23l8t1229r127b1277],
33	poor	JJ	O	poor	amod	36	SENT_273	[p23l146t1246r270b1292],
34	long-term	JJ	O	long-term	amod	36	SENT_273	[p23l287t1229r556b1293],
35	clinical	JJ	O	clinical	amod	36	SENT_273	[p23l576t1229r768b1277],
36	outcome	NN	O	outcome	prep_with	3	SENT_273	[p23l788t1233r1069b1277],
37	.	.	O	.	_	0	SENT_273	[p23l788t1233r1069b1277],

1	“	NN	O	“	_	0	SENT_274	[p23l788t1233r1069b1277],

1	Most	JJS	O	most	amod	2	SENT_275	[p23l62t1312r193b1355],
2	patients	NNS	O	patient	nsubj	8	SENT_275	[p23l209t1310r418b1370],
3	who	WP	O	who	nsubj	4	SENT_275	[p23l436t1307r548b1355],
4	entered	VBD	O	enter	rcmod	2	SENT_275	[p23l567t1307r768b1355],
5	the	DT	O	the	det	7	SENT_275	[p23l783t1307r866b1355],
6	AFIII	NNP	O	AFIII	nn	7	SENT_275	[p23l882t1310r1029b1369],
7	registry	NN	O	registry	dobj	4	SENT_275	[p23l1049t1310r1250b1371],
8	received	VBD	O	receive	_	0	SENT_275	[p23l1266t1307r1485b1355],
9	a	DT	O	a	det	10	SENT_275	[p23l1502t1324r1529b1355],
10	stent	NN	O	stent	dobj	8	SENT_275	[p23l11t1394r140b1433],
11	for	IN	O	for	_	0	SENT_275	[p23l172t1384r248b1433],
12	management	NN	O	management	prep_for	8	SENT_275	[p23l280t1394r635b1448],
13	of	IN	O	of	_	0	SENT_275	[p23l668t1384r727b1433],
14	acute	JJ	O	acute	amod	16	SENT_275	[p23l752t1394r890b1433],
15	myocardial	JJ	O	myocardial	amod	16	SENT_275	[p23l924t1384r1218b1448],
16	infarction	NN	O	infarction	prep_of	12	SENT_275	[p23l1251t1384r1526b1433],
17	.	.	O	.	_	0	SENT_275	[p23l1251t1384r1526b1433],

1	Half	NN	O	half	nsubj	20	SENT_276	[p23l12t1462r135b1511],
2	the	DT	O	the	det	4	SENT_276	[p23l161t1462r244b1511],
3	ischaemic	JJ	O	ischaemic	amod	4	SENT_276	[p23l281t1462r548b1511],
4	events	NNS	O	event	nsubj	13	SENT_276	[p23l585t1472r750b1511],
5	that	WDT	O	that	nsubjpass	7	SENT_276	[p23l787t1462r891b1511],
6	were	VBD	O	be	auxpass	7	SENT_276	[p23l924t1480r1051b1511],
7	reported	VBN	O	report	rcmod	4	SENT_276	[p23l1088t1462r1313b1525],
8	during	IN	O	during	_	0	SENT_276	[p23l1349t1462r1529b1526],
9	follow-up	NN	O	follow-up	prep_during	7	SENT_276	[p23l9t1540r259b1603],
10	were	VBD	O	be	cop	13	SENT_276	[p23l293t1557r420b1588],
11	deﬁnite	JJ	O	deﬁnite	amod	13	SENT_276	[p23l455t1540r657b1588],
12	stent	NN	O	stent	nn	13	SENT_276	[p23l693t1549r822b1588],
13	thrombosis	NN	O	thrombosis	rcmod	1	SENT_276	[p23l855t1540r1173b1595],
14	,	,	O	,	_	0	SENT_276	[p23l855t1540r1173b1595],
15	and	CC	O	and	_	0	SENT_276	[p23l1210t1540r1309b1588],
16	half	NN	O	half	rcmod	1	SENT_276	[p23l1341t1540r1453b1588],
17	of	IN	O	of	_	0	SENT_276	[p23l1479t1540r1538b1588],
18	these	DT	O	these	det	19	SENT_276	[p23l8t1617r148b1666],
19	events	NNS	O	event	prep_of	16	SENT_276	[p23l177t1627r343b1666],
20	occurred	VBD	O	occur	_	0	SENT_276	[p23l374t1617r607b1666],
21	beyond	IN	O	beyond	_	0	SENT_276	[p23l633t1617r828b1681],
22	6	CD	DURATION	6	num	23	SENT_276	[p23l857t1621r884b1666],
23	months	NNS	NUMBER	month	prep_beyond	20	SENT_276	[p23l913t1617r1117b1666],
24	after	IN	O	after	_	0	SENT_276	[p23l1148t1617r1268b1666],
25	stenting	VBG	O	stent	prepc_after	20	SENT_276	[p23l1297t1620r1526b1681],
26	,	,	O	,	_	0	SENT_276	[p23l1297t1620r1526b1681],
27	suggesting	VBG	O	suggest	dep	25	SENT_276	[p23l11t1698r298b1759],
28	that	IN	O	that	complm	40	SENT_276	[p23l363t1695r466b1743],
29	identiﬁcation	NN	O	identiﬁcation	nsubj	40	SENT_276	[p23l531t1695r885b1743],
30	of	IN	O	of	_	0	SENT_276	[p23l951t1695r1010b1743],
31	the	DT	O	the	det	32	SENT_276	[p23l1066t1695r1149b1743],
32	CYP2C19	NN	O	cyp2c19	prep_of	29	SENT_276	[p23l1219t1698r1531b1744],
33	"	''	O	"	punct	32	SENT_276	[p23l1219t1698r1531b1744],
34	'	''	O	'	_	0	SENT_276	[p23l1219t1698r1531b1744],
35	~	FW	O	~	nn	38	SENT_276	[p23l1219t1698r1531b1744],
36	‘	FW	O	‘	dep	38	SENT_276	[p23l1219t1698r1531b1744],
37	2	CD	NUMBER	2	num	38	SENT_276	[p23l1219t1698r1531b1744],
38	polymorphism	NN	O	polymorphism	advmod	40	SENT_276	[p23l9t1773r404b1836],
39	could	MD	O	could	aux	40	SENT_276	[p23l422t1773r567b1821],
40	help	VB	O	help	ccomp	27	SENT_276	[p23l583t1773r698b1836],
41	identify	VB	O	identify	xcomp	40	SENT_276	[p23l716t1773r920b1836],
42	patients	NNS	O	patient	dobj	41	SENT_276	[p23l935t1776r1145b1836],
43	at	IN	O	at	_	0	SENT_276	[p23l1165t1782r1211b1821],
44	risk	NN	O	risk	prep_at	41	SENT_276	[p23l1227t1773r1328b1821],
45	for	IN	O	for	_	0	SENT_276	[p23l1344t1773r1420b1821],
46	late	JJ	O	late	amod	48	SENT_276	[p23l1435t1773r1528b1821],
47	stent	NN	O	stent	nn	48	SENT_276	[p23l11t1860r140b1899],
48	thrombosis	NN	O	thrombosis	prep_for	44	SENT_276	[p23l189t1850r507b1899],
49	.	.	O	.	_	0	SENT_276	[p23l189t1850r507b1899],

1	Our	PRP$	O	we	poss	2	SENT_277	[p23l562t1854r668b1899],
2	data	NNS	O	datum	nsubj	4	SENT_277	[p23l718t1850r827b1899],
3	also	RB	O	also	advmod	4	SENT_277	[p23l878t1850r980b1899],
4	indicate	VBP	O	indicate	_	0	SENT_277	[p23l1032t1850r1242b1899],
5	that	IN	O	that	complm	21	SENT_277	[p23l1292t1850r1396b1899],
6	the	DT	O	the	det	7	SENT_277	[p23l1445t1850r1528b1899],
7	CYP2C19	NN	O	cyp2c19	nsubjpass	21	SENT_277	[p23l14t1931r326b1977],
8	"	''	O	"	punct	7	SENT_277	[p23l14t1931r326b1977],
9	'	''	O	'	_	0	SENT_277	[p23l14t1931r326b1977],
10	\	JJ	O	\	amod	14	SENT_277	[p23l14t1931r326b1977],
11	‘	NN	O	‘	npadvmod	13	SENT_277	[p23l14t1931r326b1977],
12	2	CD	NUMBER	2	num	11	SENT_277	[p23l14t1931r326b1977],
13	loss-of-function	JJ	O	loss-of-function	amod	14	SENT_277	[p23l355t1928r772b1976],
14	polymorphism	NN	O	polymorphism	npadvmod	7	SENT_277	[p23l804t1928r1199b1992],
15	in	IN	O	in	_	0	SENT_277	[p23l1232t1931r1285b1976],
16	patients	NNS	O	patient	prep_in	7	SENT_277	[p23l1317t1931r1527b1991],
17	with	IN	O	with	_	0	SENT_277	[p23l8t2006r126b2055],
18	coronary	JJ	O	coronary	amod	19	SENT_277	[p23l149t2024r383b2070],
19	angioplasty	NN	O	angioplasty	prep_with	7	SENT_277	[p23l405t2006r708b2070],
20	is	VBZ	O	be	auxpass	21	SENT_277	[p23l729t2010r770b2055],
21	associated	VBN	O	associate	ccomp	4	SENT_277	[p23l796t2006r1066b2055],
22	with	IN	O	with	_	0	SENT_277	[p23l1087t2006r1205b2055],
23	new	JJ	O	new	amod	24	SENT_277	[p23l1228t2024r1339b2055],
24	events	NNS	O	event	prep_with	21	SENT_277	[p23l1361t2016r1527b2055],
25	originating	VBG	O	originate	partmod	24	SENT_277	[p23l10t2087r305b2148],
26	from	IN	O	from	_	0	SENT_277	[p23l331t2084r463b2133],
27	sites	NNS	O	site	prep_from	25	SENT_277	[p23l491t2087r605b2133],
28	distinct	JJ	O	distinct	amod	27	SENT_277	[p23l634t2084r832b2133],
29	from	IN	O	from	_	0	SENT_277	[p23l857t2084r989b2133],
30	the	DT	O	the	det	32	SENT_277	[p23l1014t2084r1097b2133],
31	coronary	JJ	O	coronary	amod	32	SENT_277	[p23l1124t2102r1358b2148],
32	stent	NN	O	stent	prep_from	28	SENT_277	[p23l1385t2094r1526b2140],
33	,	,	O	,	_	0	SENT_277	[p23l1385t2094r1526b2140],
34	and	CC	O	and	_	0	SENT_277	[p23l10t2162r108b2210],
35	identiﬁcation	NN	O	identiﬁcation	nsubj	42	SENT_277	[p23l138t2162r493b2210],
36	of	IN	O	of	_	0	SENT_277	[p23l524t2162r583b2210],
37	this	DT	O	this	det	39	SENT_277	[p23l603t2162r701b2210],
38	gene	NN	O	gene	nn	39	SENT_277	[p23l734t2179r859b2226],
39	variant	NN	O	variant	prep_of	35	SENT_277	[p23l889t2165r1074b2210],
40	could	MD	O	could	aux	42	SENT_277	[p23l1104t2162r1250b2210],
41	also	RB	O	also	advmod	42	SENT_277	[p23l1280t2162r1382b2210],
42	help	VB	O	help	conj_and	4	SENT_277	[p23l1412t2162r1528b2225],
43	with	IN	O	with	_	0	SENT_277	[p23l8t2240r126b2289],
44	the	DT	O	the	det	48	SENT_277	[p23l153t2240r236b2289],
45	global	JJ	O	global	amod	48	SENT_277	[p23l265t2240r424b2304],
46	cardiovascular	JJ	O	cardiovascular	amod	48	SENT_277	[p23l453t2240r835b2289],
47	risk	NN	O	risk	nn	48	SENT_277	[p23l862t2240r963b2289],
48	assessment	NN	O	assessment	prep_with	42	SENT_277	[p23l991t2250r1297b2289],
49	of	IN	O	of	_	0	SENT_277	[p23l1325t2240r1384b2289],
50	such	JJ	O	such	amod	51	SENT_277	[p23l1405t2240r1529b2289],
51	patients	NNS	O	patient	prep_of	48	SENT_277	[p23l9t2321r234b2381],
52	.	.	O	.	_	0	SENT_277	[p23l9t2321r234b2381],

1	Whether	IN	O	whether	complm	30	SENT_278	[p23l259t2318r494b2367],
2	increased	VBN	O	increase	amod	3	SENT_278	[p23l517t2318r771b2367],
3	doses	NNS	O	dose	nsubj	30	SENT_278	[p23l795t2318r940b2367],
4	of	IN	O	of	_	0	SENT_278	[p23l966t2318r1025b2367],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_278	[p23l1040t2318r1336b2382],
6	or	CC	O	or	_	0	SENT_278	[p23l1361t2336r1415b2367],
7	use	NN	O	use	prep_of	3	SENT_278	[p23l1437t2335r1528b2367],
8	of	IN	O	of	_	0	SENT_278	[p23l10t2396r69b2444],
9	new	JJ	O	new	amod	10	SENT_278	[p23l91t2413r203b2444],
10	drugs	NNS	O	drug	prep_of	5	SENT_278	[p23l233t2396r383b2460],
11	less	RBR	O	less	advmod	12	SENT_278	[p23l415t2396r512b2444],
12	dependent	JJ	O	dependent	amod	10	SENT_278	[p23l546t2396r829b2459],
13	of	IN	O	of	_	0	SENT_278	[p23l860t2396r919b2444],
14	CYP2C19	NN	O	cyp2c19	prep_of	10	SENT_278	[p23l947t2396r1526b2460],
15	"	''	O	"	punct	14	SENT_278	[p23l947t2396r1526b2460],
16	"	``	O	"	punct	5	SENT_278	[p23l947t2396r1526b2460],
17	2	CD	NUMBER	2	number	18	SENT_278	[p23l947t2396r1526b2460],
18	—	CD	NUMBER	—	conj_or	5	SENT_278	[p23l947t2396r1526b2460],
19	namely	RB	O	namely	advmod	18	SENT_278	[p23l947t2396r1526b2460],
20	,	,	O	,	_	0	SENT_278	[p23l947t2396r1526b2460],
21	prasugrel	NN	O	prasugrel	conj_or	5	SENT_278	[p23l9t2474r261b2538],
22	or	CC	O	or	_	0	SENT_278	[p23l332t2492r386b2523],
23	prolonged	JJ	O	prolonged	amod	24	SENT_278	[p23l455t2474r727b2538],
24	treatments	NNS	O	treatment	conj_or	5	SENT_278	[p23l795t2484r1083b2523],
25	with	IN	O	with	_	0	SENT_278	[p23l1153t2474r1271b2523],
26	thienopyridines	NNS	O	thienopyridine	nn	27	SENT_278	[p23l1340t2474r1527b2523, p23l9t2552r416b2616],
27	—	NN	O	—	prep_with	3	SENT_278	[p23l1340t2474r1527b2523, p23l9t2552r416b2616],
28	can	MD	O	can	aux	30	SENT_278	[p23l1340t2474r1527b2523, p23l9t2552r416b2616],
29	better	RB	O	better	advmod	30	SENT_278	[p23l456t2552r611b2601],
30	protect	VB	O	protect	ccomp	43	SENT_278	[p23l651t2562r837b2615],
31	carriers	NNS	O	carrier	dobj	30	SENT_278	[p23l878t2555r1077b2601],
32	of	IN	O	of	_	0	SENT_278	[p23l1121t2552r1180b2601],
33	the	DT	O	the	det	37	SENT_278	[p23l1212t2552r1295b2601],
34	genetic	JJ	O	genetic	amod	37	SENT_278	[p23l1338t2555r1529b2616],
35	variant	NN	O	variant	nn	37	SENT_278	[p23l8t2633r193b2678],
36	C	NN	O	c	nn	37	SENT_278	[p23l248t2633r286b2678],
37	YP2C197	NN	O	yp2c197	prep_of	31	SENT_278	[p23l291t2633r560b2678],
38	'	''	O	'	_	0	SENT_278	[p23l291t2633r560b2678],
39	~	FW	O	~	nn	40	SENT_278	[p23l291t2633r560b2678],
40	‘	FW	O	‘	amod	31	SENT_278	[p23l291t2633r560b2678],
41	2	CD	NUMBER	2	nsubj	43	SENT_278	[p23l291t2633r560b2678],
42	remains	VBZ	O	remain	cop	43	SENT_278	[p23l608t2633r825b2678],
43	unknown	JJ	O	unknown	_	0	SENT_278	[p23l877t2630r1147b2678],
44	.	.	O	.	_	0	SENT_278	[p23l877t2630r1147b2678],

1	However	RB	O	however	advmod	7	SENT_279	[p23l1204t2635r1448b2685],
2	,	,	O	,	_	0	SENT_279	[p23l1204t2635r1448b2685],
3	a	DT	O	a	det	4	SENT_279	[p23l1502t2647r1529b2678],
4	strategy	NN	O	strategy	nsubj	7	SENT_279	[p23l11t2717r217b2771],
5	of	IN	O	of	_	0	SENT_279	[p23l264t2707r323b2756],
6	genotyping	VBG	O	genotype	prep_of	4	SENT_279	[p23l363t2711r660b2771],
7	seems	VBZ	O	seem	_	0	SENT_279	[p23l710t2725r873b2756],
8	to	TO	O	to	aux	12	SENT_279	[p23l922t2717r971b2756],
9	be	VB	O	be	cop	12	SENT_279	[p23l1018t2707r1080b2756],
10	an	DT	O	a	det	12	SENT_279	[p23l1129t2725r1192b2756],
11	interesting	JJ	O	interesting	amod	12	SENT_279	[p23l1240t2711r1529b2771],
12	alternative	NN	O	alternative	xcomp	7	SENT_279	[p23l10t2785r287b2834],
13	to	TO	O	to	_	0	SENT_279	[p23l303t2795r352b2834],
14	a	DT	O	a	det	15	SENT_279	[p23l370t2802r396b2834],
15	strategy	NN	O	strategy	prep_to	12	SENT_279	[p23l414t2795r620b2849],
16	of	IN	O	of	_	0	SENT_279	[p23l636t2785r695b2834],
17	repeated	VBN	O	repeat	amod	19	SENT_279	[p23l702t2785r930b2848],
18	platelet	NN	O	platelet	nn	19	SENT_279	[p23l945t2785r1139b2848],
19	monitoring	NN	O	monitoring	prep_of	15	SENT_279	[p23l1154t2788r1459b2849],
20	in	IN	O	in	_	0	SENT_279	[p23l1475t2788r1529b2833],
21	patients	NNS	O	patient	prep_in	19	SENT_279	[p23l9t2866r219b2926],
22	given	VBN	O	give	partmod	21	SENT_279	[p23l248t2866r390b2927],
23	clopidogrel	NN	O	clopidogrel	dobj	22	SENT_279	[p23l417t2863r758b2927],
24	.	.	O	.	_	0	SENT_279	[p23l417t2863r758b2927],

1	“	NN	O	“	npadvmod	25	SENT_280	[p23l417t2863r758b2927],
2	In	IN	O	in	_	0	SENT_280	[p23l788t2868r844b2911],
3	the	DT	O	the	det	5	SENT_280	[p23l870t2863r953b2912],
4	EXCELSIOR	NNP	O	EXCELSIOR	nn	5	SENT_280	[p23l982t2866r1320b2912],
5	study	NN	O	study	prep_in	25	SENT_280	[p23l1348t2863r1529b2927],
6	,	,	O	,	_	0	SENT_280	[p23l1348t2863r1529b2927],
7	“	CD	NUMBER	“	nsubjpass	25	SENT_280	[p23l1348t2863r1529b2927],
8	an	DT	O	a	nsubj	9	SENT_280	[p23l10t2959r73b2990],
9	overlap	VBP	O	overlap	rcmod	7	SENT_280	[p23l119t2942r310b3005],
10	between	IN	O	between	_	0	SENT_280	[p23l355t2942r578b2990],
11	residual	JJ	O	residual	amod	13	SENT_280	[p23l623t2942r836b2990],
12	platelet	NN	O	platelet	nn	13	SENT_280	[p23l881t2942r1075b3005],
13	aggregation	NN	O	aggregation	prep_between	9	SENT_280	[p23l1119t2945r1433b3006],
14	of	IN	O	of	_	0	SENT_280	[p23l1479t2942r1538b2990],
15	carriers	NNS	O	carrier	prep_of	13	SENT_280	[p23l10t3021r209b3067],
16	and	CC	O	and	_	0	SENT_280	[p23l241t3018r339b3067],
17	non-carriers	NNS	O	non-carrier	prep_of	13	SENT_280	[p23l368t3021r692b3067],
18	of	IN	O	of	_	0	SENT_280	[p23l724t3018r783b3067],
19	the	DT	O	the	prep_of	15	SENT_280	[p23l803t3018r886b3067],
20	"	``	O	"	punct	19	SENT_280	[p23l917t3021r976b3066],
21	"	``	O	"	punct	23	SENT_280	[p23l917t3021r976b3066],
22	2	CD	NUMBER	2	num	23	SENT_280	[p23l917t3021r976b3066],
23	allele	NN	O	allele	dep	19	SENT_280	[p23l1008t3018r1144b3067],
24	was	VBD	O	be	auxpass	25	SENT_280	[p23l1173t3035r1272b3067],
25	reported	VBN	O	report	_	0	SENT_280	[p23l1304t3018r1529b3081],
26	that	WDT	O	that	nsubj	28	SENT_280	[p23l8t3096r112b3145],
27	could	MD	O	could	aux	28	SENT_280	[p23l147t3096r292b3145],
28	indicate	VB	O	indicate	ccomp	25	SENT_280	[p23l328t3096r537b3145],
29	the	DT	O	the	det	31	SENT_280	[p23l573t3096r656b3145],
30	intrinsic	JJ	O	intrinsic	amod	31	SENT_280	[p23l692t3099r917b3145],
31	variability	NN	O	variability	dobj	28	SENT_280	[p23l951t3096r1215b3160],
32	of	IN	O	of	_	0	SENT_280	[p23l1250t3096r1309b3145],
33	platelet	NN	O	platelet	nn	34	SENT_280	[p23l1335t3096r1530b3159],
34	monitoring	NN	O	monitoring	prep_of	31	SENT_280	[p23l9t3178r327b3239],
35	,	,	O	,	_	0	SENT_280	[p23l9t3178r327b3239],
36	which	WDT	O	which	nsubj	40	SENT_280	[p23l365t3175r528b3223],
37	is	VBZ	O	be	cop	40	SENT_280	[p23l564t3178r605b3223],
38	a	DT	O	a	det	40	SENT_280	[p23l644t3192r670b3223],
39	known	JJ	O	known	amod	40	SENT_280	[p23l706t3175r889b3223],
40	limitation	NN	O	limitation	rcmod	34	SENT_280	[p23l924t3175r1188b3223],
41	of	IN	O	of	_	0	SENT_280	[p23l1225t3175r1284b3223],
42	all	DT	O	all	det	43	SENT_280	[p23l1312t3175r1373b3223],
43	tests	NNS	O	test	prep_of	40	SENT_280	[p23l1408t3184r1527b3223],
44	measuring	VBG	O	measure	partmod	43	SENT_280	[p23l9t3255r297b3316],
45	platelet	NN	O	platelet	nn	46	SENT_280	[p23l315t3252r510b3315],
46	aggregation	NN	O	aggregation	dobj	44	SENT_280	[p23l527t3255r854b3316],
47	.	.	O	.	_	0	SENT_280	[p23l527t3255r854b3316],

1	Other	JJ	O	other	amod	3	SENT_281	[p23l61t3330r215b3378],
2	genetic	JJ	O	genetic	amod	3	SENT_281	[p23l229t3333r419b3394],
3	variants	NNS	O	variant	nsubj	7	SENT_281	[p23l431t3333r641b3378],
4	might	MD	O	might	aux	7	SENT_281	[p23l656t3330r818b3394],
5	also	RB	O	also	advmod	7	SENT_281	[p23l831t3330r933b3378],
6	be	VB	O	be	cop	7	SENT_281	[p23l946t3330r1008b3378],
7	relevant	JJ	O	relevant	_	0	SENT_281	[p23l1022t3330r1235b3378],
8	in	IN	O	in	_	0	SENT_281	[p23l1248t3333r1301b3378],
9	reﬁning	VBG	O	reﬁning	prepc_in	7	SENT_281	[p23l1315t3330r1529b3394],
10	risk	NN	O	risk	nn	11	SENT_281	[p23l9t3409r110b3457],
11	stratiﬁcation	NN	O	stratiﬁcation	dobj	9	SENT_281	[p23l146t3409r493b3457],
12	.	.	O	.	_	0	SENT_281	[p23l146t3409r493b3457],

1	CYP2C19	NN	O	cyp2c19	nsubj	6	SENT_282	[p23l536t3412r874b3458],
2	*	CD	NUMBER	*	number	1	SENT_282	[p23l536t3412r874b3458],
3	‘	CD	NUMBER	‘	number	1	SENT_282	[p23l536t3412r874b3458],
4	17	CD	NUMBER	17	number	1	SENT_282	[p23l536t3412r874b3458],
5	is	VBZ	O	be	cop	6	SENT_282	[p23l904t3412r945b3457],
6	related	JJ	O	related	_	0	SENT_282	[p23l983t3409r1164b3457],
7	to	TO	O	to	_	0	SENT_282	[p23l1199t3418r1248b3457],
8	extensive	JJ	O	extensive	amod	10	SENT_282	[p23l1285t3412r1528b3457],
9	metaboliser	NN	O	metaboliser	nn	10	SENT_282	[p24l9t21r324b70],
10	phenotype	NN	O	phenotype	prep_to	6	SENT_282	[p24l352t21r644b85],
11	,	,	O	,	_	0	SENT_282	[p24l352t21r644b85],
12	Which	WDT	O	which	nsubj	16	SENT_282	[p24l674t21r837b70],
13	could	MD	O	could	aux	16	SENT_282	[p24l867t21r1012b70],
14	be	VB	O	be	cop	16	SENT_282	[p24l1039t21r1100b70],
15	a	DT	O	a	det	16	SENT_282	[p24l1131t39r1157b70],
16	limitation	NN	O	limitation	rcmod	10	SENT_282	[p24l1185t21r1449b70],
17	of	IN	O	of	_	0	SENT_282	[p24l1478t21r1538b70],
18	our	PRP$	O	we	poss	19	SENT_282	[p24l10t116r101b147],
19	study	NN	O	study	prep_of	16	SENT_282	[p24l131t99r274b163],
20	since	IN	O	since	mark	22	SENT_282	[p24l304t102r439b147],
21	we	PRP	O	we	nsubj	22	SENT_282	[p24l468t116r541b147],
22	focused	VBD	O	focus	advcl	16	SENT_282	[p24l572t99r778b147],
23	speciﬁcally	RB	O	speciﬁcally	advmod	22	SENT_282	[p24l808t99r1099b163],
24	on	IN	O	on	_	0	SENT_282	[p24l1128t116r1195b147],
25	the	DT	O	the	det	29	SENT_282	[p24l1224t99r1307b147],
26	genetic	JJ	O	genetic	amod	29	SENT_282	[p24l1338t102r1529b163],
27	variant	NN	O	variant	nn	29	SENT_282	[p24l8t181r193b226],
28	C	NN	O	c	nn	29	SENT_282	[p24l220t181r259b226],
29	YP2C19	NN	O	yp2c19	prep_on	22	SENT_282	[p24l263t181r542b226],
30	"	''	O	"	punct	29	SENT_282	[p24l263t181r542b226],
31	"	``	O	"	punct	29	SENT_282	[p24l263t181r542b226],
32	2	LS	NUMBER	2	dep	29	SENT_282	[p24l263t181r542b226],
33	.	.	O	.	_	0	SENT_282	[p24l263t181r542b226],

1	Additionally	RB	O	additionally	advmod	7	SENT_283	[p24l568t177r901b241],
2	,	,	O	,	_	0	SENT_283	[p24l568t177r901b241],
3	our	PRP$	O	we	poss	4	SENT_283	[p24l928t195r1019b226],
4	investigation	NN	O	investigation	nsubj	7	SENT_283	[p24l1041t181r1384b241],
5	does	VBZ	O	do	aux	7	SENT_283	[p24l1409t177r1527b226],
6	not	RB	O	not	neg	7	SENT_283	[p24l9t265r96b304],
7	have	VB	O	have	dep	37	SENT_283	[p24l133t255r255b304],
8	measurements	NNS	O	measurement	dobj	7	SENT_283	[p24l294t265r692b304],
9	for	IN	O	for	_	0	SENT_283	[p24l732t255r808b304],
10	platelet	NN	O	platelet	nn	11	SENT_283	[p24l846t255r1040b318],
11	aggregation	NN	O	aggregation	prep_for	8	SENT_283	[p24l1078t258r1391b319],
12	and	CC	O	and	_	0	SENT_283	[p24l1431t255r1529b304],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_283	[p24l10t333r306b397],
14	metabolites	NNS	O	metabolite	conj_and	11	SENT_283	[p24l331t333r653b389],
15	,	,	O	,	_	0	SENT_283	[p24l331t333r653b389],
16	but	CC	O	but	_	0	SENT_283	[p24l679t333r768b381],
17	the	DT	O	the	det	19	SENT_283	[p24l791t333r874b381],
18	mechanistic	JJ	O	mechanistic	amod	19	SENT_283	[p24l900t333r1224b381],
19	relation	NN	O	relation	dobj	7	SENT_283	[p24l1248t333r1453b381],
20	of	IN	O	of	_	0	SENT_283	[p24l1478t333r1538b381],
21	CYP2C19	NN	O	cyp2c19	prep_of	19	SENT_283	[p24l14t415r326b460],
22	"	''	O	"	punct	19	SENT_283	[p24l14t415r326b460],
23	'	''	O	'	_	0	SENT_283	[p24l14t415r326b460],
24	~	FW	O	~	nn	27	SENT_283	[p24l14t415r326b460],
25	‘	FW	O	‘	dep	27	SENT_283	[p24l14t415r326b460],
26	2	CD	NUMBER	2	num	27	SENT_283	[p24l14t415r326b460],
27	polymorphism	NN	O	polymorphism	advmod	7	SENT_283	[p24l359t411r755b475],
28	to	TO	O	to	_	0	SENT_283	[p24l791t421r840b460],
29	clopidogrel	NN	O	clopidogrel	nn	30	SENT_283	[p24l879t411r1175b475],
30	metabolism	NN	O	metabolism	prep_to	37	SENT_283	[p24l1212t411r1529b460],
31	and	CC	O	and	_	0	SENT_283	[p24l10t489r108b538],
32	platelet	NN	O	platelet	nn	33	SENT_283	[p24l141t489r335b552],
33	aggregation	NN	O	aggregation	prep_to	37	SENT_283	[p24l369t492r682b553],
34	has	VBZ	O	have	aux	37	SENT_283	[p24l715t489r805b538],
35	been	VBN	O	be	auxpass	37	SENT_283	[p24l840t489r968b538],
36	well	RB	O	well	advmod	37	SENT_283	[p24l1001t489r1109b538],
37	established	VBN	O	establish	_	0	SENT_283	[p24l1144t489r1442b538],
38	in	IN	O	in	_	0	SENT_283	[p24l1475t492r1529b537],
39	previous	JJ	O	previous	amod	41	SENT_283	[p24l9t570r235b630],
40	reports1	JJ	O	reports1	amod	41	SENT_283	[p24l268t570r566b630],
41	‘“	NN	O	‘“	prep_in	37	SENT_283	[p24l268t570r566b630],
42	‘	CD	NUMBER	‘	number	43	SENT_283	[p24l268t570r566b630],
43	*	CD	NUMBER	*	nsubjpass	37	SENT_283	[p24l268t570r566b630],
44	21	CD	NUMBER	21	nsubj	51	SENT_283	[p24l268t570r566b630],
45	and	CC	O	and	_	0	SENT_283	[p24l597t567r696b616],
46	the	DT	O	the	det	47	SENT_283	[p24l725t567r808b616],
47	aim	NN	O	aim	nsubj	51	SENT_283	[p24l840t570r941b616],
48	of	IN	O	of	_	0	SENT_283	[p24l973t567r1032b616],
49	our	PRP$	O	we	poss	50	SENT_283	[p24l1055t585r1145b616],
50	study	NN	O	study	prep_of	47	SENT_283	[p24l1177t567r1320b631],
51	was	VBD	O	be	rcmod	43	SENT_283	[p24l1348t584r1446b616],
52	to	TO	O	to	aux	53	SENT_283	[p24l1479t577r1528b616],
53	focus	VB	O	focus	xcomp	51	SENT_283	[p24l9t646r149b694],
54	on	IN	O	on	_	0	SENT_283	[p24l173t663r240b694],
55	the	DT	O	the	det	56	SENT_283	[p24l260t646r344b694],
56	effect	NN	O	effect	prep_on	53	SENT_283	[p24l366t646r511b694],
57	of	IN	O	of	_	0	SENT_283	[p24l532t646r591b694],
58	the	DT	O	the	det	64	SENT_283	[p24l603t646r686b694],
59	genetic	JJ	O	genetic	amod	64	SENT_283	[p24l709t649r900b710],
60	variant	NN	O	variant	nn	64	SENT_283	[p24l919t649r1105b694],
61	C	NN	O	c	nn	64	SENT_283	[p24l1131t649r1169b694],
62	YP2C19	NN	O	yp2c19	nn	64	SENT_283	[p24l1173t649r1442b694],
63	*	CD	NUMBER	*	num	64	SENT_283	[p24l1173t649r1442b694],
64	‘	NN	O	‘	prep_of	56	SENT_283	[p24l1173t649r1442b694],
65	2	CD	NUMBER	2	dobj	53	SENT_283	[p24l1173t649r1442b694],
66	on	IN	O	on	_	0	SENT_283	[p24l1462t663r1529b694],
67	clinical	JJ	O	clinical	amod	68	SENT_283	[p24l10t723r199b772],
68	outcome	NN	O	outcome	prep_on	65	SENT_283	[p24l230t733r473b772],
69	.	.	O	.	_	0	SENT_283	[p24l230t733r473b772],

1	Finally	RB	O	finally	advmod	10	SENT_284	[p24l510t723r695b787],
2	,	,	O	,	_	0	SENT_284	[p24l510t723r695b787],
3	whether	IN	O	whether	_	0	SENT_284	[p24l726t723r946b772],
4	higher	JJR	O	higher	amod	6	SENT_284	[p24l975t723r1151b787],
5	maintenance	NN	O	maintenance	nn	6	SENT_284	[p24l1180t726r1528b772],
6	doses	NNS	O	dose	prep_whether	10	SENT_284	[p24l10t801r155b850],
7	of	IN	O	of	_	0	SENT_284	[p24l172t801r232b850],
8	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_284	[p24l238t801r534b865],
9	would	MD	O	would	aux	10	SENT_284	[p24l548t801r713b850],
10	override	VB	O	override	_	0	SENT_284	[p24l728t801r945b850],
11	the	DT	O	the	det	13	SENT_284	[p24l960t801r1042b850],
12	detrimental	JJ	O	detrimental	amod	13	SENT_284	[p24l1059t801r1370b850],
13	effect	NN	O	effect	dobj	10	SENT_284	[p24l1385t801r1530b850],
14	of	IN	O	of	_	0	SENT_284	[p24l10t879r69b927],
15	the	DT	O	the	det	19	SENT_284	[p24l124t879r207b927],
16	loss-of-function	JJ	O	loss-of-function	amod	19	SENT_284	[p24l272t879r689b927],
17	CYP2C19	NN	O	cyp2c19	nn	19	SENT_284	[p24l759t882r1071b927],
18	*	CD	NUMBER	*	num	19	SENT_284	[p24l759t882r1071b927],
19	‘	NN	O	‘	prep_of	13	SENT_284	[p24l759t882r1071b927],
20	2	CD	NUMBER	2	num	22	SENT_284	[p24l759t882r1071b927],
21	polymorphism	NN	O	polymorphism	nn	22	SENT_284	[p24l1133t879r1529b942],
22	Warrants	NNS	O	warrant	nsubj	10	SENT_284	[p24l8t966r240b1005],
23	further	RBR	O	further	advmod	22	SENT_284	[p24l260t956r449b1005],
24	clinical	JJ	O	clinical	amod	25	SENT_284	[p24l467t956r656b1005],
25	investigation	NN	O	investigation	pobj	23	SENT_284	[p24l674t959r1031b1020],
26	.	.	O	.	_	0	SENT_284	[p24l674t959r1031b1020],

1	In	IN	O	in	_	0	SENT_285	[p24l62t1039r118b1082],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_285	[p24l162t1034r465b1090],
3	,	,	O	,	_	0	SENT_285	[p24l162t1034r465b1090],
4	our	PRP$	O	we	poss	5	SENT_285	[p24l512t1051r603b1082],
5	study	NN	O	study	nsubj	6	SENT_285	[p24l647t1034r790b1097],
6	shows	VBZ	O	show	_	0	SENT_285	[p24l833t1034r995b1082],
7	a	DT	O	a	det	9	SENT_285	[p24l1041t1051r1068b1082],
8	strong	JJ	O	strong	amod	9	SENT_285	[p24l1113t1044r1281b1098],
9	relation	NN	O	relation	dobj	6	SENT_285	[p24l1324t1034r1529b1082],
10	between	IN	O	between	_	0	SENT_285	[p24l8t1112r231b1160],
11	the	DT	O	the	det	12	SENT_285	[p24l258t1112r341b1160],
12	presence	NN	O	presence	prep_between	9	SENT_285	[p24l369t1129r605b1175],
13	of	IN	O	of	_	0	SENT_285	[p24l634t1112r693b1160],
14	the	DT	O	the	det	19	SENT_285	[p24l711t1112r794b1160],
15	CYP2C19	NN	O	cyp2c19	nn	19	SENT_285	[p24l827t1115r1139b1160],
16	*	NN	O	*	nn	19	SENT_285	[p24l827t1115r1139b1160],
17	2	CD	NUMBER	2	num	19	SENT_285	[p24l827t1115r1139b1160],
18	allelic	JJ	O	allelic	amod	19	SENT_285	[p24l1165t1112r1318b1160],
19	variant	NN	O	variant	prep_of	12	SENT_285	[p24l1344t1115r1529b1160],
20	and	CC	O	and	_	0	SENT_285	[p24l10t1189r108b1238],
21	recurrent	JJ	O	recurrent	amod	24	SENT_285	[p24l191t1199r442b1238],
22	thrombotic	JJ	O	thrombotic	amod	24	SENT_285	[p24l524t1189r822b1238],
23	coronary	JJ	O	coronary	amod	24	SENT_285	[p24l907t1207r1140b1253],
24	events	NNS	O	event	conj_and	19	SENT_285	[p24l1224t1199r1389b1238],
25	in	IN	O	in	_	0	SENT_285	[p24l1475t1192r1529b1237],
26	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	27	SENT_285	[p24l10t1267r509b1331],
27	patients	NNS	O	patient	prep_in	24	SENT_285	[p24l534t1270r744b1330],
28	predominantly	RB	O	predominantly	advmod	27	SENT_285	[p24l772t1267r1168b1331],
29	of	IN	O	of	_	0	SENT_285	[p24l1194t1267r1253b1315],
30	European	JJ	MISC	european	amod	31	SENT_285	[p24l1273t1270r1529b1330],
31	ancestry	NN	O	ancestry	prep_of	27	SENT_285	[p24l10t1355r230b1409],
32	who	WP	O	who	nsubj	33	SENT_285	[p24l263t1345r375b1394],
33	survived	VBD	O	survive	rcmod	19	SENT_285	[p24l414t1345r636b1394],
34	a	DT	O	a	det	36	SENT_285	[p24l672t1363r698b1394],
35	myocardial	JJ	O	myocardial	amod	36	SENT_285	[p24l734t1345r1028b1409],
36	infarction	NN	O	infarction	dobj	33	SENT_285	[p24l1064t1345r1325b1394],
37	before	IN	O	before	_	0	SENT_285	[p24l1360t1345r1528b1394],
38	45	CD	DURATION	45	num	39	SENT_285	[p24l8t1426r65b1472],
39	years	NNS	NUMBER	year	prep_before	33	SENT_285	[p24l102t1440r237b1487],
40	of	IN	O	of	_	0	SENT_285	[p24l275t1423r334b1472],
41	age	NN	O	age	prep_of	39	SENT_285	[p24l362t1441r463b1487],
42	.	.	O	.	_	0	SENT_285	[p24l362t1441r463b1487],

1	Whether	IN	O	whether	complm	18	SENT_286	[p24l500t1423r735b1472],
2	the	DT	O	the	det	4	SENT_286	[p24l769t1423r852b1472],
3	prognostic	JJ	O	prognostic	amod	4	SENT_286	[p24l888t1426r1171b1487],
4	information	NN	O	information	nsubjpass	18	SENT_286	[p24l1206t1423r1529b1472],
5	associated	VBN	O	associate	partmod	4	SENT_286	[p24l10t1501r281b1549],
6	with	IN	O	with	_	0	SENT_286	[p24l312t1501r431b1549],
7	the	DT	O	the	det	8	SENT_286	[p24l464t1501r547b1549],
8	CYP2C19	NN	O	cyp2c19	prep_with	5	SENT_286	[p24l586t1504r898b1550],
9	"	''	O	"	punct	8	SENT_286	[p24l586t1504r898b1550],
10	'	''	O	'	_	0	SENT_286	[p24l586t1504r898b1550],
11	~	FW	O	~	nn	14	SENT_286	[p24l586t1504r898b1550],
12	‘	FW	O	‘	dep	14	SENT_286	[p24l586t1504r898b1550],
13	2	CD	NUMBER	2	num	14	SENT_286	[p24l586t1504r898b1550],
14	genotype	NN	O	genotype	advmod	5	SENT_286	[p24l931t1510r1169b1565],
15	can	MD	O	can	aux	18	SENT_286	[p24l1205t1518r1296b1549],
16	also	RB	O	also	advmod	18	SENT_286	[p24l1331t1501r1433b1549],
17	be	VB	O	be	auxpass	18	SENT_286	[p24l1467t1501r1528b1549],
18	used	VBN	O	use	csubj	25	SENT_286	[p24l8t1579r135b1628],
19	to	TO	O	to	aux	20	SENT_286	[p24l153t1589r202b1628],
20	guide	VB	O	guide	xcomp	18	SENT_286	[p24l223t1579r370b1643],
21	management	NN	O	management	dobj	20	SENT_286	[p24l390t1589r745b1643],
22	of	IN	O	of	_	0	SENT_286	[p24l765t1579r824b1628],
23	these	DT	O	these	det	24	SENT_286	[p24l833t1579r973b1628],
24	patients	NNS	O	patient	prep_of	21	SENT_286	[p24l993t1583r1203b1643],
25	needs	VBZ	O	need	_	0	SENT_286	[p24l1224t1579r1377b1628],
26	to	TO	O	to	aux	28	SENT_286	[p24l1398t1589r1447b1628],
27	be	VB	O	be	auxpass	28	SENT_286	[p24l1467t1579r1528b1628],
28	investigated	VBN	O	investigate	xcomp	25	SENT_286	[p24l9t1657r329b1721],
29	further	RB	O	further	advmod	28	SENT_286	[p24l392t1657r588b1706],
30	.	.	O	.	_	0	SENT_286	[p24l392t1657r588b1706],

1	These	DT	O	these	det	2	SENT_287	[p24l654t1657r813b1706],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_287	[p24l878t1657r1097b1721],
3	need	VBP	O	need	_	0	SENT_287	[p24l1162t1657r1291b1706],
4	to	TO	O	to	aux	7	SENT_287	[p24l1353t1667r1403b1706],
5	be	VB	O	be	auxpass	7	SENT_287	[p24l1467t1657r1528b1706],
6	independently	RB	O	independently	advmod	7	SENT_287	[p24l9t1735r394b1798],
7	replicated	VBN	O	replicate	xcomp	3	SENT_287	[p24l429t1735r691b1798],
8	before	IN	O	before	_	0	SENT_287	[p24l726t1735r894b1783],
9	being	VBG	O	be	auxpass	10	SENT_287	[p24l931t1735r1081b1799],
10	extrapolated	VBN	O	extrapolate	prepc_before	7	SENT_287	[p24l1119t1735r1443b1798],
11	to	TO	O	to	_	0	SENT_287	[p24l1479t1745r1528b1783],
12	older	JJR	O	older	amod	13	SENT_287	[p24l10t1813r145b1862],
13	patients	NNS	O	patient	prep_to	10	SENT_287	[p24l162t1817r372b1877],
14	or	CC	O	or	_	0	SENT_287	[p24l393t1831r447b1862],
15	those	DT	O	those	conj_or	13	SENT_287	[p24l463t1813r605b1862],
16	of	IN	O	of	_	0	SENT_287	[p24l625t1813r684b1862],
17	non-European	JJ	MISC	non-european	amod	18	SENT_287	[p24l693t1816r1076b1877],
18	ancestry	NN	O	ancestry	prep_of	15	SENT_287	[p24l1095t1823r1322b1877],
19	.	.	O	.	_	0	SENT_287	[p24l1095t1823r1322b1877],

1	Articles	NNPS	O	Articles	_	0	SENT_288	[p24l101t2280r251b2316],

1	Contributors	NNS	O	contributor	_	0	SENT_289	[p24l647t2522r901b2558],

1	GM	NNP	ORGANIZATION	GM	_	0	SENT_290	[p24l648t2584r736b2625],
2	,	,	O	,	_	0	SENT_290	[p24l648t2584r736b2625],
3	]	SYM	O	]	dep	5	SENT_290	[p24l754t2584r855b2630],
4	-	:	O	-	_	0	SENT_290	[p24l754t2584r855b2630],
5	PC	NN	O	pc	dep	1	SENT_290	[p24l754t2584r855b2630],
6	,	,	O	,	_	0	SENT_290	[p24l754t2584r855b2630],
7	and	CC	O	and	advmod	1	SENT_290	[p24l872t2582r948b2619],
8	]	SYM	O	]	dep	10	SENT_290	[p24l962t2584r1058b2630],
9	-	:	O	-	_	0	SENT_290	[p24l962t2584r1058b2630],
10	SH	NN	O	sh	dep	1	SENT_290	[p24l962t2584r1058b2630],
11	conceived	VBD	O	conceive	rcmod	10	SENT_290	[p24l1075t2582r1277b2619],
12	and	CC	O	and	_	0	SENT_290	[p24l1291t2582r1367b2619],
13	designed	VBD	O	design	conj_and	11	SENT_290	[p24l1381t2582r1566b2631],
14	the	DT	O	the	det	15	SENT_290	[p24l1578t2582r1642b2619],
15	research	NN	O	research	dobj	13	SENT_290	[p24l1657t2582r1841b2619],
16	.	.	O	.	_	0	SENT_290	[p24l1657t2582r1841b2619],

1	GM	NNP	ORGANIZATION	GM	_	0	SENT_291	[p24l1859t2584r1947b2625],
2	,	,	O	,	_	0	SENT_291	[p24l1859t2584r1947b2625],
3	]	SYM	O	]	dep	5	SENT_291	[p24l1964t2584r2066b2630],
4	-	:	O	-	_	0	SENT_291	[p24l1964t2584r2066b2630],
5	PC	NN	O	pc	dep	1	SENT_291	[p24l1964t2584r2066b2630],
6	,	,	O	,	_	0	SENT_291	[p24l1964t2584r2066b2630],

1	I-SI-I	NN	O	i-si-i	nsubj	11	SENT_292	[p24l648t2644r756b2689],
2	,	,	O	,	_	0	SENT_292	[p24l648t2644r756b2689],
3	DB	NN	O	db	appos	1	SENT_292	[p24l774t2645r848b2684],
4	,	,	O	,	_	0	SENT_292	[p24l774t2645r848b2684],
5	AP	NN	O	ap	appos	1	SENT_292	[p24l864t2644r936b2685],
6	,	,	O	,	_	0	SENT_292	[p24l864t2644r936b2685],
7	LP	NN	O	lp	appos	1	SENT_292	[p24l954t2645r1017b2685],
8	,	,	O	,	_	0	SENT_292	[p24l954t2645r1017b2685],
9	GC	NN	O	gc	appos	1	SENT_292	[p24l1034t2644r1111b2685],
10	,	,	O	,	_	0	SENT_292	[p24l1034t2644r1111b2685],
11	IS	VBZ	O	be	_	0	SENT_292	[p24l1128t2644r1182b2690],
12	,	,	O	,	_	0	SENT_292	[p24l1128t2644r1182b2690],
13	and	CC	O	and	_	0	SENT_292	[p24l1198t2642r1274b2679],
14	]	SYM	O	]	conj_and	11	SENT_292	[p24l1288t2644r1376b2689],
15	-	:	O	-	_	0	SENT_292	[p24l1288t2644r1376b2689],
16	BE	VB	O	be	auxpass	17	SENT_292	[p24l1288t2644r1376b2689],
17	acquired	VBN	O	acquire	ccomp	11	SENT_292	[p24l1392t2642r1570b2690],
18	the	DT	O	the	det	19	SENT_292	[p24l1582t2642r1647b2679],
19	data	NNS	O	datum	dobj	17	SENT_292	[p24l1661t2642r1756b2679],
20	.	.	O	.	_	0	SENT_292	[p24l1661t2642r1756b2679],

1	GM	NNP	ORGANIZATION	GM	nsubj	12	SENT_293	[p24l1773t2644r1862b2685],
2	,	,	O	,	_	0	SENT_293	[p24l1773t2644r1862b2685],
3	I-PC	NN	O	i-pc	nn	4	SENT_293	[p24l1879t2644r1969b2690],
4	I-SH	NN	O	i-sh	appos	1	SENT_293	[p24l1986t2644r2094b2689],
5	,	,	O	,	_	0	SENT_293	[p24l1986t2644r2094b2689],
6	EV	NN	O	ev	appos	1	SENT_293	[p24l649t2705r711b2746],
7	,	,	O	,	_	0	SENT_293	[p24l649t2705r711b2746],
8	CF-B	NN	O	cf-b	appos	1	SENT_293	[p24l728t2705r842b2746],
9	,	,	O	,	_	0	SENT_293	[p24l728t2705r842b2746],
10	GB	NN	O	gb	appos	1	SENT_293	[p24l859t2705r935b2746],
11	,	,	O	,	_	0	SENT_293	[p24l859t2705r935b2746],
12	IS	VBZ	O	be	_	0	SENT_293	[p24l952t2705r1005b2751],
13	,	,	O	,	_	0	SENT_293	[p24l952t2705r1005b2751],
14	GC	NN	O	gc	dep	12	SENT_293	[p24l1023t2705r1100b2745],
15	,	,	O	,	_	0	SENT_293	[p24l1023t2705r1100b2745],
16	AP	NN	ORGANIZATION	ap	dep	12	SENT_293	[p24l1115t2705r1187b2746],
17	,	,	O	,	_	0	SENT_293	[p24l1115t2705r1187b2746],
18	and	CC	O	and	_	0	SENT_293	[p24l1203t2703r1280b2740],
19	DB	NN	O	db	dep	12	SENT_293	[p24l1295t2706r1357b2739],
20	analysed	VBD	O	analyse	rcmod	14	SENT_293	[p24l1374t2703r1551b2752],
21	and	CC	O	and	_	0	SENT_293	[p24l1565t2703r1641b2740],
22	interpreted	VBD	O	interpret	rcmod	14	SENT_293	[p24l1654t2703r1884b2751],
23	the	DT	O	the	det	24	SENT_293	[p24l1897t2703r1961b2740],
24	data	NNS	O	datum	dobj	22	SENT_293	[p24l1976t2703r2070b2740],
25	.	.	O	.	_	0	SENT_293	[p24l1976t2703r2070b2740],

1	GM	NNP	ORGANIZATION	GM	_	0	SENT_294	[p24l648t2766r736b2807],
2	,	,	O	,	_	0	SENT_294	[p24l648t2766r736b2807],
3	]	SYM	O	]	dep	5	SENT_294	[p24l754t2766r855b2811],
4	-	:	O	-	_	0	SENT_294	[p24l754t2766r855b2811],
5	PC	NN	O	pc	dep	1	SENT_294	[p24l754t2766r855b2811],
6	,	,	O	,	_	0	SENT_294	[p24l754t2766r855b2811],
7	and	CC	O	and	advmod	1	SENT_294	[p24l872t2764r948b2801],
8	]	SYM	O	]	dep	10	SENT_294	[p24l962t2766r1058b2811],
9	-	:	O	-	_	0	SENT_294	[p24l962t2766r1058b2811],
10	SH	NN	O	sh	dep	1	SENT_294	[p24l962t2766r1058b2811],
11	did	VBD	O	do	rcmod	10	SENT_294	[p24l1075t2764r1140b2801],
12	the	DT	O	the	det	14	SENT_294	[p24l1152t2764r1217b2801],
13	statistical	JJ	O	statistical	amod	14	SENT_294	[p24l1232t2764r1423b2801],
14	analysis	NN	O	analysis	dobj	11	SENT_294	[p24l1437t2764r1609b2813],
15	.	.	O	.	_	0	SENT_294	[p24l1437t2764r1609b2813],

1	GM	NNP	ORGANIZATION	GM	_	0	SENT_295	[p24l1627t2766r1703b2801],
2	and	CC	O	and	advmod	1	SENT_295	[p24l1720t2764r1796b2801],
3	]	SYM	O	]	dep	5	SENT_295	[p24l1811t2766r1901b2811],
4	-	:	O	-	_	0	SENT_295	[p24l1811t2766r1901b2811],
5	PC	NN	O	pc	dep	1	SENT_295	[p24l1811t2766r1901b2811],
6	handled	VBD	O	handle	rcmod	5	SENT_295	[p24l1915t2764r2083b2801],
7	funding	NN	O	funding	dobj	6	SENT_295	[p24l646t2824r812b2874],
8	and	CC	O	and	_	0	SENT_295	[p24l826t2824r902b2862],
9	supervision	NN	O	supervision	dobj	6	SENT_295	[p24l917t2827r1165b2873],
10	.	.	O	.	_	0	SENT_295	[p24l917t2827r1165b2873],

1	GM	NNP	ORGANIZATION	GM	_	0	SENT_296	[p24l1183t2827r1271b2867],
2	,	,	O	,	_	0	SENT_296	[p24l1183t2827r1271b2867],
3	]	SYM	O	]	dep	5	SENT_296	[p24l1288t2827r1390b2872],
4	-	:	O	-	_	0	SENT_296	[p24l1288t2827r1390b2872],
5	PC	NN	O	pc	dep	1	SENT_296	[p24l1288t2827r1390b2872],
6	,	,	O	,	_	0	SENT_296	[p24l1288t2827r1390b2872],
7	and	CC	O	and	advmod	1	SENT_296	[p24l1407t2824r1482b2862],
8	]	SYM	O	]	dep	10	SENT_296	[p24l1497t2827r1605b2872],
9	-	:	O	-	_	0	SENT_296	[p24l1497t2827r1605b2872],
10	SH	NN	O	sh	dep	1	SENT_296	[p24l1497t2827r1605b2872],
11	,	,	O	,	_	0	SENT_296	[p24l1497t2827r1605b2872],
12	drafted	VBD	O	draft	rcmod	10	SENT_296	[p24l1622t2824r1767b2862],
13	the	DT	O	the	det	14	SENT_296	[p24l1779t2824r1844b2862],
14	report	NN	O	report	dobj	12	SENT_296	[p24l1858t2832r1993b2873],
15	.	.	O	.	_	0	SENT_296	[p24l1858t2832r1993b2873],

1	GM	NNP	ORGANIZATION	GM	nsubj	11	SENT_297	[p24l2010t2827r2099b2867],
2	,	,	O	,	_	0	SENT_297	[p24l2010t2827r2099b2867],
3	I-PC	NN	O	i-pc	appos	1	SENT_297	[p24l647t2887r749b2932],
4	,	,	O	,	_	0	SENT_297	[p24l647t2887r749b2932],
5	I-SI-I	NN	O	i-si-i	appos	1	SENT_297	[p24l766t2887r875b2932],
6	,	,	O	,	_	0	SENT_297	[p24l766t2887r875b2932],
7	CF-B	NN	O	cf-b	appos	1	SENT_297	[p24l892t2887r1006b2927],
8	,	,	O	,	_	0	SENT_297	[p24l892t2887r1006b2927],
9	GB	NN	O	gb	appos	1	SENT_297	[p24l1023t2887r1098b2927],
10	,	,	O	,	_	0	SENT_297	[p24l1023t2887r1098b2927],
11	IS	VBZ	O	be	_	0	SENT_297	[p24l1115t2887r1169b2932],
12	,	,	O	,	_	0	SENT_297	[p24l1115t2887r1169b2932],
13	GC	NN	O	gc	dep	11	SENT_297	[p24l1186t2887r1263b2927],
14	,	,	O	,	_	0	SENT_297	[p24l1186t2887r1263b2927],
15	AP	NN	O	ap	dep	11	SENT_297	[p24l1279t2887r1351b2927],
16	,	,	O	,	_	0	SENT_297	[p24l1279t2887r1351b2927],
17	DB	NN	O	db	dep	11	SENT_297	[p24l1369t2888r1443b2927],
18	,	,	O	,	_	0	SENT_297	[p24l1369t2888r1443b2927],
19	and	CC	O	and	_	0	SENT_297	[p24l1460t2884r1536b2922],
20	PB	NN	O	pb	dep	11	SENT_297	[p24l1551t2887r1605b2921],
21	made	VBD	O	make	rcmod	13	SENT_297	[p24l1621t2884r1734b2922],
22	critical	JJ	O	critical	amod	23	SENT_297	[p24l1749t2884r1887b2922],
23	revision	NN	O	revision	dobj	21	SENT_297	[p24l1900t2887r2065b2922],
24	of	IN	O	of	_	0	SENT_297	[p24l2079t2884r2125b2922],
25	the	DT	O	the	det	26	SENT_297	[p24l646t2945r710b2983],
26	report	NN	O	report	prep_of	23	SENT_297	[p24l724t2953r850b2994],
27	for	IN	O	for	_	0	SENT_297	[p24l863t2945r922b2983],
28	important	JJ	O	important	amod	30	SENT_297	[p24l935t2948r1143b2994],
29	intellectual	JJ	O	intellectual	amod	30	SENT_297	[p24l1156t2945r1383b2983],
30	content	NN	O	content	prep_for	21	SENT_297	[p24l1398t2953r1562b2983],
31	.	.	O	.	_	0	SENT_297	[p24l1398t2953r1562b2983],

1	EV	NN	O	ev	_	0	SENT_298	[p24l1580t2948r1638b2983],
2	and	CC	O	and	_	0	SENT_298	[p24l1652t2945r1728b2983],
3	]	SYM	O	]	dep	6	SENT_298	[p24l1743t2948r1838b2993],
4	-	:	O	-	_	0	SENT_298	[p24l1743t2948r1838b2993],
5	SH	NN	O	sh	nsubj	6	SENT_298	[p24l1743t2948r1838b2993],
6	did	VBD	O	do	conj_and	1	SENT_298	[p24l1855t2945r1920b2983],
7	the	DT	O	the	det	9	SENT_298	[p24l1933t2945r1997b2983],
8	genetic	JJ	O	genetic	amod	9	SENT_298	[p24l647t3009r794b3057],
9	analyses	NNS	O	analysis	dep	6	SENT_298	[p24l809t3007r990b3056],
10	.	.	O	.	_	0	SENT_298	[p24l809t3007r990b3056],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_299	[p24l647t3100r801b3136],
2	of	IN	O	of	_	0	SENT_299	[p24l811t3100r854b3136],
3	interest	NN	O	interest	nn	4	SENT_299	[p24l864t3102r1017b3136],
4	statement	NN	O	statement	prep_of	1	SENT_299	[p24l1028t3106r1236b3136],

1	GM	NNP	ORGANIZATION	GM	nsubj	3	SENT_300	[p25l648t21r723b56],
2	has	VBZ	O	have	aux	3	SENT_300	[p25l738t18r806b56],
3	received	VBN	O	receive	_	0	SENT_300	[p25l820t18r985b56],
4	research	NN	O	research	nn	5	SENT_300	[p25l997t18r1167b56],
5	grants	NNS	O	grant	dobj	3	SENT_300	[p25l1180t26r1304b68],
6	from	IN	O	from	_	0	SENT_300	[p25l1318t18r1418b56],
7	Bristol-Myers	NNP	O	Bristol-Myers	nn	8	SENT_300	[p25l1433t18r1700b67],
8	Squibb	NNP	O	Squibb	prep_from	3	SENT_300	[p25l1717t18r1867b67],
9	,	,	O	,	_	0	SENT_300	[p25l1717t18r1867b67],
10	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	prep_from	3	SENT_300	[p25l649t79r945b122],
11	,	,	O	,	_	0	SENT_300	[p25l649t79r945b122],
12	Eli	NNP	ORGANIZATION	Eli	nn	13	SENT_300	[p25l961t79r1012b116],
13	Lilly	NNP	ORGANIZATION	Lilly	prep_from	3	SENT_300	[p25l1027t79r1116b128],
14	,	,	O	,	_	0	SENT_300	[p25l1027t79r1116b128],
15	Guerbet	NNP	ORGANIZATION	Guerbet	nn	16	SENT_300	[p25l1132t79r1294b117],
16	Medical	NNP	ORGANIZATION	Medical	prep_from	3	SENT_300	[p25l1308t79r1474b122],
17	,	,	O	,	_	0	SENT_300	[p25l1308t79r1474b122],
18	Medtronic	NNP	ORGANIZATION	Medtronic	prep_from	3	SENT_300	[p25l1490t79r1707b122],
19	,	,	O	,	_	0	SENT_300	[p25l1490t79r1707b122],
20	Boston	NNP	ORGANIZATION	Boston	nn	31	SENT_300	[p25l1724t83r1863b117],
21	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	31	SENT_300	[p25l1878t79r2072b122],
22	,	,	O	,	_	0	SENT_300	[p25l1878t79r2072b122],
23	Cordis	NNP	ORGANIZATION	Cordis	appos	31	SENT_300	[p25l648t140r788b183],
24	,	,	O	,	_	0	SENT_300	[p25l648t140r788b183],
25	Stago	NNP	O	Stago	appos	31	SENT_300	[p25l806t143r923b190],
26	,	,	O	,	_	0	SENT_300	[p25l806t143r923b190],
27	Centocor	NNP	ORGANIZATION	Centocor	appos	31	SENT_300	[p25l940t143r1126b183],
28	,	,	O	,	_	0	SENT_300	[p25l940t143r1126b183],
29	Fondation	NNP	O	Fondation	appos	31	SENT_300	[p25l1143t140r1345b178],
30	de	NNP	O	de	nn	31	SENT_300	[p25l1359t140r1405b178],
31	France	NNP	LOCATION	France	conj_and	8	SENT_300	[p25l1420t142r1562b183],
32	,	,	O	,	_	0	SENT_300	[p25l1420t142r1562b183],
33	INSERM	NNP	ORGANIZATION	INSERM	conj_and	8	SENT_300	[p25l1579t142r1770b183],
34	,	,	O	,	_	0	SENT_300	[p25l1579t142r1770b183],
35	Fédération	NNP	PERSON	Fédération	nn	38	SENT_300	[p25l1787t140r2000b178],
36	Frangaise	NNP	PERSON	Frangaise	nn	38	SENT_300	[p25l649t203r836b249],
37	de	IN	PERSON	de	amod	38	SENT_300	[p25l850t201r896b239],
38	Cardiologie	NNP	PERSON	Cardiologie	conj_and	8	SENT_300	[p25l910t201r1149b251],
39	,	,	O	,	_	0	SENT_300	[p25l910t201r1149b251],
40	and	CC	O	and	_	0	SENT_300	[p25l1164t201r1239b239],
41	Société	NNP	PERSON	Société	nn	44	SENT_300	[p25l1254t203r1393b239],
42	Francaise	NNP	PERSON	Francaise	nn	44	SENT_300	[p25l1408t203r1596b249],
43	de	IN	PERSON	de	amod	44	SENT_300	[p25l1610t201r1655b239],
44	Cardiologie	NNP	PERSON	Cardiologie	prep_from	3	SENT_300	[p25l1670t201r1908b251],
45	;	:	O	;	_	0	SENT_300	[p25l1670t201r1908b251],
46	consulting	NN	O	consulting	nn	47	SENT_300	[p25l1924t201r2136b251],
47	fees	NNS	O	fee	prep_from	3	SENT_300	[p25l646t262r724b299],
48	from	IN	O	from	_	0	SENT_300	[p25l738t262r838b299],
49	Sanoﬁ-Aventis	NNP	LOCATION	Sanoﬁ-Aventis	prep_from	47	SENT_300	[p25l854t262r1149b305],
50	,	,	O	,	_	0	SENT_300	[p25l854t262r1149b305],
51	Eli	NNP	PERSON	Eli	nn	52	SENT_300	[p25l1166t262r1216b299],
52	Lilly	NNP	PERSON	Lilly	prep_from	47	SENT_300	[p25l1232t262r1320b311],
53	,	,	O	,	_	0	SENT_300	[p25l1232t262r1320b311],
54	Bristol-Myers	NNP	PERSON	Bristol-Myers	nn	55	SENT_300	[p25l1336t262r1604b311],
55	Squibb	NNP	PERSON	Squibb	prep_from	47	SENT_300	[p25l1621t262r1771b311],
56	,	,	O	,	_	0	SENT_300	[p25l1621t262r1771b311],
57	The	DT	ORGANIZATION	the	det	59	SENT_300	[p25l1785t262r1863b299],
58	Medicines	NNP	ORGANIZATION	Medicines	nn	59	SENT_300	[p25l1878t262r2082b299],
59	Company	NNP	ORGANIZATION	Company	prep_from	47	SENT_300	[p25l648t327r847b373],
60	,	,	O	,	_	0	SENT_300	[p25l648t327r847b373],
61	and	CC	O	and	_	0	SENT_300	[p25l862t324r937b361],
62	Schering	NNP	O	Schering	nn	63	SENT_300	[p25l952t324r1130b373],
63	Plough	NNP	O	Plough	prep_from	47	SENT_300	[p25l1145t324r1296b373],
64	;	:	O	;	_	0	SENT_300	[p25l1145t324r1296b373],
65	and	CC	O	and	_	0	SENT_300	[p25l1312t324r1387b361],
66	lecture	NN	O	lecture	nn	67	SENT_300	[p25l1398t324r1535b361],
67	fees	NNS	O	fee	conj_and	8	SENT_300	[p25l1548t324r1625b361],
68	from	IN	O	from	_	0	SENT_300	[p25l1640t324r1740b361],
69	Bristol-Myers	NNP	MISC	Bristol-Myers	nn	70	SENT_300	[p25l1755t324r2022b373],
70	Squibb	NNP	MISC	Squibb	prep_from	67	SENT_300	[p25l649t385r799b434],
71	,	,	O	,	_	0	SENT_300	[p25l649t385r799b434],
72	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	prep_from	67	SENT_300	[p25l817t385r1112b428],
73	,	,	O	,	_	0	SENT_300	[p25l817t385r1112b428],
74	Eli	NNP	ORGANIZATION	Eli	nn	75	SENT_300	[p25l1129t385r1180b422],
75	Lilly	NNP	ORGANIZATION	Lilly	conj_and	70	SENT_300	[p25l1195t385r1283b434],
76	,	,	O	,	_	0	SENT_300	[p25l1195t385r1283b434],
77	Merck	NNP	ORGANIZATION	Merck	nn	78	SENT_300	[p25l1299t385r1426b422],
78	Sharpe	NNP	ORGANIZATION	Sharpe	prep_from	67	SENT_300	[p25l1441t385r1579b434],
79	&	CC	ORGANIZATION	&	_	0	SENT_300	[p25l1593t385r1626b422],
80	Dohme	NNP	ORGANIZATION	Dohme	conj_and	78	SENT_300	[p25l1640t385r1800b428],
81	,	,	O	,	_	0	SENT_300	[p25l1640t385r1800b428],
82	Cordis	NNP	ORGANIZATION	Cordis	prep_from	67	SENT_300	[p25l1816t385r1956b428],
83	,	,	O	,	_	0	SENT_300	[p25l1816t385r1956b428],
84	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	prep_from	67	SENT_300	[p25l648t446r1004b489],
85	,	,	O	,	_	0	SENT_300	[p25l648t446r1004b489],
86	and	CC	O	and	_	0	SENT_300	[p25l1020t446r1094b483],
87	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	nn	89	SENT_300	[p25l1110t446r1455b495],
88	.	.	O	.	_	0	SENT_300	[p25l1110t446r1455b495],
89	]	NN	O	]	prep_from	67	SENT_300	[p25l1471t449r1559b494],

1	-	:	O	-	_	0	SENT_301	[p25l1471t449r1559b494],
2	PC	NN	O	pc	nsubj	4	SENT_301	[p25l1471t449r1559b494],
3	has	VBZ	O	have	aux	4	SENT_301	[p25l1573t446r1641b483],
4	received	VBN	O	receive	_	0	SENT_301	[p25l1655t446r1820b483],
5	research	NN	O	research	nn	6	SENT_301	[p25l1832t446r2002b483],
6	grants	NNS	O	grant	dobj	4	SENT_301	[p25l2015t453r2139b495],
7	from	IN	O	from	_	0	SENT_301	[p25l646t507r746b544],
8	Bristol-Myers	NNP	O	Bristol-Myers	nn	9	SENT_301	[p25l761t507r1028b556],
9	Squibb	NNP	O	Squibb	prep_from	4	SENT_301	[p25l1046t507r1195b556],
10	,	,	O	,	_	0	SENT_301	[p25l1046t507r1195b556],
11	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	9	SENT_301	[p25l1213t507r1509b550],
12	,	,	O	,	_	0	SENT_301	[p25l1213t507r1509b550],
13	Eli	NNP	ORGANIZATION	Eli	nn	14	SENT_301	[p25l1525t507r1576b544],
14	Lilly	NNP	ORGANIZATION	Lilly	conj_and	9	SENT_301	[p25l1591t507r1680b556],
15	,	,	O	,	_	0	SENT_301	[p25l1591t507r1680b556],
16	Guerbet	NNP	ORGANIZATION	Guerbet	nn	17	SENT_301	[p25l1696t507r1858b544],
17	Medical	NNP	ORGANIZATION	Medical	prep_from	4	SENT_301	[p25l1872t507r2038b550],
18	,	,	O	,	_	0	SENT_301	[p25l1872t507r2038b550],
19	Medtronic	NNP	ORGANIZATION	Medtronic	prep_from	4	SENT_301	[p25l648t568r864b611],
20	,	,	O	,	_	0	SENT_301	[p25l648t568r864b611],
21	Boston	NNP	ORGANIZATION	Boston	nn	32	SENT_301	[p25l881t571r1020b605],
22	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	32	SENT_301	[p25l1036t568r1229b611],
23	,	,	O	,	_	0	SENT_301	[p25l1036t568r1229b611],
24	Cordis	NNP	ORGANIZATION	Cordis	appos	32	SENT_301	[p25l1246t568r1386b611],
25	,	,	O	,	_	0	SENT_301	[p25l1246t568r1386b611],
26	Stago	NNP	O	Stago	appos	32	SENT_301	[p25l1403t570r1521b617],
27	,	,	O	,	_	0	SENT_301	[p25l1403t570r1521b617],
28	Centocor	NNP	ORGANIZATION	Centocor	appos	32	SENT_301	[p25l1537t570r1724b611],
29	,	,	O	,	_	0	SENT_301	[p25l1537t570r1724b611],
30	Fondation	NNP	O	Fondation	appos	32	SENT_301	[p25l1741t568r1943b605],
31	de	NNP	O	de	nn	32	SENT_301	[p25l1957t568r2002b605],
32	France	NNP	LOCATION	France	conj_and	9	SENT_301	[p25l649t631r791b672],
33	,	,	O	,	_	0	SENT_301	[p25l649t631r791b672],
34	INSERM	NNP	ORGANIZATION	INSERM	conj_and	9	SENT_301	[p25l808t631r999b672],
35	,	,	O	,	_	0	SENT_301	[p25l808t631r999b672],
36	Fédération	NNP	PERSON	Fédération	nn	39	SENT_301	[p25l1016t629r1228b666],
37	Francaise	NNP	PERSON	Francaise	nn	39	SENT_301	[p25l1243t631r1431b677],
38	de	IN	PERSON	de	amod	39	SENT_301	[p25l1445t629r1491b666],
39	Cardiologie	NNP	PERSON	Cardiologie	conj_and	9	SENT_301	[p25l1505t629r1744b678],
40	,	,	O	,	_	0	SENT_301	[p25l1505t629r1744b678],
41	and	CC	O	and	_	0	SENT_301	[p25l1759t629r1834b666],
42	Société	NNP	PERSON	Société	nn	45	SENT_301	[p25l1849t631r1987b666],
43	Francaise	NNP	PERSON	Francaise	nn	45	SENT_301	[p25l649t692r836b738],
44	de	IN	PERSON	de	amod	45	SENT_301	[p25l850t689r896b727],
45	Cardiologie	NNP	PERSON	Cardiologie	conj_and	9	SENT_301	[p25l910t689r1149b739],
46	;	:	O	;	_	0	SENT_301	[p25l910t689r1149b739],
47	consulting	NN	O	consulting	nn	48	SENT_301	[p25l1164t690r1376b739],
48	fees	NNS	O	fee	conj_and	9	SENT_301	[p25l1389t689r1466b727],
49	from	IN	O	from	_	0	SENT_301	[p25l1480t689r1581b727],
50	Sanoﬁ-Aventis	NNP	LOCATION	Sanoﬁ-Aventis	prep_from	48	SENT_301	[p25l1596t689r1891b733],
51	,	,	O	,	_	0	SENT_301	[p25l1596t689r1891b733],
52	Eli	NNP	PERSON	Eli	nn	53	SENT_301	[p25l1908t689r1959b726],
53	Lilly	NNP	PERSON	Lilly	conj_and	50	SENT_301	[p25l1974t689r2062b739],
54	,	,	O	,	_	0	SENT_301	[p25l1974t689r2062b739],
55	and	CC	O	and	_	0	SENT_301	[p25l2078t689r2152b727],
56	Bristol-Myers	NNP	O	Bristol-Myers	nn	57	SENT_301	[p25l649t750r916b799],
57	Squibb	NNP	O	Squibb	conj_and	50	SENT_301	[p25l933t750r1083b799],
58	;	:	O	;	_	0	SENT_301	[p25l933t750r1083b799],
59	and	CC	O	and	_	0	SENT_301	[p25l1098t750r1173b788],
60	lecture	NN	O	lecture	nn	61	SENT_301	[p25l1185t750r1321b788],
61	fees	NNS	O	fee	prep_from	4	SENT_301	[p25l1334t750r1412b788],
62	from	IN	O	from	_	0	SENT_301	[p25l1426t750r1526b788],
63	Bristol-Myers	NNP	MISC	Bristol-Myers	nn	64	SENT_301	[p25l1541t750r1808b799],
64	Squibb	NNP	MISC	Squibb	prep_from	61	SENT_301	[p25l1826t750r1975b799],
65	,	,	O	,	_	0	SENT_301	[p25l1826t750r1975b799],
66	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	64	SENT_301	[p25l649t811r945b854],
67	,	,	O	,	_	0	SENT_301	[p25l649t811r945b854],
68	and	CC	O	and	_	0	SENT_301	[p25l960t811r1035b849],
69	Eli	NNP	PERSON	Eli	nn	70	SENT_301	[p25l1049t811r1100b848],
70	Lilly	NNP	PERSON	Lilly	conj_and	64	SENT_301	[p25l1115t811r1203b860],
71	.	.	O	.	_	0	SENT_301	[p25l1115t811r1203b860],

1	I-SI-I	NN	O	i-si-i	nsubj	3	SENT_302	[p25l1219t814r1313b859],
2	has	VBZ	O	have	aux	3	SENT_302	[p25l1327t811r1395b849],
3	received	VBN	O	receive	_	0	SENT_302	[p25l1409t811r1574b849],
4	research	NN	O	research	nn	5	SENT_302	[p25l1586t811r1756b849],
5	grants	NNS	O	grant	dobj	3	SENT_302	[p25l1770t819r1893b861],
6	from	IN	O	from	_	0	SENT_302	[p25l1908t811r2007b849],
7	Fondation	NNP	LOCATION	Fondation	nn	11	SENT_302	[p25l649t872r851b910],
8	de	NNP	LOCATION	de	nn	11	SENT_302	[p25l864t872r910b910],
9	France	NNP	LOCATION	France	nn	11	SENT_302	[p25l926t875r1068b916],
10	,	,	O	,	_	0	SENT_302	[p25l926t875r1068b916],
11	INSERM	NNP	ORGANIZATION	INSERM	prep_from	3	SENT_302	[p25l1085t875r1276b915],
12	,	,	O	,	_	0	SENT_302	[p25l1085t875r1276b915],
13	and	CC	O	and	_	0	SENT_302	[p25l1291t872r1366b910],
14	consulting	NN	O	consulting	nn	15	SENT_302	[p25l1379t872r1591b922],
15	fees	NNS	O	fee	conj_and	11	SENT_302	[p25l1603t872r1681b910],
16	from	IN	O	from	_	0	SENT_302	[p25l1695t872r1795b910],
17	Sanoﬁ-Aventis	NNP	O	Sanoﬁ-Aventis	nn	20	SENT_302	[p25l1811t872r2095b910],
18	and	CC	O	and	_	0	SENT_302	[p25l647t933r722b970],
19	Eli	NNP	PERSON	Eli	nn	20	SENT_302	[p25l736t933r787b970],
20	Lilly	NNP	PERSON	Lilly	prep_from	3	SENT_302	[p25l802t933r890b982],
21	.	.	O	.	_	0	SENT_302	[p25l802t933r890b982],

1	All	DT	O	all	det	3	SENT_303	[p25l904t933r962b970],
2	other	JJ	O	other	amod	3	SENT_303	[p25l975t933r1080b970],
3	authors	NNS	O	author	nsubj	4	SENT_303	[p25l1093t933r1243b970],
4	declare	VBP	O	declare	_	0	SENT_303	[p25l1258t933r1399b970],
5	that	IN	O	that	complm	7	SENT_303	[p25l1412t933r1490b970],
6	they	PRP	O	they	nsubj	7	SENT_303	[p25l1502t933r1587b982],
7	have	VBP	O	have	ccomp	4	SENT_303	[p25l1599t933r1691b971],
8	no	DT	O	no	det	9	SENT_303	[p25l1704t946r1755b970],
9	conﬂict	NN	O	conﬂict	dobj	7	SENT_303	[p25l1768t933r1917b970],
10	of	IN	O	of	_	0	SENT_303	[p25l1930t933r1975b970],
11	interest	NN	O	interest	prep_of	9	SENT_303	[p25l1981t935r2141b970],
12	.	.	O	.	_	0	SENT_303	[p25l1981t935r2141b970],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	5	SENT_304	[p25l646t1026r1021b1073],
2	This	DT	O	this	det	3	SENT_304	[p25l646t1085r736b1123],
3	study	NN	O	study	dep	1	SENT_304	[p25l753t1085r862b1134],
4	was	VBD	O	be	auxpass	5	SENT_304	[p25l874t1098r950b1123],
5	sponsored	VBN	O	sponsor	_	0	SENT_304	[p25l967t1085r1179b1134],
6	and	CC	O	and	_	0	SENT_304	[p25l1193t1085r1269b1123],
7	funded	VBN	O	fund	conj_and	5	SENT_304	[p25l1283t1085r1430b1123],
8	by	IN	O	by	_	0	SENT_304	[p25l1442t1085r1491b1135],
9	the	DT	O	the	det	10	SENT_304	[p25l1502t1085r1567b1123],
10	Délégation	NNP	O	Délégation	prep_by	7	SENT_304	[p25l1583t1085r1805b1135],
11	a	DT	O	a	det	14	SENT_304	[p25l1819t1087r1840b1123],
12	la	NNP	O	la	nn	14	SENT_304	[p25l1853t1085r1888b1123],
13	Recherche	NNP	O	Recherche	nn	14	SENT_304	[p25l1904t1085r2117b1123],
14	Clinique	NNP	O	Clinique	dobj	5	SENT_304	[p25l648t1146r834b1195],
15	,	,	O	,	_	0	SENT_304	[p25l648t1146r834b1195],
16	Assistance	NNP	ORGANIZATION	Assistance	nn	17	SENT_304	[p25l850t1149r1068b1184],
17	Publique-I-Iépitaux	NNP	ORGANIZATION	Publique-I-Iépitaux	appos	14	SENT_304	[p25l1085t1146r1475b1195],
18	de	IN	ORGANIZATION	de	amod	14	SENT_304	[p25l1488t1146r1535b1184],
19	Paris	NNP	ORGANIZATION	Paris	nn	21	SENT_304	[p25l1551t1149r1650b1184],
20	(	CD	NUMBER	(	num	21	SENT_304	[p25l1668t1149r1776b1196],
21	CRC	NN	O	crc	dep	14	SENT_304	[p25l1668t1149r1776b1196],
22	#	#	MONEY	#	number	23	SENT_304	[p25l1790t1148r1957b1196],
23	97109	CD	MONEY	97109	num	24	SENT_304	[p25l1790t1148r1957b1196],
24	)	NN	O	)	dep	21	SENT_304	[p25l1790t1148r1957b1196],
25	.	.	O	.	_	0	SENT_304	[p25l1790t1148r1957b1196],

1	References	NNS	O	reference	_	0	SENT_305	[p25l649t1239r858b1275],

1	1	CD	NUMBER	1	_	0	SENT_306	[p25l648t1297r665b1330],
2	Smith	NNP	ORGANIZATION	Smith	nn	4	SENT_306	[p25l750t1293r872b1331],
3	SC	NNP	ORGANIZATION	SC	nn	4	SENT_306	[p25l889t1296r943b1331],
4	Ir	NNP	ORGANIZATION	Ir	dep	1	SENT_306	[p25l959t1297r999b1341],
5	,	,	O	,	_	0	SENT_306	[p25l959t1297r999b1341],
6	Allen	NNP	PERSON	Allen	nn	7	SENT_306	[p25l1014t1293r1123b1331],
7	I	NNP	O	I	appos	4	SENT_306	[p25l1138t1297r1164b1341],
8	,	,	O	,	_	0	SENT_306	[p25l1138t1297r1164b1341],
9	Blair	NNP	O	Blair	nn	10	SENT_306	[p25l1181t1293r1276b1331],
10	SN	NNP	O	SN	appos	4	SENT_306	[p25l1292t1296r1361b1337],
11	,	,	O	,	_	0	SENT_306	[p25l1292t1296r1361b1337],
12	et	FW	O	et	nn	13	SENT_306	[p25l1378t1301r1413b1331],
13	al.	FW	O	al.	appos	4	SENT_306	[p25l1427t1293r1470b1331],
14	.	.	O	.	_	0	SENT_306	[p25l1427t1293r1470b1331],

1	AHA/ACC	NN	O	aha/acc	nn	2	SENT_307	[p25l1485t1296r1706b1342],
2	guidelines	NNS	O	guideline	nsubj	19	SENT_307	[p25l1722t1293r1932b1343],
3	for	IN	O	for	_	0	SENT_307	[p25l1947t1293r2005b1331],
4	secondary	JJ	O	secondary	amod	5	SENT_307	[p25l748t1350r952b1399],
5	prevention	NN	O	prevention	prep_for	2	SENT_307	[p25l964t1352r1185b1399],
6	for	IN	O	for	_	0	SENT_307	[p25l1198t1350r1257b1387],
7	patients	NNS	O	patient	prep_for	5	SENT_307	[p25l1269t1352r1430b1399],
8	with	IN	O	with	_	0	SENT_307	[p25l1444t1350r1535b1387],
9	coronary	JJ	O	coronary	prep_with	7	SENT_307	[p25l1549t1363r1728b1399],
10	and	CC	O	and	_	0	SENT_307	[p25l1741t1350r1816b1387],
11	other	JJ	O	other	amod	14	SENT_307	[p25l1830t1350r1937b1387],
12	atherosclerotic	JJ	O	atherosclerotic	amod	14	SENT_307	[p25l747t1406r1045b1443],
13	vascular	JJ	O	vascular	amod	14	SENT_307	[p25l1058t1406r1226b1443],
14	disease	NN	O	disease	conj_and	9	SENT_307	[p25l1239t1406r1395b1443],
15	:	:	O	:	_	0	SENT_307	[p25l1239t1406r1395b1443],
16	2006	CD	DATE	2006	dep	2	SENT_307	[p25l1413t1409r1507b1443],
17	update	VBP	O	update	rcmod	16	SENT_307	[p25l1521t1406r1670b1455],
18	:	:	O	:	_	0	SENT_307	[p25l1521t1406r1670b1455],
19	endorsed	VBN	O	endorse	_	0	SENT_307	[p25l1686t1406r1875b1443],
20	by	IN	O	by	_	0	SENT_307	[p25l1887t1406r1935b1455],
21	the	DT	O	the	det	23	SENT_307	[p25l1947t1406r2010b1443],
22	National	NNP	O	National	nn	23	SENT_307	[p25l748t1461r919b1499],
23	Heart	NNP	O	Heart	prep_by	19	SENT_307	[p25l935t1465r1060b1504],
24	,	,	O	,	_	0	SENT_307	[p25l935t1465r1060b1504],
25	Lung	NN	O	lung	prep_by	19	SENT_307	[p25l1077t1465r1190b1511],
26	,	,	O	,	_	0	SENT_307	[p25l1077t1465r1190b1511],
27	and	CC	O	and	_	0	SENT_307	[p25l1206t1461r1282b1499],
28	Blood	NNP	ORGANIZATION	Blood	nn	29	SENT_307	[p25l1297t1461r1413b1499],
29	Institute	NNP	ORGANIZATION	Institute	prep_by	19	SENT_307	[p25l1428t1464r1609b1499],
30	.	.	O	.	_	0	SENT_307	[p25l1428t1464r1609b1499],

1	Circulation	NN	O	circulation	_	0	SENT_308	[p25l1629t1461r1846b1499],
2	2006	CD	DATE	2006	num	1	SENT_308	[p25l1860t1465r1965b1504],
3	;	:	O	;	_	0	SENT_308	[p25l1860t1465r1965b1504],
4	113	CD	NUMBER	113	num	6	SENT_308	[p25l747t1520r822b1554],
5	:	:	O	:	_	0	SENT_308	[p25l747t1520r822b1554],
6	2363-72	CD	NUMBER	2363-72	dep	1	SENT_308	[p25l838t1519r1013b1555],
7	.	.	O	.	_	0	SENT_308	[p25l838t1519r1013b1555],

1	2	CD	NUMBER	2	num	3	SENT_309	[p25l648t1583r668b1616],
2	Gurbel	NNP	ORGANIZATION	Gurbel	nn	3	SENT_309	[p25l748t1580r887b1617],
3	PA	NN	ORGANIZATION	pa	_	0	SENT_309	[p25l902t1582r971b1623],
4	,	,	O	,	_	0	SENT_309	[p25l902t1582r971b1623],
5	Bliden	NNP	PERSON	Bliden	nn	6	SENT_309	[p25l988t1579r1117b1617],
6	KP	NNP	O	KP	appos	3	SENT_309	[p25l1133t1583r1200b1623],
7	,	,	O	,	_	0	SENT_309	[p25l1133t1583r1200b1623],
8	Hiatt	NNP	PERSON	Hiatt	nn	9	SENT_309	[p25l1218t1582r1320b1617],
9	BL	NN	O	bl	appos	3	SENT_309	[p25l1334t1583r1398b1622],
10	,	,	O	,	_	0	SENT_309	[p25l1334t1583r1398b1622],
11	O'Connor	NNP	PERSON	O'Connor	nn	12	SENT_309	[p25l1414t1582r1616b1617],
12	CM	NN	O	cm	appos	3	SENT_309	[p25l1629t1582r1713b1617],
13	.	.	O	.	_	0	SENT_309	[p25l1629t1582r1713b1617],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_310	[p25l1730t1579r1966b1629],
2	for	IN	O	for	_	0	SENT_310	[p25l1979t1579r2037b1617],
3	coronary	JJ	O	coronary	amod	4	SENT_310	[p25l747t1648r925b1684],
4	stenting	NN	O	stenting	prep_for	1	SENT_310	[p25l938t1637r1111b1685],
5	:	:	O	:	_	0	SENT_310	[p25l938t1637r1111b1685],
6	response	NN	O	response	nn	7	SENT_310	[p25l1127t1648r1308b1684],
7	variability	NN	O	variability	conj_and	1	SENT_310	[p25l1321t1635r1525b1684],
8	,	,	O	,	_	0	SENT_310	[p25l1321t1635r1525b1684],
9	drug	NN	O	drug	nn	10	SENT_310	[p25l1541t1635r1636b1685],
10	resistance	NN	O	resistance	appos	7	SENT_310	[p25l1649t1637r1861b1678],
11	,	,	O	,	_	0	SENT_310	[p25l1649t1637r1861b1678],
12	and	CC	O	and	_	0	SENT_310	[p25l1877t1635r1952b1673],
13	the	DT	O	the	det	14	SENT_310	[p25l1964t1635r2027b1673],
14	effect	NN	O	effect	conj_and	1	SENT_310	[p25l2041t1635r2151b1673],
15	of	IN	O	of	_	0	SENT_310	[p25l747t1692r792b1729],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_310	[p25l798t1699r1065b1741],
17	platelet	NN	O	platelet	nn	18	SENT_310	[p25l1077t1692r1224b1741],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_310	[p25l1236t1694r1423b1741],
19	.	.	O	.	_	0	SENT_310	[p25l1236t1694r1423b1741],

1	Circulation	NN	O	circulation	_	0	SENT_311	[p25l1443t1692r1657b1729],
2	2003	CD	DATE	2003	num	1	SENT_311	[p25l1671t1695r1776b1735],
3	;	:	O	;	_	0	SENT_311	[p25l1671t1695r1776b1735],
4	107	CD	NUMBER	107	num	6	SENT_311	[p25l1792t1694r1869b1730],
5	:	:	O	:	_	0	SENT_311	[p25l1792t1694r1869b1730],
6	2908-13	CD	NUMBER	2908-13	dep	1	SENT_311	[p25l1886t1695r2058b1729],
7	.	.	O	.	_	0	SENT_311	[p25l1886t1695r2058b1729],

1	3	CD	NUMBER	3	num	3	SENT_312	[p25l649t1758r667b1792],
2	Angiolillo	NNP	O	Angiolillo	nn	3	SENT_312	[p25l746t1754r948b1804],
3	DA	NNP	O	DA	_	0	SENT_312	[p25l965t1757r1041b1797],
4	,	,	O	,	_	0	SENT_312	[p25l965t1757r1041b1797],
5	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	6	SENT_312	[p25l1059t1754r1396b1792],
6	A	NNP	O	A	appos	3	SENT_312	[p25l1410t1757r1452b1797],
7	,	,	O	,	_	0	SENT_312	[p25l1410t1757r1452b1797],
8	Bernardo	NNP	PERSON	Bernardo	nn	9	SENT_312	[p25l1470t1754r1660b1792],
9	E	NNP	PERSON	E	appos	3	SENT_312	[p25l1677t1757r1712b1797],
10	,	,	O	,	_	0	SENT_312	[p25l1677t1757r1712b1797],
11	et	FW	O	et	nn	12	SENT_312	[p25l1728t1762r1765b1792],
12	al.	FW	O	al.	appos	3	SENT_312	[p25l1778t1754r1822b1792],
13	.	.	O	.	_	0	SENT_312	[p25l1778t1754r1822b1792],

1	Variability	NN	O	variability	_	0	SENT_313	[p25l1838t1754r2048b1803],
2	in	IN	O	in	_	0	SENT_313	[p25l2061t1757r2102b1791],
3	individual	JJ	O	individual	amod	4	SENT_313	[p25l746t1811r954b1848],
4	responsiveness	NN	O	responsiveness	prep_in	1	SENT_313	[p25l967t1813r1279b1860],
5	to	TO	O	to	_	0	SENT_313	[p25l1294t1818r1332b1848],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_313	[p25l1347t1811r1576b1860],
7	clinical	JJ	O	clinical	amod	8	SENT_313	[p25l1590t1811r1736b1848],
8	implications	NNS	O	implication	prep_to	1	SENT_313	[p25l1750t1811r2017b1860],
9	,	,	O	,	_	0	SENT_313	[p25l1750t1811r2017b1860],
10	management	NN	O	management	conj_and	8	SENT_313	[p25l746t1874r1030b1916],
11	,	,	O	,	_	0	SENT_313	[p25l746t1874r1030b1916],
12	and	CC	O	and	_	0	SENT_313	[p25l1047t1867r1123b1904],
13	future	JJ	DATE	future	amod	14	SENT_313	[p25l1136t1867r1262b1904],
14	perspectives	NNS	O	perspective	conj_and	8	SENT_313	[p25l1277t1869r1539b1916],
15	.	.	O	.	_	0	SENT_313	[p25l1277t1869r1539b1916],

1	j	NN	O	j	nsubj	4	SENT_314	[p25l1550t1870r1575b1916],
2	Am	VBP	O	be	cop	4	SENT_314	[p25l1585t1870r1658b1904],
3	Coll	NNP	O	Coll	nn	4	SENT_314	[p25l1675t1867r1749b1904],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_314	[p25l1766t1867r1908b1904],
5	2007	CD	DATE	2007	dep	4	SENT_314	[p25l1922t1869r2024b1910],
6	;	:	O	;	_	0	SENT_314	[p25l1922t1869r2024b1910],
7	49	CD	NUMBER	49	num	9	SENT_314	[p25l746t1925r805b1960],
8	:	:	O	:	_	0	SENT_314	[p25l746t1925r805b1960],
9	1505-16	CD	NUMBER	1505-16	dep	4	SENT_314	[p25l822t1924r993b1960],
10	.	.	O	.	_	0	SENT_314	[p25l822t1924r993b1960],

1	4	LS	NUMBER	4	dep	2	SENT_315	[p25l645t1989r669b2023],
2	Buonamici	NN	ORGANIZATION	buonamicus	_	0	SENT_315	[p25l749t1988r972b2023],
3	P	NN	ORGANIZATION	p	dobj	2	SENT_315	[p25l988t1989r1024b2029],
4	,	,	O	,	_	0	SENT_315	[p25l988t1989r1024b2029],
5	Marcucci	NNP	PERSON	Marcucci	nn	6	SENT_315	[p25l1042t1988r1229b2023],
6	R	NNP	PERSON	R	appos	3	SENT_315	[p25l1245t1989r1284b2029],
7	,	,	O	,	_	0	SENT_315	[p25l1245t1989r1284b2029],
8	Migliorini	NNP	PERSON	Migliorini	nn	9	SENT_315	[p25l1302t1986r1508b2035],
9	A	NNP	O	A	appos	3	SENT_315	[p25l1521t1988r1564b2029],
10	,	,	O	,	_	0	SENT_315	[p25l1521t1988r1564b2029],
11	et	FW	O	et	nn	12	SENT_315	[p25l1581t1993r1617b2023],
12	al.	FW	O	al.	appos	3	SENT_315	[p25l1630t1986r1674b2023],
13	.	.	O	.	_	0	SENT_315	[p25l1630t1986r1674b2023],

1	Impact	NN	O	impact	_	0	SENT_316	[p25l1692t1989r1837b2035],
2	of	IN	O	of	_	0	SENT_316	[p25l1850t1986r1896b2023],
3	platelet	NN	O	platelet	prep_of	1	SENT_316	[p25l1903t1986r2053b2035],
4	reactivity	NN	O	reactivity	dep	1	SENT_316	[p25l746t2044r932b2091],
5	after	IN	O	after	_	0	SENT_316	[p25l946t2041r1038b2079],
6	clopidogrel	NN	O	clopidogrel	prep_after	4	SENT_316	[p25l1052t2041r1281b2091],
7	administration	NN	O	administration	dep	4	SENT_316	[p25l1295t2042r1601b2079],
8	on	IN	O	on	prep	7	SENT_316	[p25l1616t2055r1667b2079],
9	drug-eluting	JJ	O	drug-eluting	amod	11	SENT_316	[p25l1681t2042r1938b2091],
10	stent	NN	O	stent	nn	11	SENT_316	[p25l1953t2049r2052b2079],
11	thrombosis	NN	O	thrombosis	dep	8	SENT_316	[p25l746t2097r991b2134],
12	.	.	O	.	_	0	SENT_316	[p25l746t2097r991b2134],
13	]	SYM	O	]	dep	7	SENT_316	[p25l1002t2101r1027b2146],

1	Am	VBP	O	be	dep	3	SENT_317	[p25l1038t2100r1111b2134],
2	Coll	NNP	O	Coll	nn	3	SENT_317	[p25l1127t2097r1202b2134],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_317	[p25l1219t2097r1360b2134],
4	2007	CD	DATE	2007	num	3	SENT_317	[p25l1374t2099r1477b2140],
5	;	:	O	;	_	0	SENT_317	[p25l1374t2099r1477b2140],
6	49	CD	NUMBER	49	dep	3	SENT_317	[p25l1493t2100r1551b2134],
7	:	:	O	:	_	0	SENT_317	[p25l1493t2100r1551b2134],
8	2312-17	CD	NUMBER	2312-17	dep	6	SENT_317	[p25l1568t2099r1727b2136],
9	.	.	O	.	_	0	SENT_317	[p25l1568t2099r1727b2136],

1	5	CD	NUMBER	5	num	3	SENT_318	[p25l649t2163r667b2198],
2	Hochholzer	NNP	O	Hochholzer	nn	3	SENT_318	[p25l749t2160r991b2198],
3	W	NNP	O	W	_	0	SENT_318	[p25l1003t2164r1054b2204],
4	,	,	O	,	_	0	SENT_318	[p25l1003t2164r1054b2204],
5	Trenk	NNP	ORGANIZATION	Trenk	nn	6	SENT_318	[p25l1069t2160r1189b2198],
6	D	NNP	ORGANIZATION	D	appos	3	SENT_318	[p25l1204t2164r1247b2204],
7	,	,	O	,	_	0	SENT_318	[p25l1204t2164r1247b2204],
8	Bestehorn	NNP	O	Bestehorn	nn	9	SENT_318	[p25l1265t2160r1475b2198],
9	HP	NNP	O	HP	appos	3	SENT_318	[p25l1490t2164r1568b2204],
10	,	,	O	,	_	0	SENT_318	[p25l1490t2164r1568b2204],
11	et	FW	O	et	nn	12	SENT_318	[p25l1585t2168r1621b2198],
12	al.	FW	O	al.	appos	3	SENT_318	[p25l1635t2160r1678b2198],
13	.	.	O	.	_	0	SENT_318	[p25l1635t2160r1678b2198],

1	Impact	NN	O	impact	_	0	SENT_319	[p25l1697t2164r1841b2209],
2	of	IN	O	of	_	0	SENT_319	[p25l1855t2160r1900b2198],
3	the	DT	O	the	det	4	SENT_319	[p25l1906t2161r1971b2198],
4	degree	NN	O	degree	prep_of	1	SENT_319	[p25l1986t2161r2121b2210],
5	of	IN	O	of	_	0	SENT_319	[p25l747t2216r793b2254],
6	peri-interventional	JJ	O	peri-interventional	amod	8	SENT_319	[p25l799t2216r1184b2265],
7	platelet	NN	O	platelet	nn	8	SENT_319	[p25l1197t2216r1347b2265],
8	inhibition	NN	O	inhibition	prep_of	4	SENT_319	[p25l1361t2216r1566b2254],
9	after	IN	O	after	dep	1	SENT_319	[p25l1580t2216r1673b2254],
10	loading	VBG	O	load	pcomp	9	SENT_319	[p25l1685t2216r1839b2266],
11	with	IN	O	with	prt	10	SENT_319	[p25l1852t2216r1943b2254],
12	clopidogrel	NN	O	clopidogrel	dobj	10	SENT_319	[p25l747t2273r976b2322],
13	on	IN	O	on	_	0	SENT_319	[p25l990t2286r1042b2310],
14	early	JJ	O	early	amod	16	SENT_319	[p25l1056t2273r1154b2322],
15	clinical	JJ	O	clinical	amod	16	SENT_319	[p25l1167t2273r1313b2310],
16	outcome	NN	O	outcome	prep_on	12	SENT_319	[p25l1328t2280r1505b2310],
17	of	IN	O	of	prep	16	SENT_319	[p25l1521t2273r1566b2310],
18	elective	JJ	O	elective	amod	20	SENT_319	[p25l1574t2273r1725b2310],
19	coronary	JJ	O	coronary	amod	20	SENT_319	[p25l1739t2286r1920b2322],
20	stent	NN	O	stent	dep	17	SENT_319	[p25l1934t2280r2034b2310],
21	placement	NN	O	placement	dep	20	SENT_319	[p25l746t2329r971b2377],
22	.	.	O	.	_	0	SENT_319	[p25l746t2329r971b2377],
23	]	SYM	O	]	dep	12	SENT_319	[p25l982t2332r1007b2378],

1	Am	VBP	O	be	dep	3	SENT_320	[p25l1018t2331r1090b2366],
2	Coll	NNP	O	Coll	nn	3	SENT_320	[p25l1107t2329r1182b2366],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_320	[p25l1198t2329r1340b2366],
4	2006	CD	DATE	2006	num	3	SENT_320	[p25l1354t2332r1460b2372],
5	;	:	O	;	_	0	SENT_320	[p25l1354t2332r1460b2372],
6	48	CD	NUMBER	48	dep	3	SENT_320	[p25l1476t2332r1534b2366],
7	:	:	O	:	_	0	SENT_320	[p25l1476t2332r1534b2366],
8	1742-50	CD	NUMBER	1742-50	dep	6	SENT_320	[p25l1552t2331r1721b2367],
9	.	.	O	.	_	0	SENT_320	[p25l1552t2331r1721b2367],

1	6	CD	NUMBER	6	num	3	SENT_321	[p25l647t2394r669b2428],
2	Montalescot	NN	O	montalescot	nn	3	SENT_321	[p25l748t2391r998b2428],
3	G	NN	O	g	_	0	SENT_321	[p25l1012t2394r1056b2434],
4	,	,	O	,	_	0	SENT_321	[p25l1012t2394r1056b2434],
5	Sideris	NNP	PERSON	Sideris	nn	6	SENT_321	[p25l1075t2391r1212b2428],
6	G	NNP	O	G	appos	3	SENT_321	[p25l1229t2394r1273b2434],
7	,	,	O	,	_	0	SENT_321	[p25l1229t2394r1273b2434],
8	Meuleman	NNP	PERSON	Meuleman	nn	9	SENT_321	[p25l1291t2391r1513b2428],
9	C	NNP	O	C	appos	3	SENT_321	[p25l1528t2394r1568b2434],
10	,	,	O	,	_	0	SENT_321	[p25l1528t2394r1568b2434],
11	et	FW	O	et	nn	12	SENT_321	[p25l1585t2398r1621b2428],
12	al.	FW	O	al.	appos	3	SENT_321	[p25l1635t2391r1678b2428],
13	.	.	O	.	_	0	SENT_321	[p25l1635t2391r1678b2428],

1	A	DT	O	a	det	19	SENT_322	[p25l1694t2394r1727b2428],
2	randomized	VBN	O	randomize	dep	19	SENT_322	[p25l1740t2391r1990b2428],
3	comparison	NN	O	comparison	dobj	2	SENT_322	[p25l747t2450r991b2497],
4	of	IN	O	of	_	0	SENT_322	[p25l1005t2448r1051b2485],
5	high	JJ	O	high	amod	6	SENT_322	[p25l1057t2448r1151b2497],
6	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_322	[p25l1166t2448r1394b2497],
7	loading	VBG	O	load	partmod	6	SENT_322	[p25l1408t2448r1562b2497],
8	doses	NNS	O	dose	dobj	7	SENT_322	[p25l1576t2448r1688b2485],
9	in	IN	O	in	_	0	SENT_322	[p25l1703t2450r1745b2485],
10	patients	NNS	O	patient	prep_in	7	SENT_322	[p25l1758t2450r1920b2497],
11	with	IN	O	with	_	0	SENT_322	[p25l1935t2448r2026b2485],
12	non-ST-segment	JJ	O	non-st-segment	amod	13	SENT_322	[p25l746t2505r1087b2553],
13	elevation	NN	O	elevation	prep_with	10	SENT_322	[p25l1101t2503r1284b2541],
14	acute	JJ	O	acute	amod	16	SENT_322	[p25l1298t2511r1405b2541],
15	coronary	JJ	O	coronary	amod	16	SENT_322	[p25l1420t2517r1601b2553],
16	syndromes	NNS	O	syndrome	dep	13	SENT_322	[p25l1615t2503r1851b2553],
17	:	:	O	:	_	0	SENT_322	[p25l1615t2503r1851b2553],
18	the	DT	O	the	det	19	SENT_322	[p25l1866t2503r1930b2541],
19	ALBION	NNP	ORGANIZATION	ALBION	_	0	SENT_322	[p25l1944t2506r2124b2541],
20	(	CD	NUMBER	(	num	19	SENT_322	[p25l750t2562r1010b2609],
21	Assessment	NNP	O	Assessment	dep	19	SENT_322	[p25l750t2562r1010b2609],
22	of	IN	O	of	prep	21	SENT_322	[p25l1024t2559r1069b2597],
23	the	DT	O	the	det	26	SENT_322	[p25l1075t2559r1140b2597],
24	Best	JJS	O	best	amod	26	SENT_322	[p25l1156t2563r1243b2597],
25	Loading	NN	O	loading	nn	26	SENT_322	[p25l1258t2559r1422b2609],
26	Dose	NN	O	dose	dep	37	SENT_322	[p25l1438t2563r1539b2597],
27	of	IN	O	of	_	0	SENT_322	[p25l1554t2559r1600b2597],
28	Clopidogrel	NNP	O	Clopidogrel	prep_of	26	SENT_322	[p25l1608t2559r1848b2609],
29	to	TO	O	to	_	0	SENT_322	[p25l1861t2567r1899b2597],
30	Blunt	NNP	O	Blunt	nn	31	SENT_322	[p25l1916t2559r2028b2597],
31	Platelet	NN	O	platelet	prep_to	28	SENT_322	[p25l749t2616r899b2653],
32	Activation	NN	O	activation	nn	34	SENT_322	[p25l912t2618r1130b2659],
33	,	,	O	,	_	0	SENT_322	[p25l912t2618r1130b2659],
34	Inﬂammation	NN	O	inﬂammation	nn	37	SENT_322	[p25l1148t2616r1435b2653],
35	and	CC	O	and	_	0	SENT_322	[p25l1449t2616r1525b2653],
36	Ongoing	JJ	O	ongoing	conj_and	34	SENT_322	[p25l1540t2618r1720b2665],
37	Necrosis	NN	O	necrosis	dep	22	SENT_322	[p25l1735t2618r1923b2665],
38	)	CD	NUMBER	)	num	39	SENT_322	[p25l1735t2618r1923b2665],
39	Trial	NN	O	trial	dep	37	SENT_322	[p25l1939t2616r2041b2653],
40	.	.	O	.	_	0	SENT_322	[p25l1939t2616r2041b2653],
41	]	SYM	O	]	dep	21	SENT_322	[p25l741t2675r766b2721],

1	Am	VBP	O	be	dep	3	SENT_323	[p25l777t2674r850b2709],
2	Coll	NNP	O	Coll	nn	3	SENT_323	[p25l866t2672r941b2709],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_323	[p25l958t2672r1099b2709],
4	2006	CD	DATE	2006	num	3	SENT_323	[p25l1113t2675r1219b2715],
5	;	:	O	;	_	0	SENT_323	[p25l1113t2675r1219b2715],
6	48	CD	NUMBER	48	dep	3	SENT_323	[p25l1235t2675r1294b2709],
7	:	:	O	:	_	0	SENT_323	[p25l1235t2675r1294b2709],
8	931-38	CD	NUMBER	931-38	dep	6	SENT_323	[p25l1310t2675r1461b2709],
9	.	.	O	.	_	0	SENT_323	[p25l1310t2675r1461b2709],

1	7	CD	NUMBER	7	num	3	SENT_324	[p25l646t2737r667b2774],
2	Cuisset	NN	ORGANIZATION	cuisset	nn	3	SENT_324	[p25l748t2737r900b2772],
3	T	NN	ORGANIZATION	t	_	0	SENT_324	[p25l912t2737r946b2778],
4	,	,	O	,	_	0	SENT_324	[p25l912t2737r946b2778],
5	Frere	NNP	ORGANIZATION	Frere	nn	6	SENT_324	[p25l964t2737r1068b2772],
6	C	NNP	ORGANIZATION	C	appos	3	SENT_324	[p25l1084t2738r1124b2778],
7	,	,	O	,	_	0	SENT_324	[p25l1084t2738r1124b2778],
8	Quilici	NNP	PERSON	Quilici	appos	3	SENT_324	[p25l1142t2735r1280b2783],
9	I	PRP	O	I	dep	8	SENT_324	[p25l1295t2739r1321b2783],
10	,	,	O	,	_	0	SENT_324	[p25l1295t2739r1321b2783],
11	et	FW	O	et	nn	12	SENT_324	[p25l1337t2742r1374b2772],
12	al.	FW	O	al.	appos	3	SENT_324	[p25l1387t2735r1431b2772],
13	.	.	O	.	_	0	SENT_324	[p25l1387t2735r1431b2772],

1	Beneﬁt	NNP	O	Beneﬁt	_	0	SENT_325	[p25l1449t2735r1596b2772],
2	of	IN	O	of	dep	19	SENT_325	[p25l1609t2735r1655b2772],
3	a	DT	O	a	det	6	SENT_325	[p25l1662t2748r1683b2772],
4	600-mg	JJ	O	600-mg	amod	6	SENT_325	[p25l1698t2738r1852b2784],
5	loading	NN	O	loading	nn	6	SENT_325	[p25l1865t2735r2019b2784],
6	dose	NN	O	dose	pobj	2	SENT_325	[p25l2033t2735r2125b2772],
7	of	IN	O	of	_	0	SENT_325	[p25l747t2790r793b2828],
8	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_325	[p25l800t2790r1029b2840],
9	on	IN	O	on	_	0	SENT_325	[p25l1043t2804r1095b2828],
10	platelet	NN	O	platelet	nn	11	SENT_325	[p25l1108t2790r1258b2839],
11	reactivity	NN	O	reactivity	prep_on	8	SENT_325	[p25l1272t2793r1457b2840],
12	and	CC	O	and	_	0	SENT_325	[p25l1471t2790r1547b2828],
13	clinical	JJ	O	clinical	amod	14	SENT_325	[p25l1561t2790r1707b2828],
14	outcomes	NNS	O	outcome	conj_and	2	SENT_325	[p25l1721t2798r1919b2828],
15	in	IN	O	in	_	0	SENT_325	[p25l1934t2793r1975b2827],
16	patients	NNS	O	patient	prep_in	14	SENT_325	[p25l1989t2793r2151b2839],
17	with	IN	O	with	_	0	SENT_325	[p25l745t2846r836b2884],
18	non-ST-segment	JJ	O	non-st-segment	prep_with	16	SENT_325	[p25l850t2849r1191b2896],
19	elevation	NN	O	elevation	dobj	20	SENT_325	[p25l1205t2846r1388b2884],
20	acute	JJ	O	acute	dep	1	SENT_325	[p25l1402t2854r1509b2884],
21	coronary	JJ	O	coronary	nsubj	23	SENT_325	[p25l1524t2860r1705b2896],
22	syndrome	NN	O	syndrome	dep	21	SENT_325	[p25l1719t2846r1923b2896],
23	undergoing	VBG	O	undergo	ccomp	20	SENT_325	[p25l746t2903r987b2952],
24	coronary	JJ	O	coronary	amod	25	SENT_325	[p25l1002t2916r1182b2952],
25	stenting	NN	O	stenting	dobj	23	SENT_325	[p25l1196t2905r1373b2952],
26	.	.	O	.	_	0	SENT_325	[p25l1196t2905r1373b2952],
27	]	SYM	O	]	dep	1	SENT_325	[p25l1384t2907r1409b2952],

1	Am	VBP	O	be	dep	3	SENT_326	[p25l1419t2906r1492b2940],
2	Coll	NNP	O	Coll	nn	3	SENT_326	[p25l1509t2903r1583b2940],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_326	[p25l1600t2903r1741b2940],
4	2006	CD	DATE	2006	num	3	SENT_326	[p25l1756t2906r1862b2946],
5	;	:	O	;	_	0	SENT_326	[p25l1756t2906r1862b2946],
6	48	CD	NUMBER	48	dep	3	SENT_326	[p25l1878t2906r1936b2940],
7	:	:	O	:	_	0	SENT_326	[p25l1878t2906r1936b2940],
8	1339-45	CD	NUMBER	1339-45	dep	6	SENT_326	[p25l1954t2905r2126b2941],
9	.	.	O	.	_	0	SENT_326	[p25l1954t2905r2126b2941],

1	8	CD	NUMBER	8	num	3	SENT_327	[p25l647t2969r669b3003],
2	Lotrionte	NNP	O	Lotrionte	nn	3	SENT_327	[p25l749t2968r934b3003],
3	M	NN	O	m	_	0	SENT_327	[p25l950t2969r1002b3008],
4	,	,	O	,	_	0	SENT_327	[p25l950t2969r1002b3008],
5	Biondi-Zoccai	NNP	O	Biondi-Zoccai	nn	6	SENT_327	[p25l1020t2965r1303b3003],
6	GG	NNS	O	gg	appos	3	SENT_327	[p25l1319t2968r1400b3008],
7	,	,	O	,	_	0	SENT_327	[p25l1319t2968r1400b3008],
8	Agostoni	NNP	ORGANIZATION	Agostoni	nn	9	SENT_327	[p25l1415t2968r1600b3015],
9	P	NN	ORGANIZATION	p	appos	3	SENT_327	[p25l1617t2969r1653b3008],
10	,	,	O	,	_	0	SENT_327	[p25l1617t2969r1653b3008],
11	et	FW	O	et	nn	12	SENT_327	[p25l1669t2973r1705b3003],
12	al.	FW	O	al.	appos	3	SENT_327	[p25l1719t2965r1763b3003],
13	.	.	O	.	_	0	SENT_327	[p25l1719t2965r1763b3003],

1	Meta-analysis	NN	O	meta-analysis	_	0	SENT_328	[p25l1781t2965r2057b3015],
2	appraising	VBG	O	appraise	partmod	1	SENT_328	[p25l747t3023r964b3071],
3	high	JJ	O	high	amod	4	SENT_328	[p25l977t3021r1072b3071],
4	clopidogrel	NN	O	clopidogrel	dobj	2	SENT_328	[p25l1086t3021r1315b3071],
5	loading	VBG	O	load	partmod	4	SENT_328	[p25l1328t3021r1482b3071],
6	in	IN	O	in	_	0	SENT_328	[p25l1495t3024r1537b3058],
7	patients	NNS	O	patient	prep_in	5	SENT_328	[p25l1550t3023r1713b3070],
8	undergoing	VBG	O	undergo	partmod	7	SENT_328	[p25l1727t3021r1968b3071],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_328	[p25l746t3085r1023b3127],
10	coronary	JJ	O	coronary	amod	11	SENT_328	[p25l1039t3091r1220b3127],
11	intervention	NN	O	intervention	dobj	8	SENT_328	[p25l1233t3080r1496b3115],
12	.	.	O	.	_	0	SENT_328	[p25l1233t3080r1496b3115],

1	Am	VBP	O	be	dep	3	SENT_329	[p25l1511t3081r1616b3127],
2	]	CD	NUMBER	]	num	3	SENT_329	[p25l1511t3081r1616b3127],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_329	[p25l1632t3078r1773b3115],
4	2007	CD	DATE	2007	num	3	SENT_329	[p25l1787t3080r1890b3121],
5	;	:	O	;	_	0	SENT_329	[p25l1787t3080r1890b3121],
6	100	CD	NUMBER	100	dep	3	SENT_329	[p25l747t3136r826b3171],
7	:	:	O	:	_	0	SENT_329	[p25l747t3136r826b3171],
8	1199-206	CD	NUMBER	1199-206	dep	6	SENT_329	[p25l843t3136r1039b3171],
9	.	.	O	.	_	0	SENT_329	[p25l843t3136r1039b3171],

1	9	CD	NUMBER	9	num	3	SENT_330	[p25l647t3200r668b3234],
2	Wiviott	NNP	O	Wiviott	nn	3	SENT_330	[p25l746t3199r894b3234],
3	SD	NN	O	sd	_	0	SENT_330	[p25l910t3200r980b3240],
4	,	,	O	,	_	0	SENT_330	[p25l910t3200r980b3240],
5	Braunvvald	NNP	O	Braunvvald	nn	6	SENT_330	[p25l998t3197r1222b3234],
6	E	NNP	O	E	appos	3	SENT_330	[p25l1237t3199r1272b3240],
7	,	,	O	,	_	0	SENT_330	[p25l1237t3199r1272b3240],
8	Mccabe	NNP	PERSON	Mccabe	nn	9	SENT_330	[p25l1290t3197r1445b3234],
9	CH	NN	O	ch	appos	3	SENT_330	[p25l1461t3200r1542b3240],
10	,	,	O	,	_	0	SENT_330	[p25l1461t3200r1542b3240],
11	et	FW	O	et	nn	12	SENT_330	[p25l1559t3204r1595b3234],
12	al	FW	O	al	appos	3	SENT_330	[p25l1609t3197r1653b3240],
13	,	,	O	,	_	0	SENT_330	[p25l1609t3197r1653b3240],
14	for	IN	O	for	_	0	SENT_330	[p25l1668t3197r1727b3234],
15	the	DT	O	the	det	18	SENT_330	[p25l1740t3197r1804b3234],
16	Triton-Timi	NNP	O	Triton-Timi	nn	18	SENT_330	[p25l1817t3199r2056b3234],
17	38	CD	NUMBER	38	num	18	SENT_330	[p25l2072t3200r2117b3234],
18	Investigators	NNS	O	investigator	prep_for	3	SENT_330	[p25l749t3255r1023b3302],
19	.	.	O	.	_	0	SENT_330	[p25l749t3255r1023b3302],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_331	[p25l1041t3253r1237b3302],
2	versus	CC	O	versus	prep	1	SENT_331	[p25l1250t3266r1381b3290],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_331	[p25l1397t3253r1625b3302],
4	in	IN	O	in	_	0	SENT_331	[p25l1639t3255r1680b3290],
5	patients	NNS	O	patient	prep_in	1	SENT_331	[p25l1694t3255r1856b3301],
6	with	IN	O	with	_	0	SENT_331	[p25l1870t3253r1962b3290],
7	acute	JJ	O	acute	amod	9	SENT_331	[p25l1976t3260r2083b3290],
8	coronary	JJ	O	coronary	amod	9	SENT_331	[p25l747t3321r927b3357],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_331	[p25l942t3308r1177b3357],
10	.	.	O	.	_	0	SENT_331	[p25l942t3308r1177b3357],

1	N	NN	O	n	nn	3	SENT_332	[p25l1196t3312r1232b3345],
2	Engl	NNP	O	Engl	nn	3	SENT_332	[p25l1245t3308r1362b3358],
3	]	NNP	O	]	nsubj	4	SENT_332	[p25l1245t3308r1362b3358],
4	Med	VBD	O	med	_	0	SENT_332	[p25l1375t3308r1460b3346],
5	2007	CD	DATE	2007	dobj	4	SENT_332	[p25l1474t3310r1576b3351],
6	;	:	O	;	_	0	SENT_332	[p25l1474t3310r1576b3351],
7	357	CD	NUMBER	357	num	9	SENT_332	[p25l1593t3310r1675b3346],
8	:	:	O	:	_	0	SENT_332	[p25l1593t3310r1675b3346],
9	2001-15	CD	NUMBER	2001-15	dep	5	SENT_332	[p25l1693t3310r1863b3346],
10	.	.	O	.	_	0	SENT_332	[p25l1693t3310r1863b3346],

1	10	CD	NUMBER	10	_	0	SENT_333	[p25l648t3375r689b3409],
2	Bonello	NNP	ORGANIZATION	Bonello	nn	3	SENT_333	[p25l749t3372r904b3409],
3	L	NNP	ORGANIZATION	L	nn	20	SENT_333	[p25l921t3375r955b3415],
4	,	,	O	,	_	0	SENT_333	[p25l921t3375r955b3415],
5	Dignat-George	NNP	PERSON	Dignat-George	nn	6	SENT_333	[p25l973t3374r1276b3421],
6	F	NN	O	f	appos	3	SENT_333	[p25l1293t3374r1328b3415],
7	,	,	O	,	_	0	SENT_333	[p25l1293t3374r1328b3415],
8	Camoin-Iau	NNP	O	Camoin-Iau	nn	9	SENT_333	[p25l1346t3374r1591b3420],
9	L	NNP	O	L	appos	3	SENT_333	[p25l1607t3375r1641b3415],
10	,	,	O	,	_	0	SENT_333	[p25l1607t3375r1641b3415],
11	Barragan	NNP	PERSON	Barragan	nn	12	SENT_333	[p25l1659t3375r1847b3421],
12	P	NN	PERSON	p	appos	3	SENT_333	[p25l1863t3375r1900b3415],
13	,	,	O	,	_	0	SENT_333	[p25l1863t3375r1900b3415],
14	Arques	NNP	O	Arques	nn	15	SENT_333	[p25l1915t3374r2063b3421],
15	S	NNP	O	S	appos	3	SENT_333	[p25l2082t3374r2116b3415],
16	,	,	O	,	_	0	SENT_333	[p25l2082t3374r2116b3415],
17	Paganelli	NNP	PERSON	Paganelli	nn	19	SENT_333	[p25l749t3427r936b3477],
18	F.	NNP	O	F.	nn	19	SENT_333	[p25l953t3430r988b3465],
19	Adjusted	NNP	O	Adjusted	appos	3	SENT_333	[p25l1004t3427r1189b3477],
20	clopidogrel	NN	O	clopidogrel	dobj	21	SENT_333	[p25l1203t3427r1434b3477],
21	loading	VBG	O	load	dep	1	SENT_333	[p25l1448t3427r1603b3477],
22	dose	NN	O	dose	nn	24	SENT_333	[p25l1618t3427r1710b3465],
23	to	TO	O	to	dep	24	SENT_333	[p25l1724t3435r1763b3465],
24	platelet	NN	O	platelet	dep	21	SENT_333	[p25l1778t3427r1929b3476],
25	reactivity	NN	O	reactivity	nn	26	SENT_333	[p25l1942t3430r2130b3477],
26	measure	NN	O	measure	nsubj	27	SENT_333	[p25l746t3497r925b3521],
27	decrease	VB	O	decrease	rcmod	24	SENT_333	[p25l940t3484r1117b3521],
28	the	DT	O	the	det	29	SENT_333	[p25l1131t3484r1195b3521],
29	rate	NN	O	rate	dobj	27	SENT_333	[p25l1210t3491r1287b3521],
30	of	IN	O	of	_	0	SENT_333	[p25l1303t3484r1349b3521],
31	major	JJ	O	major	amod	34	SENT_333	[p25l1356t3486r1480b3533],
32	adverse	JJ	O	adverse	amod	34	SENT_333	[p25l1494t3484r1648b3521],
33	cardiovascular	JJ	O	cardiovascular	amod	34	SENT_333	[p25l1663t3484r1961b3521],
34	events	NNS	O	event	prep_of	29	SENT_333	[p25l1975t3491r2104b3521],
35	in	IN	O	in	_	0	SENT_333	[p25l746t3542r788b3577],
36	patients	NNS	O	patient	prep_in	34	SENT_333	[p25l802t3542r965b3589],
37	with	IN	O	with	_	0	SENT_333	[p25l980t3540r1072b3577],
38	clopidogrel	NN	O	clopidogrel	nn	39	SENT_333	[p25l1086t3540r1317b3589],
39	resistance	NN	O	resistance	prep_with	36	SENT_333	[p25l1331t3542r1549b3577],
40	:	:	O	:	_	0	SENT_333	[p25l1331t3542r1549b3577],
41	a	DT	O	a	det	43	SENT_333	[p25l1566t3553r1586b3577],
42	multi	JJ	O	multi	amod	43	SENT_333	[p25l1601t3540r1714b3577],
43	centric	JJ	O	centric	dep	29	SENT_333	[p25l1728t3542r1869b3577],
44	randomized	VBN	O	randomize	partmod	43	SENT_333	[p25l1883t3540r2145b3583],
45	,	,	O	,	_	0	SENT_333	[p25l1883t3540r2145b3583],
46	prospective	JJ	O	prospective	amod	47	SENT_333	[p25l746t3598r981b3644],
47	study	NN	O	study	dobj	44	SENT_333	[p25l997t3595r1113b3645],
48	.	.	O	.	_	0	SENT_333	[p25l997t3595r1113b3645],
49	]	SYM	O	]	dep	1	SENT_333	[p25l1125t3599r1150b3645],

1	Am	VBP	O	be	dep	3	SENT_334	[p25l1161t3598r1234b3632],
2	Coll	NNP	O	Coll	nn	3	SENT_334	[p25l1251t3595r1326b3633],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_334	[p25l1343t3595r1486b3633],
4	2008	CD	DATE	2008	num	3	SENT_334	[p25l1500t3599r1607b3638],
5	;	:	O	;	_	0	SENT_334	[p25l1500t3599r1607b3638],
6	51	CD	NUMBER	51	dep	3	SENT_334	[p25l1625t3597r1679b3633],
7	:	:	O	:	_	0	SENT_334	[p25l1625t3597r1679b3633],
8	1404-11	CD	DATE	1404-11	dep	6	SENT_334	[p25l1696t3599r1858b3633],
9	.	.	O	.	_	0	SENT_334	[p25l1696t3599r1858b3633],

1	Hollopeter	NNP	PERSON	Hollopeter	nn	2	SENT_335	[p26l151t176r463b246],
2	G	NNP	PERSON	G	_	0	SENT_335	[p26l484t180r547b238],
3	,	,	O	,	_	0	SENT_335	[p26l484t180r547b238],
4	Iantzen	NNP	O	Iantzen	nn	5	SENT_335	[p26l571t182r791b245],
5	HM	NNS	O	hm	appos	2	SENT_335	[p26l814t182r946b238],
6	,	,	O	,	_	0	SENT_335	[p26l814t182r946b238],
7	Vincent	NNP	PERSON	Vincent	nn	8	SENT_335	[p26l967t180r1195b230],
8	D	NNP	PERSON	D	appos	2	SENT_335	[p26l1218t182r1279b238],
9	,	,	O	,	_	0	SENT_335	[p26l1218t182r1279b238],
10	et	FW	O	et	nn	11	SENT_335	[p26l1302t187r1354b229],
11	al.	FW	O	al.	appos	2	SENT_335	[p26l1373t176r1435b229],
12	.	.	O	.	_	0	SENT_335	[p26l1373t176r1435b229],

1	Identiﬁcation	NN	O	identiﬁcation	nsubj	7	SENT_336	[p26l1462t176r1854b229],
2	of	IN	O	of	_	0	SENT_336	[p26l1875t176r1940b229],
3	the	DT	O	the	det	6	SENT_336	[p26l1949t176r2040b229],
4	platelet	NN	O	platelet	nn	6	SENT_336	[p26l148t257r361b326],
5	ADP	NN	O	adp	nn	6	SENT_336	[p26l379t260r517b309],
6	receptor	NN	O	receptor	prep_of	1	SENT_336	[p26l539t268r780b326],
7	targeted	VBN	O	target	_	0	SENT_336	[p26l798t257r1036b327],
8	by	IN	O	by	_	0	SENT_336	[p26l1054t257r1122b327],
9	antithrombotic	JJ	O	antithrombotic	amod	10	SENT_336	[p26l1142t257r1581b310],
10	drugs	NNS	O	drug	prep_by	7	SENT_336	[p26l1601t257r1782b327],
11	.	.	O	.	_	0	SENT_336	[p26l1601t257r1782b327],

1	Nature	NNP	O	Nature	_	0	SENT_337	[p26l1808t262r2001b310],
2	2001	CD	DATE	2001	num	1	SENT_337	[p26l150t340r664b398],
3	;	:	O	;	_	0	SENT_337	[p26l150t340r664b398],
4	409:202	CD	NUMBER	409:202	number	5	SENT_337	[p26l150t340r664b398],
5	—	CD	NUMBER	—	num	6	SENT_337	[p26l150t340r664b398],
6	07	CD	NUMBER	07	dep	1	SENT_337	[p26l150t340r664b398],

1	Savi	NNP	PERSON	Savi	nn	2	SENT_338	[p26l153t431r266b481],
2	P	NN	O	p	_	0	SENT_338	[p26l290t433r341b489],
3	,	,	O	,	_	0	SENT_338	[p26l290t433r341b489],
4	Pereillo	NNP	O	Pereillo	nn	5	SENT_338	[p26l367t428r585b481],
5	IM	NNP	O	IM	appos	2	SENT_338	[p26l607t433r707b496],
6	,	,	O	,	_	0	SENT_338	[p26l607t433r707b496],
7	Uzabiaga	NNP	O	Uzabiaga	nn	8	SENT_338	[p26l733t428r1004b498],
8	MF	NN	O	mf	appos	2	SENT_338	[p26l1026t431r1140b490],
9	,	,	O	,	_	0	SENT_338	[p26l1026t431r1140b490],
10	et	FW	O	et	nn	11	SENT_338	[p26l1163t439r1215b481],
11	al.	FW	O	al.	appos	2	SENT_338	[p26l1234t428r1296b481],
12	.	.	O	.	_	0	SENT_338	[p26l1234t428r1296b481],

1	Identiﬁcation	NN	O	identiﬁcation	nn	4	SENT_339	[p26l1323t428r1715b481],
2	and	CC	O	and	_	0	SENT_339	[p26l1736t428r1844b481],
3	biological	JJ	O	biological	nn	4	SENT_339	[p26l1862t428r2144b498],
4	activity	NN	O	activity	_	0	SENT_339	[p26l149t511r353b578],
5	of	IN	O	of	_	0	SENT_339	[p26l373t507r438b561],
6	the	DT	O	the	det	8	SENT_339	[p26l447t508r538b561],
7	active	JJ	O	active	amod	8	SENT_339	[p26l560t511r722b561],
8	metabolite	NN	O	metabolite	prep_of	4	SENT_339	[p26l743t508r1052b561],
9	of	IN	O	of	_	0	SENT_339	[p26l1073t508r1138b561],
10	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_339	[p26l1149t508r1488b578],
11	.	.	O	.	_	0	SENT_339	[p26l1149t508r1488b578],

1	Thromb	NNP	O	Thromb	nn	2	SENT_340	[p26l1517t508r1733b561],
2	Haemost	NNP	O	Haemost	_	0	SENT_340	[p26l1757t513r2002b561],
3	2000	CD	DATE	2000	num	2	SENT_340	[p26l150t592r301b649],
4	;	:	O	;	_	0	SENT_340	[p26l150t592r301b649],
5	84	CD	NUMBER	84	num	7	SENT_340	[p26l325t592r406b641],
6	:	:	O	:	_	0	SENT_340	[p26l325t592r406b641],
7	891-96	CD	NUMBER	891-96	dep	2	SENT_340	[p26l430t592r646b642],
8	.	.	O	.	_	0	SENT_340	[p26l430t592r646b642],

1	Savi	NNP	PERSON	Savi	nn	2	SENT_341	[p26l153t682r266b732],
2	P	NN	O	p	_	0	SENT_341	[p26l290t684r341b740],
3	,	,	O	,	_	0	SENT_341	[p26l290t684r341b740],
4	Labouret	NN	ORGANIZATION	labouret	nn	5	SENT_341	[p26l367t679r624b732],
5	C	NN	ORGANIZATION	c	appos	2	SENT_341	[p26l645t682r702b740],
6	,	,	O	,	_	0	SENT_341	[p26l645t682r702b740],
7	Delesque	JJ	O	delesque	amod	8	SENT_341	[p26l729t679r996b748],
8	N	NN	O	n	appos	5	SENT_341	[p26l1019t684r1082b740],
9	,	,	O	,	_	0	SENT_341	[p26l1019t684r1082b740],
10	Guette	NN	O	guette	nn	11	SENT_341	[p26l1106t682r1298b732],
11	F	NN	O	f	appos	5	SENT_341	[p26l1322t682r1371b740],
12	,	,	O	,	_	0	SENT_341	[p26l1322t682r1371b740],
13	Lupker	NN	O	lupker	nn	14	SENT_341	[p26l1397t679r1601b748],
14	I	NN	O	i	appos	5	SENT_341	[p26l1621t684r1658b747],
15	,	,	O	,	_	0	SENT_341	[p26l1621t684r1658b747],
16	Herbert	NNP	PERSON	Herbert	nn	17	SENT_341	[p26l1684t679r1912b732],
17	IM	NNP	O	IM	appos	5	SENT_341	[p26l1933t684r2032b747],
18	.	.	O	.	_	0	SENT_341	[p26l1933t684r2032b747],

1	P2Y	NN	O	p2y	_	0	SENT_342	[p26l151t764r388b829],
2	(	CD	NUMBER	(	num	1	SENT_342	[p26l151t764r388b829],
3	12	CD	NUMBER	12	num	4	SENT_342	[p26l151t764r388b829],
4	)	NN	O	)	dep	1	SENT_342	[p26l151t764r388b829],
5	,	,	O	,	_	0	SENT_342	[p26l151t764r388b829],
6	a	DT	O	a	det	10	SENT_342	[p26l412t777r441b812],
7	new	JJ	O	new	amod	10	SENT_342	[p26l460t777r582b812],
8	platelet	NN	O	platelet	nn	10	SENT_342	[p26l601t758r814b828],
9	ADP	NN	O	adp	nn	10	SENT_342	[p26l832t762r970b811],
10	receptor	NN	O	receptor	appos	4	SENT_342	[p26l991t769r1241b828],
11	,	,	O	,	_	0	SENT_342	[p26l991t769r1241b828],
12	target	NN	O	target	appos	4	SENT_342	[p26l1262t769r1431b829],
13	of	IN	O	of	_	0	SENT_342	[p26l1450t758r1516b812],
14	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_342	[p26l1526t758r1866b829],
15	.	.	O	.	_	0	SENT_342	[p26l1526t758r1866b829],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_343	[p26l152t839r389b892],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_343	[p26l411t839r625b909],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_343	[p26l648t844r739b892],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_343	[p26l762t843r1022b892],
5	2001	CD	DATE	2001	num	4	SENT_343	[p26l1043t844r1187b900],
6	;	:	O	;	_	0	SENT_343	[p26l1043t844r1187b900],
7	283	CD	NUMBER	283	num	9	SENT_343	[p26l1212t844r1328b892],
8	:	:	O	:	_	0	SENT_343	[p26l1212t844r1328b892],
9	379-83	CD	NUMBER	379-83	dep	4	SENT_343	[p26l1354t842r1569b894],
10	.	.	O	.	_	0	SENT_343	[p26l1354t842r1569b894],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_344	[p26l151t929r349b982],
2	IT	NNP	O	IT	_	0	SENT_344	[p26l370t932r441b997],
3	,	,	O	,	_	0	SENT_344	[p26l370t932r441b997],
4	Close	NNP	O	Close	nn	5	SENT_344	[p26l466t929r623b982],
5	Sl	NNP	O	Sl	appos	2	SENT_344	[p26l648t929r715b990],
6	,	,	O	,	_	0	SENT_344	[p26l648t929r715b990],
7	Iturria	NNP	ORGANIZATION	Iturria	nn	8	SENT_344	[p26l741t932r927b982],
8	SI	NNP	ORGANIZATION	SI	appos	2	SENT_344	[p26l951t933r1024b997],
9	,	,	O	,	_	0	SENT_344	[p26l951t933r1024b997],
10	et	FW	O	et	nn	11	SENT_344	[p26l1048t940r1100b982],
11	al.	FW	O	al.	appos	2	SENT_344	[p26l1119t929r1181b982],
12	.	.	O	.	_	0	SENT_344	[p26l1119t929r1181b982],

1	Common	JJ	O	common	amod	2	SENT_345	[p26l1207t933r1483b982],
2	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_345	[p26l1502t929r1965b999],
3	of	IN	O	of	_	0	SENT_345	[p26l1988t929r2052b982],
4	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_345	[p26l150t1012r422b1062],
5	and	CC	O	and	_	0	SENT_345	[p26l444t1008r552b1061],
6	CYP2C9	NN	O	cyp2c9	prep_of	2	SENT_345	[p26l573t1012r817b1062],
7	affect	VBP	O	affect	_	0	SENT_345	[p26l839t1008r997b1061],
8	the	DT	O	the	det	12	SENT_345	[p26l1015t1008r1106b1061],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_345	[p26l1126t1008r1621b1078],
10	and	CC	O	and	_	0	SENT_345	[p26l1641t1008r1749b1061],
11	pharmacodynamic	JJ	O	pharmacodynamic	amod	12	SENT_345	[p26l148t1089r696b1159],
12	response	NN	O	response	dobj	7	SENT_345	[p26l715t1108r977b1158],
13	to	TO	O	to	dep	12	SENT_345	[p26l997t1100r1051b1142],
14	clopidogrel	NN	O	clopidogrel	dep	12	SENT_345	[p26l1072t1089r1398b1159],
15	but	CC	O	but	_	0	SENT_345	[p26l1417t1089r1515b1142],
16	not	RB	O	not	neg	17	SENT_345	[p26l1533t1100r1629b1142],
17	prasugrel	NN	O	prasugrel	conj_but	14	SENT_345	[p26l1648t1089r1940b1159],
18	.	.	O	.	_	0	SENT_345	[p26l1648t1089r1940b1159],
19	]	SYM	O	]	dep	12	SENT_345	[p26l140t1174r176b1239],

1	Thromb	NNP	O	Thromb	nn	2	SENT_346	[p26l198t1169r414b1222],
2	Haemost	NNP	O	Haemost	_	0	SENT_346	[p26l438t1174r683b1222],
3	2007	CD	DATE	2007	num	2	SENT_346	[p26l703t1172r848b1230],
4	;	:	O	;	_	0	SENT_346	[p26l703t1172r848b1230],
5	5	CD	NUMBER	5	num	7	SENT_346	[p26l874t1171r919b1222],
6	:	:	O	:	_	0	SENT_346	[p26l874t1171r919b1222],
7	2429-36	CD	NUMBER	2429-36	dep	2	SENT_346	[p26l944t1173r1196b1222],
8	.	.	O	.	_	0	SENT_346	[p26l944t1173r1196b1222],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_347	[p26l151t1263r273b1312],
2	K	NNP	PERSON	K	_	0	SENT_347	[p26l297t1265r352b1322],
3	,	,	O	,	_	0	SENT_347	[p26l297t1265r352b1322],
4	Park	NNP	O	Park	nn	5	SENT_347	[p26l378t1260r508b1313],
5	P	NN	O	p	appos	2	SENT_347	[p26l530t1265r581b1322],
6	,	,	O	,	_	0	SENT_347	[p26l530t1265r581b1322],
7	Hong	NNP	LOCATION	Hong	nn	8	SENT_347	[p26l607t1265r771b1330],
8	S	NNP	LOCATION	S	appos	2	SENT_347	[p26l795t1264r842b1322],
9	,	,	O	,	_	0	SENT_347	[p26l795t1264r842b1322],
10	Park	NNP	O	Park	nn	11	SENT_347	[p26l868t1260r999b1313],
11	IY	NNP	O	IY	appos	2	SENT_347	[p26l1019t1265r1088b1328],
12	.	.	O	.	_	0	SENT_347	[p26l1019t1265r1088b1328],

1	The	DT	O	the	det	2	SENT_348	[p26l1111t1260r1223b1313],
2	effect	NN	O	effect	_	0	SENT_348	[p26l1244t1260r1403b1313],
3	of	IN	O	of	_	0	SENT_348	[p26l1423t1260r1487b1313],
4	C	NN	O	c	nn	5	SENT_348	[p26l1503t1264r1545b1313],
5	YPZC	NN	O	ypzc	prep_of	2	SENT_348	[p26l1550t1264r1712b1313],
6	19	CD	NUMBER	19	num	7	SENT_348	[p26l1717t1265r1775b1313],
7	polymorphism	NN	O	polymorphism	dep	2	SENT_348	[p26l148t1340r582b1410],
8	on	IN	O	on	_	0	SENT_348	[p26l603t1359r676b1393],
9	the	DT	O	the	det	10	SENT_348	[p26l695t1340r786b1393],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_348	[p26l807t1340r1328b1409],
11	and	CC	O	and	_	0	SENT_348	[p26l1351t1340r1459b1393],
12	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	10	SENT_348	[p26l1478t1340r2053b1410],
13	of	IN	O	of	_	0	SENT_348	[p26l2076t1340r2141b1393],
14	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_348	[p26l149t1419r488b1490],
15	:	:	O	:	_	0	SENT_348	[p26l149t1419r488b1490],
16	a	DT	O	a	det	18	SENT_348	[p26l513t1438r541b1473],
17	possible	JJ	O	possible	amod	18	SENT_348	[p26l561t1419r799b1489],
18	mechanism	NN	O	mechanism	dep	2	SENT_348	[p26l819t1419r1166b1473],
19	for	IN	O	for	_	0	SENT_348	[p26l1186t1419r1269b1473],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_348	[p26l1289t1419r1614b1490],
21	resistance	NN	O	resistance	prep_for	18	SENT_348	[p26l1634t1423r1941b1473],
22	.	.	O	.	_	0	SENT_348	[p26l1634t1423r1941b1473],

1	Clin	NNP	O	Clin	nn	3	SENT_349	[p26l154t1500r269b1553],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_349	[p26l291t1500r591b1553],
3	Ther	NNP	O	Ther	_	0	SENT_349	[p26l615t1500r742b1553],
4	2008	CD	DATE	2008	num	3	SENT_349	[p26l759t1505r910b1561],
5	;	:	O	;	_	0	SENT_349	[p26l759t1505r910b1561],
6	84	CD	NUMBER	84	num	8	SENT_349	[p26l935t1505r1016b1553],
7	:	:	O	:	_	0	SENT_349	[p26l935t1505r1016b1553],
8	236-42	CD	NUMBER	236-42	dep	3	SENT_349	[p26l1041t1505r1258b1553],
9	.	.	O	.	_	0	SENT_349	[p26l1041t1505r1258b1553],

1	Fayer	NNP	PERSON	Fayer	nn	3	SENT_350	[p26l151t1593r302b1659],
2	Rehmel	NNP	PERSON	Rehmel	nn	3	SENT_350	[p26l323t1589r545b1643],
3	IL	NN	PERSON	il	_	0	SENT_350	[p26l565t1595r637b1658],
4	,	,	O	,	_	0	SENT_350	[p26l565t1595r637b1658],
5	Eckstein	NN	ORGANIZATION	eckstein	nn	6	SENT_350	[p26l662t1589r904b1643],
6	IA	NN	ORGANIZATION	ia	appos	3	SENT_350	[p26l924t1594r1006b1658],
7	,	,	O	,	_	0	SENT_350	[p26l924t1594r1006b1658],
8	Farid	NNP	ORGANIZATION	Farid	nn	9	SENT_350	[p26l1031t1589r1175b1643],
9	NA	NNP	ORGANIZATION	NA	appos	3	SENT_350	[p26l1195t1594r1303b1651],
10	,	,	O	,	_	0	SENT_350	[p26l1195t1594r1303b1651],
11	et	FW	O	et	nn	12	SENT_350	[p26l1325t1600r1376b1643],
12	al.	FW	O	al.	appos	3	SENT_350	[p26l1395t1589r1456b1643],
13	.	.	O	.	_	0	SENT_350	[p26l1395t1589r1456b1643],

1	Interaction	NN	O	interaction	_	0	SENT_351	[p26l1481t1593r1796b1643],
2	of	IN	O	of	_	0	SENT_351	[p26l1816t1589r1880b1643],
3	two	CD	NUMBER	two	num	5	SENT_351	[p26l1888t1600r1991b1643],
4	major	JJ	O	major	amod	5	SENT_351	[p26l148t1673r320b1739],
5	metabolites	NNS	O	metabolite	prep_of	1	SENT_351	[p26l337t1669r670b1722],
6	of	IN	O	of	_	0	SENT_351	[p26l691t1669r755b1722],
7	prasugrel	NN	O	prasugrel	prep_of	5	SENT_351	[p26l764t1669r1051b1740],
8	,	,	O	,	_	0	SENT_351	[p26l764t1669r1051b1740],
9	a	DT	O	a	det	12	SENT_351	[p26l1073t1688r1102b1722],
10	thienopyridine	NN	O	thienopyridine	nn	12	SENT_351	[p26l1120t1669r1546b1739],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_351	[p26l1566t1669r1886b1739],
12	agent	NN	O	agent	appos	7	SENT_351	[p26l1905t1680r2076b1740],
13	,	,	O	,	_	0	SENT_351	[p26l1905t1680r2076b1740],
14	with	IN	O	with	_	0	SENT_351	[p26l147t1750r275b1803],
15	the	DT	O	the	det	17	SENT_351	[p26l292t1750r382b1803],
16	cytochromes	NNS	O	cytochrome	nn	17	SENT_351	[p26l403t1750r766b1820],
17	P450	NN	O	p450	prep_with	1	SENT_351	[p26l790t1753r941b1803],
18	.	.	O	.	_	0	SENT_351	[p26l790t1753r941b1803],

1	Drug	NN	O	drug	nn	3	SENT_352	[p26l967t1755r1108b1820],
2	Metab	NNP	O	Metab	nn	3	SENT_352	[p26l1124t1750r1294b1803],
3	Dispos	NNP	O	Dispos	_	0	SENT_352	[p26l1317t1752r1492b1819],
4	2006	CD	DATE	2006	num	3	SENT_352	[p26l1512t1755r1660b1812],
5	;	:	O	;	_	0	SENT_352	[p26l1512t1755r1660b1812],
6	34	CD	NUMBER	34	num	8	SENT_352	[p26l1683t1755r1764b1803],
7	:	:	O	:	_	0	SENT_352	[p26l1683t1755r1764b1803],
8	600-07	CD	NUMBER	600-07	dep	3	SENT_352	[p26l1787t1753r1988b1805],
9	.	.	O	.	_	0	SENT_352	[p26l1787t1753r1988b1805],

1	Fontana	NNP	ORGANIZATION	Fontana	nn	2	SENT_353	[p26l151t1844r387b1894],
2	P	NN	ORGANIZATION	p	nsubj	9	SENT_353	[p26l411t1846r463b1902],
3	,	,	O	,	_	0	SENT_353	[p26l411t1846r463b1902],
4	Hulot	NNP	PERSON	Hulot	appos	2	SENT_353	[p26l489t1840r658b1894],
5	IS	VBZ	O	be	cop	9	SENT_353	[p26l679t1844r755b1909],
6	,	,	O	,	_	0	SENT_353	[p26l679t1844r755b1909],
7	De	NNP	PERSON	De	nn	9	SENT_353	[p26l782t1846r860b1894],
8	Moerloose	NNP	PERSON	Moerloose	nn	9	SENT_353	[p26l883t1840r1188b1894],
9	P	NN	PERSON	p	_	0	SENT_353	[p26l1213t1846r1264b1902],
10	,	,	O	,	_	0	SENT_353	[p26l1213t1846r1264b1902],
11	Gaussem	NNP	PERSON	Gaussem	nn	13	SENT_353	[p26l1290t1844r1564b1894],
12	P.	NNP	PERSON	P.	nn	13	SENT_353	[p26l1587t1846r1639b1893],
13	Inﬂuence	NNP	PERSON	Inﬂuence	appos	9	SENT_353	[p26l1665t1840r1945b1894],
14	of	IN	O	of	_	0	SENT_353	[p26l1967t1840r2032b1894],
15	C	NNP	O	C	nn	16	SENT_353	[p26l154t1925r196b1974],
16	YPZC	NNP	O	YPZC	prep_of	13	SENT_353	[p26l201t1925r364b1974],
17	19	CD	NUMBER	19	nn	21	SENT_353	[p26l369t1926r428b1974],
18	and	CC	O	and	_	0	SENT_353	[p26l446t1921r554b1974],
19	CYP3A4	NN	O	cyp3a4	conj_and	17	SENT_353	[p26l579t1925r824b1974],
20	gene	NN	O	gene	nn	21	SENT_353	[p26l841t1940r978b1991],
21	polymorphisms	NNS	O	polymorphism	dep	24	SENT_353	[p26l999t1921r1465b1991],
22	on	IN	O	on	_	0	SENT_353	[p26l1488t1940r1562b1974],
23	clopidogrel	NN	O	clopidogrel	prep_on	21	SENT_353	[p26l1583t1921r1911b1991],
24	responsiveness	NN	O	responsiveness	dep	13	SENT_353	[p26l148t2004r595b2070],
25	in	IN	O	in	_	0	SENT_353	[p26l618t2004r677b2053],
26	healthy	JJ	O	healthy	amod	27	SENT_353	[p26l696t2001r913b2071],
27	subjects	NNS	O	subject	prep_in	24	SENT_353	[p26l934t2001r1186b2071],
28	.	.	O	.	_	0	SENT_353	[p26l934t2001r1186b2071],
29	]	SYM	O	]	dep	9	SENT_353	[p26l1201t2006r1237b2071],

1	Thromb	NNP	O	Thromb	nn	2	SENT_354	[p26l1260t2001r1476b2054],
2	Haemost	NNP	O	Haemost	_	0	SENT_354	[p26l1501t2006r1748b2054],
3	2007	CD	DATE	2007	num	2	SENT_354	[p26l1769t2004r1915b2062],
4	;	:	O	;	_	0	SENT_354	[p26l1769t2004r1915b2062],
5	5	CD	NUMBER	5	num	7	SENT_354	[p26l150t2083r196b2133],
6	:	:	O	:	_	0	SENT_354	[p26l150t2083r196b2133],
7	2153-55	CD	NUMBER	2153-55	dep	2	SENT_354	[p26l221t2083r472b2134],
8	.	.	O	.	_	0	SENT_354	[p26l221t2083r472b2134],

1	Hulot	NNP	PERSON	Hulot	nsubj	5	SENT_355	[p26l151t2172r317b2225],
2	IS	VBZ	O	be	cop	5	SENT_355	[p26l336t2176r411b2240],
3	,	,	O	,	_	0	SENT_355	[p26l336t2176r411b2240],
4	Bura	NNP	PERSON	Bura	nn	5	SENT_355	[p26l436t2177r570b2225],
5	A	NNP	O	A	_	0	SENT_355	[p26l588t2176r648b2233],
6	,	,	O	,	_	0	SENT_355	[p26l588t2176r648b2233],
7	Villard	NNP	O	Villard	nn	8	SENT_355	[p26l668t2172r861b2225],
8	E	NNP	O	E	appos	5	SENT_355	[p26l883t2175r932b2233],
9	,	,	O	,	_	0	SENT_355	[p26l883t2175r932b2233],
10	et	FW	O	et	nn	11	SENT_355	[p26l954t2183r1006b2225],
11	al.	FW	O	al.	appos	8	SENT_355	[p26l1024t2172r1085b2225],
12	.	.	O	.	_	0	SENT_355	[p26l1024t2172r1085b2225],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_356	[p26l1109t2172r1458b2242],
2	P450	NN	O	p450	nsubj	9	SENT_356	[p26l1480t2175r1617b2225],
3	2C19	NN	O	2c19	nn	5	SENT_356	[p26l1638t2176r1776b2225],
4	loss-of-function	NN	O	loss-of-function	nn	5	SENT_356	[p26l147t2251r596b2305],
5	polymorphism	NN	O	polymorphism	dep	2	SENT_356	[p26l615t2251r1043b2321],
6	is	VBZ	O	be	cop	9	SENT_356	[p26l1062t2255r1107b2305],
7	a	DT	O	a	det	9	SENT_356	[p26l1129t2270r1158b2305],
8	major	JJ	O	major	amod	9	SENT_356	[p26l1176t2255r1348b2321],
9	determinant	NN	O	determinant	_	0	SENT_356	[p26l1366t2251r1725b2305],
10	of	IN	O	of	_	0	SENT_356	[p26l1744t2251r1808b2305],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_356	[p26l1818t2251r2137b2322],
12	responsiveness	NN	O	responsiveness	prep_of	9	SENT_356	[p26l148t2335r584b2401],
13	in	IN	O	in	_	0	SENT_356	[p26l605t2335r663b2384],
14	healthy	JJ	O	healthy	amod	15	SENT_356	[p26l681t2331r893b2401],
15	subjects	NNS	O	subject	prep_in	12	SENT_356	[p26l912t2331r1157b2401],
16	.	.	O	.	_	0	SENT_356	[p26l912t2331r1157b2401],

1	Blood	NN	O	blood	_	0	SENT_357	[p26l1183t2331r1334b2384],
2	2006	CD	DATE	2006	num	1	SENT_357	[p26l1353t2336r1501b2393],
3	;	:	O	;	_	0	SENT_357	[p26l1353t2336r1501b2393],
4	108	CD	NUMBER	108	num	6	SENT_357	[p26l1525t2336r1634b2384],
5	:	:	O	:	_	0	SENT_357	[p26l1525t2336r1634b2384],
6	2244-47	CD	NUMBER	2244-47	dep	1	SENT_357	[p26l1658t2334r1882b2387],
7	.	.	O	.	_	0	SENT_357	[p26l1658t2334r1882b2387],

1	Frere	NNP	ORGANIZATION	Frere	nn	2	SENT_358	[p26l151t2425r300b2475],
2	C	NNP	ORGANIZATION	C	_	0	SENT_358	[p26l323t2426r381b2483],
3	,	,	O	,	_	0	SENT_358	[p26l323t2426r381b2483],
4	Cuisset	NNP	O	Cuisset	nn	5	SENT_358	[p26l406t2425r624b2475],
5	T	NN	O	t	appos	2	SENT_358	[p26l642t2425r690b2483],
6	,	,	O	,	_	0	SENT_358	[p26l642t2425r690b2483],
7	Morange	NNP	ORGANIZATION	Morange	nn	8	SENT_358	[p26l716t2427r977b2492],
8	PE	NNP	ORGANIZATION	PE	appos	2	SENT_358	[p26l1001t2425r1094b2483],
9	,	,	O	,	_	0	SENT_358	[p26l1001t2425r1094b2483],
10	et	FW	O	et	nn	11	SENT_358	[p26l1118t2433r1170b2475],
11	al.	FW	O	al.	appos	2	SENT_358	[p26l1190t2422r1253b2475],
12	.	.	O	.	_	0	SENT_358	[p26l1190t2422r1253b2475],

1	Effect	NN	O	effect	_	0	SENT_359	[p26l1279t2422r1445b2475],
2	of	IN	O	of	_	0	SENT_359	[p26l1465t2422r1530b2475],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_359	[p26l1542t2422r1885b2492],
4	P450	NN	O	p450	nn	5	SENT_359	[p26l151t2504r290b2554],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_359	[p26l310t2501r776b2571],
6	on	IN	O	on	_	0	SENT_359	[p26l799t2520r872b2554],
7	platelet	NN	O	platelet	nn	8	SENT_359	[p26l893t2501r1108b2571],
8	reactivity	NN	O	reactivity	prep_on	5	SENT_359	[p26l1127t2505r1394b2571],
9	after	IN	O	after	_	0	SENT_359	[p26l1414t2501r1547b2554],
10	treatment	NN	O	treatment	prep_after	8	SENT_359	[p26l1565t2512r1856b2554],
11	with	IN	O	with	_	0	SENT_359	[p26l1874t2501r2005b2554],
12	clopidogrel	NN	O	clopidogrel	prep_with	1	SENT_359	[p26l149t2582r477b2652],
13	in	IN	O	in	_	0	SENT_359	[p26l497t2585r556b2634],
14	acute	JJ	O	acute	amod	16	SENT_359	[p26l577t2593r730b2635],
15	coronary	JJ	O	coronary	amod	16	SENT_359	[p26l752t2601r1011b2652],
16	syndrome	NN	O	syndrome	prep_in	1	SENT_359	[p26l1032t2582r1340b2652],
17	.	.	O	.	_	0	SENT_359	[p26l1032t2582r1340b2652],

1	Am	VBP	O	be	dep	3	SENT_360	[p26l1362t2586r1512b2652],
2	]	CD	NUMBER	]	num	3	SENT_360	[p26l1362t2586r1512b2652],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_360	[p26l1535t2582r1738b2635],
4	2008	CD	DATE	2008	num	3	SENT_360	[p26l1759t2587r1911b2643],
5	;	:	O	;	_	0	SENT_360	[p26l1759t2587r1911b2643],
6	101:1088	CD	NUMBER	101:1088	num	7	SENT_360	[p26l149t2666r533b2714],
7	-93	CD	NUMBER	-93	dep	3	SENT_360	[p26l149t2666r533b2714],
8	.	.	O	.	_	0	SENT_360	[p26l149t2666r533b2714],

1	Giusti	NNP	PERSON	Giusti	nn	2	SENT_361	[p26l150t2755r326b2805],
2	B	NNP	PERSON	B	_	0	SENT_361	[p26l349t2757r403b2814],
3	,	,	O	,	_	0	SENT_361	[p26l349t2757r403b2814],
4	Gori	NNP	ORGANIZATION	Gori	nn	5	SENT_361	[p26l428t2755r556b2805],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_361	[p26l575t2756r699b2814],
6	,	,	O	,	_	0	SENT_361	[p26l575t2756r699b2814],
7	Marcucci	NNP	PERSON	Marcucci	nn	8	SENT_361	[p26l724t2755r990b2805],
8	R	NNP	PERSON	R	appos	2	SENT_361	[p26l1013t2757r1069b2814],
9	,	,	O	,	_	0	SENT_361	[p26l1013t2757r1069b2814],
10	et	FW	O	et	nn	11	SENT_361	[p26l1092t2763r1143b2805],
11	al.	FW	O	al.	appos	2	SENT_361	[p26l1163t2752r1225b2805],
12	.	.	O	.	_	0	SENT_361	[p26l1163t2752r1225b2805],

1	Cytochrome	NN	O	cytochrome	nn	5	SENT_362	[p26l1250t2752r1605b2822],
2	P450	NN	O	p450	nn	5	SENT_362	[p26l1628t2755r1766b2805],
3	2C19	NN	O	2c19	nn	5	SENT_362	[p26l1789t2756r1929b2805],
4	loss-of-function	NN	O	loss-of-function	nn	5	SENT_362	[p26l147t2832r605b2885],
5	polymorphism	NN	O	polymorphism	nsubjpass	20	SENT_362	[p26l625t2832r1074b2902],
6	,	,	O	,	_	0	SENT_362	[p26l625t2832r1074b2902],
7	but	CC	O	but	_	0	SENT_362	[p26l1095t2832r1194b2885],
8	not	RB	O	not	neg	10	SENT_362	[p26l1212t2843r1308b2885],
9	CYP3A4	NN	O	cyp3a4	nn	10	SENT_362	[p26l1329t2835r1574b2885],
10	IVS	NN	O	iv	nsubjpass	20	SENT_362	[p26l1594t2836r1696b2885],
11	10	CD	NUMBER	10	dep	10	SENT_362	[p26l1705t2837r1763b2885],
12	+	CC	O	+	_	0	SENT_362	[p26l1784t2850r1818b2884],
13	12G/A	NN	O	12g/a	conj_+	10	SENT_362	[p26l1842t2835r2025b2901],
14	and	CC	O	and	_	0	SENT_362	[p26l2045t2832r2153b2885],
15	P2Y12	NN	O	p2y12	nn	17	SENT_362	[p26l151t2917r328b2964],
16	T744C	NN	O	t744c	nn	17	SENT_362	[p26l349t2915r528b2967],
17	polymorphisms	NNS	O	polymorphism	conj_+	10	SENT_362	[p26l549t2911r1028b2981],
18	,	,	O	,	_	0	SENT_362	[p26l549t2911r1028b2981],
19	is	VBZ	O	be	auxpass	20	SENT_362	[p26l1050t2915r1095b2965],
20	associated	VBN	O	associate	_	0	SENT_362	[p26l1118t2911r1416b2965],
21	with	IN	O	with	_	0	SENT_362	[p26l1433t2911r1563b2965],
22	response	NN	O	response	nn	23	SENT_362	[p26l1583t2930r1845b2981],
23	variability	NN	O	variability	prep_with	20	SENT_362	[p26l1864t2911r2153b2981],
24	to	TO	O	to	_	0	SENT_362	[p26l147t3003r201b3045],
25	dual	JJ	O	dual	amod	27	SENT_362	[p26l223t2992r348b3045],
26	antiplatelet	JJ	O	antiplatelet	amod	27	SENT_362	[p26l369t2992r695b3062],
27	treatment	NN	O	treatment	prep_to	20	SENT_362	[p26l713t3003r1002b3045],
28	in	IN	O	in	_	0	SENT_362	[p26l1020t2995r1079b3044],
29	high-risk	JJ	O	high-risk	amod	31	SENT_362	[p26l1098t2992r1364b3062],
30	vascular	JJ	O	vascular	amod	31	SENT_362	[p26l1381t2992r1622b3045],
31	patients	NNS	O	patient	prep_in	27	SENT_362	[p26l1641t2995r1887b3062],
32	.	.	O	.	_	0	SENT_362	[p26l1641t2995r1887b3062],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_363	[p26l152t3072r576b3142],
2	Genomics	NNP	O	Genomics	_	0	SENT_363	[p26l600t3073r865b3125],
3	2007	CD	DATE	2007	num	2	SENT_363	[p26l886t3075r1032b3133],
4	;	:	O	;	_	0	SENT_363	[p26l886t3075r1032b3133],
5	17	CD	NUMBER	17	num	7	SENT_363	[p26l1056t3075r1133b3126],
6	:	:	O	:	_	0	SENT_363	[p26l1056t3075r1133b3126],
7	1057-64	CD	NUMBER	1057-64	dep	2	SENT_363	[p26l1157t3075r1398b3127],
8	.	.	O	.	_	0	SENT_363	[p26l1157t3075r1398b3127],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_364	[p26l147t3162r318b3215],
2	D	NN	O	d	_	0	SENT_364	[p26l339t3168r401b3224],
3	,	,	O	,	_	0	SENT_364	[p26l339t3168r401b3224],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_364	[p26l426t3162r771b3215],
5	W	NNP	PERSON	W	appos	2	SENT_364	[p26l789t3168r861b3224],
6	,	,	O	,	_	0	SENT_364	[p26l789t3168r861b3224],
7	Fromm	NNP	PERSON	Fromm	nn	8	SENT_364	[p26l886t3165r1104b3215],
8	MF	NN	O	mf	appos	2	SENT_364	[p26l1126t3165r1239b3224],
9	,	,	O	,	_	0	SENT_364	[p26l1126t3165r1239b3224],
10	et	FW	O	et	nn	11	SENT_364	[p26l1263t3173r1314b3215],
11	al.	FW	O	al.	appos	2	SENT_364	[p26l1334t3162r1396b3215],
12	.	.	O	.	_	0	SENT_364	[p26l1334t3162r1396b3215],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_365	[p26l1421t3162r1775b3232],
2	P450	NN	O	p450	nn	4	SENT_365	[p26l1799t3165r1936b3215],
3	2C19	NN	O	2c19	nn	4	SENT_365	[p26l1959t3166r2099b3216],
4	681G	NN	O	681g	_	0	SENT_365	[p26l149t3246r384b3296],
5	>	JJR	O	>	dep	4	SENT_365	[p26l149t3246r384b3296],
6	A	DT	O	a	det	7	SENT_365	[p26l149t3246r384b3296],
7	polymorphism	NN	O	polymorphism	nsubj	13	SENT_365	[p26l402t3243r837b3313],
8	and	CC	O	and	_	0	SENT_365	[p26l858t3243r965b3296],
9	high	JJ	O	high	amod	12	SENT_365	[p26l984t3243r1118b3313],
10	on-clopidogrel	JJ	O	on-clopidogrel	amod	12	SENT_365	[p26l1138t3243r1559b3313],
11	platelet	NN	O	platelet	nn	12	SENT_365	[p26l1579t3243r1792b3312],
12	reactivity	NN	O	reactivity	conj_and	7	SENT_365	[p26l1811t3246r2075b3313],
13	associated	VBN	O	associate	ccomp	5	SENT_365	[p26l149t3323r446b3376],
14	with	IN	O	with	_	0	SENT_365	[p26l464t3323r594b3376],
15	adverse	JJ	O	adverse	amod	18	SENT_365	[p26l614t3323r832b3376],
16	1-year	JJ	DURATION	1-year	amod	18	SENT_365	[p26l855t3328r1021b3393],
17	clinical	JJ	O	clinical	amod	18	SENT_365	[p26l1041t3323r1248b3376],
18	outcome	NN	O	outcome	prep_with	13	SENT_365	[p26l1269t3334r1522b3376],
19	of	IN	O	of	_	0	SENT_365	[p26l1543t3322r1608b3376],
20	elective	JJ	O	elective	amod	23	SENT_365	[p26l1619t3323r1834b3376],
21	percutaneous	JJ	O	percutaneous	amod	23	SENT_365	[p26l148t3413r542b3472],
22	coronary	JJ	O	coronary	amod	23	SENT_365	[p26l565t3421r822b3472],
23	intervention	NN	O	intervention	prep_of	18	SENT_365	[p26l840t3406r1200b3455],
24	with	IN	O	with	prep	5	SENT_365	[p26l1218t3402r1348b3455],
25	drug-eluting	NN	O	drug-eluting	dep	24	SENT_365	[p26l1368t3402r1733b3472],
26	or	CC	O	or	_	0	SENT_365	[p26l1754t3421r1813b3455],
27	bare-metal	JJ	O	bare-metal	amod	28	SENT_365	[p26l1831t3402r2144b3455],
28	stents	NNS	O	stent	dep	24	SENT_365	[p26l150t3494r335b3536],
29	.	.	O	.	_	0	SENT_365	[p26l150t3494r335b3536],
30	]	SYM	O	]	dep	4	SENT_365	[p26l350t3488r386b3553],

1	Am	VBP	O	be	dep	3	SENT_366	[p26l401t3487r505b3536],
2	Coll	NNP	O	Coll	nn	3	SENT_366	[p26l528t3483r634b3536],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_366	[p26l658t3483r859b3536],
4	2008	CD	DATE	2008	num	3	SENT_366	[p26l879t3488r1030b3545],
5	;	:	O	;	_	0	SENT_366	[p26l879t3488r1030b3545],
6	51	CD	NUMBER	51	dep	3	SENT_366	[p26l1056t3485r1131b3536],
7	:	:	O	:	_	0	SENT_366	[p26l1056t3485r1131b3536],
8	1925-34	CD	NUMBER	1925-34	dep	6	SENT_366	[p26l1156t3486r1401b3536],
9	.	.	O	.	_	0	SENT_366	[p26l1156t3486r1401b3536],

1	Andersson	NNP	PERSON	Andersson	nn	2	SENT_367	[p26l147t3572r466b3626],
2	T	NN	O	t	_	0	SENT_367	[p26l484t3576r532b3634],
3	,	,	O	,	_	0	SENT_367	[p26l484t3576r532b3634],
4	Flockhart	NNP	ORGANIZATION	Flockhart	nn	5	SENT_367	[p26l558t3572r832b3626],
5	DA	NNP	ORGANIZATION	DA	appos	2	SENT_367	[p26l854t3577r963b3634],
6	,	,	O	,	_	0	SENT_367	[p26l854t3577r963b3634],
7	Goldstein	NNP	PERSON	Goldstein	nn	8	SENT_367	[p26l988t3572r1269b3626],
8	DB	NNP	O	DB	appos	2	SENT_367	[p26l1292t3578r1398b3634],
9	,	,	O	,	_	0	SENT_367	[p26l1292t3578r1398b3634],
10	et	FW	O	et	nn	11	SENT_367	[p26l1422t3583r1473b3626],
11	al.	FW	O	al.	appos	2	SENT_367	[p26l1493t3572r1554b3626],
12	.	.	O	.	_	0	SENT_367	[p26l1493t3572r1554b3626],

1	Drug-metabolizing	JJ	O	drug-metabolizing	amod	2	SENT_368	[p26l1581t3572r2137b3643],
2	enzymes	NNS	O	enzyme	_	0	SENT_368	[p26l149t3671r422b3723],
3	:	:	O	:	_	0	SENT_368	[p26l149t3671r422b3723],
4	evidence	NN	O	evidence	dep	2	SENT_368	[p26l445t3653r698b3706],
5	for	IN	O	for	_	0	SENT_368	[p26l719t3653r802b3706],
6	clinical	JJ	O	clinical	amod	7	SENT_368	[p26l822t3653r1029b3706],
7	utility	NN	O	utility	prep_for	4	SENT_368	[p26l1048t3653r1220b3723],
8	of	IN	O	of	_	0	SENT_368	[p26l1239t3653r1304b3706],
9	pharmacogenomic	JJ	O	pharmacogenomic	amod	10	SENT_368	[p26l1314t3653r1865b3723],
10	tests	NNS	O	test	prep_of	7	SENT_368	[p26l1883t3664r2030b3706],
11	.	.	O	.	_	0	SENT_368	[p26l1883t3664r2030b3706],

1	Clin	NNP	O	Clin	nn	3	SENT_369	[p26l154t3733r269b3786],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_369	[p26l291t3733r591b3786],
3	Ther	NNP	O	Ther	_	0	SENT_369	[p26l615t3733r742b3785],
4	2005	CD	DATE	2005	num	3	SENT_369	[p26l759t3736r910b3794],
5	;	:	O	;	_	0	SENT_369	[p26l759t3736r910b3794],
6	78	CD	NUMBER	78	num	8	SENT_369	[p26l935t3736r1016b3787],
7	:	:	O	:	_	0	SENT_369	[p26l935t3736r1016b3787],
8	559-81	CD	NUMBER	559-81	dep	3	SENT_369	[p26l1042t3736r1255b3786],
9	.	.	O	.	_	0	SENT_369	[p26l1042t3736r1255b3786],

1	Wilkinson	NNP	PERSON	Wilkinson	_	0	SENT_370	[p27l147t20r450b74],
2	GR	NN	O	gr	dep	1	SENT_370	[p27l472t24r580b73],
3	.	.	O	.	_	0	SENT_370	[p27l472t24r580b73],

1	Drug	NN	O	drug	nn	2	SENT_371	[p27l606t26r755b91],
2	metabolism	NN	O	metabolism	_	0	SENT_371	[p27l775t20r1123b73],
3	and	CC	O	and	_	0	SENT_371	[p27l1143t20r1252b73],
4	variability	NN	O	variability	conj_and	2	SENT_371	[p27l1269t20r1559b90],
5	among	IN	O	among	_	0	SENT_371	[p27l1578t39r1782b91],
6	patients	NNS	O	patient	prep_among	2	SENT_371	[p27l1801t24r2031b90],
7	in	IN	O	in	_	0	SENT_371	[p27l2053t24r2112b73],
8	drug	NN	O	drug	nn	9	SENT_371	[p27l149t101r286b171],
9	response	NN	O	response	prep_in	2	SENT_371	[p27l306t120r582b170],
10	.	.	O	.	_	0	SENT_371	[p27l306t120r582b170],

1	N	NN	O	n	nn	3	SENT_372	[p27l608t106r659b154],
2	Engl	NNP	O	Engl	nn	3	SENT_372	[p27l678t101r845b171],
3	]	NNP	O	]	nsubj	4	SENT_372	[p27l678t101r845b171],
4	Med	VBD	O	med	_	0	SENT_372	[p27l864t101r984b154],
5	2005	CD	DATE	2005	dobj	4	SENT_372	[p27l1004t104r1154b162],
6	;	:	O	;	_	0	SENT_372	[p27l1004t104r1154b162],
7	352	CD	NUMBER	352	num	9	SENT_372	[p27l1179t103r1295b154],
8	:	:	O	:	_	0	SENT_372	[p27l1179t103r1295b154],
9	2211-21	CD	NUMBER	2211-21	dep	5	SENT_372	[p27l1320t106r1557b154],
10	.	.	O	.	_	0	SENT_372	[p27l1320t106r1557b154],

1	Collet	NNP	PERSON	Collet	nn	3	SENT_373	[p27l150t191r318b245],
2	]	CD	NUMBER	]	num	3	SENT_373	[p27l339t197r417b260],
3	P	NN	O	p	_	0	SENT_373	[p27l339t197r417b260],
4	,	,	O	,	_	0	SENT_373	[p27l339t197r417b260],
5	Allali	JJ	PERSON	allali	amod	6	SENT_373	[p27l439t191r593b245],
6	Y	NN	PERSON	y	appos	3	SENT_373	[p27l612t197r659b253],
7	,	,	O	,	_	0	SENT_373	[p27l612t197r659b253],
8	Lesty	JJ	O	lesty	amod	9	SENT_373	[p27l685t197r833b261],
9	C	NN	O	c	appos	3	SENT_373	[p27l853t196r911b253],
10	,	,	O	,	_	0	SENT_373	[p27l853t196r911b253],
11	et	FW	O	et	nn	12	SENT_373	[p27l934t202r986b245],
12	al.	FW	O	al.	appos	3	SENT_373	[p27l1005t191r1067b245],
13	.	.	O	.	_	0	SENT_373	[p27l1005t191r1067b245],

1	Altered	JJ	O	altered	amod	3	SENT_374	[p27l1089t191r1305b245],
2	ﬁbrin	NN	O	ﬁbrin	nn	3	SENT_374	[p27l1324t191r1487b245],
3	architecture	NN	O	architecture	nsubjpass	5	SENT_374	[p27l1507t191r1855b245],
4	is	VBZ	O	be	auxpass	5	SENT_374	[p27l1876t195r1921b245],
5	associated	VBN	O	associate	_	0	SENT_374	[p27l149t272r446b325],
6	with	IN	O	with	_	0	SENT_374	[p27l464t272r594b325],
7	hypoﬁbrinolysis	NN	O	hypoﬁbrinolysis	prep_with	5	SENT_374	[p27l612t272r1083b342],
8	and	CC	O	and	_	0	SENT_374	[p27l1106t272r1213b325],
9	premature	JJ	O	premature	amod	11	SENT_374	[p27l1232t283r1541b342],
10	coronary	JJ	O	coronary	amod	11	SENT_374	[p27l1562t291r1818b342],
11	atherothrombosis	NN	O	atherothrombosis	prep_with	5	SENT_374	[p27l149t352r684b405],
12	.	.	O	.	_	0	SENT_374	[p27l149t352r684b405],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_375	[p27l706t352r1023b405],
2	Thromb	NNP	O	Thromb	nn	4	SENT_375	[p27l1043t352r1259b405],
3	Vasc	NNP	O	Vasc	nn	4	SENT_375	[p27l1286t357r1406b405],
4	Biol	NNP	O	Biol	_	0	SENT_375	[p27l1427t352r1535b405],
5	2006	CD	DATE	2006	num	4	SENT_375	[p27l1555t356r1706b412],
6	;	:	O	;	_	0	SENT_375	[p27l1555t356r1706b412],
7	26	CD	NUMBER	26	num	9	SENT_375	[p27l1731t356r1812b405],
8	:	:	O	:	_	0	SENT_375	[p27l1731t356r1812b405],
9	2567-73	CD	NUMBER	2567-73	dep	4	SENT_375	[p27l1836t355r2082b406],
10	.	.	O	.	_	0	SENT_375	[p27l1836t355r2082b406],

1	Cutlip	NNP	PERSON	Cutlip	nn	2	SENT_376	[p27l150t441r330b511],
2	De	NNP	PERSON	De	_	0	SENT_376	[p27l355t447r449b503],
3	,	,	O	,	_	0	SENT_376	[p27l355t447r449b503],
4	Windecker	NNP	PERSON	Windecker	nn	5	SENT_376	[p27l472t441r792b495],
5	S	NNP	O	S	appos	2	SENT_376	[p27l816t445r864b503],
6	,	,	O	,	_	0	SENT_376	[p27l816t445r864b503],
7	Mehran	NNP	ORGANIZATION	Mehran	nn	8	SENT_376	[p27l889t441r1119b494],
8	R	NNP	ORGANIZATION	R	appos	2	SENT_376	[p27l1143t447r1199b503],
9	,	,	O	,	_	0	SENT_376	[p27l1143t447r1199b503],
10	et	FW	O	et	nn	11	SENT_376	[p27l1223t452r1274b494],
11	al	FW	O	al	appos	2	SENT_376	[p27l1295t441r1358b503],
12	,	,	O	,	_	0	SENT_376	[p27l1295t441r1358b503],
13	for	IN	O	for	_	0	SENT_376	[p27l1380t441r1465b494],
14	the	DT	O	the	det	17	SENT_376	[p27l1483t441r1575b494],
15	Academic	NNP	ORGANIZATION	Academic	nn	17	SENT_376	[p27l1595t441r1886b494],
16	Research	NNP	ORGANIZATION	Research	nn	17	SENT_376	[p27l151t522r416b575],
17	Consortium	NNP	ORGANIZATION	Consortium	prep_for	2	SENT_376	[p27l438t525r806b575],
18	.	.	O	.	_	0	SENT_376	[p27l438t525r806b575],

1	Clinical	JJ	O	clinical	amod	3	SENT_377	[p27l832t522r1057b575],
2	end	NN	O	end	nn	3	SENT_377	[p27l1078t522r1187b575],
3	points	NNS	O	point	_	0	SENT_377	[p27l1206t525r1388b591],
4	in	IN	O	in	_	0	SENT_377	[p27l1411t525r1469b574],
5	coronary	JJ	O	coronary	amod	7	SENT_377	[p27l1490t541r1749b592],
6	stent	NN	O	stent	nn	7	SENT_377	[p27l1770t533r1913b575],
7	trials	NNS	O	trial	prep_in	3	SENT_377	[p27l1931t522r2094b575],
8	:	:	O	:	_	0	SENT_377	[p27l1931t522r2094b575],
9	a	DT	O	a	det	10	SENT_377	[p27l149t620r178b654],
10	case	NN	O	case	dep	3	SENT_377	[p27l199t620r320b655],
11	for	IN	O	for	_	0	SENT_377	[p27l342t601r425b654],
12	standardized	JJ	O	standardized	amod	13	SENT_377	[p27l447t601r826b655],
13	deﬁnitions	NNS	O	deﬁnitions	prep_for	10	SENT_377	[p27l847t601r1179b654],
14	.	.	O	.	_	0	SENT_377	[p27l847t601r1179b654],

1	Circulation	NN	O	circulation	_	0	SENT_378	[p27l1208t601r1522b654],
2	2007	CD	DATE	2007	num	1	SENT_378	[p27l1543t605r1690b662],
3	;	:	O	;	_	0	SENT_378	[p27l1543t605r1690b662],
4	115	CD	NUMBER	115	num	6	SENT_378	[p27l1715t604r1823b654],
5	:	:	O	:	_	0	SENT_378	[p27l1715t604r1823b654],
6	2344-51	CD	NUMBER	2344-51	dep	1	SENT_378	[p27l1848t605r2092b655],
7	.	.	O	.	_	0	SENT_378	[p27l1848t605r2092b655],

1	Furata	JJ	ORGANIZATION	furata	amod	2	SENT_379	[p27l151t695r334b745],
2	T	NN	ORGANIZATION	t	_	0	SENT_379	[p27l353t695r401b754],
3	,	,	O	,	_	0	SENT_379	[p27l353t695r401b754],
4	Shirai	NNP	PERSON	Shirai	nn	5	SENT_379	[p27l428t692r599b745],
5	N	NNP	O	N	appos	2	SENT_379	[p27l621t697r683b754],
6	,	,	O	,	_	0	SENT_379	[p27l621t697r683b754],
7	Xiao	NNP	PERSON	Xiao	nn	8	SENT_379	[p27l705t695r836b745],
8	F	NN	PERSON	f	appos	2	SENT_379	[p27l860t695r910b754],
9	,	,	O	,	_	0	SENT_379	[p27l860t695r910b754],
10	Ohashi	NNP	LOCATION	Ohashi	nn	11	SENT_379	[p27l935t692r1144b745],
11	K	NNP	LOCATION	K	appos	2	SENT_379	[p27l1167t697r1222b754],
12	,	,	O	,	_	0	SENT_379	[p27l1167t697r1222b754],
13	Ishizaki	NNP	PERSON	Ishizaki	nn	15	SENT_379	[p27l1248t692r1478b745],
14	T.	NNP	O	T.	nn	15	SENT_379	[p27l1497t695r1545b745],
15	Effect	NN	O	effect	appos	2	SENT_379	[p27l1571t692r1735b745],
16	of	IN	O	of	_	0	SENT_379	[p27l1755t692r1820b745],
17	high-dose	JJ	O	high-dose	amod	18	SENT_379	[p27l1829t692r2117b762],
18	lansoprazole	NN	O	lansoprazole	prep_of	15	SENT_379	[p27l147t794r518b863],
19	on	IN	O	on	_	0	SENT_379	[p27l539t813r613b847],
20	intragastric	JJ	O	intragastric	amod	21	SENT_379	[p27l632t797r965b864],
21	pH	NN	O	ph	prep_on	18	SENT_379	[p27l985t799r1076b863],
22	in	IN	O	in	_	0	SENT_379	[p27l1100t797r1158b846],
23	subjects	NNS	O	subject	prep_in	21	SENT_379	[p27l1179t794r1412b864],
24	who	WP	O	who	nsubj	28	SENT_379	[p27l1433t794r1556b847],
25	are	VBP	O	be	cop	28	SENT_379	[p27l1578t813r1665b847],
26	homozygous	JJ	O	homozygous	amod	28	SENT_379	[p27l1684t794r2059b864],
27	extensive	JJ	O	extensive	amod	28	SENT_379	[p27l149t877r415b926],
28	metabolizers	NNS	O	metabolizer	rcmod	15	SENT_379	[p27l436t873r812b926],
29	of	IN	O	of	_	0	SENT_379	[p27l835t873r899b926],
30	cytochrome	NN	O	cytochrome	nn	31	SENT_379	[p27l910t873r1251b943],
31	P4502C19	NN	O	p4502c19	prep_of	28	SENT_379	[p27l1274t876r1573b927],
32	.	.	O	.	_	0	SENT_379	[p27l1274t876r1573b927],

1	Clin	NNP	O	Clin	nn	3	SENT_380	[p27l154t954r268b1007],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_380	[p27l291t954r591b1007],
3	Ther	NNP	O	Ther	_	0	SENT_380	[p27l615t954r742b1007],
4	2001	CD	DATE	2001	num	3	SENT_380	[p27l759t959r904b1015],
5	;	:	O	;	_	0	SENT_380	[p27l759t959r904b1015],
6	70	CD	NUMBER	70	num	8	SENT_380	[p27l928t957r1009b1008],
7	:	:	O	:	_	0	SENT_380	[p27l928t957r1009b1008],
8	484-92	CD	NUMBER	484-92	dep	3	SENT_380	[p27l1030t959r1247b1007],
9	.	.	O	.	_	0	SENT_380	[p27l1030t959r1247b1007],

1	Gilard	NNP	O	Gilard	nn	2	SENT_381	[p27l150t1043r331b1097],
2	M	NNP	O	M	_	0	SENT_381	[p27l353t1049r426b1105],
3	,	,	O	,	_	0	SENT_381	[p27l353t1049r426b1105],
4	Arnaud	NNP	PERSON	Arnaud	nn	5	SENT_381	[p27l448t1043r671b1097],
5	B	NNP	PERSON	B	appos	2	SENT_381	[p27l694t1049r748b1105],
6	,	,	O	,	_	0	SENT_381	[p27l694t1049r748b1105],
7	Cornily	NNP	O	Cornily	nn	9	SENT_381	[p27l772t1043r987b1113],
8	]	CD	NUMBER	]	num	9	SENT_381	[p27l1007t1048r1090b1112],
9	C	NN	O	c	appos	2	SENT_381	[p27l1007t1048r1090b1112],
10	,	,	O	,	_	0	SENT_381	[p27l1007t1048r1090b1112],
11	et	FW	O	et	nn	12	SENT_381	[p27l1114t1054r1165b1097],
12	al.	FW	O	al.	appos	2	SENT_381	[p27l1185t1043r1247b1097],
13	.	.	O	.	_	0	SENT_381	[p27l1185t1043r1247b1097],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_382	[p27l1273t1043r1551b1097],
2	of	IN	O	of	_	0	SENT_382	[p27l1572t1043r1637b1097],
3	omeprazole	NN	O	omeprazole	prep_of	1	SENT_382	[p27l1648t1043r1990b1113],
4	on	IN	O	on	dep	1	SENT_382	[p27l2012t1062r2085b1097],
5	the	DT	O	the	det	7	SENT_382	[p27l147t1124r238b1177],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_382	[p27l260t1124r586b1194],
7	action	NN	O	action	pobj	4	SENT_382	[p27l606t1127r782b1177],
8	of	IN	O	of	_	0	SENT_382	[p27l802t1124r868b1177],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_382	[p27l878t1124r1204b1194],
10	associated	VBN	O	associate	partmod	9	SENT_382	[p27l1224t1124r1522b1177],
11	with	IN	O	with	_	0	SENT_382	[p27l1539t1124r1669b1177],
12	aspirin	NN	O	aspirin	prep_with	10	SENT_382	[p27l1689t1127r1907b1194],
13	:	:	O	:	_	0	SENT_382	[p27l1689t1127r1907b1194],
14	the	DT	O	the	dep	7	SENT_382	[p27l147t1204r238b1257],
15	randomized	VBN	O	randomize	partmod	14	SENT_382	[p27l259t1204r628b1265],
16	,	,	O	,	_	0	SENT_382	[p27l259t1204r628b1265],
17	double-blind	JJ	O	double-blind	amod	18	SENT_382	[p27l652t1204r1024b1257],
18	OCLA	NN	O	oclum	appos	7	SENT_382	[p27l1045t1208r1225b1257],
19	(	CD	NUMBER	(	num	18	SENT_382	[p27l1249t1204r1626b1274],
20	Omeprazole	NNP	O	Omeprazole	nn	24	SENT_382	[p27l1249t1204r1626b1274],
21	CLopidogrel	NNP	O	CLopidogrel	nn	24	SENT_382	[p27l1648t1204r2007b1274],
22	Aspirin	NNP	O	Aspirin	nn	24	SENT_382	[p27l147t1287r384b1354],
23	)	NNP	O	)	nn	24	SENT_382	[p27l147t1287r384b1354],
24	Study	NNP	O	Study	dep	18	SENT_382	[p27l413t1283r584b1353],
25	.	.	O	.	_	0	SENT_382	[p27l413t1283r584b1353],
26	]	NN	O	]	dep	18	SENT_382	[p27l600t1289r635b1353],

1	Am	VBP	O	be	dep	3	SENT_383	[p27l651t1287r754b1336],
2	Coll	NNP	O	Coll	nn	3	SENT_383	[p27l778t1283r884b1337],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_383	[p27l908t1283r1110b1337],
4	2008	CD	DATE	2008	num	3	SENT_383	[p27l1130t1288r1280b1345],
5	;	:	O	;	_	0	SENT_383	[p27l1130t1288r1280b1345],
6	51	CD	NUMBER	51	dep	3	SENT_383	[p27l1306t1286r1381b1336],
7	:	:	O	:	_	0	SENT_383	[p27l1306t1286r1381b1336],
8	256-60	CD	NUMBER	256-60	dep	6	SENT_383	[p27l1406t1287r1627b1337],
9	.	.	O	.	_	0	SENT_383	[p27l1406t1287r1627b1337],

1	Wallentin	NNP	PERSON	Wallentin	nn	2	SENT_384	[p27l147t1375r430b1428],
2	L	NNP	PERSON	L	_	0	SENT_384	[p27l452t1380r498b1436],
3	,	,	O	,	_	0	SENT_384	[p27l452t1380r498b1436],
4	Varenhorst	NNP	O	Varenhorst	nn	5	SENT_384	[p27l519t1375r842b1428],
5	C	NNP	O	C	appos	2	SENT_384	[p27l863t1379r919b1436],
6	,	,	O	,	_	0	SENT_384	[p27l863t1379r919b1436],
7	Iames	NNP	O	Iames	nn	8	SENT_384	[p27l943t1380r1117b1443],
8	S	NNP	O	S	appos	2	SENT_384	[p27l1142t1378r1189b1436],
9	,	,	O	,	_	0	SENT_384	[p27l1142t1378r1189b1436],
10	et	FW	O	et	nn	11	SENT_384	[p27l1213t1386r1264b1428],
11	al.	FW	O	al.	appos	2	SENT_384	[p27l1283t1375r1344b1428],
12	.	.	O	.	_	0	SENT_384	[p27l1283t1375r1344b1428],

1	Prasugrel	NNP	O	Prasugrel	nsubj	2	SENT_385	[p27l1370t1375r1646b1445],
2	achieves	VBZ	O	achieve	_	0	SENT_385	[p27l1666t1375r1906b1428],
3	greater	JJR	O	greater	amod	8	SENT_385	[p27l1929t1386r2131b1445],
4	and	CC	O	and	_	0	SENT_385	[p27l149t1455r256b1508],
5	faster	RBR	O	faster	advmod	6	SENT_385	[p27l275t1454r436b1508],
6	p2Y12receptor-mediated	JJ	O	p2y12receptor-mediated	conj_and	3	SENT_385	[p27l455t1455r1160b1524],
7	platelet	NN	O	platelet	nn	8	SENT_385	[p27l1178t1455r1390b1524],
8	inhibition	NN	O	inhibition	dobj	2	SENT_385	[p27l1408t1455r1698b1508],
9	than	IN	O	than	_	0	SENT_385	[p27l1716t1455r1848b1508],
10	clopidogrel	NN	O	clopidogrel	prep_than	2	SENT_385	[p27l149t1534r471b1605],
11	due	JJ	O	due	_	0	SENT_385	[p27l491t1534r597b1587],
12	to	TO	O	to	_	0	SENT_385	[p27l616t1545r670b1587],
13	more	RBR	O	more	advmod	14	SENT_385	[p27l690t1553r842b1587],
14	eﬂicient	JJ	O	eﬂicient	amod	15	SENT_385	[p27l864t1534r1099b1587],
15	generation	NN	O	generation	prep_due_to	10	SENT_385	[p27l1118t1538r1430b1605],
16	of	IN	O	of	_	0	SENT_385	[p27l1449t1534r1515b1587],
17	its	PRP$	O	its	poss	19	SENT_385	[p27l1524t1538r1589b1587],
18	active	JJ	O	active	amod	19	SENT_385	[p27l1612t1538r1773b1587],
19	metabolite	NN	O	metabolite	prep_of	15	SENT_385	[p27l1793t1534r2100b1587],
20	in	IN	O	in	_	0	SENT_385	[p27l148t1618r206b1667],
21	aspirin-treated	JJ	O	aspirin-treated	amod	22	SENT_385	[p27l226t1615r648b1684],
22	patients	NNS	O	patient	prep_in	19	SENT_385	[p27l667t1618r895b1684],
23	with	IN	O	with	_	0	SENT_385	[p27l915t1615r1045b1668],
24	coronary	JJ	O	coronary	amod	26	SENT_385	[p27l1064t1634r1319b1685],
25	artery	NN	O	artery	nn	26	SENT_385	[p27l1337t1626r1504b1685],
26	disease	NN	O	disease	prep_with	22	SENT_385	[p27l1523t1615r1746b1668],
27	.	.	O	.	_	0	SENT_385	[p27l1523t1615r1746b1668],

1	Eur	NNP	O	Eur	nn	2	SENT_386	[p27l1772t1618r1874b1668],
2	Heart	NNP	O	Heart	_	0	SENT_386	[p27l1893t1620r2097b1685],
3	]	CD	NUMBER	]	num	4	SENT_386	[p27l1893t1620r2097b1685],
4	2008	CD	DATE	2008	dep	2	SENT_386	[p27l150t1700r300b1755],
5	;	:	O	;	_	0	SENT_386	[p27l150t1700r300b1755],
6	29	CD	NUMBER	29	num	8	SENT_386	[p27l324t1700r405b1748],
7	:	:	O	:	_	0	SENT_386	[p27l324t1700r405b1748],
8	21-30	CD	NUMBER	21-30	dep	2	SENT_386	[p27l428t1700r606b1748],
9	.	.	O	.	_	0	SENT_386	[p27l428t1700r606b1748],

1	Angiolillo	NN	O	angiolillo	nn	2	SENT_387	[p27l147t1785r441b1855],
2	D	NN	O	d	_	0	SENT_387	[p27l466t1790r554b1854],
3	]	CD	NUMBER	]	dep	2	SENT_387	[p27l466t1790r554b1854],
4	,	,	O	,	_	0	SENT_387	[p27l466t1790r554b1854],
5	Shoemaker	NNP	O	Shoemaker	nn	6	SENT_387	[p27l582t1785r917b1838],
6	SB	NN	O	sb	appos	3	SENT_387	[p27l941t1789r1035b1846],
7	,	,	O	,	_	0	SENT_387	[p27l941t1789r1035b1846],
8	Desai	NNP	PERSON	Desai	nn	9	SENT_387	[p27l1061t1788r1224b1838],
9	B	NNP	O	B	appos	3	SENT_387	[p27l1248t1790r1303b1847],
10	,	,	O	,	_	0	SENT_387	[p27l1248t1790r1303b1847],
11	et	FW	O	et	nn	12	SENT_387	[p27l1327t1796r1380b1838],
12	al.	FW	O	al.	appos	3	SENT_387	[p27l1400t1785r1463b1838],
13	.	.	O	.	_	0	SENT_387	[p27l1400t1785r1463b1838],

1	Randomized	VBN	O	randomize	dep	19	SENT_388	[p27l1491t1785r1866b1838],
2	comparison	NN	O	comparison	dobj	1	SENT_388	[p27l149t1868r501b1934],
3	of	IN	O	of	_	0	SENT_388	[p27l523t1865r588b1918],
4	a	DT	O	a	det	8	SENT_388	[p27l600t1884r629b1918],
5	high	JJ	O	high	amod	8	SENT_388	[p27l649t1865r785b1935],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_388	[p27l807t1865r1137b1935],
7	maintenance	NN	O	maintenance	nn	8	SENT_388	[p27l1159t1868r1546b1918],
8	dose	NN	O	dose	prep_of	2	SENT_388	[p27l1568t1865r1701b1918],
9	in	IN	O	in	_	0	SENT_388	[p27l1723t1868r1782b1917],
10	patients	NNS	O	patient	prep_in	8	SENT_388	[p27l1802t1868r2036b1934],
11	with	IN	O	with	_	0	SENT_388	[p27l147t1944r278b1998],
12	diabetes	NN	O	diabetes	nn	13	SENT_388	[p27l300t1944r540b1998],
13	mellitus	NN	O	mellitus	prep_with	1	SENT_388	[p27l563t1944r805b1998],
14	and	CC	O	and	_	0	SENT_388	[p27l829t1944r938b1998],
15	coronary	JJ	O	coronary	amod	17	SENT_388	[p27l959t1963r1220b2014],
16	artery	NN	O	artery	nn	17	SENT_388	[p27l1240t1955r1411b2014],
17	disease	NN	O	disease	prep_with	1	SENT_388	[p27l1431t1944r1660b1998],
18	:	:	O	:	_	0	SENT_388	[p27l1431t1944r1660b1998],
19	results	NNS	O	result	_	0	SENT_388	[p27l1684t1944r1881b1998],
20	of	IN	O	of	_	0	SENT_388	[p27l1905t1944r1970b1998],
21	the	DT	O	the	det	24	SENT_388	[p27l1981t1944r2073b1998],
22	Optimizing	VBG	O	optimize	amod	24	SENT_388	[p27l150t2028r493b2095],
23	Antiplatelet	JJ	O	antiplatelet	amod	24	SENT_388	[p27l513t2025r862b2095],
24	Therapy	NN	O	therapy	prep_of	19	SENT_388	[p27l881t2025r1127b2095],
25	in	IN	O	in	_	0	SENT_388	[p27l1146t2028r1205b2077],
26	Diabetes	NNP	O	Diabetes	nn	27	SENT_388	[p27l1229t2025r1482b2078],
27	Mellitus	NNP	O	Mellitus	prep_in	24	SENT_388	[p27l1507t2025r1747b2078],
28	(	CD	NUMBER	(	num	31	SENT_388	[p27l1774t2028r2131b2095],
29	OPTIMUS	NNP	O	OPTIMUS	nn	31	SENT_388	[p27l1774t2028r2131b2095],
30	)	CD	NUMBER	)	num	31	SENT_388	[p27l1774t2028r2131b2095],
31	Study	NNP	O	Study	dep	27	SENT_388	[p27l153t2105r326b2175],
32	.	.	O	.	_	0	SENT_388	[p27l153t2105r326b2175],

1	Circulation	NN	O	circulation	_	0	SENT_389	[p27l356t2105r673b2158],
2	2007	CD	DATE	2007	num	1	SENT_389	[p27l695t2108r843b2166],
3	;	:	O	;	_	0	SENT_389	[p27l695t2108r843b2166],
4	115	CD	NUMBER	115	num	6	SENT_389	[p27l868t2107r977b2158],
5	:	:	O	:	_	0	SENT_389	[p27l868t2107r977b2158],
6	708-16	CD	NUMBER	708-16	dep	1	SENT_389	[p27l1000t2108r1215b2160],
7	.	.	O	.	_	0	SENT_389	[p27l1000t2108r1215b2160],

1	Price	NN	O	price	nn	3	SENT_390	[p27l151t2198r296b2247],
2	M	NN	O	m	nn	3	SENT_390	[p27l319t2200r418b2263],
3	]	NN	O	]	_	0	SENT_390	[p27l319t2200r418b2263],
4	,	,	O	,	_	0	SENT_390	[p27l319t2200r418b2263],
5	Endemann	NNP	ORGANIZATION	Endemann	nn	6	SENT_390	[p27l444t2194r766b2247],
6	S	NNP	ORGANIZATION	S	appos	3	SENT_390	[p27l790t2198r837b2256],
7	,	,	O	,	_	0	SENT_390	[p27l790t2198r837b2256],
8	Gollapudi	NNP	O	Gollapudi	nn	9	SENT_390	[p27l862t2194r1149b2264],
9	RR	NNP	O	RR	appos	3	SENT_390	[p27l1172t2200r1273b2256],
10	,	,	O	,	_	0	SENT_390	[p27l1172t2200r1273b2256],
11	et	FW	O	et	nn	12	SENT_390	[p27l1297t2205r1348b2247],
12	al.	FW	O	al.	appos	3	SENT_390	[p27l1368t2194r1430b2247],
13	.	.	O	.	_	0	SENT_390	[p27l1368t2194r1430b2247],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_391	[p27l1456t2198r1768b2265],
2	signiﬁcance	NN	O	signiﬁcance	nsubj	7	SENT_391	[p27l1789t2194r2137b2265],
3	of	IN	O	of	_	0	SENT_391	[p27l149t2275r214b2328],
4	post-clopidogrel	JJ	O	post-clopidogrel	amod	6	SENT_391	[p27l224t2275r693b2345],
5	platelet	NN	O	platelet	nn	6	SENT_391	[p27l713t2275r926b2344],
6	reactivity	NN	O	reactivity	prep_of	2	SENT_391	[p27l945t2278r1209b2345],
7	assessed	VBN	O	assess	_	0	SENT_391	[p27l1229t2275r1478b2328],
8	by	IN	O	by	_	0	SENT_391	[p27l1496t2275r1565b2345],
9	a	DT	O	a	det	11	SENT_391	[p27l1584t2294r1613b2328],
10	point-of-care	JJ	O	point-of-care	amod	11	SENT_391	[p27l1633t2275r2001b2344],
11	assay	NN	O	assay	prep_by	7	SENT_391	[p27l149t2373r302b2425],
12	on	IN	O	on	_	0	SENT_391	[p27l321t2374r394b2408],
13	thrombotic	JJ	O	thrombotic	amod	14	SENT_391	[p27l413t2355r741b2408],
14	events	NNS	O	event	prep_on	7	SENT_391	[p27l761t2366r943b2408],
15	after	IN	O	after	_	0	SENT_391	[p27l966t2355r1098b2408],
16	drug-eluting	JJ	O	drug-eluting	amod	18	SENT_391	[p27l1117t2355r1482b2425],
17	stent	NN	O	stent	nn	18	SENT_391	[p27l1503t2366r1645b2408],
18	implantation	NN	O	implantation	prep_after	7	SENT_391	[p27l1664t2355r2058b2424],
19	.	.	O	.	_	0	SENT_391	[p27l1664t2355r2058b2424],

1	Eur	NNP	O	Eur	nn	2	SENT_392	[p27l152t2437r254b2486],
2	Heart	NNP	O	Heart	_	0	SENT_392	[p27l274t2439r479b2503],
3	]	CD	NUMBER	]	num	4	SENT_392	[p27l274t2439r479b2503],
4	2008	CD	DATE	2008	dep	2	SENT_392	[p27l498t2438r648b2495],
5	;	:	O	;	_	0	SENT_392	[p27l498t2438r648b2495],
6	29	CD	NUMBER	29	num	8	SENT_392	[p27l673t2438r754b2486],
7	:	:	O	:	_	0	SENT_392	[p27l673t2438r754b2486],
8	992-1000	CD	NUMBER	992-1000	dep	2	SENT_392	[p27l778t2438r1064b2487],
9	.	.	O	.	_	0	SENT_392	[p27l778t2438r1064b2487],

1	www	NN	O	www	_	0	SENT_393	[p27l806t2684r1343b2735],
2	.	.	O	.	_	0	SENT_393	[p27l806t2684r1343b2735],

1	the	DT	O	the	det	2	SENT_394	[p27l806t2684r1343b2735],
2	|	NN	O	|	_	0	SENT_394	[p27l806t2684r1343b2735],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_394	[p27l806t2684r1343b2735],
4	Vol	NNP	O	Vol	dep	2	SENT_394	[p27l1386t2684r1474b2735],
5	373	CD	NUMBER	373	num	4	SENT_394	[p27l1494t2690r1593b2742],
6	January	NNP	DATE	January	tmod	4	SENT_394	[p27l1635t2688r1853b2749],
7	24	CD	DATE	24	num	6	SENT_394	[p27l1871t2690r1957b2743],
8	,	,	DATE	,	_	0	SENT_394	[p27l1871t2690r1957b2743],
9	2009	CD	DATE	2009	num	6	SENT_394	[p27l1976t2690r2122b2742],

1	Articles	NNPS	O	Articles	_	0	SENT_395	[p27l6t2987r156b3023],
2	I	PRP	O	I	dep	1	SENT_395	[p27l204t2824r252b3023],

1	Angiolillo	NN	O	angiolillo	nn	3	SENT_396	[p27l137t3269r398b3333],
2	D	NN	O	d	nn	3	SENT_396	[p27l419t3274r498b3332],
3	]	NN	O	]	_	0	SENT_396	[p27l419t3274r498b3332],
4	,	,	O	,	_	0	SENT_396	[p27l419t3274r498b3332],
5	Femandez-Ortiz	NN	O	femandez-ortiz	nn	6	SENT_396	[p27l521t3269r954b3318],
6	A	NN	O	a	appos	3	SENT_396	[p27l972t3273r1027b3325],
7	,	,	O	,	_	0	SENT_396	[p27l972t3273r1027b3325],
8	Bemardo	NNP	O	Bemardo	nn	9	SENT_396	[p27l1050t3269r1295b3318],
9	E	NNP	O	E	appos	3	SENT_396	[p27l1316t3272r1361b3325],
10	,	,	O	,	_	0	SENT_396	[p27l1316t3272r1361b3325],
11	et	FW	O	et	nn	12	SENT_396	[p27l1382t3279r1429b3318],
12	al.	FW	O	al.	appos	3	SENT_396	[p27l1446t3269r1502b3318],
13	.	.	O	.	_	0	SENT_396	[p27l1446t3269r1502b3318],

1	High	JJ	O	high	amod	2	SENT_397	[p27l1525t3269r1659b3333],
2	clopidogrel	NN	O	clopidogrel	_	0	SENT_397	[p27l1677t3269r1972b3334],
3	38	CD	NUMBER	38	num	2	SENT_397	[p27l2095t3273r2153b3318],
4	loading	VBG	O	load	partmod	2	SENT_397	[p27l137t3343r336b3407],
5	dose	NN	O	dose	dobj	4	SENT_397	[p27l354t3343r473b3392],
6	during	IN	O	during	_	0	SENT_397	[p27l492t3343r671b3407],
7	coronary	JJ	O	coronary	amod	8	SENT_397	[p27l689t3360r922b3407],
8	stenting	NN	O	stenting	prep_during	4	SENT_397	[p27l939t3346r1166b3407],
9	:	:	O	:	_	0	SENT_397	[p27l939t3346r1166b3407],
10	effects	NNS	O	effect	dep	2	SENT_397	[p27l1187t3343r1355b3392],
11	on	IN	O	on	_	0	SENT_397	[p27l1375t3360r1442b3392],
12	drug	NN	O	drug	nn	13	SENT_397	[p27l1460t3343r1584b3407],
13	response	NN	O	response	prep_on	10	SENT_397	[p27l1602t3360r1839b3406],
14	and	CC	O	and	_	0	SENT_397	[p27l1858t3343r1956b3392],
15	interindividual	JJ	O	interindividual	amod	16	SENT_397	[p27l138t3416r532b3465],
16	variability	NN	O	variability	conj_and	13	SENT_397	[p27l548t3416r816b3479],
17	.	.	O	.	_	0	SENT_397	[p27l548t3416r816b3479],

1	Eur	NNP	O	Eur	nn	2	SENT_398	[p27l840t3418r933b3464],
2	Heart	NNP	O	Heart	_	0	SENT_398	[p27l950t3420r1136b3479],
3	]	CD	NUMBER	]	num	4	SENT_398	[p27l950t3420r1136b3479],
4	2004	CD	DATE	2004	dep	2	SENT_398	[p27l1152t3420r1286b3471],
5	;	:	O	;	_	0	SENT_398	[p27l1152t3420r1286b3471],
6	25	CD	NUMBER	25	num	8	SENT_398	[p27l1307t3418r1381b3464],
7	:	:	O	:	_	0	SENT_398	[p27l1307t3418r1381b3464],
8	1903-10	CD	DATE	1903-10	dep	2	SENT_398	[p27l1403t3420r1623b3465],
9	.	.	O	.	_	0	SENT_398	[p27l1403t3420r1623b3465],

1	I-Iochholzer	NN	O	i-iochholzer	nn	2	SENT_399	[p27l141t3499r459b3548],
2	W	NN	O	w	_	0	SENT_399	[p27l475t3504r541b3555],
3	,	,	O	,	_	0	SENT_399	[p27l475t3504r541b3555],
4	Trenk	NN	PERSON	trenk	nn	5	SENT_399	[p27l561t3499r719b3548],
5	D	NN	O	d	appos	2	SENT_399	[p27l738t3504r795b3555],
6	,	,	O	,	_	0	SENT_399	[p27l738t3504r795b3555],
7	Frundi	NN	O	frundus	nn	8	SENT_399	[p27l819t3499r999b3548],
8	D	NN	O	d	appos	2	SENT_399	[p27l1019t3504r1076b3555],
9	,	,	O	,	_	0	SENT_399	[p27l1019t3504r1076b3555],
10	et	FW	O	et	nn	11	SENT_399	[p27l1098t3509r1145b3548],
11	al.	FW	O	al.	appos	2	SENT_399	[p27l1164t3499r1221b3548],
12	.	.	O	.	_	0	SENT_399	[p27l1164t3499r1221b3548],

1	Time	NNP	O	Time	nn	2	SENT_400	[p27l1241t3502r1381b3548],
2	dependence	NN	O	dependence	_	0	SENT_400	[p27l1401t3499r1724b3563],
3	of	IN	O	of	_	0	SENT_400	[p27l1743t3499r1803b3548],
4	platelet	NN	O	platelet	nn	5	SENT_400	[p27l138t3572r335b3635],
5	inhibition	NN	O	inhibition	prep_of	2	SENT_400	[p27l352t3572r621b3621],
6	after	IN	O	after	_	0	SENT_400	[p27l640t3572r761b3621],
7	a	DT	O	a	det	10	SENT_400	[p27l779t3589r806b3621],
8	600-mg	JJ	O	600-mg	amod	10	SENT_400	[p27l825t3576r1027b3636],
9	loading	NN	O	loading	nn	10	SENT_400	[p27l1045t3572r1246b3636],
10	dose	NN	O	dose	prep_after	2	SENT_400	[p27l1265t3572r1386b3621],
11	of	IN	O	of	_	0	SENT_400	[p27l1406t3571r1466b3621],
12	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_400	[p27l1475t3572r1775b3636],
13	in	IN	O	in	_	0	SENT_400	[p27l1793t3575r1847b3620],
14	a	DT	O	a	det	18	SENT_400	[p27l1866t3589r1893b3621],
15	large	JJ	O	large	amod	18	SENT_400	[p27l137t3644r284b3709],
16	,	,	O	,	_	0	SENT_400	[p27l137t3644r284b3709],
17	unselected	JJ	O	unselected	amod	18	SENT_400	[p27l303t3644r593b3693],
18	cohort	NN	O	cohort	prep_in	2	SENT_400	[p27l612t3644r784b3693],
19	of	IN	O	of	_	0	SENT_400	[p27l802t3644r862b3693],
20	candidates	NNS	O	candidate	prep_of	18	SENT_400	[p27l872t3644r1155b3693],
21	for	IN	O	for	_	0	SENT_400	[p27l1175t3644r1252b3693],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_400	[p27l1269t3654r1632b3708],
23	coronary	JJ	O	coronary	amod	24	SENT_400	[p27l1653t3662r1890b3708],
24	intervention	NN	O	intervention	prep_for	20	SENT_400	[p27l138t3721r483b3767],
25	.	.	O	.	_	0	SENT_400	[p27l138t3721r483b3767],

1	Circulation	NN	O	circulation	_	0	SENT_401	[p27l509t3718r796b3767],
2	2005	CD	DATE	2005	num	1	SENT_401	[p27l815t3721r954b3775],
3	;	:	O	;	_	0	SENT_401	[p27l815t3721r954b3775],
4	111	CD	NUMBER	111	num	6	SENT_401	[p27l976t3722r1070b3767],
5	:	:	O	:	_	0	SENT_401	[p27l976t3722r1070b3767],
6	2560-64	CD	NUMBER	2560-64	dep	1	SENT_401	[p27l1092t3721r1325b3767],
7	.	.	O	.	_	0	SENT_401	[p27l1092t3721r1325b3767],

1	Angiolillo	NN	O	angiolillo	nn	2	SENT_402	[p28l137t20r403b85],
2	D	NN	O	d	_	0	SENT_402	[p28l425t25r505b83],
3	]	CD	NUMBER	]	dep	2	SENT_402	[p28l425t25r505b83],
4	,	,	O	,	_	0	SENT_402	[p28l425t25r505b83],
5	Bernardo	NNP	PERSON	Bernardo	nn	6	SENT_402	[p28l529t20r777b69],
6	E	NNP	PERSON	E	appos	3	SENT_402	[p28l799t23r845b76],
7	,	,	O	,	_	0	SENT_402	[p28l799t23r845b76],
8	Palazuelos	NNP	PERSON	Palazuelos	appos	3	SENT_402	[p28l869t20r1150b69],
9	I	PRP	O	I	dep	8	SENT_402	[p28l1172t25r1205b83],
10	,	,	O	,	_	0	SENT_402	[p28l1172t25r1205b83],
11	et	FW	O	et	nn	12	SENT_402	[p28l1227t30r1274b69],
12	al.	FW	O	al.	appos	3	SENT_402	[p28l1292t20r1349b69],
13	.	.	O	.	_	0	SENT_402	[p28l1292t20r1349b69],

1	Functional	JJ	O	functional	amod	2	SENT_403	[p28l1374t20r1660b69],
2	impact	NN	O	impact	_	0	SENT_403	[p28l1678t24r1864b84],
3	of	IN	O	of	_	0	SENT_403	[p28l1882t20r1942b69],
4	high	JJ	O	high	amod	7	SENT_403	[p28l137t114r261b178],
5	clopidogrel	NN	O	clopidogrel	nn	7	SENT_403	[p28l280t114r579b178],
6	maintenance	NN	O	maintenance	nn	7	SENT_403	[p28l597t117r950b163],
7	dosing	NN	O	dosing	prep_of	2	SENT_403	[p28l969t114r1149b178],
8	in	IN	O	in	_	0	SENT_403	[p28l1167t117r1222b162],
9	patients	NNS	O	patient	prep_in	7	SENT_403	[p28l1239t117r1452b178],
10	undergoing	VBG	O	undergo	partmod	2	SENT_403	[p28l1471t114r1788b178],
11	elective	JJ	O	elective	amod	14	SENT_403	[p28l139t187r336b236],
12	percutaneous	JJ	O	percutaneous	amod	14	SENT_403	[p28l355t197r718b250],
13	coronary	JJ	O	coronary	amod	14	SENT_403	[p28l739t204r976b251],
14	interventions	NNS	O	intervention	dobj	10	SENT_403	[p28l993t190r1365b236],
15	.	.	O	.	_	0	SENT_403	[p28l993t190r1365b236],

1	Results	NNS	O	result	nsubj	4	SENT_404	[p28l1389t187r1581b236],
2	of	IN	O	of	advmod	4	SENT_404	[p28l1602t187r1662b236],
3	a	DT	O	a	dep	2	SENT_404	[p28l1672t204r1698b236],
4	randomized	VBN	O	randomize	_	0	SENT_404	[p28l138t259r466b308],
5	study	NN	O	study	dobj	4	SENT_404	[p28l485t259r636b323],
6	.	.	O	.	_	0	SENT_404	[p28l485t259r636b323],

1	Thromb	NNP	O	Thromb	nn	2	SENT_405	[p28l662t259r861b308],
2	Haemost	NNP	O	Haemost	_	0	SENT_405	[p28l883t264r1109b308],
3	2008	CD	DATE	2008	num	2	SENT_405	[p28l1127t264r1266b315],
4	;	:	O	;	_	0	SENT_405	[p28l1127t264r1266b315],
5	99	CD	NUMBER	99	num	7	SENT_405	[p28l1289t264r1364b308],
6	:	:	O	:	_	0	SENT_405	[p28l1289t264r1364b308],
7	161-68	CD	NUMBER	161-68	dep	2	SENT_405	[p28l1387t264r1578b308],
8	.	.	O	.	_	0	SENT_405	[p28l1387t264r1578b308],

1	Angiolillo	NN	O	angiolillo	nn	2	SENT_406	[p28l137t343r396b407],
2	D	NN	O	d	_	0	SENT_406	[p28l417t348r495b405],
3	]	CD	NUMBER	]	dep	2	SENT_406	[p28l417t348r495b405],
4	,	,	O	,	_	0	SENT_406	[p28l417t348r495b405],
5	Bemardo	NNP	PERSON	Bemardo	nn	6	SENT_406	[p28l517t343r760b392],
6	E	NNP	PERSON	E	appos	3	SENT_406	[p28l781t346r826b399],
7	,	,	O	,	_	0	SENT_406	[p28l781t346r826b399],
8	Sabaté	NNP	O	Sabaté	nn	9	SENT_406	[p28l849t343r1016b392],
9	M	NNP	O	M	appos	3	SENT_406	[p28l1036t348r1103b399],
10	,	,	O	,	_	0	SENT_406	[p28l1036t348r1103b399],
11	et	FW	O	et	nn	12	SENT_406	[p28l1123t353r1169b392],
12	al.	FW	O	al.	appos	3	SENT_406	[p28l1186t343r1242b392],
13	.	.	O	.	_	0	SENT_406	[p28l1186t343r1242b392],

1	Impact	NN	O	impact	_	0	SENT_407	[p28l1264t348r1449b407],
2	of	IN	O	of	_	0	SENT_407	[p28l1466t343r1525b392],
3	platelet	NN	O	platelet	prep_of	1	SENT_407	[p28l1532t343r1723b407],
4	reactivity	NN	O	reactivity	dep	3	SENT_407	[p28l1739t346r1975b407],
5	on	IN	O	on	prep	4	SENT_407	[p28l139t433r206b465],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_407	[p28l223t416r600b465],
7	outcomes	NNS	O	outcome	dep	14	SENT_407	[p28l616t425r870b465],
8	in	IN	O	in	_	0	SENT_407	[p28l888t419r942b464],
9	patients	NNS	O	patient	prep_in	7	SENT_407	[p28l958t419r1165b479],
10	with	IN	O	with	_	0	SENT_407	[p28l1182t416r1299b465],
11	type	NN	O	type	prep_with	9	SENT_407	[p28l1316t425r1424b480],
12	2	CD	NUMBER	2	num	14	SENT_407	[p28l1443t420r1469b464],
13	diabetes	NN	O	diabetes	nn	14	SENT_407	[p28l1489t416r1701b465],
14	mellitus	NN	O	mellitus	dep	5	SENT_407	[p28l1720t416r1934b465],
15	and	CC	O	and	_	0	SENT_407	[p28l139t488r237b537],
16	coronary	JJ	O	coronary	amod	18	SENT_407	[p28l253t506r485b552],
17	artery	NN	O	artery	nn	18	SENT_407	[p28l501t498r652b552],
18	disease	NN	O	disease	dep	5	SENT_407	[p28l668t488r870b537],
19	.	.	O	.	_	0	SENT_407	[p28l668t488r870b537],
20	]	SYM	O	]	dep	4	SENT_407	[p28l882t493r915b552],

1	Am	VBP	O	be	dep	3	SENT_408	[p28l927t492r1022b537],
2	Coll	NNP	O	Coll	nn	3	SENT_408	[p28l1042t488r1138b537],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_408	[p28l1158t488r1338b537],
4	2007	CD	DATE	2007	num	6	SENT_408	[p28l1356t491r1487b545],
5	;	:	O	;	_	0	SENT_408	[p28l1356t491r1487b545],
6	50	CD	NUMBER	50	dep	3	SENT_408	[p28l1509t490r1581b537],
7	:	:	O	:	_	0	SENT_408	[p28l1509t490r1581b537],
8	1541-47	CD	NUMBER	1541-47	num	10	SENT_408	[p28l1602t491r1798b539],
9	Bliden	NNP	PERSON	Bliden	nn	10	SENT_408	[p28l141t572r316b621],
10	KP	NNP	O	KP	dep	3	SENT_408	[p28l338t576r429b628],
11	,	,	O	,	_	0	SENT_408	[p28l338t576r429b628],
12	Dichiara	NNP	PERSON	Dichiara	nn	13	SENT_408	[p28l453t572r685b621],
13	I	NNP	O	I	appos	10	SENT_408	[p28l705t576r740b634],
14	,	,	O	,	_	0	SENT_408	[p28l705t576r740b634],
15	Tantry	NNP	LOCATION	Tantry	nn	16	SENT_408	[p28l761t575r935b636],
16	US	NNP	LOCATION	US	appos	13	SENT_408	[p28l956t575r1053b628],
17	,	,	O	,	_	0	SENT_408	[p28l956t575r1053b628],
18	et	FW	O	et	nn	19	SENT_408	[p28l1076t582r1124b621],
19	al.	FW	O	al.	appos	13	SENT_408	[p28l1143t572r1201b621],
20	.	.	O	.	_	0	SENT_408	[p28l1143t572r1201b621],

1	Increased	VBN	O	increase	amod	2	SENT_409	[p28l1226t572r1491b621],
2	risk	NN	O	risk	_	0	SENT_409	[p28l1509t572r1613b621],
3	in	IN	O	in	_	0	SENT_409	[p28l1631t575r1686b620],
4	patients	NNS	O	patient	prep_in	2	SENT_409	[p28l1704t575r1921b635],
5	with	IN	O	with	_	0	SENT_409	[p28l137t644r258b693],
6	high	JJ	O	high	amod	8	SENT_409	[p28l276t644r401b709],
7	platelet	NN	O	platelet	nn	8	SENT_409	[p28l420t644r620b708],
8	aggregation	NN	O	aggregation	prep_with	4	SENT_409	[p28l640t647r962b709],
9	receiving	VBG	O	receive	partmod	2	SENT_409	[p28l981t647r1231b709],
10	chronic	JJ	O	chronic	amod	12	SENT_409	[p28l1250t644r1457b693],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_409	[p28l1477t644r1781b709],
12	therapy	NN	O	therapy	dobj	9	SENT_409	[p28l137t718r344b782],
13	undergoing	VBG	O	undergo	partmod	12	SENT_409	[p28l361t718r682b782],
14	percutaneous	JJ	O	percutaneous	amod	16	SENT_409	[p28l701t728r1070b782],
15	coronary	JJ	O	coronary	amod	16	SENT_409	[p28l1092t735r1332b782],
16	intervention	NN	O	intervention	dobj	13	SENT_409	[p28l1350t721r1701b767],
17	:	:	O	:	_	0	SENT_409	[p28l1350t721r1701b767],
18	is	VBZ	O	be	cop	21	SENT_409	[p28l1723t721r1766b767],
19	the	DT	O	the	det	21	SENT_409	[p28l1786t718r1871b767],
20	current	JJ	DATE	current	amod	21	SENT_409	[p28l139t801r341b840],
21	antiplatelet	JJ	O	antiplatelet	rcmod	12	SENT_409	[p28l360t791r666b854],
22	therapy	NN	O	therapy	rcmod	21	SENT_409	[p28l683t791r890b855],
23	adequate	JJ	O	adequate	amod	22	SENT_409	[p28l909t791r1177b854],
24	?	.	O	?	_	0	SENT_409	[p28l909t791r1177b854],
25	]	SYM	O	]	dep	21	SENT_409	[p28l1192t795r1225b855],

1	Am	VBP	O	be	dep	3	SENT_410	[p28l1240t794r1336b839],
2	Coll	NNP	O	Coll	nn	3	SENT_410	[p28l1359t791r1458b840],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_410	[p28l1481t791r1669b840],
4	2007	CD	DATE	2007	num	3	SENT_410	[p28l1689t794r1826b847],
5	;	:	O	;	_	0	SENT_410	[p28l1689t794r1826b847],
6	49	CD	NUMBER	49	dep	3	SENT_410	[p28l138t867r216b912],
7	:	:	O	:	_	0	SENT_410	[p28l138t867r216b912],
8	657-66	CD	NUMBER	657-66	dep	6	SENT_410	[p28l239t866r441b914],
9	.	.	O	.	_	0	SENT_410	[p28l239t866r441b914],

1	Collet	NNP	PERSON	Collet	nn	2	SENT_411	[p28l140t948r295b997],
2	IP	NNP	O	IP	_	0	SENT_411	[p28l314t952r387b1010],
3	,	,	O	,	_	0	SENT_411	[p28l314t952r387b1010],
4	Silvain	NNP	O	Silvain	nn	5	SENT_411	[p28l411t948r590b997],
5	I	NNP	O	I	appos	2	SENT_411	[p28l610t952r643b1010],
6	,	,	O	,	_	0	SENT_411	[p28l610t952r643b1010],
7	Landivier	NNP	O	Landivier	nn	8	SENT_411	[p28l667t948r918b997],
8	A	NNP	O	A	appos	2	SENT_411	[p28l935t951r991b1004],
9	,	,	O	,	_	0	SENT_411	[p28l935t951r991b1004],
10	et	FW	O	et	nn	11	SENT_411	[p28l1012t958r1060b997],
11	al.	FW	O	al.	appos	2	SENT_411	[p28l1078t948r1135b997],
12	.	.	O	.	_	0	SENT_411	[p28l1078t948r1135b997],

1	Dose-effect	NN	O	dose-effect	_	0	SENT_412	[p28l1159t948r1458b997],
2	of	IN	O	of	_	0	SENT_412	[p28l1476t948r1537b997],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_412	[p28l1546t948r1846b1012],
4	re-loading	NN	O	re-loading	prep_of	1	SENT_412	[p28l138t1021r411b1085],
5	in	IN	O	in	_	0	SENT_412	[p28l429t1024r483b1069],
6	patients	NNS	O	patient	prep_in	4	SENT_412	[p28l501t1024r713b1084],
7	already	RB	O	already	advmod	6	SENT_412	[p28l734t1021r926b1085],
8	on	IN	O	on	_	0	SENT_412	[p28l945t1038r1012b1070],
9	75	CD	NUMBER	75	num	12	SENT_412	[p28l1029t1024r1085b1071],
10	mg	NN	O	mg	nn	12	SENT_412	[p28l1106t1038r1194b1085],
11	maintenance	NN	O	maintenance	nn	12	SENT_412	[p28l1212t1024r1564b1070],
12	dose	NN	O	dose	prep_on	6	SENT_412	[p28l1584t1021r1719b1070],
13	:	:	O	:	_	0	SENT_412	[p28l1584t1021r1719b1070],
14	the	DT	O	the	det	16	SENT_412	[p28l1739t1021r1823b1070],
15	RELOAD	NNP	O	RELOAD	nn	16	SENT_412	[p28l141t1096r388b1142],
16	study	NN	O	study	dep	1	SENT_412	[p28l410t1093r561b1157],
17	.	.	O	.	_	0	SENT_412	[p28l410t1093r561b1157],

1	Circulation	NN	O	circulation	_	0	SENT_413	[p28l587t1093r874b1142],
2	2008	CD	DATE	2008	num	1	SENT_413	[p28l893t1097r1032b1149],
3	;	:	O	;	_	0	SENT_413	[p28l893t1097r1032b1149],
4	118	CD	NUMBER	118	num	6	SENT_413	[p28l1055t1097r1153b1142],
5	:	:	O	:	_	0	SENT_413	[p28l1055t1097r1153b1142],
6	1225-33	CD	NUMBER	1225-33	dep	1	SENT_413	[p28l1175t1096r1405b1142],
7	.	.	O	.	_	0	SENT_413	[p28l1175t1096r1405b1142],

1	Steinhubl	NNP	O	Steinhubl	nn	5	SENT_414	[p28l142t1176r399b1225],
2	SR	JJ	O	sr	amod	5	SENT_414	[p28l420t1180r505b1232],
3	,	,	O	,	_	0	SENT_414	[p28l420t1180r505b1232],
4	Berger	NNP	PERSON	Berger	dep	5	SENT_414	[p28l528t1181r703b1241],
5	S	NNP	O	S	_	0	SENT_414	[p28l724t1180r767b1232],
6	,	,	O	,	_	0	SENT_414	[p28l724t1180r767b1232],
7	Mann	NNP	PERSON	Mann	nn	8	SENT_414	[p28l789t1181r945b1226],
8	IT	NNP	O	IT	appos	5	SENT_414	[p28l964t1179r1028b1239],
9	,	,	O	,	_	0	SENT_414	[p28l964t1179r1028b1239],
10	et	FW	O	et	nn	11	SENT_414	[p28l1048t1186r1095b1225],
11	al	FW	O	al	appos	5	SENT_414	[p28l1113t1177r1169b1232],
12	,	,	O	,	_	0	SENT_414	[p28l1113t1177r1169b1232],
13	for	IN	O	for	_	0	SENT_414	[p28l1189t1176r1265b1225],
14	the	DT	O	the	det	16	SENT_414	[p28l1280t1177r1364b1225],
15	CREDO	NNP	O	CREDO	nn	16	SENT_414	[p28l1383t1179r1595b1226],
16	Investigators	NNS	O	investigator	prep_for	5	SENT_414	[p28l1617t1180r1969b1241],
17	.	.	O	.	_	0	SENT_414	[p28l1617t1180r1969b1241],

1	Early	RB	O	early	advmod	3	SENT_415	[p28l141t1249r273b1313],
2	and	CC	O	and	nsubj	3	SENT_415	[p28l290t1249r388b1298],
3	sustained	VBD	O	sustain	_	0	SENT_415	[p28l407t1249r660b1298],
4	dual	JJ	O	dual	amod	7	SENT_415	[p28l677t1249r791b1298],
5	oral	JJ	O	oral	amod	7	SENT_415	[p28l809t1249r908b1298],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_415	[p28l926t1249r1221b1313],
7	therapy	NN	O	therapy	dobj	3	SENT_415	[p28l1237t1249r1437b1313],
8	following	VBG	O	follow	_	0	SENT_415	[p28l1453t1249r1702b1314],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_415	[p28l138t1332r496b1387],
10	coronary	JJ	O	coronary	amod	11	SENT_415	[p28l515t1340r749b1387],
11	intervention	NN	O	intervention	prep_following	7	SENT_415	[p28l764t1326r1103b1372],
12	.	.	O	.	_	0	SENT_415	[p28l764t1326r1103b1372],
13	]	SYM	O	]	dep	3	SENT_415	[p28l1116t1326r1291b1387],

1	AMA	NNP	O	AMA	_	0	SENT_416	[p28l1116t1326r1291b1387],
2	2002	CD	DATE	2002	num	1	SENT_416	[p28l1308t1327r1445b1379],
3	;	:	O	;	_	0	SENT_416	[p28l1308t1327r1445b1379],
4	288	CD	NUMBER	288	num	6	SENT_416	[p28l1467t1327r1573b1372],
5	:	:	O	:	_	0	SENT_416	[p28l1467t1327r1573b1372],
6	2411	CD	DATE	2411	dep	1	SENT_416	[p28l1594t1327r1715b1372],
7	.	.	O	.	_	0	SENT_416	[p28l1594t1327r1715b1372],

1	www	NN	O	www	_	0	SENT_417	[p28l6t1554r500b1601],
2	.	.	O	.	_	0	SENT_417	[p28l6t1554r500b1601],

1	the	DT	O	the	det	2	SENT_418	[p28l6t1554r500b1601],
2	|	NN	O	|	dep	6	SENT_418	[p28l6t1554r500b1601],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_418	[p28l6t1554r500b1601],
4	Vol	NNP	O	Vol	dep	2	SENT_418	[p28l540t1554r621b1601],
5	373	CD	NUMBER	373	dep	6	SENT_418	[p28l639t1560r731b1608],
6	January	NNP	DATE	January	dep	28	SENT_418	[p28l769t1558r971b1614],
7	24	CD	DATE	24	num	6	SENT_418	[p28l987t1560r1066b1609],
8	,	,	DATE	,	_	0	SENT_418	[p28l987t1560r1066b1609],
9	2009	CD	DATE	2009	num	11	SENT_418	[p28l1084t1560r1218b1608],
10	Yusuf	NNP	PERSON	Yusuf	nn	11	SENT_418	[p28l7t1618r137b1658],
11	S	NN	PERSON	s	appos	6	SENT_418	[p28l147t1621r181b1664],
12	,	,	O	,	_	0	SENT_418	[p28l147t1621r181b1664],
13	Zhao	NNP	PERSON	Zhao	nn	14	SENT_418	[p28l199t1618r308b1658],
14	F	NN	O	f	appos	6	SENT_418	[p28l324t1621r360b1664],
15	,	,	O	,	_	0	SENT_418	[p28l324t1621r360b1664],
16	Mehta	NNP	ORGANIZATION	Mehta	nn	17	SENT_418	[p28l377t1618r510b1658],
17	SR	NN	ORGANIZATION	sr	appos	6	SENT_418	[p28l527t1621r595b1664],
18	,	,	O	,	_	0	SENT_418	[p28l527t1621r595b1664],
19	Chrolavicius	NNP	O	Chrolavicius	nn	20	SENT_418	[p28l613t1618r876b1658],
20	S	NNP	O	S	appos	6	SENT_418	[p28l894t1621r929b1664],
21	,	,	O	,	_	0	SENT_418	[p28l894t1621r929b1664],
22	Tognoni	NNP	PERSON	Tognoni	nn	23	SENT_418	[p28l944t1621r1120b1671],
23	G	NNP	PERSON	G	appos	6	SENT_418	[p28l1134t1621r1181b1664],
24	,	,	O	,	_	0	SENT_418	[p28l1134t1621r1181b1664],
25	Fox	NNP	ORGANIZATION	Fox	nn	26	SENT_418	[p28l1199t1621r1271b1658],
26	KK	NNP	ORGANIZATION	KK	appos	6	SENT_418	[p28l1286t1622r1360b1664],
27	;	:	O	;	_	0	SENT_418	[p28l1286t1622r1360b1664],
28	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_418	[p28l9t1678r256b1730],
29	in	IN	O	in	_	0	SENT_418	[p28l270t1680r312b1717],
30	Unstable	NNP	O	Unstable	nn	31	SENT_418	[p28l328t1678r517b1718],
31	Angina	NNP	O	Angina	prep_in	28	SENT_418	[p28l530t1680r687b1730],
32	to	TO	O	to	aux	33	SENT_418	[p28l700t1686r740b1718],
33	Prevent	VB	O	prevent	infmod	31	SENT_418	[p28l756t1682r917b1718],
34	Recurrent	JJ	O	recurrent	amod	35	SENT_418	[p28l932t1682r1143b1718],
35	Events	NNS	O	event	nsubj	37	SENT_418	[p28l1158t1680r1293b1718],
36	Trial	NNP	O	Trial	nn	37	SENT_418	[p28l1308t1678r1402b1718],
37	Investigators	NNS	O	investigator	xcomp	33	SENT_418	[p28l10t1739r292b1789],
38	.	.	O	.	_	0	SENT_418	[p28l10t1739r292b1789],

1	Effects	NNS	O	effect	_	0	SENT_419	[p28l310t1737r449b1776],
2	of	IN	O	of	_	0	SENT_419	[p28l464t1736r512b1776],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_419	[p28l519t1737r754b1789],
4	in	IN	O	in	_	0	SENT_419	[p28l767t1739r810b1776],
5	addition	NN	O	addition	_	0	SENT_419	[p28l824t1737r999b1776],
6	to	TO	O	to	_	0	SENT_419	[p28l1012t1744r1051b1776],
7	aspirin	NN	O	aspirin	prep_in_addition_to	1	SENT_419	[p28l1066t1739r1213b1788],
8	in	IN	O	in	_	0	SENT_419	[p28l1227t1739r1270b1776],
9	patients	NNS	O	patient	prep_in	1	SENT_419	[p28l1283t1739r1450b1788],
10	with	IN	O	with	_	0	SENT_419	[p28l7t1795r101b1835],
11	acute	JJ	O	acute	amod	13	SENT_419	[p28l115t1803r226b1835],
12	coronary	JJ	O	coronary	amod	13	SENT_419	[p28l240t1809r427b1847],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_419	[p28l441t1795r672b1847],
14	without	IN	O	without	_	0	SENT_419	[p28l686t1795r851b1835],
15	ST	JJ	O	st	amod	18	SENT_419	[p28l867t1798r1117b1848],
16	—	NN	O	—	nn	18	SENT_419	[p28l867t1798r1117b1848],
17	segment	NN	O	segment	nn	18	SENT_419	[p28l867t1798r1117b1848],
18	elevation	NN	O	elevation	prep_without	13	SENT_419	[p28l1130t1795r1329b1835],
19	.	.	O	.	_	0	SENT_419	[p28l1130t1795r1329b1835],

1	N	NN	O	n	nn	3	SENT_420	[p28l10t1859r48b1894],
2	Engl	NNP	O	Engl	nn	3	SENT_420	[p28l61t1855r182b1907],
3	]	NNP	O	]	nsubj	4	SENT_420	[p28l61t1855r182b1907],
4	Med	VBD	O	med	_	0	SENT_420	[p28l195t1855r282b1894],
5	2001	CD	DATE	2001	dobj	4	SENT_420	[p28l296t1858r401b1900],
6	;	:	O	;	_	0	SENT_420	[p28l296t1858r401b1900],
7	345	CD	NUMBER	345	num	9	SENT_420	[p28l418t1857r502b1895],
8	:	:	O	:	_	0	SENT_420	[p28l418t1857r502b1895],
9	494-502	CD	NUMBER	494-502	dep	5	SENT_420	[p28l517t1857r700b1895],
10	.	.	O	.	_	0	SENT_420	[p28l517t1857r700b1895],

1	Pearson	NNP	ORGANIZATION	Pearson	nn	2	SENT_421	[p28l10t1926r185b1962],
2	TA	NNP	ORGANIZATION	TA	_	0	SENT_421	[p28l199t1925r273b1968],
3	,	,	O	,	_	0	SENT_421	[p28l199t1925r273b1968],
4	Mensah	NNP	PERSON	Mensah	nn	5	SENT_421	[p28l292t1922r467b1962],
5	GA	NNP	O	GA	appos	2	SENT_421	[p28l484t1925r567b1968],
6	,	,	O	,	_	0	SENT_421	[p28l484t1925r567b1968],
7	Alexander	NNP	PERSON	Alexander	nn	8	SENT_421	[p28l583t1922r808b1962],
8	RW	NNP	PERSON	RW	appos	2	SENT_421	[p28l825t1926r911b1968],
9	,	,	O	,	_	0	SENT_421	[p28l825t1926r911b1968],
10	et	FW	O	et	nn	11	SENT_421	[p28l929t1930r968b1962],
11	al.	FW	O	al.	appos	2	SENT_421	[p28l983t1922r1030b1962],
12	.	.	O	.	_	0	SENT_421	[p28l983t1922r1030b1962],

1	Markers	NNS	O	marker	_	0	SENT_422	[p28l1049t1922r1229b1962],
2	of	IN	O	of	_	0	SENT_422	[p28l1246t1922r1295b1962],
3	inﬂammation	NN	O	inﬂammation	nn	6	SENT_422	[p28l8t1982r313b2022],
4	and	CC	O	and	_	0	SENT_422	[p28l329t1982r410b2022],
5	cardiovascular	JJ	O	cardiovascular	nn	6	SENT_422	[p28l426t1982r743b2022],
6	disease	NN	O	disease	prep_of	1	SENT_422	[p28l758t1982r928b2022],
7	:	:	O	:	_	0	SENT_422	[p28l758t1982r928b2022],
8	application	NN	O	application	dep	1	SENT_422	[p28l947t1982r1191b2034],
9	to	TO	O	to	_	0	SENT_422	[p28l1205t1990r1246b2022],
10	clinical	JJ	O	clinical	prep_to	8	SENT_422	[p28l1263t1982r1420b2022],
11	and	CC	O	and	_	0	SENT_422	[p28l9t2041r90b2080],
12	public	JJ	O	public	amod	14	SENT_422	[p28l104t2041r242b2092],
13	health	NN	O	health	nn	14	SENT_422	[p28l256t2040r394b2080],
14	practice	NN	O	practice	prep_to	8	SENT_422	[p28l409t2043r593b2092],
15	.	.	O	.	_	0	SENT_422	[p28l409t2043r593b2092],

1	A	DT	O	a	det	2	SENT_423	[p28l610t2043r645b2080],
2	statement	NN	O	statement	_	0	SENT_423	[p28l661t2048r880b2080],
3	for	IN	O	for	_	0	SENT_423	[p28l894t2040r957b2080],
4	healthcare	NN	O	healthcare	nn	5	SENT_423	[p28l971t2041r1200b2080],
5	professionals	NNS	O	professional	prep_for	2	SENT_423	[p28l8t2099r300b2151],
6	from	IN	O	from	_	0	SENT_423	[p28l317t2099r426b2139],
7	the	DT	O	the	det	8	SENT_423	[p28l441t2099r509b2139],
8	Centers	NNPS	ORGANIZATION	Centers	prep_from	2	SENT_423	[p28l527t2102r694b2139],
9	for	IN	ORGANIZATION	for	_	0	SENT_423	[p28l711t2099r774b2139],
10	Disease	NNP	ORGANIZATION	Disease	nn	11	SENT_423	[p28l791t2102r958b2139],
11	Control	NNP	ORGANIZATION	Control	prep_for	2	SENT_423	[p28l976t2099r1141b2139],
12	and	CC	ORGANIZATION	and	_	0	SENT_423	[p28l1157t2099r1238b2139],
13	Prevention	NNP	ORGANIZATION	Prevention	conj_and	11	SENT_423	[p28l1255t2102r1495b2139],
14	and	CC	O	and	_	0	SENT_423	[p28l9t2159r90b2199],
15	the	DT	O	the	det	18	SENT_423	[p28l104t2159r173b2199],
16	American	JJ	O	american	amod	18	SENT_423	[p28l188t2162r406b2199],
17	Heart	NNP	ORGANIZATION	Heart	nn	18	SENT_423	[p28l424t2163r549b2199],
18	Association	NNP	ORGANIZATION	Association	prep_for	2	SENT_423	[p28l562t2162r830b2199],
19	.	.	O	.	_	0	SENT_423	[p28l562t2162r830b2199],

1	Circulation	NN	O	circulation	_	0	SENT_424	[p28l852t2159r1087b2199],
2	2003	CD	DATE	2003	num	1	SENT_424	[p28l1104t2162r1218b2205],
3	;	:	O	;	_	0	SENT_424	[p28l1104t2162r1218b2205],
4	107	CD	NUMBER	107	num	6	SENT_424	[p28l9t2220r93b2258],
5	:	:	O	:	_	0	SENT_424	[p28l9t2220r93b2258],
6	499-511	CD	NUMBER	499-511	dep	1	SENT_424	[p28l110t2221r293b2257],
7	.	.	O	.	_	0	SENT_424	[p28l110t2221r293b2257],

1	I-Iamsten	NN	O	i-iamsten	nn	2	SENT_425	[p28l10t2287r211b2323],
2	A	NN	O	a	_	0	SENT_425	[p28l225t2286r270b2329],
3	,	,	O	,	_	0	SENT_425	[p28l225t2286r270b2329],
4	Wiman	NN	PERSON	wiman	nn	5	SENT_425	[p28l286t2286r447b2323],
5	B	NN	PERSON	b	appos	2	SENT_425	[p28l464t2287r504b2329],
6	,	,	O	,	_	0	SENT_425	[p28l464t2287r504b2329],
7	De	NNP	ORGANIZATION	De	nn	9	SENT_425	[p28l523t2287r581b2323],
8	Faire	NNP	ORGANIZATION	Faire	nn	9	SENT_425	[p28l599t2286r703b2323],
9	U	NNP	ORGANIZATION	U	appos	5	SENT_425	[p28l721t2287r768b2329],
10	,	,	O	,	_	0	SENT_425	[p28l721t2287r768b2329],
11	Blomback	NNP	PERSON	Blomback	nn	12	SENT_425	[p28l787t2283r1003b2323],
12	M.	NNP	O	M.	appos	2	SENT_425	[p28l1018t2287r1073b2323],
13	Increased	VBN	O	increase	amod	15	SENT_425	[p28l1092t2283r1302b2323],
14	plasma	NN	O	plasma	nn	15	SENT_425	[p28l1316t2283r1473b2335],
15	levels	NNS	O	level	dep	2	SENT_425	[p28l7t2343r126b2383],
16	of	IN	O	of	_	0	SENT_425	[p28l143t2343r191b2383],
17	a	DT	O	a	det	19	SENT_425	[p28l199t2357r220b2383],
18	rapid	JJ	O	rapid	amod	19	SENT_425	[p28l235t2343r348b2394],
19	inhibitor	NN	O	inhibitor	prep_of	15	SENT_425	[p28l362t2343r555b2383],
20	of	IN	O	of	_	0	SENT_425	[p28l569t2343r618b2383],
21	tissue	NN	O	tissue	nn	24	SENT_425	[p28l624t2345r751b2383],
22	plasminogen	NN	O	plasminogen	nn	24	SENT_425	[p28l766t2343r1051b2395],
23	activator	NN	O	activator	nn	24	SENT_425	[p28l1066t2345r1250b2383],
24	inhibitor	NN	O	inhibitor	prep_of	19	SENT_425	[p28l1264t2343r1456b2383],
25	in	IN	O	in	_	0	SENT_425	[p28l8t2404r51b2441],
26	young	JJ	O	young	amod	27	SENT_425	[p28l65t2416r200b2454],
27	survivors	NNS	O	survivor	prep_in	15	SENT_425	[p28l217t2404r412b2441],
28	of	IN	O	of	_	0	SENT_425	[p28l429t2401r477b2441],
29	myocardial	JJ	O	myocardial	amod	30	SENT_425	[p28l485t2402r725b2454],
30	infarction	NN	O	infarction	prep_of	15	SENT_425	[p28l740t2401r964b2441],
31	.	.	O	.	_	0	SENT_425	[p28l740t2401r964b2441],

1	N	NN	O	n	nn	3	SENT_426	[p28l983t2405r1021b2441],
2	Engl	NNP	O	Engl	nn	3	SENT_426	[p28l1035t2401r1125b2454],
3	]	NNP	O	]	nsubj	4	SENT_426	[p28l1133t2405r1159b2454],
4	Med	VBD	O	med	_	0	SENT_426	[p28l1173t2402r1262b2441],
5	1985	CD	DATE	1985	dobj	4	SENT_426	[p28l1277t2404r1384b2447],
6	;	:	O	;	_	0	SENT_426	[p28l1277t2404r1384b2447],
7	313	CD	NUMBER	313	num	9	SENT_426	[p28l9t2464r92b2500],
8	:	:	O	:	_	0	SENT_426	[p28l9t2464r92b2500],
9	1557-63	CD	NUMBER	1557-63	dep	5	SENT_426	[p28l110t2463r292b2501],
10	.	.	O	.	_	0	SENT_426	[p28l110t2463r292b2501],

1	Bertrand-Thiébault	NN	O	bertrand-thiébault	nn	2	SENT_427	[p28l10t2527r426b2566],
2	C	NN	O	c	_	0	SENT_427	[p28l441t2529r484b2572],
3	,	,	O	,	_	0	SENT_427	[p28l441t2529r484b2572],
4	Berrahmoune	NN	O	berrahmoune	nn	5	SENT_427	[p28l503t2527r805b2566],
5	H	NN	O	h	appos	2	SENT_427	[p28l823t2530r873b2572],
6	,	,	O	,	_	0	SENT_427	[p28l823t2530r873b2572],
7	Thompson	NNP	PERSON	Thompson	nn	8	SENT_427	[p28l890t2527r1129b2578],
8	A	NNP	O	A	appos	2	SENT_427	[p28l1143t2529r1188b2572],
9	,	,	O	,	_	0	SENT_427	[p28l1143t2529r1188b2572],
10	et	FW	O	et	nn	11	SENT_427	[p28l1205t2535r1244b2566],
11	al.	FW	O	al.	appos	2	SENT_427	[p28l1258t2527r1304b2566],
12	.	.	O	.	_	0	SENT_427	[p28l1258t2527r1304b2566],

1	Genetic	JJ	O	genetic	amod	2	SENT_428	[p28l1323t2529r1489b2566],
2	polymorphism	NN	O	polymorphism	_	0	SENT_428	[p28l8t2585r330b2637],
3	of	IN	O	of	_	0	SENT_428	[p28l346t2585r394b2625],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_428	[p28l403t2588r605b2625],
5	gene	NN	O	gene	prep_of	2	SENT_428	[p28l622t2599r723b2638],
6	in	IN	O	in	_	0	SENT_428	[p28l739t2588r782b2625],
7	the	DT	O	the	det	9	SENT_428	[p28l796t2585r864b2625],
8	stanislas	NNS	O	stanisla	nn	9	SENT_428	[p28l881t2585r1064b2625],
9	cohort	NN	O	cohort	prep_in	2	SENT_428	[p28l1081t2585r1230b2625],
10	.	.	O	.	_	0	SENT_428	[p28l1081t2585r1230b2625],

1	A	DT	O	a	det	2	SENT_429	[p28l1246t2588r1281b2625],
2	link	NN	O	link	_	0	SENT_429	[p28l1294t2585r1380b2625],
3	with	IN	O	with	_	0	SENT_429	[p28l1392t2585r1489b2625],
4	inﬂammation	NN	O	inﬂammation	prep_with	2	SENT_429	[p28l8t2645r319b2685],
5	.	.	O	.	_	0	SENT_429	[p28l8t2645r319b2685],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_430	[p28l336t2648r427b2685],
2	Hum	NNP	PERSON	Hum	nn	3	SENT_430	[p28l444t2649r552b2685],
3	Genet	NNP	PERSON	Genet	_	0	SENT_430	[p28l570t2648r686b2685],
4	2008	CD	DATE	2008	num	3	SENT_430	[p28l701t2648r813b2691],
5	;	:	O	;	_	0	SENT_430	[p28l701t2648r813b2691],
6	72	CD	NUMBER	72	num	8	SENT_430	[p28l832t2647r892b2686],
7	:	:	O	:	_	0	SENT_430	[p28l832t2647r892b2686],
8	178-83	CD	NUMBER	178-83	dep	3	SENT_430	[p28l910t2647r1066b2687],
9	.	.	O	.	_	0	SENT_430	[p28l910t2647r1066b2687],

1	Franco	NNP	PERSON	Franco	nn	2	SENT_431	[p28l10t2714r155b2751],
2	E	NNP	PERSON	E	_	0	SENT_431	[p28l173t2714r210b2757],
3	,	,	O	,	_	0	SENT_431	[p28l173t2714r210b2757],
4	Palumbo	NNP	PERSON	Palumbo	nn	5	SENT_431	[p28l229t2711r422b2751],
5	L	NNP	O	L	appos	2	SENT_431	[p28l440t2715r474b2757],
6	,	,	O	,	_	0	SENT_431	[p28l440t2715r474b2757],
7	Crobu	NNP	O	Crobu	nn	8	SENT_431	[p28l493t2711r626b2751],
8	F	NN	O	f	appos	2	SENT_431	[p28l642t2714r679b2757],
9	,	,	O	,	_	0	SENT_431	[p28l642t2714r679b2757],
10	et	FW	O	et	nn	11	SENT_431	[p28l697t2719r735b2751],
11	al.	FW	O	al.	appos	2	SENT_431	[p28l749t2711r795b2751],
12	.	.	O	.	_	0	SENT_431	[p28l749t2711r795b2751],

1	Renin-angiotensin-aldosterone	NN	O	renin-angiotensin-aldosterone	nn	3	SENT_432	[p28l815t2711r1484b2764],
2	system	NN	O	system	nn	3	SENT_432	[p28l9t2778r159b2822],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_432	[p28l173t2770r529b2822],
4	:	:	O	:	_	0	SENT_432	[p28l173t2770r529b2822],
5	a	DT	O	a	det	6	SENT_432	[p28l547t2784r568b2810],
6	role	NN	O	role	dep	3	SENT_432	[p28l583t2770r665b2810],
7	or	CC	O	or	_	0	SENT_432	[p28l681t2784r725b2810],
8	a	DT	O	a	det	9	SENT_432	[p28l740t2784r761b2810],
9	hole	NN	O	hole	dep	3	SENT_432	[p28l775t2770r868b2810],
10	in	IN	O	in	_	0	SENT_432	[p28l883t2773r927b2809],
11	occurrence	NN	O	occurrence	nn	14	SENT_432	[p28l942t2784r1180b2810],
12	and	CC	O	and	_	0	SENT_432	[p28l1196t2770r1276b2810],
13	long-term	JJ	O	long-term	conj_and	11	SENT_432	[p28l7t2830r223b2882],
14	prognosis	NN	O	prognosis	prep_in	9	SENT_432	[p28l238t2832r451b2882],
15	of	IN	O	of	_	0	SENT_432	[p28l468t2830r516b2870],
16	acute	JJ	O	acute	amod	18	SENT_432	[p28l524t2838r637b2870],
17	myocardial	JJ	O	myocardial	amod	18	SENT_432	[p28l652t2830r892b2882],
18	infarction	NN	O	infarction	prep_of	14	SENT_432	[p28l907t2830r1120b2870],
19	at	IN	O	at	_	0	SENT_432	[p28l1135t2838r1173b2870],
20	young	JJ	O	young	amod	21	SENT_432	[p28l1186t2844r1322b2882],
21	age	NN	O	age	prep_at	18	SENT_432	[p28l1337t2844r1420b2882],
22	.	.	O	.	_	0	SENT_432	[p28l1337t2844r1420b2882],

1	BM	NN	O	bm	nn	2	SENT_433	[p28l11t2892r89b2928],
2	C	NN	O	c	nsubj	3	SENT_433	[p28l92t2891r124b2928],
3	Med	VBD	O	med	_	0	SENT_433	[p28l138t2888r227b2928],
4	Genet	NNP	O	Genet	dobj	3	SENT_433	[p28l244t2891r361b2928],
5	2007	CD	DATE	2007	num	4	SENT_433	[p28l375t2891r484b2934],
6	;	:	O	;	_	0	SENT_433	[p28l375t2891r484b2934],
7	8	CD	NUMBER	8	num	9	SENT_433	[p28l502t2892r536b2928],
8	:	:	O	:	_	0	SENT_433	[p28l502t2892r536b2928],
9	27	CD	NUMBER	27	dep	4	SENT_433	[p28l554t2891r601b2930],
10	.	.	O	.	_	0	SENT_433	[p28l554t2891r601b2930],

1	O’Donoghue	NN	O	o’donoghue	nn	2	SENT_434	[p28l9t2956r289b3008],
2	M	NN	O	m	_	0	SENT_434	[p28l306t2960r361b3002],
3	,	,	O	,	_	0	SENT_434	[p28l306t2960r361b3002],
4	Wiviott	NNP	PERSON	Wiviott	nn	5	SENT_434	[p28l377t2959r534b2996],
5	SD	NN	O	sd	appos	2	SENT_434	[p28l551t2959r625b2996],
6	.	.	O	.	_	0	SENT_434	[p28l551t2959r625b2996],

1	Clopidogrel	NNP	O	Clopidogrel	nn	3	SENT_435	[p28l643t2956r896b3008],
2	response	NN	O	response	nn	3	SENT_435	[p28l911t2970r1105b3008],
3	variability	NN	O	variability	nsubj	10	SENT_435	[p28l1119t2956r1335b3008],
4	and	CC	O	and	_	0	SENT_435	[p28l1349t2956r1429b2996],
5	future	JJ	DATE	future	amod	6	SENT_435	[p28l8t3014r141b3054],
6	therapies	NNS	O	therapy	nsubj	10	SENT_435	[p28l156t3015r367b3066],
7	:	:	O	:	_	0	SENT_435	[p28l156t3015r367b3066],
8	clopidogrel	NN	O	clopidogrel	dep	3	SENT_435	[p28l385t3014r637b3067],
9	:	:	O	:	_	0	SENT_435	[p28l385t3014r637b3067],
10	does	VBZ	O	do	_	0	SENT_435	[p28l655t3015r752b3054],
11	one	CD	NUMBER	one	num	13	SENT_435	[p28l768t3029r846b3054],
12	size	NN	O	size	nn	13	SENT_435	[p28l863t3017r944b3054],
13	ﬁt	NN	O	ﬁt	dobj	10	SENT_435	[p28l960t3014r1005b3054],
14	all	DT	O	all	advmod	10	SENT_435	[p28l1020t3015r1088b3054],
15	?	.	O	?	_	0	SENT_435	[p28l1020t3015r1088b3054],

1	Circulation	NN	O	circulation	_	0	SENT_436	[p28l1109t3015r1340b3054],
2	2006	CD	DATE	2006	num	1	SENT_436	[p28l1356t3018r1468b3060],
3	;	:	O	;	_	0	SENT_436	[p28l1356t3018r1468b3060],
4	114	CD	NUMBER	114	dep	1	SENT_436	[p28l9t3077r88b3113],
5	:	:	O	:	_	0	SENT_436	[p28l9t3077r88b3113],
6	e600-06	NN	O	e600-06	dep	4	SENT_436	[p28l105t3077r294b3114],
7	.	.	O	.	_	0	SENT_436	[p28l105t3077r294b3114],

